,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC000155-17,"October 01, 2006 -  September 30, 2007",The Effect of Phytochemicals on Biochemical Mechanisms Relevant to Carcinogenesi,Grace  Yeh; PhD,NULL,"Laboratory of Metabolism, NCI","Christopher J Macdonald



Sara  Bass



Yuk Sing Robert Cheng",NULL,"Terry  Moody; PhD (Experimental Biochemistry Sect)



Laurie  Zipper (National Cancer Institute)



David Anderson Wink (National Cancer Institute)



Miriam Christine Poirier; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45194
1,BC000189-14,"October 01, 2006 -  September 30, 2007",Dietary Regulation of BiochemicalMolecular Changes in Carcinogen Resistant Cells,Grace  Yeh; PhD,NULL,"Laboratory of Metabolism, NCI","Christopher J Macdonald



Sara  Bass



Yuk Sing Robert Cheng","Henry  Ciolino; PhD
(NCI)




Paul  Hergenrother
(Chemistry, University of Illinois)




S.  King
(Chemistry, Wake Forest University)




Edward  Sausville
(Hematology/Oncology, University of Maryland)




Keith  Singletary
(Department of Food Science and Human Nutrition, University of Illinois)",Lucy M Anderson; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45195
2,BC003229-37,"October 01, 2006 -  September 30, 2007",T-Cell Antigen Recognition and Tumor Antigens,"Ettore  Appella; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Ryo  Hayashi



Hidetsugu  Fujigaki","Esteban  Celis





Edward  Collins
(Dept. of Biochemistry and Biophysics, Univ. of North Carolina, Chapel Hill)




Albert  DeLeo
(Cancer Institute, Univ. of Pittsburgh)",Jonathan D Ashwell; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Ito D, Visus C, Hoffmann TK, Balz V, Bier H, Appella E, Whiteside TL, Ferris RL, DeLeo AB (2007). Immunological characterization of missense mutations occurring within cytotoxic T cell-defined p53 epitopes in HLA-A*0201+ squamous cell carcinomas of the head and neck. Int J Cancer  120, 2618-24.   https://doi.org/10.1002/ijc.22584




PubMed


 


PubMed ID 17294448
    
     


 



2.
Sakakura K, Chikamatsu K, Furuya N, Appella E, Whiteside TL, Deleo AB (2007). Toward the development of multi-epitope p53 cancer vaccines: an in vitro assessment of CD8(+) T cell responses to HLA class I-restricted wild-type sequence p53 peptides. Clin Immunol  125, 43-51.   https://doi.org/10.1016/j.clim.2007.05.015




PubMed



        
     
Free Article


 


PubMed ID 17631051
         Pubmed Central ID 2583371",https://intramural.nih.gov/search/searchview.taf?ipid=45196
3,BC004496-30,"October 01, 2006 -  September 30, 2007",Chromosomal Proteins and Chromosomal Functions,"Michael  Bustin; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Takashi  Furusawa



Yuri  Postnikov; MD, PhD



Tetsuya  Ueda



Eyal  Rand



Srujana  Cherukuri



Galina Ivanovna Belova



Show all 8","Marco  Bianchi
(NA, DIBIT)




Melinda K Duncan; PhD
(Biological Sciences, The University of Delaware)




Robert  Hock
(Wuerzburg U)




Leon  Mullenders
(Radiation Genetics, University of Leiden)




Yosef  Shiloh
(Tel Aviv University)




Hitoshi  Shirakawa
(Tohoku U)","Andre A Nussenzweig; PhD (National Cancer Institute)



Kenneth H Kraemer; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Gerlitz G, Livnat I, Ziv C, Yarden O, Bustin M, Reiner O (2007). Migration cues induce chromatin alterations. Traffic  8, 1521-9.   https://doi.org/10.1111/j.1600-0854.2007.00638.x




PubMed


 


PubMed ID 17822403
    
     


 



2.
Hock R, Furusawa T, Ueda T, Bustin M (2007). HMG chromosomal proteins in development and disease. Trends Cell Biol  17, 72-9.   https://doi.org/10.1016/j.tcb.2006.12.001




PubMed



        
     
Free Article


 


PubMed ID 17169561
         Pubmed Central ID 2442274 


 



3.
Postnikov YV, Belova GI, Lim JH, Bustin M (2006). Chromosomal protein HMGN1 modulates the phosphorylation of serine 1 in histone H2A. Biochemistry  45, 15092-9.   https://doi.org/10.1021/bi0613271




PubMed



        
     
Free Article


 


PubMed ID 17154547
         Pubmed Central ID 2440507",https://intramural.nih.gov/search/searchview.taf?ipid=45197
4,BC004504-35,"October 01, 2006 -  September 30, 2007",Alterations in Interacting Signaling Pathways that Initiate Squamous Carcinogene,"Stuart H Yuspa; MD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Christophe  Cataisson



Ulrike F Lichti; PhD



Andrew O Ryscavage



Joanna  Anders



Christina K Cheng



Luowei  Li



Show all 11","Shunsuki  Ishii
(Molecular Genetics, Riken Tsukuba Institute)




Saveria  Pastore
(Dermatology, Instituto Dermapatico del' Immaculata)




Mary Ann Stepp; PhD
(Anatomy and Cell Biology, George Washington University)




Kwang  Suh
(Tumor Bank and Genomics Program, Hackensack University Medical Center)




David  Threadgill; PhD
(Department of Genetics, University of North Carolina School of Medicine)","Paul  Goldsmith; PhD (National Cancer Institute)



Ola Mae Zack Howard (National Cancer Institute)



Joost J Oppenheim; MD (National Cancer Institute)



Rao L Divi (National Cancer Institute)



Triantafyllos  Chavakis (National Cancer Institute)



Larry K Keefer; PhD (National Cancer Institute)",Bijan  Ahvazi; PhD (NIAMS),"Ordered by publication type and then author name.



1.
Pastore S, Mascia F (2008) Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin. Expert Rev Dermatol 3:525-527.




PubMed



        
     
Free Article


 


PubMed ID 19649143
         Pubmed Central ID 2600505 


 



2.
Stepp MA, Liu Y, Pal-Ghosh S, Jurjus RA, Tadvalkar G, Sekaran A, Losicco K, Jiang L, Larsen M, Li L, Yuspa SH (2007). Reduced migration, altered matrix and enhanced TGFbeta1 signaling are signatures of mouse keratinocytes lacking Sdc1. J Cell Sci  120, 2851-63.   https://doi.org/10.1242/jcs.03480




PubMed


 


PubMed ID 17666434
    
     


 



3.
Suh KS, Mutoh M, Mutoh T, Li L, Ryscavage A, Crutchley JM, Dumont RA, Cheng C, Yuspa SH (2007). CLIC4 mediates and is required for Ca2+-induced keratinocyte differentiation. J Cell Sci  120, 2631-40.   https://doi.org/10.1242/jcs.002741




PubMed


 


PubMed ID 17636002",https://intramural.nih.gov/search/searchview.taf?ipid=45198
5,BC004517-31,"October 01, 2006 -  September 30, 2007",DNA Repair in Human Cancer-Prone Genetic Diseases,"Kenneth H Kraemer; MD



IRP Faculty Profile",NULL,"Basic Research Laboratory, NCI","Sikandar  Khan



John  Digiovanna



Kyu-Seon  Oh","Douglas  Brash
(Neurology, Yale Univ)




Steffen  Emmert





Engin  Gozukara
(Biochemistry, Malatya Univ)




Yuko  Hirai
(Genetics, Radiation Effects Research Foundation)




N G  Jaspers
(Genetics, Erasmus Univ)




Allen  Lehmann
(Genome Damage and Stability Centre, Univ of Sussex)


Show all 12","Yun  Wang (Nucleic Acid NMR Section)



Yves  Pommier; PhD (National Cancer Institute)



Carl C Baker; MD, PhD (Laboratory of Cellular Oncology)



Margaret Anne Tucker (National Cancer Institute)



Alisa  Goldstein; PhD (National Cancer Institute)



Thomas J Hornyak (National Cancer Institute)","Raphael  Schiffmann; MD (NINDS) 



Ira W Levin; PhD (NIDDK) 



Nicholas  Patronas; MD (CC) 



Vilhelm A Bohr; MD, PhD (NIA) 



Brian Patrick Brooks; MD, PhD (NEI) 



Philip John Brooks; PhD (NIAAA)","Ordered by publication type and then author name.



1.
Kraemer K   (2007) Genome instability, DNA repair and cancer., in Fitzpatrick’s Dermatology in General Medicine. Wolff K, Katz S, Goldsmith L, Gilchrist B, Leffell D, Paller A, eds.,  Mc-Graw Hill, in press.




 



2.
Kraemer K   (2007) Xeroderma pigmentosum and other repair deficient photodermatoses., in Photodermatology. Lim H, Hoenigsmann H, Hawk J, eds., Informa Healthcare (New York), pp. 239-249.




 



3.
Kraemer K   (2007) Xeroderma pigmentosum., in Neurocutaneous disorders: Phakomatoses. Springer-Verlag (New York), in press.




 



4.
Kraemer K, DiGiovanna J   (2007) Hereditary Diseases of genome instability and DNA repair, in Fitzpatrick’s Dermatology in General Medicine. Wolff K, Katz S, Goldsmith L, Gilchrist B, Leffell D, Paller A, eds.,  Mc-Graw Hill, in press.




 



5.
Kraemer K, Kraemer K (2007) Disorders of DNA repair, in Therapy of Skin Diseases, in press.




 



6.
Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, DiGiovanna JJ (2007). Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience  145, 1388-96.   https://doi.org/10.1016/j.neuroscience.2006.12.020




PubMed



        
     
Free Article


 


PubMed ID 17276014
         Pubmed Central ID 2288663 


 



7.
Kraemer KH, Sander M, Bohr VA (2007). New areas of focus at workshop on human diseases involving DNA repair deficiency and premature aging. Mech Ageing Dev  128, 229-35.   https://doi.org/10.1016/j.mad.2006.11.028




PubMed


 


PubMed ID 17361460
    
     


 



8.
Oh KS, Imoto K, Boyle J, Khan SG, Kraemer KH (2007). Influence of XPB helicase on recruitment and redistribution of nucleotide excision repair proteins at sites of UV-induced DNA damage. DNA Repair (Amst)  6, 1359-70.   https://doi.org/10.1016/j.dnarep.2007.03.025




PubMed



        
     
Free Article


 


PubMed ID 17509950
         Pubmed Central ID 3471374",https://intramural.nih.gov/search/searchview.taf?ipid=45199
6,BC004582-32,"October 01, 2006 -  September 30, 2007",Mechanisms of Transition Metal-Induced Carcinogenesis,Kazimierz Wojcieck Kasprzak,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Robert M Bare



Susan L North



Konstantin V Salnikow



Monika  Kaczmarek",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kaczmarek M, Timofeeva OA, Karaczyn A, Malyguine A, Kasprzak KS, Salnikow K (2007). The role of ascorbate in the modulation of HIF-1alpha protein and HIF-dependent transcription by chromium(VI) and nickel(II). Free Radic Biol Med  42, 1246-57.   https://doi.org/10.1016/j.freeradbiomed.2007.01.026




PubMed



        
     
Free Article


 


PubMed ID 17382205
         Pubmed Central ID 1920179 


 



2.
Romanowska M, Kikawa KD, Fields JR, Maciag A, North SL, Shiao YH, Kasprzak KS, Anderson LM (2007). Effects of selenium supplementation on expression of glutathione peroxidase isoforms in cultured human lung adenocarcinoma cell lines. Lung Cancer  55, 35-42.   https://doi.org/10.1016/j.lungcan.2006.09.007




PubMed


 


PubMed ID 17052796
    
     


 



3.
Romanowska M, Maciag A, Smith AL, Fields JR, Fornwald LW, Kikawa KD, Kasprzak KS, Anderson LM (2007). DNA damage, superoxide, and mutant K-ras in human lung adenocarcinoma cells. Free Radic Biol Med  43, 1145-55.   https://doi.org/10.1016/j.freeradbiomed.2007.07.004




PubMed


 


PubMed ID 17854710",https://intramural.nih.gov/search/searchview.taf?ipid=45200
7,BC005093-29,"October 01, 2006 -  September 30, 2007",GrowthDifferentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI","Sergey  Plisov



Yili D Yang



Honghe  Wang



Nirmala D Sharma



Yutaka  Ueda","Frank  Costantini; PhD
(Columbia University)




Mark  de Caestecker
(Medicine, Vanderbilt University)




Robert  Koesters","Terence P Yamaguchi; PhD (National Cancer Institute)



Mark B Lewandoski (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Tarasova NI, Gaponenko VI, Michejda CI, Perantoni AI, Tarasov SI, Timofeeva OI (submitted in 2007) Peptide-based Stat Inhibitor. Patent issued: 9,540,427 (US in 2017). Patents pending: 15/397,053 (US application); PCT/US2008/065352 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45201
8,BC005148-28,"October 01, 2006 -  September 30, 2007",Mammary Tumorigenesis in Inbred and Feral Mice,Robert  Callahan; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Sharon A Bargo



David M Mccurdy



Ahmed M Raafat



Malgorzata B Klauzinska



Joseph Moon-Hee Lee","Spyros  Artavanis-Tsakonas
(Developmental Biology and Cancer, Harvard Medical School)




Antonio  Marchetti
(Clinical Research Center, University of Chieti)




Robert  Rhoads
(LSU Shreveport)",NULL,NULL,"Ordered by publication type and then author name.



1.
Raafat A, Zoltan-Jones A, Strizzi L, Bargo S, Kimura K, Salomon D, Robert C   (2007) Kit and PDGFR-a activities are necessary for Notch4/Int3 induced tumorigenesis.  Oncogene  662-672 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=45202
9,BC005177-27,"October 01, 2006 -  September 30, 2007",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Marie E Shockley



Paul  Sirajuddin



Rao L Divi



M. Margaret  Pratt","Soterios  Kyrtopoulos
(National Hellenic Research Foundation, Institute of Biological Research and Biotechnology)




Allen  MacLean
(Obstetrics and Gynaecology, Royal Free and University of London Medical School)




David  Manchester
(Clinical Genetics and Metabolism, Children's Hospital, Denver)




Francis  Martin
(Biological Sciences, Lancaster University)




David  Phillips





Bernadette  Schoket
(Fodor Joszef Health Centre, National Institute of Environmental Health)


Show all 9",Sanford Martin Dawsey; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Divi RL, Leonard SL, Walker BL, Kuo MM, Shockley ME, St Claire MC, Nagashima K, Harbaugh SW, Harbaugh JW, Poirier MC (2007). Erythrocebus patas monkey offspring exposed perinatally to NRTIs sustain skeletal muscle mitochondrial compromise at birth and at 1 year of age. Toxicol Sci  99, 203-13.   https://doi.org/10.1093/toxsci/kfm143




PubMed


 


PubMed ID 17545213
    
     


 



2.
Gunter MJ, Divi RL, Kulldorff M, Vermeulen R, Haverkos KJ, Kuo MM, Strickland P, Poirier MC, Rothman N, Sinha R (2007). Leukocyte polycyclic aromatic hydrocarbon-DNA adduct formation and colorectal adenoma. Carcinogenesis  28, 1426-9.   https://doi.org/10.1093/carcin/bgm022




PubMed


 


PubMed ID 17277232
    
     


 



3.
Pratt MM, Sirajuddin P, Poirier MC, Schiffman M, Glass AG, Scott DR, Rush BB, Olivero OA, Castle PE (2007). Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study. Mutat Res  624, 114-23.   https://doi.org/10.1016/j.mrfmmm.2007.04.008




PubMed



        
     
Free Article


 


PubMed ID 17583755
         Pubmed Central ID 4383290 


 



4.
van Gijssel HE, Leil TA, Weinberg WC, Divi RL, Olivero OA, Poirier MC (2007). Cisplatin-DNA damage in p21WAF1/Cip1 deficient mouse keratinocytes exposed to cisplatin. Mutagenesis  22, 49-54.   https://doi.org/10.1093/mutage/gel050




PubMed


 


PubMed ID 17158520",https://intramural.nih.gov/search/searchview.taf?ipid=45203
10,BC005216-36,"October 01, 2006 -  September 30, 2007",cAMP-Dependent Protein Kinase in Human Cancer: Basic Research,"Yoon S Cho-Chung; MD, PhD",NULL,"Basic Research Laboratory, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45204
11,BC005254-26,"October 01, 2006 -  September 30, 2007",Regulation of HTLV-I Transcription,John N Brady; PhD,NULL,"Laboratory of Cellular Oncology, NCI","Meisheng  Zhou



Won-Kyung  Cho



Arindam  Dasgupta



Keven H Huang",NULL,Dinah  Singer; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Cho WK, Zhou M, Jang MK, Huang K, Jeong SJ, Ozato K, Brady JN (2007). Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein. J Virol  81, 11179-86.   https://doi.org/10.1128/JVI.00408-07




PubMed



        
     
Free Article


 


PubMed ID 17686863
         Pubmed Central ID 2045532",https://intramural.nih.gov/search/searchview.taf?ipid=45205
12,BC005258-28,"October 01, 2006 -  September 30, 2007",Molecular Studies of Eukaryotic Gene Regulation,"Bruce  Paterson; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,Yikang  Rong (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45206
13,BC005263-26,"October 01, 2006 -  September 30, 2007",Eukaryotic Chromatin Structure and Gene Regulation,"Carl  Wu; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Joseph W Landry



Manabu  Mizuguchi



Subhojit  Sen



Debbie  Wei



Wei-Hua  Wu



Hua  Xiao; PhD



Show all 10","C. David  Allis
(Chromatin Biology, Rockefeller University)




M.  Smith
(University of Texas)",Yawen  Bai; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Aravind L, Iyer LM, Wu C   (2007) Domain Architectures of the Scm3p Protein Provide Insights into Centromere Function and Evolution.  Cell Cycle, in press (e-pub ahead of print).




 



2.
Luk E, Vu ND, Patteson K, Mizuguchi G, Wu WH, Ranjan A, Backus J, Sen S, Lewis M, Bai Y, Wu C (2007). Chz1, a nuclear chaperone for histone H2AZ. Mol Cell  25, 357-68.   https://doi.org/10.1016/j.molcel.2006.12.015




PubMed


 


PubMed ID 17289584
    
     


 



3.
Mizuguchi G, Xiao H, Wisniewski J, Smith MM, Wu C (2007). Nonhistone Scm3 and histones CenH3-H4 assemble the core of centromere-specific nucleosomes. Cell  129, 1153-64.   https://doi.org/10.1016/j.cell.2007.04.026




PubMed


 


PubMed ID 17574026",https://intramural.nih.gov/search/searchview.taf?ipid=45207
14,BC005268-20,"October 01, 2006 -  September 30, 2007",Mechanism of Meiotic Recombination,"Michael Joseph Lichten; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Robert A Shroff



Anuradha  Sourirajan



Yaron  Dayani



Tamara  Goldfarb","Alastair  Goldman
(Molecular Biology and Biotechnology, University of Sheffield)




Franz  Klein
(Department of Botany, University of Vienna)




Shirleen  Roeder
(Yale University)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45208
15,BC005270-26,"October 01, 2006 -  September 30, 2007",Molecular Mechanism of Action of Phorbol Ester,"Peter  Blumberg; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Noemi  Kedei



Nancy E Lewin



Larry V Pearce



Dazhi  Yang



Vladimir  Pavlyukovets



Jozsef  Lazar



Show all 8","Tamas  Biro
(Physiology, Debrecen Medical School)




Tamas  Biro
(Physiology, Debrecen Medical School)




Chaya  Brodie
(Depart;ment of Neurosurgery, Henry Ford Hospital)




Chaya  Brodie
(Depart;ment of Neurosurgery, Henry Ford Hospital)




Alan  Fields
(Pharmacology, Mayo Clinic)




Marcelo G Kazanietz; PhD
(Pharmacology, University of Pennsylvania)


Show all 18","Joost J Oppenheim; MD (National Cancer Institute)



Victor  Marquez; PhD (National Cancer Institute)



Susan H Garfield (National Cancer Institute)



Stuart H Yuspa; MD (National Cancer Institute)



Paul  Goldsmith; PhD (National Cancer Institute)












Yun  Wang  (Nucleic Acid NMR Section)",NULL,"Ordered by publication type and then author name.



1.
Choi Y, Pu Y, Peach ML, Kang JH, Lewin NE, Sigano DM, Garfield SH, Blumberg PM, Marquez VE (2007). Conformationally constrained analogues of diacylglycerol (DAG). 28. DAG-dioxolanones reveal a new additional interaction site in the C1b domain of PKC delta. J Med Chem  50, 3465-81.   https://doi.org/10.1021/jm0702579




PubMed


 


PubMed ID 17591763
    
     


 



2.
Chung JU, Kim SY, Lim JO, Choi HK, Kang SU, Yoon HS, Ryu H, Kang DW, Lee J, Kang B, Choi S, Toth A, Pearce LV, Pavlyukovets VA, Lundberg DJ, Blumberg PM (2007). Alpha-substituted N-(4-tert-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as potent and stereospecific TRPV1 antagonists. Bioorg Med Chem  15, 6043-53.   https://doi.org/10.1016/j.bmc.2007.06.041




PubMed


 


PubMed ID 17629487
    
     


 



3.
Kang DW, Ryu H, Lee J, Lang KA, Pavlyukovets VA, Pearce LV, Ikeda T, Lazar J, Blumberg PM (2007). Halogenation of 4-hydroxy-3-methoxybenzyl thiourea TRPV1 agonists showed enhanced antagonism to capsaicin. Bioorg Med Chem Lett  17, 214-9.   https://doi.org/10.1016/j.bmcl.2006.09.059




PubMed


 


PubMed ID 17035013
    
     


 



4.
Malolanarasimhan K, Kedei N, Sigano DM, Kelley JA, Lai CC, Lewin NE, Surawski RJ, Pavlyukovets VA, Garfield SH, Wincovitch S, Blumberg PM, Marquez VE (2007). Conformationally constrained analogues of diacylglycerol (DAG). 27. Modulation of membrane translocation of protein kinase C (PKC) isozymes alpha and delta by diacylglycerol lactones (DAG-lactones) containing rigid-rod acyl groups. J Med Chem  50, 962-78.   https://doi.org/10.1021/jm061289j




PubMed


 


PubMed ID 17284021
    
     


 



5.
Tang L, Chen Y, Chen Z, Blumberg PM, Kozikowski AP, Wang ZJ (2007). Antinociceptive pharmacology of N-(4-chlorobenzyl)-N'-(4-hydroxy-3-iodo-5-methoxybenzyl) thiourea, a high-affinity competitive antagonist of the transient receptor potential vanilloid 1 receptor. J Pharmacol Exp Ther  321, 791-8.   https://doi.org/10.1124/jpet.106.117572




PubMed


 


PubMed ID 17312187",https://intramural.nih.gov/search/searchview.taf?ipid=45209
16,BC005271-16,"October 01, 2006 -  September 30, 2007",Gene Regulation and Function: The B-ZIP Proteins,"Charles  Vinson; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",NULL,NULL,"Frank Jess Gonzalez; PhD (National Cancer Institute)



Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"Ordered by publication type and then author name.



1.
Hursting SD, Nunez NP, Varticovski L, Vinson C (2007). The obesity-cancer link: lessons learned from a fatless mouse. Cancer Res  67, 2391-3.   https://doi.org/10.1158/0008-5472.CAN-06-4237




PubMed


 


PubMed ID 17363554
    
     


 



2.
Oh WJ, Rishi V, Orosz A, Gerdes MJ, Vinson C (2007). Inhibition of CCAAT/enhancer binding protein family DNA binding in mouse epidermis prevents and regresses papillomas. Cancer Res  67, 1867-76.   https://doi.org/10.1158/0008-5472.CAN-06-2746




PubMed


 


PubMed ID 17308129
    
     


 



3.
Oh WJ, Rishi V, Pelech S, Vinson C (2007). Histological and proteomic analysis of reversible H-RasV12G expression in transgenic mouse skin. Carcinogenesis  28, 2244-52.   https://doi.org/10.1093/carcin/bgm127




PubMed


 


PubMed ID 17551062",https://intramural.nih.gov/search/searchview.taf?ipid=45210
17,BC005317-24,"October 01, 2006 -  September 30, 2007",Role of Selenium in Cancer and Health,"Dolph Lee Hatfield; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Bradley A Carlson



Rajeev K Shrimali



Min-Hyuk  Yoo



Aniruddha  Sengupta



Xueming  Xu","Marla  Berry
(Molecular Biology, U of Hawaii)




Vadim  Gladyshev
(Department of Biochemistry, University of Nebraska)




Ulrich  Schweizer
(Neuroscience Research Center and, Charit-Universittsmedizin Berlin)","Cindy D Davis (National Cancer Institute)



Jeffrey E Green; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dikiy A, Novoselov SV, Fomenko DE, Sengupta A, Carlson BA, Cerny RL, Ginalski K, Grishin NV, Hatfield DL, Gladyshev VN (2007). SelT, SelW, SelH, and Rdx12: genomics and molecular insights into the functions of selenoproteins of a novel thioredoxin-like family. Biochemistry  46, 6871-82.   https://doi.org/10.1021/bi602462q




PubMed


 


PubMed ID 17503775
    
     


 



2.
Hatfield D (2007) Thioredoxin reductase 1: A double-edged sword in cancer prevention and promotion. CCR Frontiers in Science 1-3.




 



3.
Hatfield D, Xu X, Shrimali R, Sengupta A, Yoo M, Gladyshev V (2007) Mouse models for elucidating the role of selenium and selenoproteins in health. Selenium in Health and Disease. Proceedings of the International Symposium on Selenium in Health and Disease, in press.




 



4.
Labunskyy VM, Hatfield DL, Gladyshev VN (2007). The Sep15 protein family: roles in disulfide bond formation and quality control in the endoplasmic reticulum. IUBMB Life  59, 1-5.   https://doi.org/10.1080/15216540601126694




PubMed


 


PubMed ID 17365173
    
     


 



5.
Novoselov SV, Kryukov GV, Xu XM, Carlson BA, Hatfield DL, Gladyshev VN (2007). Selenoprotein H is a nucleolar thioredoxin-like protein with a unique expression pattern. J Biol Chem  282, 11960-8.   https://doi.org/10.1074/jbc.M701605200




PubMed


 


PubMed ID 17337453
    
     


 



6.
Novoselov SV, Lobanov AV, Hua D, Kasaikina MV, Hatfield DL, Gladyshev VN (2007). A highly efficient form of the selenocysteine insertion sequence element in protozoan parasites and its use in mammalian cells. Proc Natl Acad Sci U S A  104, 7857-62.   https://doi.org/10.1073/pnas.0610683104




PubMed



        
     
Free Article


 


PubMed ID 17470795
         Pubmed Central ID 1876537 


 



7.
Sheridan PA, Zhong N, Carlson BA, Perella CM, Hatfield DL, Beck MA (2007). Decreased selenoprotein expression alters the immune response during influenza virus infection in mice. J Nutr  137, 1466-71.   https://doi.org/10.1093/jn/137.6.1466




PubMed


 


PubMed ID 17513408
    
     


 



8.
Shrimali RK, Weaver JA, Miller GF, Starost MF, Carlson BA, Novoselov SV, Kumaraswamy E, Gladyshev VN, Hatfield DL (2007). Selenoprotein expression is essential in endothelial cell development and cardiac muscle function. Neuromuscul Disord  17, 135-42.   https://doi.org/10.1016/j.nmd.2006.10.006




PubMed



        
     
Free Article


 


PubMed ID 17142041
         Pubmed Central ID 1894657 


 



9.
Yoo MH, Xu XM, Turanov AA, Carlson BA, Gladyshev VN, Hatfield DL (2007). A new strategy for assessing selenoprotein function: siRNA knockdown/knock-in targeting the 3'-UTR. RNA  13, 921-9.   https://doi.org/10.1261/rna.533007




PubMed



        
     
Free Article


 


PubMed ID 17468436
         Pubmed Central ID 1869036",https://intramural.nih.gov/search/searchview.taf?ipid=45211
18,BC005352-25,"October 01, 2006 -  September 30, 2007",Mechanisms in Perinatal Carcinogenesis,Lucy M Anderson; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Laura  Fornwald



Yih-horng  Shiao



Janet R Fields



Sorin  Lupascu","Gregory  Alvord
(Data Management Services)




Adele  Schmidt
(CSIRO Plant Industry)",NULL,"Gregory  Travlos; DVM, PhD (NIEHS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45213
19,BC005367-24,"October 01, 2006 -  September 30, 2007",The Genetic Structure of Natural Populations Past and Present,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Shujin  Luo



Warren  Johnson



Mary A Thompson



Michael E Weedon



Bailey D Kessing



Nicole J Crumpler



Show all 13","Eduardo  Eizirik
(Biosciences Department, Pontifcia Universidade Catlica do Rio Grande do Sul)




William J. Murphy
(NCI-FCRDC, NCI)","Beena  Neelam (National Cancer Institute)



Robert H Stephens (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Driscoll CA, Menotti-Raymond M, Roca AL, Hupe K, Johnson WE, Geffen E, Harley EH, Delibes M, Pontier D, Kitchener AC, Yamaguchi N, O'brien SJ, Macdonald DW (2007). The Near Eastern origin of cat domestication. Science  317, 519-23.   https://doi.org/10.1126/science.1139518




PubMed



        
     
Free Article


 


PubMed ID 17600185
         Pubmed Central ID 5612713 


 



2.
Luo SJ, Johnson WE, David VA, Menotti-Raymond M, Stanyon R, Cai QX, Beck T, Yuhki N, Pecon-Slattery J, Smith JL, O'Brien SJ (2007). Development of Y chromosome intraspecific polymorphic markers in the Felidae. J Hered  98, 400-13.   https://doi.org/10.1093/jhered/esm063




PubMed


 


PubMed ID 17646273
    
     


 



3.
Miller-Butterworth CM, Murphy WJ, O'Brien SJ, Jacobs DS, Springer MS, Teeling EC (2007). A family matter: conclusive resolution of the taxonomic position of the long-fingered bats, miniopterus. Mol Biol Evol  24, 1553-61.   https://doi.org/10.1093/molbev/msm076




PubMed


 


PubMed ID 17449895
    
     


 



4.
O'Brien S, Brown M, Shindle D, Hayes K, Terrell S, Johnson W, Land E, Roelke M, O'Brien S (2007) Epizootiology of Feline Leukemia Virus in the Florida Panther. J. Wildlife Disease, in press.




 



5.
O'Brien S, David V, Pflueger S, Johnson W   (2007) Patterns of molecular genetic variation among cat breeds.  Genomics, in press.




 



6.
O'Brien S, Mullikin J, Smith D, Agencourt Sequencing Team, Lindblad-Toh K, Gnerre S, Clamp M, Chang J, Stephens R, Neelam B, Volfovsky N, Schaffer A, Agarwala R, Narfstrom K, Murphy W, Giger U, Roca A, Antunes A, Menotti-Raymond M, Yuhki N, Pecon-Slattery J, Johnson W, Bourque G, Tesler G   (2007) The domestic cat genome sequence: annotation and comparative inferences.  Genome Research, in press.




 



7.
Wilting A, Buckley-Beason VA, Feldhaar H, Gadau J, O'Brien SJ, Linsenmair KE (2007). Clouded leopard phylogeny revisited: support for species recognition and population division between Borneo and Sumatra. Front Zool  4, 15.   https://doi.org/10.1186/1742-9994-4-15




PubMed



        
     
Free Article


 


PubMed ID 17535420
         Pubmed Central ID 1904214",https://intramural.nih.gov/search/searchview.taf?ipid=45214
20,BC005385-24,"October 01, 2006 -  September 30, 2007","The Development of the Domestic Cat, IFelis catusI, as an Animal Model for Genet",Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Victor A David



Warren  Johnson



Carlos Antonio Driscoll; PhD



Alfred L Roca



Bailey D Kessing



Marilyn  Raymond; PhD



Show all 9","Greg  Barsh
(Howard Hughes Medical Institute, Stanford University School of Medicine)




Eduardo  Eizirik
(Biosciences Department, Pontifcia Universidade Catlica do Rio Grande do Sul)




Steven  Hannah
(Nestle Purina PetCare Co.)




Mikko  Koskinen
(Finnzymes)




Rajendra  Kumar-Singh
(Dept. of Ophthalmology, Tufts University School of Medicine)




Kristina  Narfstrom; DVM
(Veterinary Medicine, University of Missouri)


Show all 8","Beena  Neelam (National Cancer Institute)



Robert H Stephens (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
O'Brien S, David V   (2007) STR based forensic analysis of felid samples from domestic and exotic cats., in Non-Human DNA Typing: Theory and Casework Applications. Taylor and Francis Group, LLC (Boca Raton, FL), in press.




 



2.
O'Brien S, O'Brien S (2007) The domestic cat, Felis catus, as a model of hereditary and infectious disease, in Sourcebook of Models for Biomedical Research. Humana Press, Inc. (Totowa, NJ), in press.




 



3.
Coomber N, David VA, O'Brien SJ, Menotti-Raymond M (2007). Validation of a short tandem repeat multiplex typing system for genetic individualization of domestic cat samples. Croat Med J  48, 547-55.




PubMed



        
     
Free Article


 


PubMed ID 17696310
         Pubmed Central ID 2080565 


 



4.
Driscoll CA, Menotti-Raymond M, Roca AL, Hupe K, Johnson WE, Geffen E, Harley EH, Delibes M, Pontier D, Kitchener AC, Yamaguchi N, O'brien SJ, Macdonald DW (2007). The Near Eastern origin of cat domestication. Science  317, 519-23.   https://doi.org/10.1126/science.1139518




PubMed



        
     
Free Article


 


PubMed ID 17600185
         Pubmed Central ID 5612713 


 



5.
Luo SJ, Johnson WE, David VA, Menotti-Raymond M, Stanyon R, Cai QX, Beck T, Yuhki N, Pecon-Slattery J, Smith JL, O'Brien SJ (2007). Development of Y chromosome intraspecific polymorphic markers in the Felidae. J Hered  98, 400-13.   https://doi.org/10.1093/jhered/esm063




PubMed


 


PubMed ID 17646273
    
     


 



6.
Murphy WJ, Davis B, David VA, Agarwala R, Schäffer AA, Pearks Wilkerson AJ, Neelam B, O'Brien SJ, Menotti-Raymond M (2007). A 1.5-Mb-resolution radiation hybrid map of the cat genome and comparative analysis with the canine and human genomes. Genomics  89, 189-96.   https://doi.org/10.1016/j.ygeno.2006.08.007




PubMed



        
     
Free Article


 


PubMed ID 16997530
         Pubmed Central ID 3760348 


 



7.
O'Brien S, David V, Pflueger S, Johnson W   (2007) Patterns of molecular genetic variation among cat breeds.  Genomics, in press.




 



8.
O'Brien S, David V, Schaffer A, Eizirik E, Ryugo D, Hannah S, Menotti-Raymond M   (2007) Four separate mutations in the feline fibroblast growth factor 5 gene are responsible for long hair in the domestic cat.  Journal of Heredity, in press.




 



9.
O'Brien S, Mullikin J, Smith D, Agencourt Sequencing Team, Lindblad-Toh K, Gnerre S, Clamp M, Chang J, Stephens R, Neelam B, Volfovsky N, Schaffer A, Agarwala R, Narfstrom K, Murphy W, Giger U, Roca A, Antunes A, Menotti-Raymond M, Yuhki N, Pecon-Slattery J, Johnson W, Bourque G, Tesler G   (2007) The domestic cat genome sequence: annotation and comparative inferences.  Genome Research, in press.




 



10.
Troyer JL, Brown MA (2011) Feline models of viral pathogenesis: opportunity knocks. Vet J 188:252-3




PubMed



        
     
Free Article


 


PubMed ID 20716490
         Pubmed Central ID 2988874",https://intramural.nih.gov/search/searchview.taf?ipid=45215
21,BC005389-24,"October 01, 2006 -  September 30, 2007",Reproductive Strategies in Animal Species Emphasizing Developmental Biology,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",James  Kehler,"William J. Murphy
(NCI-FCRDC, NCI)




Kristina  Narfstrom; DVM
(Veterinary Medicine, University of Missouri)




David  Ryogo
(Center for Hearing Sciences, Johns Hopkins University)",NULL,NULL,"Ordered by publication type and then author name.



1.
O'Brien S, David V, Schaffer A, Eizirik E, Ryugo D, Hannah S, Menotti-Raymond M   (2007) Four separate mutations in the feline fibroblast growth factor 5 gene are responsible for long hair in the domestic cat.  Journal of Heredity, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45216
22,BC005399-24,"October 01, 2006 -  September 30, 2007",Mechanistic Targeting of Lung Cancer,Lucy M Anderson; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Richard J Calvert



Laura  Fornwald



Janet R Fields



Gunamani  Sithanandam



Keith D Kikawa



Razi  Raziuddin",NULL,"Kazimierz S Kasprzak; PhD, DSc (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Romanowska M, Kikawa KD, Fields JR, Maciag A, North SL, Shiao YH, Kasprzak KS, Anderson LM (2007). Effects of selenium supplementation on expression of glutathione peroxidase isoforms in cultured human lung adenocarcinoma cell lines. Lung Cancer  55, 35-42.   https://doi.org/10.1016/j.lungcan.2006.09.007




PubMed


 


PubMed ID 17052796
    
     


 



2.
Sithanandam G, Fornwald LW, Fields JR, Morris NL, Anderson LM (2012). Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts. Int J Cancer  130, 251-8.   https://doi.org/10.1002/ijc.26041




PubMed



        
     
Free Article


 


PubMed ID 21387307
         Pubmed Central ID 3220928",https://intramural.nih.gov/search/searchview.taf?ipid=45217
23,BC005445-23,"October 01, 2006 -  September 30, 2007",Analysis of Pathways that Suppress or Accelerate Premalignant Progression and Ma,"Stuart H Yuspa; MD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Christophe  Cataisson



Ulrike F Lichti; PhD



Andrew O Ryscavage



Joanna  Anders



Christina K Cheng



Luowei  Li



Show all 11","Jeffrey  Arbeit
(Surgery, Washington University)




Nadine  Darwich
(Biochemistry, American University in Beruit)




Adam  Glick; PhD
(NCI)




Peter  Watson
(Pathology, University of Manitoba)","Peter  Blumberg; PhD (National Cancer Institute)



Akira  Oshima (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)



Joseph  Riss; PhD (National Cancer Institute)



Victor  Marquez; PhD (National Cancer Institute)",Jiliang  Gao (NIAID),"Ordered by publication type and then author name.



1.
Darwiche N, Ryscavage A, Perez-Lorenzo R, Wright L, Bae DS, Hennings H, Yuspa SH, Glick AB (2007). Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion. Oncogene  26, 6885-95.   https://doi.org/10.1038/sj.onc.1210491




PubMed


 


PubMed ID 17525749
    
     


 



2.
Suh KS, Malik M, Shukla A, Yuspa SH (2007). CLIC4, skin homeostasis and cutaneous cancer: surprising connections. Mol Carcinog  46, 599-604.   https://doi.org/10.1002/mc.20324




PubMed


 


PubMed ID 17443730",https://intramural.nih.gov/search/searchview.taf?ipid=45218
24,BC005450-24,"October 01, 2006 -  September 30, 2007",Chromatin Structure and Gene Expression,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Sam  John



Tom  Johnson



Anindya P Hendarwanto



Anuja  George



Kip  Nalley","Donald  DeFranco; PhD

(Department of Pharmacology)




Philippe  Georgel
(NCI)




Anthony  Imbalzano
(Department of Cell Biology, University of Massachusetts Medical School)




Donald  McDonnell
(Pharmacology and Cancer Biology, Duke University Medical Center)




Bhavin  Parekh
(Lilly Corporate Center, Eli Lilly)




Ken  Pearce
(Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)


Show all 10","Paul S Meltzer; MD, PhD (National Cancer Institute)



Sean Richard Davis; MD, PhD (National Cancer Institute)",S Stoney  Simons; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Klokk TI, Kurys P, Elbi C, Nagaich AK, Hendarwanto A, Slagsvold T, Chang CY, Hager GL, Saatcioglu F (2007). Ligand-specific dynamics of the androgen receptor at its response element in living cells. Mol Cell Biol  27, 1823-43.   https://doi.org/10.1128/MCB.01297-06




PubMed



        
     
Free Article


 


PubMed ID 17189428
         Pubmed Central ID 1820481 


 



2.
Sung MH, Bagain L, Chen Z, Karpova T, Yang X, Silvin C, Voss TC, McNally JG, Van Waes C, Hager GL (2008). Dynamic effect of bortezomib on nuclear factor-kappaB activity and gene expression in tumor cells. Mol Pharmacol  74, 1215-22.   https://doi.org/10.1124/mol.108.049114




PubMed



        
     
Free Article


 


PubMed ID 18684839
         Pubmed Central ID 2715175",https://intramural.nih.gov/search/searchview.taf?ipid=45219
25,BC005453-23,"October 01, 2006 -  September 30, 2007",Cellular and Molecular Biology of the Hepatic Stem Cell Compartment,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Timothy V Benjamin



Elizabeth A Conner



Anita  Ton



Tanya N Hoang



Jeonghoon  Heo



Joe W Grisham","Hanne  Bisgaard
(Medical Biochemistry and Genetics, University of Copenhagen)




Nelson  Fausto
(Pathology, University of Washington School of Medicine)




Stefan  Karlsson; MD, PhD
(University of Lund)




Ju-Seog  Lee; PhD
(NCI)




Peter  Nagy
(Pathology, Sammelweiss University)




Aranzazu  Sanchez-munoz
(Biochemsitry and Molecular Biology, Complutense University of Madrid)",Valentina  Factor (Cellular and Molecular Biology Section),NULL,"Ordered by publication type and then author name.



1.
Kaji K, Factor VM, Andersen JB, Durkin ME, Tomokuni A, Marquardt JU, Matter MS, Hoang T, Conner EA, Thorgeirsson SS (2016) DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration. Hepatology 64:582-98




PubMed



        
     
Free Article


 


PubMed ID 26999257
         Pubmed Central ID 5841553 


 



2.
Thorgeirsson SS (2017). Stemness in Liver Cancer. Dig Dis  35, 387-389.   https://doi.org/10.1159/000456592




PubMed



        
     
Free Article


 


PubMed ID 28467999
         Pubmed Central ID 5841535",https://intramural.nih.gov/search/searchview.taf?ipid=45220
26,BC005480-22,"October 01, 2006 -  September 30, 2007",Molecular Epidemiology and Molecular Carcinogenesis of Human Cancer,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Elise Dawn Bowman



Mohammed A. Khan; PhD



Mary G Mcmenamin



Leah E Mechanic



Elisa A Spillare



Glennwood E Trivers



Show all 15","Carlo M Croce





V  Rotter
(Dept. of Cell Biology, The Weizman Institute of Science)




Jun  Yokota
(National Cancer Center Research Institute)","Neil Edward Caporaso; MS, MD (National Cancer Institute)



Karl Thomas Ried; MD (National Cancer Institute)



Michael  Alavanja; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
George J, Saito M, Tsuta K, Iwakawa R, Shiraishi K, Scheel AH, Uchida S, Watanabe SI, Nishikawa R, Noguchi M, Peifer M, Jang SJ, Petersen I, Büttner R, Harris CC, Yokota J, Thomas RK, Kohno T (2017). Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer. Clin Cancer Res  23, 1220-1226.   https://doi.org/10.1158/1078-0432.CCR-16-1069




PubMed



        
     
Free Article


 


PubMed ID 27620277
         Pubmed Central ID 6329376 


 



2.
Greathouse KL, Harris CC, Bultman SJ (2015). Dysfunctional families: Clostridium scindens and secondary bile acids inhibit the growth of Clostridium difficile. Cell Metab  21, 9-10.   https://doi.org/10.1016/j.cmet.2014.12.016




PubMed



        
     
Free Article


 


PubMed ID 25565200
         Pubmed Central ID 6333312 


 



3.
Hussain SP, Schwank J, Staib F, Wang XW, Harris CC (2007). TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene  26, 2166-76.   https://doi.org/10.1038/sj.onc.1210279




PubMed


 


PubMed ID 17401425
    
     


 



4.
Mechanic LE, Bowman ED, Welsh JA, Khan MA, Hagiwara N, Enewold L, Shields PG, Burdette L, Chanock S, Harris CC (2007). Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors. Cancer Epidemiol Biomarkers Prev  16, 214-22.   https://doi.org/10.1158/1055-9965.EPI-06-0790




PubMed


 


PubMed ID 17301252
    
     


 



5.
Mehrian-Shai R, Reichardt JKV, Harris CC, Toren A (2019). The Gut-Brain Axis, Paving the Way to Brain Cancer. Trends Cancer  5, 200-207.   https://doi.org/10.1016/j.trecan.2019.02.008




PubMed



        
     
Free Article


 


PubMed ID 30961828
         Pubmed Central ID 6734924 


 



6.
Pine SR, Mechanic LE, Enewold L, Bowman ED, Ryan BM, Cote ML, Wenzlaff AS, Loffredo CA, Olivo-Marston S, Chaturvedi A, Caporaso NE, Schwartz AG, Harris CC (2016). Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans. Cancer Epidemiol Biomarkers Prev  25, 488-97.   https://doi.org/10.1158/1055-9965.EPI-15-0378




PubMed



        
     
Free Article


 


PubMed ID 26711330
         Pubmed Central ID 4779723 


 



7.
Robles AI, Harris CC (2017). Lung Cancer Field Cancerization: Implications for Screening by Low-Dose Computed Tomography. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djw328




PubMed



        
     
Free Article


 


PubMed ID 28376183
         Pubmed Central ID 6059243 


 



8.
Robles AI, Traverso G, Zhang M, Roberts NJ, Khan MA, Joseph C, Lauwers GY, Selaru FM, Popoli M, Pittman ME, Ke X, Hruban RH, Meltzer SJ, Kinzler KW, Vogelstein B, Harris CC, Papadopoulos N (2016). Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. Gastroenterology  150, 931-43.   https://doi.org/10.1053/j.gastro.2015.12.036




PubMed



        
     
Free Article


 


PubMed ID 26764183
         Pubmed Central ID 5270616 


 



9.
Saito M, Shiraishi K, Matsumoto K, Schetter AJ, Ogata-Kawata H, Tsuchiya N, Kunitoh H, Nokihara H, Watanabe S, Tsuta K, Kumamoto K, Takenoshita S, Yokota J, Harris CC, Kohno T (2014). A three-microRNA signature predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinoma. Clin Cancer Res  20, 4784-93.   https://doi.org/10.1158/1078-0432.CCR-14-1096




PubMed



        
     
Free Article


 


PubMed ID 25142144
         Pubmed Central ID 6329384 


 



10.
Sander M, Slaga TJ, Trump BF, Harris CC (2008). The twenty-second Aspen Cancer Conference: Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention, and Cancer Therapy, 2007. Mol Carcinog  47, 554-71.   https://doi.org/10.1002/mc.20408




PubMed



        
     
Free Article


 


PubMed ID 18092321
         Pubmed Central ID 2642617 


 



11.
Sander M, Trump BF, Harris CC, Tennant RW (2008). The 20th Aspen Cancer Conference: Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention, and Cancer Therapy 2005. Mol Carcinog  47, 707-32.   https://doi.org/10.1002/mc.20214




PubMed



        
     
Free Article


 


PubMed ID 18286481
         Pubmed Central ID 2610844 


 



12.
Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC (2008). MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA  299, 425-36.   https://doi.org/10.1001/jama.299.4.425




PubMed



        
     
Free Article


 


PubMed ID 18230780
         Pubmed Central ID 2614237 


 



13.
Seike M, Yanaihara N, Bowman ED, Zanetti KA, Budhu A, Kumamoto K, Mechanic LE, Matsumoto S, Yokota J, Shibata T, Sugimura H, Gemma A, Kudoh S, Wang XW, Harris CC (2007). Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. J Natl Cancer Inst  99, 1257-69.   https://doi.org/10.1093/jnci/djm083




PubMed


 


PubMed ID 17686824
    
     


 



14.
Shepshelovich D, Xu W, Lu L, Fares A, Yang P, Christiani D, Zhang J, Shiraishi K, Ryan BM, Chen C, Schwartz AG, Tardon A, Wu X, Schabath MB, Teare MD, Le Marchand L, Zhang ZF, Field JK, Brenner H, Diao N, Xie J, Kohno T, Harris CC, Wenzlaff AS, Fernandez-Tardon G, et al. [12 more authors] (2019). Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium. J Thorac Oncol  14, 1594-1607.   https://doi.org/10.1016/j.jtho.2019.05.031




PubMed



               Available in future as a Free Article 


 


PubMed ID 31163278
         Pubmed Central ID 6734935 


 



15.
Ui A, Ogiwara H, Nakajima S, Kanno S, Watanabe R, Harata M, Okayama H, Harris CC, Yokota J, Yasui A, Kohno T (2014). Possible involvement of LKB1-AMPK signaling in non-homologous end joining. Oncogene  33, 1640-8.   https://doi.org/10.1038/onc.2013.125




PubMed



        
     
Free Article


 


PubMed ID 23584481
         Pubmed Central ID 6508539 


 



16.
Vargas AJ, Harris CC (2016). Biomarker development in the precision medicine era: lung cancer as a case study. Nat Rev Cancer  16, 525-37.   https://doi.org/10.1038/nrc.2016.56




PubMed



        
     
Free Article


 


PubMed ID 27388699
         Pubmed Central ID 6662593 


 



17.
Xi S, Inchauste S, Guo H, Shan J, Xiao Z, Xu H, Miettenen M, Zhang MR, Hong JA, Raiji MT, Altorki NK, Casson AG, Beer DG, Robles AI, Bowman ED, Harris CC, Steinberg SM, Schrump DS (2015). Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis. Oncogene  34, 5548-59.   https://doi.org/10.1038/onc.2015.10




PubMed



        
     
Free Article


 


PubMed ID 25703328
         Pubmed Central ID 6301032",https://intramural.nih.gov/search/searchview.taf?ipid=45221
27,BC005488-22,"October 01, 2006 -  September 30, 2007",Mechanisms of Inorganic Carcinogenesis,Michael  Waalkes; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Jie  Liu; MD, PhD



Wei  Qu; PhD



Robert A Goyer



Jean-Francois L Coppin



Erik James Tokar; PhD



Chikara  Kojima



Show all 8","Min-Liang  Cheng
(Guiyang Medical College)




Curt  Klaassen
(Toxicology, University of Kansas)




Jingbo  Pi
(Pharmacology, CIIT)




Walt  Prozialeck
(Midwestern University)




Ellen  Silbergeld
(Environmental Health Sciences, Johns Hopkins)




Mukta  Webber
(Biology, Michigan State)",Alan O Perantoni; PhD (National Cancer Institute),"Raymond W. Tennant; PhD (NIEHS) 



Colin F Chignell; PhD (NIEHS) 



Jau Shyong  Hong; PhD (NIEHS)","Ordered by publication type and then author name.



1.
Benbrahim-Tallaa L, Liu J, Webber MM, Waalkes MP (2007). Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells. Prostate  67, 135-45.   https://doi.org/10.1002/pros.20479




PubMed


 


PubMed ID 17075824
    
     


 



2.
Benbrahim-Tallaa L, Webber MM, Waalkes MP (2007). Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells. Environ Health Perspect  115, 243-7.   https://doi.org/10.1289/ehp.9630




PubMed



        
     
Free Article


 


PubMed ID 17384772
         Pubmed Central ID 1817693 


 



3.
Liu J, Xie Y, Cooper R, Ducharme DM, Tennant R, Diwan BA, Waalkes MP (2007). Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism. Toxicol Appl Pharmacol  220, 284-91.   https://doi.org/10.1016/j.taap.2007.01.018




PubMed



        
     
Free Article


 


PubMed ID 17350061
         Pubmed Central ID 2680420 


 



4.
Pi J, Bai Y, Reece JM, Williams J, Liu D, Freeman ML, Fahl WE, Shugar D, Liu J, Qu W, Collins S, Waalkes MP (2007). Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic Biol Med  42, 1797-806.   https://doi.org/10.1016/j.freeradbiomed.2007.03.001




PubMed



        
     
Free Article


 


PubMed ID 17512459
         Pubmed Central ID 1950666 


 



5.
Shen J, Liu J, Xie Y, Diwan BA, Waalkes MP (2007). Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure. Toxicol Sci  95, 313-20.   https://doi.org/10.1093/toxsci/kfl151




PubMed



        
     
Free Article


 


PubMed ID 17077188
         Pubmed Central ID 2692318 


 



6.
Waalkes M, Cheng M, Yang Q, Shan K, Shen J, Zhou Y, Zhang X, Dill A   (2007) Blood metallothionein transcript as a biomarker for metal sensitivity: low blood metallothionein transcripts in arsenicosis patients from Guizhou, China.  Environ Health Perspect, in press.




 



7.
Waalkes M, Ke H, Pi J, Broderick D, French J, Webber M   (2007) Acquisition of apoptotic resistance in cadmium-transformed human prostate epithelial cells: Bcl-2 overexpression blocks the activation of JNK signal transduction pathway.  Environ Health Perspect, in press.




 



8.
Waalkes MP, Liu J, Diwan BA (2007). Transplacental arsenic carcinogenesis in mice. Toxicol Appl Pharmacol  222, 271-80.   https://doi.org/10.1016/j.taap.2006.12.034




PubMed



        
     
Free Article


 


PubMed ID 17306315
         Pubmed Central ID 1995036 


 



9.
Xie Y, Liu J, Benbrahim-Tallaa L, Ward JM, Logsdon D, Diwan BA, Waalkes MP (2007). Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology  236, 7-15.   https://doi.org/10.1016/j.tox.2007.03.021




PubMed



        
     
Free Article


 


PubMed ID 17451858
         Pubmed Central ID 2465467",https://intramural.nih.gov/search/searchview.taf?ipid=45222
28,BC005522-20,"October 01, 2006 -  September 30, 2007",Role of Thyroid-Specific Enhancer-Binding Protein in Development and Homeostasis,"Shioko  Kimura; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Yoshihito  Sasaki



Takashi  Ozaki",NULL,"Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hoshi N, Kusakabe T, Taylor BJ, Kimura S (2007). Side population cells in the mouse thyroid exhibit stem/progenitor cell-like characteristics. Endocrinology  148, 4251-8.   https://doi.org/10.1210/en.2006-0490




PubMed



        
     
Free Article


 


PubMed ID 17584961
         Pubmed Central ID 2582754 


 



2.
Yeager N, Klein-Szanto A, Kimura S, Di Cristofano A (2007). Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis. Cancer Res  67, 959-66.   https://doi.org/10.1158/0008-5472.CAN-06-3524




PubMed


 


PubMed ID 17283127
    
     


 



3.
Zhang Y, Rath N, Hannenhalli S, Wang Z, Cappola T, Kimura S, Atochina-Vasserman E, Lu MM, Beers MF, Morrisey EE (2007). GATA and Nkx factors synergistically regulate tissue-specific gene expression and development in vivo. Development  134, 189-98.   https://doi.org/10.1242/dev.02720




PubMed


 


PubMed ID 17164424",https://intramural.nih.gov/search/searchview.taf?ipid=45223
29,BC005536-21,"October 01, 2006 -  September 30, 2007",Basic and Applied Studies in Development of an AIDS Vaccine,"Marjorie  Robert-Guroff; PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Janet M Dipasquale



Mary K Aldrich



Ruth  Florese



Thorsten  Demberg



Rachmat  Hidajat



Mara E Daltabuit-test



Show all 9","Susan  Barnett
(Chiron Corporation)




Barbara  Ensoli
(Istituto Superiore di Sanita)




Donald  Forthal
(School of Medicine, Univ of CA)




Nancy  Haigwood
(Department of Microbiology, SBRI and the University of Washington)




Marta  Marthas
(California National Primate Research Center, University of California, Davis)




David C Montefiori; PhD
(Department of Surgery, NIAID)


Show all 8","Barbara K Felber (National Cancer Institute)



George N Pavlakis; MD, PhD (National Cancer Institute)



Genoveffa  Franchini; MD (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)",George J Grimes (CC),"Ordered by publication type and then author name.



1.
Robert-Guroff M, Shiver J   (2007) Replication-defective and competent adenovirus recombinants as vaccine vectors., in New Generation Vaccines, 4th Edition. Levine M, ed., Informa Healthcare (New York), in press.




 



2.
Demberg T, Florese RH, Heath MJ, Larsen K, Kalisz I, Kalyanaraman VS, Lee EM, Pal R, Venzon D, Grant R, Patterson LJ, Korioth-Schmitz B, Buzby A, Dombagoda D, Montefiori DC, Letvin NL, Cafaro A, Ensoli B, Robert-Guroff M (2007). A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J Virol  81, 3414-27.   https://doi.org/10.1128/JVI.02453-06




PubMed



        
     
Free Article


 


PubMed ID 17229693
         Pubmed Central ID 1866031 


 



3.
Demberg T, Mohanram V, Musich T, Brocca-Cofano E, McKinnon KM, Venzon D, Robert-Guroff M (2015). Loss of marginal zone B-cells in SHIVSF162P4 challenged rhesus macaques despite control of viremia to low or undetectable levels in chronic infection. Virology  484, 323-33.   https://doi.org/10.1016/j.virol.2015.06.022




PubMed



        
     
Free Article


 


PubMed ID 26151223
         Pubmed Central ID 4567457 


 



4.
Demberg T, Robert-Guroff M (2009). Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. Int Rev Immunol  28, 20-48.   https://doi.org/10.1080/08830180802684331




PubMed



        
     
Free Article


 


PubMed ID 19241252
         Pubmed Central ID 3466469 


 



5.
Florese RH, Demberg T, Xiao P, Kuller L, Larsen K, Summers LE, Venzon D, Cafaro A, Ensoli B, Robert-Guroff M (2009). Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. J Immunol  182, 3718-27.   https://doi.org/10.4049/jimmunol.0803115




PubMed



        
     
Free Article


 


PubMed ID 19265150
         Pubmed Central ID 2744397 


 



6.
Florese RH, Wiseman RW, Venzon D, Karl JA, Demberg T, Larsen K, Flanary L, Kalyanaraman VS, Pal R, Titti F, Patterson LJ, Heath MJ, O'Connor DH, Cafaro A, Ensoli B, Robert-Guroff M (2008). Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection. Vaccine  26, 3312-21.   https://doi.org/10.1016/j.vaccine.2008.03.100




PubMed



        
     
Free Article


 


PubMed ID 18486283
         Pubmed Central ID 2577850 


 



7.
Mohanram V, Demberg T, Musich T, Tuero I, Vargas-Inchaustegui DA, Miller-Novak L, Venzon D, Robert-Guroff M (2016). B Cell Responses Associated with Vaccine-Induced Delayed SIVmac251 Acquisition in Female Rhesus Macaques. J Immunol  197, 2316-24.   https://doi.org/10.4049/jimmunol.1600544




PubMed



        
     
Free Article


 


PubMed ID 27534560
         Pubmed Central ID 5010965 


 



8.
Musich T, Demberg T, Morgan IL, Estes JD, Franchini G, Robert-Guroff M (2015). Purification and functional characterization of mucosal IgA from vaccinated and SIV-infected rhesus macaques. Clin Immunol  158, 127-39.   https://doi.org/10.1016/j.clim.2015.03.020




PubMed



        
     
Free Article


 


PubMed ID 25840105
         Pubmed Central ID 4464970 


 



9.
Musich T, Rahman MA, Mohanram V, Miller-Novak L, Demberg T, Venzon DJ, Felber BK, Franchini G, Pavlakis GN, Robert-Guroff M (2018). Neutrophil Vaccination Dynamics and Their Capacity To Mediate B Cell Help in Rhesus Macaques. J Immunol  201, 2287-2302.   https://doi.org/10.4049/jimmunol.1800677




PubMed



        
     
Free Article


 


PubMed ID 30217830
         Pubmed Central ID 6179953 


 



10.
Musich T, Robert-Guroff M (2016). New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design. Expert Rev Vaccines  15, 1015-27.   https://doi.org/10.1586/14760584.2016.1158108




PubMed



        
     
Free Article


 


PubMed ID 26910195
         Pubmed Central ID 6290472 


 



11.
Patterson LJ, Robert-Guroff M (2008). Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development. Expert Opin Biol Ther  8, 1347-63.   https://doi.org/10.1517/14712598.8.9.1347




PubMed



        
     
Free Article


 


PubMed ID 18694354
         Pubmed Central ID 2538611 


 



12.
Rahman MA, McKinnon KM, Karpova TS, Ball DA, Venzon DJ, Fan W, Kang G, Li Q, Robert-Guroff M (2018). Associations of Simian Immunodeficiency Virus (SIV)-Specific Follicular CD8+ T Cells with Other Follicular T Cells Suggest Complex Contributions to SIV Viremia Control. J Immunol  200, 2714-2726.   https://doi.org/10.4049/jimmunol.1701403




PubMed



        
     
Free Article


 


PubMed ID 29507105
         Pubmed Central ID 5893362 


 



13.
Robert-Guroff M   (2007) Non-neutralizing antibodies and vaccine-induced protection against HIV.  Future HIV Therapy  259-71 pp.




 



14.
Robert-Guroff M, Cafaro A, Ferrantelli F, Tripiciano A, Moretti S, Caputo A, Gavioli R, Ensoli F, Barnett S, Ensoli B   (2007) Problems and emerging approaches in HIV/AIDS vaccine development.  Expert Opinion on Emerging Drugs  23-48 pp.




 



15.
Robert-Guroff M, Hidajat R, Peng B, Venzon D, Aldrich M, Richardson E, Lee E, Kalyanaraman V, Grimes G, Gomez-Roman V, Summers L, Malkevich N   (2007) Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIVmac251.  Vaccine, in press.




 



16.
Tuero I, Venzon D, Robert-Guroff M (2016). Mucosal and Systemic γδ+ T Cells Associated with Control of Simian Immunodeficiency Virus Infection. J Immunol  197, 4686-4695.   https://doi.org/10.4049/jimmunol.1600579




PubMed



        
     
Free Article


 


PubMed ID 27815422
         Pubmed Central ID 5136305 


 



17.
Vargas-Inchaustegui DA, Robert-Guroff M (2013). Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention. Curr HIV Res  11, 407-20.   https://doi.org/10.2174/1570162x113116660063




PubMed



        
     
Free Article


 


PubMed ID 24191937
         Pubmed Central ID 6288814",https://intramural.nih.gov/search/searchview.taf?ipid=45224
30,BC005548-20,"October 01, 2006 -  September 30, 2007",Biological Functions of the Oncogenes Encoding Rho-Specific Exchange Factors,Toru  Miki; PhD,NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45225
31,BC005561-20,"October 01, 2006 -  September 30, 2007",Liver-Enriched Transcription Factors,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",Sung-Hoon  Ahn,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Aibara D, Matsusue K, Takiguchi S, Gonzalez FJ, Yamano S (2018). Fat-specific protein 27 is a novel target gene of liver X receptor α. Mol Cell Endocrinol  474, 48-56.   https://doi.org/10.1016/j.mce.2018.02.006




PubMed



        
     
Free Article


 


PubMed ID 29454584
         Pubmed Central ID 6594021 


 



2.
Battistelli C, Sabarese G, Santangelo L, Montaldo C, Gonzalez FJ, Tripodi M, Cicchini C (2019). The lncRNA HOTAIR transcription is controlled by HNF4α-induced chromatin topology modulation. Cell Death Differ  26, 890-901.   https://doi.org/10.1038/s41418-018-0170-z




PubMed



               Available in future as a Free Article 


 


PubMed ID 30154449
         Pubmed Central ID 6461983 


 



3.
Chen Y, Wang Y, Huang Y, Zeng H, Hu B, Guan L, Zhang H, Yu AM, Johnson CH, Gonzalez FJ, Huang M, Bi H (2017). PPARα regulates tumor cell proliferation and senescence via a novel target gene carnitine palmitoyltransferase 1C. Carcinogenesis  38, 474-483.   https://doi.org/10.1093/carcin/bgx023




PubMed



        
     
Free Article


 


PubMed ID 28334197
         Pubmed Central ID 6248526 


 



4.
Cicchini C, de Nonno V, Battistelli C, Cozzolino AM, De Santis Puzzonia M, Ciafrè SA, Brocker C, Gonzalez FJ, Amicone L, Tripodi M (2015). Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29. Biochim Biophys Acta  1849, 919-29.   https://doi.org/10.1016/j.bbagrm.2015.05.005




PubMed



        
     
Free Article


 


PubMed ID 26003733
         Pubmed Central ID 6319628 


 



5.
Climaco-Arvizu S, Domínguez-Acosta O, Cabañas-Cortés MA, Rodríguez-Sosa M, Gonzalez FJ, Vega L, Elizondo G (2016). Aryl hydrocarbon receptor influences nitric oxide and arginine production and alters M1/M2 macrophage polarization. Life Sci  155, 76-84.   https://doi.org/10.1016/j.lfs.2016.05.001




PubMed



        
     
Free Article


 


PubMed ID 27153778
         Pubmed Central ID 6300993 


 



6.
Dai M, Hua H, Lin H, Xu G, Hu X, Li F, Gonzalez FJ, Liu A, Yang J (2018). Targeted Metabolomics Reveals a Protective Role for Basal PPARα in Cholestasis Induced by α-Naphthylisothiocyanate. J Proteome Res  17, 1500-1508.   https://doi.org/10.1021/acs.jproteome.7b00838




PubMed



        
     
Free Article


 


PubMed ID 29498526
         Pubmed Central ID 6628934 


 



7.
Dongol B, Shah Y, Kim I, Gonzalez FJ, Hunt MC (2007). The acyl-CoA thioesterase I is regulated by PPARalpha and HNF4alpha via a distal response element in the promoter. J Lipid Res  48, 1781-91.   https://doi.org/10.1194/jlr.M700119-JLR200




PubMed


 


PubMed ID 17485727
    
     


 



8.
Elentner A, Ortner D, Clausen B, Gonzalez FJ, Fernández-Salguero PM, Schmuth M, Dubrac S (2015). Skin response to a carcinogen involves the xenobiotic receptor pregnane X receptor. Exp Dermatol  24, 835-40.   https://doi.org/10.1111/exd.12766




PubMed



        
     
Free Article


 


PubMed ID 26013842
         Pubmed Central ID 6334296 


 



9.
Fang ZZ, Tanaka N, Lu D, Jiang CT, Zhang WH, Zhang C, Du Z, Fu ZW, Gao P, Cao YF, Sun HZ, Zhu ZT, Cai Y, Krausz KW, Yao Z, Gonzalez FJ (2017). Role of the lipid-regulated NF-κB/IL-6/STAT3 axis in alpha-naphthyl isothiocyanate-induced liver injury. Arch Toxicol  91, 2235-2244.   https://doi.org/10.1007/s00204-016-1877-6




PubMed



        
     
Free Article


 


PubMed ID 27853831
         Pubmed Central ID 6331015 


 



10.
González-Barbosa E, Mejía-García A, Bautista E, Gonzalez FJ, Segovia J, Elizondo G (2017). TCDD induces UbcH7 expression and synphilin-1 protein degradation in the mouse ventral midbrain. J Biochem Mol Toxicol  31.   https://doi.org/10.1002/jbt.21947




PubMed



        
     
Free Article


 


PubMed ID 28621812
         Pubmed Central ID 6309283 


 



11.
Gonzalez FJ, Jiang C (2017). A Western diet-induced mouse model reveals a possible mechanism by which metformin decreases obesity. Eur J Clin Pharmacol  73, 1337-1339.   https://doi.org/10.1007/s00228-017-2322-3




PubMed



        
     
Free Article


 


PubMed ID 28831566
         Pubmed Central ID 5693664 


 



12.
Gonzalez FJ, Jiang C, Bisson WH, Patterson AD (2015). Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity. J Hepatol  62, 1234-6.   https://doi.org/10.1016/j.jhep.2015.02.043




PubMed



        
     
Free Article


 


PubMed ID 25747705
         Pubmed Central ID 6346267 


 



13.
Gonzalez FJ, Jiang C, Xie C, Patterson AD (2017). Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease. Dig Dis  35, 178-184.   https://doi.org/10.1159/000450908




PubMed



        
     
Free Article


 


PubMed ID 28249275
         Pubmed Central ID 6595218 


 



14.
Gonzalez FJ, Moschetta A (2014). Potential role of the vitamin D receptor in control of cholesterol levels. Gastroenterology  146, 899-902.   https://doi.org/10.1053/j.gastro.2014.02.022




PubMed



        
     
Free Article


 


PubMed ID 24566107
         Pubmed Central ID 6350777 


 



15.
Gu X, Song Y, Chai Y, Lu F, Gonzalez FJ, Fan G, Qi Y (2015). GC-MS metabolomics on PPARα-dependent exacerbation of colitis. Mol Biosyst  11, 1329-37.   https://doi.org/10.1039/c5mb00048c




PubMed



        
     
Free Article


 


PubMed ID 25790429
         Pubmed Central ID 6334306 


 



16.
Harada M, Kamijo Y, Nakajima T, Hashimoto K, Yamada Y, Shimojo H, Gonzalez FJ, Aoyama T (2016). Peroxisome proliferator-activated receptor α-dependent renoprotection of murine kidney by irbesartan. Clin Sci (Lond)  130, 1969-1981.   https://doi.org/10.1042/CS20160343




PubMed



        
     
Free Article


 


PubMed ID 27496805
         Pubmed Central ID 6331013 


 



17.
Harada Y, Tanaka N, Ichikawa M, Kamijo Y, Sugiyama E, Gonzalez FJ, Aoyama T (2016). PPARα-dependent cholesterol/testosterone disruption in Leydig cells mediates 2,4-dichlorophenoxyacetic acid-induced testicular toxicity in mice. Arch Toxicol  90, 3061-3071.   https://doi.org/10.1007/s00204-016-1669-z




PubMed



        
     
Free Article


 


PubMed ID 26838045
         Pubmed Central ID 6334304 


 



18.
Hu X, Tanaka N, Guo R, Lu Y, Nakajima T, Gonzalez FJ, Aoyama T (2017). PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis. J Nutr Biochem  39, 77-85.   https://doi.org/10.1016/j.jnutbio.2016.09.015




PubMed



        
     
Free Article


 


PubMed ID 27816763
         Pubmed Central ID 6331014 


 



19.
Hua H, Yang J, Lin H, Xi Y, Dai M, Xu G, Wang F, Liu L, Zhao T, Huang J, Gonzalez FJ, Liu A (2018). PPARα-independent action against metabolic syndrome development by fibrates is mediated by inhibition of STAT3 signalling. J Pharm Pharmacol  70, 1630-1642.   https://doi.org/10.1111/jphp.13014




PubMed



        
     
Free Article


 


PubMed ID 30251457
         Pubmed Central ID 6281295 


 



20.
Idris-Khodja N, Ouerd S, Trindade M, Gornitsky J, Rehman A, Barhoumi T, Offermanns S, Gonzalez FJ, Neves MF, Paradis P, Schiffrin EL (2017). Vascular smooth muscle cell peroxisome proliferator-activated receptor γ protects against endothelin-1-induced oxidative stress and inflammation. J Hypertens  35, 1390-1401.   https://doi.org/10.1097/HJH.0000000000001324




PubMed



        
     
Free Article


 


PubMed ID 28234672
         Pubmed Central ID 6338076 


 



21.
Kim JH, Qu A, Reddy JK, Gao B, Gonzalez FJ (2014). Hepatic oxidative stress activates the Gadd45b gene by way of degradation of the transcriptional repressor STAT3. Hepatology  59, 695-704.   https://doi.org/10.1002/hep.26683




PubMed



        
     
Free Article


 


PubMed ID 23939942
         Pubmed Central ID 3880633 


 



22.
Kim JH, Wahyudi LD, Kim KK, Gonzalez FJ (2016). PPARα activation drives demethylation of the CpG islands of the Gadd45b promoter in the mouse liver. Biochem Biophys Res Commun  476, 293-298.   https://doi.org/10.1016/j.bbrc.2016.05.115




PubMed



        
     
Free Article


 


PubMed ID 27233605
         Pubmed Central ID 6300979 


 



23.
Komatsu M, Kimura T, Yazaki M, Tanaka N, Yang Y, Nakajima T, Horiuchi A, Fang ZZ, Joshita S, Matsumoto A, Umemura T, Tanaka E, Gonzalez FJ, Ikeda S, Aoyama T (2015). Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα. Biochim Biophys Acta  1852, 473-81.   https://doi.org/10.1016/j.bbadis.2014.12.011




PubMed



        
     
Free Article


 


PubMed ID 25533124
         Pubmed Central ID 6371055 


 



24.
Li F, Jiang C, Krausz KW, Li Y, Albert I, Hao H, Fabre KM, Mitchell JB, Patterson AD, Gonzalez FJ (2013). Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun  4, 2384.   https://doi.org/10.1038/ncomms3384




PubMed



        
     
Free Article


 


PubMed ID 24064762
         Pubmed Central ID 6595219 


 



25.
Li G, Brocker CN, Xie C, Yan T, Noguchi A, Krausz KW, Xiang R, Gonzalez FJ (2018). Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643. J Gastroenterol Hepatol  33, 1138-1145.   https://doi.org/10.1111/jgh.14046




PubMed



        
     
Free Article


 


PubMed ID 29141109
         Pubmed Central ID 6334298 


 



26.
Liu A, Krausz KW, Fang ZZ, Brocker C, Qu A, Gonzalez FJ (2014). Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARα and its relevance to hepatotoxicity. Arch Toxicol  88, 983-96.   https://doi.org/10.1007/s00204-013-1188-0




PubMed



        
     
Free Article


 


PubMed ID 24385052
         Pubmed Central ID 6398607 


 



27.
Liu A, Tanaka N, Sun L, Guo B, Kim JH, Krausz KW, Fang Z, Jiang C, Yang J, Gonzalez FJ (2014). Saikosaponin d protects against acetaminophen-induced hepatotoxicity by inhibiting NF-κB and STAT3 signaling. Chem Biol Interact  223, 80-6.   https://doi.org/10.1016/j.cbi.2014.09.012




PubMed



        
     
Free Article


 


PubMed ID 25265579
         Pubmed Central ID 4376644 


 



28.
Luo M, Tan Z, Dai M, Song D, Lin J, Xie M, Yang J, Sun L, Wei D, Zhao J, Gonzalez FJ, Liu A (2017). Dual action of peroxisome proliferator-activated receptor alpha in perfluorodecanoic acid-induced hepatotoxicity. Arch Toxicol  91, 897-907.   https://doi.org/10.1007/s00204-016-1779-7




PubMed



        
     
Free Article


 


PubMed ID 27344344
         Pubmed Central ID 6350782 


 



29.
Manna SK, Thompson MD, Gonzalez FJ (2015). Application of mass spectrometry-based metabolomics in identification of early noninvasive biomarkers of alcohol-induced liver disease using mouse model. Adv Exp Med Biol  815, 217-38.   https://doi.org/10.1007/978-3-319-09614-8_13




PubMed



        
     
Free Article


 


PubMed ID 25427910
         Pubmed Central ID 6335647 


 



30.
Matsubara T, Tanaka N, Krausz KW, Manna SK, Kang DW, Anderson ER, Luecke H, Patterson AD, Shah YM, Gonzalez FJ (2012). Metabolomics identifies an inflammatory cascade involved in dioxin- and diet-induced steatohepatitis. Cell Metab  16, 634-44.   https://doi.org/10.1016/j.cmet.2012.10.006




PubMed



        
     
Free Article


 


PubMed ID 23140643
         Pubmed Central ID 3496181 


 



31.
Matsusue K, Aibara D, Hayafuchi R, Matsuo K, Takiguchi S, Gonzalez FJ, Yamano S (2014). Hepatic PPARγ and LXRα independently regulate lipid accumulation in the livers of genetically obese mice. FEBS Lett  588, 2277-81.   https://doi.org/10.1016/j.febslet.2014.05.012




PubMed



        
     
Free Article


 


PubMed ID 24857376
         Pubmed Central ID 6301023 


 



32.
Mejia-Garcia A, Sanchez-Ocampo EM, Galindo-Gomez S, Shibayama M, Reyes-Hernandez O, Guzman-Leon S, Gonzalez FJ, Elizondo G (2013). 2,3,7,8-Tetrachlorodibenzo-p-dioxin enhances CCl4-induced hepatotoxicity in an aryl hydrocarbon receptor-dependent manner. Xenobiotica  43, 161-8.   https://doi.org/10.3109/00498254.2012.707790




PubMed



        
     
Free Article


 


PubMed ID 22834477
         Pubmed Central ID 6319626 


 



33.
Nakagawa K, Tanaka N, Morita M, Sugioka A, Miyagawa S, Gonzalez FJ, Aoyama T (2012). PPARα is down-regulated following liver transplantation in mice. J Hepatol  56, 586-94.   https://doi.org/10.1016/j.jhep.2011.08.021




PubMed



        
     
Free Article


 


PubMed ID 22037025
         Pubmed Central ID 6399745 


 



34.
Nakagawa T, Ramdhan DH, Tanaka N, Naito H, Tamada H, Ito Y, Li Y, Hayashi Y, Yamagishi N, Yanagiba Y, Aoyama T, Gonzalez FJ, Nakajima T (2012). Modulation of ammonium perfluorooctanoate-induced hepatic damage by genetically different PPARα in mice. Arch Toxicol  86, 63-74.   https://doi.org/10.1007/s00204-011-0704-3




PubMed



        
     
Free Article


 


PubMed ID 21499893
         Pubmed Central ID 6594146 


 



35.
Nakashima R, Hayashi Y, Md K, Jia X, Wang D, Naito H, Ito Y, Kamijima M, Gonzalez FJ, Nakajima T (2013). Exposure to DEHP decreased four fatty acid levels in plasma of prepartum mice. Toxicology  309, 52-60.   https://doi.org/10.1016/j.tox.2013.04.010




PubMed



        
     
Free Article


 


PubMed ID 23619606
         Pubmed Central ID 6413867 


 



36.
Patterson AD, Carlson BA, Li F, Bonzo JA, Yoo MH, Krausz KW, Conrad M, Chen C, Gonzalez FJ, Hatfield DL (2013). Disruption of thioredoxin reductase 1 protects mice from acute acetaminophen-induced hepatotoxicity through enhanced NRF2 activity. Chem Res Toxicol  26, 1088-96.   https://doi.org/10.1021/tx4001013




PubMed



        
     
Free Article


 


PubMed ID 23697945
         Pubmed Central ID 6334300 


 



37.
Pillai R, Paglialunga S, Hoang M, Cousteils K, Prentice KJ, Bombardier E, Huang M, Gonzalez FJ, Tupling AR, Wheeler MB, Joseph JW (2015). Deletion of ARNT/HIF1β in pancreatic beta cells does not impair glucose homeostasis in mice, but is associated with defective glucose sensing ex vivo. Diabetologia  58, 2832-42.   https://doi.org/10.1007/s00125-015-3768-4




PubMed



        
     
Free Article


 


PubMed ID 26409461
         Pubmed Central ID 6338330 


 



38.
Sato S, Shirakawa H, Tomita S, Tohkin M, Gonzalez FJ, Komai M (2013). The aryl hydrocarbon receptor and glucocorticoid receptor interact to activate human metallothionein 2A. Toxicol Appl Pharmacol  273, 90-9.   https://doi.org/10.1016/j.taap.2013.08.017




PubMed



        
     
Free Article


 


PubMed ID 23994556
         Pubmed Central ID 6301017 


 



39.
Shah YM, Ito S, Morimura K, Chen C, Yim SH, Haase VH, Gonzalez FJ (2008). Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology  134, 2036-48, 2048.e1-3.   https://doi.org/10.1053/j.gastro.2008.03.009




PubMed



        
     
Free Article


 


PubMed ID 18439915
         Pubmed Central ID 2533811 


 



40.
Song CY, Ghafoor K, Ghafoor HU, Khan NS, Thirunavukkarasu S, Jennings BL, Estes AM, Zaidi S, Bridges D, Tso P, Gonzalez FJ, Malik KU (2016). Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice. Hypertension  67, 206-13.   https://doi.org/10.1161/HYPERTENSIONAHA.115.06427




PubMed



        
     
Free Article


 


PubMed ID 26573711
         Pubmed Central ID 4672747 


 



41.
Song D, Luo M, Dai M, Bu S, Wang W, Zhang B, Gonzalez FJ, Liu A (2017). PPARα-dependent increase of mouse urine output by gemfibrozil and fenofibrate. Can J Physiol Pharmacol  95, 199-205.   https://doi.org/10.1139/cjpp-2016-0140




PubMed



        
     
Free Article


 


PubMed ID 27918198
         Pubmed Central ID 6334299 


 



42.
Sumi K, Tanaka T, Uchida A, Magoori K, Urashima Y, Ohashi R, Ohguchi H, Okamura M, Kudo H, Daigo K, Maejima T, Kojima N, Sakakibara I, Jiang S, Hasegawa G, Kim I, Osborne TF, Naito M, Gonzalez FJ, Hamakubo T, Kodama T, Sakai J (2007). Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8. Mol Cell Biol  27, 4248-60.   https://doi.org/10.1128/MCB.01894-06




PubMed



        
     
Free Article


 


PubMed ID 17403900
         Pubmed Central ID 1900057 


 



43.
Tan Z, Luo M, Yang J, Cheng Y, Huang J, Lu C, Song D, Ye M, Dai M, Gonzalez FJ, Liu A, Guo B (2016). Chlorogenic acid inhibits cholestatic liver injury induced by α-naphthylisothiocyanate: involvement of STAT3 and NFκB signalling regulation. J Pharm Pharmacol  68, 1203-13.   https://doi.org/10.1111/jphp.12592




PubMed



        
     
Free Article


 


PubMed ID 27367057
         Pubmed Central ID 6300992 


 



44.
Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ (2012). Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology  56, 118-29.   https://doi.org/10.1002/hep.25630




PubMed



        
     
Free Article


 


PubMed ID 22290395
         Pubmed Central ID 6371056 


 



45.
Tanaka N, Takahashi S, Hu X, Lu Y, Fujimori N, Golla S, Fang ZZ, Aoyama T, Krausz KW, Gonzalez FJ (2017). Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet. Biochim Biophys Acta Mol Basis Dis  1863, 3170-3182.   https://doi.org/10.1016/j.bbadis.2017.08.017




PubMed



        
     
Free Article


 


PubMed ID 28844958
         Pubmed Central ID 5675002 


 



46.
Thakur A, Wong JCH, Wang EY, Lotto J, Kim D, Cheng JC, Mingay M, Cullum R, Moudgil V, Ahmed N, Tsai SH, Wei W, Walsh CP, Stephan T, Bilenky M, Fuglerud BM, Karimi MM, Gonzalez FJ, Hirst M, Hoodless PA (2019). Hepatocyte Nuclear Factor 4-Alpha Is Essential for the Active Epigenetic State at Enhancers in Mouse Liver. Hepatology  70, 1360-1376.   https://doi.org/10.1002/hep.30631




PubMed



               Available in future as a Free Article 


 


PubMed ID 30933372
         Pubmed Central ID 6773525 


 



47.
Tian Y, Yang Y, Zhang X, Nakajima T, Tanaka N, Sugiyama E, Kamijo Y, Lu Y, Moriya K, Koike K, Gonzalez FJ, Aoyama T (2016). Age-dependent PPARα activation induces hepatic sulfatide accumulation in transgenic mice carrying the hepatitis C virus core gene. Glycoconj J  33, 927-936.   https://doi.org/10.1007/s10719-016-9703-1




PubMed



        
     
Free Article


 


PubMed ID 27318478
         Pubmed Central ID 6309323 


 



48.
Wang BL, Zhang CW, Wang L, Tang KL, Tanaka N, Gonzalez FJ, Xu Y, Fang ZZ (2019). Lipidomics reveal aryl hydrocarbon receptor (Ahr)-regulated lipid metabolic pathway in alpha-naphthyl isothiocyanate (ANIT)-induced intrahepatic cholestasis. Xenobiotica  49, 591-601.   https://doi.org/10.1080/00498254.2018.1467065




PubMed



        
     
Free Article


 


PubMed ID 29737914
         Pubmed Central ID 6643298 


 



49.
Xie C, Yagai T, Luo Y, Liang X, Chen T, Wang Q, Sun D, Zhao J, Ramakrishnan SK, Sun L, Jiang C, Xue X, Tian Y, Krausz KW, Patterson AD, Shah YM, Wu Y, Jiang C, Gonzalez FJ (2017). Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis. Nat Med  23, 1298-1308.   https://doi.org/10.1038/nm.4412




PubMed



        
     
Free Article


 


PubMed ID 29035368
         Pubmed Central ID 6410352 


 



50.
Yang XN, Liu XM, Fang JH, Zhu X, Yang XW, Xiao XR, Huang JF, Gonzalez FJ, Li F (2018). PPARα Mediates the Hepatoprotective Effects of Nutmeg. J Proteome Res  17, 1887-1897.   https://doi.org/10.1021/acs.jproteome.7b00901




PubMed



        
     
Free Article


 


PubMed ID 29664296
         Pubmed Central ID 6628927 


 



51.
Yao PL, Chen L, Dobrzański TP, Zhu B, Kang BH, Müller R, Gonzalez FJ, Peters JM (2017). Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation. Mol Carcinog  56, 1472-1483.   https://doi.org/10.1002/mc.22607




PubMed



        
     
Free Article


 


PubMed ID 27996177
         Pubmed Central ID 6361394 


 



52.
Zhen Y, Krausz KW, Chen C, Idle JR, Gonzalez FJ (2007). Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation. Mol Endocrinol  21, 2136-51.   https://doi.org/10.1210/me.2007-0150




PubMed



        
     
Free Article


 


PubMed ID 17550978
         Pubmed Central ID 2084472",https://intramural.nih.gov/search/searchview.taf?ipid=45226
32,BC005562-20,"October 01, 2006 -  September 30, 2007",Xenobiotic-Metabolizing Enzymes,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Kristopher W Krausz



Xiaochao  Ma



Andrew  Patterson



Ting  Wang",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Chen C, Ma X, Malfatti MA, Krausz KW, Kimura S, Felton JS, Idle JR, Gonzalez FJ (2007). A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach. Chem Res Toxicol  20, 531-42.   https://doi.org/10.1021/tx600320w




PubMed



        
     
Free Article


 


PubMed ID 17279779
         Pubmed Central ID 1850849 


 



2.
Giri S, Krausz KW, Idle JR, Gonzalez FJ (2007). The metabolomics of (+/-)-arecoline 1-oxide in the mouse and its formation by human flavin-containing monooxygenases. Biochem Pharmacol  73, 561-73.   https://doi.org/10.1016/j.bcp.2006.10.017




PubMed


 


PubMed ID 17123469
    
     


 



3.
Gonzalez FJ (2007). Animal models for human risk assessment: the peroxisome proliferator-activated receptor alpha-humanized mouse. Nutr Rev  65, S2-6.   https://doi.org/10.1111/j.1753-4887.2007.tb00323.x




PubMed


 


PubMed ID 17605307
    
     


 



4.
Gonzalez FJ (2007). The 2006 Bernard B. Brodie Award Lecture. Cyp2e1. Drug Metab Dispos  35, 1-8.   https://doi.org/10.1124/dmd.106.012492




PubMed


 


PubMed ID 17020953
    
     


 



5.
Lee CH, Ito Y, Yanagiba Y, Yamanoshita O, Kim H, Zhang SY, Kamijima M, Gonzalez FJ, Nakajima T (2007). Pyrene-induced CYP1A2 and SULT1A1 may be regulated by CAR and not by AhR. Toxicology  238, 147-56.   https://doi.org/10.1016/j.tox.2007.05.026




PubMed


 


PubMed ID 17618724
    
     


 



6.
Ma X, Idle JR, Malfatti MA, Krausz KW, Nebert DW, Chen CS, Felton JS, Waxman DJ, Gonzalez FJ (2007). Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis  28, 732-7.   https://doi.org/10.1093/carcin/bgl184




PubMed



        
     
Free Article


 


PubMed ID 17052995
         Pubmed Central ID 1829392 


 



7.
Ma X, Shah Y, Cheung C, Guo GL, Feigenbaum L, Krausz KW, Idle JR, Gonzalez FJ (2007). The PREgnane X receptor gene-humanized mouse: a model for investigating drug-drug interactions mediated by cytochromes P450 3A. Drug Metab Dispos  35, 194-200.   https://doi.org/10.1124/dmd.106.012831




PubMed


 


PubMed ID 17093002
    
     


 



8.
Ma X, Shah YM, Guo GL, Wang T, Krausz KW, Idle JR, Gonzalez FJ (2007). Rifaximin is a gut-specific human pregnane X receptor activator. J Pharmacol Exp Ther  322, 391-8.   https://doi.org/10.1124/jpet.107.121913




PubMed


 


PubMed ID 17442842
    
     


 



9.
Wolf KK, Wood SG, Allard JL, Hunt JA, Gorman N, Walton-Strong BW, Szakacs JG, Duan SX, Hao Q, Court MH, von Moltke LL, Greenblatt DJ, Kostrubsky V, Jeffery EH, Wrighton SA, Gonzalez FJ, Sinclair PR, Sinclair JF (2007). Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) mice. Drug Metab Dispos  35, 1223-31.   https://doi.org/10.1124/dmd.107.014738




PubMed


 


PubMed ID 17392391
    
     


 



10.
Zhen Y, Krausz KW, Chen C, Idle JR, Gonzalez FJ (2007). Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation. Mol Endocrinol  21, 2136-51.   https://doi.org/10.1210/me.2007-0150




PubMed



        
     
Free Article


 


PubMed ID 17550978
         Pubmed Central ID 2084472",https://intramural.nih.gov/search/searchview.taf?ipid=45227
33,BC005596-38,"October 01, 2006 -  September 30, 2007",Pathogenesis of plasma cell tumors in mice,Michael  Potter; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Elizabeth B Mushinski



Brad  Burkholder



Andrea R Levine","Sam  Baron
(Internal Medicine, University of Texas)




Garnett  Kelsoe
(Immunology, Duke)




Clifford  Snapper
(Pathology, USUHS)","Alexander L Kovalchuk; MD, PhD (Laboratory of Genetics)



David  Levens; PhD (National Cancer Institute)



James B Mitchell; PhD (National Cancer Institute)",Herbert Carpenter Morse; MD (NIAID),"Ordered by publication type and then author name.



1.
Park ES, Shaughnessy JD, Gupta S, Wang H, Lee JS, Woo HG, Zhan F, Owens JD, Potter M, Janz S, Mushinski JF (2007). Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia. BMC Genomics  8, 302.   https://doi.org/10.1186/1471-2164-8-302




PubMed



        
     
Free Article


 


PubMed ID 17764563
         Pubmed Central ID 2040348 


 



2.
Potter M (2007). The early history of plasma cell tumors in mice, 1954-1976. Adv Cancer Res  98, 17-51.   https://doi.org/10.1016/S0065-230X(06)98002-6




PubMed


 


PubMed ID 17433907",https://intramural.nih.gov/search/searchview.taf?ipid=45228
34,BC005597-18,"October 01, 2006 -  September 30, 2007",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,"Michael  Maurizi; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Mark A Lies



Agnieszka  Szyk



Yang  Zhang



Sarada  Viswanathan



Ebenezer  Joseph",NULL,"Susan  Gottesman; PhD (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)","Alasdair C Steven; PhD (NIAMS) 



Ann  Ginsburg; PhD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45229
35,BC005598-18,"October 01, 2006 -  September 30, 2007",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,"Michael Marc Gottesman; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Adorjan  Aszalos



Carol O Cardarelli



Wilfred D Vieira



Jill K Paterson



Mitsunori  Okabe



Matthew David Hall



Show all 8","Ariella  Oppenheim; PhD
(Hebrew University-Hadassah Medical School)




Gergely  Szakács
(Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences)",NULL,NULL,"Ordered by publication type and then author name.



1.
Gottesman M, Kimchi-Sarfaty C (2007) Efficient gene therapy delivery by SV40-derived vectors, in Virus Expression Vectors. Hefferon K, ed, Transworld Research Network (Trivandrum, India), in press.




 



2.
Gottesman M, Oh J, Kim I, Sauna Z, Calcagno A, Ambudkar S   (2007) A 'silent' polymorphism in the MDR1 gene changes substrate specificity.  Science  525-528 pp.




 



3.
Kimchi-Sarfaty C, Marple AH, Shinar S, Kimchi AM, Scavo D, Roma MI, Kim IW, Jones A, Arora M, Gribar J, Gurwitz D, Gottesman MM (2007). Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Pharmacogenomics  8, 29-39.   https://doi.org/10.2217/14622416.8.1.29




PubMed



        
     
Free Article


 


PubMed ID 17187507
         Pubmed Central ID 1876748 


 



4.
Paterson JK, Gottesman MM (2007). P-Glycoprotein is not present in mitochondrial membranes. Exp Cell Res  313, 3100-5.   https://doi.org/10.1016/j.yexcr.2007.04.019




PubMed



        
     
Free Article


 


PubMed ID 17512524
         Pubmed Central ID 2075362 


 



5.
Sauna Z, Kimchi-Sarfaty C, Ambudkar S, Gottsman M   (2007) 'Silent' polymorphisms speak: How they affect pharmacogenomics and the treatment  of cancer.  Cancer Research, in press.




 



6.
Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM (2007). The sounds of silence: synonymous mutations affect function. Pharmacogenomics  8, 527-32.   https://doi.org/10.2217/14622416.8.6.527




PubMed


 


PubMed ID 17559340
    
     


 



7.
Shomron N, Hamasaki-Katagiri N, Hunt R, Hershko K, Pommier E, Geetha S, Blaisdell A, Marple A, Roma I, Newell J, Allen C, Friedman S, Kimchi-Sarfaty C (2010) A splice variant of ADAMTS13 is expressed in human hepatic stellate cells and cancerous tissues. Thromb Haemost 104:531-5.




PubMed



        
     
Free Article


 


PubMed ID 20664912
         Pubmed Central ID 2982681",https://intramural.nih.gov/search/searchview.taf?ipid=45230
36,BC005599-17,"October 01, 2006 -  September 30, 2007","Tumor Suppressor Protein, p53","Ettore  Appella; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Sharlyn  Mazur; PhD



Hiroshi  Yamaguchi



Jeong Kyu Bang



Matteo  Rossi



Lisa Marie Jenkins



Silvia  Pandolfi



Show all 8","James G. Omichinski; PhD
(Department of Biochemistry, University of Montreal)




Yang  Xu
(California Breast Cancer Research Program, University of California)




Yang  Xu
(California Breast Cancer Research Program, University of California)",Jonathan D Ashwell; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Appella E, Durrell S, Chatterjee D, Anderson C   (2007) The Wip1 phosphatase, PPM1D, dephosphorylates SQ/TQ motifs in checkpoint  substrates phosphorylated by P13K-like kinases.  Biochemistry, in press.




 



2.
Appella E, Kachirskala I, Yamaguchi H, West L, Wen H, Wang E, Dutta S, Gozani O   (2007) Modulation of p53 function by SET8-mediated methylation at lysine 382.  Mol. Cell  636-46 pp.




 



3.
Appella E, Timofeev O, Lwin H, Kek C, Bulavin D   (2007) Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and  tumorigenesis in the mouse intestine.  Cell Stem Cell  180-190 pp.




 



4.
Demidov ON, Kek C, Shreeram S, Timofeev O, Fornace AJ, Appella E, Bulavin DV (2007). The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis. Oncogene  26, 2502-6.   https://doi.org/10.1038/sj.onc.1210032




PubMed


 


PubMed ID 17016428
    
     


 



5.
Shi X, Kachirskaia I, Yamaguchi H, West LE, Wen H, Wang EW, Dutta S, Appella E, Gozani O (2007). Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol Cell  27, 636-46.   https://doi.org/10.1016/j.molcel.2007.07.012




PubMed



        
     
Free Article


 


PubMed ID 17707234
         Pubmed Central ID 2693209",https://intramural.nih.gov/search/searchview.taf?ipid=45231
37,BC005617-19,"October 01, 2006 -  September 30, 2007",Molecular mechanisms of resistance to TGF-beta signaling,Seong-Jin  Kim; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,"Isaac  Kim
(Division of Urologic Oncology, The Cancer Institute of New Jersey)




John  Letterio
(Division of Pediatric Hematology/Oncology, Case Western Reserve University)




Seok Hee  Park
(Department of Pathology, Inha University School of Medicine)




Poul  Sorensen
(Department of Pathology and Pediatrics, University British Columbia)




Xiao-Jing  Wang
(Departments of Dermatology & Otolaryngology, Oregon Health & Science University)","Lino  Tessarollo (National Cancer Institute)



James B Mitchell; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45232
38,BC005643-17,"October 01, 2006 -  September 30, 2007",Mechanism and Regulation of mRNA Export,Ravi  Dhar; PhD,NULL,"Basic Research Laboratory, NCI","Saravana P Selvanathan



Saikat  Saha",NULL,Andrew  Patterson (Gene Response Section),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45233
39,BC005645-18,"October 01, 2006 -  September 30, 2007",T-cell Transformation by Oncoviruses,"Genoveffa  Franchini; MD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Robyn  Parks



Steven J Snodgrass



Vibeke  Andresen



Risaku  Fukumoto



Valerio William Valeri



Izabela  Bialuk","Vincenzo  Ciminale
(Department of Oncology and Surgical Sciences, University of Padova)




Christophe  Nicot
(-, University of Kansas Medical Center)","Barbara K Felber (National Cancer Institute)



Lawrence Elliot Samelson; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45234
40,BC005652-17,"October 01, 2006 -  September 30, 2007",Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes,"Michael  Dean; PhD



IRP Faculty Profile",NULL,"Laboratory of Genomic Diversity, NCI","Shawn R Palmer



Zhang-Qun  Chen



Michael J Malasky



Mary  Mcnally



Julie  Sawitzke



Stefan Alexandrov Stefanov



Show all 14","Rando  Allikmets
(NCI)




Greg  Hageman
(Ophthalmology, University of Iowa)




Ken  Offitt
(Medicine, Sloan Kettering Cancer Center)




Joe  Sodroski
(Immunology & Infectious Diseases, Harvard School of Public Health)","Stephen J O'Brien; PhD (National Cancer Institute)



Thomas R O'Brien; BA, MPH, MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Li X, Gold B, O'hUigin C, Diaz-Griffero F, Song B, Si Z, Li Y, Yuan W, Stremlau M, Mische C, Javanbakht H, Scally M, Winkler C, Dean M, Sodroski J (2007). Unique features of TRIM5alpha among closely related human TRIM family members. Virology  360, 419-33.   https://doi.org/10.1016/j.virol.2006.10.035




PubMed


 


PubMed ID 17156811
    
     


 



2.
Lou H, Dean M (2007). Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene  26, 1357-60.   https://doi.org/10.1038/sj.onc.1210200




PubMed


 


PubMed ID 17322922
    
     


 



3.
O'Brien TR, Kachapati K, Zhang M, Bergeron J, Edlin BR, Dean M (2007). HCV infection clearance with functional or non-functional caspase-12. Scand J Gastroenterol  42, 416-7.   https://doi.org/10.1080/00365520601076074




PubMed


 


PubMed ID 17354126
    
     


 



4.
Remsberg JR, Lou H, Tarasov SG, Dean M, Tarasova NI (2007). Structural analogues of smoothened intracellular loops as potent inhibitors of Hedgehog pathway and cancer cell growth. J Med Chem  50, 4534-8.   https://doi.org/10.1021/jm0705657




PubMed



        
     
Free Article


 


PubMed ID 17685505
         Pubmed Central ID 3956439 


 



5.
Tan W, Wang Y, Gold B, Chen J, Dean M, Harrison PJ, Weinberger DR, Law AJ (2007). Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem  282, 24343-51.   https://doi.org/10.1074/jbc.M702953200




PubMed


 


PubMed ID 17565985",https://intramural.nih.gov/search/searchview.taf?ipid=45187
41,BC005657-18,"October 01, 2006 -  September 30, 2007",Molecular Basis for the Pathogenesis of Murine Retroviruses,Sandra  Ruscetti; PhD,NULL,"Laboratory of Cancer Prevention, NCI","Charlotte A Hanson



Delores M Thompson



Joan L Cmarik



Monika  Kaczmarek



Karen  Wylie","Paul  Hoffman
(Depts of Neuroscience and Neurology, University of Florida School of Medicine)




Marcel  Leist
(Dept. of Neuroscience and Neurology, H. Lundbeck A/S)




Michiaki  Masuda
(Dokkyo University, Japan)","Michael I Lerman; MD, PhD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)



Michael  Birrer (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45235
42,BC005673-17,"October 01, 2006 -  September 30, 2007",Diazeniumdiolate Chemistry as a Platform for Designing Nitric Oxide-Based Therap,Larry K Keefer; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Michael Louis Citro



Joseph  Saavedra



Li  Kong



Thomas C Wilde



Carlos A Velazquez Martinez



Daniela  Andrei



Show all 7","Kenneth  Anderson
(Dana-Farber Cancer Institute, Harvard)




Melina  Kibbe
(Division of Vascular Surgery, Northwestern University)




Tanyel  Kiziltepe
(Dana-Farber Cancer Institute, Harvard)




Edward  Knaus
(Department of Chemistry, University of Alberta)




Mark  Meyerhoff
(Department of Chemistry, University of Michigan)




Katrina  Miranda
(Dept of Cell and Molecular Pharmacology and Experimental Therapeutics, University of Arizona)


Show all 10","Mariam Q Malik (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)



Michael  Waalkes; PhD (National Cancer Institute)



Jie  Liu (National Cancer Institute)



David Anderson Wink (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Andrei D, Maciag AE, Chakrapani H, Citro ML, Keefer LK, Saavedra JE (2008). Aryl bis(diazeniumdiolates): potent inducers of S-glutathionylation of cellular proteins and their in vitro antiproliferative activities. J Med Chem  51, 7944-52.   https://doi.org/10.1021/jm800831y




PubMed



        
     
Free Article


 


PubMed ID 19053760
         Pubmed Central ID 2629944 


 



2.
Chakrapani H, Showalter BM, Kong L, Keefer LK, Saavedra JE (2007). V-PROLI/NO, a prodrug of the nitric oxide donor, PROLI/NO. Org Lett  9, 3409-12.   https://doi.org/10.1021/ol701419a




PubMed


 


PubMed ID 17658755
    
     


 



3.
DeRosa F, Kibbe MR, Najjar SF, Citro ML, Keefer LK, Hrabie JA (2007). Nitric oxide-releasing fabrics and other acrylonitrile-based diazeniumdiolates. J Am Chem Soc  129, 3786-7.   https://doi.org/10.1021/ja0686864




PubMed


 


PubMed ID 17343382
    
     


 



4.
Keefer L, Chow L, Tsihlis N, Ahanchi S, Eng J, Murar J, Martinez J, Popowich D, Jiang Q, Hrabie J, Saavedra J, Hulvat J, Stupp S, Kibbe M   (2007) Nitric oxide and nanotechnology: A novel approach to inhibit neointimal hyperplasia.  J. Vasc. Surg, in press.




 



5.
Keefer L, Roman J, Issaq H, Veenstra T, Ziegler R   (2007) Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry.  Anal. Chem, in press.




 



6.
Kiziltepe T, Hideshima T, Ishitsuka K, Ocio EM, Raje N, Catley L, Li CQ, Trudel LJ, Yasui H, Vallet S, Kutok JL, Chauhan D, Mitsiades CS, Saavedra JE, Wogan GN, Keefer LK, Shami PJ, Anderson KC (2007). JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells. Blood  110, 709-18.   https://doi.org/10.1182/blood-2006-10-052845




PubMed



        
     
Free Article


 


PubMed ID 17384201
         Pubmed Central ID 1924477 


 



7.
Qu W, Liu J, Fuquay R, Saavedra JE, Keefer LK, Waalkes MP (2007). The nitric oxide prodrug, V-PYRRO/NO, mitigates arsenic-induced liver cell toxicity and apoptosis. Cancer Lett  256, 238-45.   https://doi.org/10.1016/j.canlet.2007.06.009




PubMed



        
     
Free Article


 


PubMed ID 17658681
         Pubmed Central ID 2093999 


 



8.
Velázquez CA, Praveen Rao PN, Citro ML, Keefer LK, Knaus EE (2007). O2-acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): synthesis, nitric oxide release, and biological evaluation studies. Bioorg Med Chem  15, 4767-74.   https://doi.org/10.1016/j.bmc.2007.05.009




PubMed



        
     
Free Article


 


PubMed ID 17509888
         Pubmed Central ID 2990403 


 



9.
Xu X, Keefer LK, Ziegler RG, Veenstra TD (2007). A liquid chromatography-mass spectrometry method for the quantitative analysis of urinary endogenous estrogen metabolites. Nat Protoc  2, 1350-5.   https://doi.org/10.1038/nprot.2007.176




PubMed


 


PubMed ID 17545972",https://intramural.nih.gov/search/searchview.taf?ipid=45236
43,BC005688-17,"October 01, 2006 -  September 30, 2007",Preventive and therapeutic T cell vaccines to mitigate HIV-1 replication; Preven,"Genoveffa  Franchini; MD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Robyn  Parks



Steven J Snodgrass



Wen-Po  Tsai



Jean-Michel  Heraud



Monica  Vaccari



Elzbieta A Tryniszewska","Michael R Betts





Claire  Chougnet
(University of Cincinnati)




Claire  Chougnet
(University of Cincinnati)




Donald  Forthal
(School of Medicine, Univ of CA)




Jay  Hooper
(USAMRIID)




Israel  Lowy
(Medarex)


Show all 10","Barbara K Felber (National Cancer Institute)



George N Pavlakis; MD, PhD (National Cancer Institute)



Gene  Shearer; PhD (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Lauren V Wood; MD (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)","Richard A Koup; MD (NIAID) 



David A Price (NIAID) 



Daniel C Douek; MD (NIAID) 



Nancy R Miller (NIAID) 



Vanessa  Hirsch (NIAID)","Ordered by publication type and then author name.



1.
Gordon SN, Doster MN, Kines RC, Keele BF, Brocca-Cofano E, Guan Y, Pegu P, Liyanage NP, Vaccari M, Cuburu N, Buck CB, Ferrari G, Montefiori D, Piatak M, Lifson JD, Xenophontos AM, Venzon D, Robert-Guroff M, Graham BS, Lowy DR, Schiller JT, Franchini G (2014) Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia. J Immunol 193:6172-83




PubMed



        
     
Free Article


 


PubMed ID 25398324
         Pubmed Central ID 4335709 


 



2.
Gordon SN, Liyanage NP, Doster MN, Vaccari M, Vargas-Inchaustegui DA, Pegu P, Schifanella L, Shen X, Tomaras GD, Rao M, Billings EA, Schwartz J, Prado I, Bobb K, Zhang W, Montefiori DC, Foulds KE, Ferrari G, Robert-Guroff M, Roederer M, Phan TB, Forthal DN, Stablein DM, Phogat S, Venzon DJ, et al. [2 more authors] (2016) Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition. J Immunol 197:2726-37




PubMed



               Available in future as a Free Article 


 


PubMed ID 27591322
         Pubmed Central ID 5026031 


 



3.
Hryniewicz A, Price DA, Moniuszko M, Boasso A, Edghill-Spano Y, West SM, Venzon D, Vaccari M, Tsai WP, Tryniszewska E, Nacsa J, Villinger F, Ansari AA, Trindade CJ, Morre M, Brooks D, Arlen P, Brown HJ, Kitchen CM, Zack JA, Douek DC, Shearer GM, Lewis MG, Koup RA, Franchini G (2007). Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques. J Immunol  178, 3492-504.   https://doi.org/10.4049/jimmunol.178.6.3492




PubMed


 


PubMed ID 17339444
    
     


 



4.
Petrovas C, Price DA, Mattapallil J, Ambrozak DR, Geldmacher C, Cecchinato V, Vaccari M, Tryniszewska E, Gostick E, Roederer M, Douek DC, Morgan SH, Davis SJ, Franchini G, Koup RA (2007). SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood  110, 928-36.   https://doi.org/10.1182/blood-2007-01-069112




PubMed



        
     
Free Article


 


PubMed ID 17440051
         Pubmed Central ID 1924769",https://intramural.nih.gov/search/searchview.taf?ipid=45237
44,BC005691-16,"October 01, 2006 -  September 30, 2007",Inhibition of p53 Tumor Suppressor Function by HTLV-I,John N Brady; PhD,NULL,"Laboratory of Cellular Oncology, NCI","Michael  Radonovich



Arindam  Dasgupta",NULL,"Michael  Birrer (National Cancer Institute)



Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)","Warren J Leonard; MD (NHLBI) 



Lance  Pohl; PharmD, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Brady J, Dasgupta A, Jung K, Um J, Burke A, Park H   (2007) PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1 transformed  cells.  Virology, in press.




 



2.
Couto FM, Minn AH, Pise-Masison CA, Radonovich M, Brady JN, Hanson M, Fernandez LA, Wang P, Kendziorski C, Shalev A (2007). Exenatide blocks JAK1-STAT1 in pancreatic beta cells. Metabolism  56, 915-8.   https://doi.org/10.1016/j.metabol.2007.02.004




PubMed


 


PubMed ID 17570252",https://intramural.nih.gov/search/searchview.taf?ipid=45238
45,BC005708-16,"October 01, 2006 -  September 30, 2007",Xenobiotic Receptors,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Yatrik  Shah



Shinji  Ito



Tomokazu  Nagano



Andrew  Patterson



Tomotaka  Tanabe



Tsutomu  Matsubara","Toshifumi  Aoyama
(Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)




Steven  Kliewer
(Department of Molecular Biology, University of Texas Southwestern Medical Center,)




Jeffrey  Peters
(NCI)",NULL,NULL,"Ordered by publication type and then author name.



1.
Arpiainen S, Lämsä V, Pelkonen O, Yim SH, Gonzalez FJ, Hakkola J (2007). Aryl hydrocarbon receptor nuclear translocator and upstream stimulatory factor regulate Cytochrome P450 2a5 transcription through a common E-box site. J Mol Biol  369, 640-52.   https://doi.org/10.1016/j.jmb.2007.03.075




PubMed


 


PubMed ID 17466327
    
     


 



2.
Dongol B, Shah Y, Kim I, Gonzalez FJ, Hunt MC (2007). The acyl-CoA thioesterase I is regulated by PPARalpha and HNF4alpha via a distal response element in the promoter. J Lipid Res  48, 1781-91.   https://doi.org/10.1194/jlr.M700119-JLR200




PubMed


 


PubMed ID 17485727
    
     


 



3.
Duan SZ, Ivashchenko CY, Whitesall SE, D'Alecy LG, Duquaine DC, Brosius FC, Gonzalez FJ, Vinson C, Pierre MA, Milstone DS, Mortensen RM (2007). Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality. J Clin Invest  117, 812-22.   https://doi.org/10.1172/JCI28859




PubMed



        
     
Free Article


 


PubMed ID 17304352
         Pubmed Central ID 1794117 


 



4.
Gonzalez FJ (2007). Animal models for human risk assessment: the peroxisome proliferator-activated receptor alpha-humanized mouse. Nutr Rev  65, S2-6.   https://doi.org/10.1111/j.1753-4887.2007.tb00323.x




PubMed


 


PubMed ID 17605307
    
     


 



5.
Hevener AL, Olefsky JM, Reichart D, Nguyen MT, Bandyopadyhay G, Leung HY, Watt MJ, Benner C, Febbraio MA, Nguyen AK, Folian B, Subramaniam S, Gonzalez FJ, Glass CK, Ricote M (2007). Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest  117, 1658-69.   https://doi.org/10.1172/JCI31561




PubMed



        
     
Free Article


 


PubMed ID 17525798
         Pubmed Central ID 1868788 


 



6.
Hollingshead HE, Morimura K, Adachi M, Kennett MJ, Billin AN, Willson TM, Gonzalez FJ, Peters JM (2007). PPARbeta/delta protects against experimental colitis through a ligand-independent mechanism. Dig Dis Sci  52, 2912-9.   https://doi.org/10.1007/s10620-006-9644-9




PubMed


 


PubMed ID 17404849
    
     


 



7.
Ichihara S, Yamada Y, Ichihara G, Nakajima T, Li P, Kondo T, Gonzalez FJ, Murohara T (2007). A role for the aryl hydrocarbon receptor in regulation of ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol  27, 1297-304.   https://doi.org/10.1161/ATVBAHA.106.138701




PubMed


 


PubMed ID 17413038
    
     


 



8.
Ito S, Chen C, Satoh J, Yim S, Gonzalez FJ (2007). Dietary phytochemicals regulate whole-body CYP1A1 expression through an arylhydrocarbon receptor nuclear translocator-dependent system in gut. J Clin Invest  117, 1940-50.   https://doi.org/10.1172/JCI31647




PubMed



        
     
Free Article


 


PubMed ID 17607366
         Pubmed Central ID 1890999 


 



9.
Ito Y, Yamanoshita O, Asaeda N, Tagawa Y, Lee CH, Aoyama T, Ichihara G, Furuhashi K, Kamijima M, Gonzalez FJ, Nakajima T   (2007) Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway.  J Occup Health 49:172-82.




PubMed


 


PubMed ID 17575397
    
     


 



10.
Kamijo Y, Hora K, Nakajima T, Kono K, Takahashi K, Ito Y, Higuchi M, Kiyosawa K, Shigematsu H, Gonzalez FJ, Aoyama T   (2007) Peroxisome proliferator-activated receptor alpha protects against glomerulonephritis induced by long-term exposure to the plasticizer di-(2-ethylhexyl)phthalate.  J Am Soc Nephrol 18:176-88.




PubMed


 


PubMed ID 17135395
    
     


 



11.
Ma X, Shah Y, Cheung C, Guo GL, Feigenbaum L, Krausz KW, Idle JR, Gonzalez FJ (2007). The PREgnane X receptor gene-humanized mouse: a model for investigating drug-drug interactions mediated by cytochromes P450 3A. Drug Metab Dispos  35, 194-200.   https://doi.org/10.1124/dmd.106.012831




PubMed


 


PubMed ID 17093002
    
     


 



12.
Ma X, Shah YM, Guo GL, Wang T, Krausz KW, Idle JR, Gonzalez FJ (2007). Rifaximin is a gut-specific human pregnane X receptor activator. J Pharmacol Exp Ther  322, 391-8.   https://doi.org/10.1124/jpet.107.121913




PubMed


 


PubMed ID 17442842
    
     


 



13.
Mandard S, Stienstra R, Escher P, Tan NS, Kim I, Gonzalez FJ, Wahli W, Desvergne B, Müller M, Kersten S (2007). Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors. Cell Mol Life Sci  64, 1145-57.   https://doi.org/10.1007/s00018-007-7006-1




PubMed



        
     
Free Article


 


PubMed ID 17437057
         Pubmed Central ID 2771145 


 



14.
Matsumoto K, Yu S, Jia Y, Ahmed MR, Viswakarma N, Sarkar J, Kashireddy PV, Rao MS, Karpus W, Gonzalez FJ, Reddy JK   (2007) Critical role for transcription coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein/TRAP220 in liver regeneration and PPARalpha ligand-induced liver tumor development.  J Biol Chem 282:17053-60.




PubMed


 


PubMed ID 17438330
    
     


 



15.
Reddy AB, Maywood ES, Karp NA, King VM, Inoue Y, Gonzalez FJ, Lilley KS, Kyriacou CP, Hastings MH (2007). Glucocorticoid signaling synchronizes the liver circadian transcriptome. Hepatology  45, 1478-88.   https://doi.org/10.1002/hep.21571




PubMed


 


PubMed ID 17538967
    
     


 



16.
Shah YM, Ma X, Morimura K, Kim I, Gonzalez FJ (2007). Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression. Am J Physiol Gastrointest Liver Physiol  292, G1114-22.   https://doi.org/10.1152/ajpgi.00528.2006




PubMed


 


PubMed ID 17170021
    
     


 



17.
Shah YM, Morimura K, Gonzalez FJ (2007). Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis. Am J Physiol Gastrointest Liver Physiol  292, G657-66.   https://doi.org/10.1152/ajpgi.00381.2006




PubMed



        
     
Free Article


 


PubMed ID 17095756
         Pubmed Central ID 1796914 


 



18.
Shah YM, Morimura K, Yang Q, Tanabe T, Takagi M, Gonzalez FJ (2007). Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol Cell Biol  27, 4238-47.   https://doi.org/10.1128/MCB.00317-07




PubMed



        
     
Free Article


 


PubMed ID 17438130
         Pubmed Central ID 1900062 


 



19.
Yang Q, Ito S, Gonzalez FJ (2007). Hepatocyte-restricted constitutive activation of PPAR alpha induces hepatoproliferation but not hepatocarcinogenesis. Carcinogenesis  28, 1171-7.   https://doi.org/10.1093/carcin/bgm046




PubMed



        
     
Free Article


 


PubMed ID 17331954
         Pubmed Central ID 1885989 


 



20.
Yang Q, Nagano T, Shah Y, Cheung C, Ito S, Gonzalez FJ (2008). The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha. Toxicol Sci  101, 132-9.   https://doi.org/10.1093/toxsci/kfm206




PubMed



        
     
Free Article


 


PubMed ID 17690133
         Pubmed Central ID 2197159 


 



21.
Zhen Y, Krausz KW, Chen C, Idle JR, Gonzalez FJ (2007). Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation. Mol Endocrinol  21, 2136-51.   https://doi.org/10.1210/me.2007-0150




PubMed



        
     
Free Article


 


PubMed ID 17550978
         Pubmed Central ID 2084472",https://intramural.nih.gov/search/searchview.taf?ipid=45239
46,BC005725-15,"October 01, 2006 -  September 30, 2007",ABC Transporters in Human Disease and Multidrug Resistance,"Michael  Dean; PhD



IRP Faculty Profile",NULL,"Laboratory of Genomic Diversity, NCI","Zhang-Qun  Chen



Wei  Tan



Hong  Lou



Adam K Olsh



Mark  Scally","Rando  Allikmets
(NCI)




Stephen  Farber
(Pediatrics, Carnegie Institute)




Larry  Nogee
(Pediatrics, Johns Hopkins University)




Ina  Urbatsch
(Cell Biology and Biochemistry, Texas Tech University Health Sciences)","Antonio  Fojo; MD, PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chloupková M, Pickert A, Lee JY, Souza S, Trinh YT, Connelly SM, Dumont ME, Dean M, Urbatsch IL (2007). Expression of 25 human ABC transporters in the yeast Pichia pastoris and characterization of the purified ABCC3 ATPase activity. Biochemistry  46, 7992-8003.   https://doi.org/10.1021/bi700020m




PubMed


 


PubMed ID 17569508
    
     


 



2.
Henrich CJ, Robey RW, Bokesch HR, Bates SE, Shukla S, Ambudkar SV, Dean M, McMahon JB (2007). New inhibitors of ABCG2 identified by high-throughput screening. Mol Cancer Ther  6, 3271-8.   https://doi.org/10.1158/1535-7163.MCT-07-0352




PubMed



        
     
Free Article


 


PubMed ID 18089721
         Pubmed Central ID 2760480 


 



3.
Li X, Gold B, O'hUigin C, Diaz-Griffero F, Song B, Si Z, Li Y, Yuan W, Stremlau M, Mische C, Javanbakht H, Scally M, Winkler C, Dean M, Sodroski J (2007). Unique features of TRIM5alpha among closely related human TRIM family members. Virology  360, 419-33.   https://doi.org/10.1016/j.virol.2006.10.035




PubMed


 


PubMed ID 17156811
    
     


 



4.
Lou H, Dean M (2007). Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene  26, 1357-60.   https://doi.org/10.1038/sj.onc.1210200




PubMed


 


PubMed ID 17322922
    
     


 



5.
Saugstad OD, Hansen TW, Rønnestad A, Nakstad B, Tølløfsrud PA, Reinholt F, Hamvas A, Coles FS, Dean M, Wert SE, Whitsett JA, Nogee LM (2007). Novel mutations in the gene encoding ATP binding cassette protein member A3 (ABCA3) resulting in fatal neonatal lung disease. Acta Paediatr  96, 185-90.   https://doi.org/10.1111/j.1651-2227.2007.00016.x




PubMed


 


PubMed ID 17429902
    
     


 



6.
Henrich C, Ambudkar S, Bates S, Bokesch H, Cartner L, Dean M, Fuller R, Gustafson K, McMahon J, Robey R, Shukla S, Takada K (submitted in 2007) Method Of Inhibiting Abcg2 And Other Treatment Methods. Patents issued: 8,470,888 (US in 2013); 9,314,448 (US in 2016). Patent pending: PCT/US2008/088446 (PC application).




 



7.
Henrich C, Ambudkar S, Bates S, Bokesch H, Dean M, McMahon J, Robey R, Shukla S (submitted in 2007) Method Of Inhibiting Abcg2 And Related Treatments. Patents issued: 9,114,102 (US in 2015); 9,937,217 (US in 2018). Patent pending: PCT/US2008/082414 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45188
47,BC005740-15,"October 01, 2006 -  September 30, 2007",Transgenic Models for Prostate and Breast Cancer,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Dalit  Barkan



Zi-yao  Liu



Ting-Hu  Qiu



Mark  Hoenerhoff; DVM, PhD



Christina  Bennett



Min  Zhu","Chu-Xia  Deng
(NIDDK)





Hynda K Kleinman; PhD
(NIDCR)
















Khalil  Ahmed
(University of Minnessota, University of Minnessota)




Alfonso  Calvo
(University of Pamplona)




Ann  Chambers
(London Regional Cancer Center)




Bruce  Crise
(SAIC, SAIC)


Show all 18","Dolph Lee Hatfield; PhD (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45240
48,BC005753-15,"October 01, 2006 -  September 30, 2007",HIV Tat Transcriptional Activation,John N Brady; PhD,NULL,"Laboratory of Cellular Oncology, NCI","Meisheng  Zhou



Won-Kyung  Cho



Keven H Huang","Fatah  Kashanchi
(Department of Biochemistry and Molecular Biology, George Washington University Medical Center)




Fatah  Kashanchi
(Department of Biochemistry and Molecular Biology, George Washington University Medical Center)




Sergei  Nekhai
(Biochemistry Department, Howard University)",Dinah  Singer; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Cho WK, Zhou M, Jang MK, Huang K, Jeong SJ, Ozato K, Brady JN (2007). Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein. J Virol  81, 11179-86.   https://doi.org/10.1128/JVI.00408-07




PubMed



        
     
Free Article


 


PubMed ID 17686863
         Pubmed Central ID 2045532",https://intramural.nih.gov/search/searchview.taf?ipid=45241
49,BC005785-13,"October 01, 2006 -  September 30, 2007",TGF-betas in breast cancer progression,"Lalage  Wakefield; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Binwu  Tang



Ethan  Kohn



Misako  Sato



Yu-an  Yang



Jeong-Seok  Nam



Helen  Chae","Jay  Harper
(Cytokine Biology, Genzyme Corp)




Scott  Lonning
(Gene Therapy, Genzyme Corp.)




Ian  Paterson





Michael  Sporn
(Pharmacology, Dartmouth Medical School)","Masaki  Terabe (National Cancer Institute)



Maxwell P Lee; PhD (National Cancer Institute)



Miriam R Anver (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Christina  Stuelten (National Cancer Institute)",Arian  Laurence (NIAMS),"Ordered by publication type and then author name.



1.
Nam JS, Hirohashi S, Wakefield LM (2007). Dysadherin: a new player in cancer progression. Cancer Lett  255, 161-9.   https://doi.org/10.1016/j.canlet.2007.02.018




PubMed



        
     
Free Article


 


PubMed ID 17442482
         Pubmed Central ID 2094007 


 



2.
Varticovski L, Hollingshead MG, Robles AI, Wu X, Cherry J, Munroe DJ, Lukes L, Anver MR, Carter JP, Borgel SD, Stotler H, Bonomi CA, Nunez NP, Hursting SD, Qiao W, Deng CX, Green JE, Hunter KW, Merlino G, Steeg PS, Wakefield LM, Barrett JC (2007). Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models. Clin Cancer Res  13, 2168-77.   https://doi.org/10.1158/1078-0432.CCR-06-0918




PubMed


 


PubMed ID 17404101
    
     


 



3.
Wakefield L, Kamaraju A, Roberts A   (2007) Lentiviral reporter constructs for fluorescence tracking of the temporospatial pattern of Smad3 signaling.  Biotechniques, in press.




 



4.
Wakefield L, Yoo N, Vu M, Mamura M, Nam J, Ooshima A, Du Z, Desprez P, Anver M, Michalowska A, Shih J, Parks T   (2007) Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cells and committed progeny in a breast cancer xenograft model.  Cancer Res, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45242
50,BC005793-13,"October 01, 2006 -  September 30, 2007",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,"Xin Wei Wang; PhD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Anuradha Samantha Budhu



Marshonna J Forgues



Junfang  Ji",NULL,"Nicolae C Popescu; PhD (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Budhu A, Chen Y, Kim JW, Forgues M, Valerie K, Harris CC, Wang XW (2007). Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins. Carcinogenesis  28, 1552-60.   https://doi.org/10.1093/carcin/bgm075




PubMed


 


PubMed ID 17404395",https://intramural.nih.gov/search/searchview.taf?ipid=45243
51,BC005795-13,"October 01, 2006 -  September 30, 2007",p53 Tumor Suppressor Pathway,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Izumi  Horikawa



John  Bradsher



Mary G Mcmenamin



Elisa A Spillare



Ran  Zhang



Kensuke  Kumamoto



Show all 9","Ian  Hickson
(Univ of Oxford, John Radcliffe Hospital, Weatherall Institution of Molecular Medicine)




V  Rotter
(Dept. of Cell Biology, The Weizman Institute of Science)",Ettore  Appella; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Cooks T, Harris CC (2014). p53 mutations and inflammation-associated cancer are linked through TNF signaling. Mol Cell  56, 611-2.   https://doi.org/10.1016/j.molcel.2014.11.018




PubMed



        
     
Free Article


 


PubMed ID 25479634
         Pubmed Central ID 6333310 


 



2.
Harris C, Matsubara K, Zhou X, Okamura S, Kubo T, Murase Y, Shikauchi Y, Esteller M, Herman J, Wang X   (2007) WNT10B funtional dualism: beta-catenin/Tcf-dependent growth promotion or  independent suppression with deregulated expression in cancer.  Cancer Research, in press.




 



3.
Harris C, Zhang R, Horikawa I, Fujita K, Afshar Y, Kokko A, Laiho P, Aaltonen L   (2007) Functional diversity of human POT1 isoforms in telomere protection and cellular  senescence.  Cancer Research, in press.




 



4.
Horikawa I, Fujita K, Jenkins LM, Hiyoshi Y, Mondal AM, Vojtesek B, Lane DP, Appella E, Harris CC (2014). Autophagic degradation of the inhibitory p53 isoform Δ133p53α as a regulatory mechanism for p53-mediated senescence. Nat Commun  5, 4706.   https://doi.org/10.1038/ncomms5706




PubMed



        
     
Free Article


 


PubMed ID 25144556
         Pubmed Central ID 6662595 


 



5.
Hussain SP, Schwank J, Staib F, Wang XW, Harris CC (2007). TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene  26, 2166-76.   https://doi.org/10.1038/sj.onc.1210279




PubMed


 


PubMed ID 17401425
    
     


 



6.
Koshiji M, Kumamoto K, Morimura K, Utsumi Y, Aizawa M, Hoshino M, Ohki S, Takenoshita S, Costa M, Commes T, Piquemal D, Harris CC, Tchou-Wong KM (2007). Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity. World J Gastroenterol  13, 2803-10.   https://doi.org/10.3748/wjg.v13.i20.2803




PubMed



        
     
Free Article


 


PubMed ID 17569115
         Pubmed Central ID 4395631 


 



7.
Kumamoto K, Spillare EA, Fujita K, Horikawa I, Yamashita T, Appella E, Nagashima M, Takenoshita S, Yokota J, Harris CC (2008). Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res  68, 3193-203.   https://doi.org/10.1158/0008-5472.CAN-07-2780




PubMed



        
     
Free Article


 


PubMed ID 18451145
         Pubmed Central ID 2440635 


 



8.
Shen JC, Unoki M, Ythier D, Duperray A, Varticovski L, Kumamoto K, Pedeux R, Harris CC (2007). Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1. Cancer Res  67, 2552-8.   https://doi.org/10.1158/0008-5472.CAN-06-3870




PubMed



        
     
Free Article


 


PubMed ID 17363573
         Pubmed Central ID 2569966 


 



9.
Solomon H, Dinowitz N, Pateras IS, Cooks T, Shetzer Y, Molchadsky A, Charni M, Rabani S, Koifman G, Tarcic O, Porat Z, Kogan-Sakin I, Goldfinger N, Oren M, Harris CC, Gorgoulis VG, Rotter V (2018). Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers. Oncogene  37, 1669-1684.   https://doi.org/10.1038/s41388-017-0060-8




PubMed



        
     
Free Article


 


PubMed ID 29343849
         Pubmed Central ID 6448595 


 



10.
Unoki M, Kumamoto K, Robles AI, Shen JC, Zheng ZM, Harris CC (2008). A novel ING2 isoform, ING2b, synergizes with ING2a to prevent cell cycle arrest and apoptosis. FEBS Lett  582, 3868-74.   https://doi.org/10.1016/j.febslet.2008.10.024




PubMed



        
     
Free Article


 


PubMed ID 18951897
         Pubmed Central ID 2613974",https://intramural.nih.gov/search/searchview.taf?ipid=45244
52,BC005800-13,"October 01, 2006 -  September 30, 2007",Discovering Disease Susceptibility Genes in African Americans,Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI","Taras K Oleksyk



Ann  Truelove



Mary A Thompson



Michael E Weedon



Yvette  Berthier-schaad



Viktoriya  Grinberg



Show all 8","Francisco  De La Vega
(Applied Biosystems)




Myron  Essex
(Dept. of Immunology & Infectious Diseases, Harvard School of Public Health)




Dennis  Gilbert
(Applied Biosystems)




Linda  Kao
(Dept. of Epidemiology, Johns Hopkins University)




Michael  Klag
(Johns Hopkins University)




Jason H. Moore; PhD
(Division of Biomedical Informatics, The Perelman School of Medicine)


Show all 13",Stephen J O'Brien; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Berthier-Schaad Y, Kao WH, Coresh J, Zhang L, Ingersoll RG, Stephens R, Smith MW (2007). Reliability of high-throughput genotyping of whole genome amplified DNA in SNP genotyping studies. Electrophoresis  28, 2812-7.   https://doi.org/10.1002/elps.200600674




PubMed


 


PubMed ID 17702060
    
     


 



2.
Iyengar SK, Abboud HE, Goddard KA, Saad MF, Adler SG, Arar NH, Bowden DW, Duggirala R, Elston RC, Hanson RL, Ipp E, Kao WH, Kimmel PL, Klag MJ, Knowler WC, Meoni LA, Nelson RG, Nicholas SB, Pahl MV, Parekh RS, Quade SR, Rich SS, Rotter JI, Scavini M, Schelling JR, Family Investigation of Nephropathy and Diabetes Research Group, et al. [8 more authors] (2007). Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes  56, 1577-85.   https://doi.org/10.2337/db06-1154




PubMed


 


PubMed ID 17363742
    
     


 



3.
Lind JM, Hutcheson-Dilks HB, Williams SM, Moore JH, Essex M, Ruiz-Pesini E, Wallace DC, Tishkoff SA, O'Brien SJ, Smith MW (2007). Elevated male European and female African contributions to the genomes of African American individuals. Hum Genet  120, 713-22.   https://doi.org/10.1007/s00439-006-0261-7




PubMed


 


PubMed ID 17006671
    
     


 



4.
Zhang L, Kao WH, Berthier-Schaad Y, Plantinga L, Fink N, Smith MW, Coresh J (2007). C-Reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort. Am J Kidney Dis  49, 118-26.   https://doi.org/10.1053/j.ajkd.2006.10.008




PubMed


 


PubMed ID 17185152",https://intramural.nih.gov/search/searchview.taf?ipid=45245
53,BC006140-31,"October 01, 2006 -  September 30, 2007",Studies of Histone Functions in Chromatin; H2AX and DNA DSBs,"William M Bonner; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Olga A Sedelnikova; PhD



Asako  Nakamura



Jennifer Susan Dickey



Mykyta  Sokolov



Christophe  Redon","David  Brenner
(Columbia University)




Eric  Hall
(Columbia University, New York, NY)




L  HUANG
(Department of Neurosurgery, University of Utah School of Medicine)




Koji  Kikuchi
(CREST Laboratory, Department of Radiation Genetics, Kyoto University Graduate School of Medicine)




Masaoki  Kohzaki
(Department of Radiology and Radiation Biology, Graduate School of Biomedical Sciences, Nagasaki University)




Igor  Koturbash
(Department of Biological Sciences, University of Lethbridge)


Show all 14","Michael Joseph Lichten; PhD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Mirit I Aladjem; PhD (National Cancer Institute)



Robert A Shroff (National Cancer Institute)","Ronald D Neumann; MD (CC) 



Igor  Panyutin; PhD (CC) 



Irina  Panyutin; MD (CC)","Ordered by publication type and then author name.



1.
Sedelnikova OA, Nakamura A, Kovalchuk O, Koturbash I, Mitchell SA, Marino SA, Brenner DJ, Bonner WM (2007). DNA double-strand breaks form in bystander cells after microbeam irradiation of three-dimensional human tissue models. Cancer Res  67, 4295-302.   https://doi.org/10.1158/0008-5472.CAN-06-4442




PubMed


 


PubMed ID 17483342",https://intramural.nih.gov/search/searchview.taf?ipid=45246
54,BC006150-26,"October 01, 2006 -  September 30, 2007","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs","Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Christophe  Marchand



Ann  Orr



Hongliang  Zhang



Keli  Agama



Jennifer A Seiler



Olivier  Sordet



Show all 12","Mark  Cushman
(Medicinal Chemistry, Purdue University)




William  Gmeiner
(PHARMACOLOGY, WAKE FOREST UNIVERSITY)




Lawrence F. Povirk; PhD
(Department of Pharmacology and Toxicology, Virginia Commonwealth University)","Frank M Balis; MD, PhD (National Cancer Institute)



Robert  Shoemaker (National Cancer Institute)



Robert J Fisher (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)



Mirit I Aladjem; PhD (National Cancer Institute)



Frank Jess Gonzalez; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Antony S, Marchand C, Stephen AG, Thibaut L, Agama KK, Fisher RJ, Pommier Y (2007). Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1. Nucleic Acids Res  35, 4474-84.   https://doi.org/10.1093/nar/gkm463




PubMed



        
     
Free Article


 


PubMed ID 17576665
         Pubmed Central ID 1935015 


 



2.
Conti C, Saccà B, Herrick J, Lalou C, Pommier Y, Bensimon A (2007). Replication fork velocities at adjacent replication origins are coordinately modified during DNA replication in human cells. Mol Biol Cell  18, 3059-67.   https://doi.org/10.1091/mbc.e06-08-0689




PubMed



        
     
Free Article


 


PubMed ID 17522385
         Pubmed Central ID 1949372 


 



3.
Jobson AG, Cardellina JH, Scudiero D, Kondapaka S, Zhang H, Kim H, Shoemaker R, Pommier Y (2007). Identification of a Bis-guanylhydrazone [4,4'-Diacetyldiphenylurea-bis(guanylhydrazone); NSC 109555] as a novel chemotype for inhibition of Chk2 kinase. Mol Pharmacol  72, 876-84.   https://doi.org/10.1124/mol.107.035832




PubMed


 


PubMed ID 17616632
    
     


 



4.
Meng LH, Kohn KW, Pommier Y (2007). Dose-response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1/CIP1 in response to the novel anticancer agent, aminoflavone (NSC 686,288). Oncogene  26, 4806-16.   https://doi.org/10.1038/sj.onc.1210283




PubMed


 


PubMed ID 17297446
    
     


 



5.
Rao VA, Conti C, Guirouilh-Barbat J, Nakamura A, Miao ZH, Davies SL, Saccá B, Hickson ID, Bensimon A, Pommier Y (2007). Endogenous gamma-H2AX-ATM-Chk2 checkpoint activation in Bloom's syndrome helicase deficient cells is related to DNA replication arrested forks. Mol Cancer Res  5, 713-24.   https://doi.org/10.1158/1541-7786.MCR-07-0028




PubMed


 


PubMed ID 17634426
    
     


 



6.
Reinhold WC, Reimers MA, Maunakea AK, Kim S, Lababidi S, Scherf U, Shankavaram UT, Ziegler MS, Stewart C, Kouros-Mehr H, Cui H, Dolginow D, Scudiero DA, Pommier YG, Munroe DJ, Feinberg AP, Weinstein JN (2007). Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells. Mol Cancer Ther  6, 391-403.   https://doi.org/10.1158/1535-7163.MCT-06-0609




PubMed


 


PubMed ID 17272646
    
     


 



7.
Seiler JA, Conti C, Syed A, Aladjem MI, Pommier Y (2007). The intra-S-phase checkpoint affects both DNA replication initiation and elongation: single-cell and -DNA fiber analyses. Mol Cell Biol  27, 5806-18.   https://doi.org/10.1128/MCB.02278-06




PubMed



        
     
Free Article


 


PubMed ID 17515603
         Pubmed Central ID 1952133 


 



8.
Wang Y, Miao ZH, Pommier Y, Kawasaki ES, Player A (2007). Characterization of mismatch and high-signal intensity probes associated with Affymetrix genechips. Bioinformatics  23, 2088-95.   https://doi.org/10.1093/bioinformatics/btm306




PubMed


 


PubMed ID 17553856",https://intramural.nih.gov/search/searchview.taf?ipid=45247
55,BC006161-24,"October 01, 2006 -  September 30, 2007",DNA Topoisomerases as Target of Action of Anticancer Drugs,"Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Christophe  Marchand



Ann  Orr



Hongliang  Zhang



Keli  Agama



Olivier  Sordet



Smitha  Antony



Show all 7","Mark  Cushman
(Medicinal Chemistry, Purdue University)




Lawrence F. Povirk; PhD
(Department of Pharmacology and Toxicology, Virginia Commonwealth University)",Melinda  Hollingshead (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Morrell A, Placzek M, Parmley S, Antony S, Dexheimer TS, Pommier Y, Cushman M (2007). Nitrated indenoisoquinolines as topoisomerase I inhibitors: a systematic study and optimization. J Med Chem  50, 4419-30.   https://doi.org/10.1021/jm070361q




PubMed


 


PubMed ID 17696418
    
     


 



2.
Morrell A, Placzek M, Parmley S, Grella B, Antony S, Pommier Y, Cushman M (2007). Optimization of the indenone ring of indenoisoquinoline topoisomerase I inhibitors. J Med Chem  50, 4388-404.   https://doi.org/10.1021/jm070307+




PubMed


 


PubMed ID 17676830
    
     


 



3.
Morrell A, Placzek MS, Steffen JD, Antony S, Agama K, Pommier Y, Cushman M (2007). Investigation of the lactam side chain length necessary for optimal indenoisoquinoline topoisomerase I inhibition and cytotoxicity in human cancer cell cultures. J Med Chem  50, 2040-8.   https://doi.org/10.1021/jm0613119




PubMed



        
     
Free Article


 


PubMed ID 17402722
         Pubmed Central ID 2519145 


 



4.
Zhang H, Meng LH, Pommier Y (2007). Mitochondrial topoisomerases and alternative splicing of the human TOP1mt gene. Biochimie  89, 474-81.   https://doi.org/10.1016/j.biochi.2006.11.002




PubMed


 


PubMed ID 17161897",https://intramural.nih.gov/search/searchview.taf?ipid=45248
56,BC006173-22,"October 01, 2006 -  September 30, 2007",Dideoxynucleosides as Potential Anti-AIDS Drugs,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI","Pamela L Russ



Hisao  Saneyoshi",NULL,Stephen H Hughes; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Boyer PL, Julias JG, Ambrose Z, Siddiqui MA, Marquez VE, Hughes SH (2007). The nucleoside analogs 4'C-methyl thymidine and 4'C-ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants. J Mol Biol  371, 873-82.   https://doi.org/10.1016/j.jmb.2007.05.043




PubMed


 


PubMed ID 17597154
    
     


 



2.
Marquez VE, Sun G, Siddiqui MA, Lee YC, Barchi JJ, Filippov IV, Landsman NA, Kelley JA (2008). What are the consequences of freezing the anomeric effect in nucleosides? Nucleic Acids Symp Ser (Oxf)   543-4  https://doi.org/10.1093/nass/nrn275




PubMed



        
     
Free Article


 


PubMed ID 18776494
         Pubmed Central ID 2700545 


 



3.
Siddiqui MA, Marquez VE (2007). The triphosphate of beta-D-4'-C-ethynyl-2',3'-dideoxycytidine is the preferred enantiomer substrate for HIV reverse transcriptase. Bioorg Med Chem  15, 283-7.   https://doi.org/10.1016/j.bmc.2006.09.061




PubMed



        
     
Free Article


 


PubMed ID 17046266
         Pubmed Central ID 1764207",https://intramural.nih.gov/search/searchview.taf?ipid=45249
57,BC006174-22,"October 01, 2006 -  September 30, 2007",Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI","Hisao  Saneyoshi



Minghong  Zhong","Riad  Agbaria
(Department of Virology, Ben-Gurion Univ of the Negev)




Jeffrey  Deschamps
(Crystallography, Naval Research Laboratory)




Shizuko  Sei
(Lab of Antiviral Drug Mechanism, SAIC)","Stephen H Hughes; PhD (National Cancer Institute)



Joseph John Barchi (National Cancer Institute)","Kenneth A Jacobson; BA, MS, PhD (NIDDK) 



Adriaan  Bax; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Comin MJ, Agbaria R, Ben-Kasus T, Huleihel M, Liao C, Sun G, Nicklaus MC, Deschamps JR, Parrish DA, Marquez VE (2007). Sculpting the bicyclo[3.1.0]hexane template of carbocyclic nucleosides to improve recognition by herpes thymidine kinase. J Am Chem Soc  129, 6216-22.   https://doi.org/10.1021/ja0688732




PubMed


 


PubMed ID 17451242
    
     


 



2.
Maderia M, Shenoy S, Van QN, Marquez VE, Barchi JJ (2007). Biophysical studies of DNA modified with conformationally constrained nucleotides: comparison of 2'-exo (north) and 3'-exo (south) 'locked' templates. Nucleic Acids Res  35, 1978-91.   https://doi.org/10.1093/nar/gkm025




PubMed



        
     
Free Article


 


PubMed ID 17341464
         Pubmed Central ID 1895885 


 



3.
Moon HR, Siddiqui MA, Sun G, Filippov IV, Landsman NA, Lee YC, Adams KM, Barchi JJ, Deschamps JR, Nicklaus MC, Kelley JA, Marquez VE (2010). Using conformationally locked nucleosides to calibrate the anomeric effect: Implications for glycosyl bond stability. Tetrahedron  66, 6707-6717.   https://doi.org/10.1016/j.tet.2010.06.044




PubMed



        
     
Free Article


 


PubMed ID 21052524
         Pubmed Central ID 2967253 


 



4.
Saneyoshi H, Deschamps JR, Marquez VE (2010). Synthesis of conformationally locked L-deoxythreosyl phosphonate nucleosides built on a bicyclo[3.1.0]hexane template. J Org Chem  75, 7659-69.   https://doi.org/10.1021/jo101475p




PubMed



        
     
Free Article


 


PubMed ID 20964394
         Pubmed Central ID 3041872 


 



5.
Saneyoshi H, Michel BY, Choi Y, Strazewski P, Marquez VE (2008). Synthesis of conformationally locked versions of puromycin analogues. J Org Chem  73, 9435-8.   https://doi.org/10.1021/jo8016132




PubMed



        
     
Free Article


 


PubMed ID 18991379
         Pubmed Central ID 2765511",https://intramural.nih.gov/search/searchview.taf?ipid=45250
58,BC006176-22,"October 01, 2006 -  September 30, 2007",Enzyme Inhibitors as Potential Anticancer and Antiviral Drugs,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Olaf R Ludek,"Riad  Agbaria
(Department of Virology, Ben-Gurion Univ of the Negev)




Manel  Esteller
(Cancer Epigenetics Laboratory, Spanish National Cancer Center)




Adriana  Haimovitz-Friedman
(Radiation Oncology, Memorial Sloan-Kettering Cancer Center)




Peter  Jones
(Norris Comprehensive Cancer Center, University of Southern California)","Peter  Blumberg; PhD (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)



William  Farrar (National Cancer Institute)



James A Kelley; PhD (National Cancer Institute)



Marc C Nicklaus (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Byun HM, Choi SH, Laird PW, Trinh B, Siddiqui MA, Marquez VE, Yang AS (2008). 2'-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: a novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase 1. Cancer Lett  266, 238-48.   https://doi.org/10.1016/j.canlet.2008.02.069




PubMed



        
     
Free Article


 


PubMed ID 18499340
         Pubmed Central ID 2528876 


 



2.
Choi Y, Pu Y, Peach ML, Kang JH, Lewin NE, Sigano DM, Garfield SH, Blumberg PM, Marquez VE (2007). Conformationally constrained analogues of diacylglycerol (DAG). 28. DAG-dioxolanones reveal a new additional interaction site in the C1b domain of PKC delta. J Med Chem  50, 3465-81.   https://doi.org/10.1021/jm0702579




PubMed


 


PubMed ID 17591763
    
     


 



3.
Comin MJ, Czifra G, Kedei N, Telek A, Lewin NE, Kolusheva S, Velasquez JF, Kobylarz R, Jelinek R, Blumberg PM, Marquez VE (2009). Conformationally constrained analogues of diacylglycerol (DAG). 31. Modulation of the biological properties of diacylgycerol lactones (DAG-lactones) containing rigid-rod acyl groups separated from the core lactone by spacer units of different lengths. J Med Chem  52, 3274-83.   https://doi.org/10.1021/jm900186m




PubMed



        
     
Free Article


 


PubMed ID 19379015
         Pubmed Central ID 2708097 


 



4.
Ludek OR, Schroeder GK, Wolfenden R, Marquez VE (2008). Synthesis of conformationally locked carbocyclic 1,3-diazepinone nucleosides as inhibitors of cytidine deaminase. Nucleic Acids Symp Ser (Oxf)   659-60  https://doi.org/10.1093/nass/nrn333




PubMed



        
     
Free Article


 


PubMed ID 18776552
         Pubmed Central ID 2730941 


 



5.
Malolanarasimhan K, Kedei N, Sigano DM, Kelley JA, Lai CC, Lewin NE, Surawski RJ, Pavlyukovets VA, Garfield SH, Wincovitch S, Blumberg PM, Marquez VE (2007). Conformationally constrained analogues of diacylglycerol (DAG). 27. Modulation of membrane translocation of protein kinase C (PKC) isozymes alpha and delta by diacylglycerol lactones (DAG-lactones) containing rigid-rod acyl groups. J Med Chem  50, 962-78.   https://doi.org/10.1021/jm061289j




PubMed


 


PubMed ID 17284021
    
     


 



6.
Philosof-Mazor L, Volinsky R, Comin MJ, Lewin NE, Kedei N, Blumberg PM, Marquez VE, Jelinek R (2008). Self-assembly and lipid interactions of diacylglycerol lactone derivatives studied at the air/water interface. Langmuir  24, 11043-52.   https://doi.org/10.1021/la802204n




PubMed



        
     
Free Article


 


PubMed ID 18788772
         Pubmed Central ID 2756192 


 



7.
Yoo CB, Valente R, Congiatu C, Gavazza F, Angel A, Siddiqui MA, Jones PA, McGuigan C, Marquez VE (2008). Activation of p16 gene silenced by DNA methylation in cancer cells by phosphoramidate derivatives of 2'-deoxyzebularine. J Med Chem  51, 7593-601.   https://doi.org/10.1021/jm8005965




PubMed



        
     
Free Article


 


PubMed ID 19006382
         Pubmed Central ID 2659950",https://intramural.nih.gov/search/searchview.taf?ipid=45251
59,BC006177-22,"October 01, 2006 -  September 30, 2007",The Analytical Chemistry of Anti-AIDS Agents,James A Kelley; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI","Christopher Cong Lai



Nicholas A Landsman","Riad  Agbaria
(Clinical Pharmacology, Ben-Gurion University of the Negev)




Nouri  Neamati
(NCI)","Victor  Marquez; PhD (National Cancer Institute)



John H Cardellina (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Lawrence R Phillips (National Cancer Institute)



Joseph John Barchi (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45252
60,BC006178-22,"October 01, 2006 -  September 30, 2007",Applications of New Mass Spectral Techniques,James A Kelley; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI","Christopher Cong Lai



Nicholas A Landsman",NULL,"Victor  Marquez; PhD (National Cancer Institute)



Kirk R Gustafson; PhD (National Cancer Institute)



Lawrence R Phillips (National Cancer Institute)",Serge  Beaucage (OD),"Ordered by publication type and then author name.



1.
Malolanarasimhan K, Kedei N, Sigano DM, Kelley JA, Lai CC, Lewin NE, Surawski RJ, Pavlyukovets VA, Garfield SH, Wincovitch S, Blumberg PM, Marquez VE (2007). Conformationally constrained analogues of diacylglycerol (DAG). 27. Modulation of membrane translocation of protein kinase C (PKC) isozymes alpha and delta by diacylglycerol lactones (DAG-lactones) containing rigid-rod acyl groups. J Med Chem  50, 962-78.   https://doi.org/10.1021/jm061289j




PubMed


 


PubMed ID 17284021
    
     


 



2.
Qian WJ, Park JE, Grant R, Lai CC, Kelley JA, Yaffe MB, Lee KS, Burke TR (2015). Neighbor-directed histidine N (τ)-alkylation: A route to imidazolium-containing phosphopeptide macrocycles. Biopolymers  104, 663-73.   https://doi.org/10.1002/bip.22698




PubMed



        
     
Free Article


 


PubMed ID 26152807
         Pubmed Central ID 4865893",https://intramural.nih.gov/search/searchview.taf?ipid=45253
61,BC006192-19,"October 01, 2006 -  September 30, 2007",Investigations on the integrated behavior of molecular regulatory networks that,"Kurt  Kohn; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",Sohyoung  Kim,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45254
62,BC006198-18,"October 01, 2006 -  September 30, 2007",Inhibitors of Tyrosine Kinase-Dependent Signalling as Anticancer Agents,"Terrence R Burke; PhD



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Fa  Liu



Won-Jun  Choi



Sung-Eun  Kim



Joshua D Thomas",NULL,"David S Waugh; PhD (Protein Engineering Section)



Donald P Bottaro; PhD (National Cancer Institute)



William  Farrar (National Cancer Institute)



Christoph  Rader; PhD (Experimental Transplantation and Immunology Branch)",NULL,"Ordered by publication type and then author name.



1.
Burke T, Kang S (2007) Preparation of orthogonally-protected 3-methoxy-4-phosphonomethyl-L-phenylalanine, a new reagent for the synthesis of phosphotyrosyl mimetic-containing peptides. Lett. Org. Chem. 433-439.




 



2.
Giubellino A, Gao Y, Lee S, Lee MJ, Vasselli JR, Medepalli S, Trepel JB, Burke TR, Bottaro DP (2007). Inhibition of tumor metastasis by a growth factor receptor bound protein 2 Src homology 2 domain-binding antagonist. Cancer Res  67, 6012-6.   https://doi.org/10.1158/0008-5472.CAN-07-0022




PubMed


 


PubMed ID 17616655
    
     


 



3.
Kang SU, Choi WJ, Oishi S, Lee K, Karki RG, Worthy KM, Bindu LK, Nicklaus MC, Fisher RJ, Burke TR (2007). Examination of acylated 4-aminopiperidine-4-carboxylic acid residues in the phosphotyrosyl+1 position of Grb2 SH2 domain-binding tripeptides. J Med Chem  50, 1978-82.   https://doi.org/10.1021/jm0614073




PubMed


 


PubMed ID 17371004
    
     


 



4.
Kim HJ, Kim JY, Meng Z, Wang LH, Liu F, Conrads TP, Burke TR, Veenstra TD, Farrar WL (2007). 15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. Cancer Res  67, 2595-602.   https://doi.org/10.1158/0008-5472.CAN-06-3043




PubMed


 


PubMed ID 17363578
    
     


 



5.
Liu F, Worthy KM, Bindu L, Giubellino A, Bottaro DP, Fisher RJ, Burke TR (2007). Utilization of achiral alkenyl amines for the preparation of high affinity Grb2 SH2 domain-binding macrocycles by ring-closing metathesis. Org Biomol Chem  5, 367-72.   https://doi.org/10.1039/b611887a




PubMed


 


PubMed ID 17205182
    
     


 



6.
Liu F, Worthy KM, Bindu LK, Fisher RJ, Burke TR (2007). Structural examination of ring-closing metathesis-derived 15-member macrocycles as Grb2 SH2 domain-binding tetrapeptide mimetics. J Org Chem  72, 9635-42.   https://doi.org/10.1021/jo701831q




PubMed



        
     
Free Article


 


PubMed ID 17990895
         Pubmed Central ID 2533429 


 



7.
Bottaro DP, Burke TP, Choyke SP, Dharmawardana (athauda) PP, Giubellino AP, Nicklaus MP, Peach MP, Shi ZP, Tan NP (submitted in 2007) Compositions And Methods For Inhibition Of Hepatocyte Growth Factor Receptor C-met Signaling. Patents issued: 8,754,081 (US in 2014); 8,569,360 (US in 2014); 2009231841 (AU in 2014). Patents pending: 09727676.0 (EP application); 11106440.0 (HK application); PCT/US2009/038915 (PC application); 2720350 (CA application).




 



8.
Rader C, Burke T, Hofer T, Thomas J (submitted in 2007) Selenocysteine Mediated Hybrid Antibody Molecules. Patent issued: 8,916,159 (US in 2015). Patent pending: 14/579,180 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=45255
63,BC007333-16,"October 01, 2006 -  September 30, 2007",Pharmacology of HIV Viral DNA & Retroviral Integrases,"Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Christophe  Marchand



Ann  Orr



Keli  Agama",NULL,"Robert  Yarchoan; MD (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)



Victor  Marquez; PhD (National Cancer Institute)



Stuart F J Le Grice; PhD (National Cancer Institute)",Donald M Jerina; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Chi G, Nair V, Semenova E, Pommier Y (2007). A novel diketo phosphonic acid that exhibits specific, strand-transfer inhibition of HIV integrase and anti-HIV activity. Bioorg Med Chem Lett  17, 1266-9.   https://doi.org/10.1016/j.bmcl.2006.12.009




PubMed



        
     
Free Article


 


PubMed ID 17188872
         Pubmed Central ID 1839884 


 



2.
Johnson AA, Marchand C, Patil SS, Costi R, Di Santo R, Burke TR, Pommier Y (2007). Probing HIV-1 integrase inhibitor binding sites with position-specific integrase-DNA cross-linking assays. Mol Pharmacol  71, 893-901.   https://doi.org/10.1124/mol.106.030817




PubMed


 


PubMed ID 17172465
    
     


 



3.
Liao C, Karki RG, Marchand C, Pommier Y, Nicklaus MC (2007). Virtual screening application of a model of full-length HIV-1 integrase complexed with viral DNA. Bioorg Med Chem Lett  17, 5361-5.   https://doi.org/10.1016/j.bmcl.2007.08.011




PubMed


 


PubMed ID 17719223
    
     


 



4.
Shults EE, Semenova EA, Johnson AA, Bondarenko SP, Bagryanskaya IY, Gatilov YV, Tolstikov GA, Pommier Y (2007). Synthesis and HIV-1 integrase inhibitory activity of spiroundecane(ene) derivatives. Bioorg Med Chem Lett  17, 1362-8.   https://doi.org/10.1016/j.bmcl.2006.11.094




PubMed



        
     
Free Article


 


PubMed ID 17189685
         Pubmed Central ID 1899478",https://intramural.nih.gov/search/searchview.taf?ipid=45256
64,BC007349-15,"October 01, 2006 -  September 30, 2007",New Strategies for Cancer Drug Discovery: Integrative Pharmacogenomics and Pharm,"John N Weinstein; MD, PhD",NULL,"Developmental Therapeutics Branch, NCI","Satoshi  Nishizuka



William Curtis Reinhold



Margot  Sunshine



Hong  Cao



David  Kane



Barry R Zeeberg; PhD



Show all 8","Michael  Barrett
(., TGen)




Paul  Blower
(., Ohio State Univ.)




Geoffrey  Cossman
(GeneLogic, Inc., .)




Carlo M Croce





Douglas  Dolginow
(., GeneLogic, Inc.)




Peggy  Eis
(., NimbleGen, Inc.)


Show all 20","Natasha  Caplen (National Cancer Institute)



Paul  Goldsmith; PhD (National Cancer Institute)



Robert H Stephens (National Cancer Institute)



Stefan  Ambs (National Cancer Institute)



Mirit I Aladjem; PhD (National Cancer Institute)



Frank Jess Gonzalez; PhD (National Cancer Institute)","Peter Jonathan Munson; BA, MA, PhD (CIT) 



Henry M. Fales; PhD (NHLBI)","Ordered by publication type and then author name.



1.
Blower PE, Verducci JS, Lin S, Zhou J, Chung JH, Dai Z, Liu CG, Reinhold W, Lorenzi PL, Kaldjian EP, Croce CM, Weinstein JN, Sadee W (2007). MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther  6, 1483-91.   https://doi.org/10.1158/1535-7163.MCT-07-0009




PubMed


 


PubMed ID 17483436
    
     


 



2.
Ikediobi ON, Reimers M, Durinck S, Blower PE, Futreal AP, Stratton MR, Weinstein JN (2008). In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation. Mol Cancer Ther  7, 1337-46.   https://doi.org/10.1158/1535-7163.MCT-07-2308




PubMed



        
     
Free Article


 


PubMed ID 18524847
         Pubmed Central ID 2705835 


 



3.
Lee JK, Havaleshko DM, Cho H, Weinstein JN, Kaldjian EP, Karpovich J, Grimshaw A, Theodorescu D (2007). A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proc Natl Acad Sci U S A  104, 13086-91.   https://doi.org/10.1073/pnas.0610292104




PubMed



        
     
Free Article


 


PubMed ID 17666531
         Pubmed Central ID 1941805 


 



4.
Liu H, D'Andrade P, Fulmer-Smentek S, Lorenzi P, Kohn KW, Weinstein JN, Pommier Y, Reinhold WC (2010). mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities. Mol Cancer Ther  9, 1080-91.   https://doi.org/10.1158/1535-7163.MCT-09-0965




PubMed



        
     
Free Article


 


PubMed ID 20442302
         Pubmed Central ID 2879615 


 



5.
Lorenzi PL, Reinhold WC, Varma S, Hutchinson AA, Pommier Y, Chanock SJ, Weinstein JN (2009). DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther  8, 713-24.   https://doi.org/10.1158/1535-7163.MCT-08-0921




PubMed



        
     
Free Article


 


PubMed ID 19372543
         Pubmed Central ID 4020356 


 



6.
Martin SE, Jones TL, Thomas CL, Lorenzi PL, Nguyen DA, Runfola T, Gunsior M, Weinstein JN, Goldsmith PK, Lader E, Huppi K, Caplen NJ (2007). Multiplexing siRNAs to compress RNAi-based screen size in human cells. Nucleic Acids Res  35, e57.   https://doi.org/10.1093/nar/gkm141




PubMed



        
     
Free Article


 


PubMed ID 17392344
         Pubmed Central ID 1885663 


 



7.
Okabe M, Szakács G, Reimers MA, Suzuki T, Hall MD, Abe T, Weinstein JN, Gottesman MM (2008). Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters. Mol Cancer Ther  7, 3081-91.   https://doi.org/10.1158/1535-7163.MCT-08-0539




PubMed



        
     
Free Article


 


PubMed ID 18790787
         Pubmed Central ID 2597359 


 



8.
Reinhold WC, Reimers MA, Maunakea AK, Kim S, Lababidi S, Scherf U, Shankavaram UT, Ziegler MS, Stewart C, Kouros-Mehr H, Cui H, Dolginow D, Scudiero DA, Pommier YG, Munroe DJ, Feinberg AP, Weinstein JN (2007). Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells. Mol Cancer Ther  6, 391-403.   https://doi.org/10.1158/1535-7163.MCT-06-0609




PubMed


 


PubMed ID 17272646
    
     


 



9.
Shankavaram UT, Reinhold WC, Nishizuka S, Major S, Morita D, Chary KK, Reimers MA, Scherf U, Kahn A, Dolginow D, Cossman J, Kaldjian EP, Scudiero DA, Petricoin E, Liotta L, Lee JK, Weinstein JN (2007). Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther  6, 820-32.   https://doi.org/10.1158/1535-7163.MCT-06-0650




PubMed


 


PubMed ID 17339364
    
     


 



10.
Sheehan KM, Gulmann C, Eichler GS, Weinstein JN, Barrett HL, Kay EW, Conroy RM, Liotta LA, Petricoin EF (2008). Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition. Oncogene  27, 323-31.   https://doi.org/10.1038/sj.onc.1210647




PubMed


 


PubMed ID 17621268
    
     


 



11.
Weinstein J, Reimers M, Yi M, Ludwig J, Luke B, Stephens R, Yfantis H, Lee D, Ambs S   (2007) The stromal gene expression signature is associated with inflammatory breast cancer and disease outcome.  International Journal of Cancer, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45257
65,BC007354-14,"October 01, 2006 -  September 30, 2007",Peptide-based Inhibitors of HDM2 Protein,Peter P Roller; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45258
66,BC007363-13,"October 01, 2006 -  September 30, 2007",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,"Terrence R Burke; PhD



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI",Fa  Liu,"Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)




Nouri  Neamati
(NCI)","Yves  Pommier; PhD (National Cancer Institute)



Eric O Freed; PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Johnson AA, Marchand C, Patil SS, Costi R, Di Santo R, Burke TR, Pommier Y (2007). Probing HIV-1 integrase inhibitor binding sites with position-specific integrase-DNA cross-linking assays. Mol Pharmacol  71, 893-901.   https://doi.org/10.1124/mol.106.030817




PubMed


 


PubMed ID 17172465
    
     


 



2.
Liu F, Stephen AG, Adamson CS, Gousset K, Aman MJ, Freed EO, Fisher RJ, Burke TR (2006). Hydrazone- and hydrazide-containing N-substituted glycines as peptoid surrogates for expedited library synthesis: application to the preparation of Tsg101-directed HIV-1 budding antagonists. Org Lett  8, 5165-8.   https://doi.org/10.1021/ol0622211




PubMed



        
     
Free Article


 


PubMed ID 17048869
         Pubmed Central ID 2547129 


 



3.
Ogura K, Shiga T, Yokochi M, Yuzawa S, Burke TR, Inagaki F (2008). Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor. J Biomol NMR  42, 197-207.   https://doi.org/10.1007/s10858-008-9272-0




PubMed



        
     
Free Article


 


PubMed ID 18830565
         Pubmed Central ID 3719385 


 



4.
Thomas JD, Hofer T, Rader C, Burke TR (2008). Application of a trifunctional reactive linker for the construction of antibody-drug hybrid conjugates. Bioorg Med Chem Lett  18, 5785-8.   https://doi.org/10.1016/j.bmcl.2008.09.078




PubMed



        
     
Free Article


 


PubMed ID 18922692
         Pubmed Central ID 3461582",https://intramural.nih.gov/search/searchview.taf?ipid=45259
67,BC007365-13,"October 01, 2006 -  September 30, 2007",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Xiaoying  Jian; PhD



Hye-Young  Yoon



Fanny  Campa



Vi Luan  Ha



Hiroki  Inoue



Sanita  Bharti



Show all 7",NULL,Lino  Tessarollo (National Cancer Institute),"Kenneth Manao Yamada; MD, PhD (NIDCR) 



Susette C Mueller; PhD (NIDCR) 



James  Gruschus; PhD (NHLBI) 



J Silvio  Gutkind; PhD (NIDCR)","Ordered by publication type and then author name.



1.
Inoue H, Randazzo PA (2007). Arf GAPs and their interacting proteins. Traffic  8, 1465-75.   https://doi.org/10.1111/j.1600-0854.2007.00624.x




PubMed


 


PubMed ID 17666108
    
     


 



2.
Luo R, Ahvazi B, Amariei D, Shroder D, Burrola B, Losert W, Randazzo PA (2007). Kinetic analysis of GTP hydrolysis catalysed by the Arf1-GTP-ASAP1 complex. Biochem J  402, 439-47.   https://doi.org/10.1042/BJ20061217




PubMed



        
     
Free Article


 


PubMed ID 17112341
         Pubmed Central ID 1863566 


 



3.
Zhang Q, Major MB, Takanashi S, Camp ND, Nishiya N, Peters EC, Ginsberg MH, Jian X, Randazzo PA, Schultz PG, Moon RT, Ding S (2007). Small-molecule synergist of the Wnt/beta-catenin signaling pathway. Proc Natl Acad Sci U S A  104, 7444-8.   https://doi.org/10.1073/pnas.0702136104




PubMed



        
     
Free Article


 


PubMed ID 17460038
         Pubmed Central ID 1863490",https://intramural.nih.gov/search/searchview.taf?ipid=45260
68,BC008000-37,"October 01, 2006 -  September 30, 2007",Regulation of EGFR Gene Activity,Alfred Charles Johnson; PhD,NULL,"Laboratory of Molecular Biology, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45261
69,BC008226-31,"October 01, 2006 -  September 30, 2007",Prolactin Interactions in Mammary Gland Development and Tumorigenesis,Barbara V Vonderhaar; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Renqin  Duan



Erika P Ginsburg



Anita  Goldhar



Jessica M Faupel-Badger



Joshua James Plant



Luwanda  Jenkins



Show all 8","Patricia  Berg
(George Washington University)




Kennichi  Satoh
(Gastroenterology, Tohoku University School of Medicine)","Nancy A Potischman (National Cancer Institute)



Paul  Goldsmith; PhD (National Cancer Institute)



David  Salomon; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Li W, Xiao C, Vonderhaar BK, Deng CX (2007). A role of estrogen/ERalpha signaling in BRCA1-associated tissue-specific tumor formation. Oncogene  26, 7204-12.   https://doi.org/10.1038/sj.onc.1210527




PubMed


 


PubMed ID 17496925
    
     


 



2.
Satoh K, Hovey RC, Malewski T, Warri A, Goldhar AS, Ginsburg E, Saito K, Lydon JP, Vonderhaar BK (2007). Progesterone enhances branching morphogenesis in the mouse mammary gland by increased expression of Msx2. Oncogene  26, 7526-34.   https://doi.org/10.1038/sj.onc.1210555




PubMed


 


PubMed ID 17546050",https://intramural.nih.gov/search/searchview.taf?ipid=45262
70,BC008281-25,"October 01, 2006 -  September 30, 2007",Protein kinase A and Human Cancer: Translational Research,"Yoon S Cho-Chung; MD, PhD",NULL,"Basic Research Laboratory, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45263
71,BC008303-35,"October 01, 2006 -  September 30, 2007",Regulation of Membrane Fusion by Viral and Cellular Proteins and Lipids,"Robert  Blumenthal; PhD



IRP Faculty Profile",NULL,"Center for Cancer Research Nanobiology Program, NCI","Anu  Puri; PhD



Yossef  Raviv



Mathias  Viard



Benitra T Johnson



Himanshu  Garg



Amy L Jacobs



Show all 9","Javad  Aman
(Medicine, USAMRID)




Robert W Doms; MD, PhD
(Microbiology, University of Pennsylvania)




Alfredo  Garzino-Demo
(Dept of Medicine, University of Maryland Biotechnology Institute)




Alfredo  Garzino-Demo
(Dept of Medicine, University of Maryland Biotechnology Institute)




Robert  Hogan
(Image Analysis Lab,Research Technology Program, University of Georgia)




James  Hoxie
(CFAR, UPenn)


Show all 11","Victor  Marquez; PhD (National Cancer Institute)



Ji Ming  Wang; MD, PhD (National Cancer Institute)



Vineet Narain KewalRamani; PhD (National Cancer Institute)



Jeffrey D Lifson; MD (National Cancer Institute)



Eric O Freed; PhD (National Cancer Institute)



Stephen J Lockett; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Blumenthal R, Dimitrov DS (2007). Targeting the sticky fingers of HIV-1. Cell  129, 243-5.   https://doi.org/10.1016/j.cell.2007.04.005




PubMed


 


PubMed ID 17448985
    
     


 



2.
Dimitrov AS, Jacobs A, Finnegan CM, Stiegler G, Katinger H, Blumenthal R (2007). Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion. Biochemistry  46, 1398-401.   https://doi.org/10.1021/bi062245f




PubMed


 


PubMed ID 17260969
    
     


 



3.
Finnegan CM, Rawat SS, Cho EH, Guiffre DL, Lockett S, Merrill AH, Blumenthal R (2007). Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion. J Virol  81, 5294-304.   https://doi.org/10.1128/JVI.02553-06




PubMed



        
     
Free Article


 


PubMed ID 17344303
         Pubmed Central ID 1900240 


 



4.
Garg H, Joshi A, Freed EO, Blumenthal R (2007). Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion. J Biol Chem  282, 16899-906.   https://doi.org/10.1074/jbc.M701701200




PubMed


 


PubMed ID 17416587
    
     


 



5.
Jacobs A, Quraishi O, Huang X, Bousquet-Gagnon N, Nault G, Francella N, Alvord WG, Pham N, Soucy C, Robitaille M, Bridon D, Blumenthal R (2007). A covalent inhibitor targeting an intermediate conformation of the fusogenic subunit of the HIV-1 envelope complex. J Biol Chem  282, 32406-13.   https://doi.org/10.1074/jbc.M705577200




PubMed


 


PubMed ID 17726011
    
     


 



6.
Sharma A, Raviv Y, Puri A, Viard M, Blumenthal R, Maheshwari RK (2007). Complete inactivation of Venezuelan equine encephalitis virus by 1,5-iodonaphthylazide. Biochem Biophys Res Commun  358, 392-8.   https://doi.org/10.1016/j.bbrc.2007.04.115




PubMed


 


PubMed ID 17493582",https://intramural.nih.gov/search/searchview.taf?ipid=45264
72,BC008382-24,"October 01, 2006 -  September 30, 2007",Computer Analysis of Nucleic Acid Structure,"Bruce Allen Shapiro; PhD



IRP Faculty Profile",NULL,"Center for Cancer Research Nanobiology Program, NCI","Kazimierz Wojcieck Kasprzak



Whitney A Hastings



Yaroslava G Yingling; PhD



Eckart  Bindewald



Robert G Hayes



Calvin P Grunewald","Juan  Arroyo
(Developmental Biology, Mitre Corporation)




John  Casey
(Microbiology and Immunology, Georgetown University)




Gregory  Chirikjian
(Mechanical Engineering, Johns Hopkins University)




John  Grefenstette
(Bioinformatics and Compuational BIology, George Mason University)




Luc  Jaeger
(University of California Santa Barbara)




Hugo  Martinez
(Consultant, SAIC)


Show all 12","Shu Yun  Le (National Cancer Institute)



Yun  Wang (Nucleic Acid NMR Section)



Nancy H Colburn; PhD (National Cancer Institute)



Thomas Dana Schneider; PhD (National Cancer Institute)","Jack A Ragheb (NEI) 



Richard D Leapman; PhD (NIBIB)","Ordered by publication type and then author name.



1.
Shapiro B, Wen D, Herbert K, Li J, Ghosh K   (2007) Toward an Integrated RNA Motif Database., in Data Integration in the Life Sciences/Lecture Notes in Bioinformatics. Cohen-Boulakia S, Tannen V, eds., Springer (Berlin), pp. 27-36.




 



2.
Khaladkar M, Bellofatto V, Wang JT, Tian B, Shapiro BA (2007). RADAR: a web server for RNA data analysis and research. Nucleic Acids Res  35, W300-4.   https://doi.org/10.1093/nar/gkm253




PubMed



        
     
Free Article


 


PubMed ID 17517784
         Pubmed Central ID 1933136 


 



3.
Shapiro BA, Yingling YG, Kasprzak W, Bindewald E (2007). Bridging the gap in RNA structure prediction. Curr Opin Struct Biol  17, 157-65.   https://doi.org/10.1016/j.sbi.2007.03.001




PubMed


 


PubMed ID 17383172
    
     


 



4.
Yingling YG, Shapiro BA (2007). Computational design of an RNA hexagonal nanoring and an RNA nanotube. Nano Lett  7, 2328-34.   https://doi.org/10.1021/nl070984r




PubMed


 


PubMed ID 17616164
    
     


 



5.
Yingling YG, Shapiro BA (2007). The impact of dyskeratosis congenita mutations on the structure and dynamics of the human telomerase RNA pseudoknot domain. J Biomol Struct Dyn  24, 303-20.   https://doi.org/10.1080/07391102.2007.10531238




PubMed


 


PubMed ID 17206847",https://intramural.nih.gov/search/searchview.taf?ipid=45266
73,BC008396-19,"October 01, 2006 -  September 30, 2007",Molecular Information Theory,Thomas Dana Schneider; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Ilya  Lyakhov



Danielle  Needle



Adam C Diehl



Peyman  Khalichi; PhD","Paul  Anagnostopoulos
(-, Windfall Software)




Zehua  Chen





Henry  Hess
(Department of Materials Science and Engineering, University of Florida)




Karen A Lewis





Peter  Rogan
(Laboratory of Human Molecular Genetics, The Children's Mercy Hospital)




Kenneth E. Rudd; PhD
(Department of Biochemistry and Molecular Biology, University of Miami School of Medicine)


Show all 9","Donald L Court; PhD (National Cancer Institute)



Ding Jun Jin (National Cancer Institute)



Mikhail V Kashlev (National Cancer Institute)



Robert J Fisher (National Cancer Institute)



Bruce Allen Shapiro; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Shultzaberger RK, Chen Z, Lewis KA, Schneider TD (2007). Anatomy of Escherichia coli sigma70 promoters. Nucleic Acids Res  35, 771-88.   https://doi.org/10.1093/nar/gkl956




PubMed



        
     
Free Article


 


PubMed ID 17189297
         Pubmed Central ID 1807945 


 



2.
Shultzaberger RK, Roberts LR, Lyakhov IG, Sidorov IA, Stephen AG, Fisher RJ, Schneider TD (2007). Correlation between binding rate constants and individual information of E. coli Fis binding sites. Nucleic Acids Res  35, 5275-83.   https://doi.org/10.1093/nar/gkm471




PubMed



        
     
Free Article


 


PubMed ID 17617646
         Pubmed Central ID 2018646",https://intramural.nih.gov/search/searchview.taf?ipid=45267
74,BC008579-14,"October 01, 2006 -  September 30, 2007",Functional Analysis of Cancer Genes from Human Chromosome 3p,"Michael I Lerman; MD, PhD",NULL,"Basic Research Laboratory, NCI",Razi  Raziuddin,"Deborah  Angelony
(Biochemistry, Scuola Superiore Sant'Anna and IFC-CNR)




Charles  Buys
(Genetics, University of Groningen)




George  Klein
(MTC, Karolinska Institute)




Shu  Liao
(Pathology, UCI)




Dusty  Miller
(Basic Science, Fred Hutchinson Cancer Institute,)




Eric  Stanbridge
(Microbiology, UCI)


Show all 7",NULL,"Richard  Childs; MD (NHLBI) 



Arya  Biragyn; PhD (NIA)","Ordered by publication type and then author name.



1.
Angeloni D, Danilkovitch-Miagkova A, Ivanova T, Braga E, Zabarovsky E, Lerman MI (2007). Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter. Oncogene  26, 4499-512.   https://doi.org/10.1038/sj.onc.1210238




PubMed


 


PubMed ID 17297469
    
     


 



2.
Ivanov SV, Ivanova AV, Salnikow K, Timofeeva O, Subramaniam M, Lerman MI (2008). Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors. Biochem Biophys Res Commun  370, 536-40.   https://doi.org/10.1016/j.bbrc.2008.03.066




PubMed



        
     
Free Article


 


PubMed ID 18359287
         Pubmed Central ID 2413015 


 



3.
Ivanova AV, Ivanov SV, Pascal V, Lumsden JM, Ward JM, Morris N, Tessarolo L, Anderson SK, Lerman MI (2007). Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1. J Pathol  211, 591-601.   https://doi.org/10.1002/path.2146




PubMed


 


PubMed ID 17318811
    
     


 



4.
Lo PH, Xie D, Chan KC, Xu FP, Kuzmin I, Lerman MI, Law S, Chua D, Sham J, Lung ML (2007). Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage. Cancer Lett  257, 199-205.   https://doi.org/10.1016/j.canlet.2007.07.018




PubMed


 


PubMed ID 17720308",https://intramural.nih.gov/search/searchview.taf?ipid=45268
75,BC008710-29,"October 01, 2006 -  September 30, 2007",Molecular Chaperones and DNA Replication,"Sue H Wickner; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Joel R Hoskins



Matthew R Chenoweth; BA



Shannon M Doyle



Jodi  Camberg","Susan  Lindquist
(Biology, Whiteheat Institute for Biomedical Research)




James  Shorter
(MIT)




Nancy  Trun; PhD
(NCI)




Michal  Zolkiewski; PhD
(Kansas State University)",Susan  Gottesman; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Chenoweth MR, Trun N, Wickner S (2007). In vivo modulation of a DnaJ homolog, CbpA, by CbpM. J Bacteriol  189, 3635-8.   https://doi.org/10.1128/JB.01757-06




PubMed



        
     
Free Article


 


PubMed ID 17337578
         Pubmed Central ID 1855902 


 



2.
Doyle SM, Hoskins JR, Wickner S (2007). Collaboration between the ClpB AAA+ remodeling protein and the DnaK chaperone system. Proc Natl Acad Sci U S A  104, 11138-44.   https://doi.org/10.1073/pnas.0703980104




PubMed



        
     
Free Article


 


PubMed ID 17545305
         Pubmed Central ID 2040865 


 



3.
Doyle SM, Shorter J, Zolkiewski M, Hoskins JR, Lindquist S, Wickner S (2007). Asymmetric deceleration of ClpB or Hsp104 ATPase activity unleashes protein-remodeling activity. Nat Struct Mol Biol  14, 114-22.   https://doi.org/10.1038/nsmb1198




PubMed



        
     
Free Article


 


PubMed ID 17259993
         Pubmed Central ID 1793998",https://intramural.nih.gov/search/searchview.taf?ipid=45189
76,BC008714-30,"October 01, 2006 -  September 30, 2007",Bacterial Functions Involved in Cell Growth Control,"Susan  Gottesman; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Nadim  Majdalani



Colleen A Mccullen



Maude  Guillier



Pierre Marquis Mandin



Kyung  Moon



Alexandre  Bougdour",NULL,"David J Fitzgerald; PhD (National Cancer Institute)



Sue H Wickner; PhD (DNA Molecular Biology Section)



Yan Ning H Zhou (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)



Michael  Maurizi; PhD (National Cancer Institute)



Peter C Fitzgerald (National Cancer Institute)",Stephen H Leppla; PhD (NIAID),"Ordered by publication type and then author name.



1.
Bougdour A, Gottesman S (2007). ppGpp regulation of RpoS degradation via anti-adaptor protein IraP. Proc Natl Acad Sci U S A  104, 12896-901.   https://doi.org/10.1073/pnas.0705561104




PubMed



        
     
Free Article


 


PubMed ID 17640895
         Pubmed Central ID 1937563 


 



2.
Gottesman S, McCullen CA, Guillier M, Vanderpool CK, Majdalani N, Benhammou J, Thompson KM, FitzGerald PC, Sowa NA, FitzGerald DJ (2006). Small RNA regulators and the bacterial response to stress. Cold Spring Harb Symp Quant Biol  71, 1-11.   https://doi.org/10.1101/sqb.2006.71.016




PubMed



        
     
Free Article


 


PubMed ID 17381274
         Pubmed Central ID 3592358 


 



3.
Majdalani N, Gottesman S (2007). Genetic dissection of signaling through the Rcs phosphorelay. Methods Enzymol  423, 349-62.   https://doi.org/10.1016/S0076-6879(07)23016-2




PubMed


 


PubMed ID 17609140
    
     


 



4.
Ranquet C, Gottesman S (2007). Translational regulation of the Escherichia coli stress factor RpoS: a role for SsrA and Lon. J Bacteriol  189, 4872-9.   https://doi.org/10.1128/JB.01838-06




PubMed



        
     
Free Article


 


PubMed ID 17449615
         Pubmed Central ID 1913435 


 



5.
Thompson KM, Rhodius VA, Gottesman S (2007). SigmaE regulates and is regulated by a small RNA in Escherichia coli. J Bacteriol  189, 4243-56.   https://doi.org/10.1128/JB.00020-07




PubMed



        
     
Free Article


 


PubMed ID 17416652
         Pubmed Central ID 1913397 


 



6.
Vanderpool CK, Gottesman S (2007). The novel transcription factor SgrR coordinates the response to glucose-phosphate stress. J Bacteriol  189, 2238-48.   https://doi.org/10.1128/JB.01689-06




PubMed



        
     
Free Article


 


PubMed ID 17209026
         Pubmed Central ID 1899371",https://intramural.nih.gov/search/searchview.taf?ipid=45269
77,BC008727-29,"October 01, 2006 -  September 30, 2007",Gene Expression and Signal Transduction in Transformation and Differentiation,J. Frederic Mushinski; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","James D Owens



Shalu  Gupta



Leigh-Ann  Cruz



Jason  Legrand","Siegfried  Janz
(Department of Pathology, University of Iowa, Carver College of Medicine)




Sabine  Mai
(Institute of Cell Biology, University of Manitoba)




Larisa  Romanova
(Massachusetts General Cancer Center, Harvard Medical School)




John  Shaughnessy
(Laboratory of Myeloma Genetics, University of Arkansas for Medical Sciences)




Qiming  Wang
(NCI)","Konrad  Huppi; MD, PhD (National Cancer Institute)



Joanna H Shih (National Cancer Institute)",Robert F Bonner; PhD (NICHD),"Ordered by publication type and then author name.



1.
Mushinski J, Shaughnessy J, Gupta S, Wang H, Lee J, Woo H, Zhan F, Owens J, Potter M, Janz S   (2007) Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.  BMC Genomics  302 pp.




 



2.
Park ES, Lee JS, Woo HG, Zhan F, Shih JH, Shaughnessy JD, Frederic Mushinski J (2007). Heterologous tissue culture expression signature predicts human breast cancer prognosis. PLoS One  2, e145.   https://doi.org/10.1371/journal.pone.0000145




PubMed



        
     
Free Article


 


PubMed ID 17206280
         Pubmed Central ID 1764035",https://intramural.nih.gov/search/searchview.taf?ipid=45270
78,BC008751-27,"October 01, 2006 -  September 30, 2007",Regulation of Gene Transcription,"Sankar  Adhya; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Sudeshna  Kar



Konstantin  Virnik



Dale  Lewis; PhD



Thomas  Soares



Andrei  Trostel



Sang Jun  Lee



Show all 9","Laura  Finzi
(University of Milan)




Kim  Sneppen
(Center for Models of Life, Niels Bohr Institute)",Victor  Zhurkin; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Court DL, Oppenheim AB, Adhya SL (2007). A new look at bacteriophage lambda genetic networks. J Bacteriol  189, 298-304.   https://doi.org/10.1128/JB.01215-06




PubMed



        
     
Free Article


 


PubMed ID 17085553
         Pubmed Central ID 1797383 


 



2.
Guo F, Adhya S (2007). Spiral structure of Escherichia coli HUalphabeta provides foundation for DNA supercoiling. Proc Natl Acad Sci U S A  104, 4309-14.   https://doi.org/10.1073/pnas.0611686104




PubMed



        
     
Free Article


 


PubMed ID 17360520
         Pubmed Central ID 1838598",https://intramural.nih.gov/search/searchview.taf?ipid=45271
79,BC008752-27,"October 01, 2006 -  September 30, 2007",Thyroid Hormone Receptors in Health and Disease,"Sheueyann  Cheng; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Li  Zhou; PhD



Hao  Ying



Osamu  Araki



Celine Julie Guigon



Changxue  Lu","John  Lazarus
(College of Medicine, UK, University of Wales)




J.K.  Liao
(Harvard University, Harvard University)




CHRIS  MCCABE
(University of Birmingham)




MICHAEL  MCDONALD
(Vanderbilt University)




MICHAEL  MCDONALD
(Vanderbilt University)




T  Scnalon
(University of California SanFrancisco Medical Center, University of California San Francisco Medical Center)


Show all 8","Paul S Meltzer; MD, PhD (National Cancer Institute)



Chandramouli  Gadisetti (National Cancer Institute)",John Allan Hanover; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Cheng S (2007) Thyroid hormone receptor mutations and disease: insights from knockin mouse models. Exp. Rvw. of Endocrinol. Metabolism 47-57.




 



2.
Cheng S, Willingham M   (2007) The steroid receptor coactivator-3 is a tumor promoter in a mouse model of  thyroid cancer.  Oncogene, in press.




 



3.
Furuya F, Guigon CJ, Zhao L, Lu C, Hanover JA, Cheng SY (2007). Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling. Mol Cell Biol  27, 6116-26.   https://doi.org/10.1128/MCB.00900-07




PubMed



        
     
Free Article


 


PubMed ID 17606624
         Pubmed Central ID 1952145 


 



4.
Furuya F, Lu C, Willingham MC, Cheng SY (2007). Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer. Carcinogenesis  28, 2451-8.   https://doi.org/10.1093/carcin/bgm174




PubMed


 


PubMed ID 17660507
    
     


 



5.
Furuya F, Ying H, Zhao L, Cheng SY (2007). Novel functions of thyroid hormone receptor mutants: beyond nucleus-initiated transcription. Steroids  72, 171-9.   https://doi.org/10.1016/j.steroids.2006.11.005




PubMed



        
     
Free Article


 


PubMed ID 17169389
         Pubmed Central ID 2794798 


 



6.
Kim CS, Ying H, Willingham MC, Cheng SY (2007). The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer. Carcinogenesis  28, 932-9.   https://doi.org/10.1093/carcin/bgl231




PubMed


 


PubMed ID 17127711
    
     


 



7.
O'Shea PJ, Guigon CJ, Williams GR, Cheng SY (2007). Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone: identification of a thyroid hormone response element in the murine Fgfr1 promoter. Endocrinology  148, 5966-76.   https://doi.org/10.1210/en.2007-0114




PubMed


 


PubMed ID 17761769
    
     


 



8.
Owen PJ, Ying H, Lang D, Tomlinson D, Lewis MJ, Cheng SY, Lazarus JH (2007). Endothelial dysfunction in a murine model of thyroid hormone resistance. Eur J Clin Invest  37, 390-5.   https://doi.org/10.1111/j.1365-2362.2007.01799.x




PubMed


 


PubMed ID 17461985
    
     


 



9.
Pemberton HN, Franklyn JA, Boelaert K, Chan SY, Kim DS, Kim C, Cheng SY, Kilby MD, McCabe CJ (2007). Separase, securin and Rad21 in neural cell growth. J Cell Physiol  213, 45-53.   https://doi.org/10.1002/jcp.21086




PubMed


 


PubMed ID 17450531
    
     


 



10.
Ying H, Araki O, Furuya F, Kato Y, Cheng SY (2007). Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor. Mol Cell Biol  27, 2359-71.   https://doi.org/10.1128/MCB.02189-06




PubMed



        
     
Free Article


 


PubMed ID 17220280
         Pubmed Central ID 1820484",https://intramural.nih.gov/search/searchview.taf?ipid=45272
80,BC008753-25,"October 01, 2006 -  September 30, 2007",Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Masanori  Onda



Richard A Beers



Mitchell  Ho



Tomoko  Ise



Satoshi  Nagata; PhD



Laiman  Xiang



Show all 10","DARELL  BIGNER
(Dept of Pathology, Duke University Medical Center, Dept. of Pathology)




Giuliana  Salvatore
(Universita degli Studi di Napoli)","David J Fitzgerald; PhD (National Cancer Institute)



Raffit  Hassan (National Cancer Institute)



Robert J Kreitman; MD, PhD (National Cancer Institute)",Jorge A Carrasquillo; MD (CC),"Ordered by publication type and then author name.



1.
Du X, Ho M, Pastan I (2007). New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells. J Immunother  30, 607-13.   https://doi.org/10.1097/CJI.0b013e318053ed8e




PubMed


 


PubMed ID 17667524
    
     


 



2.
Ho M, Bera TK, Willingham MC, Onda M, Hassan R, FitzGerald D, Pastan I (2007). Mesothelin expression in human lung cancer. Clin Cancer Res  13, 1571-5.   https://doi.org/10.1158/1078-0432.CCR-06-2161




PubMed


 


PubMed ID 17332303
    
     


 



3.
Ise T, Nagata S, Kreitman RJ, Wilson WH, Wayne AS, Stetler-Stevenson M, Bishop MR, Scheinberg DA, Rassenti L, Kipps TJ, Kyle RA, Jelinek DF, Pastan I (2007). Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma. Leukemia  21, 169-74.   https://doi.org/10.1038/sj.leu.2404445




PubMed


 


PubMed ID 17051241
    
     


 



4.
Motoyoshi Y, Matsusaka T, Saito A, Pastan I, Willnow TE, Mizutani S, Ichikawa I (2008). Megalin contributes to the early injury of proximal tubule cells during nonselective proteinuria. Kidney Int  74, 1262-9.   https://doi.org/10.1038/ki.2008.405




PubMed



        
     
Free Article


 


PubMed ID 18769366
         Pubmed Central ID 2615689 


 



5.
Ochiai H, Archer GE, Herndon JE, Kuan CT, Mitchell DA, Bigner DD, Pastan IH, Sampson JH (2008). EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells. Cancer Immunol Immunother  57, 115-21.   https://doi.org/10.1007/s00262-007-0363-7




PubMed



        
     
Free Article


 


PubMed ID 17634939
         Pubmed Central ID 2846815 


 



6.
Pastan I, Hassan R, FitzGerald DJ, Kreitman RJ (2007). Immunotoxin treatment of cancer. Annu Rev Med  58, 221-37.   https://doi.org/10.1146/annurev.med.58.070605.115320




PubMed


 


PubMed ID 17059365
    
     


 



7.
Pastan IH, Fitzgerald DH, Weldon JH (submitted in 2007) Deletions In Domain Ii Of Pseudomonas Exotoxin A That Reduce Non-specific Toxicity. Patents issued: 2008296194 (AU in 2013); 2197903 (BE in 2015); 2197903 (BG in 2015); 2197903 (CH in 2015); 2197903 (CY in 2015); 2197903 (DE in 2015); 2197903 (DK in 2015); 2197903 (EE in 2015); 2197903 (EP in 2015); 2197903 (ES in 2015); 2197903 (FI in 2015); 2197903 (FR in 2015); 2197903 (AT in 2015); 2197903 (GB in 2015); 2197903 (GR in 2015); 2197903 (cr in 2015); 2197903 (HU in 2015); 2197903 (IE in 2015); 2197903 (IT in 2015); 2197903 (LT in 2015); 2197903 (LU in 2015); 2197903 (LV in 2015); 2197903 (MC in 2015); 2197903 (MT in 2015); 2197903 (NL in 2015); 2197903 (NO in 2015); 2197903 (PL in 2015); 2197903 (PT in 2015); 2197903 (RO in 2015); 2197903 (SI in 2015); 2197903 (SK in 2015); 2197903 (TR in 2015); 8,871,906 (US in 2015); 2698357 (CA in 2017); 2570425 (EP in 2017); 2570425 (ES in 2018). Patents pending: 12184319.7 (DE application); 12184319.7 (FR application); 12184319.7 (GB application); 13106628.2 (HK application); 12184319.7 (IT application); PCT/US2008/075296 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45273
81,BC008756-20,"October 01, 2006 -  September 30, 2007",Genetically Engineered Mice as Models to Study Receptor Tyrosine Kinase Function,"Glenn  Merlino; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Chamelli  Jhappan; PhD



Yanlin  Yu



Richard D Sharp



Linan  Ha



Muhammad R Zaidi



Chi-Ping  Day","Dot  Bennett
(St. George's Hospital Medical School)




Edward  De Fabo
(GWU)




Ron  DePinho
(Dana Farber, Harvard)




Frances  Noonan
(GWU)




Hitoshi  Takagi
(First Dept of Internal Medicien, Gunma University School of Medicine)




Timothy  Triche
(Keck School of Medicine, USC)


Show all 7","Javed  Khan; MD (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)



Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)



Miriam R Anver (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)



Paul S Meltzer; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Booth BW, Jhappan C, Merlino G, Smith GH (2007). TGFbeta1 and TGFalpha contrarily affect alveolar survival and tumorigenesis in mouse mammary epithelium. Int J Cancer  120, 493-9.   https://doi.org/10.1002/ijc.22310




PubMed


 


PubMed ID 17096338
    
     


 



2.
Gareau DS, Merlino G, Corless C, Kulesz-Martin M, Jacques SL (2007). Noninvasive imaging of melanoma with reflectance mode confocal scanning laser microscopy in a murine model. J Invest Dermatol  127, 2184-90.   https://doi.org/10.1038/sj.jid.5700829




PubMed


 


PubMed ID 17460734
    
     


 



3.
Ha L, Ichikawa T, Anver M, Dickins R, Lowe S, Sharpless NE, Krimpenfort P, Depinho RA, Bennett DC, Sviderskaya EV, Merlino G (2007). ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence. Proc Natl Acad Sci U S A  104, 10968-73.   https://doi.org/10.1073/pnas.0611638104




PubMed



        
     
Free Article


 


PubMed ID 17576930
         Pubmed Central ID 1904138 


 



4.
Merlino G, Khanna C (2007). Fishing for the origins of cancer. Genes Dev  21, 1275-9.   https://doi.org/10.1101/gad.1563707




PubMed


 


PubMed ID 17545462
    
     


 



5.
Varticovski L, Hollingshead MG, Robles AI, Wu X, Cherry J, Munroe DJ, Lukes L, Anver MR, Carter JP, Borgel SD, Stotler H, Bonomi CA, Nunez NP, Hursting SD, Qiao W, Deng CX, Green JE, Hunter KW, Merlino G, Steeg PS, Wakefield LM, Barrett JC (2007). Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models. Clin Cancer Res  13, 2168-77.   https://doi.org/10.1158/1078-0432.CCR-06-0918




PubMed


 


PubMed ID 17404101",https://intramural.nih.gov/search/searchview.taf?ipid=45274
82,BC008757-20,"October 01, 2006 -  September 30, 2007",Bio-Therapies for the Treatment of Cancer and Infectious Disease,"David J Fitzgerald; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Robert J Sarnovsky



Diana  Pastrana","Everett  Greenberg
(Microbiology, U of Washington)




Randall  Mrsny
(Trinity Biosystems)","Ira H Pastan; MD (National Cancer Institute)



Sankar  Adhya; PhD (National Cancer Institute)



Susan  Gottesman; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Pastan IH, Fitzgerald DH, Weldon JH (submitted in 2007) Deletions In Domain Ii Of Pseudomonas Exotoxin A That Reduce Non-specific Toxicity. Patents issued: 2008296194 (AU in 2013); 2197903 (BE in 2015); 2197903 (BG in 2015); 2197903 (CH in 2015); 2197903 (CY in 2015); 2197903 (DE in 2015); 2197903 (DK in 2015); 2197903 (EE in 2015); 2197903 (EP in 2015); 2197903 (ES in 2015); 2197903 (FI in 2015); 2197903 (FR in 2015); 2197903 (AT in 2015); 2197903 (GB in 2015); 2197903 (GR in 2015); 2197903 (cr in 2015); 2197903 (HU in 2015); 2197903 (IE in 2015); 2197903 (IT in 2015); 2197903 (LT in 2015); 2197903 (LU in 2015); 2197903 (LV in 2015); 2197903 (MC in 2015); 2197903 (MT in 2015); 2197903 (NL in 2015); 2197903 (NO in 2015); 2197903 (PL in 2015); 2197903 (PT in 2015); 2197903 (RO in 2015); 2197903 (SI in 2015); 2197903 (SK in 2015); 2197903 (TR in 2015); 8,871,906 (US in 2015); 2698357 (CA in 2017); 2570425 (EP in 2017); 2570425 (ES in 2018). Patents pending: 12184319.7 (DE application); 12184319.7 (FR application); 12184319.7 (GB application); 13106628.2 (HK application); 12184319.7 (IT application); PCT/US2008/075296 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45275
83,BC008759-16,"October 01, 2006 -  September 30, 2007",Molecular Modeling and Bioinformatics,"Byungkook  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Bangalore K Sathyanarayana



Chin-Hsien  Tai



Changhoon  Kim","Jean  Garnier; PhD





Jean-Francois  Gibrat
(Mathematique Informatique et Genome, INRA)",Ira H Pastan; MD (National Cancer Institute),"Peter Jonathan Munson; BA, MA, PhD (CIT)","Ordered by publication type and then author name.



1.
Das S, Hahn Y, Nagata S, Willingham MC, Bera TK, Lee B, Pastan I (2007). NGEP, a prostate-specific plasma membrane protein that promotes the association of LNCaP cells. Cancer Res  67, 1594-601.   https://doi.org/10.1158/0008-5472.CAN-06-2673




PubMed


 


PubMed ID 17308099
    
     


 



2.
Das S, Hahn Y, Walker DA, Nagata S, Willingham MC, Peehl DM, Bera TK, Lee B, Pastan I (2008). Topology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade level. Cancer Res  68, 6306-12.   https://doi.org/10.1158/0008-5472.CAN-08-0870




PubMed



        
     
Free Article


 


PubMed ID 18676855
         Pubmed Central ID 2562772 


 



3.
Grigoryev DN, Ma SF, Shimoda LA, Johns RA, Lee B, Garcia JG (2007). Exon-based mapping of microarray probes: recovering differential gene expression signal in underpowered hypoxia experiment. Mol Cell Probes  21, 134-9.   https://doi.org/10.1016/j.mcp.2006.09.002




PubMed



        
     
Free Article


 


PubMed ID 17071053
         Pubmed Central ID 1852466 


 



4.
Hahn Y, Jeong S, Lee B (2007). Inactivation of MOXD2 and S100A15A by exon deletion during human evolution. Mol Biol Evol  24, 2203-12.   https://doi.org/10.1093/molbev/msm146




PubMed


 


PubMed ID 17642472",https://intramural.nih.gov/search/searchview.taf?ipid=45276
84,BC008905-26,"October 01, 2006 -  September 30, 2007",Tumor gene expression in vitro and in vivo,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Richard B Braverman



Alex  Papageorge



Xiaolan  Qian; MD, PhD



William C Vass



Laura  Asnaghi



Guorong  Li",NULL,"Kent W Hunter; PhD (National Cancer Institute)



Nicolae C Popescu; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45277
85,BC008952-21,"October 01, 2006 -  September 30, 2007",Oncogenes and tumor suppressors in murine acute myeloid leukemia,"Linda  Wolff; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Juraj  Bies



Richard P Koller



Jan  Markus



Michael  Rosu-Myles



Thomas  Paul","Michelle  Le Beau
(Medicine, Universtiy of Chicago)




Janet  Rowley
(Medicine, University of Chicago)




Michael  Thirman
(Medicine, University of Chicago)",Peter D Aplan; MD (National Cancer Institute),"Paul P. Liu; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Markus J, Garin MT, Bies J, Galili N, Raza A, Thirman MJ, Le Beau MM, Rowley JD, Liu PP, Wolff L (2007). Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16). Cancer Res  67, 992-1000.   https://doi.org/10.1158/0008-5472.CAN-06-2964




PubMed


 


PubMed ID 17283131
    
     


 



2.
Rosu-Myles M, Taylor BJ, Wolff L (2007). Loss of the tumor suppressor p15Ink4b enhances myeloid progenitor formation from common myeloid progenitors. Exp Hematol  35, 394-406.   https://doi.org/10.1016/j.exphem.2006.11.005




PubMed


 


PubMed ID 17309820
    
     


 



3.
Slape C, Hartung H, Lin YW, Bies J, Wolff L, Aplan PD (2007). Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation. Cancer Res  67, 5148-55.   https://doi.org/10.1158/0008-5472.CAN-07-0075




PubMed



        
     
Free Article


 


PubMed ID 17545593
         Pubmed Central ID 1950322 


 



4.
Wolff L, Ackerman SJ, Nucifora G (2008). Meeting report: Seventh International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia, Annapolis, MD, May 13-16, 2007. Exp Hematol  36, 523-32.   https://doi.org/10.1016/j.exphem.2007.12.018




PubMed



        
     
Free Article


 


PubMed ID 18295966
         Pubmed Central ID 6019283",https://intramural.nih.gov/search/searchview.taf?ipid=45278
86,BC009003-25,"October 01, 2006 -  September 30, 2007",The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,David  Salomon; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI",NULL,"Gabriella  Minchiotti
(CNR, Institute of Genetics)




Masaharu  Seno
(Biotechnology, Okayama University)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45279
87,BC009029-15,"October 01, 2006 -  September 30, 2007",Mechanisms of CTL-Mediated Antitumor Activity In Vivo in Mouse Models of Active,Scott  Abrams; PhD,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Trina J Stewart,"Kebin  Liu
(Biochemistry & Molecular Biology, Medical College of Georgia)




Kebin  Liu
(Biochemistry & Molecular Biology, Medical College of Georgia)




Michail  Sitkovsky
(New England Inflammation and Tissue Protection Institute, Northeastern University)




Michail  Sitkovsky
(New England Inflammation and Tissue Protection Institute, Northeastern University)","James W Hodge; PhD (National Cancer Institute)



Philip M Arlen; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)",Richard  Childs; MD (NHLBI),"Ordered by publication type and then author name.



1.
Stewart TJ, Liewehr DJ, Steinberg SM, Greeneltch KM, Abrams SI (2009). Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells. J Immunol  183, 117-28.   https://doi.org/10.4049/jimmunol.0804132




PubMed



        
     
Free Article


 


PubMed ID 19542426
         Pubmed Central ID 2744444",https://intramural.nih.gov/search/searchview.taf?ipid=45280
88,BC009052-18,"October 01, 2006 -  September 30, 2007",Papillomavirus Virion Proteins and Vaccines,"John  Schiller; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI",NULL,"Denise  Nardelli-Haefliger
(Centre Hospitalier Universitaire Vaudois)




Richard  Roden
(Pathology, Johns Hopkins University)","Allan  Hildesheim; PhD (National Cancer Institute)



Samir N. Khleif; MD (National Cancer Institute)



Ligia  Pinto (Infection & Immunoepidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Day PM, Thompson CD, Buck CB, Pang YY, Lowy DR, Schiller JT (2007). Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol  81, 8784-92.   https://doi.org/10.1128/JVI.00552-07




PubMed



        
     
Free Article


 


PubMed ID 17553881
         Pubmed Central ID 1951340 


 



2.
García-Piñeres A, Hildesheim A, Dodd L, Kemp TJ, Williams M, Harro C, Lowy DR, Schiller JT, Pinto LA (2007). Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 Virus-like particles. Clin Vaccine Immunol  14, 984-9.   https://doi.org/10.1128/CVI.00090-07




PubMed



        
     
Free Article


 


PubMed ID 17596432
         Pubmed Central ID 2044489 


 



3.
Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, Schiller JT, Gonzalez P, Dubin G, Porras C, Jimenez SE, Lowy DR, Costa Rican HPV Vaccine Trial Group (2007). Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA  298, 743-53.   https://doi.org/10.1001/jama.298.7.743




PubMed


 


PubMed ID 17699008
    
     


 



4.
Revaz V, Zurbriggen R, Moser C, Schiller JT, Ponci F, Bobst M, Nardelli-Haefliger D (2007). Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants. Antiviral Res  76, 75-85.   https://doi.org/10.1016/j.antiviral.2007.05.005




PubMed


 


PubMed ID 17617476
    
     


 



5.
Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, Lowy DR, Schiller JT (2007). Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med  13, 857-61.   https://doi.org/10.1038/nm1598




PubMed


 


PubMed ID 17603495
    
     


 



6.
Roberts J, Lowy D, Schiller J (submitted in 2007) Papilloma Pseudovirus For Detection And Therapy Of Tumors. Patents issued: 8,394,411 (US in 2013); 8,999,290 (US in 2015); 2008251615 (AU in 2015); 2145189 (BE in 2016); 2145189 (BG in 2016); 2145189 (CH in 2016); 2145189 (CY in 2016); 2145189 (CZ in 2016); 602008043324 (DE in 2016); 2145189 (DK in 2016); 2145189 (EE in 2016); 2145189 (EP in 2016); 2145189 (ES in 2016); 2145189 (FI in 2016); 2145189 (FR in 2016); 2145189 (GB in 2016); 2145189 (GR in 2016); 2145189 (cr in 2016); 2145189 (HU in 2016); 2145189 (IE in 2016); 2145189 (IS in 2016); 2145189 (IT in 2016); 2145189 (LT in 2016); 2145189 (LU in 2016); 2145189 (LV in 2016); 2145189 (MC in 2016); 2145189 (MT in 2016); 2145189 (NL in 2016); 2145189 (NO in 2016); 2145189 (PL in 2016); 2145189 (PT in 2016); 2145189 (RO in 2016); 2145189 (SE in 2016); 2145189 (SI in 2016); 2145189 (SK in 2016); 2145189 (TR in 2016); 788363 (AT in 2016). Patents pending: 14/558,301 (US application); 2,686,990 (CA application); PCT/US2008/062296 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45281
89,BC009101-15,"October 01, 2006 -  September 30, 2007",Design of Antiviral Drugs Effective Against the HIV-1 Virus,"Ettore  Appella; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Lisa Marie Jenkins



Kan  Tanoue","Cecilia  Cheng-Mayer
(The Aaron Diamond AIDS Research Center, Rockefeller University)




James G. Omichinski; PhD
(Department of Biochemistry, University of Montreal)




Robin  Shattock; PhD
(St George's Hospital Medical School)",NULL,NULL,"Ordered by publication type and then author name.



1.
Appella E, Hara T, Durell S, Hayashi R, Inman J, Piquemal J, Gresh N   (2007) The specificity of acyl transfer from 2-mercaptobenzamide thioesters to the HIV-1  nucleocapsid protein.  J Am Chem Soc, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45283
90,BC009254-33,"October 01, 2006 -  September 30, 2007",Innate Immunity,David M Segal; PhD,NULL,"Experimental Immunology Branch, NCI","Anna K Manlapat



Joshua  Leonard



Yan  Wang",NULL,NULL,"David Harvey Margulies; MD, PhD (NIAID) 



David R Davies; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Kocabas C, Katsenelson N, Kanswal S, Kennedy MN, Cui X, Blake MS, Segal DM, Akkoyunlu M (2007). Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14. Cell Microbiol  9, 1297-310.   https://doi.org/10.1111/j.1462-5822.2006.00872.x




PubMed


 


PubMed ID 17250593",https://intramural.nih.gov/search/searchview.taf?ipid=45284
91,BC009255-32,"October 01, 2006 -  September 30, 2007",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI","Anthony J Adams



Larry  Granger



Don  Plugge",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Callén E, Jankovic M, Difilippantonio S, Daniel JA, Chen HT, Celeste A, Pellegrini M, McBride K, Wangsa D, Bredemeyer AL, Sleckman BP, Ried T, Nussenzweig M, Nussenzweig A (2007). ATM prevents the persistence and propagation of chromosome breaks in lymphocytes. Cell  130, 63-75.   https://doi.org/10.1016/j.cell.2007.06.016




PubMed


 


PubMed ID 17599403
    
     


 



2.
Chiang JY, Jang IK, Hodes R, Gu H (2007). Ablation of Cbl-b provides protection against transplanted and spontaneous tumors. J Clin Invest  117, 1029-36.   https://doi.org/10.1172/JCI29472




PubMed



        
     
Free Article


 


PubMed ID 17364027
         Pubmed Central ID 1810570 


 



3.
Difilippantonio S, Celeste A, Kruhlak MJ, Lee Y, Difilippantonio MJ, Feigenbaum L, Jackson SP, McKinnon PJ, Nussenzweig A (2007). Distinct domains in Nbs1 regulate irradiation-induced checkpoints and apoptosis. J Exp Med  204, 1003-11.   https://doi.org/10.1084/jem.20070319




PubMed



        
     
Free Article


 


PubMed ID 17485521
         Pubmed Central ID 2118591 


 



4.
Fukumoto R, Dundr M, Nicot C, Adams A, Valeri VW, Samelson LE, Franchini G (2007). Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1. J Virol  81, 9088-99.   https://doi.org/10.1128/JVI.02703-06




PubMed



        
     
Free Article


 


PubMed ID 17582004
         Pubmed Central ID 1951423 


 



5.
Liu Y, Kruhlak MJ, Hao JJ, Shaw S (2007). Rapid T cell receptor-mediated SHP-1 S591 phosphorylation regulates SHP-1 cellular localization and phosphatase activity. J Leukoc Biol  82, 742-51.   https://doi.org/10.1189/jlb.1206736




PubMed



        
     
Free Article


 


PubMed ID 17575265
         Pubmed Central ID 2084461 


 



6.
Shen X, Zhou J, Hathcock KS, Robbins P, Powell DJ, Rosenberg SA, Hodes RJ (2007). Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length. J Immunother  30, 123-9.   https://doi.org/10.1097/01.cji.0000211321.07654.b8




PubMed



        
     
Free Article


 


PubMed ID 17198091
         Pubmed Central ID 2151201 


 



7.
Song H, Zhang J, Chiang YJ, Siraganian RP, Hodes RJ (2007). Redundancy in B cell developmental pathways: c-Cbl inactivation rescues early B cell development through a B cell linker protein-independent pathway. J Immunol  178, 926-35.   https://doi.org/10.4049/jimmunol.178.2.926




PubMed


 


PubMed ID 17202354
    
     


 



8.
Tai X, Van Laethem F, Sharpe AH, Singer A (2007). Induction of autoimmune disease in CTLA-4-/- mice depends on a specific CD28 motif that is required for in vivo costimulation. Proc Natl Acad Sci U S A  104, 13756-61.   https://doi.org/10.1073/pnas.0706509104




PubMed



        
     
Free Article


 


PubMed ID 17702861
         Pubmed Central ID 1949493 


 



9.
Vacchio MS, Olaru A, Livak F, Hodes RJ (2007). ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor alpha locus coding end breaks. Proc Natl Acad Sci U S A  104, 6323-8.   https://doi.org/10.1073/pnas.0611222104




PubMed



        
     
Free Article


 


PubMed ID 17405860
         Pubmed Central ID 1851038",https://intramural.nih.gov/search/searchview.taf?ipid=45190
92,BC009257-32,"October 01, 2006 -  September 30, 2007",Mechanisms of Cellular Immune Responses,"James Stephen Shaw; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Yin  Liu



Natalya  Belkina



Jian-Jiang  Hao



Khadija  Ben-aissa","Mitsunori  Fukuda
(Fukuda Initiative Research Unit, RIKEN)




E. Michael  Ostap
(Pennsylvania Muscle Institute, University of Pennsylvania)","Alfred  Singer; MD (National Cancer Institute)



Michael John Kruhlak; PhD (National Cancer Institute)



Philip J Lucas; PhD (National Cancer Institute)



Lawrence Elliot Samelson; MD (National Cancer Institute)



Kelsie M Bernot (National Cancer Institute)",Fabio  Candotti; MD (NHGRI),"Ordered by publication type and then author name.



1.
Dong X, Patino-Lopez G, Candotti F, Shaw S (2007). Structure-function analysis of the WIP role in T cell receptor-stimulated NFAT activation: evidence that WIP-WASP dissociation is not required and that the WIP NH2 terminus is inhibitory. J Biol Chem  282, 30303-10.   https://doi.org/10.1074/jbc.M704972200




PubMed



        
     
Free Article


 


PubMed ID 17711847
         Pubmed Central ID 2094122 


 



2.
Liu Y, Kruhlak MJ, Hao JJ, Shaw S (2007). Rapid T cell receptor-mediated SHP-1 S591 phosphorylation regulates SHP-1 cellular localization and phosphatase activity. J Leukoc Biol  82, 742-51.   https://doi.org/10.1189/jlb.1206736




PubMed



        
     
Free Article


 


PubMed ID 17575265
         Pubmed Central ID 2084461",https://intramural.nih.gov/search/searchview.taf?ipid=45285
93,BC009262-25,"October 01, 2006 -  September 30, 2007",Immunophysiological Mechanisms in the Biological Therapy of Cancer,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Timothy  Back



Jeffrey J Subleski



Jonathan  Weiss



Veronica L Hall



Tim  Chan



Jimmy  Stauffer","Tom  Sayers
(SAIC)
















Bruce  Blazar
(Department of Pediatrics, University of Minnesota)




Stephen A Miller





Bill  Murphy
(Clinical Research, University of Nevada at Reno)




Mark  Smyth
(Department of Microbiology-Immunology, Peter Macallum Cancer Center)




Jon Marc Wigginton; MD
(NCI)","John R Ortaldo; PhD (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)



William  Farrar (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)



Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Berner V, Liu H, Zhou Q, Alderson KL, Sun K, Weiss JM, Back TC, Longo DL, Blazar BR, Wiltrout RH, Welniak LA, Redelman D, Murphy WJ (2007). IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy. Nat Med  13, 354-60.   https://doi.org/10.1038/nm1554




PubMed


 


PubMed ID 17334371
    
     


 



2.
Kudo-Saito C, Wansley EK, Gruys ME, Wiltrout R, Schlom J, Hodge JW (2007). Combination therapy of an orthotopic renal cell carcinoma model using intratumoral vector-mediated costimulation and systemic interleukin-2. Clin Cancer Res  13, 1936-46.   https://doi.org/10.1158/1078-0432.CCR-06-2398




PubMed


 


PubMed ID 17363550
    
     


 



3.
Kummar S, Kinders R, Rubinstein L, Parchment RE, Murgo AJ, Collins J, Pickeral O, Low J, Steinberg SM, Gutierrez M, Yang S, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH (2007). Compressing drug development timelines in oncology using phase '0' trials. Nat Rev Cancer  7, 131-9.   https://doi.org/10.1038/nrc2066




PubMed


 


PubMed ID 17251919
    
     


 



4.
Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, Newell MK, Owen LB, Pope RM, Tschopp J, Wajant H, Wallach D, Wiltrout RH, Zörnig M, Lynch DH (2007). The CD95 receptor: apoptosis revisited. Cell  129, 447-50.   https://doi.org/10.1016/j.cell.2007.04.031




PubMed


 


PubMed ID 17482535
    
     


 



5.
Weiss JM, Subleski JJ, Wigginton JM, Wiltrout RH (2007). Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther  7, 1705-21.   https://doi.org/10.1517/14712598.7.11.1705




PubMed



        
     
Free Article


 


PubMed ID 17961093
         Pubmed Central ID 2430051",https://intramural.nih.gov/search/searchview.taf?ipid=45286
94,BC009264-24,"October 01, 2006 -  September 30, 2007",Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Daniel C Bertolette



Maria  Birchenall-Roberts



Tao  Fu



Yi  Huang



Kathryn  Jones; PhD



Cari  Sadowski



Show all 7","Steven  Bartelmez
(stem cell biology, Betastem Therapeutics)




David  Danielpour
(NCI)




Pat  Iversen
(AVI-Biopharma)




John  Letterio
(Pediatric Oncology, Case Western Medical Center)","Seong-Jin  Kim; PhD (National Cancer Institute)



Lalage  Wakefield; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ruscetti F, Bertolette D   (2007) Levels of Smad 7 regulate Smad and mitogen activated kinase signaling and controls erythroid and megakaryocytic differentiation of erythroleukemic cells.  Platelets, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45287
95,BC009265-25,"October 01, 2006 -  September 30, 2007",Analysis of the T Cell Repertoire,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Karen  Hathcock



Sumeena  Bhatia



Joy A Williams



Sarah Rhiannon Jenkinson",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45288
96,BC009267-25,"October 01, 2006 -  September 30, 2007",Immune ProtectionDysregulation in HIVAIDS,"Gene  Shearer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Adriano  Boasso



Andrew W Hardy","Jan  Andersson
(Medicine, Karolinska Institutet)




Claire  Chougnet
(Molecular Immunology, Children's Hospital)




Fuchs  Dietmar
(Chemestry and Biochemestry, Innsbruck Medical University)




Matthew  Dolan
(AIDS, Wilford Hall Med Inst)




Jean-Philippe  Herbeuval",Genoveffa  Franchini; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Boasso A, Herbeuval JP, Hardy AW, Anderson SA, Dolan MJ, Fuchs D, Shearer GM (2007). HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood  109, 3351-9.   https://doi.org/10.1182/blood-2006-07-034785




PubMed



        
     
Free Article


 


PubMed ID 17158233
         Pubmed Central ID 1852248 


 



2.
Boasso A, Shearer GM (2007). How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. Curr Drug Metab  8, 217-23.   https://doi.org/10.2174/138920007780362527




PubMed


 


PubMed ID 17430110
    
     


 



3.
Chougnet CA, Shearer GM (2007). Regulatory T cells (Treg) and HIV/AIDS: summary of the September 7-8, 2006 workshop. AIDS Res Hum Retroviruses  23, 945-52.   https://doi.org/10.1089/aid.2006.0259




PubMed


 


PubMed ID 17678480
    
     


 



4.
Herbeuval JP, Shearer GM (2007). HIV-1 immunopathogenesis: how good interferon turns bad. Clin Immunol  123, 121-8.   https://doi.org/10.1016/j.clim.2006.09.016




PubMed



        
     
Free Article


 


PubMed ID 17112786
         Pubmed Central ID 1930161 


 



5.
Hryniewicz A, Price DA, Moniuszko M, Boasso A, Edghill-Spano Y, West SM, Venzon D, Vaccari M, Tsai WP, Tryniszewska E, Nacsa J, Villinger F, Ansari AA, Trindade CJ, Morre M, Brooks D, Arlen P, Brown HJ, Kitchen CM, Zack JA, Douek DC, Shearer GM, Lewis MG, Koup RA, Franchini G (2007). Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques. J Immunol  178, 3492-504.   https://doi.org/10.4049/jimmunol.178.6.3492




PubMed


 


PubMed ID 17339444",https://intramural.nih.gov/search/searchview.taf?ipid=45289
97,BC009273-20,"October 01, 2006 -  September 30, 2007",T Cell Differentiation and Repertoire Selection,"Alfred  Singer; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Amala Shenai Alag



Terry I Guinter



Jung-Hyun  Park



Xuguang C Tai



Francois  Van Laethem



Stanley  Adoro



Show all 8","Wilfried  Ellmeier
(Immunology, University of Vienna)




Batu M Erman





Deitmar  Kappes
(Immunology, Fox Chase Cancer Center)




David  McKean
(Immunology, Mayo Clinic)




Arlene  Sharpe
(Dept of Pathology, Harvard Medical School)




Naomi  Taylor","Remy J Bosselut; MD, PhD (National Cancer Institute)



Lionel  Feigenbaum (Office Of The Director)



Dinah  Singer; PhD (National Cancer Institute)","Paul E Love; MD, PhD (NICHD)","Ordered by publication type and then author name.



1.
Singer A, Adoro S, Lucas P, Sarafova S, Alag A, Doan L, Erman B, Liu X, Ellmeier W, Bosselut R, Feigenbaum L   (2007) Coreceptor tuning: Cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR.  Natrure Immunology  1049-1059 pp.




 



2.
Tai X, Van Laethem F, Sharpe AH, Singer A (2007). Induction of autoimmune disease in CTLA-4-/- mice depends on a specific CD28 motif that is required for in vivo costimulation. Proc Natl Acad Sci U S A  104, 13756-61.   https://doi.org/10.1073/pnas.0706509104




PubMed



        
     
Free Article


 


PubMed ID 17702861
         Pubmed Central ID 1949493",https://intramural.nih.gov/search/searchview.taf?ipid=45290
98,BC009279-22,"October 01, 2006 -  September 30, 2007",Regulation of Expression of MHC Class I Genes,"Dinah  Singer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Jocelyn D Weissman



Aparna  Kotekar



Helit  Cohen



Shankar  Iyer



Anat  Ohali",NULL,Brian  Lewis (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45291
99,BC009281-21,"October 01, 2006 -  September 30, 2007",Receptor Mediated T and B Cell Activation,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Yungping  Chiang



Haifeng  Song","Hua  Gu
(Microbiology, Columbia University)




Gary  Koretsky
(School of Medicine, University of Pennsylvania)",NULL,"Reuben P Siraganian; MD, PhD (NIDCR)","Ordered by publication type and then author name.



1.
Williams JA, Lumsden JM, Yu X, Feigenbaum L, Zhang J, Steinberg SM, Hodes RJ (2008). Regulation of thymic NKT cell development by the B7-CD28 costimulatory pathway. J Immunol  181, 907-17.   https://doi.org/10.4049/jimmunol.181.2.907




PubMed



        
     
Free Article


 


PubMed ID 18606642
         Pubmed Central ID 2535925",https://intramural.nih.gov/search/searchview.taf?ipid=45292
100,BC009283-23,"October 01, 2006 -  September 30, 2007",Control of Cytokine Gene Expression in LymphoidMyeloid Cells,"Howard A Young; PhD



IRP Faculty Profile",Robert  Wiltrout; PhD,"Laboratory of Experimental Immunology, NCI","Deborah L Hodge



Della A Reynolds



Michael E Sanford



Ram  Savan



Thomas B Wolfe



Sophia Y Cleland



Show all 8",NULL,"Thomas Joseph Sayers; PhD (National Cancer Institute)



Daniel  McVicar; PhD (National Cancer Institute)



Victor  Marquez; PhD (ORGANIC CHEMSTRY SECT)



Nancy H Colburn; PhD (National Cancer Institute)



Barbara K Felber (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45293
101,BC009285-21,"October 01, 2006 -  September 30, 2007",Responses of MHC Class I Genes to Exogeneous Stimuli,"Dinah  Singer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Jocelyn D Weissman



Aparna  Kotekar



Shankar  Iyer","Leonard  Kohn
(Edison Biotechnology Institue, Ohio State Universit)




Martin  Villalba
(Institut de Génétique Moléculaire de Montpellier (IGMM))","Xuguang C Tai (National Cancer Institute)



Alfred  Singer; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45294
102,BC009287-23,"October 01, 2006 -  September 30, 2007",Cytokines and T Cell Development,"Scott K Durum; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Benyam  Asefa




Ashraf Omar Abdel Aziz El Fiky




Qiong  Jiang




Wenqing  Li",NULL,"Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)



Jonathan  Keller; PhD (Cancer and Developmental Biology Laboratory)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45295
103,BC009297-16,"October 01, 2006 -  September 30, 2007",Ubiquitin And SUMO Post-Translational Modifications In Development And Disease,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI","George T Lezin



Prashant  Sharma","Francesca  Bernassola
(Biochemistry Laboratory, University of Rome ‘‘Tor Vergata’’)




Gerry  Melino; MD, PhD
(Experimental Biology, University Tor Vergata)




Moshe  Oren
(Department of Molecular Cell Biology, Weizmann Institute of Science)","Allan M Weissman; MD (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45297
104,BC009304-13,"October 01, 2006 -  September 30, 2007",Structure-Function Studies and Design of Novel Glycosyltransferases,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Elizabeth  Boeggeman



Boopathy  Ramakrishna



Marta  Pasek



Carrie C Hightman",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Qasba PK, Ramakrishnan B (2007). Letter to the Glyco-Forum: catalytic domains of glycosyltransferases with 'add-on' domains. Glycobiology  17, 7G-9G.   https://doi.org/10.1093/glycob/cwm013




PubMed


 


PubMed ID 17283039
    
     


 



2.
Ramakrishnan B, Qasba PK (2007). Role of a single amino acid in the evolution of glycans of invertebrates and vertebrates. J Mol Biol  365, 570-6.   https://doi.org/10.1016/j.jmb.2006.10.034




PubMed



        
     
Free Article


 


PubMed ID 17084860
         Pubmed Central ID 1850938",https://intramural.nih.gov/search/searchview.taf?ipid=45298
105,BC009322-19,"October 01, 2006 -  September 30, 2007",Mechanisms of Leukocyte Migration Following Cytokine Administration to Mice,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Timothy  Back



Jeffrey J Subleski



Jimmy  Stauffer",NULL,"John R Ortaldo; PhD (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, Newell MK, Owen LB, Pope RM, Tschopp J, Wajant H, Wallach D, Wiltrout RH, Zörnig M, Lynch DH (2007). The CD95 receptor: apoptosis revisited. Cell  129, 447-50.   https://doi.org/10.1016/j.cell.2007.04.031




PubMed


 


PubMed ID 17482535",https://intramural.nih.gov/search/searchview.taf?ipid=45299
106,BC009369-17,"October 01, 2006 -  September 30, 2007",Consequences of Chemokine-Receptor Interactions with Chemokines and Chemokine Mi,"Joost J Oppenheim; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Christina  Burks




Gonzalo  De La Rosa




Ola Mae Zack Howard




Yana  Li




Poonam  Tewary




De  Yang","Robert  Goldman
(Peptides, Peprotech)




Kouji  Matsushima
(Molecular Preventive Medicine, University of Toyko)




Kevin  Tracey
(Ctr Patient Oriented Res, North Shore-Long Island Jewish Res Inst)","Jacek Tadeusz Lubkowski (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)



Michael  Bustin; PhD (National Cancer Institute)","Rachel R Caspi; PhD (NEI) 



Helene Fischer Rosenberg; PhD, MD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45300
107,BC009392-14,"October 01, 2006 -  September 30, 2007",Determining the Fate of Transmembrane Proteins,"Allan M Weissman; MD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Jennifer B Mariano



Yien-Che  Tsai



Mickael M Cohen



Guillaume  Leboucher","Robert  Gemmill
(Medical Oncology, UCHSC)




Michael  Glickman





William  Lennarz
(Cell Biology and Biochemistry, Stony Brook University)","Barry R O'Keefe (National Cancer Institute)



John A Beutler (National Cancer Institute)



Chand  Khanna; MD (Pediatric Oncology Br)



Robert Andrew Byrd (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)



Walter M Kuehl; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Weissman A, Tsai Y   (2007) Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation., in Seminars in Cell and Developmental Biology, in press.




 



2.
Brauweiler A, Lorick KL, Lee JP, Tsai YC, Chan D, Weissman AM, Drabkin HA, Gemmill RM (2007). RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene. Oncogene  26, 2263-71.   https://doi.org/10.1038/sj.onc.1210017




PubMed


 


PubMed ID 17016439",https://intramural.nih.gov/search/searchview.taf?ipid=45172
108,BC009404-13,"October 01, 2006 -  September 30, 2007",Protein Trafficking in Lymphocytes,"Paul A Roche; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Niti  Puri



Neil J Poloso



Even  Walseng



Adam  Berger



Karis  Faust","Lisa  Denzin
(Immunology Program, Sloan-Kettering Institute)




Sidney  Whiteheart
(Mol and Cellular Biochemistry, Univ. of Kentucky)",NULL,NULL,"Ordered by publication type and then author name.



1.
Bryceson YT, Rudd E, Zheng C, Edner J, Ma D, Wood SM, Bechensteen AG, Boelens JJ, Celkan T, Farah RA, Hultenby K, Winiarski J, Roche PA, Nordenskjöld M, Henter JI, Long EO, Ljunggren HG (2007). Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood  110, 1906-15.   https://doi.org/10.1182/blood-2007-02-074468




PubMed



        
     
Free Article


 


PubMed ID 17525286
         Pubmed Central ID 1976360 


 



2.
Muntasell A, Berger AC, Roche PA (2007). T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes. EMBO J  26, 4263-72.   https://doi.org/10.1038/sj.emboj.7601842




PubMed



        
     
Free Article


 


PubMed ID 17805347
         Pubmed Central ID 2230838",https://intramural.nih.gov/search/searchview.taf?ipid=45301
109,BC009405-13,"October 01, 2006 -  September 30, 2007",Regulation of Lymphocyte Proliferation and Replicative Capacity,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Yungping  Chiang



Brian  Schram","Judy  Campisi





Susan  Smith
(School of Medicine, New York University)","Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)



James Carl Barrett; PhD (National Cancer Institute)",Peter E Lipsky; MD (NIAMS),"Ordered by publication type and then author name.



1.
Shen X, Zhou J, Hathcock KS, Robbins P, Powell DJ, Rosenberg SA, Hodes RJ (2007). Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length. J Immunother  30, 123-9.   https://doi.org/10.1097/01.cji.0000211321.07654.b8




PubMed



        
     
Free Article


 


PubMed ID 17198091
         Pubmed Central ID 2151201",https://intramural.nih.gov/search/searchview.taf?ipid=45302
110,BC010001-12,"October 01, 2006 -  September 30, 2007",MolecularCellular Regulation of Hematopoiesis,Jonathan  Keller; PhD,NULL,"Laboratory of Cancer Prevention, NCI","Kimberly D Klarmann



Hyung-Chang  Suh



Kristbjorn O Gudmundsson; MSc, PhD



Ming  Ji



Huajie  Li",NULL,"Laura  Schmidt (National Cancer Institute)



Scott K Durum; PhD (National Cancer Institute)



Terence P Yamaguchi; PhD (National Cancer Institute)



Gisela Esta Sterneck; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Asefa B, Dermott JM, Kaldis P, Stefanisko K, Garfinkel DJ, Keller JR (2006). p205, a potential tumor suppressor, inhibits cell proliferation via multiple pathways of cell cycle regulation. FEBS Lett  580, 1205-14.   https://doi.org/10.1016/j.febslet.2006.01.032




PubMed


 


PubMed ID 16458891
    
     


 



2.
Berthet C, Klarmann KD, Hilton MB, Suh HC, Keller JR, Kiyokawa H, Kaldis P (2006). Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation. Dev Cell  10, 563-73.   https://doi.org/10.1016/j.devcel.2006.03.004




PubMed


 


PubMed ID 16678773
    
     


 



3.
Liepinsh DJ, Grivennikov SI, Klarmann KD, Lagarkova MA, Drutskaya MS, Lockett SJ, Tessarollo L, McAuliffe M, Keller JR, Kuprash DV, Nedospasov SA (2006). Novel lymphotoxin alpha (LTalpha) knockout mice with unperturbed tumor necrosis factor expression: reassessing LTalpha biological functions. Mol Cell Biol  26, 4214-25.   https://doi.org/10.1128/MCB.01751-05




PubMed



        
     
Free Article


 


PubMed ID 16705172
         Pubmed Central ID 1489085 


 



4.
Suh HC, Gooya J, Renn K, Friedman AD, Johnson PF, Keller JR (2006). C/EBPalpha determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation. Blood  107, 4308-16.   https://doi.org/10.1182/blood-2005-06-2216




PubMed



        
     
Free Article


 


PubMed ID 16469877
         Pubmed Central ID 1895788",https://intramural.nih.gov/search/searchview.taf?ipid=45303
111,BC010003-12,"October 01, 2006 -  September 30, 2007",Molecular Mechanisms of HTLV-1 Infection and Replication,David  Derse; PhD,NULL,"Retroviral Replication Laboratory, NCI","Shawn A Hill



Gisela H Fanning-Heidecker



Patricia  Lloyd



Gerald L Princler



Michael S Mitchell



Anna N Ilinskaya



Show all 8","Reuben  Harris
(Biochemistry, University of Minnesota)




Karin  Musier-Forsyth
(School of Medicine, Ohio State University)




Karin  Musier-Forsyth
(School of Medicine, Ohio State University)




Lee  Ratner
(School of Medicine, Washington University)




William  Switzer
(-, Centers for Disease Control and Prevention)",Xiaolin  Wu; PhD (Office Of The Director),NULL,"Ordered by publication type and then author name.



1.
Derse D (2007) Role of mouse APOBEC3 in the restriction of mouse mammary tumor virus replication in vivo. Future HIV Therapy, in press.




 



2.
Derse D, Crise B, Li Y, Princler G, Lum N, Stewart C, McGrath CF, Hughes SH, Munroe DJ, Wu X (2007). Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses. J Virol  81, 6731-41.   https://doi.org/10.1128/JVI.02752-06




PubMed



        
     
Free Article


 


PubMed ID 17409138
         Pubmed Central ID 1900082 


 



3.
Derse D, Hill SA, Princler G, Lloyd P, Heidecker G (2007). Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid. Proc Natl Acad Sci U S A  104, 2915-20.   https://doi.org/10.1073/pnas.0609444104




PubMed



        
     
Free Article


 


PubMed ID 17299050
         Pubmed Central ID 1815281 


 



4.
Heidecker G, Lloyd PA, Soheilian F, Nagashima K, Derse D (2007). The role of WWP1-Gag interaction and Gag ubiquitination in assembly and release of human T-cell leukemia virus type 1. J Virol  81, 9769-77.   https://doi.org/10.1128/JVI.00642-07




PubMed



        
     
Free Article


 


PubMed ID 17609263
         Pubmed Central ID 2045422 


 



5.
Mazurov D, Heidecker G, Derse D (2007). The inner loop of tetraspanins CD82 and CD81 mediates interactions with human T cell lymphotrophic virus type 1 Gag protein. J Biol Chem  282, 3896-903.   https://doi.org/10.1074/jbc.M607322200




PubMed


 


PubMed ID 17166843
    
     


 



6.
Mitchell MS, Bodine ET, Hill S, Princler G, Lloyd P, Mitsuya H, Matsuoka M, Derse D (2007). Phenotypic and genotypic comparisons of human T-cell leukemia virus type 1 reverse transcriptases from infected T-cell lines and patient samples. J Virol  81, 4422-8.   https://doi.org/10.1128/JVI.02660-06




PubMed



        
     
Free Article


 


PubMed ID 17287279
         Pubmed Central ID 1900182 


 



7.
Wencker M, Sausse C, Derse D, Gazzolo L, Duc Dodon M (2007). Human T-cell leukemia virus type 1 Tax protein down-regulates pre-T-cell receptor alpha gene transcription in human immature thymocytes. J Virol  81, 301-8.   https://doi.org/10.1128/JVI.00766-06




PubMed



        
     
Free Article


 


PubMed ID 17050604
         Pubmed Central ID 1797236",https://intramural.nih.gov/search/searchview.taf?ipid=45304
112,BC010006-12,"October 01, 2006 -  September 30, 2007",Developmental Signal Transduction in Xenopus Oocytes and Embryos,"Ira  Daar; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Kathleen T Soria



Yong-Sik  Bong



Hyun-Shik  Lee



Zongjian  Jia","Sally  Moody
(Department of Anatomy and Cell Biology, George Washington University Medical Center)




Sally  Moody
(Department of Anatomy and Cell Biology, George Washington University Medical Center)




Morag  Park
(Dept. Biochemistry and Oncology, McGill University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Lee HS, Nishanian TG, Mood K, Bong YS, Daar IO (2008). EphrinB1 controls cell-cell junctions through the Par polarity complex. Nat Cell Biol  10, 979-86.   https://doi.org/10.1038/ncb1758




PubMed



        
     
Free Article


 


PubMed ID 18604196
         Pubmed Central ID 2614381",https://intramural.nih.gov/search/searchview.taf?ipid=45305
113,BC010008-12,"October 01, 2006 -  September 30, 2007",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"Beverly  Mock; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Shuling  Zhang; MD, PhD



Valery  Bliskovsky; PhD



Wendy Dianne Du Bois De Vroylande



Tina M Wellington



Richard C Robinson



Jyoti  Patel



Show all 9",NULL,Carole A Parent; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45306
114,BC010012-12,"October 01, 2006 -  September 30, 2007",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Alan  Brooks



Anil  Shanker



Kristen M Jacobsen","Avi  Ashkenazi
(Genentech, Inc.)




Mark  Smyth
(Cancer Immunology Program, Peter MacCallum Cancer Center)




Hideo  Yagita
(Immunology, Juntendo University)",NULL,William T Murphy (OD),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45307
115,BC010013-12,"October 01, 2006 -  September 30, 2007",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Hong-Chuan  Li




Veronique  Pascal




Venkateswaran  Ramakrishnan




Neeraj  Sharma




Paul  Wright","Colin  Brooks
(School of Biosciences, University of Newcastle)




Dan  Kaufman
(Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center)




Andrew  Makrigiannis
(Lab of Molecular Immunology, ICRM)




Andrew  Makrigiannis
(Lab of Molecular Immunology, ICRM)




Jeffrey  Miller
(Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center)




Jeffrey  Miller
(Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center)","Daniel  McVicar; PhD (National Cancer Institute)












Mary  Carrington; MS, PhD  (Laboratory of Genomic Diversity)",NULL,"Ordered by publication type and then author name.



1.
Anderson S   (2007) Ly49W.  UCSD-Nature Molecule Pages  1 pp.




 



2.
Anderson S (2007) Ly49O. UCSD-Nature Molecule Pages 1.




 



3.
Anderson S (2007) Ly49P. UCSD-Nature Molecule Pages 1.




 



4.
Anderson S (2007) Ly49V. UCSD-Nature Molecule Pages 1.




 



5.
Davies GE, Locke SM, Wright PW, Li H, Hanson RJ, Miller JS, Anderson SK (2007). Identification of bidirectional promoters in the human KIR genes. Genes Immun  8, 245-53.   https://doi.org/10.1038/sj.gene.6364381




PubMed


 


PubMed ID 17315044",https://intramural.nih.gov/search/searchview.taf?ipid=45308
116,BC010014-12,"October 01, 2006 -  September 30, 2007",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Laboratory of Cancer Prevention, NCI","Heming  Zhu



Theresa M Geiman



Sichuan  Xi","Rabindranath  de la Fuente





Ina  Dobrinski





Albert  Jeltsch
(University of Bremen)","Jonathan  Keller; PhD (National Cancer Institute)



Sandra  Ruscetti; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Xi S, Zhu H, Xu H, Schmidtmann A, Geiman TM, Muegge K (2007). Lsh controls Hox gene silencing during development. Proc Natl Acad Sci U S A  104, 14366-71.   https://doi.org/10.1073/pnas.0703669104




PubMed



        
     
Free Article


 


PubMed ID 17726103
         Pubmed Central ID 1955459",https://intramural.nih.gov/search/searchview.taf?ipid=45309
117,BC010015-12,"October 01, 2006 -  September 30, 2007",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Nancy M Dunlop



Wang-Hua  Gong



Jian  Huang","Xiuwu  Bian
(Southwest Hospital, Institute of Pathology)




Gert  Schmid-Schonbein
(Whitaker Institute, UC San Diego)




Chunfu  Wu
(Medicinal Chemistry, Shenyang Pharmaceutical University)",NULL,Philip M Murphy; MD (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45310
118,BC010017-12,"October 01, 2006 -  September 30, 2007","The Use of Bacteriophage in the Prevention, Diagnosis, and Treatment of Human Di","Sankar  Adhya; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Rotem  Edgar



Catherine  Bair",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45311
119,BC010020-12,"October 01, 2006 -  September 30, 2007",Clinical Trials with Immunotoxins,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Mitchell  Ho



Satoshi  Nagata; PhD



Dawn A Walker","DARELL  BIGNER
(Dept of Pathology, Duke University Medical Center, Dept. of Pathology)




JOHN  SAMPSON
(Div of Neurosurgery, Duke University Medical Center, Div. of Neurosurgery)","David J Fitzgerald; PhD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)



Alan S Wayne; MD (National Cancer Institute)



Raffit  Hassan (National Cancer Institute)



Robert J Kreitman; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Pastan I, Kreitman R   (2007) Monoclonal antibodies and immunotoxins as new therapeutic agents for childhood acute lymphoblastic leukemia., in American Society of Clinical Oncology 2007 Educational Book. American Society of Clinical Oncology (Alexandria, VA), pp. 596-601.




 



2.
Du X, Beers R, Fitzgerald DJ, Pastan I (2008). Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity. Cancer Res  68, 6300-5.   https://doi.org/10.1158/0008-5472.CAN-08-0461




PubMed



        
     
Free Article


 


PubMed ID 18676854
         Pubmed Central ID 2561922 


 



3.
Onda M, Beers R, Xiang L, Nagata S, Wang QC, Pastan I (2008). An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes. Proc Natl Acad Sci U S A  105, 11311-6.   https://doi.org/10.1073/pnas.0804851105




PubMed



        
     
Free Article


 


PubMed ID 18678888
         Pubmed Central ID 2516223 


 



4.
Pastan I, Felipe-Silva A, Merino M, Ahmadzadeh J, Allen T, Levy C, White D, Mavroukakis S, Kreitman R, Rosenberg S   (2007) Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cell in vivo.  J Immunol, in press.




 



5.
Sampson JH, Brady ML, Petry NA, Croteau D, Friedman AH, Friedman HS, Wong T, Bigner DD, Pastan I, Puri RK, Pedain C (2007). Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning. Neurosurgery  60, ONS89-98; discussion ONS98-9.   https://doi.org/10.1227/01.NEU.0000249256.09289.5F




PubMed


 


PubMed ID 17297371
    
     


 



6.
Sampson JH, Raghavan R, Brady ML, Provenzale JM, Herndon JE, Croteau D, Friedman AH, Reardon DA, Coleman RE, Wong T, Bigner DD, Pastan I, Rodríguez-Ponce MI, Tanner P, Puri R, Pedain C (2007). Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. Neuro Oncol  9, 343-53.   https://doi.org/10.1215/15228517-2007-007




PubMed



        
     
Free Article


 


PubMed ID 17435179
         Pubmed Central ID 1907410 


 



7.
Sampson JH, Raghavan R, Provenzale JM, Croteau D, Reardon DA, Coleman RE, Rodríguez Ponce I, Pastan I, Puri RK, Pedain C (2007). Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin. AJR Am J Roentgenol  188, 703-9.   https://doi.org/10.2214/AJR.06.0428




PubMed


 


PubMed ID 17312057
    
     


 



8.
Sterman DH, Recio A, Carroll RG, Gillespie CT, Haas A, Vachani A, Kapoor V, Sun J, Hodinka R, Brown JL, Corbley MJ, Parr M, Ho M, Pastan I, Machuzak M, Benedict W, Zhang XQ, Lord EM, Litzky LA, Heitjan DF, June CH, Kaiser LR, Vonderheide RH, Albelda SM, Kanther M (2007). A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Clin Cancer Res  13, 4456-66.   https://doi.org/10.1158/1078-0432.CCR-07-0403




PubMed


 


PubMed ID 17671130",https://intramural.nih.gov/search/searchview.taf?ipid=45312
120,BC010021-12,"October 01, 2006 -  September 30, 2007",Biology of Mammary Gland Development and Tumorigenesis,"Gilbert  Smith; PhD



IRP Faculty Profile",NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Corinne A Boulanger-Espeut



David L Mack



Brian  Booth



Lisa  Higginbotham",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Booth BW, Boulanger CA, Smith GH (2007). Alveolar progenitor cells develop in mouse mammary glands independent of pregnancy and lactation. J Cell Physiol  212, 729-36.   https://doi.org/10.1002/jcp.21071




PubMed


 


PubMed ID 17443685
    
     


 



2.
Booth BW, Jhappan C, Merlino G, Smith GH (2007). TGFbeta1 and TGFalpha contrarily affect alveolar survival and tumorigenesis in mouse mammary epithelium. Int J Cancer  120, 493-9.   https://doi.org/10.1002/ijc.22310




PubMed


 


PubMed ID 17096338
    
     


 



3.
Boulanger CA, Mack DL, Booth BW, Smith GH (2007). Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo. Proc Natl Acad Sci U S A  104, 3871-6.   https://doi.org/10.1073/pnas.0611637104




PubMed



        
     
Free Article


 


PubMed ID 17360445
         Pubmed Central ID 1820676 


 



4.
Mack DL, Boulanger CA, Callahan R, Smith GH (2007). Expression of truncated Int6/eIF3e in mammary alveolar epithelium leads to persistent hyperplasia and tumorigenesis. Breast Cancer Res  9, R42.   https://doi.org/10.1186/bcr1742




PubMed



        
     
Free Article


 


PubMed ID 17626637
         Pubmed Central ID 2206715",https://intramural.nih.gov/search/searchview.taf?ipid=45313
121,BC010022-12,"October 01, 2006 -  September 30, 2007",Genetics of Renal Disease in African Americans,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI","Shawn R Palmer



Michael J Malasky



Elizabeth  Binns-Roemer



Mary A Thompson



Michael E Weedon



Mary  Mcnally



Show all 11","David  Gasser
(Department of Genetics, University of Pennsylvania)




Sudha  Iyengar
(Division of Genetic and Molecular Epidemiology, Case Western Reserve University)",NULL,Jeffrey Burnett Kopp; MD (NIDDK),"Ordered by publication type and then author name.



1.
Iyengar SK, Abboud HE, Goddard KA, Saad MF, Adler SG, Arar NH, Bowden DW, Duggirala R, Elston RC, Hanson RL, Ipp E, Kao WH, Kimmel PL, Klag MJ, Knowler WC, Meoni LA, Nelson RG, Nicholas SB, Pahl MV, Parekh RS, Quade SR, Rich SS, Rotter JI, Scavini M, Schelling JR, Family Investigation of Nephropathy and Diabetes Research Group, et al. [8 more authors] (2007). Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes  56, 1577-85.   https://doi.org/10.2337/db06-1154




PubMed


 


PubMed ID 17363742",https://intramural.nih.gov/search/searchview.taf?ipid=45314
122,BC010025-12,"October 01, 2006 -  September 30, 2007",The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention,"Nancy H Colburn; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Glenn  Hegamyer



Alyson R Baker



Moon-Il  Kang



Gerd  Bobe



Roycelynn  Mentor-Marcel","George  Beck
(Emory University)




George  Beck
(Emory University)




Powel  Brown
(Baylor Breast Center, Baylor College of Medicine)




Robert  Chapkin
(Texas A&M)




Terry  Hartman
(Penn State Univ)




Terry  Hartman
(Penn State Univ)","Peter L Choyke; MD (National Cancer Institute)



Curtis  Henrich (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bobe G, Sansbury LB, Albert PS, Cross AJ, Kahle L, Ashby J, Slattery ML, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Daston C, Marshall JR, Schatzkin A, Lanza E (2008). Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev  17, 1344-53.   https://doi.org/10.1158/1055-9965.EPI-07-0747




PubMed



        
     
Free Article


 


PubMed ID 18559549
         Pubmed Central ID 2517243 


 



2.
Colburn N, Young M   (2007) AP-1 a Target for Cancer Prevention.  Current Cancer Drug Targets  317-324 pp.




 



3.
Matthews CP, Birkholz AM, Baker AR, Perella CM, Beck GR, Young MR, Colburn NH (2007). Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis. Cancer Res  67, 2430-8.   https://doi.org/10.1158/0008-5472.CAN-06-0522




PubMed


 


PubMed ID 17363560
    
     


 



4.
Ruocco KM, Goncharova EI, Young MR, Colburn NH, McMahon JB, Henrich CJ (2007). A high-throughput cell-based assay to identify specific inhibitors of transcription factor AP-1. J Biomol Screen  12, 133-9.   https://doi.org/10.1177/1087057106296686




PubMed


 


PubMed ID 17175522",https://intramural.nih.gov/search/searchview.taf?ipid=45315
123,BC010026-12,"October 01, 2006 -  September 30, 2007","The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression","Nancy H Colburn; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Glenn  Hegamyer



Alyson R Baker



Arti  Santhanam



Tobias  Schmid","Heike  Allgayer
(University of Munich)




Myung  Cho
(Laboratory of Toxicology, Seoul National University)




Gabriel  Lopez-Berestein
(MD Anderson Cancer Ctr)




Michele  Pagano
(New York Univ)




Robert  Rhoads
(LSU Shreveport)","Lee Jay Helman; MD (National Cancer Institute)



Bruce Allen Shapiro; PhD (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)



Stuart F J Le Grice; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hwang SK, Jin H, Kwon JT, Chang SH, Kim TH, Cho CS, Lee KH, Young MR, Colburn NH, Beck GR, Yang HS, Cho MH (2007). Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther  14, 1353-61.   https://doi.org/10.1038/sj.gt.3302983




PubMed


 


PubMed ID 17611588
    
     


 



2.
LaRonde-LeBlanc N, Santhanam AN, Baker AR, Wlodawer A, Colburn NH (2007). Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol Cell Biol  27, 147-56.   https://doi.org/10.1128/MCB.00867-06




PubMed



        
     
Free Article


 


PubMed ID 17060447
         Pubmed Central ID 1800662 


 



3.
Leupold JH, Yang HS, Colburn NH, Asangani I, Post S, Allgayer H (2007). Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene  26, 4550-62.   https://doi.org/10.1038/sj.onc.1210234




PubMed


 


PubMed ID 17297470
    
     


 



4.
Mudduluru G, Medved F, Grobholz R, Jost C, Gruber A, Leupold JH, Post S, Jansen A, Colburn NH, Allgayer H (2007). Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer  110, 1697-707.   https://doi.org/10.1002/cncr.22983




PubMed


 


PubMed ID 17849461
    
     


 



5.
Ozpolat B, Akar U, Steiner M, Zorrilla-Calancha I, Tirado-Gomez M, Colburn N, Danilenko M, Kornblau S, Berestein GL (2007). Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Mol Cancer Res  5, 95-108.   https://doi.org/10.1158/1541-7786.MCR-06-0125




PubMed


 


PubMed ID 17259349",https://intramural.nih.gov/search/searchview.taf?ipid=45316
124,BC010027-13,"October 01, 2006 -  September 30, 2007",Function of Steroid Receptors in Subcellular Compartments,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Diana  Stavreva



Anindya P Hendarwanto



Ty Cole Voss



Rebecca C Chiffer",NULL,Angie  Dull (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45317
125,BC010030-12,"October 01, 2006 -  September 30, 2007",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,"Suresh V Ambudkar; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Zuben  Sauna; PhD



In Wha  Kim



John E Golin



Suneet  Shukla



Anna Maria Calcagno



Luciann L Cuenca","Maria  Baer
(Medicine, Roswell Park Cancer Institute)




Catherine  Booth-Genthe
(Pharamcokinetics and drug metabolism, Amgen, Inc.)




Zhe-Sheng  Chen
(Pharmaceutical Sciences, St. John's University)




Peter  Chiba
(Inst Med Chem, Med Univ Vienna)




Rajendra  Prasad
(School of Biological Sciences, Jawaharlal Nehru University)




Rajendra  Prasad
(School of Biological Sciences, Jawaharlal Nehru University)","Lyuba  Varticovski (National Cancer Institute)



Michael Marc Gottesman; MD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)



Peter C Fitzgerald (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Brendel C, Scharenberg C, Dohse M, Robey RW, Bates SE, Shukla S, Ambudkar SV, Wang Y, Wennemuth G, Burchert A, Boudriot U, Neubauer A (2007). Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells. Leukemia  21, 1267-75.   https://doi.org/10.1038/sj.leu.2404638




PubMed


 


PubMed ID 17519960
    
     


 



2.
Golin J, Ambudkar SV, May L (2007). The yeast Pdr5p multidrug transporter: how does it recognize so many substrates? Biochem Biophys Res Commun  356, 1-5.   https://doi.org/10.1016/j.bbrc.2007.02.011




PubMed


 


PubMed ID 17316560
    
     


 



3.
Henrich CJ, Robey RW, Bokesch HR, Bates SE, Shukla S, Ambudkar SV, Dean M, McMahon JB (2007). New inhibitors of ABCG2 identified by high-throughput screening. Mol Cancer Ther  6, 3271-8.   https://doi.org/10.1158/1535-7163.MCT-07-0352




PubMed



        
     
Free Article


 


PubMed ID 18089721
         Pubmed Central ID 2760480 


 



4.
Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM (2007). A ""silent"" polymorphism in the MDR1 gene changes substrate specificity. Science  315, 525-8.   https://doi.org/10.1126/science.1135308




PubMed


 


PubMed ID 17185560
    
     


 



5.
Paterson JK, Shukla S, Black CM, Tachiwada T, Garfield S, Wincovitch S, Ernst DN, Agadir A, Li X, Ambudkar SV, Szakacs G, Akiyama S, Gottesman MM (2007). Human ABCB6 localizes to both the outer mitochondrial membrane and the plasma membrane. Biochemistry  46, 9443-52.   https://doi.org/10.1021/bi700015m




PubMed


 


PubMed ID 17661442
    
     


 



6.
Pawarode A, Shukla S, Minderman H, Fricke SM, Pinder EM, O'Loughlin KL, Ambudkar SV, Baer MR (2007). Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins. Cancer Chemother Pharmacol  60, 179-88.   https://doi.org/10.1007/s00280-006-0357-8




PubMed


 


PubMed ID 17031644
    
     


 



7.
Rai V, Gaur M, Shukla S, Shukla S, Ambudkar SV, Komath SS, Prasad R (2006). Conserved Asp327 of walker B motif in the N-terminal nucleotide binding domain (NBD-1) of Cdr1p of Candida albicans has acquired a new role in ATP hydrolysis. Biochemistry  45, 14726-39.   https://doi.org/10.1021/bi061535t




PubMed



        
     
Free Article


 


PubMed ID 17144665
         Pubmed Central ID 2526123 


 



8.
Robey RW, Shukla S, Steadman K, Obrzut T, Finley EM, Ambudkar SV, Bates SE (2007). Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure. Mol Cancer Ther  6, 1877-85.   https://doi.org/10.1158/1535-7163.MCT-06-0811




PubMed


 


PubMed ID 17575116
    
     


 



9.
Sauna ZE, Ambudkar SV (2007). About a switch: how P-glycoprotein (ABCB1) harnesses the energy of ATP binding and hydrolysis to do mechanical work. Mol Cancer Ther  6, 13-23.   https://doi.org/10.1158/1535-7163.MCT-06-0155




PubMed


 


PubMed ID 17237262
    
     


 



10.
Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM (2007). The sounds of silence: synonymous mutations affect function. Pharmacogenomics  8, 527-32.   https://doi.org/10.2217/14622416.8.6.527




PubMed


 


PubMed ID 17559340
    
     


 



11.
Shi Z, Jain S, Kim IW, Peng XX, Abraham I, Youssef DT, Fu LW, El Sayed K, Ambudkar SV, Chen ZS (2007). Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Cancer Sci  98, 1373-80.   https://doi.org/10.1111/j.1349-7006.2007.00554.x




PubMed


 


PubMed ID 17640301
    
     


 



12.
Shukla S, Sauna ZE, Ambudkar SV (2008). Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2. Leukemia  22, 445-7.   https://doi.org/10.1038/sj.leu.2404897




PubMed


 


PubMed ID 17690695
    
     


 



13.
Henrich C, Ambudkar S, Bates S, Bokesch H, Cartner L, Dean M, Fuller R, Gustafson K, McMahon J, Robey R, Shukla S, Takada K (submitted in 2007) Method Of Inhibiting Abcg2 And Other Treatment Methods. Patents issued: 8,470,888 (US in 2013); 9,314,448 (US in 2016). Patent pending: PCT/US2008/088446 (PC application).




 



14.
Henrich C, Ambudkar S, Bates S, Bokesch H, Dean M, McMahon J, Robey R, Shukla S (submitted in 2007) Method Of Inhibiting Abcg2 And Related Treatments. Patents issued: 9,114,102 (US in 2015); 9,937,217 (US in 2018). Patent pending: PCT/US2008/082414 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45318
126,BC010033-12,"October 01, 2006 -  September 30, 2007",Inflammation and Cancer,"Curtis  Harris; MD



IRP Faculty Profile",Robert  Wiltrout; PhD,"Laboratory of Human Carcinogenesis, NCI","Elise Dawn Bowman



Mary G Mcmenamin



Elisa A Spillare



Glennwood E Trivers



Krista Anne Zanetti



Sharon R Pine



Show all 9","Stanley  Hamilton
(MD Anderson)




Gerald N Wogan",David Anderson Wink (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Harris C, Mechanic L, Ambs S, Bowman E, Chanock S, Loffredo C, Shields P   (2007) Lung cancer survival and functional polymorphisms in mannose-binding lectin-2,  and innate immunity gene.  JNCI, in press.




 



2.
Stauffer JK, Scarzello AJ, Jiang Q, Wiltrout RH (2012). Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology  56, 1567-74.   https://doi.org/10.1002/hep.25674




PubMed



        
     
Free Article


 


PubMed ID 22378061
         Pubmed Central ID 3381981",https://intramural.nih.gov/search/searchview.taf?ipid=45319
127,BC010036-12,"October 01, 2006 -  September 30, 2007",Comparative functional genomics approach to identify best-fit models to study hu,"Snorri S. Thorgeirsson; MD, PhD",Robert  Wiltrout; PhD,"Laboratory of Experimental Carcinogenesis, NCI","Timothy V Benjamin



Elizabeth A Conner



Marian E Durkin



Anita  Ton



Tanya N Hoang



Joe W Grisham



Show all 11","Diego F Calvisi
(NCI)




Nelson  Fausto
(Pathology, University of Washington School of Medicine)




Gen-Sheng  Feng
(Program in Signal Transduction and Stem Cells& Regeneration, Burnham Institute for Medical Research)




Stefan  Karlsson; MD, PhD
(University of Lund)




Sara  Kozma
(Genome Research Institute, University of Cincinnati)




Ju-Seog  Lee; PhD
(NCI)


Show all 10","Valentina  Factor (Cellular and Molecular Biology Section)



Douglas  Lowy; MD (National Cancer Institute)



Nicolae C Popescu; PhD (National Cancer Institute)



Frank Jess Gonzalez; PhD (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)","Irwin Monroe Arias; BS, MD (NICHD)","Ordered by publication type and then author name.



1.
van Hagen JM, van der Geest JN, van der Giessen RS, Lagers-van Haselen GC, Eussen HJ, Gille JJ, Govaerts LC, Wouters CH, de Coo IF, Hoogenraad CC, Koekkoek SK, Frens MA, van Camp N, van der Linden A, Jansweijer MC, Thorgeirsson SS, De Zeeuw CI (2007). Contribution of CYLN2 and GTF2IRD1 to neurological and cognitive symptoms in Williams Syndrome. Neurobiol Dis  26, 112-24.   https://doi.org/10.1016/j.nbd.2006.12.009




PubMed


 


PubMed ID 17270452",https://intramural.nih.gov/search/searchview.taf?ipid=45320
128,BC010038-12,"October 01, 2006 -  September 30, 2007",Molecular Cytogenetics of Solid Tumors,Nicolae C Popescu; PhD,NULL,"Laboratory of Experimental Carcinogenesis, NCI","Marian E Durkin



Xiaoling  Zhou



Drazen  Zimonjic; PhD



Veenu  Tripathi; PhD","George  Klein
(Karolinska Institutet)




Robert  Weinberg
(Department of Biology, Massachusetts Institute of Technology,)","Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)



Douglas  Lowy; MD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Durkin ME, Ullmannova V, Guan M, Popescu NC (2007). Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth. Oncogene  26, 4580-9.   https://doi.org/10.1038/sj.onc.1210244




PubMed


 


PubMed ID 17297465
    
     


 



2.
Min JN, Huang L, Zimonjic DB, Moskophidis D, Mivechi NF (2007). Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene  26, 5086-97.   https://doi.org/10.1038/sj.onc.1210317




PubMed


 


PubMed ID 17310987
    
     


 



3.
Popescu N, Jefferson A, Millecchia L, Reynolds S   (2007) Morphological changes and nuclear translocation of DLC1 tumor suppressor protein precede apoptosis in human non-small cell lung carcinoma cells.  Exp.Cell Res, in press.




 



4.
Popescu N, Player A, Shankavaram U, Wang Y, Zimonjic D, Lorenzi P, Liao Z, Liu H, Shimura T, Zhang H, Meng L, Zhang Y, Kawasaki E, Mirit I, Goldstein D, Weinstein J, Pommier Y   (2007) Non-Classical Functions of Human Topoisomerase I: Genome-wide and Pharmacological Analyses.  Cancer Res, in press.




 



5.
Popescu N, Yuan B, Zhou X, Zimonjic D, Lowy D, Thorgeirsson S   (2007) DLC-1: a Rho GTPase-activating protein and tumor suppressor.  J. Cell. and Mol. Med, in press.




 



6.
Popescu N, Zhang C, Zhou B, Zimonjic D, Mani S, Kaba M, Gifford A, Reinhardt F, Guo W, Ng Eaton E, Lodish H, Weinberg R   (2007).: Enrichment of a population of mammary gland cells that forms mammospheres and has in vivo repopulating activity.  Cancer Res, in press.




 



7.
Popescu NC, Goodison S (2014). Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene. Mol Diagn Ther  18, 293-302.   https://doi.org/10.1007/s40291-014-0086-3




PubMed



        
     
Free Article


 


PubMed ID 24519699
         Pubmed Central ID 4032595 


 



8.
Qian X, Li G, Asmussen HK, Asnaghi L, Vass WC, Braverman R, Yamada KM, Popescu NC, Papageorge AG, Lowy DR (2007). Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities. Proc Natl Acad Sci U S A  104, 9012-7.   https://doi.org/10.1073/pnas.0703033104




PubMed



        
     
Free Article


 


PubMed ID 17517630
         Pubmed Central ID 1868654 


 



9.
Ullmannova V, Popescu NC (2007). Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. Cancer Detect Prev  31, 110-8.   https://doi.org/10.1016/j.cdp.2007.02.005




PubMed



        
     
Free Article


 


PubMed ID 17418982
         Pubmed Central ID 1950447 


 



10.
Zhou X, Popescu NC, Klein G, Imreh S (2007). The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. Cancer Genet Cytogenet  177, 6-15.   https://doi.org/10.1016/j.cancergencyto.2007.04.007




PubMed



        
     
Free Article


 


PubMed ID 17693185
         Pubmed Central ID 2034301",https://intramural.nih.gov/search/searchview.taf?ipid=45321
129,BC010041-12,"October 01, 2006 -  September 30, 2007","Oligosaccharide Substrate and Inhibitor Interactions with beta-1,4-Gal-T1",Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Elizabeth  Boeggeman



Boopathy  Ramakrishna",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45322
130,BC010251-12,"October 01, 2006 -  September 30, 2007",Secreted Frizzled-Related Proteins and Wnt Signaling,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Bolormaa  Baljinnyam



Osler A Andres



Shengjian  Li



Yun  Ji","Abbot  Clark
(Alcon Labs, Alcon Research, Ltd.)




Paul  Marker
(University of Minnesota Cancer Center)




Bart  Williams
(Laboratory of Cell Signaling and Carcinogenesis, Van Andel Research Institute)",Donald P Bottaro; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Endo Y, Rubin JS (2007). Wnt signaling and neurite outgrowth: insights and questions. Cancer Sci  98, 1311-7.   https://doi.org/10.1111/j.1349-7006.2007.00536.x




PubMed


 


PubMed ID 17627619
    
     


 



2.
Rubin JS, Bottaro DP (2007). Loss of secreted frizzled-related protein-1 expression in renal cell carcinoma reveals a critical tumor suppressor function. Clin Cancer Res  13, 4660-3.   https://doi.org/10.1158/1078-0432.CCR-07-1077




PubMed


 


PubMed ID 17699841",https://intramural.nih.gov/search/searchview.taf?ipid=45323
131,BC010252-12,"October 01, 2006 -  September 30, 2007",Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Daniel C Bertolette



Yi  Huang



Kathryn  Jones; PhD



Cari  Sadowski



Sara E Reynolds",NULL,"Robert  Blumenthal; PhD (National Cancer Institute)



Gene  Shearer; PhD (National Cancer Institute)",Samuel W Cushman; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Takenouchi N, Jones KS, Lisinski I, Fugo K, Yao K, Cushman SW, Ruscetti FW, Jacobson S (2007). GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1. J Virol  81, 1506-10.   https://doi.org/10.1128/JVI.01522-06




PubMed



        
     
Free Article


 


PubMed ID 17108050
         Pubmed Central ID 1797527",https://intramural.nih.gov/search/searchview.taf?ipid=45324
132,BC010253-12,"October 01, 2006 -  September 30, 2007",Molecular Mechanisms of Growth Factor Modulated Proliferation,William  Farrar,NULL,"Laboratory of Cancer Prevention, NCI","Suneethe  Thomas



Han-Jong  Kim



Elaine M Hurt",NULL,Ettore  Appella; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Hurt EM, Thomas SB, Peng B, Farrar WL (2007). Integrated molecular profiling of SOD2 expression in multiple myeloma. Blood  109, 3953-62.   https://doi.org/10.1182/blood-2006-07-035162




PubMed



        
     
Free Article


 


PubMed ID 17192397
         Pubmed Central ID 1874573 


 



2.
Kim HJ, Kim JY, Meng Z, Wang LH, Liu F, Conrads TP, Burke TR, Veenstra TD, Farrar WL (2007). 15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. Cancer Res  67, 2595-602.   https://doi.org/10.1158/0008-5472.CAN-06-3043




PubMed


 


PubMed ID 17363578
    
     


 



3.
Kim JY, Kim HJ, Hurt EM, Chen X, Howard OMZ, Farrar WL (2007). Functional and genomic analyses of FOXP3-transduced Jurkat-T cells as regulatory T (Treg)-like cells. Biochem Biophys Res Commun  362, 44-50.   https://doi.org/10.1016/j.bbrc.2007.07.187




PubMed


 


PubMed ID 17706604
    
     


 



4.
Qin HR, Kim HJ, Kim JY, Hurt EM, Klarmann GJ, Kawasaki BT, Duhagon Serrat MA, Farrar WL (2008). Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation. Cancer Res  68, 7736-41.   https://doi.org/10.1158/0008-5472.CAN-08-1125




PubMed



        
     
Free Article


 


PubMed ID 18829527
         Pubmed Central ID 2859454 


 



5.
Sharifi N, Hamel E, Lill MA, Risbood P, Kane CT, Hossain MT, Jones A, Dalton JT, Farrar WL (2007). A bifunctional colchicinoid that binds to the androgen receptor. Mol Cancer Ther  6, 2328-36.   https://doi.org/10.1158/1535-7163.MCT-07-0163




PubMed


 


PubMed ID 17699728
    
     


 



6.
Sharifi N, Hurt EM, Kawasaki BT, Farrar WL (2007). TGFBR3 loss and consequences in prostate cancer. Prostate  67, 301-11.   https://doi.org/10.1002/pros.20526




PubMed


 


PubMed ID 17192875",https://intramural.nih.gov/search/searchview.taf?ipid=45325
133,BC010256-12,"October 01, 2006 -  September 30, 2007",The Nodal Signaling Pathway In Embryonic Development,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI","George T Lezin



Oyvind  Dahle","Xin-Yuan  Fu
(Yale University)




Jean-Louis  Guénet
(Unit de Gynatique fonctionnelle de la Souris, Pasteur Institute)","Mark B Lewandoski (National Cancer Institute)



Terence P Yamaguchi; PhD (National Cancer Institute)",Amit  Kumar; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Kuehn M, Yamaguchi T, Sharma P   (2007) Transgenic Mouse Lines Expressing Cre Recombinase Specifically in Posterior Notochord (PNC) and Notochord.  Genesis, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45326
134,BC010263-11,"October 01, 2006 -  September 30, 2007",Comparative Feline Genomics: High-Throughput BACPACFosmid Mapping of the MHC,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Naoya  Yuhki; MD



Thomas  Beck



Lisa  Maslan","Martin  Lochelt
(German Cancer Research Center)




Carsten  Muenk
(Div. of Medical Biotechnology, Paul-Ehrlich-Institute)




William J. Murphy
(NCI-FCRDC, NCI)




Douglas U Smith",Robert H Stephens (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Luo SJ, Johnson WE, David VA, Menotti-Raymond M, Stanyon R, Cai QX, Beck T, Yuhki N, Pecon-Slattery J, Smith JL, O'Brien SJ (2007). Development of Y chromosome intraspecific polymorphic markers in the Felidae. J Hered  98, 400-13.   https://doi.org/10.1093/jhered/esm063




PubMed


 


PubMed ID 17646273
    
     


 



2.
Vàzquez-Salat N, Yuhki N, Beck T, O'Brien SJ, Murphy WJ (2007). Gene conversion between mammalian CCR2 and CCR5 chemokine receptor genes: a potential mechanism for receptor dimerization. Genomics  90, 213-24.   https://doi.org/10.1016/j.ygeno.2007.04.009




PubMed


 


PubMed ID 17544254",https://intramural.nih.gov/search/searchview.taf?ipid=45328
135,BC010270-11,"October 01, 2006 -  September 30, 2007",High-Throughput Genotyping for Genetic Epidemiology,Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI","Shawn R Palmer



Michael J Malasky



Taras K Oleksyk



Ann  Truelove



Mary  Mcnally



Yvette  Berthier-schaad



Show all 8","Anthony  Alberg
(Dept. of Epidemiology, Johns Hopkins University)




Josef  Coresh; MD, PhD
(Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health)




Linda  Kao
(Dept. of Epidemiology, Johns Hopkins University)




Elizabeth  Platz; PhD
(School of Public Health, Johns Hopkins University)




Sadeep  Shrestha





Paul  Strickland
(Dept. of Environmental Health Sciences, Johns Hopkins University)",Stephen J O'Brien; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Berthier-Schaad Y, Kao WH, Coresh J, Zhang L, Ingersoll RG, Stephens R, Smith MW (2007). Reliability of high-throughput genotyping of whole genome amplified DNA in SNP genotyping studies. Electrophoresis  28, 2812-7.   https://doi.org/10.1002/elps.200600674




PubMed


 


PubMed ID 17702060
    
     


 



2.
Lind JM, Hutcheson-Dilks HB, Williams SM, Moore JH, Essex M, Ruiz-Pesini E, Wallace DC, Tishkoff SA, O'Brien SJ, Smith MW (2007). Elevated male European and female African contributions to the genomes of African American individuals. Hum Genet  120, 713-22.   https://doi.org/10.1007/s00439-006-0261-7




PubMed


 


PubMed ID 17006671
    
     


 



3.
Zhang L, Kao WH, Berthier-Schaad Y, Plantinga L, Fink N, Smith MW, Coresh J (2007). C-Reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort. Am J Kidney Dis  49, 118-26.   https://doi.org/10.1053/j.ajkd.2006.10.008




PubMed


 


PubMed ID 17185152",https://intramural.nih.gov/search/searchview.taf?ipid=45331
136,BC010271-11,"October 01, 2006 -  September 30, 2007","Identification of Genes Involved in HIV-1AIDS, HBV and HCV",Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI","Taras K Oleksyk



Ann  Truelove



Viktoriya  Grinberg



Cheryl Ann Winkler","Gregory D Kirk





Sadeep  Shrestha





David  Vlahov
(Center for Urban Epidemiologic Studies, New York Academy of Medicine)","James Jerome Goedert; MD (National Cancer Institute)



Stephen J O'Brien; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Berthier-Schaad Y, Kao WH, Coresh J, Zhang L, Ingersoll RG, Stephens R, Smith MW (2007). Reliability of high-throughput genotyping of whole genome amplified DNA in SNP genotyping studies. Electrophoresis  28, 2812-7.   https://doi.org/10.1002/elps.200600674




PubMed


 


PubMed ID 17702060
    
     


 



2.
Lind JM, Hutcheson-Dilks HB, Williams SM, Moore JH, Essex M, Ruiz-Pesini E, Wallace DC, Tishkoff SA, O'Brien SJ, Smith MW (2007). Elevated male European and female African contributions to the genomes of African American individuals. Hum Genet  120, 713-22.   https://doi.org/10.1007/s00439-006-0261-7




PubMed


 


PubMed ID 17006671",https://intramural.nih.gov/search/searchview.taf?ipid=45332
137,BC010272-11,"October 01, 2006 -  September 30, 2007",Facilitating Access to Information on Human Proteins and Their Phosphorylation,"James Stephen Shaw; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",Natalya  Belkina,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Dong X, Patino-Lopez G, Candotti F, Shaw S (2007). Structure-function analysis of the WIP role in T cell receptor-stimulated NFAT activation: evidence that WIP-WASP dissociation is not required and that the WIP NH2 terminus is inhibitory. J Biol Chem  282, 30303-10.   https://doi.org/10.1074/jbc.M704972200




PubMed



        
     
Free Article


 


PubMed ID 17711847
         Pubmed Central ID 2094122 


 



2.
Liu Y, Kruhlak MJ, Hao JJ, Shaw S (2007). Rapid T cell receptor-mediated SHP-1 S591 phosphorylation regulates SHP-1 cellular localization and phosphatase activity. J Leukoc Biol  82, 742-51.   https://doi.org/10.1189/jlb.1206736




PubMed



        
     
Free Article


 


PubMed ID 17575265
         Pubmed Central ID 2084461",https://intramural.nih.gov/search/searchview.taf?ipid=45333
138,BC010275-10,"October 01, 2006 -  September 30, 2007",Neuronal Cell Death Regulation in Drosophila,"Florence M Davidson; MS, PhD, BA",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45334
139,BC010276-10,"October 01, 2006 -  September 30, 2007",Protein Folding Mechanism,"Yawen  Bai; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Hanqiao  Feng



Zheng  Zhou



Hidenori  Kato",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kato H, Feng H, Bai Y (2007). The folding pathway of T4 lysozyme: the high-resolution structure and folding of a hidden intermediate. J Mol Biol  365, 870-80.   https://doi.org/10.1016/j.jmb.2006.10.047




PubMed



        
     
Free Article


 


PubMed ID 17109883
         Pubmed Central ID 2494534 


 



2.
Kato H, Vu ND, Feng H, Zhou Z, Bai Y (2007). The folding pathway of T4 lysozyme: an on-pathway hidden folding intermediate. J Mol Biol  365, 881-91.   https://doi.org/10.1016/j.jmb.2006.10.048




PubMed



        
     
Free Article


 


PubMed ID 17097105
         Pubmed Central ID 2494531 


 



3.
Zhou Z, Feng H, Ghirlando R, Bai Y (2008). The high-resolution NMR structure of the early folding intermediate of the Thermus thermophilus ribonuclease H. J Mol Biol  384, 531-9.   https://doi.org/10.1016/j.jmb.2008.09.044




PubMed



        
     
Free Article


 


PubMed ID 18848567
         Pubmed Central ID 2628467",https://intramural.nih.gov/search/searchview.taf?ipid=45335
140,BC010277-10,"October 01, 2006 -  September 30, 2007",Mechanisms of Chromosome Maintenance in Bacteria,"Dhruba K Chattoraj; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Tatiana B Venkova-Canova



Ryosuke  Kadoya



Ranajit Kumar Ghosh



Gaelle  Demarre","Chanchal  Dasgupta
(Biophysics, Mol Biol & Genetics, U of Calcutta)




Petra  Levin; PhD
(Biology, Washington U)




Johan  Paulsson
(Appl Math and Theoretical Physics, U of Cambridge)",James G McNally; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45336
141,BC010278-10,"October 01, 2006 -  September 30, 2007",Imaging cellular assemblies with three-dimensional electron microscopy,"Sriram  Subramaniam; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Jurgen A Heymann



Martin  Kessel; BSc, PhD



Jeffrey S Lengyel



Sang J Kim","Esther H Chang





Mark  Hildebrand
(Scripps Institute of Oceanography)




John Henry  Scott
(NIST)",NULL,NULL,"Ordered by publication type and then author name.



1.
Bartesaghi A, Sprechmann P, Liu J, Randall G, Sapiro G, Subramaniam S (2008). Classification and 3D averaging with missing wedge correction in biological electron tomography. J Struct Biol  162, 436-50.   https://doi.org/10.1016/j.jsb.2008.02.008




PubMed



        
     
Free Article


 


PubMed ID 18440828
         Pubmed Central ID 2556382",https://intramural.nih.gov/search/searchview.taf?ipid=45337
142,BC010279-10,"October 01, 2006 -  September 30, 2007",Interaction of Progesterone Receptor with Chromatin,Catharine L Smith; PhD,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45338
143,BC010283-10,"October 01, 2006 -  September 30, 2007",DNA Repair,"Andre A Nussenzweig; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Arkady  Celeste



Simone  Difilippantonio



Hua Tang (Henry)  Chen



Maria Elsa  Callen Moreu



Samuel  Bunting



Jeremy A Daniel",NULL,Karl Thomas Ried; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Callén E, Jankovic M, Difilippantonio S, Daniel JA, Chen HT, Celeste A, Pellegrini M, McBride K, Wangsa D, Bredemeyer AL, Sleckman BP, Ried T, Nussenzweig M, Nussenzweig A (2007). ATM prevents the persistence and propagation of chromosome breaks in lymphocytes. Cell  130, 63-75.   https://doi.org/10.1016/j.cell.2007.06.016




PubMed


 


PubMed ID 17599403
    
     


 



2.
Curry JD, Schulz D, Guidos CJ, Danska JS, Nutter L, Nussenzweig A, Schlissel MS (2007). Chromosomal reinsertion of broken RSS ends during T cell development. J Exp Med  204, 2293-303.   https://doi.org/10.1084/jem.20070583




PubMed



        
     
Free Article


 


PubMed ID 17785508
         Pubmed Central ID 2118463 


 



3.
Difilippantonio S, Celeste A, Kruhlak MJ, Lee Y, Difilippantonio MJ, Feigenbaum L, Jackson SP, McKinnon PJ, Nussenzweig A (2007). Distinct domains in Nbs1 regulate irradiation-induced checkpoints and apoptosis. J Exp Med  204, 1003-11.   https://doi.org/10.1084/jem.20070319




PubMed



        
     
Free Article


 


PubMed ID 17485521
         Pubmed Central ID 2118591 


 



4.
Downs JA, Nussenzweig MC, Nussenzweig A (2007). Chromatin dynamics and the preservation of genetic information. Nature  447, 951-8.   https://doi.org/10.1038/nature05980




PubMed


 


PubMed ID 17581578
    
     


 



5.
Jankovic M, Nussenzweig A, Nussenzweig MC (2007). Antigen receptor diversification and chromosome translocations. Nat Immunol  8, 801-8.   https://doi.org/10.1038/ni1498




PubMed


 


PubMed ID 17641661
    
     


 



6.
Kim JA, Kruhlak M, Dotiwala F, Nussenzweig A, Haber JE (2007). Heterochromatin is refractory to gamma-H2AX modification in yeast and mammals. J Cell Biol  178, 209-18.   https://doi.org/10.1083/jcb.200612031




PubMed



        
     
Free Article


 


PubMed ID 17635934
         Pubmed Central ID 2064441 


 



7.
Kruhlak M, Crouch EE, Orlov M, Montaño C, Gorski SA, Nussenzweig A, Misteli T, Phair RD, Casellas R (2007). The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks. Nature  447, 730-4.   https://doi.org/10.1038/nature05842




PubMed


 


PubMed ID 17554310
    
     


 



8.
Kuznetsov S, Pellegrini M, Shuda K, Fernandez-Capetillo O, Liu Y, Martin BK, Burkett S, Southon E, Pati D, Tessarollo L, West SC, Donovan PJ, Nussenzweig A, Sharan SK (2007). RAD51C deficiency in mice results in early prophase I arrest in males and sister chromatid separation at metaphase II in females. J Cell Biol  176, 581-92.   https://doi.org/10.1083/jcb.200608130




PubMed



        
     
Free Article


 


PubMed ID 17312021
         Pubmed Central ID 2064017 


 



9.
Ramiro A, Reina San-Martin B, McBride K, Jankovic M, Barreto V, Nussenzweig A, Nussenzweig MC (2007). The role of activation-induced deaminase in antibody diversification and chromosome translocations. Adv Immunol  94, 75-107.   https://doi.org/10.1016/S0065-2776(06)94003-6




PubMed


 


PubMed ID 17560272
    
     


 



10.
Reina-San-Martin B, Chen J, Nussenzweig A, Nussenzweig MC (2007). Enhanced intra-switch region recombination during immunoglobulin class switch recombination in 53BP1-/- B cells. Eur J Immunol  37, 235-9.   https://doi.org/10.1002/eji.200636789




PubMed


 


PubMed ID 17183606
    
     


 



11.
Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL (2007). Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature  447, 725-9.   https://doi.org/10.1038/nature05862




PubMed


 


PubMed ID 17554309
    
     


 



12.
Soutoglou E, Dorn JF, Sengupta K, Jasin M, Nussenzweig A, Ried T, Danuser G, Misteli T (2007). Positional stability of single double-strand breaks in mammalian cells. Nat Cell Biol  9, 675-82.   https://doi.org/10.1038/ncb1591




PubMed



        
     
Free Article


 


PubMed ID 17486118
         Pubmed Central ID 2442898",https://intramural.nih.gov/search/searchview.taf?ipid=45339
144,BC010289-10,"October 01, 2006 -  September 30, 2007",Chromatin Targets of Cyclic Nucleotide Signaling Pathways,Catharine L Smith; PhD,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,"Jackie  Dudley; PhD
(University of Texas)




Hans-Gottfried  Genieser
(BIOLOG Life Science Institute)",NULL,NULL,"Ordered by publication type and then author name.



1.
Rodriguez-Collazo P, Snyder SK, Chiffer RC, Zlatanova J, Leuba SH, Smith CL (2008). cAMP signaling induces rapid loss of histone H3 phosphorylation in mammary adenocarcinoma-derived cell lines. Exp Cell Res  314, 1-10.   https://doi.org/10.1016/j.yexcr.2007.09.011




PubMed



        
     
Free Article


 


PubMed ID 17950276
         Pubmed Central ID 4426871",https://intramural.nih.gov/search/searchview.taf?ipid=45340
145,BC010292-09,"October 01, 2006 -  September 30, 2007",Enzymes and Substrates of the Ubiquitin Conjugating System,"Allan M Weissman; MD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Jennifer B Mariano



Yien-Che  Tsai



Jirouta  Kitagaki



Andrew  Fotia



Zlatka  Kostova Lenard



Simone  Scholz



Show all 7",NULL,"Barry R O'Keefe (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Michael Robert Kuehn; PhD (National Cancer Institute)












Karen H Vousden  (Regulation of Cell Growth Laboratory)","Juan S Bonifacino; PhD (NICHD) 



James H Hurley; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Weissman A, Tsai Y   (2007) Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation., in Seminars in Cell and Developmental Biology, in press.




 



2.
Weissman A, Kitagaki J, Dai R, Tsai Y, Lorick K, Ludwig R, Pierre S, Jensen J, Davydov I, Oberoi P, Li C, Kenten J, Beutler J, Vousden K   (2007) Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics.  Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45173
146,BC010297-10,"October 01, 2006 -  September 30, 2007",Identification of Candidate Gene Polymorphisms Associated with Infectious Diseas,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI","Ping  An; PhD



Elizabeth  Binns-Roemer



Bailey D Kessing



George  Nelson



Yu-Chun  Zhou



Louise  Mckenzie



Show all 10","Sharyne  Donfield
(Hemophilia Growth and Development Study, Rho, Inc.)




Max  Essex
(Department of Immuology and Infectious Diseases, Harvard Medical School)




Edward  Gomperts
(Pediatrics and Hematology, Childrens Hospital LA)




Gregory D Kirk





John P Phair





Joseph  Sodroski
(Department of Immunology and Infectious Diseases, Harvard Medical School)","James Jerome Goedert; MD (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)



Albert M Gold (National Cancer Institute)



Stephen J O'Brien; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
An P, Duggal P, Wang LH, O'Brien SJ, Donfield S, Goedert JJ, Phair J, Buchbinder S, Kirk GD, Winkler CA (2007). Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals. PLoS Genet  3, e19.   https://doi.org/10.1371/journal.pgen.0030019




PubMed



        
     
Free Article


 


PubMed ID 17257057
         Pubmed Central ID 1781497 


 



2.
An P, Wang LH, Hutcheson-Dilks H, Nelson G, Donfield S, Goedert JJ, Rinaldo CR, Buchbinder S, Kirk GD, O'Brien SJ, Winkler CA (2007). Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS. PLoS Pathog  3, e88.   https://doi.org/10.1371/journal.ppat.0030088




PubMed



        
     
Free Article


 


PubMed ID 17590083
         Pubmed Central ID 1894826 


 



3.
Li X, Gold B, O'hUigin C, Diaz-Griffero F, Song B, Si Z, Li Y, Yuan W, Stremlau M, Mische C, Javanbakht H, Scally M, Winkler C, Dean M, Sodroski J (2007). Unique features of TRIM5alpha among closely related human TRIM family members. Virology  360, 419-33.   https://doi.org/10.1016/j.virol.2006.10.035




PubMed


 


PubMed ID 17156811",https://intramural.nih.gov/search/searchview.taf?ipid=45341
147,BC010298-10,"October 01, 2006 -  September 30, 2007",Gene Discovery,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Richard A Beers



Tomoko  Ise



Satoshi  Nagata; PhD



Laiman  Xiang



Tapan K Bera



Xiu-Fen  Liu



Show all 8",NULL,"Robert J Kreitman; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Das S, Hahn Y, Nagata S, Willingham MC, Bera TK, Lee B, Pastan I (2007). NGEP, a prostate-specific plasma membrane protein that promotes the association of LNCaP cells. Cancer Res  67, 1594-601.   https://doi.org/10.1158/0008-5472.CAN-06-2673




PubMed


 


PubMed ID 17308099
    
     


 



2.
Das S, Hahn Y, Walker DA, Nagata S, Willingham MC, Peehl DM, Bera TK, Lee B, Pastan I (2008). Topology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade level. Cancer Res  68, 6306-12.   https://doi.org/10.1158/0008-5472.CAN-08-0870




PubMed



        
     
Free Article


 


PubMed ID 18676855
         Pubmed Central ID 2562772 


 



3.
Epel M, Carmi I, Soueid-Baumgarten S, Oh S, Bera T, Pastan I, Berzofsky J, Reiter Y (2008). Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies. Eur J Immunol  38, 1706-20.   https://doi.org/10.1002/eji.200737524




PubMed



        
     
Free Article


 


PubMed ID 18446790
         Pubmed Central ID 2682370 


 



4.
Yokokawa J, Bera TK, Palena C, Cereda V, Remondo C, Gulley JL, Arlen PM, Pastan I, Schlom J, Tsang KY (2007). Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4). Int J Cancer  121, 595-605.   https://doi.org/10.1002/ijc.22698




PubMed


 


PubMed ID 17397028",https://intramural.nih.gov/search/searchview.taf?ipid=45342
148,BC010300-10,"October 01, 2006 -  September 30, 2007",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,"Daniel  McVicar; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Selinda Jane Orr




Laura Ann R Quigley




Gillian C Whittaker




Eriko  Yamada","Mary  Nakamura
(Laboratoire d'Hematologie, UCSF)




Valance  Washington
(Anatomy and Cell biology, Universidad Central del Caribe)




Thomas  Yankee
(Microbiology, Univ. Kansas Medical Center)




Weiguo  Zhang
(NICHHD)","Stephen K Anderson; PhD (National Cancer Institute)



Jacek Tadeusz Lubkowski (National Cancer Institute)","Ivo  Francischetti; MD, PhD (NIAID) 



Pamela Lee Schwartzberg; MD, PhD (NHGRI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45343
149,BC010301-10,"October 01, 2006 -  September 30, 2007",Development of Recombinant Toxins for Treatment of Patients with Hematologic Mal,"Robert J Kreitman; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Evgeny  Arons



Linda  Ellison-Dejewski



Inger M Margulies



Barbara  Debrah



David  Waters",NULL,"Wyndham H Wilson; MD, PhD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)



Alan S Wayne; MD (National Cancer Institute)



Daniel J Powell (National Cancer Institute)



Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Arons E, Suntum T, Sunshine J, Stetler-Stevenson M, Kreitman RJ (2007). Immunoglobulin light chain repertoire in hairy cell leukemia. Leuk Res  31, 1231-6.   https://doi.org/10.1016/j.leukres.2006.11.019




PubMed


 


PubMed ID 17462732
    
     


 



2.
Pastan I, Hassan R, FitzGerald DJ, Kreitman RJ (2007). Immunotoxin treatment of cancer. Annu Rev Med  58, 221-37.   https://doi.org/10.1146/annurev.med.58.070605.115320




PubMed


 


PubMed ID 17059365",https://intramural.nih.gov/search/searchview.taf?ipid=45344
150,BC010303-09,"October 01, 2006 -  September 30, 2007",MicroArray Explorer: Data Mining the Expression Profiles of DNA Microarrays,Peter F Lemkin; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45345
151,BC010304-09,"October 01, 2006 -  September 30, 2007",Biochemical Basis of T Cell Activation,"Lawrence Elliot Samelson; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,Ettore  Appella; MD (National Cancer Institute),"Peter W Schuck; PhD (NIBIB) 



Paul E Love; MD, PhD (NICHD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45346
152,BC010306-09,"October 01, 2006 -  September 30, 2007",Identification of Needle Sharing: A Risk Factor for Viral Infection,Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI",Ann  Truelove,"Karl  Broman
(University of Michigan)




Homayoon  Farzadegan
(Dept. of Epidemiology, Johns Hopkins University)




Sadeep  Shrestha





Steffanie  Strathdee
(Dept of Epidemiology, Johns Hopkins University)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45351
153,BC010307-08,"October 01, 2006 -  September 30, 2007",Cell Growth Control In Vivo by CEBPbeta and CEBPdelta,"Gisela Esta Sterneck; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Shikha  Sharan



Snehalata Anil Pawar



Jun  Wang



Youhong  Zhang","Lane  Christenson
(Center for Research on Reproduction and Women's Health, University of Pennsylvania)




Vadivel  Ganapathy
(Department of Biochemistry and Molecular Biology, Medical College of Georgia)




Zdenek  Kleibel
(Dept. of Biochemistry and Experimental Oncology, Charles University in Prague)




Cynthia  Zahnow
(The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University)




Teresa  Zimmers
(Miller School of Medicine, University of Miami)","Thomas Dana Schneider; PhD (National Cancer Institute)



Stefan  Ambs (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45191
154,BC010308-09,"October 01, 2006 -  September 30, 2007",In vivo Imaging Analysis of SteroidNuclear Receptor Function,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Sam  John



Tom  Johnson



Diana  Stavreva



Anindya P Hendarwanto



Ty Cole Voss



Ofir  Hakim","Donald  DeFranco; PhD

(Department of Pharmacology)




Miroslav  Dundr





Brian  Freeman
(University of Illinois, Dept. of Cell and Developmental Biology)




Donald  McDonnell
(Pharmacology and Cancer Biology, Duke University Medical Center)




Fahri  Saatcioglu
(Department of Biology, University of Oslo)




Keith A Yamamoto",James G McNally; PhD (National Cancer Institute),S Stoney  Simons; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Huh JI, Qiu TH, Chandramouli GV, Charles R, Wiench M, Hager GL, Catena R, Calvo A, LaVallee TM, Desprez PY, Green JE (2007). 2-methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant mice. Endocrinology  148, 1266-77.   https://doi.org/10.1210/en.2006-0964




PubMed


 


PubMed ID 17158205
    
     


 



2.
Klokk TI, Kurys P, Elbi C, Nagaich AK, Hendarwanto A, Slagsvold T, Chang CY, Hager GL, Saatcioglu F (2007). Ligand-specific dynamics of the androgen receptor at its response element in living cells. Mol Cell Biol  27, 1823-43.   https://doi.org/10.1128/MCB.01297-06




PubMed



        
     
Free Article


 


PubMed ID 17189428
         Pubmed Central ID 1820481 


 



3.
Meijsing SH, Elbi C, Luecke HF, Hager GL, Yamamoto KR (2007). The ligand binding domain controls glucocorticoid receptor dynamics independent of ligand release. Mol Cell Biol  27, 2442-51.   https://doi.org/10.1128/MCB.01570-06




PubMed



        
     
Free Article


 


PubMed ID 17261597
         Pubmed Central ID 1899895",https://intramural.nih.gov/search/searchview.taf?ipid=45352
155,BC010309-09,"October 01, 2006 -  September 30, 2007",Nuclear Architecture and Disease,"Thomas A Misteli; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Stephen A Mabon



Paola  Scaffidi



Sara K Snyder



Manjari  Mazumdar



Evi  Soutoglou



Takumi  Takizawa



Show all 10","David  Brown
(Biochemistry, University of Mississippi)




Tom  Gingeras
(Array Technology, Affymetrix)




Ingrid  Grummt
(Cancer Biology, DKFZ)




Pier-Paolo  Pandolfi
(Cancer Biology, Memorial Sloan Kettering Cancer Center)




Katherine  Wilson
(Cell Biology, Johns Hopkins University)","Karl Thomas Ried; MD (National Cancer Institute)



Andre A Nussenzweig; PhD (National Cancer Institute)



Stephen J Lockett; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kruhlak M, Crouch EE, Orlov M, Montaño C, Gorski SA, Nussenzweig A, Misteli T, Phair RD, Casellas R (2007). The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks. Nature  447, 730-4.   https://doi.org/10.1038/nature05842




PubMed


 


PubMed ID 17554310
    
     


 



2.
Meaburn KJ, Misteli T (2007). Cell biology: chromosome territories. Nature  445, 379-781.   https://doi.org/10.1038/445379a




PubMed


 


PubMed ID 17251970
    
     


 



3.
Meaburn KJ, Misteli T, Soutoglou E (2007). Spatial genome organization in the formation of chromosomal translocations. Semin Cancer Biol  17, 80-90.   https://doi.org/10.1016/j.semcancer.2006.10.008




PubMed



        
     
Free Article


 


PubMed ID 17137790
         Pubmed Central ID 1805052 


 



4.
Misteli T (2007). Beyond the sequence: cellular organization of genome function. Cell  128, 787-800.   https://doi.org/10.1016/j.cell.2007.01.028




PubMed


 


PubMed ID 17320514
    
     


 



5.
Soutoglou E, Dorn JF, Sengupta K, Jasin M, Nussenzweig A, Ried T, Danuser G, Misteli T (2007). Positional stability of single double-strand breaks in mammalian cells. Nat Cell Biol  9, 675-82.   https://doi.org/10.1038/ncb1591




PubMed



        
     
Free Article


 


PubMed ID 17486118
         Pubmed Central ID 2442898 


 



6.
Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H, Pavletich NP, Carver BS, Cordon-Cardo C, Erdjument-Bromage H, Tempst P, Chi SG, Kim HJ, Misteli T, Jiang X, Pandolfi PP (2007). Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell  128, 141-56.   https://doi.org/10.1016/j.cell.2006.11.040




PubMed



        
     
Free Article


 


PubMed ID 17218261
         Pubmed Central ID 1855245",https://intramural.nih.gov/search/searchview.taf?ipid=45353
156,BC010313-09,"October 01, 2006 -  September 30, 2007",Molecular profiling of human hepatocellular cancer,"Xin Wei Wang; PhD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Anuradha Samantha Budhu



Marshonna J Forgues



Zhipeng  Yu



Chuan-Ging  Wu



Taro  Yamashita



Stephanie  Roessler



Show all 9","Anne W Hamburger





Ping  He





Lun-Xiu  Qin
(Liver Cancer Institute)




Erin  Schuetz
(Pharmaceutical Sciences, St Jude Children's Research Hospital)




Zhao-You  Tang
(Liver Cancer Institute)




Chuan-Ging  Wu","Paul  Goldsmith; PhD (National Cancer Institute)



Nicolae C Popescu; PhD (National Cancer Institute)



Udai S Kammula (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Budhu A, Chen Y, Kim JW, Forgues M, Valerie K, Harris CC, Wang XW (2007). Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins. Carcinogenesis  28, 1552-60.   https://doi.org/10.1093/carcin/bgm075




PubMed


 


PubMed ID 17404395
    
     


 



2.
Chen XC, Yu B, Dong JC, Gu YX, Chen L, Wu QZ, Hou NP, Liu JX, Xu JT, Jin RX, Jin GQ, Yang XD, Cao YW, Tan JJ, Zhu B, Shen JC, Xu Z, Varticovski L, Wang XW (2007). A phase II clinical trial with cytotropic heterogeneous molecular lipids (CHML) for patients with hepatic malignancies. Anticancer Res  27, 1593-600.




PubMed


 


PubMed ID 17595781
    
     


 



3.
Hussain SP, Schwank J, Staib F, Wang XW, Harris CC (2007). TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene  26, 2166-76.   https://doi.org/10.1038/sj.onc.1210279




PubMed


 


PubMed ID 17401425
    
     


 



4.
Jia HL, Ye QH, Qin LX, Budhu A, Forgues M, Chen Y, Liu YK, Sun HC, Wang L, Lu HZ, Shen F, Tang ZY, Wang XW (2007). Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin Cancer Res  13, 1133-9.   https://doi.org/10.1158/1078-0432.CCR-06-1025




PubMed


 


PubMed ID 17317821
    
     


 



5.
Roessler S, Budhu A, Wang XW (2007). Future of molecular profiling of human hepatocellular carcinoma. Future Oncol  3, 429-39.   https://doi.org/10.2217/14796694.3.4.429




PubMed


 


PubMed ID 17661718
    
     


 



6.
Seike M, Yanaihara N, Bowman ED, Zanetti KA, Budhu A, Kumamoto K, Mechanic LE, Matsumoto S, Yokota J, Shibata T, Sugimura H, Gemma A, Kudoh S, Wang XW, Harris CC (2007). Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. J Natl Cancer Inst  99, 1257-69.   https://doi.org/10.1093/jnci/djm083




PubMed


 


PubMed ID 17686824
    
     


 



7.
Takafuji V, Forgues M, Unsworth E, Goldsmith P, Wang XW (2007). An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene  26, 6361-71.   https://doi.org/10.1038/sj.onc.1210463




PubMed


 


PubMed ID 17452979
    
     


 



8.
Croce CM, Budhu AM, Tang ZM, Wang XM (submitted in 2007) Microrna Expression Signature For Predicting Survival And Metastases In Hepatocellular Carcinoma. Patents issued: 8,252,538 (US in 2012); 2087135 (DE in 2013); 2087135 (EP in 2013); 2087135 (ES in 2013); 5501766 (JP in 2014); 2007314212 (AU in 2014). Patents pending: PCT/US2007/023660 (PC application); 13/595,192 (US application); 2667617 (CA application).




 



9.
Wang XW, Croce CW, Ji JW, Yamashita TW (submitted in 2007) Methods For Determining A Hepatocellular Carcinoma Subtype. Patents issued: 8,465,917 (US in 2013); 2008262252 (AU in 2014); 2559773 (DE in 2015); 2152900 (EP in 2015); 2559773 (EP in 2015); 2559772 (EP in 2015); 2559773 (ES in 2015); 5690588 (JP in 2015). Patents pending: 2690144 (CA application); 200880025276.8 (CN application); 201310394618.6 (CN application); 201610142734.2 (CN application); PCT/US2008/007196 (PC application); 13/916,154 (US application); 2013207631 (AU application).",https://intramural.nih.gov/search/searchview.taf?ipid=45355
157,BC010317-09,"October 01, 2006 -  September 30, 2007",Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS Cohorts,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Shawn R Palmer



Michael J Malasky



Mary  Mcnally



James  Lautenberger; PhD



Bailey D Kessing



George  Nelson



Show all 11",NULL,Robert H Stephens (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45356
158,BC010319-09,"October 01, 2006 -  September 30, 2007",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Lothar  Esser



Jichun  Ma



Kazuya  Nishio



Wai-Kwan  Tang



Robert M Rutledge",NULL,"Susan  Bates; MD (National Cancer Institute)



Michael Marc Gottesman; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Li YF, Polgar O, Okada M, Esser L, Bates SE, Xia D (2007). Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: a molecular modeling study. J Mol Graph Model  25, 837-51.   https://doi.org/10.1016/j.jmgm.2006.08.005




PubMed


 


PubMed ID 17027309
    
     


 



2.
Xia D, Esser L, Yu L, Yu CA (2007). Structural basis for the mechanism of electron bifurcation at the quinol oxidation site of the cytochrome bc1 complex. Photosynth Res  92, 17-34.   https://doi.org/10.1007/s11120-007-9155-3




PubMed


 


PubMed ID 17457691",https://intramural.nih.gov/search/searchview.taf?ipid=45358
159,BC010326-08,"October 01, 2006 -  September 30, 2007","Biomolecular Structure and Mechanism, Structure-Based Drug Design","Xinhua  Ji; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Jianhua  Gan



Gary X Shaw



Chao  Tu



Hehua  Liu



Ravi Charan Reddy Kalathur



Priadarsini  Subburaman","Shivendra  Singh
(Cancer Insititue, University of Pittsburgh)




Honggao  Yan","Donald L Court; PhD (National Cancer Institute)



Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)



Ding Jun Jin (National Cancer Institute)



Larry K Keefer; PhD (National Cancer Institute)



David S Waugh; PhD (Protein Engineering Section)",NULL,"Ordered by publication type and then author name.



1.
Ji X   (2007) The mechanism of RNase III action: How Dicer dices., in RNAi edition of Current Topics in Microbiology and Immunology. Springer Publishers (New York), in press.




 



2.
Blaszczyk J, Li Y, Gan J, Yan H, Ji X (2007). Structural basis for the aldolase and epimerase activities of Staphylococcus aureus dihydroneopterin aldolase. J Mol Biol  368, 161-9.   https://doi.org/10.1016/j.jmb.2007.02.009




PubMed



        
     
Free Article


 


PubMed ID 17331536
         Pubmed Central ID 1885205 


 



3.
Gan J, Wu Y, Prabakaran P, Gu Y, Li Y, Andrykovitch M, Liu H, Gong Y, Yan H, Ji X (2007). Structural and biochemical analyses of shikimate dehydrogenase AroE from Aquifex aeolicus: implications for the catalytic mechanism. Biochemistry  46, 9513-22.   https://doi.org/10.1021/bi602601e




PubMed


 


PubMed ID 17649975
    
     


 



4.
Ji X, Pal A, Kalathur R, Hu X, Gu Y, Saavedra JE, Buzard GS, Srinivasan A, Keefer LK, Singh SV (2008). Structure-Based Design of Anticancer Prodrug PABA/NO. Drug Des Devel Ther  2, 123-130.   https://doi.org/10.2147/dddt.s3931




PubMed



        
     
Free Article


 


PubMed ID 19662104
         Pubmed Central ID 2721280",https://intramural.nih.gov/search/searchview.taf?ipid=45359
160,BC010328-08,"October 01, 2006 -  September 30, 2007",Role of CEBP transcription factors in regulating cell growth and tumorigenesis,"Peter F Johnson; PhD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Thomas  Sebastian



Nancy C Martin



Sook  Lee



Barbara L Shankle



Radek  Malik



Krisada  Sakchaisri



Show all 7","Maria  Hatzoglou
(Dept of Nutrition, Case Western Reserve University School of Medicine)




Stephen D Hursting; PhD, MPH
(Epidemiology and Carcinogenesis, NCI)




Richard  Schwartz
(Department of Microbiology and Molecular Genetics, Michigan State University)




Robert  Smart
(Department of Environmental and Molecular Toxicology, North Carolina State University)","Jonathan  Keller; PhD (National Cancer Institute)



Maria  Miller (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Loomis KD, Zhu S, Yoon K, Johnson PF, Smart RC (2007). Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis. Cancer Res  67, 6768-76.   https://doi.org/10.1158/0008-5472.CAN-07-0139




PubMed



        
     
Free Article


 


PubMed ID 17638888
         Pubmed Central ID 3773581 


 



2.
Lopez AB, Wang C, Huang CC, Yaman I, Li Y, Chakravarty K, Johnson PF, Chiang CM, Snider MD, Wek RC, Hatzoglou M (2007). A feedback transcriptional mechanism controls the level of the arginine/lysine transporter cat-1 during amino acid starvation. Biochem J  402, 163-73.   https://doi.org/10.1042/BJ20060941




PubMed



        
     
Free Article


 


PubMed ID 17042743
         Pubmed Central ID 1783987 


 



3.
Spooner CJ, Guo X, Johnson PF, Schwartz RC (2007). Differential roles of C/EBP beta regulatory domains in specifying MCP-1 and IL-6 transcription. Mol Immunol  44, 1384-92.   https://doi.org/10.1016/j.molimm.2006.05.004




PubMed


 


PubMed ID 16784777
    
     


 



4.
Spooner CJ, Sebastian T, Shuman JD, Durairaj S, Guo X, Johnson PF, Schwartz RC (2007). C/EBPbeta serine 64, a phosphoacceptor site, has a critical role in LPS-induced IL-6 and MCP-1 transcription. Cytokine  37, 119-27.   https://doi.org/10.1016/j.cyto.2007.03.001




PubMed


 


PubMed ID 17433708",https://intramural.nih.gov/search/searchview.taf?ipid=45360
161,BC010329-08,"October 01, 2006 -  September 30, 2007",Regulation of Ras-Dependent Signal Transduction Pathways,"Deborah K Morrison



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Michele Kathleen Dougherty



Junghwa  Lim



Melissa M Mckay","Robert  Lewis
(Univeristy of Nebraska Medical Center)




Kun-Ping  Lu
(Cancer Biology Program, Harvard Medical School)




John  Scott
(Vollum Institute, Oregon Health and Science University)




J.  Sweatt
(Department of Neurobiology, Univerisity of Alabama at Birmingham)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45361
162,BC010331-08,"October 01, 2006 -  September 30, 2007",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Teresa  Kosakowska Cholo



Chang-Qing  Yuan



Pralhada Rao  Raghavendra","Usha  Acharya
(Programe in Gene Function and Expression, University of Mass. Medical School)




Usha  Acharya
(Programe in Gene Function and Expression, University of Mass. Medical School)




Pedro  Labarca
(Arturo Prat 514, Centro de Estudios Cientificos)




Alfred  Merrill Jr
(Schools of Biology and Chemistry and Biochemistry, Georgia Institute of Technology)","Deborah K Morrison (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



Shyam K Sharan (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Rao RP, Yuan C, Allegood JC, Rawat SS, Edwards MB, Wang X, Merrill AH, Acharya U, Acharya JK (2007). Ceramide transfer protein function is essential for normal oxidative stress response and lifespan. Proc Natl Acad Sci U S A  104, 11364-9.   https://doi.org/10.1073/pnas.0705049104




PubMed



        
     
Free Article


 


PubMed ID 17592126
         Pubmed Central ID 1899189",https://intramural.nih.gov/search/searchview.taf?ipid=45362
163,BC010333-08,"October 01, 2006 -  September 30, 2007",The Segregation of Bacterial Chromosomes to Daughter Cells,"Stuart J Austin



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Therese G Brendler; BS, PhD



Brenda L Youngren



Manjistha  Sengupta",NULL,Donald L Court; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45363
164,BC010334-08,"October 01, 2006 -  September 30, 2007",Posttranscriptional control of gene expression,"Barbara K Felber



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Jenifer L Bear



Andrei S Zolotukhin



Rashmi  Jalah



Gen-Mu  Zhang","Michael  Egan
(Department of Pathology and Laboratory Medicine, Wyeth Lederle Vaccines)




Michael  Egan
(Department of Pathology and Laboratory Medicine, Wyeth Lederle Vaccines)




John  Eldridge
(Wyeth Lederle Vaccines)




George  Panayotou
(Molecular Oncology, Alexander Fleming Biomedicine Sciences Research Center)




Ralf  Schneider
(GSF-National Research Center for Environment and Health)




David  Weiner
(University of Pennsylvania)","George N Pavlakis; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Felber B, Rosati M, Kulkarni V, Patel V, Bergamaschi C, Valentin A, Zhang G, Sidhu M, Eldridge J, Weiner D, Pavlakis G   (2007) Efficient systemic expression of bioactive IL-15 in mice upon delivery of  optimized DNA expression plasmids.  DNA Cell Biol, in press.




 



2.
Felber BK, Zolotukhin AS, Pavlakis GN (2007). Posttranscriptional control of HIV-1 and other retroviruses and its practical applications. Adv Pharmacol  55, 161-97.   https://doi.org/10.1016/S1054-3589(07)55005-2




PubMed


 


PubMed ID 17586315",https://intramural.nih.gov/search/searchview.taf?ipid=45364
165,BC010336-08,"October 01, 2006 -  September 30, 2007",Genetic Networks and Red-mediated Recombination,"Donald L Court; PhD



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Nina C Costantino



Lynn C Thomason



James A Sawitzke



Teresa L Baker



Xiaomei  Zhou","Gloria  Culver
(Biochemistry, biophysics, and Molecular Biology, Iowa State University)




David  Friedman
(Microbiology and Immunology, University of Michigan School of Medicine)




David  Friedman
(Microbiology and Immunology, University of Michigan School of Medicine)




Max  Gottesman
(Institute of Cancer Research, Columbia University)




Kenon  Murphy
(Molecular Genetics and Microbiology, University of Massachusetts Med. School)




Amos  Oppenheim



Show all 7","Neal G Copeland; PhD (National Cancer Institute)



Mikhail V Kashlev (National Cancer Institute)



Sankar  Adhya; PhD (National Cancer Institute)



Ding Jun Jin (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)



David S Waugh; PhD (Protein Engineering Section)",Nancy L Jenkins (CC),"Ordered by publication type and then author name.



1.
Bubunenko M, Baker T, Court DL (2007). Essentiality of ribosomal and transcription antitermination proteins analyzed by systematic gene replacement in Escherichia coli. J Bacteriol  189, 2844-53.   https://doi.org/10.1128/JB.01713-06




PubMed



        
     
Free Article


 


PubMed ID 17277072
         Pubmed Central ID 1855809 


 



2.
Chan W, Costantino N, Li R, Lee SC, Su Q, Melvin D, Court DL, Liu P (2007). A recombineering based approach for high-throughput conditional knockout targeting vector construction. Nucleic Acids Res  35, e64.   https://doi.org/10.1093/nar/gkm163




PubMed



        
     
Free Article


 


PubMed ID 17426124
         Pubmed Central ID 1885671 


 



3.
Court DL, Oppenheim AB, Adhya SL (2007). A new look at bacteriophage lambda genetic networks. J Bacteriol  189, 298-304.   https://doi.org/10.1128/JB.01215-06




PubMed



        
     
Free Article


 


PubMed ID 17085553
         Pubmed Central ID 1797383 


 



4.
Korepanov AP, Gongadze GM, Garber MB, Court DL, Bubunenko MG (2007). Importance of the 5 S rRNA-binding ribosomal proteins for cell viability and translation in Escherichia coli. J Mol Biol  366, 1199-208.   https://doi.org/10.1016/j.jmb.2006.11.097




PubMed



        
     
Free Article


 


PubMed ID 17198710
         Pubmed Central ID 1939977 


 



5.
Phadtare S, Kazakov T, Bubunenko M, Court DL, Pestova T, Severinov K (2007). Transcription antitermination by translation initiation factor IF1. J Bacteriol  189, 4087-93.   https://doi.org/10.1128/JB.00188-07




PubMed



        
     
Free Article


 


PubMed ID 17384193
         Pubmed Central ID 1913383 


 



6.
Sawitzke JA, Thomason LC, Costantino N, Bubunenko M, Datta S, Court DL (2007). Recombineering: in vivo genetic engineering in E. coli, S. enterica, and beyond. Methods Enzymol  421, 171-99.   https://doi.org/10.1016/S0076-6879(06)21015-2




PubMed


 


PubMed ID 17352923
    
     


 



7.
Thomason LC, Costantino N, Shaw DV, Court DL (2007). Multicopy plasmid modification with phage lambda Red recombineering. Plasmid  58, 148-58.   https://doi.org/10.1016/j.plasmid.2007.03.001




PubMed



        
     
Free Article


 


PubMed ID 17434584
         Pubmed Central ID 2706537 


 



8.
Wang Y, Stieglitz KA, Bubunenko M, Court DL, Stec B, Roberts MF (2007). The structure of the R184A mutant of the inositol monophosphatase encoded by suhB and implications for its functional interactions in Escherichia coli. J Biol Chem  282, 26989-96.   https://doi.org/10.1074/jbc.M701210200




PubMed


 


PubMed ID 17652087",https://intramural.nih.gov/search/searchview.taf?ipid=45365
166,BC010337-08,"October 01, 2006 -  September 30, 2007",Identifying Protein Factors and Pathways Leading to the Active Chromatin State,"Mikhail V Kashlev



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Yuri  Purtov,"Zachary  Burton
(Department of Biochemistry and Molecular Biology, Michigan State University)




Carlos  Bustamante
(University of California - Berkeley)




Leonard C Lutter; PhD
(Molecular Biology Research Program, Henry Ford Hospital)




Sergei  Mirkin
(University of Illinois)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45366
167,BC010338-08,"October 01, 2006 -  September 30, 2007",The Role of Fgf Signaling in Vertebrate Development,"Mark B Lewandoski



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Cindy  Elder



Michelle B Warren



Nakisha D Moore","Gregg  Duester
(Department of OncoDevelopmental Biology, Burnham Institute)




Martyn  Goulding
(Molecular Neurobiology Laborator, Salk Institute)




Olivier  Pourquie
(Stowers Institute)","Terence P Yamaguchi; PhD (National Cancer Institute)



Alan O Perantoni; PhD (National Cancer Institute)



Carl  Wu; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Jacques BE, Montcouquiol ME, Layman EM, Lewandoski M, Kelley MW (2007). Fgf8 induces pillar cell fate and regulates cellular patterning in the mammalian cochlea. Development  134, 3021-9.   https://doi.org/10.1242/dev.02874




PubMed


 


PubMed ID 17634195
    
     


 



2.
Lewandoski M (2007). Analysis of mouse development with conditional mutagenesis. Handb Exp Pharmacol   235-62  https://doi.org/10.1007/978-3-540-35109-2_10




PubMed


 


PubMed ID 17203658",https://intramural.nih.gov/search/searchview.taf?ipid=45367
168,BC010339-08,"October 01, 2006 -  September 30, 2007",The Role of Rx in the Adult Retina,"Mark B Lewandoski



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Cindy  Elder



Michelle B Warren",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45368
169,BC010340-08,"October 01, 2006 -  September 30, 2007",Ty Element Retrotransposition in Saccharomyces cerevisiae,David J. Garfinkel; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Sharon P Moore



Karen Marie Stefanisko



Arun  Dakshinamurthy



Emiko  Matsuda



Mary Ann  Checkley",NULL,Dwight V Nissley (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45369
170,BC010341-08,"October 01, 2006 -  September 30, 2007",Protein Expression and Purification in the Fast Lane,"David S Waugh; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Sreedevi  Nallamsetty



Brian P Austin



Di  Zhang",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Nallamsetty S, Waugh DS (2007). A generic protocol for the expression and purification of recombinant proteins in Escherichia coli using a combinatorial His6-maltose binding protein fusion tag. Nat Protoc  2, 383-91.   https://doi.org/10.1038/nprot.2007.50




PubMed


 


PubMed ID 17406599
    
     


 



2.
Tropea JE, Cherry S, Nallamsetty S, Bignon C, Waugh DS (2007). A generic method for the production of recombinant proteins in Escherichia coli using a dual hexahistidine-maltose-binding protein affinity tag. Methods Mol Biol  363, 1-19.   https://doi.org/10.1007/978-1-59745-209-0_1




PubMed


 


PubMed ID 17272834",https://intramural.nih.gov/search/searchview.taf?ipid=45370
171,BC010342-08,"October 01, 2006 -  September 30, 2007",Structural Proteomics of the Yersinia Yop Virulon,"David S Waugh; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Brian P Austin



George T Lountos



Ping  Sun



Di  Zhang","Gregory  Plano; PhD
(Microbiology and Immunology, University of Miami School of Medicine)




Robert  Ulrich
(Molecular Immunology, USAMRIID)",Terrence R Burke; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Phan J, Tropea JE, Waugh DS (2007). Structure-assisted discovery of Variola major H1 phosphatase inhibitors. Acta Crystallogr D Biol Crystallogr  63, 698-704.   https://doi.org/10.1107/S0907444907014904




PubMed


 


PubMed ID 17505108",https://intramural.nih.gov/search/searchview.taf?ipid=45371
172,BC010345-08,"October 01, 2006 -  September 30, 2007",The Role of Wnt Genes in Vertebrate Development and Cancer,"Terence P Yamaguchi; PhD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Kristin K Biris



William C Dunty



Ravindra Babu  Chalamalasetty","Ryoichiro  Kageyama
(Institute for Virus Research, Kyoto University)




Mark  Taketo
(Graduate School of Pharmaceutical Sciences, University of Tokyo)","Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)



Mark B Lewandoski (National Cancer Institute)



Alan O Perantoni; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Yamaguchi T, Biris K, Chalamalasetty R, Taketo M, Lewandoski M   (2007) Wnt3a/beta catenin signaling controls posterior body development by coordinating mesoderm formation and segmentation.  Development, in press.




 



2.
Yamaguchi T, Dunty W   (2007) Mouse Ripply2 is downstream of Wnt3a and is dynamically expressed during somitogenesis.  Developmental Dynamics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45372
173,BC010346-08,"October 01, 2006 -  September 30, 2007",Structural Biology of Proteins Involved in Signal Transduction and Regulation of,"Robert Andrew Byrd



IRP Faculty Profile",NULL,"Structural Biophysics Laboratory, NCI","Amanda S Altieri; PhD



Jess R Li



Robert L Mcfeeters



Hana  Krizova



Ranabir  Das



Aaren  Gonzales",NULL,"Allan M Weissman; MD (National Cancer Institute)



Barry R O'Keefe (National Cancer Institute)



Donald L Court; PhD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)



David S Waugh; PhD (Protein Engineering Section)",John J Kuszewski; PhD (CIT),"Ordered by publication type and then author name.



1.
Chakrabarti KS, Li J, Das R, Byrd RA (2017). Conformational Dynamics and Allostery in E2:E3 Interactions Drive Ubiquitination: gp78 and Ube2g2. Structure  25, 794-805.e5.   https://doi.org/10.1016/j.str.2017.03.016




PubMed



        
     
Free Article


 


PubMed ID 28434917
         Pubmed Central ID 5512444 


 



2.
Chao FA, Byrd RA (2016). Geometric Approximation: A New Computational Approach To Characterize Protein Dynamics from NMR Adiabatic Relaxation Dispersion Experiments. J Am Chem Soc  138, 7337-45.   https://doi.org/10.1021/jacs.6b02786




PubMed



        
     
Free Article


 


PubMed ID 27225523
         Pubmed Central ID 6344943 


 



3.
Chao FA, Byrd RA (2017). Application of geometric approximation to the CPMG experiment: Two- and three-site exchange. J Magn Reson  277, 8-14.   https://doi.org/10.1016/j.jmr.2017.01.022




PubMed



        
     
Free Article


 


PubMed ID 28189995
         Pubmed Central ID 5405725 


 



4.
Gill ML, Byrd RA (2014). Dynamic activation of apoptosis: conformational ensembles of cIAP1 are linked to a spring-loaded mechanism. Nat Struct Mol Biol  21, 1022-3.   https://doi.org/10.1038/nsmb.2925




PubMed



        
     
Free Article


 


PubMed ID 25469840
         Pubmed Central ID 6309400 


 



5.
McFeeters RL, Xiong C, O'Keefe BR, Bokesch HR, McMahon JB, Ratner DM, Castelli R, Seeberger PH, Byrd RA (2007). The novel fold of scytovirin reveals a new twist for antiviral entry inhibitors. J Mol Biol  369, 451-61.   https://doi.org/10.1016/j.jmb.2007.03.030




PubMed



        
     
Free Article


 


PubMed ID 17434526
         Pubmed Central ID 2696897 


 



6.
Sun S, Gill M, Li Y, Huang M, Byrd RA (2015). Efficient and generalized processing of multidimensional NUS NMR data: the NESTA algorithm and comparison of regularization terms. J Biomol NMR  62, 105-117.   https://doi.org/10.1007/s10858-015-9923-x




PubMed



        
     
Free Article


 


PubMed ID 25808220
         Pubmed Central ID 4438710",https://intramural.nih.gov/search/searchview.taf?ipid=45373
174,BC010347-08,"October 01, 2006 -  September 30, 2007",Design of Drugs Against Cancer and Viral Diseases,Christopher J Michejda; PhD,NULL,"Structural Biophysics Laboratory, NCI","Nadya I Tarasova; PhD



Piotr  Kaczmarek



Sheng  Jiang","Edward  Arnold; CABM
(Rutgers University)




Brian  Carr
(SURGERY, University of Pittsburgh)




William  Jorgensen
(CHEMISTRY, Yale University)




Susan  Keay





Anne  Monks
(STB, SAIC-Frederick)




Veenstra  Timothy
(RTP, SAIC-Frederick)","Yves  Pommier; PhD (National Cancer Institute)



Stuart F J Le Grice; PhD (National Cancer Institute)



Stephen H Hughes; PhD (National Cancer Institute)



Michael Marc Gottesman; MD (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kaczmarek P, Keay SK, Tocci GM, Koch KR, Zhang CO, Barchi JJ, Grkovic D, Guo L, Michejda CJ (2008). Structure-activity relationship studies for the peptide portion of the bladder epithelial cell antiproliferative factor from interstitial cystitis patients. J Med Chem  51, 5974-83.   https://doi.org/10.1021/jm8002763




PubMed



        
     
Free Article


 


PubMed ID 18788730
         Pubmed Central ID 2778288 


 



2.
Moody DL, Dyba M, Kosakowska-Cholody T, Tarasova NI, Michejda CJ (2007). Synthesis and biological activity of 5-aza-ellipticine derivatives. Bioorg Med Chem Lett  17, 2380-4.   https://doi.org/10.1016/j.bmcl.2006.09.093




PubMed



        
     
Free Article


 


PubMed ID 17376678
         Pubmed Central ID 2262287 


 



3.
Morningstar ML, Roth T, Farnsworth DW, Smith MK, Watson K, Buckheit RW, Das K, Zhang W, Arnold E, Julias JG, Hughes SH, Michejda CJ (2007). Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme. J Med Chem  50, 4003-15.   https://doi.org/10.1021/jm060103d




PubMed



        
     
Free Article


 


PubMed ID 17663538
         Pubmed Central ID 3057568 


 



4.
Remsberg JR, Lou H, Tarasov SG, Dean M, Tarasova NI (2007). Structural analogues of smoothened intracellular loops as potent inhibitors of Hedgehog pathway and cancer cell growth. J Med Chem  50, 4534-8.   https://doi.org/10.1021/jm0705657




PubMed



        
     
Free Article


 


PubMed ID 17685505
         Pubmed Central ID 3956439 


 



5.
Tarasova NI, Loeppky RN, Byrd RA, Keefer LK (2007). In memoriam: Christopher J. Michejda (December 19, 1937-January 9, 2007). Chem Res Toxicol  20, 323-5.   https://doi.org/10.1021/tx700056k




PubMed


 


PubMed ID 17335248
    
     


 



6.
Tarasova NI, Dean MI, Lou HI (submitted in 2007) Smoothened Polypeptides And Methods Of Use. Patents issued: 8,546,524 (US in 2014); IDP000042910 (ID in 2017). Patents pending: 07871292.4 (EP application); 11179413.7 (EP application); 815/MUMNP/2009 (IN application); 088291/2015 (JP application); PI 2013000956 (MY application); 576467 (NZ application); 597715 (NZ application); PCT/US2007/083027 (PC application); 13/956,628 (US application); 2007329678 (AU application); 2667821 (CA application). Tracking number: E-014-2007-0-HK-24 (HK application).




 



7.
Tarasova NI, Gaponenko VI, Michejda CI, Perantoni AI, Tarasov SI, Timofeeva OI (submitted in 2007) Peptide-based Stat Inhibitor. Patent issued: 9,540,427 (US in 2017). Patents pending: 15/397,053 (US application); PCT/US2008/065352 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45374
175,BC010348-08,"October 01, 2006 -  September 30, 2007",Protein Structure,"Alexander  Wlodawer; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Alla E Gustchina



Maria E Miller



Alexander S Zdanov



Tinoush  Moulaei



Prasenjit  Bhaumik



Jamaine S Davis","Ben  Dunn
(Biochem. & Mol. Biol., University of Florida)




Hong  Guo; PhD





Mariusz  Jaskolski





Toru  Nakayama
(Biomolecular Engineering, Tohoku University)




Kohei  Oda
(Dept. Applied Biology, Kyoto Inst. of Technology)","Nancy H Colburn; PhD (National Cancer Institute)



Barry R O'Keefe (National Cancer Institute)



Zbigniew  Dauter (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Demartini DR, Wlodawer A, Carlini CR (2007). A comparative study of the expression of serine proteinases in quiescent seeds and in developing Canavalia ensiformis plants. J Exp Bot  58, 521-32.   https://doi.org/10.1093/jxb/erl223




PubMed


 


PubMed ID 17158110
    
     


 



2.
Jaskolski M, Gilski M, Dauter Z, Wlodawer A (2007). Stereochemical restraints revisited: how accurate are refinement targets and how much should protein structures be allowed to deviate from them? Acta Crystallogr D Biol Crystallogr  63, 611-20.   https://doi.org/10.1107/S090744490700978X




PubMed


 


PubMed ID 17452786
    
     


 



3.
LaRonde-LeBlanc N, Santhanam AN, Baker AR, Wlodawer A, Colburn NH (2007). Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol Cell Biol  27, 147-56.   https://doi.org/10.1128/MCB.00867-06




PubMed



        
     
Free Article


 


PubMed ID 17060447
         Pubmed Central ID 1800662 


 



4.
Sanches M, Krauchenco S, Martins NH, Gustchina A, Wlodawer A, Polikarpov I (2007). Structural characterization of B and non-B subtypes of HIV-protease: insights into the natural susceptibility to drug resistance development. J Mol Biol  369, 1029-40.   https://doi.org/10.1016/j.jmb.2007.03.049




PubMed


 


PubMed ID 17467738
    
     


 



5.
Wlodawer A (2007). Deposition of structural data redux. Acta Crystallogr D Biol Crystallogr  63, 421-3.   https://doi.org/10.1107/S0907444907006336




PubMed


 


PubMed ID 17327681
    
     


 



6.
Xu Q, Guo HB, Wlodawer A, Nakayama T, Guo H (2007). The QM/MM molecular dynamics and free energy simulations of the acylation reaction catalyzed by the serine-carboxyl peptidase kumamolisin-As. Biochemistry  46, 3784-92.   https://doi.org/10.1021/bi061737p




PubMed



        
     
Free Article


 


PubMed ID 17326662
         Pubmed Central ID 2533263 


 



7.
Zdanov A (2010) Structural analysis of cytokines comprising the IL-10 family. Cytokine Growth Factor Rev 21:325-30




PubMed



               Available in future as a Free Article 


 


PubMed ID 20846897
         Pubmed Central ID 2997900 


 



8.
Ziółkowska NE, Shenoy SR, O'Keefe BR, McMahon JB, Palmer KE, Dwek RA, Wormald MR, Wlodawer A (2007). Crystallographic, thermodynamic, and molecular modeling studies of the mode of binding of oligosaccharides to the potent antiviral protein griffithsin. Proteins  67, 661-70.   https://doi.org/10.1002/prot.21336




PubMed


 


PubMed ID 17340634",https://intramural.nih.gov/search/searchview.taf?ipid=45375
176,BC010349-08,"October 01, 2006 -  September 30, 2007",Genomic Imprinting in Development and Disease,Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI","Serguei V Kozlov



Teresa L Sullivan



Yanmei  Wang



Lidia F Hernandez","Gregg  Hannon
(Bigshotlab, Cold Spring Harbor Laboratory)




Eric  Herzog
(Biology, University of Washington)




Russel  van Gelder
(School of Medicine, Washington University)




Rachel  Wevrick
(Medical Genetics, University of Edmonton)",NULL,NULL,"Ordered by publication type and then author name.



1.
Bischof JM, Stewart CL, Wevrick R (2007). Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome. Hum Mol Genet  16, 2713-9.   https://doi.org/10.1093/hmg/ddm225




PubMed


 


PubMed ID 17728320
    
     


 



2.
Kozlov SV, Bogenpohl JW, Howell MP, Wevrick R, Panda S, Hogenesch JB, Muglia LJ, Van Gelder RN, Herzog ED, Stewart CL (2007). The imprinted gene Magel2 regulates normal circadian output. Nat Genet  39, 1266-72.   https://doi.org/10.1038/ng2114




PubMed


 


PubMed ID 17893678
    
     


 



3.
Sharova LV, Sharov AA, Piao Y, Shaik N, Sullivan T, Stewart CL, Hogan BL, Ko MS (2007). Global gene expression profiling reveals similarities and differences among mouse pluripotent stem cells of different origins and strains. Dev Biol  307, 446-59.   https://doi.org/10.1016/j.ydbio.2007.05.004




PubMed



        
     
Free Article


 


PubMed ID 17560561
         Pubmed Central ID 2000702",https://intramural.nih.gov/search/searchview.taf?ipid=45376
177,BC010350-08,"October 01, 2006 -  September 30, 2007",Prevention of AIDS,"Barbara K Felber



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Jenifer L Bear



Candido  Alicea; PhD



Rashmi  Jalah



Gen-Mu  Zhang



Viraj M Kulkarni","J. Thomas  August
(Molecular Biology and Genetics Department, Johns Hopkins University School of Medicine)




Ronald  Desrosiers
(New England Primate Research Center)




Michael  Egan
(Cancer Immunology and AIDS, Wyeth Lederle Vaccines)




Michael  Egan
(Cancer Immunology and AIDS, Wyeth Lederle Vaccines)




John  Eldridge
(Wyeth Lederle Vaccines)




R. Paul  Johnson
(New England Primate Research Center)


Show all 17","Antonio L Valentin (National Cancer Institute)



George N Pavlakis; MD, PhD (National Cancer Institute)



Genoveffa  Franchini; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Felber B, Rosati M, Kulkarni V, Patel V, Bergamaschi C, Valentin A, Zhang G, Sidhu M, Eldridge J, Weiner D, Pavlakis G   (2007) Efficient systemic expression of bioactive IL-15 in mice upon delivery of  optimized DNA expression plasmids.  DNA Cell Biol, in press.




 



2.
Luckay A, Sidhu MK, Kjeken R, Megati S, Chong SY, Roopchand V, Garcia-Hand D, Abdullah R, Braun R, Montefiori DC, Rosati M, Felber BK, Pavlakis GN, Mathiesen I, Israel ZR, Eldridge JH, Egan MA (2007). Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol  81, 5257-69.   https://doi.org/10.1128/JVI.00055-07




PubMed



        
     
Free Article


 


PubMed ID 17329330
         Pubmed Central ID 1900241 


 



3.
Robinson TM, Sidhu MK, Pavlakis GN, Felber BK, Silvera P, Lewis MG, Eldridge J, Weiner DB, Boyer JD (2007). Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses. J Med Primatol  36, 276-84.   https://doi.org/10.1111/j.1600-0684.2007.00245.x




PubMed


 


PubMed ID 17669216
    
     


 



4.
von Gegerfelt AS, Rosati M, Alicea C, Valentin A, Roth P, Bear J, Franchini G, Albert PS, Bischofberger N, Boyer JD, Weiner DB, Markham P, Israel ZR, Eldridge JH, Pavlakis GN, Felber BK (2007). Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization. J Virol  81, 1972-9.   https://doi.org/10.1128/JVI.01990-06




PubMed



        
     
Free Article


 


PubMed ID 17135321
         Pubmed Central ID 1797580 


 



5.
Pavlakis GN, Felber BN (submitted in 2007) Improved Dna Vaccination Protocol. Patent issued: 8,586,055 (US in 2014). Patent pending: 60/934,366 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45377
178,BC010376-08,"October 01, 2006 -  September 30, 2007",Leukemia Inhibitory Factor and Embryo Development,Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI","Teresa L Sullivan



Jianbo  Hu



Yanmei  Wang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45378
179,BC010377-08,"October 01, 2006 -  September 30, 2007","The Nuclear Envelope in Development, Disease and Ageing",Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI","Serguei V Kozlov



Teresa L Sullivan



Ourania  Kosti



Federica  Polato



Yanmei  Wang



Jason Cheol Choi



Show all 7","Brian  Burke
(Cell Biology, University of Florida)




Roland  Foisner
(Medical Biochemistry, Medical University of Vienna)




Didier  Hodzic
(Cell Biology and Physiology, Washington University School of Medicine)




Eric  Hoffman
(Research Center for Genetic Medicine, Children's National Medical Center)




Jan  Lammerding
(Cardiovascular Division, Harvard Medical School)




Richard  Lee
(Cardiovascular Division, Harvard Medical School)


Show all 8",NULL,NULL,"Ordered by publication type and then author name.



1.
Cohen TV, Kosti O, Stewart CL (2007). The nuclear envelope protein MAN1 regulates TGFbeta signaling and vasculogenesis in the embryonic yolk sac. Development  134, 1385-95.   https://doi.org/10.1242/dev.02816




PubMed


 


PubMed ID 17329363
    
     


 



2.
Gotic I, Leschnik M, Kolm U, Markovic M, Haubner BJ, Biadasiewicz K, Metzler B, Stewart CL, Foisner R (2010). Lamina-associated polypeptide 2alpha loss impairs heart function and stress response in mice. Circ Res  106, 346-53.   https://doi.org/10.1161/CIRCRESAHA.109.205724




PubMed



        
     
Free Article


 


PubMed ID 19926876
         Pubmed Central ID 2818815 


 



3.
Grover J, Lee ER, Mounkes LC, Stewart CL, Roughley PJ (2007). The consequence of PRELP overexpression on skin. Matrix Biol  26, 140-3.   https://doi.org/10.1016/j.matbio.2006.10.005




PubMed


 


PubMed ID 17123807
    
     


 



4.
Ji JY, Lee RT, Vergnes L, Fong LG, Stewart CL, Reue K, Young SG, Zhang Q, Shanahan CM, Lammerding J (2007). Cell nuclei spin in the absence of lamin b1. J Biol Chem  282, 20015-26.   https://doi.org/10.1074/jbc.M611094200




PubMed


 


PubMed ID 17488709
    
     


 



5.
Kebache S, Ash J, Annis MG, Hagan J, Huber M, Hassard J, Stewart CL, Whiteway M, Nantel A (2007). Grb10 and active Raf-1 kinase promote Bad-dependent cell survival. J Biol Chem  282, 21873-83.   https://doi.org/10.1074/jbc.M611066200




PubMed


 


PubMed ID 17535812
    
     


 



6.
Lee JS, Hale CM, Panorchan P, Khatau SB, George JP, Tseng Y, Stewart CL, Hodzic D, Wirtz D (2007). Nuclear lamin A/C deficiency induces defects in cell mechanics, polarization, and migration. Biophys J  93, 2542-52.   https://doi.org/10.1529/biophysj.106.102426




PubMed



        
     
Free Article


 


PubMed ID 17631533
         Pubmed Central ID 1965451 


 



7.
Schmitt J, Benavente R, Hodzic D, Höög C, Stewart CL, Alsheimer M (2007). Transmembrane protein Sun2 is involved in tethering mammalian meiotic telomeres to the nuclear envelope. Proc Natl Acad Sci U S A  104, 7426-31.   https://doi.org/10.1073/pnas.0609198104




PubMed



        
     
Free Article


 


PubMed ID 17452644
         Pubmed Central ID 1863442 


 



8.
Stewart CL, Kozlov S, Fong LG, Young SG (2007). Mouse models of the laminopathies. Exp Cell Res  313, 2144-56.   https://doi.org/10.1016/j.yexcr.2007.03.026




PubMed



        
     
Free Article


 


PubMed ID 17493612
         Pubmed Central ID 1949387",https://intramural.nih.gov/search/searchview.taf?ipid=45379
180,BC010378-08,"October 01, 2006 -  September 30, 2007",Macromolecular Crystallography Research with Synchrotron Radiation,"Zbigniew  Dauter



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","John  Cobuzzi



Sergei V Pletnev



Robert P Jedrzejczak



Elzbieta  Nowak



Jiawei  Wang","Zygmunt  Derewenda
(Dept of Molecular Physiology and Biophysics, University of Virginia)




Zygmunt  Derewenda
(Dept of Molecular Physiology and Biophysics, University of Virginia)




Mariusz  Jaskolski





Andrzej  Joachimiak
(Biosciences, Argonne Natl. Lab.)




Jozef  Kur
(Microbiology, University of Technology)




Wladek  Minor



Show all 8",Alexander  Wlodawer; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Dauter Z, Pletnev S, Chudakov D, Tikhonov T, Popov V, Martynov V, Wlodawer A, Pletnev V (2007) Three-dimensional structure of yellow fluorescent protein zYFP538 from Zoanthus sp. at the resolution 1.8 angstrom. Russ. J. Bioorg. Chem. 390-398.




 



2.
Jaskolski M, Gilski M, Dauter Z, Wlodawer A (2007). Stereochemical restraints revisited: how accurate are refinement targets and how much should protein structures be allowed to deviate from them? Acta Crystallogr D Biol Crystallogr  63, 611-20.   https://doi.org/10.1107/S090744490700978X




PubMed


 


PubMed ID 17452786
    
     


 



3.
Meijers R, Adolph HW, Dauter Z, Wilson KS, Lamzin VS, Cedergren-Zeppezauer ES (2007). Structural evidence for a ligand coordination switch in liver alcohol dehydrogenase. Biochemistry  46, 5446-54.   https://doi.org/10.1021/bi6023594




PubMed


 


PubMed ID 17429946
    
     


 



4.
Wang J, Dauter M, Alkire R, Joachimiak A, Dauter Z (2007). Triclinic lysozyme at 0.65 A resolution. Acta Crystallogr D Biol Crystallogr  63, 1254-68.   https://doi.org/10.1107/S0907444907054224




PubMed


 


PubMed ID 18084073
    
     


 



5.
Wang J, Wlodawer A, Dauter Z (2007). What happens when the signs of anomalous differences or the handedness of substructure are inverted? Acta Crystallogr D Biol Crystallogr  63, 751-8.   https://doi.org/10.1107/S0907444907025620




PubMed


 


PubMed ID 17582166",https://intramural.nih.gov/search/searchview.taf?ipid=45380
181,BC010379-08,"October 01, 2006 -  September 30, 2007",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun  Wang,NULL,"Nucleic Acid NMR Section, NCI","Ping  Yu



Jinbu  Wang","Susan  Krueger
(NIST Center for Neutron Research, National Institute of Standards and Technology)




Dudley  Strickland
(Center for Vascular and Inflammatory Disease and the Departments of Surgery and Physiology, University of Maryland School of Medicine)




David  Tilde
(Argonne National Laboratory)","Terence P Yamaguchi; PhD (National Cancer Institute)



Bruce Allen Shapiro; PhD (National Cancer Institute)



Sandra  Smith-Gill; MS, PhD, BS (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)","Jeffrey S Rubin; MD, PhD (NCI)","Ordered by publication type and then author name.



1.
Lee D, Walsh JD, Migliorini M, Yu P, Cai T, Schwieters CD, Krueger S, Strickland DK, Wang YX (2007). The structure of receptor-associated protein (RAP). Protein Sci  16, 1628-40.   https://doi.org/10.1110/ps.072865407




PubMed



        
     
Free Article


 


PubMed ID 17656581
         Pubmed Central ID 2203372 


 



2.
Lee D, Walsh JD, Yu P, Markus MA, Choli-Papadopoulou T, Schwieters CD, Krueger S, Draper DE, Wang YX (2007). The structure of free L11 and functional dynamics of L11 in free, L11-rRNA(58 nt) binary and L11-rRNA(58 nt)-thiostrepton ternary complexes. J Mol Biol  367, 1007-22.   https://doi.org/10.1016/j.jmb.2007.01.013




PubMed



        
     
Free Article


 


PubMed ID 17292917
         Pubmed Central ID 2045704 


 



3.
Wang Y, Wang Y   (2007) Periodicity, planarity, and pixel (3P): A program using the intrinsic residual dipolar coupling periodicity-to-peptide plane correlation and phi/psi angles to derive protein backbone structures.  J. Magn.Res, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45381
182,BC010380-08,"October 01, 2006 -  September 30, 2007",Recombination and Regulation,Jeffrey N Strathern,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Alison J Rattray



Brenda K Shafer



Deanna R Gotte



Jordan D Irvin",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Nissley DV, Radzio J, Ambrose Z, Sheen CW, Hamamouch N, Moore KL, Tachedjian G, Sluis-Cremer N   (2007) Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT.  Biochem J 404:151-7.




PubMed



        
     
Free Article


 


PubMed ID 17286555
         Pubmed Central ID 1868834",https://intramural.nih.gov/search/searchview.taf?ipid=45382
183,BC010381-08,"October 01, 2006 -  September 30, 2007",Studies on Silencing,Amar J S Klar; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Gurjeet  Singh



Michael J Bonaduce



Deepak  Sidhu",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Klar A   (2007) Mutations in nucleotide biosynthesis pathway cause spreading of silencing across heterochromatic barriers at the mating-type region of the fission years.  Yeast, in press.




 



2.
Klar AJ (2007). Lessons learned from studies of fission yeast mating-type switching and silencing. Annu Rev Genet  41, 213-36.   https://doi.org/10.1146/annurev.genet.39.073103.094316




PubMed


 


PubMed ID 17614787",https://intramural.nih.gov/search/searchview.taf?ipid=45383
184,BC010382-08,"October 01, 2006 -  September 30, 2007",Chemotherapy Adjuvants,Robert C Moschel; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Gary T Pauly,"Henry  Friedman
(Oncology, Duke University Medical Center)




Anthony  Pegg
(Department of Physiology, Penn State College of Medicine)","Melinda  Hollingshead (National Cancer Institute)



Michael  Alley (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Javanmard S, Loktionova NA, Fang Q, Pauly GT, Pegg AE, Moschel RC (2007). Inactivation of O(6)-alkylguanine-DNA alkyltransferase by folate esters of O(6)-benzyl-2'-deoxyguanosine and of O(6)-[4-(hydroxymethyl)benzyl]guanine. J Med Chem  50, 5193-201.   https://doi.org/10.1021/jm0705859




PubMed



        
     
Free Article


 


PubMed ID 17880193
         Pubmed Central ID 2597536 


 



2.
Pauly GT, Javanmard ST, Loktionova NT, Moschel RT, Pegg AT (submitted in 2007) Inactivators Of 06-alkylguanine-dna Alkytransferase. Patent issued: 8,188,055 (US in 2012). Patent pending: PCT/US2008/056570 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45384
185,BC010385-08,"October 01, 2006 -  September 30, 2007",Studies on Imat1I Imprinting,Amar J S Klar; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Gurjeet  Singh



Deepak  Sidhu",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Klar A   (2007) Mutations in nucleotide biosynthesis pathway cause spreading of silencing across heterochromatic barriers at the mating-type region of the fission years.  Yeast, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45385
186,BC010386-08,"October 01, 2006 -  September 30, 2007",Human Handedness Psychosis Etiology Studies,Amar J S Klar; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Gurjeet  Singh,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Armakolas A, Klar AJ (2007). Left-right dynein motor implicated in selective chromatid segregation in mouse cells. Science  315, 100-1.   https://doi.org/10.1126/science.1129429




PubMed


 


PubMed ID 17204651
    
     


 



2.
Singh G, Klar AJ (2007). A hypothesis for how chromosome 11 translocations cause psychiatric disorders. Genetics  177, 1259-62.   https://doi.org/10.1534/genetics.107.077875




PubMed



        
     
Free Article


 


PubMed ID 17720908
         Pubmed Central ID 2034632",https://intramural.nih.gov/search/searchview.taf?ipid=45386
187,BC010387-08,"October 01, 2006 -  September 30, 2007",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,"Shyam K Sharan



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Susan L North



Sergey  Kuznetsov



Subha  Philip



Kajal  Biswas



Stacey S Stauffer



Suhwan  Chang",NULL,Andre A Nussenzweig; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Kuznetsov S, Pellegrini M, Shuda K, Fernandez-Capetillo O, Liu Y, Martin BK, Burkett S, Southon E, Pati D, Tessarollo L, West SC, Donovan PJ, Nussenzweig A, Sharan SK (2007). RAD51C deficiency in mice results in early prophase I arrest in males and sister chromatid separation at metaphase II in females. J Cell Biol  176, 581-92.   https://doi.org/10.1083/jcb.200608130




PubMed



        
     
Free Article


 


PubMed ID 17312021
         Pubmed Central ID 2064017 


 



2.
Sharan SK, Kuznetsov SG (2007). Resolving RAD51C function in late stages of homologous recombination. Cell Div  2, 15.   https://doi.org/10.1186/1747-1028-2-15




PubMed



        
     
Free Article


 


PubMed ID 17547768
         Pubmed Central ID 1892012",https://intramural.nih.gov/search/searchview.taf?ipid=45387
188,BC010390-08,"October 01, 2006 -  September 30, 2007",Role of Neurotrophins and Their Receptors in the Development of the Mammalian Ne,"Lino  Tessarollo



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Vincenzo  Coppola



Mary Ellen  Palko



Sudhirkumar U Yanpallewar



Henry C Schaefer","Susan G Dorsey





Francis  Lee
(Bristol Myers Squibb Pharmaceutical Research Institute)




Italo  Mocchetti
(Pharmacology, Georgetown University)




Uri  Saragovi
(Pharmacology and Therapeutics, McGill University)","Paul A Randazzo; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Nosheny RL, Ahmed F, Yakovlev A, Meyer EM, Ren K, Tessarollo L, Mocchetti I (2007). Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo. Eur J Neurosci  25, 2275-84.   https://doi.org/10.1111/j.1460-9568.2007.05506.x




PubMed


 


PubMed ID 17445226",https://intramural.nih.gov/search/searchview.taf?ipid=45388
189,BC010391-08,"October 01, 2006 -  September 30, 2007",Role of Trk receptors in the development and function of non-neuronal structures,"Lino  Tessarollo



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Vincenzo  Coppola



Mary Ellen  Palko",NULL,"Paul A Randazzo; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45389
190,BC010411-08,"October 01, 2006 -  September 30, 2007",Initiation of DNA replication in Mammalian Cells,"Mirit I Aladjem; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Chiimei (Cindy) L Tseng



Melvenia  Martin",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Aladjem M   (2007) Replication in Context: Dynamic Regulation of DNA Replication Patterns in  Metazoans.  Nature Reviews Genetics, in press.




 



2.
Seiler JA, Conti C, Syed A, Aladjem MI, Pommier Y (2007). The intra-S-phase checkpoint affects both DNA replication initiation and elongation: single-cell and -DNA fiber analyses. Mol Cell Biol  27, 5806-18.   https://doi.org/10.1128/MCB.02278-06




PubMed



        
     
Free Article


 


PubMed ID 17515603
         Pubmed Central ID 1952133 


 



3.
Shimura T, Martin MM, Torres MJ, Gu C, Pluth JM, DeBernardi MA, DiBernardi MA, McDonald JS, Aladjem MI (2007). DNA-PK is involved in repairing a transient surge of DNA breaks induced by deceleration of DNA replication. J Mol Biol  367, 665-80.   https://doi.org/10.1016/j.jmb.2007.01.018




PubMed



        
     
Free Article


 


PubMed ID 17280685
         Pubmed Central ID 1855631",https://intramural.nih.gov/search/searchview.taf?ipid=45390
191,BC010412-08,"October 01, 2006 -  September 30, 2007",Structural Analysis of Macromolecular Complexes by Electron Microscopy,Jacqueline L Milne,NULL,"Laboratory of Cell Biology, NCI","Dan  Shi



Paul  Youn",NULL,NULL,Bernard R Brooks; PhD (NHLBI),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45391
192,BC010413-07,"October 01, 2006 -  September 30, 2007",Comparative Analysis of Cancer-Associated Genes and Development of a Gene Delive,"Vladimir L Larionov; PhD, DSc



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Natalay  Kouprina



Vladimir  Noskov; PhD



Jun-Ichirou  Ohzeki



Megumi  Nakano



Hiroshi  Masumoto","William  Earnshaw
(Laboratory of Cell Biology, Wellcome Trust Centre for Cell Biology)




Mitsuo  Oshimura
(Graduate Program, Tottori University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Kouprina N, Noskov VN, Pavlicek A, Collins NK, Schoppee Bortz PD, Ottolenghi C, Loukinov D, Goldsmith P, Risinger JI, Kim JH, Westbrook VA, Solomon G, Sounders H, Herr JC, Jurka J, Lobanenkov V, Schlessinger D, Larionov V (2007). Evolutionary diversification of SPANX-N sperm protein gene structure and expression. PLoS One  2, e359.   https://doi.org/10.1371/journal.pone.0000359




PubMed



        
     
Free Article


 


PubMed ID 17406683
         Pubmed Central ID 1831492 


 



2.
Kouprina N, Noskov VN, Solomon G, Otstot J, Isaacs W, Xu J, Schleutker J, Larionov V (2007). Mutational analysis of SPANX genes in families with X-linked prostate cancer. Prostate  67, 820-8.   https://doi.org/10.1002/pros.20561




PubMed


 


PubMed ID 17373721
    
     


 



3.
Okamoto Y, Nakano M, Ohzeki J, Larionov V, Masumoto H (2007). A minimal CENP-A core is required for nucleation and maintenance of a functional human centromere. EMBO J  26, 1279-91.   https://doi.org/10.1038/sj.emboj.7601584




PubMed



        
     
Free Article


 


PubMed ID 17318187
         Pubmed Central ID 1817632",https://intramural.nih.gov/search/searchview.taf?ipid=45192
193,BC010418-08,"October 01, 2006 -  September 30, 2007",Signaling events regulating chemotaxis,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Paul W Kriebel



Anna  Bagorda



Mirkka Maarit Janka-junttila



Lunhua  Liu



Colin P Mccann",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Comer FI, Parent CA (2007). Phosphoinositides specify polarity during epithelial organ development. Cell  128, 239-40.   https://doi.org/10.1016/j.cell.2007.01.010




PubMed


 


PubMed ID 17254962
    
     


 



2.
Parent C, Janka-Juntilla M, Smoot R, Roselova P   (2007) A chemoattractant-mediated Gi-coupled pathway activates adenylyl cyclase in human neutrophils.  Mol. Biol. Cell  512-522 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=45392
194,BC010419-08,"October 01, 2006 -  September 30, 2007",Molecular Mechanisms of TGF-beta Signaling Pathway,"Ying  Zhang



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Mary E Heller



Motozo  Yamashita



Caroline  Millet



Chaoyang  Jin



Xiangchun  Wang



Yi  Tang","Chu-Xia  Deng
(NIDDK)
















Zhigang  He
(Program in Neurobiology, Children's Hospital Boston, Harvard Medical School)




Emmanuel  Lemichez
(Faculté de Médecine de Nice, INSERM U627)




Lianping  Xing
(Department of Pathology, University of Rochester)",NULL,NULL,"Ordered by publication type and then author name.



1.
Landry J, Sharov AA, Piao Y, Sharova LV, Xiao H, Southon E, Matta J, Tessarollo L, Zhang YE, Ko MS, Kuehn MR, Yamaguchi TP, Wu C (2008). Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells. PLoS Genet  4, e1000241.   https://doi.org/10.1371/journal.pgen.1000241




PubMed



        
     
Free Article


 


PubMed ID 18974875
         Pubmed Central ID 2570622 


 



2.
Millet C, Zhang YE (2007). Roles of Smad3 in TGF-beta signaling during carcinogenesis. Crit Rev Eukaryot Gene Expr  17, 281-93.   https://doi.org/10.1615/critreveukargeneexpr.v17.i4.30




PubMed



        
     
Free Article


 


PubMed ID 17725494
         Pubmed Central ID 2639747 


 



3.
Zhang Y   (2007) Roles of Smad3 in TGF-beta signaling During Carcinogenesis.  Critical Reviews in Eukaryotic Gene Expression  281-293 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=45393
195,BC010425-08,"October 01, 2006 -  September 30, 2007",Human T-Cell Responses to Tumor Antigens,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Diana G Chambers



Debra L Weingarten



Robin E Riley



Marjorie P Duberstein



Diane J Poole



Kwong Yok Tsang



Show all 16","Kenneth  Foon
(Hematology-Oncology, University of Pittsburgh Cancer Institute)




Alex  Franzusoff
(Research and Development, GlobeImmune)




Andrei  Kozlov
(biology, The Biomedical Center/St. Petersburg University)","Ira H Pastan; MD (National Cancer Institute)



Vladimir L Larionov; PhD, DSc (National Cancer Institute)



Natalay  Kouprina (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Palena C, Polev DE, Tsang KY, Fernando RI, Litzinger M, Krukovskaya LL, Baranova AV, Kozlov AP, Schlom J (2007). The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy. Clin Cancer Res  13, 2471-8.   https://doi.org/10.1158/1078-0432.CCR-06-2353




PubMed


 


PubMed ID 17438107
    
     


 



2.
Schlom J, Arlen P   (2007) The role of vaccine therapy in cancer: biology and practice.  Curr Oncol, in press.




 



3.
Schlom J, Arlen PM, Gulley JL (2007). Cancer vaccines: moving beyond current paradigms. Clin Cancer Res  13, 3776-82.   https://doi.org/10.1158/1078-0432.CCR-07-0588




PubMed



        
     
Free Article


 


PubMed ID 17606707
         Pubmed Central ID 2536755 


 



4.
Schlom J, Gulley J, Madan R, Hodge J   (2007) Design and development of recombinant vaccines for the therapy of carcinomas.  Crit Rev Immunol, in press.




 



5.
Schlom J, Madan R, Hodge J, Gulley J   (2007) Combining vaccines with conventional therapies for cancer.  Update on Cancer Therapeutics, in press.




 



6.
Schlom J, Skarupa L, Pazdur M, Seetharam M, Tsang K, Grosenbach D, Feldman J, Poole D, Litzinger M, Steinberg S, Jones E, Chen C, Marte J, Parnes H, Wright J, Dahut W, Gulley J   (2007) Clinical safety of a viral vector-based prostate cancer vaccine strategy.  J Urol, in press.




 



7.
Yokokawa J, Bera TK, Palena C, Cereda V, Remondo C, Gulley JL, Arlen PM, Pastan I, Schlom J, Tsang KY (2007). Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4). Int J Cancer  121, 595-605.   https://doi.org/10.1002/ijc.22698




PubMed


 


PubMed ID 17397028
    
     


 



8.
Schlom J, Koslov A, Palena C, Tsang K (submitted in 2007) Brachyury Polypeptides And Methods For Use. Patents issued: 8,188,214 (US in 2012); 2008221383 (AU in 2013); 5596980 (JP in 2014); 8,613,933 (US in 2014); 2125868 (DE in 2015); 2125868 (EP in 2015); 2125868 (FR in 2015); 2125868 (GB in 2015); 5767733 (JP in 2015); 2012261687 (AU in 2016). Patents pending: 2678404 (CA application); 11195533.2 (EP application); 15162282.6 (EP application); 12110614.1 (HK application); 16103006.8 (HK application); PCT/US2008/055185 (PC application); 14/138,629 (US application). Tracking number: E-074-2007-0-US-14 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=45394
196,BC010435-07,"October 01, 2006 -  September 30, 2007",Developmental Therapeutics,Sandra M Swain; MD,NULL,"Medical Oncology Branch, NCI",NULL,NULL,"Stephen M Hewitt; MD, PhD (National Cancer Institute)



Seth M Steinberg; PhD (Biostatistics and Data Management Section)



Stanley  Lipkowitz; MD, PhD (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)",Douglas R Rosing; MD (NHLBI),"Ordered by publication type and then author name.



1.
Portera CC, Walshe JM, Rosing DR, Denduluri N, Berman AW, Vatas U, Velarde M, Chow CK, Steinberg SM, Nguyen D, Yang SX, Swain SM (2008). Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer. Clin Cancer Res  14, 2710-6.   https://doi.org/10.1158/1078-0432.CCR-07-4636




PubMed



        
     
Free Article


 


PubMed ID 18451236
         Pubmed Central ID 4406095",https://intramural.nih.gov/search/searchview.taf?ipid=45395
197,BC010440-06,"October 01, 2006 -  September 30, 2007","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Chung  Tsai



Buyong  Ma



Hyunbum  Jang



Jie  Zheng","Carlos  Aleman
(Engineering, Univ. Barcelona)




Carlos  Cativiela
(Chemistry, Univ. Zaragoza)




Antonio  del Sol
(Research & Development, Fujirebio Inc)




Ratnesh  Lal
(Medical School, University of Chicago)




Haim  Wolfson
(Computer Science, Tel Aviv Univ)




David  Zanuy",NULL,NULL,"Ordered by publication type and then author name.



1.
Casanovas J, Zanuy D, Nussinov R, Alemán C (2007). Intrinsic conformational characteristics of alpha,alpha-diphenylglycine. J Org Chem  72, 2174-81.   https://doi.org/10.1021/jo0624905




PubMed


 


PubMed ID 17291048
    
     


 



2.
Curcó D, Nussinov R, Aleman C (2007). Coarse-grained representation of beta-helical protein building blocks. J Phys Chem B  111, 10538-49.   https://doi.org/10.1021/jp072832q




PubMed


 


PubMed ID 17691836
    
     


 



3.
Del Sol A, Araúzo-Bravo MJ, Amoros D, Nussinov R (2007). Modular architecture of protein structures and allosteric communications: potential implications for signaling proteins and regulatory linkages. Genome Biol  8, R92.   https://doi.org/10.1186/gb-2007-8-5-r92




PubMed



        
     
Free Article


 


PubMed ID 17531094
         Pubmed Central ID 1929157 


 



4.
Flores-Ortega A, Casanovas J, Zanuy D, Nussinov R, Alemán C (2007). Conformations of proline analogues having double bonds in the ring. J Phys Chem B  111, 5475-82.   https://doi.org/10.1021/jp0712001




PubMed


 


PubMed ID 17458993
    
     


 



5.
Haspel N, Wainreb G, Inbar Y, Tsai HH, Tsai CJ, Wolfson HJ, Nussinov R (2007). A hierarchical protein folding scheme based on the building block folding model. Methods Mol Biol  350, 189-204.   https://doi.org/10.1385/1-59745-189-4:189




PubMed


 


PubMed ID 16957324
    
     


 



6.
Haspel N, Zanuy D, Zheng J, Aleman C, Wolfson H, Nussinov R (2007). Changing the charge distribution of beta-helical-based nanostructures can provide the conditions for charge transfer. Biophys J  93, 245-53.   https://doi.org/10.1529/biophysj.106.100644




PubMed



        
     
Free Article


 


PubMed ID 17416628
         Pubmed Central ID 1914416 


 



7.
Jang H, Ma B, Nussinov R (2007). Conformational study of the protegrin-1 (PG-1) dimer interaction with lipid bilayers and its effect. BMC Struct Biol  7, 21.   https://doi.org/10.1186/1472-6807-7-21




PubMed



        
     
Free Article


 


PubMed ID 17407565
         Pubmed Central ID 1858697 


 



8.
Jang H, Zheng J, Nussinov R (2007). Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process. Biophys J  93, 1938-49.   https://doi.org/10.1529/biophysj.107.110148




PubMed



        
     
Free Article


 


PubMed ID 17526580
         Pubmed Central ID 1959551 


 



9.
Tsai CJ, Zheng J, Zanuy D, Haspel N, Wolfson H, Alemán C, Nussinov R (2007). Principles of nanostructure design with protein building blocks. Proteins  68, 1-12.   https://doi.org/10.1002/prot.21413




PubMed


 


PubMed ID 17407160
    
     


 



10.
Tuncbag N, Gursoy A, Guney E, Nussinov R, Keskin O (2008). Architectures and functional coverage of protein-protein interfaces. J Mol Biol  381, 785-802.   https://doi.org/10.1016/j.jmb.2008.04.071




PubMed



        
     
Free Article


 


PubMed ID 18620705
         Pubmed Central ID 2605427 


 



11.
Zanuy D, Jiménez AI, Cativiela C, Nussinov R, Alemán C (2007). Use of constrained synthetic amino acids in beta-helix proteins for conformational control. J Phys Chem B  111, 3236-42.   https://doi.org/10.1021/jp065025k




PubMed


 


PubMed ID 17388467
    
     


 



12.
Zheng J, Jang H, Ma B, Tsai CJ, Nussinov R (2007). Modeling the Alzheimer Abeta17-42 fibril architecture: tight intermolecular sheet-sheet association and intramolecular hydrated cavities. Biophys J  93, 3046-57.   https://doi.org/10.1529/biophysj.107.110700




PubMed



        
     
Free Article


 


PubMed ID 17675353
         Pubmed Central ID 2025669 


 



13.
Zheng J, Zanuy D, Haspel N, Tsai CJ, Alemán C, Nussinov R (2007). Nanostructure design using protein building blocks enhanced by conformationally constrained synthetic residues. Biochemistry  46, 1205-18.   https://doi.org/10.1021/bi061674a




PubMed


 


PubMed ID 17260950",https://intramural.nih.gov/search/searchview.taf?ipid=45348
198,BC010441-06,"October 01, 2006 -  September 30, 2007",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Chung  Tsai



Buyong  Ma



Yongping  Pan



Jin  Liu","Carlos  Aleman
(Engineering, Univ. Barcelona)




Antonio  del Sol
(Research & Development, Fujirebio Inc)




Attila  Gursoy
(Computer Science Dept., Koc University)




Turkan  Haliloglu





Ozlem  Keskin
(Chemical Engineering, Koc University)




Roded  Sharan
(Computer Science Dept., Tel Aviv University)


Show all 7",NULL,NULL,"Ordered by publication type and then author name.



1.
Andrusier N, Nussinov R, Wolfson HJ (2007). FireDock: fast interaction refinement in molecular docking. Proteins  69, 139-59.   https://doi.org/10.1002/prot.21495




PubMed


 


PubMed ID 17598144
    
     


 



2.
Cohen-Gihon I, Nussinov R, Sharan R (2007). Comprehensive analysis of co-occurring domain sets in yeast proteins. BMC Genomics  8, 161.   https://doi.org/10.1186/1471-2164-8-161




PubMed



        
     
Free Article


 


PubMed ID 17562021
         Pubmed Central ID 1919370 


 



3.
Del Sol A, Araúzo-Bravo MJ, Amoros D, Nussinov R (2007). Modular architecture of protein structures and allosteric communications: potential implications for signaling proteins and regulatory linkages. Genome Biol  8, R92.   https://doi.org/10.1186/gb-2007-8-5-r92




PubMed



        
     
Free Article


 


PubMed ID 17531094
         Pubmed Central ID 1929157 


 



4.
Dror O, Lasker K, Nussinov R, Wolfson H (2007). EMatch: an efficient method for aligning atomic resolution subunits into intermediate-resolution cryo-EM maps of large macromolecular assemblies. Acta Crystallogr D Biol Crystallogr  63, 42-9.   https://doi.org/10.1107/S0907444906041059




PubMed



        
     
Free Article


 


PubMed ID 17164525
         Pubmed Central ID 2483490 


 



5.
Fishelovitch D, Hazan C, Shaik S, Wolfson HJ, Nussinov R (2007). Structural dynamics of the cooperative binding of organic molecules in the human cytochrome P450 3A4. J Am Chem Soc  129, 1602-11.   https://doi.org/10.1021/ja066007j




PubMed


 


PubMed ID 17284003
    
     


 



6.
Gunasekaran K, Nussinov R (2007). How different are structurally flexible and rigid binding sites? Sequence and structural features discriminating proteins that do and do not undergo conformational change upon ligand binding. J Mol Biol  365, 257-73.   https://doi.org/10.1016/j.jmb.2006.09.062




PubMed


 


PubMed ID 17059826
    
     


 



7.
Hu Z, Bowen D, Southerland WM, del Sol A, Pan Y, Nussinov R, Ma B (2007). Ligand binding and circular permutation modify residue interaction network in DHFR. PLoS Comput Biol  3, e117.   https://doi.org/10.1371/journal.pcbi.0030117




PubMed



        
     
Free Article


 


PubMed ID 17571919
         Pubmed Central ID 1892607 


 



8.
Keskin O, Gursoy A, Ma B, Nussinov R (2007). Towards drugs targeting multiple proteins in a systems biology approach. Curr Top Med Chem  7, 943-51.   https://doi.org/10.2174/156802607780906690




PubMed


 


PubMed ID 17508925
    
     


 



9.
Keskin O, Nussinov R (2007). Similar binding sites and different partners: implications to shared proteins in cellular pathways. Structure  15, 341-54.   https://doi.org/10.1016/j.str.2007.01.007




PubMed


 


PubMed ID 17355869
    
     


 



10.
Lasker K, Dror O, Shatsky M, Nussinov R, Wolfson HJ (2007). EMatch: discovery of high resolution structural homologues of protein domains in intermediate resolution cryo-EM maps. IEEE/ACM Trans Comput Biol Bioinform  4, 28-39.   https://doi.org/10.1109/TCBB.2007.1003




PubMed


 


PubMed ID 17277411
    
     


 



11.
Ma B, Nussinov R (2007). Trp/Met/Phe hot spots in protein-protein interactions: potential targets in drug design. Curr Top Med Chem  7, 999-1005.   https://doi.org/10.2174/156802607780906717




PubMed


 


PubMed ID 17508933
    
     


 



12.
Ma B, Pan Y, Zheng J, Levine AJ, Nussinov R (2007). Sequence analysis of p53 response-elements suggests multiple binding modes of the p53 tetramer to DNA targets. Nucleic Acids Res  35, 2986-3001.   https://doi.org/10.1093/nar/gkm192




PubMed



        
     
Free Article


 


PubMed ID 17439973
         Pubmed Central ID 1888811 


 



13.
Pan Y, Nussinov R (2007). Structural basis for p53 binding-induced DNA bending. J Biol Chem  282, 691-9.   https://doi.org/10.1074/jbc.M605908200




PubMed


 


PubMed ID 17085447",https://intramural.nih.gov/search/searchview.taf?ipid=45349
199,BC010442-06,"October 01, 2006 -  September 30, 2007",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Chung  Tsai



Buyong  Ma



Jie  Zheng","Attila  Gursoy
(Computer Science Dept., Koc University)




Turkan  Haliloglu





Ozlem  Keskin
(Chemical Engineering, Koc University)




Roded  Sharan
(Computer Science Dept., Tel Aviv University)




Haim  Wolfson
(Computer Science, Tel Aviv Univ)",NULL,NULL,"Ordered by publication type and then author name.



1.
Andrusier N, Nussinov R, Wolfson HJ (2007). FireDock: fast interaction refinement in molecular docking. Proteins  69, 139-59.   https://doi.org/10.1002/prot.21495




PubMed


 


PubMed ID 17598144
    
     


 



2.
Cohen-Gihon I, Nussinov R, Sharan R (2007). Comprehensive analysis of co-occurring domain sets in yeast proteins. BMC Genomics  8, 161.   https://doi.org/10.1186/1471-2164-8-161




PubMed



        
     
Free Article


 


PubMed ID 17562021
         Pubmed Central ID 1919370 


 



3.
Dror O, Lasker K, Nussinov R, Wolfson H (2007). EMatch: an efficient method for aligning atomic resolution subunits into intermediate-resolution cryo-EM maps of large macromolecular assemblies. Acta Crystallogr D Biol Crystallogr  63, 42-9.   https://doi.org/10.1107/S0907444906041059




PubMed



        
     
Free Article


 


PubMed ID 17164525
         Pubmed Central ID 2483490 


 



4.
Hu Z, Bowen D, Southerland WM, del Sol A, Pan Y, Nussinov R, Ma B (2007). Ligand binding and circular permutation modify residue interaction network in DHFR. PLoS Comput Biol  3, e117.   https://doi.org/10.1371/journal.pcbi.0030117




PubMed



        
     
Free Article


 


PubMed ID 17571919
         Pubmed Central ID 1892607 


 



5.
Keskin O, Gursoy A, Ma B, Nussinov R (2007). Towards drugs targeting multiple proteins in a systems biology approach. Curr Top Med Chem  7, 943-51.   https://doi.org/10.2174/156802607780906690




PubMed


 


PubMed ID 17508925
    
     


 



6.
Keskin O, Nussinov R (2007). Similar binding sites and different partners: implications to shared proteins in cellular pathways. Structure  15, 341-54.   https://doi.org/10.1016/j.str.2007.01.007




PubMed


 


PubMed ID 17355869
    
     


 



7.
Lasker K, Dror O, Shatsky M, Nussinov R, Wolfson HJ (2007). EMatch: discovery of high resolution structural homologues of protein domains in intermediate resolution cryo-EM maps. IEEE/ACM Trans Comput Biol Bioinform  4, 28-39.   https://doi.org/10.1109/TCBB.2007.1003




PubMed


 


PubMed ID 17277411",https://intramural.nih.gov/search/searchview.taf?ipid=45354
200,BC010446-06,"October 01, 2006 -  September 30, 2007",DNA Double Strand Break Repair in Drosophila Melanogaster,Yikang  Rong,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Min  Gong



Xiaolin  Bi



Conor  Mcmahon



Natalia  Wesolowska",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Wei DS, Rong YS (2007). A genetic screen for DNA double-strand break repair mutations in Drosophila. Genetics  177, 63-77.   https://doi.org/10.1534/genetics.107.077693




PubMed



        
     
Free Article


 


PubMed ID 17660539
         Pubmed Central ID 2013711 


 



2.
Wei Q, Rong Y, Paterson BM (2007). Stereotypic founder cell patterning and embryonic muscle formation in Drosophila require nautilus (MyoD) gene function. Proc Natl Acad Sci U S A  104, 5461-6.   https://doi.org/10.1073/pnas.0608739104




PubMed



        
     
Free Article


 


PubMed ID 17376873
         Pubmed Central ID 1838484",https://intramural.nih.gov/search/searchview.taf?ipid=45357
201,BC010448-06,"October 01, 2006 -  September 30, 2007",Genetic Alterations in Lung Cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Zhihong  Shan



Jyotsna  Pandey",NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Vikis H, Sato M, James M, Wang D, Wang Y, Wang M, Jia D, Liu Y, Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Yang P, Wiest JS, Fain PR, Schwartz AG, Gazdar A, Gaba C, Rothschild H, Mandal D, Kupert E, Seminara D, Viswanathan A, Govindan R, et al. [3 more authors] (2007). EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Cancer Res  67, 4665-70.   https://doi.org/10.1158/0008-5472.CAN-07-0217




PubMed



        
     
Free Article


 


PubMed ID 17510392
         Pubmed Central ID 3460269 


 



2.
Wang M, Vikis HG, Wang Y, Jia D, Wang D, Bierut LJ, Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Yang P, Wiest JS, Fain PR, Schwartz AG, Gazdar A, Minna J, Gaba C, Rothschild H, Mandal D, Kupert E, Seminara D, Liu Y, Viswanathan A, Govindan R, et al. [2 more authors] (2007). Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1. Cancer Res  67, 93-9.   https://doi.org/10.1158/0008-5472.CAN-06-2723




PubMed



        
     
Free Article


 


PubMed ID 17210687
         Pubmed Central ID 3461257",https://intramural.nih.gov/search/searchview.taf?ipid=45396
202,BC010449-06,"October 01, 2006 -  September 30, 2007",Role of Uteroglobin-Related Protein (UGRP) 1 in Lung,"Shioko  Kimura; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Takeshi  Tomita



Taketomo  Kido",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Chen C, Ma X, Malfatti MA, Krausz KW, Kimura S, Felton JS, Idle JR, Gonzalez FJ (2007). A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach. Chem Res Toxicol  20, 531-42.   https://doi.org/10.1021/tx600320w




PubMed



        
     
Free Article


 


PubMed ID 17279779
         Pubmed Central ID 1850849",https://intramural.nih.gov/search/searchview.taf?ipid=45397
203,BC010450-06,"October 01, 2006 -  September 30, 2007",Development of Akt Inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI","Chunyu  Zhang



Joell J Gills



Wei  Han","Alan  Kozikowski
(Medicinal Chemistry, University of Illinois at Chicago)




Alan  Kozikowski
(Medicinal Chemistry, University of Illinois at Chicago)","Susan L Holbeck (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Maria  Tsokos; MD (National Cancer Institute)



Mones S Abu Asab (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Gills JJ, Castillo SS, Zhang C, Petukhov PA, Memmott RM, Hollingshead M, Warfel N, Han J, Kozikowski AP, Dennis PA (2007). Phosphatidylinositol ether lipid analogues that inhibit AKT also independently activate the stress kinase, p38alpha, through MKK3/6-independent and -dependent mechanisms. J Biol Chem  282, 27020-9.   https://doi.org/10.1074/jbc.M701108200




PubMed


 


PubMed ID 17631503
    
     


 



2.
Gills JJ, Lopiccolo J, Tsurutani J, Shoemaker RH, Best CJ, Abu-Asab MS, Borojerdi J, Warfel NA, Gardner ER, Danish M, Hollander MC, Kawabata S, Tsokos M, Figg WD, Steeg PS, Dennis PA (2007). Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin Cancer Res  13, 5183-94.   https://doi.org/10.1158/1078-0432.CCR-07-0161




PubMed


 


PubMed ID 17785575
    
     


 



3.
LoPiccolo J, Granville CA, Gills JJ, Dennis PA (2007). Targeting Akt in cancer therapy. Anticancer Drugs  18, 861-74.   https://doi.org/10.1097/CAD.0b013e3280cc2c6f




PubMed


 


PubMed ID 17667591",https://intramural.nih.gov/search/searchview.taf?ipid=45398
204,BC010451-06,"October 01, 2006 -  September 30, 2007",NMR Group Project: Preparation and Properties of Novel Multivalent Nanoparticles,Joseph John Barchi,Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI",NULL,"Vladislav  Glinskii
(Biochemistry, University of Missouri)




Kate  Rittenhouse-Olson
(Biotechnical and Clinical Laboratory Science, University of Buffalo)",Robert  Blumenthal; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45557
205,BC010453-06,"October 01, 2006 -  September 30, 2007",Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Douglas K Price



Erika K Smith



Akinobu  Hamada



Caitlin  Baum",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Arlen PM, Bianco F, Dahut WL, D'Amico A, Figg WD, Freedland SJ, Gulley JL, Kantoff PW, Kattan MW, Lee A, Regan MM, Sartor O, Prostate Specific Antigen Working Group (2008). Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time. J Urol  179, 2181-5; discussion 2185-6.   https://doi.org/10.1016/j.juro.2008.01.099




PubMed



        
     
Free Article


 


PubMed ID 18423743
         Pubmed Central ID 2667701 


 



2.
Figg W, Danesi R, Price D, Venzon D, Sparreboom A, Dahut W   (2007) Association of CYP17 polymorphism with the Overall Survival in Androgen  Independent Prostate Cancer Patients.  Urology, in press.




 



3.
Gardner ER, Ahlers CM, Shukla S, Sissung TM, Ockers SB, Price DK, Hamada A, Robey RW, Steinberg SM, Ambudkar SV, Dahut WL, Figg WD (2008). Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival. BJU Int  102, 1694-9.   https://doi.org/10.1111/j.1464-410X.2008.07913.x




PubMed



        
     
Free Article


 


PubMed ID 18710444
         Pubmed Central ID 2605573 


 



4.
Sissung TM, Baum CE, Deeken J, Price DK, Aragon-Ching J, Steinberg SM, Dahut W, Sparreboom A, Figg WD (2008). ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel. Clin Cancer Res  14, 4543-9.   https://doi.org/10.1158/1078-0432.CCR-07-4230




PubMed



        
     
Free Article


 


PubMed ID 18628469
         Pubmed Central ID 2723795",https://intramural.nih.gov/search/searchview.taf?ipid=45399
206,BC010459-06,"October 01, 2006 -  September 30, 2007",Gene Methylation in Prostate Cancer,Karen  Woodson,NULL,"Cancer Genetics Branch, NCI",NULL,"Mark  Lawler
(Molecular Medicine, St James Hospital, Trinity College)




Keith  O'Reilly





David  Ward
(Pathology, Madigan Army Medical Center)","Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



Joseph A Tangrea (National Cancer Institute)



John W Gillespie (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Perry AS, Loftus B, Moroose R, Lynch TH, Hollywood D, Watson RW, Woodson K, Lawler M (2007). In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer. Br J Cancer  96, 1587-94.   https://doi.org/10.1038/sj.bjc.6603767




PubMed



        
     
Free Article


 


PubMed ID 17453001
         Pubmed Central ID 2359953 


 



2.
Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, Richardson AM, Pinto PA, Linehan WM, Gillespie JW, Merino MJ, Libutti SK, Woodson KG, Emmert-Buck MR, Chuaqui RF (2007). Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol  211, 410-9.   https://doi.org/10.1002/path.2133




PubMed


 


PubMed ID 17278115",https://intramural.nih.gov/search/searchview.taf?ipid=45401
207,BC010465-04,"October 01, 2006 -  September 30, 2007",Protemics Bioinformatics Tools,Peter F Lemkin; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,"Gregory  Alvord
(Data Management Services)
















John  Cornell
(Center Epidemiology & Biostatistics, Univ. Texas Health Science Center)




Jai A Evans





Howard  Gutstein
(UT-MD Anderson Cancer Center)




Djamel None Medjahed





Arlan G Richardson



Show all 9",Scott E McNeil (Office Of The Director),"Mark A Knepper; PhD, MD (NHLBI) 



Donita  Garland; PhD (NEI)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45178
208,BC010468-05,"October 01, 2006 -  September 30, 2007",The Role of Cytopathology in Biomedical Research,"Andrea  Abati; BS, MD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Armando  Filie



Keith R Brosky



Dana K Erickson



Patricia A Fetsch



Anna-Maria  Wilder",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Fetsch PA, Abati A (2007). The effects of antibody clone and pretreatment method on the results of HER2 immunostaining in cytologic samples of metastatic breast cancer: A query and a review of the literature. Diagn Cytopathol  35, 319-28.   https://doi.org/10.1002/dc.20638




PubMed


 


PubMed ID 17497656
    
     


 



2.
Manosca F, Schinstine M, Fetsch PA, Sorbara L, Maria Wilder A, Brosky K, Erickson D, Raffeld M, Filie AC, Abati A (2007). Diagnostic effects of prolonged storage on fresh effusion samples. Diagn Cytopathol  35, 6-11.   https://doi.org/10.1002/dc.20587




PubMed


 


PubMed ID 17173298
    
     


 



3.
Panelli MC, Stashower ME, Slade HB, Smith K, Norwood C, Abati A, Fetsch P, Filie A, Walters SA, Astry C, Aricó E, Zhao Y, Selleri S, Wang E, Marincola FM (2007). Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection. Genome Biol  8, R8.   https://doi.org/10.1186/gb-2007-8-1-r8




PubMed



        
     
Free Article


 


PubMed ID 17222352
         Pubmed Central ID 1839129 


 



4.
Rapkiewicz A, Espina V, Zujewski JA, Lebowitz PF, Filie A, Wulfkuhle J, Camphausen K, Petricoin EF, Liotta LA, Abati A (2007). The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology. Cancer  111, 173-84.   https://doi.org/10.1002/cncr.22686




PubMed


 


PubMed ID 17487852",https://intramural.nih.gov/search/searchview.taf?ipid=45402
209,BC010469-05,"October 01, 2006 -  September 30, 2007",Molecular Targets Development Program,James  McMahon; PhD,NULL,"Molecular Targets Development Program, NCI","Kirk R Gustafson; PhD



John A Beutler



Heidi  Bokesch



Laura  Cartner



Richard W Fuller



Roberta  Gardella



Show all 22","Edward  Arnold
(X-Ray Crystallography, Rutgers University)




U.A.  Baltayev
(Natural Product, Industrial Biotechnology)




John W Blunt; PhD
(Chemistry Department, Natural products group)




Anders  Bolmstedt
(Glycovirology, Univ. of Goteborg)




Emma/Barry  Bowman
(V-ATPase, UC Santa Barbara)




Ihsan  Calis
(Natural product diversity librarires, Hacteppe University)


Show all 25","William D Figg; PharmD (National Cancer Institute)



Howard A Fine; MD, PhD (National Cancer Institute)



Nealapheur L Khan (National Cancer Institute)



Giuseppe  Giaccone; MD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



David  Salomon; PhD (National Cancer Institute)",Michael P Bray (NIAID),"Ordered by publication type and then author name.



1.
Dat NT, Bae K, Wamiru A, McMahon JB, Le Grice SF, Bona M, Beutler JA, Kim YH (2007). A dimeric lactone from Ardisia japonica with inhibitory activity for HIV-1 and HIV-2 ribonuclease H. J Nat Prod  70, 839-41.   https://doi.org/10.1021/np060359m




PubMed


 


PubMed ID 17397219
    
     


 



2.
Giomarelli B, Washington VA, Chisholm MM, Quigley L, McMahon JB, Mori T, McVicar DW (2007). Inhibition of thrombin-induced platelet aggregation using human single-chain Fv antibodies specific for TREM-like transcript-1. Thromb Haemost  97, 955-63.




PubMed


 


PubMed ID 17549298
    
     


 



3.
Henrich CJ, Goncharova EI, Wilson JA, Gardella RS, Johnson TR, McMahon JB, Takada K, Bokesch HR, Gustafson KR (2007). Natural products active in aberrant c-Kit signaling. Chem Biol Drug Des  69, 321-30.   https://doi.org/10.1111/j.1747-0285.2007.00508.x




PubMed


 


PubMed ID 17539824
    
     


 



4.
Henrich CJ, Robey RW, Bokesch HR, Bates SE, Shukla S, Ambudkar SV, Dean M, McMahon JB (2007). New inhibitors of ABCG2 identified by high-throughput screening. Mol Cancer Ther  6, 3271-8.   https://doi.org/10.1158/1535-7163.MCT-07-0352




PubMed



        
     
Free Article


 


PubMed ID 18089721
         Pubmed Central ID 2760480 


 



5.
McFeeters RL, Xiong C, O'Keefe BR, Bokesch HR, McMahon JB, Ratner DM, Castelli R, Seeberger PH, Byrd RA (2007). The novel fold of scytovirin reveals a new twist for antiviral entry inhibitors. J Mol Biol  369, 451-61.   https://doi.org/10.1016/j.jmb.2007.03.030




PubMed



        
     
Free Article


 


PubMed ID 17434526
         Pubmed Central ID 2696897 


 



6.
Mente NR, Wiemer AJ, Neighbors JD, Beutler JA, Hohl RJ, Wiemer DF (2007). Total synthesis of (R,R,R)- and (S,S,S)-schweinfurthin F: differences of bioactivity in the enantiomeric series. Bioorg Med Chem Lett  17, 911-5.   https://doi.org/10.1016/j.bmcl.2006.11.096




PubMed


 


PubMed ID 17236766
    
     


 



7.
Meragelman TL, Willis RH, Woldemichael GM, Heaton A, Murphy PT, Snader KM, Newman DJ, van Soest R, Boyd MR, Cardellina JH, McKee TC (2007). Candidaspongiolides, distinctive analogues of tedanolide from sponges of the genus Candidaspongia. J Nat Prod  70, 1133-8.   https://doi.org/10.1021/np0700974




PubMed



        
     
Free Article


 


PubMed ID 17564468
         Pubmed Central ID 2288652 


 



8.
Ruocco KM, Goncharova EI, Young MR, Colburn NH, McMahon JB, Henrich CJ (2007). A high-throughput cell-based assay to identify specific inhibitors of transcription factor AP-1. J Biomol Screen  12, 133-9.   https://doi.org/10.1177/1087057106296686




PubMed


 


PubMed ID 17175522
    
     


 



9.
Ziółkowska NE, Shenoy SR, O'Keefe BR, McMahon JB, Palmer KE, Dwek RA, Wormald MR, Wlodawer A (2007). Crystallographic, thermodynamic, and molecular modeling studies of the mode of binding of oligosaccharides to the potent antiviral protein griffithsin. Proteins  67, 661-70.   https://doi.org/10.1002/prot.21336




PubMed


 


PubMed ID 17340634
    
     


 



10.
Henrich C, Ambudkar S, Bates S, Bokesch H, Cartner L, Dean M, Fuller R, Gustafson K, McMahon J, Robey R, Shukla S, Takada K (submitted in 2007) Method Of Inhibiting Abcg2 And Other Treatment Methods. Patents issued: 8,470,888 (US in 2013); 9,314,448 (US in 2016). Patent pending: PCT/US2008/088446 (PC application).




 



11.
Henrich C, Ambudkar S, Bates S, Bokesch H, Dean M, McMahon J, Robey R, Shukla S (submitted in 2007) Method Of Inhibiting Abcg2 And Related Treatments. Patents issued: 9,114,102 (US in 2015); 9,937,217 (US in 2018). Patent pending: PCT/US2008/082414 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45446
210,BC010470-05,"October 01, 2006 -  September 30, 2007",Bioinformatic Tools in Cancer Research,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Jinghui E Zhang; PhD



William L Rowe



Richard Phillip Finney



Peisen  Zhang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45405
211,BC010472-05,"October 01, 2006 -  September 30, 2007",High-Density Marker Studies Near Founder BRCA12 Mutations,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI",NULL,"Andrew  Collins
(Genetics, University of Southampton)




Kenneth  Offit",Mark H Greene; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45445
212,BC010474-05,"October 01, 2006 -  September 30, 2007",Signal Transduction Mechanisms of Type I IFNs,Ana M Gamero,Howard A Young; PhD,"Laboratory of Experimental Immunology, NCI","Ana L Romero




Anthony J Scarzello",NULL,"Mary  Carrington; MS, PhD  (Laboratory of Genomic Diversity)



Timothy D Veenstra  (Office Of The Director)",NULL,"Ordered by publication type and then author name.



1.
Gamero AM, Potla R, Sakamoto S, Baker DP, Abraham R, Larner AC (2006). Type I interferons activate apoptosis in a Jurkat cell variant by caspase-dependent and independent mechanisms. Cell Signal  18, 1299-308.   https://doi.org/10.1016/j.cellsig.2005.10.008




PubMed



        
     
Free Article


 


PubMed ID 16337360
         Pubmed Central ID 1862448 


 



2.
Scarzello AJ, Romero-Weaver AL, Maher SG, Veenstra TD, Zhou M, Qin A, Donnelly RP, Sheikh F, Gamero AM (2007). A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis. Mol Biol Cell  18, 2455-62.   https://doi.org/10.1091/mbc.e06-09-0843




PubMed



        
     
Free Article


 


PubMed ID 17442890
         Pubmed Central ID 1924825",https://intramural.nih.gov/search/searchview.taf?ipid=45412
213,BC010476-05,"October 01, 2006 -  September 30, 2007",Time Domian Electron Paramagnetic Resonance Imaging,"Murali  Krishna; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Nallathamby  Devasahayam



Sankaran  Subramanian; MD



Fuminori  Hyodo



Shingo  Matsumoto



Emi  Hyodo",NULL,James B Mitchell; PhD (National Cancer Institute),"Anthony R Fletcher; PhD (CIT) 



Jeeva P Munasinghe (NINDS) 



Alan Paul Koretsky; PhD (NINDS) 



Calvin A Johnson; PhD (CIT) 



Thomas J Pohida; MS (CIT)","Ordered by publication type and then author name.



1.
Devasahayam N, Subramanian S, Murugesan R, Hyodo F, Matsumoto K, Mitchell JB, Krishna MC (2007). Strategies for improved temporal and spectral resolution in in vivo oximetric imaging using time-domain EPR. Magn Reson Med  57, 776-83.   https://doi.org/10.1002/mrm.21194




PubMed


 


PubMed ID 17390350
    
     


 



2.
Durairaj DC, Krishna MC, Murugesan R   (2007) A neural network approach for image reconstruction in electron magnetic resonance tomography.  Comput Biol Med 37:1492-501.




PubMed


 


PubMed ID 17362904
    
     


 



3.
Matsumoto K, Subramanian S, Murugesan R, Mitchell JB, Krishna MC (2007). Spatially resolved biologic information from in vivo EPRI, OMRI, and MRI. Antioxid Redox Signal  9, 1125-41.   https://doi.org/10.1089/ars.2007.1638




PubMed


 


PubMed ID 17571957
    
     


 



4.
Matsumoto K, Szajek L, Krishna MC, Cook JA, Seidel J, Grimes K, Carson J, Sowers AL, English S, Green MV, Bacharach SL, Eckelman WC, Mitchell JB (2007). The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography. Int J Oncol  30, 873-81.




PubMed


 


PubMed ID 17332926
    
     


 



5.
Subramanian S, Krishna MC (2008) DANCING WITH THE ELECTRONS: TIME-DOMAIN AND CW IN VIVO EPR IMAGING. Magn Reson Insights 2:43-74.




PubMed



        
     
Free Article


 


PubMed ID 22025900
         Pubmed Central ID 3198805",https://intramural.nih.gov/search/searchview.taf?ipid=45427
214,BC010477-05,"October 01, 2006 -  September 30, 2007",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),"Murali  Krishna; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Nallathamby  Devasahayam



Sankaran  Subramanian; MD



Fuminori  Hyodo



Shingo  Matsumoto



Emi  Hyodo",NULL,James B Mitchell; PhD (National Cancer Institute),"Jeeva P Munasinghe (NINDS) 



Sardha Lalith Talagala; PhD (NINDS) 



Alan Paul Koretsky; PhD (NINDS)","Ordered by publication type and then author name.



1.
Hama Y, Bernardo M, Regino CA, Koyama Y, Brechbiel MW, Krishna MC, Choyke PL, Kobayashi H (2007). MR lymphangiography using dendrimer-based contrast agents: a comparison at 1.5T and 3.0T. Magn Reson Med  57, 431-6.   https://doi.org/10.1002/mrm.21126




PubMed


 


PubMed ID 17260373
    
     


 



2.
Matsumoto K, Subramanian S, Murugesan R, Mitchell JB, Krishna MC (2007). Spatially resolved biologic information from in vivo EPRI, OMRI, and MRI. Antioxid Redox Signal  9, 1125-41.   https://doi.org/10.1089/ars.2007.1638




PubMed


 


PubMed ID 17571957",https://intramural.nih.gov/search/searchview.taf?ipid=45425
215,BC010478-05,"October 01, 2006 -  September 30, 2007",Continuous Wave Electron Paramagnetic Resonance Imaging,"Murali  Krishna; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Nallathamby  Devasahayam



Sankaran  Subramanian; MD



Fuminori  Hyodo



Shingo  Matsumoto



Janusz W Koscielniak",NULL,James B Mitchell; PhD (National Cancer Institute),Thomas J Pohida; MS (CIT),"Ordered by publication type and then author name.



1.
Aronovitch Y, Godinger D, Israeli A, Krishna MC, Samuni A, Goldstein S   (2007) Dual activity of nitroxides as pro- and antioxidants: catalysis of copper-mediated DNA breakage and H2O2 dismutation.  Free Radic Biol Med 42:1317-25.




PubMed


 


PubMed ID 17395005
    
     


 



2.
Isenberg JS, Hyodo F, Matsumoto K, Romeo MJ, Abu-Asab M, Tsokos M, Kuppusamy P, Wink DA, Krishna MC, Roberts DD (2007). Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation. Blood  109, 1945-52.   https://doi.org/10.1182/blood-2006-08-041368




PubMed



        
     
Free Article


 


PubMed ID 17082319
         Pubmed Central ID 1801044 


 



3.
Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB (2007). The chemistry and biology of nitroxide compounds. Free Radic Biol Med  42, 1632-50.   https://doi.org/10.1016/j.freeradbiomed.2007.02.030




PubMed



        
     
Free Article


 


PubMed ID 17462532
         Pubmed Central ID 1991293 


 



4.
Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB (2007). Therapeutic and clinical applications of nitroxide compounds. Antioxid Redox Signal  9, 1731-43.   https://doi.org/10.1089/ars.2007.1722




PubMed


 


PubMed ID 17665971
    
     


 



5.
Subramanian S, Koscielniak JW, Devasahayam N, Pursley RH, Pohida TJ, Krishna MC (2007). A new strategy for fast radiofrequency CW EPR imaging: direct detection with rapid scan and rotating gradients. J Magn Reson  186, 212-9.   https://doi.org/10.1016/j.jmr.2007.01.023




PubMed



        
     
Free Article


 


PubMed ID 17350865
         Pubmed Central ID 2084379",https://intramural.nih.gov/search/searchview.taf?ipid=45426
216,BC010479-05,"October 01, 2006 -  September 30, 2007",Regulation of Melanocyte Development and Differentiation,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Shunlin  Jiang,"David  Dolan
(Department of Otolaryngology, Kresge Hearing Research Institute, The University of Michigan)




Yehoash  Raphael; PhD
(Department of Otolaryngology, University of Michigan)




Faith  Strickland
(Department of Dermatology, Henry Ford Health System)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45416
217,BC010481-05,"October 01, 2006 -  September 30, 2007",Structure and Function of HIV-1 Reverse Transcriptase,"Stephen H Hughes; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Paul L Boyer



Andrea L Ferris



Baohan Christie Vu



Rafal  Wierzchoslawski



Gunnar  Gunnarsson","Eddy  Arnold; PhD
(Chemistry and Chemical Biology, CABM and Rutgers University)




William  Jorgensen
(CHEMISTRY, Yale University)




Maxine  Linial; CABM
(University of Washington)




Michael  Parniak; PhD
(Department of Medicine, McGill University)",Victor  Marquez; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Boyer PL, Julias JG, Ambrose Z, Siddiqui MA, Marquez VE, Hughes SH (2007). The nucleoside analogs 4'C-methyl thymidine and 4'C-ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants. J Mol Biol  371, 873-82.   https://doi.org/10.1016/j.jmb.2007.05.043




PubMed


 


PubMed ID 17597154
    
     


 



2.
Boyer PL, Stenbak CR, Hoberman D, Linial ML, Hughes SH (2007). In vitro fidelity of the prototype primate foamy virus (PFV) RT compared to HIV-1 RT. Virology  367, 253-64.   https://doi.org/10.1016/j.virol.2007.05.034




PubMed



        
     
Free Article


 


PubMed ID 17631930
         Pubmed Central ID 2720797 


 



3.
Das K, Sarafianos SG, Clark AD, Boyer PL, Hughes SH, Arnold E (2007). Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097. J Mol Biol  365, 77-89.   https://doi.org/10.1016/j.jmb.2006.08.097




PubMed


 


PubMed ID 17056061
    
     


 



4.
Hughes S, Clark A, Lewi P, Arnold E   (2007) Detection of non-nucleoside inhibitor binding to HIV-1 reverse transcriptase by dynamic light scattering.  Biophys J, in press.




 



5.
Jones FD, Hughes SH (2007). In vitro analysis of the effects of mutations in the G-tract of the human immunodeficiency virus type 1 polypurine tract on RNase H cleavage specificity. Virology  360, 341-9.   https://doi.org/10.1016/j.virol.2006.10.008




PubMed


 


PubMed ID 17123564
    
     


 



6.
Morningstar ML, Roth T, Farnsworth DW, Smith MK, Watson K, Buckheit RW, Das K, Zhang W, Arnold E, Julias JG, Hughes SH, Michejda CJ (2007). Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme. J Med Chem  50, 4003-15.   https://doi.org/10.1021/jm060103d




PubMed



        
     
Free Article


 


PubMed ID 17663538
         Pubmed Central ID 3057568 


 



7.
Mulky A, Vu BC, Conway JA, Hughes SH, Kappes JC (2007). Analysis of amino acids in the beta7-beta8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication. J Mol Biol  365, 1368-78.   https://doi.org/10.1016/j.jmb.2006.10.089




PubMed


 


PubMed ID 17141805
    
     


 



8.
Wu CK, Gousset K, Hughes SH (2007). Targeting to the endoplasmic reticulum improves the folding of recombinant human telomerase reverse transcriptase. Protein Expr Purif  56, 8-19.   https://doi.org/10.1016/j.pep.2007.05.016




PubMed



        
     
Free Article


 


PubMed ID 17658270
         Pubmed Central ID 2790190",https://intramural.nih.gov/search/searchview.taf?ipid=45421
218,BC010482-05,"October 01, 2006 -  September 30, 2007",Retroviral Replication and Vector Design,"Stephen H Hughes; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Linda L Dunn



Andrea L Ferris



Mary J McWilliams



Baohan Christie Vu



Rafal  Wierzchoslawski



Michael E Abram","Robert J. Gorelick; PhD
(AIDS and Cancer Virus Program, SAIC-Frederick, Inc.)
















Mark  Federspiel
(Mayo Clinic)




Daria  Hazuda
(Merck & Co.)




Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)","Vineet Narain KewalRamani; PhD (National Cancer Institute)



Jeffrey D Lifson; MD (Office Of The Director)



Dwight V Nissley (Genome Recombination and Regulation Section)","Gary Leonard Griffiths; BSc, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Hughes S   (2007) Using viral vectors in animal research., in Anthology of Biosafety X: Animal Issues, in press.




 



2.
Derse D, Crise B, Li Y, Princler G, Lum N, Stewart C, McGrath CF, Hughes SH, Munroe DJ, Wu X (2007). Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses. J Virol  81, 6731-41.   https://doi.org/10.1128/JVI.02752-06




PubMed



        
     
Free Article


 


PubMed ID 17409138
         Pubmed Central ID 1900082 


 



3.
Dunn LL, Boyer PL, McWilliams MJ, Smith SJ, Hughes SH (2015). Mutations in human immunodeficiency virus type 1 reverse transcriptase that make it sensitive to degradation by the viral protease in virions are selected against in patients. Virology  484, 127-35.   https://doi.org/10.1016/j.virol.2015.05.020




PubMed



        
     
Free Article


 


PubMed ID 26093496
         Pubmed Central ID 4887144 


 



4.
Hu J, Ferris A, Larochelle A, Krouse AE, Metzger ME, Donahue RE, Hughes SH, Dunbar CE (2007). Transduction of rhesus macaque hematopoietic stem and progenitor cells with avian sarcoma and leukosis virus vectors. Hum Gene Ther  18, 691-700.   https://doi.org/10.1089/hum.2006.175




PubMed


 


PubMed ID 17655493
    
     


 



5.
Jones FD, Hughes SH (2007). In vitro analysis of the effects of mutations in the G-tract of the human immunodeficiency virus type 1 polypurine tract on RNase H cleavage specificity. Virology  360, 341-9.   https://doi.org/10.1016/j.virol.2006.10.008




PubMed


 


PubMed ID 17123564",https://intramural.nih.gov/search/searchview.taf?ipid=45420
219,BC010483-05,"October 01, 2006 -  September 30, 2007",TEM5 Ligand Hunt,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Steven  Seaman



Janine P Stevens",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45441
220,BC010484-05,"October 01, 2006 -  September 30, 2007",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Steven  Seaman



Michael G Cullen",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45442
221,BC010485-05,"October 01, 2006 -  September 30, 2007",Mechanism of DC-SIGNMediated Transmission of HIV,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI",Pui Yee  Chung,"Derya  Unutmaz
(Vanderbilt University)




Li  Wu",Alan  Rein; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Wang JH, Janas AM, Olson WJ, KewalRamani VN, Wu L (2007). CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1. J Virol  81, 2497-507.   https://doi.org/10.1128/JVI.01970-06




PubMed



        
     
Free Article


 


PubMed ID 17151103
         Pubmed Central ID 1865928",https://intramural.nih.gov/search/searchview.taf?ipid=45422
222,BC010486-05,"October 01, 2006 -  September 30, 2007",Search for New Tumor Endothelial Markers,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45443
223,BC010487-05,"October 01, 2006 -  September 30, 2007",The Postentry Pathway of HIV-1,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Kyeongeun  Lee



Taichiro  Takemura



Alok  Mulky","Paul  Bieniasz
(Rockefeller University, Aaron Diamond AIDS Research Center)




John  Coffin
(Microbiology, Tufts University)




Alan  Engelman; PhD
(Dana-Farber, Harvard University)




Dan  Littman
(Medical School, New York University)




Ronald  Montelaro; MD
(Molecular Genetics and Biochemistry, University of Pittsburg School of Medicine)




Derya  Unutmaz
(Vanderbilt University)",Stephen H Hughes; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45423
224,BC010488-05,"October 01, 2006 -  September 30, 2007","New Animal Models to Study HIV-1 Pathogenesis, Therapy, and Reservoirs","Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI",Matthew A Bess,"Paul  Bieniasz
(Rockefeller University, Aaron Diamond AIDS Research Center)




John  Coffin
(Microbiology, Tufts University)




Shiu-Lok  Hu
(National Primate Research Center, University of Washington)




Jason  Kimata
(Southwest Foundation)




John W Mellors","Stephen H Hughes; PhD (National Cancer Institute)



Jeffrey D Lifson; MD (National Cancer Institute)



Sarah E Palmer (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ambrose Z, KewalRamani VN, Bieniasz PD, Hatziioannou T (2007). HIV/AIDS: in search of an animal model. Trends Biotechnol  25, 333-7.   https://doi.org/10.1016/j.tibtech.2007.05.004




PubMed


 


PubMed ID 17574286
    
     


 



2.
Ambrose Z, Palmer S, Boltz VF, Kearney M, Larsen K, Polacino P, Flanary L, Oswald K, Piatak M, Smedley J, Shao W, Bischofberger N, Maldarelli F, Kimata JT, Mellors JW, Hu SL, Coffin JM, Lifson JD, KewalRamani VN (2007). Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy. J Virol  81, 12145-55.   https://doi.org/10.1128/JVI.01301-07




PubMed



        
     
Free Article


 


PubMed ID 17855539
         Pubmed Central ID 2169021",https://intramural.nih.gov/search/searchview.taf?ipid=45424
225,BC010493-05,"October 01, 2006 -  September 30, 2007",High-Resolution Protein and Nucleic Acid Footprinting,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Chandravanu  Dash



Jennifer T Miller



Hye Young  Yi-Brunozzi



Christopher S Badorrek



Robert G Brinson; PhD



Michal  Legiewicz","Dan  Fabris
(Chemistry and Biochemistry, University of Maryland, Baltimore County)




Matthias  Goette
(McGill University)




Myron F Goodman; PhD
(University of Southern California)




Marie-Louise  Hammarskjold; PhD
(Microbiology, University of Virginia)




Sidney  Hecht
(Lady Davis Institute-Jewish General Hospital, University of Virginia)




John  Marino
(DEpartment of Structural Biology, Center for Advanced Research in Biotechnology)


Show all 9","Nancy H Colburn; PhD (National Cancer Institute)



Barbara K Felber (National Cancer Institute)",Robert Joseph Crouch; PhD (NICHD),"Ordered by publication type and then author name.



1.
Kvaratskhelia M, Grice SF (2008) Structural analysis of protein-RNA interactions with mass spectrometry. Methods Mol Biol 488:213-9.




PubMed



        
     
Free Article


 


PubMed ID 18982294
         Pubmed Central ID 2586912 


 



2.
Kvaratskhelia M, LeGrice S   (2007) Structural analysis of protein-RNA interactions with mass spectrometry.  Methods Mol Biol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45431
226,BC010494-05,"October 01, 2006 -  September 30, 2007",Viral and Host Proteins as Therapeutic Targets,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Marion Karla Bona; PhD



Chandravanu  Dash



Jennifer T Miller



Jason William Rausch



Christopher S Badorrek



Michal  Legiewicz



Show all 7","Robert J. Gorelick; PhD
(AIDS and Cancer Virus Program, SAIC-Frederick, Inc.)
















Matthias  Goette
(McGill University)




John  Marino
(DEpartment of Structural Biology, Center for Advanced Research in Biotechnology)




David  Stammers
(Division of Structural Biology, University of Oxford)




Xiaowei  Zhuang
(Chemistry and Biology, Harvard University)",John A Beutler (National Cancer Institute),Robert Joseph Crouch; PhD (NICHD),"Ordered by publication type and then author name.



1.
Le Grice S   (2007) HIV-1 reverse transcriptase., in Viral Genome Replication (M Gotte, CE Cameron, and K Raney, eds). Springer Publications Company (New York), in press.




 



2.
Dat NT, Bae K, Wamiru A, McMahon JB, Le Grice SF, Bona M, Beutler JA, Kim YH (2007). A dimeric lactone from Ardisia japonica with inhibitory activity for HIV-1 and HIV-2 ribonuclease H. J Nat Prod  70, 839-41.   https://doi.org/10.1021/np060359m




PubMed


 


PubMed ID 17397219",https://intramural.nih.gov/search/searchview.taf?ipid=45428
227,BC010495-05,"October 01, 2006 -  September 30, 2007",Nucleoside and Amino Acid Analogs as Probes of HIV Replication Complexes,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Noel  Baichoo



Chandravanu  Dash



Jason William Rausch



Hye Young  Yi-Brunozzi



Michaela  Wendeler","Matthias  Goette
(McGill University)




Myron F Goodman; PhD
(University of Southern California)




Sidney  Hecht
(Lady Davis Institute-Jewish General Hospital, University of Virginia)",NULL,NULL,"Ordered by publication type and then author name.



1.
Klarmann GJ, Eisenhauer BM, Zhang Y, Gotte M, Pata JD, Chatterjee DK, Hecht SM, Le Grice SF (2007). Investigating the ""steric gate"" of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by targeted insertion of unnatural amino acids. Biochemistry  46, 2118-26.   https://doi.org/10.1021/bi061772w




PubMed


 


PubMed ID 17274599
    
     


 



2.
Rausch JW, Le Grice SF (2007). Exploiting structurally diverse nucleoside analogs as probes of reverse transcription complexes. Curr HIV Res  5, 11-22.   https://doi.org/10.2174/157016207779316332




PubMed


 


PubMed ID 17266554
    
     


 



3.
Rausch JW, Le Grice SF (2007). Purine analog substitution of the HIV-1 polypurine tract primer defines regions controlling initiation of plus-strand DNA synthesis. Nucleic Acids Res  35, 256-68.   https://doi.org/10.1093/nar/gkl909




PubMed



        
     
Free Article


 


PubMed ID 17164285
         Pubmed Central ID 1802577",https://intramural.nih.gov/search/searchview.taf?ipid=45429
228,BC010499-05,"October 01, 2006 -  September 30, 2007",Maryland Prostate Cancer Case-Control Study,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Tiffany A Wallace



Robert Scott Hudson","William  Isaacs; PhD
(Department of Urology, Johns Hopkins School of Medicine)




Chris  Loffredo
(Cancer Genetics and Epidemiology Program, Georgetown University)




Jun  Luo
(Urology, Johns Hopkins University)","Neil Edward Caporaso; MS, MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45403
229,BC010504-05,"October 01, 2006 -  September 30, 2007","HIV Recombination, Double Infection, and Replication Fitness","Wei-Shau  Hu; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Olga A Nikolaitchik



Jianbo  Chen



Po San Mario  Chin","Weiqun  Peng
(George Washington University)




Marcelo  Soares; PhD
(Instituto Nacional de Cancer do Brasil)




Ronald I Swanstrom





Kevin  Weeks
(University of North Carolina)","Matthew  Fivash (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hu W, Chin M   (2007) HIV-1 recombination: An experimental assay and a phylogenetic approach., in HIV Protocols, 2nd Edition (V Prasad and G Kalpana, eds).  Humana Press, Inc., in press.




 



2.
Chin MP, Chen J, Nikolaitchik OA, Hu WS (2007). Molecular determinants of HIV-1 intersubtype recombination potential. Virology  363, 437-46.   https://doi.org/10.1016/j.virol.2007.01.034




PubMed


 


PubMed ID 17336363
    
     


 



3.
Fu W, Prasad VV, Chen J, Nikolaitchik O, Hu WS (2007). Molecular mechanisms of simian immunodeficiency virus SIV(agm) RNA encapsidation. Virology  363, 210-9.   https://doi.org/10.1016/j.virol.2007.01.030




PubMed



        
     
Free Article


 


PubMed ID 17321560
         Pubmed Central ID 2920611 


 



4.
Nikolaitchik OA, Gorelick RJ, Leavitt MG, Pathak VK, Hu WS (2008). Functional complementation of nucleocapsid and late domain PTAP mutants of human immunodeficiency virus type 1 during replication. Virology  375, 539-49.   https://doi.org/10.1016/j.virol.2008.02.026




PubMed



        
     
Free Article


 


PubMed ID 18353416
         Pubmed Central ID 2459335",https://intramural.nih.gov/search/searchview.taf?ipid=45418
230,BC010506-05,"October 01, 2006 -  September 30, 2007",Assembly and Complementation of Viral Proteins during Retroviral Replication,"Wei-Shau  Hu; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Jianbo  Chen



Vitaly P Boyko



Islam T Mohammad Hussein","Robert J. Gorelick; PhD
(AIDS and Cancer Virus Program, SAIC-Frederick, Inc.)





David  Ott
(SAIC-Frederick)","Eric O Freed; PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)



Alan  Rein; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Fu W, Prasad VV, Chen J, Nikolaitchik O, Hu WS (2007). Molecular mechanisms of simian immunodeficiency virus SIV(agm) RNA encapsidation. Virology  363, 210-9.   https://doi.org/10.1016/j.virol.2007.01.030




PubMed



        
     
Free Article


 


PubMed ID 17321560
         Pubmed Central ID 2920611 


 



2.
Lee SK, Boyko V, Hu WS (2007). Capsid is an important determinant for functional complementation of murine leukemia virus and spleen necrosis virus Gag proteins. Virology  360, 388-97.   https://doi.org/10.1016/j.virol.2006.10.038




PubMed



        
     
Free Article


 


PubMed ID 17156810
         Pubmed Central ID 2706498",https://intramural.nih.gov/search/searchview.taf?ipid=45417
231,BC010511-05,"October 01, 2006 -  September 30, 2007",Retrovirus Assembly and Maturation,"Alan  Rein; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Siddhartha  Datta; PhD



Demetria P Harvin



Jane  Mirro



Shilpa  Kulkarni



Rachael M Crist



Lakew  Temeselew","Eran  Bacharach
(Tel Aviv University)




Alexander A Kogon





Susan  Krueger
(National Institute of Standards and Technology)




Massimo  Palmarini
(Veterinary School, University of Glasgow)




Elena N Peletskaya





Itay  Rousso
(Weizmann Institute)


Show all 7","Raul Eduardo Cachau (National Cancer Institute)



Robert J Fisher (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Rein A   (2007) Preparation of recombinant HIV-1 Gag protein and assembly of virus-like particles in vitro., in HIV Protocols, 2nd Edition (V Prasad and G Kalpana, eds).  Humana Press, Inc., in press.




 



2.
Datta SA, Curtis JE, Ratcliff W, Clark PK, Crist RM, Lebowitz J, Krueger S, Rein A (2007). Conformation of the HIV-1 Gag protein in solution. J Mol Biol  365, 812-24.   https://doi.org/10.1016/j.jmb.2006.10.073




PubMed



        
     
Free Article


 


PubMed ID 17097677
         Pubmed Central ID 1866279 


 



3.
Datta SA, Zhao Z, Clark PK, Tarasov S, Alexandratos JN, Campbell SJ, Kvaratskhelia M, Lebowitz J, Rein A (2007). Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J Mol Biol  365, 799-811.   https://doi.org/10.1016/j.jmb.2006.10.072




PubMed



        
     
Free Article


 


PubMed ID 17098251
         Pubmed Central ID 1829305 


 



4.
Rulli SJ, Hibbert CS, Mirro J, Pederson T, Biswal S, Rein A (2007). Selective and nonselective packaging of cellular RNAs in retrovirus particles. J Virol  81, 6623-31.   https://doi.org/10.1128/JVI.02833-06




PubMed



        
     
Free Article


 


PubMed ID 17392359
         Pubmed Central ID 1900105 


 



5.
Rulli SJ, Mirro J, Hill SA, Lloyd P, Gorelick RJ, Coffin JM, Derse D, Rein A (2008). Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses. J Virol  82, 6566-75.   https://doi.org/10.1128/JVI.01357-07




PubMed



        
     
Free Article


 


PubMed ID 18448535
         Pubmed Central ID 2447093 


 



6.
Wilkinson KA, Gorelick RJ, Vasa SM, Guex N, Rein A, Mathews DH, Giddings MC, Weeks KM (2008). High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states. PLoS Biol  6, e96.   https://doi.org/10.1371/journal.pbio.0060096




PubMed



        
     
Free Article


 


PubMed ID 18447581
         Pubmed Central ID 2689691",https://intramural.nih.gov/search/searchview.taf?ipid=45439
232,BC010512-05,"October 01, 2006 -  September 30, 2007",Interactions of Retroviral Proteins with Nucleic Acids,"Alan  Rein; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Siddhartha  Datta; PhD



Demetria P Harvin



Jane  Mirro","Karin  Musier-Forsyth
(Ohio State University)




Kevin  Weeks
(University of North Carolina)




Mark  Williams
(Northeastern University)",Robert J Fisher (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Rein A, Datta S, Worthy K, Bindu L, Fivash M, Turner K, Fabris D, Fisher R   (2007) Measuring the binding stoichiometry of HIV-1 Gag to very low density oligonucleotide surfaces using surface plasmon resonance spectroscopy.  J Biomol Tech, in press.




 



2.
Rulli SJ, Hibbert CS, Mirro J, Pederson T, Biswal S, Rein A (2007). Selective and nonselective packaging of cellular RNAs in retrovirus particles. J Virol  81, 6623-31.   https://doi.org/10.1128/JVI.02833-06




PubMed



        
     
Free Article


 


PubMed ID 17392359
         Pubmed Central ID 1900105 


 



3.
Rulli SJ, Mirro J, Hill SA, Lloyd P, Gorelick RJ, Coffin JM, Derse D, Rein A (2008). Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses. J Virol  82, 6566-75.   https://doi.org/10.1128/JVI.01357-07




PubMed



        
     
Free Article


 


PubMed ID 18448535
         Pubmed Central ID 2447093",https://intramural.nih.gov/search/searchview.taf?ipid=45440
233,BC010516-05,"October 01, 2006 -  September 30, 2007",Gated Optical DetectorsDose Guided Radiotherapy,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","George  Li; PhD



Hu-Chen  Xie



Holly  Ning



Frank S Harrington



Barbara Chin Arora



Jason Yulin Cheng; PhD","Wei  Chen
(Physics, University of Texas)




Paul  Falkenstein
(Optical Sciences Division, Naval Research Laboratory)




Alan  Huston
(Optical Sciences Division, Naval Research Laboratory)




Brian  Justus
(Optical Sciences Division, Naval Research Lab (NRL))




Maria  Plazas
(Departmento de Fiscia, Universidad Nacional de Colombia)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45447
234,BC010517-05,"October 01, 2006 -  September 30, 2007",Large Databases of Small Molecules - Drug Development Tool and Public Resource,Marc C Nicklaus,Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI","Igor V Filippov



Megan L Peach



Markus  Sitzmann",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45450
235,BC010518-05,"October 01, 2006 -  September 30, 2007",Role of BMP and FGF signaling during limb development,"Mark B Lewandoski



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Sangeeta  Underwood



Cindy  Elder



Michelle B Warren",NULL,NULL,Yuji  Mishina; PhD (NIEHS),"Ordered by publication type and then author name.



1.
Lewandoski M (2007). Analysis of mouse development with conditional mutagenesis. Handb Exp Pharmacol   235-62  https://doi.org/10.1007/978-3-540-35109-2_10




PubMed


 


PubMed ID 17203658
    
     


 



2.
Pajni-Underwood S, Wilson CP, Elder C, Mishina Y, Lewandoski M (2007). BMP signals control limb bud interdigital programmed cell death by regulating FGF signaling. Development  134, 2359-68.   https://doi.org/10.1242/dev.001677




PubMed


 


PubMed ID 17537800",https://intramural.nih.gov/search/searchview.taf?ipid=45455
236,BC010519-05,"October 01, 2006 -  September 30, 2007",Development of Novel Therapeutic Strategies for Thoracic Malignancies by Targeti,"Dao M Nguyen; MD, MS",NULL,"Surgery Branch, NCI",NULL,"Avi  Ashkenazi
(Genentech, Inc.)




Marc  Dupuis
(Oncology, Apoxis SA)




Bing Liang  Fang
(Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center)","John R Wunderlich (National Cancer Institute)



Peter L Choyke; MD (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)



Stanley  Lipkowitz; MD, PhD (National Cancer Institute)



David  Schrump; MD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)",Bradford J Wood; MD (CC),"Ordered by publication type and then author name.



1.
Kang Y, Hong JA, Chen GA, Nguyen DM, Schrump DS (2007). Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells. Oncogene  26, 4394-403.   https://doi.org/10.1038/sj.onc.1210218




PubMed


 


PubMed ID 17260018
    
     


 



2.
Koyama Y, Hama Y, Urano Y, Nguyen DM, Choyke PL, Kobayashi H (2007). Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin Cancer Res  13, 2936-45.   https://doi.org/10.1158/1078-0432.CCR-06-2240




PubMed


 


PubMed ID 17504994
    
     


 



3.
Reddy RM, Yeow WS, Chua A, Nguyen DM, Baras A, Ziauddin MF, Shamimi-Noori SM, Maxhimer JB, Schrump DS, Nguyen DM (2007). Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade. Apoptosis  12, 55-71.   https://doi.org/10.1007/s10495-006-0484-z




PubMed


 


PubMed ID 17136498
    
     


 



4.
Rosas IO, Ren P, Avila NA, Chow CK, Franks TJ, Travis WD, McCoy JP, May RM, Wu HP, Nguyen DM, Arcos-Burgos M, MacDonald SD, Gochuico BR (2007). Early interstitial lung disease in familial pulmonary fibrosis. Am J Respir Crit Care Med  176, 698-705.   https://doi.org/10.1164/rccm.200702-254OC




PubMed



        
     
Free Article


 


PubMed ID 17641157
         Pubmed Central ID 1994234 


 



5.
Stewart JH, Tran TL, Levi N, Tsai WS, Schrump DS, Nguyen DM (2007). The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma. J Surg Res  141, 120-31.   https://doi.org/10.1016/j.jss.2007.03.048




PubMed


 


PubMed ID 17574045
    
     


 



6.
Toro JR, Pautler SE, Stewart L, Glenn GM, Weinreich M, Toure O, Wei MH, Schmidt LS, Davis L, Zbar B, Choyke P, Steinberg SM, Nguyen DM, Linehan WM (2007). Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome. Am J Respir Crit Care Med  175, 1044-53.   https://doi.org/10.1164/rccm.200610-1483OC




PubMed



        
     
Free Article


 


PubMed ID 17322109
         Pubmed Central ID 1899269",https://intramural.nih.gov/search/searchview.taf?ipid=45448
237,BC010520-05,"October 01, 2006 -  September 30, 2007","Characterization of PBIP1, a novel polo-box-interacting protein at the kinetocho","Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Qian WJ, Park JE, Grant R, Lai CC, Kelley JA, Yaffe MB, Lee KS, Burke TR (2015). Neighbor-directed histidine N (τ)-alkylation: A route to imidazolium-containing phosphopeptide macrocycles. Biopolymers  104, 663-73.   https://doi.org/10.1002/bip.22698




PubMed



        
     
Free Article


 


PubMed ID 26152807
         Pubmed Central ID 4865893 


 



2.
Qian WJ, Park JE, Lim D, Lai CC, Kelley JA, Park SY, Lee KW, Yaffe MB, Lee KS, Burke TR (2014). Mono-anionic phosphopeptides produced by unexpected histidine alkylation exhibit high Plk1 polo-box domain-binding affinities and enhanced antiproliferative effects in HeLa cells. Biopolymers  102, 444-55.   https://doi.org/10.1002/bip.22569




PubMed



        
     
Free Article


 


PubMed ID 25283071
         Pubmed Central ID 4895914",https://intramural.nih.gov/search/searchview.taf?ipid=45432
238,BC010523-04,"October 01, 2006 -  September 30, 2007",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,"Shivinder Singh Grewal



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Tomoyasu  Sugiyama



Martin  Zofall



Hugh P Cam



Ee Sin  Chen



Xi  Chen; MD



Rie  Sugiyama



Show all 9",NULL,Peter C Fitzgerald (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Sugiyama T, Cam HP, Sugiyama R, Noma K, Zofall M, Kobayashi R, Grewal SI (2007). SHREC, an effector complex for heterochromatic transcriptional silencing. Cell  128, 491-504.   https://doi.org/10.1016/j.cell.2006.12.035




PubMed


 


PubMed ID 17289569",https://intramural.nih.gov/search/searchview.taf?ipid=45176
239,BC010524-05,"October 01, 2006 -  September 30, 2007",HIV Integrase Modeling and Computer-Aided Inhibitor Development,Marc C Nicklaus,Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI","Igor V Filippov



Chenzhong  Liao",NULL,"Yves  Pommier; PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Liao C, Karki RG, Marchand C, Pommier Y, Nicklaus MC (2007). Virtual screening application of a model of full-length HIV-1 integrase complexed with viral DNA. Bioorg Med Chem Lett  17, 5361-5.   https://doi.org/10.1016/j.bmcl.2007.08.011




PubMed


 


PubMed ID 17719223",https://intramural.nih.gov/search/searchview.taf?ipid=45449
240,BC010525-05,"October 01, 2006 -  September 30, 2007",Immune Reconstitution,"Ronald E Gress; MD



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Sarfraz A Memon



Francis  Flomerfelt; PhD



Philip J Lucas; PhD



Yu-Waye (Wayne)  Chu



Jiun  Wang","Gregory  Hadley
(Immunology, University of Maryland)




Robert  Korngold
(Cancer Center, Hackensack University)




Andrew  Pecora
(Cancer Center, Hackensack University)




Wayne  Streilein
(Ophthamology, Yale)","Martin  Gutierrez (National Cancer Institute)



Shivaani  Kummar; PhD (National Cancer Institute)



Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)



Alfred  Singer; MD (National Cancer Institute)



James Stephen Shaw; PhD (National Cancer Institute)



Richard J Hodes; MD (National Cancer Institute)","Daniel C Douek; MD (NIAID) 



Catherine K Chow; MD (CC) 



Peter E Lipsky; MD (NIAMS) 



Arya  Biragyn; PhD (NIA)","Ordered by publication type and then author name.



1.
Baatar D, Olkhanud P, Sumitomo K, Taub D, Gress R, Biragyn A (2007). Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL. J Immunol  178, 4891-900.   https://doi.org/10.4049/jimmunol.178.8.4891




PubMed



        
     
Free Article


 


PubMed ID 17404270
         Pubmed Central ID 2262930 


 



2.
Gress RE, Komanduri KV, Einsele H, Cooper LJ (2007). Lymphoid reconstruction and vaccines. Biol Blood Marrow Transplant  13, 17-22.   https://doi.org/10.1016/j.bbmt.2006.10.012




PubMed



        
     
Free Article


 


PubMed ID 17222765
         Pubmed Central ID 1858644 


 



3.
Hakim FT, Gress RE (2007). Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens  70, 179-89.   https://doi.org/10.1111/j.1399-0039.2007.00891.x




PubMed


 


PubMed ID 17661905
    
     


 



4.
Hardy NM, Hakim F, Steinberg SM, Krumlauf M, Cvitkovic R, Babb R, Odom J, Fowler DH, Gress RE, Bishop MR (2007). Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation. Biol Blood Marrow Transplant  13, 1022-30.   https://doi.org/10.1016/j.bbmt.2007.05.008




PubMed



        
     
Free Article


 


PubMed ID 17697964
         Pubmed Central ID 2699412 


 



5.
Kochenderfer JN, Chien CD, Simpson JL, Gress RE (2007). Maximizing CD8+ T cell responses elicited by peptide vaccines containing CpG oligodeoxynucleotides. Clin Immunol  124, 119-30.   https://doi.org/10.1016/j.clim.2007.04.003




PubMed



        
     
Free Article


 


PubMed ID 17584532
         Pubmed Central ID 1995015 


 



6.
Kochenderfer JN, Simpson JL, Chien CD, Gress RE (2007). Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing homeostatic peripheral expansion after BMT. Blood  110, 450-60.   https://doi.org/10.1182/blood-2006-11-057935




PubMed



        
     
Free Article


 


PubMed ID 17371943
         Pubmed Central ID 1896127",https://intramural.nih.gov/search/searchview.taf?ipid=45413
241,BC010529-05,"October 01, 2006 -  September 30, 2007",Regulated proteolysis in developmental signaling,Mark E Fortini,NULL,"Cancer and Developmental Biology Laboratory, NCI","Mary K Ernst



Ritu  Kanwar



Casper  Groth



Nikolaos  Tountas



Takeshi  Sasamura","David  Bilder; MCB
(University of California)




Tom  Jongens
(Genetics, University of Pennsylvania)",NULL,NULL,"Ordered by publication type and then author name.



1.
Fortini M (2007) Meeting report: Drosophila as a model for human diseases. Fly 47-54.




 



2.
Fortini ME (2007). Medicine. Anticipating trouble from gene transcription. Science  315, 1800-1.   https://doi.org/10.1126/science.1141279




PubMed


 


PubMed ID 17395816
    
     


 



3.
Lu Y, Lv Y, Ye Y, Wang Y, Hong Y, Fortini ME, Zhong Y, Xie Z (2007). A role for presenilin in post-stress regulation: effects of presenilin mutations on Ca2+ currents in Drosophila. FASEB J  21, 2368-78.   https://doi.org/10.1096/fj.06-6380com




PubMed


 


PubMed ID 17428965",https://intramural.nih.gov/search/searchview.taf?ipid=45411
242,BC010530-05,"October 01, 2006 -  September 30, 2007",Molecular Therapeutics for HIVAIDS,"Dean H. Hamer; PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI",NULL,"Laurel  Lagenaur; PhD





Dominik  Wodarz
(U C Irvine)",NULL,NULL,"Ordered by publication type and then author name.



1.
Wodarz D, Hamer DH (2007). Infection dynamics in HIV-specific CD4 T cells: does a CD4 T cell boost benefit the host or the virus? Math Biosci  209, 14-29.   https://doi.org/10.1016/j.mbs.2007.01.007




PubMed



        
     
Free Article


 


PubMed ID 17379260
         Pubmed Central ID 4058052",https://intramural.nih.gov/search/searchview.taf?ipid=45414
243,BC010532-05,"October 01, 2006 -  September 30, 2007",Role of Connection and RNase H Domains of HIV-1 RT in Antiviral Drug Resistance,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Galina  Nikolenko



Abhay  Jere","Robert J. Gorelick; PhD
(AIDS and Cancer Virus Program, SAIC-Frederick, Inc.)
















Jeffrey  Anderson





John W Mellors





Deborah  Persaud
(Johns Hopkins University)




Marcelo  Soares; PhD
(Instituto Nacional de Cancer do Brasil)




Ronald I Swanstrom","Frank  Maldarelli (National Cancer Institute)



Sarah E Palmer (National Cancer Institute)



David  Derse; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Brehm JH, Koontz D, Meteer JD, Pathak V, Sluis-Cremer N, Mellors JW (2007). Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine. J Virol  81, 7852-9.   https://doi.org/10.1128/JVI.02203-06




PubMed



        
     
Free Article


 


PubMed ID 17507476
         Pubmed Central ID 1951314 


 



2.
Delviks-Frankenberry KA, Nikolenko GN, Barr R, Pathak VK (2007). Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3'-azido-3'-deoxythymidine resistance. J Virol  81, 6837-45.   https://doi.org/10.1128/JVI.02820-06




PubMed



        
     
Free Article


 


PubMed ID 17428874
         Pubmed Central ID 1933283 


 



3.
Nikolenko GN, Delviks-Frankenberry KA, Palmer S, Maldarelli F, Fivash MJ, Coffin JM, Pathak VK (2007). Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistance. Proc Natl Acad Sci U S A  104, 317-22.   https://doi.org/10.1073/pnas.0609642104




PubMed



        
     
Free Article


 


PubMed ID 17179211
         Pubmed Central ID 1765458",https://intramural.nih.gov/search/searchview.taf?ipid=45452
244,BC010533-05,"October 01, 2006 -  September 30, 2007",Mechanisms of HIV-1 Reverse Transcription,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Krista A Delviks-Frankenberry



Yeshitila  Friew",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Pathak V, Delviks-Frankenberry K, Thomas J, Gorelick R   (2007) Real-time PCR analysis of HIV-1 replication post-entry events., in HIV Protocols, 2nd Edition (V Prasad and G Kalpana, eds).  Humana Press, Inc., in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45453
245,BC010537-05,"October 01, 2006 -  September 30, 2007",Comparative Genomics: Mechanism(s) Against Emerging Infectious Diseases,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Naoya  Yuhki; MD



Thomas  Beck



Lisa  Maslan","Carsten  Muenk
(Div. of Medical Biotechnology, Paul-Ehrlich-Institute)




William J. Murphy
(NCI-FCRDC, NCI)




Douglas U Smith",Robert H Stephens (National Cancer Institute),James Copeland Mullikin; PhD (NHGRI),"Ordered by publication type and then author name.



1.
Luo SJ, Johnson WE, David VA, Menotti-Raymond M, Stanyon R, Cai QX, Beck T, Yuhki N, Pecon-Slattery J, Smith JL, O'Brien SJ (2007). Development of Y chromosome intraspecific polymorphic markers in the Felidae. J Hered  98, 400-13.   https://doi.org/10.1093/jhered/esm063




PubMed


 


PubMed ID 17646273
    
     


 



2.
O'Brien S, Beck T, Stephens R, Neelam B   (2007) Comparative genomic structure of human, dog, and cat MHC: HLA, DLA, and FLA.  Journal of Heredity  390-399 pp.




 



3.
O'Brien S, Mullikin J, Smith D, Agencourt Sequencing Team, Lindblad-Toh K, Gnerre S, Clamp M, Chang J, Stephens R, Neelam B, Volfovsky N, Schaffer A, Agarwala R, Narfstrom K, Murphy W, Giger U, Roca A, Antunes A, Menotti-Raymond M, Yuhki N, Pecon-Slattery J, Johnson W, Bourque G, Tesler G   (2007) The domestic cat genome sequence: annotation and comparative inferences.  Genome Research, in press.




 



4.
Troyer JL, Vandewoude S, Pecon-Slattery J, McIntosh C, Franklin S, Antunes A, Johnson W, O'Brien SJ (2008). FIV cross-species transmission: an evolutionary prospective. Vet Immunol Immunopathol  123, 159-66.   https://doi.org/10.1016/j.vetimm.2008.01.023




PubMed



        
     
Free Article


 


PubMed ID 18299153
         Pubmed Central ID 2442884 


 



5.
Vàzquez-Salat N, Yuhki N, Beck T, O'Brien SJ, Murphy WJ (2007). Gene conversion between mammalian CCR2 and CCR5 chemokine receptor genes: a potential mechanism for receptor dimerization. Genomics  90, 213-24.   https://doi.org/10.1016/j.ygeno.2007.04.009




PubMed


 


PubMed ID 17544254",https://intramural.nih.gov/search/searchview.taf?ipid=45451
246,BC010538-05,"October 01, 2006 -  September 30, 2007",Molecular Analysis of Breast Cancer Metastasis to the Brain,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Christine E Horak



Diane  Palmieri



Jong Heun Lee



Brunilde M Gril



Daniel  Fitzgerald



Emily  Hua



Show all 7","Kenneth Dean Aldape; MD
(Laboratory Of Pathology)




Ann  Chambers
(London Regional Cancer Center)




Raffael  Kurek
(Department of Obstetrics and Gynecology, University of Tuebingen)




Victoria  Richon
(Cancer Biology and Therapeutics, Merck)




Steven  Rubin
(Oncology, GlaxoSmithKline)




Andreas  Stark
(Neurosurgery, University of Schleswig-Holstein Medical Center)


Show all 8","Paul S Meltzer; MD, PhD (National Cancer Institute)



Jeanne  Herring (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)



Lionel  Feigenbaum (Office Of The Director)",Alexander Oliver Vortmeyer; MD (NINDS),"Ordered by publication type and then author name.



1.
Palmieri D, Bronder JL, Herring JM, Yoneda T, Weil RJ, Stark AM, Kurek R, Vega-Valle E, Feigenbaum L, Halverson D, Vortmeyer AO, Steinberg SM, Aldape K, Steeg PS (2007). Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res  67, 4190-8.   https://doi.org/10.1158/0008-5472.CAN-06-3316




PubMed


 


PubMed ID 17483330
    
     


 



2.
Palmieri D, Chambers AF, Felding-Habermann B, Huang S, Steeg PS (2007). The biology of metastasis to a sanctuary site. Clin Cancer Res  13, 1656-62.   https://doi.org/10.1158/1078-0432.CCR-06-2659




PubMed


 


PubMed ID 17363518",https://intramural.nih.gov/search/searchview.taf?ipid=45444
247,BC010539-05,"October 01, 2006 -  September 30, 2007",Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI","Jessica Catherine Walrath



Jessica Corinne Van Schaick","Karl  Broman
(University of Michigan)




Frederik  Mertens
(Clinical Genetics, Lund University)




Brian  Rood
(Pediatric Hematology-Oncology, Children's National Medical Center)","Colin L Stewart; PhD (National Cancer Institute)



David  Munroe (National Cancer Institute)","Douglas Russell Stewart; BA, MD (NHGRI)","Ordered by publication type and then author name.



1.
Hawes JJ, Tuskan RG, Reilly KM (2007). Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies. Neurogenetics  8, 121-30.   https://doi.org/10.1007/s10048-006-0078-5




PubMed



        
     
Free Article


 


PubMed ID 17216419
         Pubmed Central ID 6687394",https://intramural.nih.gov/search/searchview.taf?ipid=45437
248,BC010540-05,"October 01, 2006 -  September 30, 2007",Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI","Jessica J Hawes



Yvette Simone Connell-Albert



Jessica Catherine Walrath","Ancha  Baranov
(Molecular and Microbiology, George Mason University)




Ken  McCarthy
(Pharmacology, U. North Carolina-Chapel Hill)","Thomas J Turbyville (National Cancer Institute)



Colin L Stewart; PhD (National Cancer Institute)



David  Munroe (National Cancer Institute)



John A Beutler (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Tuskan RG, Tsang S, Sun Z, Baer J, Rozenblum E, Wu X, Munroe DJ, Reilly KM (2008). Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels. Epigenetics  3, 43-50.   https://doi.org/10.4161/epi.3.1.5469




PubMed



        
     
Free Article


 


PubMed ID 18188004
         Pubmed Central ID 2507877",https://intramural.nih.gov/search/searchview.taf?ipid=45438
249,BC010541-05,"October 01, 2006 -  September 30, 2007",Development of Mouse Astrocytoma Model for Preclinical Testing of Experimental T,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Jessica J Hawes,"Brian  Rood
(Pediatric Hematology-Oncology, Children's National Medical Center)




David  Wiemer
(organic synthesis/molecular target identification, University of Iowa)","Brigitte  Widemann; MD (National Cancer Institute)



Thomas J Turbyville (National Cancer Institute)



John A Beutler (National Cancer Institute)



Peter L Choyke; MD (National Cancer Institute)



Marcelino  Bernardo (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45436
250,BC010542-05,"October 01, 2006 -  September 30, 2007",Biology of Keratinocyte and Cancer Stem Cells,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI",NULL,NULL,"Mark  Udey; MD (National Cancer Institute)



John N Brady; PhD (National Cancer Institute)



William G Telford (National Cancer Institute)



Christoph  Rader; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ohyama M, Vogel JC, Amagai M (2007). Gene ontology analysis of human hair follicle bulge molecular signature. J Dermatol Sci  45, 147-50.   https://doi.org/10.1016/j.jdermsci.2006.09.009




PubMed


 


PubMed ID 17071058
    
     


 



2.
Terunuma A, Kapoor V, Yee C, Telford WG, Udey MC, Vogel JC (2007). Stem cell activity of human side population and alpha6 integrin-bright keratinocytes defined by a quantitative in vivo assay. Stem Cells  25, 664-9.   https://doi.org/10.1634/stemcells.2006-0434




PubMed


 


PubMed ID 17332515
    
     


 



3.
Vogel J, Cross J, Dyck M, Kapoor V, Telford W   (2007) Behavior of human foreskin keratinocytes expressing a hair follicle stem cell marker CD200.  J Investig Dermatol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45434
251,BC010543-04,"October 01, 2006 -  September 30, 2007",HSP90 as a Molecular Target for Ionizing Radiation,"David R Gius; MD, PhD",NULL,"Radiation Oncology Branch, NCI","Kheem Singh Bisht



Lunching  Sun



Lei  Huang



Alexandra  Lin",NULL,Leonard  Neckers; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45174
252,BC010544-04,"October 01, 2006 -  September 30, 2007",Epigenetic regulation of of Gene Expression and multi-modality resistance in tum,"David R Gius; MD, PhD",NULL,"Radiation Oncology Branch, NCI","Kheem Singh Bisht



Lunching  Sun



Lei  Huang



Kristi  Jacobs



Alexandra  Lin",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Gius D, Funk MC, Chuang EY, Feng S, Huettner PC, Nguyen L, Bradbury CM, Mishra M, Gao S, Buttin BM, Cohn DE, Powell MA, Horowitz NS, Whitcomb BP, Rader JS (2007). Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. Cancer Res  67, 7113-23.   https://doi.org/10.1158/0008-5472.CAN-07-0260




PubMed


 


PubMed ID 17671178",https://intramural.nih.gov/search/searchview.taf?ipid=45175
253,BC010547-05,"October 01, 2006 -  September 30, 2007",Development of Drugs That Target Prostate Cancer,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Caitlin  Baum



Haihao  Sun



Rui  Gao



Nima  Sharifi



Cindy Huong-Bich Chau



Erika K Smith","Anthony  D'Amico
(Radiation Oncology, Harvard Medical School)




Sylvia  Ng
(Advanced Therapeutics, BC Cancer Research Centre)","Howard  Parnes (National Cancer Institute)



Mustafa  Hussain (National Cancer Institute)



John J Wright (National Cancer Institute)



Philip M Arlen; MD (National Cancer Institute)



James L Gulley; MD, PhD (National Cancer Institute)



William Laurence Dahut; MD (National Cancer Institute)",Clara Chi Chen; MD (CC),"Ordered by publication type and then author name.



1.
Figg W   (2007) Androgen Receptor Modulation: Lessons Learned from Beyond the Prostate.  Cancer Bio Therap, in press.




 



2.
Figg W, Dahut W   (2007) Secondary Hormonal Therapy for Prostate Cancer: What Lies on the Horizon?  Br J Urology, in press.




 



3.
Figg WD, Hamada AD, Price DD, Sparreboom AD (submitted in 2007) Slco1b3 Genotype. Patents issued: 2115173 (DE in 2011); 2115173 (EP in 2011); 2115173 (FR in 2011); 2115173 (GB in 2011); 2008205330 (AU in 2015). Patents pending: PCT/US2008/000310 (PC application); 12/522,480 (US application); 2,674,788 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=45410
254,BC010548-02,"October 01, 2006 -  September 30, 2007",Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Matthew  Danish



Kathryn  Compton",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50241
255,BC010549-04,"October 01, 2006 -  September 30, 2007",Zebrafish models of human leukemia and sarcoma,"Dennis D Hickstein



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Robert R West



Lisa J Embree



Hatem E Sabaawy



Mizuki  Azuma",NULL,Paul Saiho Liu; PhD (Pharmaceutical Resources Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45177
256,BC010558-04,"October 01, 2006 -  September 30, 2007",The Maintenance of Plasmids in Pathogenic Organisms,"Stuart J Austin



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Therese G Brendler; BS, PhD



Brenda L Youngren



Manjistha  Sengupta","Flemming  Hansen
(BioCentrum, Technical University of Denmank)




Finbarr  Hayes
(Genetics, University of Manchester)","Donald L Court; PhD (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45552
257,BC010559-04,"October 01, 2006 -  September 30, 2007",Identification of Non-BRCA12 Susceptibility Genes in Special Populations,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI",NULL,"Mahmoud  Al-Masri
(Surgical Oncology, King Hussein Cancer Center)




James  Coyne
(Psychiatry, University of Pennsylvania)




Emmanualle  Genin
(Genetic Epidemiology, INSERM)","Kathleen A Calzone (National Cancer Institute)



Margaret Anne Tucker (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45456
258,BC010560-04,"October 01, 2006 -  September 30, 2007",Adjuvant Therapy of Breast Cancer,Sandra M Swain; MD,NULL,"Medical Oncology Branch, NCI",NULL,"Charles  Geyer
(NSABP)




Norman  Wolmark
(National Surgical Adjuvant Breast and Bowel Project)",NULL,NULL,"Ordered by publication type and then author name.



1.
Denduluri N, Lee JJ, Walshe J, Berman AW, Vatas U, Chow CK, Steinberg SM, Cox MC, Low JA, Swain SM (2007). Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer. Invest New Drugs  25, 63-7.   https://doi.org/10.1007/s10637-006-9006-7




PubMed


 


PubMed ID 16933153
    
     


 



2.
Denduluri N, Low JA, Lee JJ, Berman AW, Walshe JM, Vatas U, Chow CK, Steinberg SM, Yang SX, Swain SM (2007). Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanes. J Clin Oncol  25, 3421-7.   https://doi.org/10.1200/JCO.2006.10.0784




PubMed


 


PubMed ID 17606971
    
     


 



3.
Dennison SK, Jacobs SA, Wilson JW, Seeger J, Cescon TP, Raymond JM, Geyer CE, Wolmark N, Swain SM (2007). A phase II clinical trial of ZD1839 (Iressa) in combination with docetaxel as first-line treatment in patients with advanced breast cancer. Invest New Drugs  25, 545-51.   https://doi.org/10.1007/s10637-007-9055-6




PubMed


 


PubMed ID 17563856
    
     


 



4.
Korde LA, Lusa L, McShane L, Lebowitz PF, Lukes L, Camphausen K, Parker JS, Swain SM, Hunter K, Zujewski JA (2010). Gene expression pathway analysis to predict response   to neoadjuvant docetaxel and capecitabine for breast cancer. Breast Cancer Res Treat  119, 685-99.   https://doi.org/10.1007/s10549-009-0651-3




PubMed



        
     
Free Article


 


PubMed ID 20012355
         Pubmed Central ID 5892182 


 



5.
Portera CC, Swain SM (2007). The heart of the matter. J Clin Oncol  25, 3794-6.   https://doi.org/10.1200/JCO.2007.11.9537




PubMed


 


PubMed ID 17664459
    
     


 



6.
Thukral A, Thomasson DM, Chow CK, Eulate R, Wedam SB, Gupta SN, Wise BJ, Steinberg SM, Liewehr DJ, Choyke PL, Swain SM (2007). Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab--initial experience. Radiology  244, 727-35.   https://doi.org/10.1148/radiol.2443060926




PubMed


 


PubMed ID 17709827
    
     


 



7.
Walshe JM, Berman AW, Vatas U, Steinberg SM, Anderson WF, Lippman ME, Swain SM (2007). A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up. Breast Cancer Res Treat  103, 177-83.   https://doi.org/10.1007/s10549-006-9363-0




PubMed


 


PubMed ID 17039267
    
     


 



8.
Yang SX, Hewitt SM, Steinberg SM, Liewehr DJ, Swain SM (2007). Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray. Oncol Rep  17, 281-7.




PubMed


 


PubMed ID 17203162
    
     


 



9.
Yang SX, Steinberg SM, Nguyen D, Wu TD, Modrusan Z, Swain SM (2008). Gene expression profile and angiogenic marker correlates with response to neoadjuvant bevacizumab followed by bevacizumab plus chemotherapy in breast cancer. Clin Cancer Res  14, 5893-9.   https://doi.org/10.1158/1078-0432.CCR-07-4762




PubMed



        
     
Free Article


 


PubMed ID 18794102
         Pubmed Central ID 2587275",https://intramural.nih.gov/search/searchview.taf?ipid=45458
259,BC010561-04,"October 01, 2006 -  September 30, 2007",Transcription factor mobility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI","Timothy J Stasevich



Tatiana  Karpova



Min Jeong Kim



Florian  Mueller","David  Auble
(Univ. Virginia)




Paul  Wach
(Biophysics, Graz University of Technology)",Charles  Vinson; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Braga J, McNally JG, Carmo-Fonseca M (2007). A reaction-diffusion model to study RNA motion by quantitative fluorescence recovery after photobleaching. Biophys J  92, 2694-703.   https://doi.org/10.1529/biophysj.106.096693




PubMed



        
     
Free Article


 


PubMed ID 17259280
         Pubmed Central ID 1831683",https://intramural.nih.gov/search/searchview.taf?ipid=45496
260,BC010562-04,"October 01, 2006 -  September 30, 2007",Molecular Interaction Maps and Analysis of Bioregulatory Networks,"Mirit I Aladjem; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,Yves  Pommier; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45472
261,BC010563-04,"October 01, 2006 -  September 30, 2007",Modulating T cell tolerance to elicit tumor immunity and autoimmunity,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI","Vinod  Singh




Terri L Stull




Jami D Willette brown




Thomas Y Wuest","Vincenzo  Bronte





Protul  Shrikant
(Department of Immunology, Roswell Park Cancer Institute)","Lionel  Feigenbaum (Office Of The Director)



Scott K Durum; PhD (National Cancer Institute)



Joost J Oppenheim; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Shafer-Weaver KA, Watkins SK, Anderson MJ, Draper LJ, Malyguine A, Alvord WG, Greenberg NM, Hurwitz AA (2009). Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells. Cancer Res  69, 6256-64.   https://doi.org/10.1158/0008-5472.CAN-08-4516




PubMed



        
     
Free Article


 


PubMed ID 19622771
         Pubmed Central ID 2732120 


 



2.
Singh V, Ji Q, Feigenbaum L, Leighty RM, Hurwitz AA (2009). Melanoma progression despite infiltration by in vivo-primed TRP-2-specific T cells. J Immunother  32, 129-39.   https://doi.org/10.1097/CJI.0b013e31819144d7




PubMed



        
     
Free Article


 


PubMed ID 19238011
         Pubmed Central ID 2648128",https://intramural.nih.gov/search/searchview.taf?ipid=45482
262,BC010564-04,"October 01, 2006 -  September 30, 2007",Large Scale Chromatin Structure,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Hillary  Mueller,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Müller WG, Rieder D, Karpova TS, John S, Trajanoski Z, McNally JG (2007). Organization of chromatin and histone modifications at a transcription site. J Cell Biol  177, 957-67.   https://doi.org/10.1083/jcb.200703157




PubMed



        
     
Free Article


 


PubMed ID 17576795
         Pubmed Central ID 2064357",https://intramural.nih.gov/search/searchview.taf?ipid=45497
263,BC010565-04,"October 01, 2006 -  September 30, 2007",Determinants of Melanocyte Transformation and Melanoma Progression,Thomas J Hornyak,NULL,"Dermatology Branch, NCI","Tao  Fan



Shunlin  Jiang",NULL,"Leonard  Neckers; PhD (National Cancer Institute)



Jane Beth Trepel (Medical Oncology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45480
264,BC010566-04,"October 01, 2006 -  September 30, 2007",Tumor and Metastasis Biology,Chand  Khanna; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Tanasa S Osborne



Joseph  Briggs



Lauren E Buquo



Anita C Epps



Ling  Ren



Sung-Hyeok  Hong



Show all 7","Tim  Veenstra
(Laboratory of Systems Biology, SAIC Frederick)
















Mark  Berryman
(Department of Biomedical Sciences, Ohio University College of Osteopathic Medicine)




Matthew  Breen; PhD
(Veterinary Medicine, North Carolina State University)




Anthony  Bretscher
(Cell Biology, Cornell University)




Richard  Gorlick
(Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)




Timothy  Green
(Preclinical, AstraZeneca)


Show all 12","Allan M Weissman; MD (National Cancer Institute)



Patricia  Steeg; PhD (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)



Jeffrey E Green; MD (National Cancer Institute)



Nancy H Colburn; PhD (National Cancer Institute)



Joseph John Barchi (National Cancer Institute)",Rocky S Tuan; PhD (NIAMS),"Ordered by publication type and then author name.



1.
Bruce B, Khanna G, Ren L, Landberg G, Jirström K, Powell C, Borczuk A, Keller ET, Wojno KJ, Meltzer P, Baird K, McClatchey A, Bretscher A, Hewitt SM, Khanna C (2007). Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis  24, 69-78.   https://doi.org/10.1007/s10585-006-9050-x




PubMed


 


PubMed ID 17370041
    
     


 



2.
Gordon N, Koshkina NV, Jia SF, Khanna C, Mendoza A, Worth LL, Kleinerman ES (2007). Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine. Clin Cancer Res  13, 4503-10.   https://doi.org/10.1158/1078-0432.CCR-07-0313




PubMed



        
     
Free Article


 


PubMed ID 17671136
         Pubmed Central ID 4503209 


 



3.
Merchant MS, Melchionda F, Sinha M, Khanna C, Helman L, Mackall CL (2007). Immune reconstitution prevents metastatic recurrence of murine osteosarcoma. Cancer Immunol Immunother  56, 1037-46.   https://doi.org/10.1007/s00262-006-0257-0




PubMed


 


PubMed ID 17149595
    
     


 



4.
Merlino G, Khanna C (2007). Fishing for the origins of cancer. Genes Dev  21, 1275-9.   https://doi.org/10.1101/gad.1563707




PubMed


 


PubMed ID 17545462
    
     


 



5.
Werner S, Mendoza A, Hilger RA, Erlacher M, Reichardt W, Lissat A, Konanz C, Uhl M, Niemeyer CM, Khanna C, Kontny U (2008). Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma. Cancer Chemother Pharmacol  62, 19-31.   https://doi.org/10.1007/s00280-007-0566-9




PubMed


 


PubMed ID 17823799
    
     


 



6.
Whiteford CC, Bilke S, Greer BT, Chen Q, Braunschweig TA, Cenacchi N, Wei JS, Smith MA, Houghton P, Morton C, Reynolds CP, Lock R, Gorlick R, Khanna C, Thiele CJ, Takikita M, Catchpoole D, Hewitt SM, Khan J (2007). Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis. Cancer Res  67, 32-40.   https://doi.org/10.1158/0008-5472.CAN-06-0610




PubMed


 


PubMed ID 17210681",https://intramural.nih.gov/search/searchview.taf?ipid=45492
265,BC010569-04,"October 01, 2006 -  September 30, 2007",Comparative Oncology Program,Chand  Khanna; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Tanasa S Osborne



Christina  Mazcko



Melissa C Paoloni



Anita C Epps","Tim  Veenstra
(Laboratory of Systems Biology, SAIC Frederick)
















Lisa  Barber
(Veterinary Medicine, Tufts University)




Philip  Bergman
(Veterinary Medicine, The Animal Medical Center)




Matthew  Breen; PhD
(Veterinary Medicine, North Carolina State University)




Kenine  Comstock
(Cancer Center, Univeristy of MIchigan)




Timothy  Fan
(Veterinary Clinical Medicine, University of Illinois)


Show all 23","Howard A Fine; MD, PhD (National Cancer Institute)



Caryn  Steakley; BA, BSN, MSW (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)



Stephen M Hewitt; MD, PhD (National Cancer Institute)



Paul S Meltzer; MD, PhD (National Cancer Institute)












Daryl  Brooks  (Pharmaceutical Management Branch)",NULL,"Ordered by publication type and then author name.



1.
Khanna C, Khanna C (2007) Clinical Trial Design and Access, in Kirk's Current Veterinary Therapy. Elsevier, in press.




 



2.
Khanna C, Khanna C (2007) Clinical Trial Design and Access, in Small Animal Oncology. Elsevier, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45493
266,BC010571-04,"October 01, 2006 -  September 30, 2007",Fluorescence Imaging Facility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Tatiana  Karpova,NULL,NULL,"Mary C Dasso; BA, PhD (NICHD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45495
267,BC010572-04,"October 01, 2006 -  September 30, 2007",Thyroid NodulesCancer and Radiation,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,"Charles E. Land; PhD (National Cancer Institute)



Alice  Sigurdson; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45457
268,BC010575-04,"October 01, 2006 -  September 30, 2007",Identification of New Markers for Ovarian Cancer,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Linda S Wrathall



Vladmir Alexander Valera Romero; MD, PhD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Stegmann BJ, Sinaii N, Liu S, Segars J, Merino M, Nieman LK, Stratton P (2008). Using location, color, size, and depth to characterize and identify endometriosis lesions in a cohort of 133 women. Fertil Steril  89, 1632-6.   https://doi.org/10.1016/j.fertnstert.2007.05.042




PubMed



        
     
Free Article


 


PubMed ID 17662280
         Pubmed Central ID 2505050",https://intramural.nih.gov/search/searchview.taf?ipid=45498
269,BC010578-04,"October 01, 2006 -  September 30, 2007",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Steven  Seaman



Amit Madhulal Chaudhary",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45183
270,BC010579-04,"October 01, 2006 -  September 30, 2007",Papillomavirus Virion Proteins and Vaccines,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Alex  Papageorge



William C Vass","Joel  Palefsky
(Department of Medicine, University of California at San Francisco)




Richard  Roden
(Department of Pathology, Johns Hopkins School of Medicine)","John  Schiller; PhD (National Cancer Institute)



Lauren V Wood; MD (National Cancer Institute)



Allan  Hildesheim; PhD (National Cancer Institute)



Ligia  Pinto (Infection & Immunoepidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Day PM, Thompson CD, Buck CB, Pang YY, Lowy DR, Schiller JT (2007). Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol  81, 8784-92.   https://doi.org/10.1128/JVI.00552-07




PubMed



        
     
Free Article


 


PubMed ID 17553881
         Pubmed Central ID 1951340 


 



2.
García-Piñeres A, Hildesheim A, Dodd L, Kemp TJ, Williams M, Harro C, Lowy DR, Schiller JT, Pinto LA (2007). Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 Virus-like particles. Clin Vaccine Immunol  14, 984-9.   https://doi.org/10.1128/CVI.00090-07




PubMed



        
     
Free Article


 


PubMed ID 17596432
         Pubmed Central ID 2044489 


 



3.
Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, Schiller JT, Gonzalez P, Dubin G, Porras C, Jimenez SE, Lowy DR, Costa Rican HPV Vaccine Trial Group (2007). Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA  298, 743-53.   https://doi.org/10.1001/jama.298.7.743




PubMed


 


PubMed ID 17699008
    
     


 



4.
Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, Lowy DR, Schiller JT (2007). Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med  13, 857-61.   https://doi.org/10.1038/nm1598




PubMed


 


PubMed ID 17603495
    
     


 



5.
Roberts J, Lowy D, Schiller J (submitted in 2007) Papilloma Pseudovirus For Detection And Therapy Of Tumors. Patents issued: 8,394,411 (US in 2013); 8,999,290 (US in 2015); 2008251615 (AU in 2015); 2145189 (BE in 2016); 2145189 (BG in 2016); 2145189 (CH in 2016); 2145189 (CY in 2016); 2145189 (CZ in 2016); 602008043324 (DE in 2016); 2145189 (DK in 2016); 2145189 (EE in 2016); 2145189 (EP in 2016); 2145189 (ES in 2016); 2145189 (FI in 2016); 2145189 (FR in 2016); 2145189 (GB in 2016); 2145189 (GR in 2016); 2145189 (cr in 2016); 2145189 (HU in 2016); 2145189 (IE in 2016); 2145189 (IS in 2016); 2145189 (IT in 2016); 2145189 (LT in 2016); 2145189 (LU in 2016); 2145189 (LV in 2016); 2145189 (MC in 2016); 2145189 (MT in 2016); 2145189 (NL in 2016); 2145189 (NO in 2016); 2145189 (PL in 2016); 2145189 (PT in 2016); 2145189 (RO in 2016); 2145189 (SE in 2016); 2145189 (SI in 2016); 2145189 (SK in 2016); 2145189 (TR in 2016); 788363 (AT in 2016). Patents pending: 14/558,301 (US application); 2,686,990 (CA application); PCT/US2008/062296 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45494
271,BC010580-04,"October 01, 2006 -  September 30, 2007",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent,NULL,"Frank M Balis; MD, PhD (National Cancer Institute)



Paul Stuart Albert (National Cancer Institute)



Pamela  Wolters (National Cancer Institute)","John Anthony Butman; MD, PhD (CC)","Ordered by publication type and then author name.



1.
Hayward RM, Patronas N, Baker EH, Vézina G, Albert PS, Warren KE (2008). Inter-observer variability in the measurement of diffuse intrinsic pontine gliomas. J Neurooncol  90, 57-61.   https://doi.org/10.1007/s11060-008-9631-4




PubMed



        
     
Free Article


 


PubMed ID 18587536
         Pubmed Central ID 2600617",https://intramural.nih.gov/search/searchview.taf?ipid=45466
272,BC010581-04,"October 01, 2006 -  September 30, 2007",1H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Laurie  Steffen,NULL,"Frank M Balis; MD, PhD (National Cancer Institute)



Paul Stuart Albert (National Cancer Institute)



Pamela  Wolters (National Cancer Institute)",Nicholas  Patronas; MD (CC),"Ordered by publication type and then author name.



1.
Steffen-Smith EA, Baker EH, Venzon D, Shandilya S, Bent RS, Warren KE (2014). Measurements of the pons as a biomarker of progression for pediatric DIPG. J Neurooncol  116, 127-33.   https://doi.org/10.1007/s11060-013-1266-4




PubMed



        
     
Free Article


 


PubMed ID 24113877
         Pubmed Central ID 6301003",https://intramural.nih.gov/search/searchview.taf?ipid=45467
273,BC010582-04,"October 01, 2006 -  September 30, 2007",A Comparative Study of Pediatric CNS Tumor Activity as Assessed by18F-- FDG PET,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Laurie  Steffen,NULL,NULL,"John Anthony Butman; MD, PhD (CC) 



Nicholas  Patronas; MD (CC) 



Peter  Herscovitch; MD (CC)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45468
274,BC010583-04,"October 01, 2006 -  September 30, 2007",Phase I Trial and Pharmacokinetic Study of Temozolomide and O6-Benzylguanine in,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,"Frank M Balis; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Meany HJ, Warren KE, Fox E, Cole DE, Aikin AA, Balis FM (2009). Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors. Cancer Chemother Pharmacol  65, 137-42.   https://doi.org/10.1007/s00280-009-1015-8




PubMed



        
     
Free Article


 


PubMed ID 19430790
         Pubmed Central ID 6301000",https://intramural.nih.gov/search/searchview.taf?ipid=45465
275,BC010584-04,"October 01, 2006 -  September 30, 2007",A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatri,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Laurie  Steffen



Robyn S Bent",NULL,NULL,"Joseph A Frank; MD, MS (CC)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45556
276,BC010585-04,"October 01, 2006 -  September 30, 2007",A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent o,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent,"Susan  Blaney
(Ped Onc, Baylor University/TCCC)




Stewart  Goldman
(Pediatric Oncology, Children's Memorial Hospital)




Larry  Kun
(Radiation Oncology, St. Jude Children's Research Hospital)




Roger  Packer
(Neurology, CNMC)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45555
277,BC010586-04,"October 01, 2006 -  September 30, 2007",Evaluation of the Natural History of Patients with Tumors of the Central Nervous,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent,NULL,Kevin A Camphausen; MD (National Cancer Institute),Russell R Lonser; MD (NINDS),"Ordered by publication type and then author name.



1.
Baugh J, Bartels U, Leach J, Jones B, Chaney B, Warren KE, Kirkendall J, Doughman R, Hawkins C, Miles L, Fuller C, Hassall T, Bouffet E, Lane A, Hargrave D, Grill J, Hoffman LM, Jones C, Towbin A, Savage SA, Monje M, Li XN, Ziegler DS, Veldhuijzen van Zanten S, Kramm CM, et al. [2 more authors] (2017). The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease. J Neurooncol  132, 323-331.   https://doi.org/10.1007/s11060-017-2372-5




PubMed



        
     
Free Article


 


PubMed ID 28093680
         Pubmed Central ID 6343830 


 



2.
Fangusaro J, Warren KE (2013). Unclear standard of care for pediatric high grade glioma patients. J Neurooncol  113, 341-2.   https://doi.org/10.1007/s11060-013-1104-8




PubMed



        
     
Free Article


 


PubMed ID 23471572
         Pubmed Central ID 6343828 


 



3.
Morales La Madrid A, Ranjan S, Warren KE (2018). Gliomatosis cerebri: a consensus summary report from the Second International Gliomatosis cerebri Group Meeting, June 22-23, 2017, Bethesda, USA. J Neurooncol  140, 1-4.   https://doi.org/10.1007/s11060-018-2938-x




PubMed



        
     
Free Article


 


PubMed ID 29998396
         Pubmed Central ID 6301002",https://intramural.nih.gov/search/searchview.taf?ipid=45464
278,BC010589-04,"October 01, 2006 -  September 30, 2007",Imaging characteristics of Diffuse Pontine Gliomas after Radiation Therapy,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Laurie  Steffen



Robyn S Bent",NULL,NULL,"John Anthony Butman; MD, PhD (CC) 



Joseph A Frank; MD, MS (CC) 



Eva Halle Baker; MD, PhD (CC)","Ordered by publication type and then author name.



1.
Baugh J, Bartels U, Leach J, Jones B, Chaney B, Warren KE, Kirkendall J, Doughman R, Hawkins C, Miles L, Fuller C, Hassall T, Bouffet E, Lane A, Hargrave D, Grill J, Hoffman LM, Jones C, Towbin A, Savage SA, Monje M, Li XN, Ziegler DS, Veldhuijzen van Zanten S, Kramm CM, et al. [2 more authors] (2017). The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease. J Neurooncol  132, 323-331.   https://doi.org/10.1007/s11060-017-2372-5




PubMed



        
     
Free Article


 


PubMed ID 28093680
         Pubmed Central ID 6343830",https://intramural.nih.gov/search/searchview.taf?ipid=45462
279,BC010590-04,"October 01, 2006 -  September 30, 2007",Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with H,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent,"Susan  Blaney
(Ped Onc, Baylor University/TCCC)




Stewart  Goldman
(Pediatric Oncology, Children's Memorial Hospital)




Larry  Kun
(Radiation Oncology, St. Jude Children's Research Hospital)




Roger  Packer
(Neurology, CNMC)","Frank M Balis; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45463
280,BC010591-04,"October 01, 2006 -  September 30, 2007",Characterization of Xenograft Models of Childhood Cancers,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Jun S Wei



Young K Song



Patricia S Tsang; PhD",NULL,"Chand  Khanna; MD (Pediatric Oncology Br)



Malcolm A Smith (National Cancer Institute)



Carol J Thiele (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Whiteford CC, Bilke S, Greer BT, Chen Q, Braunschweig TA, Cenacchi N, Wei JS, Smith MA, Houghton P, Morton C, Reynolds CP, Lock R, Gorlick R, Khanna C, Thiele CJ, Takikita M, Catchpoole D, Hewitt SM, Khan J (2007). Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis. Cancer Res  67, 32-40.   https://doi.org/10.1158/0008-5472.CAN-06-0610




PubMed


 


PubMed ID 17210681",https://intramural.nih.gov/search/searchview.taf?ipid=45490
281,BC010592-04,"October 01, 2006 -  September 30, 2007",Comparative Genomic Hybridization of Neuroblastoma,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Jun S Wei,"John  Maris
(Pharmacology, Children's Hospital of Philadelphia)




Andrew  Pearson
(Paediatric Section, Institute of Cancer Research)




Manfred  Schwab
(Division Tumour Genetics, German Cancer Research Center)",NULL,NULL,"Ordered by publication type and then author name.



1.
Wei JS, Badgett TC, Khan J (2008). New Technologies for Diagnosing Pediatric Tumors Expert Opinion on Medical Diagnostics. Expert Opin Med Diagn  2, 1205-1219.   https://doi.org/10.1517/17530059.2.11.1205




PubMed



        
     
Free Article


 


PubMed ID 19554203
         Pubmed Central ID 2700769",https://intramural.nih.gov/search/searchview.taf?ipid=45491
282,BC010593-04,"October 01, 2006 -  September 30, 2007",Gene Expression Profiling of Normal Tissues,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Jun S Wei,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Chen QR, Vansant G, Oades K, Pickering M, Wei JS, Song YK, Monforte J, Khan J (2007). Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction. J Mol Diagn  9, 80-8.   https://doi.org/10.2353/jmoldx.2007.060111




PubMed



        
     
Free Article


 


PubMed ID 17251339
         Pubmed Central ID 1867426 


 



2.
Greer B, Khan J (2007). Online analysis of microarray data using artificial neural networks. Methods Mol Biol  377, 61-74.   https://doi.org/10.1007/978-1-59745-390-5_3




PubMed


 


PubMed ID 17634609
    
     


 



3.
Whiteford CC, Bilke S, Greer BT, Chen Q, Braunschweig TA, Cenacchi N, Wei JS, Smith MA, Houghton P, Morton C, Reynolds CP, Lock R, Gorlick R, Khanna C, Thiele CJ, Takikita M, Catchpoole D, Hewitt SM, Khan J (2007). Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis. Cancer Res  67, 32-40.   https://doi.org/10.1158/0008-5472.CAN-06-0610




PubMed


 


PubMed ID 17210681
    
     


 



4.
Gomez RD, Aschenbach KD, Fuhrer MD, Khan JD, Pandana HD, Wei JD (submitted in 2007) Apparatus For Microarray Binding Sensors Having Biological Probe Materials Using Carbon Nanotube Transistors. Patents issued: 8,017,938 (US in 2011); 5048752 (JP in 2012); 2007227415 (AU in 2013); 1999277 (DE in 2015); 2646465 (CA in 2015); 1999277 (EP in 2015); 1999277 (FR in 2015); 1999277 (GB in 2015); 1999277 (IE in 2015); 2570490 (DE in 2017); 2570490 (EP in 2017); 2570490 (FR in 2017); 2570490 (GB in 2017).",https://intramural.nih.gov/search/searchview.taf?ipid=45488
283,BC010594-04,"October 01, 2006 -  September 30, 2007",Molecular Mechanisms of Drugs,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Patricia S Tsang; PhD



Jun S Wei



Young K Song",NULL,Carol J Thiele (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Alabran JL, Cheuk A, Liby K, Sporn M, Khan J, Letterio J, Leskov KS (2008). Human neuroblastoma cells rapidly enter cell cycle arrest and apoptosis following exposure to C-28 derivatives of the synthetic triterpenoid CDDO. Cancer Biol Ther  7, 709-17.   https://doi.org/10.4161/cbt.7.5.5713




PubMed



        
     
Free Article


 


PubMed ID 18277094
         Pubmed Central ID 2727860 


 



2.
Gheeya J, Johansson P, Chen QR, Dexheimer T, Metaferia B, Song YK, Wei JS, He J, Pommier Y, Khan J (2010). Expression profiling identifies epoxy anthraquinone derivative as a DNA topoisomerase inhibitor. Cancer Lett  293, 124-31.   https://doi.org/10.1016/j.canlet.2010.01.004




PubMed



        
     
Free Article


 


PubMed ID 20133050
         Pubmed Central ID 4698332",https://intramural.nih.gov/search/searchview.taf?ipid=45489
284,BC010595-04,"October 01, 2006 -  September 30, 2007",Structure and Function of APOBEC Proteins,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Rebecca A Russell



Yeshitila  Friew



Jean L Mbisa



Patricia A Henry; PhD



Krista A Delviks-Frankenberry","Robert J. Gorelick; PhD
(AIDS and Cancer Virus Program, SAIC-Frederick, Inc.)





David  Ott
(SAIC-Frederick)





Dominic  Esposito
(Protein Expression Laboratory, SAIC-Frederick)
















Alan  Engelman; PhD
(Dana-Farber, Harvard University)




Reuben  Harris
(Biochemistry, University of Minnesota)




Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)


Show all 8","Eric O Freed; PhD (National Cancer Institute)



David  Derse; PhD (National Cancer Institute)



Elena  Chertova (National Cancer Institute)



William  Gillette (National Cancer Institute)



Alan  Rein; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Pathak V, Delviks-Frankenberry K, Thomas J, Gorelick R   (2007) Real-time PCR analysis of HIV-1 replication post-entry events., in HIV Protocols, 2nd Edition (V Prasad and G Kalpana, eds).  Humana Press, Inc., in press.




 



2.
Mbisa JL, Barr R, Thomas JA, Vandegraaff N, Dorweiler IJ, Svarovskaia ES, Brown WL, Mansky LM, Gorelick RJ, Harris RS, Engelman A, Pathak VK (2007). Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J Virol  81, 7099-110.   https://doi.org/10.1128/JVI.00272-07




PubMed



        
     
Free Article


 


PubMed ID 17428871
         Pubmed Central ID 1933301 


 



3.
Russell RA, Pathak VK (2007). Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F. J Virol  81, 8201-10.   https://doi.org/10.1128/JVI.00395-07




PubMed



        
     
Free Article


 


PubMed ID 17522216
         Pubmed Central ID 1951317 


 



4.
Xu H, Chertova E, Chen J, Ott DE, Roser JD, Hu WS, Pathak VK (2007). Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions. Virology  360, 247-56.   https://doi.org/10.1016/j.virol.2006.10.036




PubMed


 


PubMed ID 17126871",https://intramural.nih.gov/search/searchview.taf?ipid=45500
285,BC010596-04,"October 01, 2006 -  September 30, 2007",Pediatric Graft-vs-Host Disease,Alan S Wayne; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Cynthia P Love



Kristin  Baird",NULL,"Michael R Bishop; MD (National Cancer Institute)



Steven  Pavletic; MD, MS (National Cancer Institute)



Terry J Fry (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Frances  Hakim; PhD (National Cancer Institute)



Daniel H Fowler (National Cancer Institute)","Austin John Barrett; MD (NHLBI) 



Charles  Bolan; BS, MS, MD (CC) 



Susan  Leitman; MD (CC) 



Harry Lewis Malech; MD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45469
286,BC010598-04,"October 01, 2006 -  September 30, 2007",Development of Novel Vaccine Strategies,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Diana G Chambers



Debra L Weingarten



Robin E Riley



Garland M Davis



Judith M Dipietro



James W Hodge; PhD



Show all 18","Tyler  Curiel
(Medical Oncology, University of Texas Health Science Center)




Alex  Franzusoff
(Research and Development, GlobeImmune)




Stephen D Hursting; PhD, MPH
(Epidemiology and Carcinogenesis, NCI)




Howard  Kaufman
(Surgical Oncology, Columbia University College of Physicians and Surgeons)




Jacques  Neefjes
(Division of Tumor Biology, The Netherlands Cancer Institute)




Silvia  Vidal
(Immunology, Institut Recerca Hospital Sant Pau)","Yutaka  Tagaya; MD, PhD (National Cancer Institute)



Marta Liliana Catalfamo; PhD (Lymphocyte Cytotoxicity Section)","Roshanak  Tolouei Semnani; PhD (NIAID) 



J Silvio  Gutkind; PhD (NIDCR)","Ordered by publication type and then author name.



1.
Chakraborty M, Schlom J, Hodge JW (2007). The combined activation of positive costimulatory signals with modulation of a negative costimulatory signal for the enhancement of vaccine-mediated T-cell responses. Cancer Immunol Immunother  56, 1471-84.   https://doi.org/10.1007/s00262-007-0291-6




PubMed


 


PubMed ID 17318654
    
     


 



2.
Kudo-Saito C, Garnett CT, Wansley EK, Schlom J, Hodge JW (2007). Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T cell avidity and anti-tumor activity. Cancer Immunol Immunother  56, 1897-910.   https://doi.org/10.1007/s00262-007-0332-1




PubMed


 


PubMed ID 17503041
    
     


 



3.
Kudo-Saito C, Wansley EK, Gruys ME, Wiltrout R, Schlom J, Hodge JW (2007). Combination therapy of an orthotopic renal cell carcinoma model using intratumoral vector-mediated costimulation and systemic interleukin-2. Clin Cancer Res  13, 1936-46.   https://doi.org/10.1158/1078-0432.CCR-06-2398




PubMed


 


PubMed ID 17363550
    
     


 



4.
Litzinger MT, Fernando R, Curiel TJ, Grosenbach DW, Schlom J, Palena C (2007). IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity. Blood  110, 3192-201.   https://doi.org/10.1182/blood-2007-06-094615




PubMed



        
     
Free Article


 


PubMed ID 17616639
         Pubmed Central ID 2200901 


 



5.
Mostböck S, Catalfamo M, Tagaya Y, Schlom J, Sabzevari H (2007). Acquisition of antigen presentasome (APS), an MHC/costimulatory complex, is a checkpoint of memory T-cell homeostasis. Blood  109, 2488-95.   https://doi.org/10.1182/blood-2006-09-047290




PubMed



        
     
Free Article


 


PubMed ID 17105811
         Pubmed Central ID 1852200 


 



6.
Schlom J, Arlen PM, Gulley JL (2007). Cancer vaccines: moving beyond current paradigms. Clin Cancer Res  13, 3776-82.   https://doi.org/10.1158/1078-0432.CCR-07-0588




PubMed



        
     
Free Article


 


PubMed ID 17606707
         Pubmed Central ID 2536755 


 



7.
Schlom J, Vidal S, Sabzevari H   (2007) Enhanced levels of costimulation lead to reduced effector/memory CD8+ T cell functionality.  J. Immunol, in press.




 



8.
Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW (2007). Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine  25, 2085-94.   https://doi.org/10.1016/j.vaccine.2006.11.034




PubMed



        
     
Free Article


 


PubMed ID 17258843
         Pubmed Central ID 1890043 


 



9.
Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW (2007). Chitosan solution enhances the immunoadjuvant properties of GM-CSF. Vaccine  25, 8673-86.   https://doi.org/10.1016/j.vaccine.2007.10.037




PubMed



        
     
Free Article


 


PubMed ID 18037196
         Pubmed Central ID 2532845",https://intramural.nih.gov/search/searchview.taf?ipid=45179
287,BC010599-04,"October 01, 2006 -  September 30, 2007",Mechanisms of Transcriptional Repression by Histone Deacetylase Inhibitors,Catharine L Smith; PhD,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,Carol J Thiele (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45180
288,BC010600-04,"October 01, 2006 -  September 30, 2007",Study of AAA proteins by X-ray protein crystallography,"Di S Xia; PhD, MS, BS



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Lothar  Esser



Wai-Kwan  Tang",NULL,Michael  Maurizi; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45471
289,BC010603-04,"October 01, 2006 -  September 30, 2007",Receptor -directed therapy,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI","Arlethia J Spencer



Diana  O'Hagan



Leslie S Moses



Cathryn C Lee



Deirdre  O'Mahony



Kamal  Sharma



Show all 8",NULL,"John N Brady; PhD (National Cancer Institute)



Jane Beth Trepel (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Zhang M, Yao Z, Patel H, Garmestani K, Zhang Z, Talanov VS, Plascjak PS, Goldman CK, Janik JE, Brechbiel MW, Waldmann TA (2007). Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1. Proc Natl Acad Sci U S A  104, 8444-8.   https://doi.org/10.1073/pnas.0702496104




PubMed



        
     
Free Article


 


PubMed ID 17488826
         Pubmed Central ID 1895969",https://intramural.nih.gov/search/searchview.taf?ipid=45483
290,BC010604-04,"October 01, 2006 -  September 30, 2007",Epigenetic Studies of Gastro-Intestinal Cancers,Karen  Woodson,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,"Sanford Martin Dawsey; MD (National Cancer Institute)



Christian Cormac Abnet; PhD, MPH (National Cancer Institute)



Mark J Roth (National Cancer Institute)



Philip  Taylor; MD, ScD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45470
291,BC010607-04,"October 01, 2006 -  September 30, 2007",Ras-mediated signals in human epithelial cell transformation and metastasis,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Ivy (Juan Juan)  Yin



Michael David Oberst



Claire  Pollock



Kirsten  Tracy



Orla Majella Casey



Beth Marion Toste",NULL,"Glenn  Merlino; PhD (National Cancer Institute)



Louis  Staudt; MD (Metabolism Br)",Alan Paul Koretsky; PhD (NINDS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45487
292,BC010608-03,"October 01, 2006 -  September 30, 2007",CCR RNAi Initiative: Overview,Natasha  Caplen,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD



Scott E Martin



Tamara L Jones",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Martin SE, Caplen NJ (2007). Applications of RNA interference in mammalian systems. Annu Rev Genomics Hum Genet  8, 81-108.   https://doi.org/10.1146/annurev.genom.8.080706.092424




PubMed


 


PubMed ID 17477824
    
     


 



2.
Martin SE, Jones TL, Thomas CL, Lorenzi PL, Nguyen DA, Runfola T, Gunsior M, Weinstein JN, Goldsmith PK, Lader E, Huppi K, Caplen NJ (2007). Multiplexing siRNAs to compress RNAi-based screen size in human cells. Nucleic Acids Res  35, e57.   https://doi.org/10.1093/nar/gkm141




PubMed



        
     
Free Article


 


PubMed ID 17392344
         Pubmed Central ID 1885663",https://intramural.nih.gov/search/searchview.taf?ipid=45513
293,BC010609-03,"October 01, 2006 -  September 30, 2007",RNAi Analysis of the ATP-binding Cassette (ABC) Family of Proteins,Natasha  Caplen,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Scott E Martin,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Martin SE, Caplen NJ (2007). Applications of RNA interference in mammalian systems. Annu Rev Genomics Hum Genet  8, 81-108.   https://doi.org/10.1146/annurev.genom.8.080706.092424




PubMed


 


PubMed ID 17477824
    
     


 



2.
Martin SE, Jones TL, Thomas CL, Lorenzi PL, Nguyen DA, Runfola T, Gunsior M, Weinstein JN, Goldsmith PK, Lader E, Huppi K, Caplen NJ (2007). Multiplexing siRNAs to compress RNAi-based screen size in human cells. Nucleic Acids Res  35, e57.   https://doi.org/10.1093/nar/gkm141




PubMed



        
     
Free Article


 


PubMed ID 17392344
         Pubmed Central ID 1885663",https://intramural.nih.gov/search/searchview.taf?ipid=45514
294,BC010612-03,"October 01, 2006 -  September 30, 2007",The Role of MicroRNAs in the Regulation of Gene Expression,Natasha  Caplen,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD



Mark  Mackiewicz



Brady  Wahlberg",NULL,"J. Frederic Mushinski; MD (National Cancer Institute)



Robert H Stephens (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Huppi K, Volfovsky N, Mackiewicz M, Runfola T, Jones TL, Martin SE, Stephens R, Caplen NJ (2007). MicroRNAs and genomic instability. Semin Cancer Biol  17, 65-73.   https://doi.org/10.1016/j.semcancer.2006.10.004




PubMed



        
     
Free Article


 


PubMed ID 17113784
         Pubmed Central ID 1839944",https://intramural.nih.gov/search/searchview.taf?ipid=45516
295,BC010613-03,"October 01, 2006 -  September 30, 2007",CCR RNAi Initiative: Validation of siRNAs Against Cancer-Associated Genes,Natasha  Caplen,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD



Scott E Martin



Tamara L Jones",NULL,Paul  Goldsmith; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Martin SE, Caplen NJ (2007). Applications of RNA interference in mammalian systems. Annu Rev Genomics Hum Genet  8, 81-108.   https://doi.org/10.1146/annurev.genom.8.080706.092424




PubMed


 


PubMed ID 17477824
    
     


 



2.
Martin SE, Jones TL, Thomas CL, Lorenzi PL, Nguyen DA, Runfola T, Gunsior M, Weinstein JN, Goldsmith PK, Lader E, Huppi K, Caplen NJ (2007). Multiplexing siRNAs to compress RNAi-based screen size in human cells. Nucleic Acids Res  35, e57.   https://doi.org/10.1093/nar/gkm141




PubMed



        
     
Free Article


 


PubMed ID 17392344
         Pubmed Central ID 1885663",https://intramural.nih.gov/search/searchview.taf?ipid=45517
296,BC010614-03,"October 01, 2006 -  September 30, 2007",CCR RNAi Initiative: Establishment of shRNA RNAi Library Screens,Natasha  Caplen,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45518
297,BC010615-03,"October 01, 2006 -  September 30, 2007",CCR RNAi Initiative: Technology and Assay Development,Natasha  Caplen,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD



Scott E Martin



Tamara L Jones",NULL,"Karl Thomas Ried; MD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Paul  Goldsmith; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45519
298,BC010620-04,"October 01, 2006 -  September 30, 2007",Clinical Studies of Multidrug Resistance Reversal,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Robert W Robey



Zhirong  Zhan



Richard Lawrence Piekarz","Thomas  Litman
(BioInformatics, University of Copenhagen)




Thomas  Litman
(BioInformatics, University of Copenhagen)




Wilfred  Stein
(Biological Chemistry, Silberman Institute of Life Sciences, Hebrew University of Jerusalem)","William D Figg; PharmD (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)","Clara Chi Chen; MD (CC) 



Robert  Innis; MD (NIMH)","Ordered by publication type and then author name.



1.
Deeken JF, Figg WD, Bates SE, Sparreboom A (2007). Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics. Anticancer Drugs  18, 111-26.   https://doi.org/10.1097/CAD.0b013e3280109411




PubMed


 


PubMed ID 17159598
    
     


 



2.
Fox E, Bates SE (2007). Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor. Expert Rev Anticancer Ther  7, 447-59.   https://doi.org/10.1586/14737140.7.4.447




PubMed


 


PubMed ID 17428165
    
     


 



3.
Stein WD, Litman T, Fojo T, Bates SE (2007). A database study that identifies genes whose expression correlates, negatively or positively, with 5-year survival of cancer patients. Biochim Biophys Acta  1770, 857-71.   https://doi.org/10.1016/j.bbagen.2006.12.013




PubMed


 


PubMed ID 17398010",https://intramural.nih.gov/search/searchview.taf?ipid=45475
299,BC010621-04,"October 01, 2006 -  September 30, 2007",II. Clinical and Laboratory Studies of the Histone Deacetylase Inhibitor Depsipe,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Robert W Robey



Zhirong  Zhan



Richard Lawrence Piekarz



Victoria  Luchenko",NULL,"William D Figg; PharmD (National Cancer Institute)



Elaine S Jaffe; MD (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)



Maria L Turner; MD (National Cancer Institute)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)","Douglas R Rosing; MD (NHLBI) 



April R Robbins; PhD (NIDDK) 



Danny L Sackett; PhD (NICHD) 



Alexander  Ling (CC)","Ordered by publication type and then author name.



1.
Bates SE, Piekarz RL (2007). Histone deacetylase inhibitors in combinations: will the preclinical promises be kept? Cancer J  13, 80-3.   https://doi.org/10.1097/PPO.0b013e318063bd9f




PubMed


 


PubMed ID 17476134
    
     


 



2.
Goldsmith ME, Aguila A, Steadman K, Martinez A, Steinberg SM, Alley MC, Waud WR, Bates SE, Fojo T (2007). The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems. Mol Cancer Ther  6, 496-505.   https://doi.org/10.1158/1535-7163.MCT-06-0431




PubMed


 


PubMed ID 17308048
    
     


 



3.
Piekarz RL, Sackett DL, Bates SE (2007). Histone deacetylase inhibitors and demethylating agents: clinical development of histone deacetylase inhibitors for cancer therapy. Cancer J  13, 30-9.   https://doi.org/10.1097/PPO.0b013e31803c73cc




PubMed


 


PubMed ID 17464244",https://intramural.nih.gov/search/searchview.taf?ipid=45473
300,BC010622-04,"October 01, 2006 -  September 30, 2007",III. Investigation of the ABC Half-Transporter ABCG2,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Robert W Robey



Zhirong  Zhan



Orsolya  Polgar



Kin Wah  To","Gary  Kruh; MD, PhD
(Medical Science Division, Fox Chase Cancer Center)




Thomas  Litman
(BioInformatics, University of Copenhagen)




Thomas  Litman
(BioInformatics, University of Copenhagen)




Balazs  Sarkadi
(Dept Cell Metabolism, National Insitute of Hematology and Immunology)




Alex  Sparreboom





Hendrik  van Veen
(Department of Pharmacology, University of Cambridge)","William D Figg; PharmD (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)



Andrea  Abati; BS, MD (National Cancer Institute)



Curtis  Henrich (National Cancer Institute)



Patricia A Fetsch (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Brendel C, Scharenberg C, Dohse M, Robey RW, Bates SE, Shukla S, Ambudkar SV, Wang Y, Wennemuth G, Burchert A, Boudriot U, Neubauer A (2007). Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells. Leukemia  21, 1267-75.   https://doi.org/10.1038/sj.leu.2404638




PubMed


 


PubMed ID 17519960
    
     


 



2.
Dai CL, Tiwari AK, Wu CP, Su XD, Wang SR, Liu DG, Ashby CR, Huang Y, Robey RW, Liang YJ, Chen LM, Shi CJ, Ambudkar SV, Chen ZS, Fu LW (2008). Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Cancer Res  68, 7905-14.   https://doi.org/10.1158/0008-5472.CAN-08-0499




PubMed



        
     
Free Article


 


PubMed ID 18829547
         Pubmed Central ID 2652245 


 



3.
Henrich CJ, Robey RW, Bokesch HR, Bates SE, Shukla S, Ambudkar SV, Dean M, McMahon JB (2007). New inhibitors of ABCG2 identified by high-throughput screening. Mol Cancer Ther  6, 3271-8.   https://doi.org/10.1158/1535-7163.MCT-07-0352




PubMed



        
     
Free Article


 


PubMed ID 18089721
         Pubmed Central ID 2760480 


 



4.
Li J, Cusatis G, Brahmer J, Sparreboom A, Robey RW, Bates SE, Hidalgo M, Baker SD (2007). Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients. Cancer Biol Ther  6, 432-8.   https://doi.org/10.4161/cbt.6.3.3763




PubMed


 


PubMed ID 17312388
    
     


 



5.
Li YF, Polgar O, Okada M, Esser L, Bates SE, Xia D (2007). Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: a molecular modeling study. J Mol Graph Model  25, 837-51.   https://doi.org/10.1016/j.jmgm.2006.08.005




PubMed


 


PubMed ID 17027309
    
     


 



6.
Robey RW, Polgar O, Deeken J, To KW, Bates SE (2007). ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev  26, 39-57.   https://doi.org/10.1007/s10555-007-9042-6




PubMed


 


PubMed ID 17323127
    
     


 



7.
Robey RW, Shukla S, Steadman K, Obrzut T, Finley EM, Ambudkar SV, Bates SE (2007). Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure. Mol Cancer Ther  6, 1877-85.   https://doi.org/10.1158/1535-7163.MCT-06-0811




PubMed


 


PubMed ID 17575116
    
     


 



8.
Telford WG, Bradford J, Godfrey W, Robey RW, Bates SE (2007). Side population analysis using a violet-excited cell-permeable DNA binding dye. Stem Cells  25, 1029-36.   https://doi.org/10.1634/stemcells.2006-0567




PubMed


 


PubMed ID 17185610
    
     


 



9.
Henrich C, Ambudkar S, Bates S, Bokesch H, Cartner L, Dean M, Fuller R, Gustafson K, McMahon J, Robey R, Shukla S, Takada K (submitted in 2007) Method Of Inhibiting Abcg2 And Other Treatment Methods. Patents issued: 8,470,888 (US in 2013); 9,314,448 (US in 2016). Patent pending: PCT/US2008/088446 (PC application).




 



10.
Henrich C, Ambudkar S, Bates S, Bokesch H, Dean M, McMahon J, Robey R, Shukla S (submitted in 2007) Method Of Inhibiting Abcg2 And Related Treatments. Patents issued: 9,114,102 (US in 2015); 9,937,217 (US in 2018). Patent pending: PCT/US2008/082414 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45474
301,BC010623-04,"October 01, 2006 -  September 30, 2007",The molecular recognition of proteins by antibodies: A model for rational design,"Sandra  Smith-Gill; MS, PhD, BS",NULL,"Structural Biophysics Laboratory, NCI","Claudia A Lipschultz



Mauro  Acchione



Morgan  Desantis","Roy  Mariuzza
(WM Keck Laboratory for Structural Biology, University of Maryland Biotechnology Institute)




Neeti  Sinha





Richard  Willson
(Chemical Engineering, University of Houston)","Joseph John Barchi (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Smith-Gill S, Li Y, Lipschultz C   (2007) Understanding antibody-antigen associations by molecular dynamics simulations: Detection of important intra- and inter-molecular salt bridges.  Cell Biochem Biophys  361-375 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=45181
302,BC010624-03,"October 01, 2006 -  September 30, 2007",The Molecular Profile of Prostate Tumors in African-American Men,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Tiffany Marie Howe



Tiffany A Wallace



Robert Scott Hudson","Carlo M Croce





Chris  Loffredo
(Cancer Genetics and Epidemiology Program, Georgetown University)","Neil Edward Caporaso; MS, MD (National Cancer Institute)



James Jerome Goedert; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, Yfantis HG, Stephens RM, Croce CM (2008). Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res  68, 6162-70.   https://doi.org/10.1158/0008-5472.CAN-08-0144




PubMed



        
     
Free Article


 


PubMed ID 18676839
         Pubmed Central ID 2597340 


 



2.
Ambs S, Croce C (submitted in 2007) Microrna-based Methods And Compositions For The Diagnosis, Pronosis And Treatment Of Prostate Related Disorders. Patents issued: ZL 2009-8011 (CN in 2014); 2009219197 (AU in 2014); 2799557 (EP in 2016). Patents pending: 09715064.3 (EP application); 16175539.2 (EP application); 2010-548904 (JP application); PCT/US2009/035470 (PC application); 12/919,888 (US application); 13/622,487 (US application); 15/062,404 (US application); 15/062,407 (US application); 15/062,411 (US application); 15/062,414 (US application); 2716938 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=45506
303,BC010625-04,"October 01, 2006 -  September 30, 2007",Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI","Marianne  Poruchynsky



Shana Y Trostel",NULL,"Yvona  Ward; PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)",Danny L Sackett; PhD (NICHD),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45477
304,BC010626-4,"October 01, 2006 -  September 30, 2007",Adrenocortical Cancer (ACC) and Thyroid Carcinomas: Models of Cancers with Uniqu,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",NULL,NULL,"Susan  Bates; MD (National Cancer Institute)



Richard Lawrence Piekarz (National Cancer Institute)",Bradford J Wood; MD (CC),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50243
305,BC010627-04,"October 01, 2006 -  September 30, 2007",Clinical Pharmacogenetics,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Tristan  Sissung



Douglas K Price



Akinobu  Hamada



Caitlin  Baum",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Figg W, Gardner E, Gao R (2007) Pharmacogenetics of Membrane Transporters: A Review of Current Approaches, in Molecular Techniques in Pharmacogenetics. Yu Q, ed, Humana Press (New Jersey), in press.




 



2.
Beverage JN, Sissung TM, Sion AM, Danesi R, Figg WD (2007). CYP2D6 polymorphisms and the impact on tamoxifen therapy. J Pharm Sci  96, 2224-31.   https://doi.org/10.1002/jps.20892




PubMed


 


PubMed ID 17518364
    
     


 



3.
Deeken JF, Figg WD, Bates SE, Sparreboom A (2007). Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics. Anticancer Drugs  18, 111-26.   https://doi.org/10.1097/CAD.0b013e3280109411




PubMed


 


PubMed ID 17159598
    
     


 



4.
Lal S, Wong ZW, Jada SR, Xiang X, Chen Shu X, Ang PC, Figg WD, Lee EJ, Chowbay B (2007). Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients. Pharmacogenomics  8, 567-75.   https://doi.org/10.2217/14622416.8.6.567




PubMed


 


PubMed ID 17559346
    
     


 



5.
Sharifi N, Dahut WL, Figg WD (2008). The genetics of castration-resistant prostate cancer: what can the germline tell us? Clin Cancer Res  14, 4691-3.   https://doi.org/10.1158/1078-0432.CCR-08-0453




PubMed



        
     
Free Article


 


PubMed ID 18676736
         Pubmed Central ID 2698703 


 



6.
Smith NF, Marsh S, Scott-Horton TJ, Hamada A, Mielke S, Mross K, Figg WD, Verweij J, McLeod HL, Sparreboom A (2007). Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics. Clin Pharmacol Ther  81, 76-82.   https://doi.org/10.1038/sj.clpt.6100011




PubMed


 


PubMed ID 17186002",https://intramural.nih.gov/search/searchview.taf?ipid=45476
306,BC010628-04,"October 01, 2006 -  September 30, 2007","Genomic, Transcriptional and Epigenetic Variation Due to Retrotransposition",David E Symer,NULL,"Mouse Cancer Genetics Program, NCI",NULL,"Jef  Boeke
(Molecular Biology and Genetics, Johns Hopkins University)




Jennifer  Doudna
(MCB and Chemistry, University of California, Berkeley)




Edith  Heard
(Research Section, Curie Institute)




Giovanni  Parmigiani
(The Sydney Kimmel Comprehensive Cancer Center)




Gerald  Schumann
(Federal Agency for Sera and Vaccines, Paul Ehrlich Institute)","Robert H Stephens (National Cancer Institute)



Keiko  Akagi (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Agrawal Y, Koch WM, Xiao W, Westra WH, Trivett AL, Symer DE, Gillison ML (2008). Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. Clin Cancer Res  14, 7143-50.   https://doi.org/10.1158/1078-0432.CCR-08-0498




PubMed



        
     
Free Article


 


PubMed ID 18981014
         Pubmed Central ID 2598779",https://intramural.nih.gov/search/searchview.taf?ipid=45459
307,BC010629-04,"October 01, 2006 -  September 30, 2007",Characterization of Signaling Pathways involved in Cell Death and Survival,Srinivasa M Srinivasula,NULL,"Laboratory of Immune Cell Biology, NCI","Wentao  Liao



Qi  Xiao



Zhiyong  Liao



Ken-Ichi  Fujita","Wafik  El-Deiry
(Department of Medicine, University of Pennsylvania)




Stefan  Schütze
(Universitatsklinikum Schleswig Holstein, Institut für Immunologie)","Susan H Garfield (National Cancer Institute)



Triantafyllos  Chavakis (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45182
308,BC010630-04,"October 01, 2006 -  September 30, 2007",Cancer Vaccines and Modulation of Checkpoint Controls in Immunization,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI","Arlethia J Spencer



Diana  O'Hagan



Leslie S Moses



Suzanne E Fioravanti



Guinevere Joy Ng Chun",NULL,"Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Louis  Staudt; MD (Lymphoid Malignancies Branch)",NULL,"Ordered by publication type and then author name.



1.
O'Mahony D, Morris JC, Quinn C, Gao W, Wilson WH, Gause B, Pittaluga S, Neelapu S, Brown M, Fleisher TA, Gulley JL, Schlom J, Nussenblatt R, Albert P, Davis TA, Lowy I, Petrus M, Waldmann TA, Janik JE (2007). A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy. Clin Cancer Res  13, 958-64.   https://doi.org/10.1158/1078-0432.CCR-06-1974




PubMed


 


PubMed ID 17289891",https://intramural.nih.gov/search/searchview.taf?ipid=45484
309,BC010631-04,"October 01, 2006 -  September 30, 2007",Characterization of candidate histone methyltransferases,David E Symer,NULL,"Mouse Cancer Genetics Program, NCI",Elizabeth K Flynn,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Van Duyne R, Easley R, Wu W, Berro R, Pedati C, Klase Z, Kehn-Hall K, Flynn EK, Symer DE, Kashanchi F (2008). Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR. Retrovirology  5, 40.   https://doi.org/10.1186/1742-4690-5-40




PubMed



        
     
Free Article


 


PubMed ID 18498648
         Pubmed Central ID 2412914",https://intramural.nih.gov/search/searchview.taf?ipid=45460
310,BC010632-04,"October 01, 2006 -  September 30, 2007",Transcription Machinery and Regulation in E. coli,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,Xinhua  Ji; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Norris V, den Blaauwen T, Cabin-Flaman A, Doi RH, Harshey R, Janniere L, Jimenez-Sanchez A, Jin DJ, Levin PA, Mileykovskaya E, Minsky A, Saier M, Skarstad K (2007). Functional taxonomy of bacterial hyperstructures. Microbiol Mol Biol Rev  71, 230-53.   https://doi.org/10.1128/MMBR.00035-06




PubMed



        
     
Free Article


 


PubMed ID 17347523
         Pubmed Central ID 1847379 


 



2.
Wickstrum JR, Skredenske JM, Kolin A, Jin DJ, Fang J, Egan SM (2007). Transcription activation by the DNA-binding domain of the AraC family protein RhaS in the absence of its effector-binding domain. J Bacteriol  189, 4984-93.   https://doi.org/10.1128/JB.00530-07




PubMed



        
     
Free Article


 


PubMed ID 17513476
         Pubmed Central ID 1951867",https://intramural.nih.gov/search/searchview.taf?ipid=45485
311,BC010633-04,"October 01, 2006 -  September 30, 2007",Transcription Regulation and Pathogenesis in H. pylori,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,NULL,William G Coleman; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Jin DJ, Mata Martin C, Sun Z, Cagliero C, Zhou YN (2017). Nucleolus-like compartmentalization of the transcription machinery in fast-growing bacterial cells. Crit Rev Biochem Mol Biol  52, 96-106.   https://doi.org/10.1080/10409238.2016.1269717




PubMed



        
     
Free Article


 


PubMed ID 28006965
         Pubmed Central ID 5575888",https://intramural.nih.gov/search/searchview.taf?ipid=45486
312,BC010638-04,"October 01, 2006 -  September 30, 2007",The role of c-met in liver biology,"Snorri S. Thorgeirsson; MD, PhD",Robert  Wiltrout; PhD,"Laboratory of Experimental Carcinogenesis, NCI","Timothy V Benjamin



Elizabeth A Conner



Anita  Ton



Tanya N Hoang



Joe W Grisham



Tsuyoshi  Ishikawa","Sanjoy  Das
(Pediatrics and Cancer Biology, Vanderbilt University Medical Center)




Anthony  Demetris
(Transplantation Pathology, University of Pittsburgh Medical Center)




Ju-Seog  Lee; PhD
(NCI)




Hiroyuki  Nakai
(Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine)




Enid  Neptune
(Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine)




Alexander  Nikitin
(Biomedical Sciences, Cornell University)


Show all 10","Valentina  Factor (Cellular and Molecular Biology Section)



Glenn  Merlino; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45461
313,BC010639-04,"October 01, 2006 -  September 30, 2007",In Silico Screening for Cancer Targets,Marc C Nicklaus,Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI","Igor V Filippov



Megan L Peach



Markus  Sitzmann



Iwona Elzbieta Weidlich



Chenzhong  Liao",NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)



Kyung  Lee; PhD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Stuart F J Le Grice; PhD (National Cancer Institute)



Peter  Blumberg; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bottaro DP, Burke TP, Choyke SP, Dharmawardana (athauda) PP, Giubellino AP, Nicklaus MP, Peach MP, Shi ZP, Tan NP (submitted in 2007) Compositions And Methods For Inhibition Of Hepatocyte Growth Factor Receptor C-met Signaling. Patents issued: 8,754,081 (US in 2014); 8,569,360 (US in 2014); 2009231841 (AU in 2014). Patents pending: 09727676.0 (EP application); 11106440.0 (HK application); PCT/US2009/038915 (PC application); 2720350 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=45499
314,BC010641-04,"October 01, 2006 -  September 30, 2007",Molecular Oncology,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",Maria  Zajac-Kaye; PhD,NULL,"Stanley  Lipkowitz; MD, PhD (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chen M, Voeller D, Marquez VE, Kaye FJ, Steeg PS, Giaccone G, Zajac-Kaye M (2010). Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A. Int J Oncol  37, 963-71.   https://doi.org/10.3892/ijo_00000747




PubMed



        
     
Free Article


 


PubMed ID 20811718
         Pubmed Central ID 6545580 


 



2.
Khan I, Steeg PS (2018). Metastasis suppressors: functional pathways. Lab Invest  98, 198-210.   https://doi.org/10.1038/labinvest.2017.104




PubMed



        
     
Free Article


 


PubMed ID 28967874
         Pubmed Central ID 6545599 


 



3.
Marino N, Marshall JC, Steeg PS (2011). Protein-protein interactions: a mechanism regulating the anti-metastatic properties of Nm23-H1. Naunyn Schmiedebergs Arch Pharmacol  384, 351-62.   https://doi.org/10.1007/s00210-011-0646-6




PubMed



        
     
Free Article


 


PubMed ID 21713383
         Pubmed Central ID 6545597 


 



4.
Sleeman J, Steeg PS (2010). Cancer metastasis as a therapeutic target. Eur J Cancer  46, 1177-80.   https://doi.org/10.1016/j.ejca.2010.02.039




PubMed



        
     
Free Article


 


PubMed ID 20307970
         Pubmed Central ID 6545591 


 



5.
Zimmer AS, Steeg PS (2015). Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns. J Mol Med (Berl)  93, 13-29.   https://doi.org/10.1007/s00109-014-1226-2




PubMed



        
     
Free Article


 


PubMed ID 25412774
         Pubmed Central ID 6545582",https://intramural.nih.gov/search/searchview.taf?ipid=45184
315,BC010642-04,"October 01, 2006 -  September 30, 2007",Chemistry,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",Richard  Cysyk; PhD,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45553
316,BC010643-04,"October 01, 2006 -  September 30, 2007",Molecular Technologies,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",Satoshi  Nishizuka,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45185
317,BC010644-04,"October 01, 2006 -  September 30, 2007",Preclinical Models Strategy Team,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",Lyuba  Varticovski,NULL,"Glenn  Merlino; PhD (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45554
318,BC010646-04,"October 01, 2006 -  September 30, 2007",Chromatin Remodeling Proteins,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Sam  John



Ronit  Salomon",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45479
319,BC010647-03,"October 01, 2006 -  September 30, 2007",Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies,Christoph  Rader; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Ka Yin  Kwong



Sivasubramanian  Baskar



Thomas  Hofer","CARL  BATT
(Nanobiotechnology Center, Cornell University)




Roman  Giger
(CENTER FOR AGING AND DEVELOPMENTAL BIOLOGY, University of Rochester School of Medicine and Dentistry)




GERALD  QUINNAN, JR.
(Preventive Medicine, Uniformed Services University of the Health Sciences)","Wyndham H Wilson; MD, PhD (National Cancer Institute)



Jeffrey D Lifson; MD (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)



Jonathan  Vogel; MD (National Cancer Institute)



Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)",Rose G Mage; PhD (NIAID),"Ordered by publication type and then author name.



1.
Rader C   (2007) Monoclonal Antibodies in Cancer Therapy., in General Principles of Tumor Immunotherapy. Kaufman H, Wolchok J, eds., Springer (New York), in press.




 



2.
Abraham S, Guo F, Li LS, Rader C, Liu C, Barbas CF, Lerner RA, Sinha SC (2007). Synthesis of the next-generation therapeutic antibodies that combine cell targeting and antibody-catalyzed prodrug activation. Proc Natl Acad Sci U S A  104, 5584-9.   https://doi.org/10.1073/pnas.0700223104




PubMed



        
     
Free Article


 


PubMed ID 17372220
         Pubmed Central ID 1838444 


 



3.
Hofer T, Tangkeangsirisin W, Kennedy MG, Mage RG, Raiker SJ, Venkatesh K, Lee H, Giger RJ, Rader C (2007). Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector. J Immunol Methods  318, 75-87.   https://doi.org/10.1016/j.jim.2006.10.007




PubMed



        
     
Free Article


 


PubMed ID 17140598
         Pubmed Central ID 1930160 


 



4.
Rader C, Burke T, Hofer T, Thomas J (submitted in 2007) Selenocysteine Mediated Hybrid Antibody Molecules. Patent issued: 8,916,159 (US in 2015). Patent pending: 14/579,180 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=45542
320,BC010648-03,"October 01, 2006 -  September 30, 2007","Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL",Christoph  Rader; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Ka Yin  Kwong



Sivasubramanian  Baskar



Thomas  Hofer","DANIEL  LEAHY
(Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine)




ELIZABETH  RAVECHE
(Department of Pathology, New Jersey Medical School)","Wyndham H Wilson; MD, PhD (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Steven  Pavletic; MD, MS (National Cancer Institute)","Rose G Mage; PhD (NIAID) 



Adrian U Wiestner; MD, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Rader C   (2007) Monoclonal Antibodies in Cancer Therapy., in General Principles of Tumor Immunotherapy. Kaufman H, Wolchok J, eds., Springer (New York), in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45543
321,BC010649-03,"October 01, 2006 -  September 30, 2007",Development of Immunotherapy Strategies for Gastrointestinal Cancers with focus,Udai S Kammula,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Danielle  Hari



Simon  Choi",NULL,"Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)



Xin Wei Wang; PhD (National Cancer Institute)",Francesco M. Marincola; MD (CC),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45533
322,BC010651-03,"October 01, 2006 -  September 30, 2007",Robo4: Function and Signaling Mechanisms in Vascular Development,Ramani I Ramchandran,Elaine S Jaffe; MD,"Laboratory of Pathology, NCI",NULL,"Jack  Arbiser
(Dermatology, Emory University, Winship Cancer Center)




Vikas  Sukhatme
(Renal Division, Harvard Medical School)","Mary  Stracke (National Cancer Institute)



Dave  Roberts (National Cancer Institute)



Maria  Tsokos; MD (National Cancer Institute)



Michael  Birrer (National Cancer Institute)","J Silvio  Gutkind; PhD (NIDCR) 



Harish C Pant; PhD (NINDS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45544
323,BC010652-03,"October 01, 2006 -  September 30, 2007",Lipid-Based Nanocapsules and Nano Fusion Machines,"Robert  Blumenthal; PhD



IRP Faculty Profile",NULL,"Center for Cancer Research Nanobiology Program, NCI","Anu  Puri; PhD



Yossef  Raviv



Mathias  Viard



Himanshu  Garg



Amy L Jacobs



Nicholas  Francella



Show all 8","Wei  Chen
(Physics, University of Texas at Arlington)




Wei  Chen
(Physics, University of Texas at Arlington)




Mark  Kester
(Pharmacology, Penn State College of Medicine)




Radha  Maheshwari
(Dept of Pathology, Uniformed Services University of the Health Sciences)




Alok  Singh
(Center for Bio/Molecular Science & Engineering, Naval Research Laboratory)","Victor  Marquez; PhD (National Cancer Institute)



Joseph John Barchi (National Cancer Institute)



Jacek  Capala; PhD (National Cancer Institute)



Stephen J Lockett; PhD (National Cancer Institute)



Scott E McNeil (National Cancer Institute)



Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Garg H, Blumenthal R (2008). Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis. Cell Mol Life Sci  65, 3134-44.   https://doi.org/10.1007/s00018-008-8147-6




PubMed



        
     
Free Article


 


PubMed ID 18500445
         Pubmed Central ID 2574860 


 



2.
Jacobs A, Garg H, Viard M, Raviv Y, Puri A, Blumenthal R (2008). HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development. Vaccine  26, 3026-35.   https://doi.org/10.1016/j.vaccine.2007.12.026




PubMed



        
     
Free Article


 


PubMed ID 18242797
         Pubmed Central ID 2490604",https://intramural.nih.gov/search/searchview.taf?ipid=45511
324,BC010653-03,"October 01, 2006 -  September 30, 2007",Inflammation and Prostatic Carcinogenesis,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI","Terri L Stull




Jami D Willette brown",NULL,"William  Farrar (National Cancer Institute)



Lionel  Feigenbaum (Office Of The Director)",NULL,"Ordered by publication type and then author name.



1.
Shafer-Weaver KA, Watkins SK, Anderson MJ, Draper LJ, Malyguine A, Alvord WG, Greenberg NM, Hurwitz AA (2009). Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells. Cancer Res  69, 6256-64.   https://doi.org/10.1158/0008-5472.CAN-08-4516




PubMed



        
     
Free Article


 


PubMed ID 19622771
         Pubmed Central ID 2732120",https://intramural.nih.gov/search/searchview.taf?ipid=45530
325,BC010654-03,"October 01, 2006 -  September 30, 2007",Lymphatic Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Hisataka  Kobayashi



Marcelino  Bernardo



Yoshinori  Koyama



Gregory C Ravizzini",NULL,Martin W Brechbiel; PhD (Radiation Oncology Branch),David M Thomasson; PhD (CC),"Ordered by publication type and then author name.



1.
Hama Y, Koyama Y, Urano Y, Choyke PL, Kobayashi H (2007). Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity. Breast Cancer Res Treat  103, 23-8.   https://doi.org/10.1007/s10549-006-9347-0




PubMed


 


PubMed ID 17028977
    
     


 



2.
Kobayashi H, Koyama Y, Barrett T, Hama Y, Regino CA, Shin IS, Jang BS, Le N, Paik CH, Choyke PL, Urano Y (2007). Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging. ACS Nano  1, 258-64.   https://doi.org/10.1021/nn700062z




PubMed



        
     
Free Article


 


PubMed ID 19079788
         Pubmed Central ID 2600721 


 



3.
Xu H, Regino CA, Bernardo M, Koyama Y, Kobayashi H, Choyke PL, Brechbiel MW (2007). Toward improved syntheses of dendrimer-based magnetic resonance imaging contrast agents: new bifunctional diethylenetriaminepentaacetic acid ligands and nonaqueous conjugation chemistry. J Med Chem  50, 3185-93.   https://doi.org/10.1021/jm061324m




PubMed


 


PubMed ID 17552504
    
     


 



4.
Xu H, Regino CA, Koyama Y, Hama Y, Gunn AJ, Bernardo M, Kobayashi H, Choyke PL, Brechbiel MW (2007). Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjug Chem  18, 1474-82.   https://doi.org/10.1021/bc0701085




PubMed


 


PubMed ID 17711320",https://intramural.nih.gov/search/searchview.taf?ipid=45524
326,BC010655-03,"October 01, 2006 -  September 30, 2007",Prostate Cancer Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Marcelino  Bernardo



Tristan  Barrett



Gregory C Ravizzini",NULL,"William Marston Linehan; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



William Laurence Dahut; MD (National Cancer Institute)



Peter A Pinto; MD (Urologic Oncology Branch)



Martin W Brechbiel; PhD (Radiation Oncology Branch)","David M Thomasson; PhD (CC) 



Bradford J Wood; MD (CC)","Ordered by publication type and then author name.



1.
Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT (2007). Imaging prostate cancer: a multidisciplinary perspective. Radiology  243, 28-53.   https://doi.org/10.1148/radiol.2431030580




PubMed


 


PubMed ID 17392247
    
     


 



2.
Lattouf JB, Grubb RL, Lee SJ, Bjurlin MA, Albert P, Singh AK, Ocak I, Choyke P, Coleman JA (2007). Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer. BJU Int  99, 1041-6.   https://doi.org/10.1111/j.1464-410X.2006.06690.x




PubMed


 


PubMed ID 17437438",https://intramural.nih.gov/search/searchview.taf?ipid=45525
327,BC010656-03,"October 01, 2006 -  September 30, 2007",Growth Factor Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Karen J Wong



Hisataka  Kobayashi



Yoshinori  Koyama



Tristan  Barrett



Peter  Eck; PhD



Gregory C Ravizzini",NULL,"William Marston Linehan; MD (National Cancer Institute)



Sandra M Swain; MD (National Cancer Institute)



Peter A Pinto; MD (Urologic Oncology Branch)



Martin W Brechbiel; PhD (Radiation Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Hama Y, Urano Y, Koyama Y, Kamiya M, Bernardo M, Paik RS, Shin IS, Paik CH, Choyke PL, Kobayashi H (2007). A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. Cancer Res  67, 2791-9.   https://doi.org/10.1158/0008-5472.CAN-06-3315




PubMed


 


PubMed ID 17363601
    
     


 



2.
Kamiya M, Kobayashi H, Hama Y, Koyama Y, Bernardo M, Nagano T, Choyke PL, Urano Y (2007). An enzymatically activated fluorescence probe for targeted tumor imaging. J Am Chem Soc  129, 3918-29.   https://doi.org/10.1021/ja067710a




PubMed



        
     
Free Article


 


PubMed ID 17352471
         Pubmed Central ID 2555972 


 



3.
Koyama Y, Hama Y, Urano Y, Nguyen DM, Choyke PL, Kobayashi H (2007). Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin Cancer Res  13, 2936-45.   https://doi.org/10.1158/1078-0432.CCR-06-2240




PubMed


 


PubMed ID 17504994",https://intramural.nih.gov/search/searchview.taf?ipid=45526
328,BC010657-03,"October 01, 2006 -  September 30, 2007",Intracellular In vivo Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Gunn AJ, Brechbiel MW, Choyke PL (2007). The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis. Expert Opin Drug Deliv  4, 389-402.   https://doi.org/10.1517/17425247.4.4.389




PubMed


 


PubMed ID 17683252
    
     


 



2.
Gunn AJ, Hama Y, Koyama Y, Kohn EC, Choyke PL, Kobayashi H (2007). Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore. Cancer Sci  98, 1727-33.   https://doi.org/10.1111/j.1349-7006.2007.00602.x




PubMed



        
     
Free Article


 


PubMed ID 17784874
         Pubmed Central ID 2585545 


 



3.
Hama Y, Koyama Y, Bernardo M, Choyke PL, Kobayashi H (2007). Spectral near-infrared fluorescence imaging of curved surfaces using projection reconstruction algorithms. Contrast Media Mol Imaging  2, 82-7.   https://doi.org/10.1002/cmmi.129




PubMed


 


PubMed ID 17451166
    
     


 



4.
Hama Y, Koyama Y, Urano Y, Choyke PL, Kobayashi H (2007). Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity. Breast Cancer Res Treat  103, 23-8.   https://doi.org/10.1007/s10549-006-9347-0




PubMed


 


PubMed ID 17028977
    
     


 



5.
Hama Y, Urano Y, Koyama Y, Bernardo M, Choyke PL, Kobayashi H (2006). A comparison of the emission efficiency of four common green fluorescence dyes after internalization into cancer cells. Bioconjug Chem  17, 1426-31.   https://doi.org/10.1021/bc0601626




PubMed



        
     
Free Article


 


PubMed ID 17105220
         Pubmed Central ID 2556176 


 



6.
Hama Y, Urano Y, Koyama Y, Choyke PL, Kobayashi H (2007). Activatable fluorescent molecular imaging of peritoneal metastases following pretargeting with a biotinylated monoclonal antibody. Cancer Res  67, 3809-17.   https://doi.org/10.1158/0008-5472.CAN-06-3794




PubMed


 


PubMed ID 17440095
    
     


 



7.
Hama Y, Urano Y, Koyama Y, Kamiya M, Bernardo M, Paik RS, Shin IS, Paik CH, Choyke PL, Kobayashi H (2007). A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. Cancer Res  67, 2791-9.   https://doi.org/10.1158/0008-5472.CAN-06-3315




PubMed


 


PubMed ID 17363601
    
     


 



8.
Kamiya M, Kobayashi H, Hama Y, Koyama Y, Bernardo M, Nagano T, Choyke PL, Urano Y (2007). An enzymatically activated fluorescence probe for targeted tumor imaging. J Am Chem Soc  129, 3918-29.   https://doi.org/10.1021/ja067710a




PubMed



        
     
Free Article


 


PubMed ID 17352471
         Pubmed Central ID 2555972 


 



9.
Kobayashi H, Hama Y, Koyama Y, Barrett T, Regino CA, Urano Y, Choyke PL (2007). Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. Nano Lett  7, 1711-6.   https://doi.org/10.1021/nl0707003




PubMed


 


PubMed ID 17530812
    
     


 



10.
Koyama Y, Hama Y, Urano Y, Nguyen DM, Choyke PL, Kobayashi H (2007). Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin Cancer Res  13, 2936-45.   https://doi.org/10.1158/1078-0432.CCR-06-2240




PubMed


 


PubMed ID 17504994
    
     


 



11.
Koyama Y, Talanov VS, Bernardo M, Hama Y, Regino CA, Brechbiel MW, Choyke PL, Kobayashi H (2007). A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging  25, 866-71.   https://doi.org/10.1002/jmri.20852




PubMed


 


PubMed ID 17345640
    
     


 



12.
Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, Lowy DR, Schiller JT (2007). Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med  13, 857-61.   https://doi.org/10.1038/nm1598




PubMed


 


PubMed ID 17603495
    
     


 



13.
Xu H, Baidoo K, Gunn AJ, Boswell CA, Milenic DE, Choyke PL, Brechbiel MW (2007). Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging. J Med Chem  50, 4759-65.   https://doi.org/10.1021/jm070657w




PubMed



        
     
Free Article


 


PubMed ID 17725340
         Pubmed Central ID 2366096 


 



14.
Xu H, Regino CA, Koyama Y, Hama Y, Gunn AJ, Bernardo M, Kobayashi H, Choyke PL, Brechbiel MW (2007). Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjug Chem  18, 1474-82.   https://doi.org/10.1021/bc0701085




PubMed


 


PubMed ID 17711320",https://intramural.nih.gov/search/searchview.taf?ipid=45527
329,BC010658-03,"October 01, 2006 -  September 30, 2007",Combination of Radiation with Multi-Target Molecular Therapy for Cancer,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI","Alesia J Holly



Rafal Jerzy Zielinski",NULL,NULL,"Teresa M Przytycka (NLM) 



Martin  Meier-Schellersheim; PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45512
330,BC010660-03,"October 01, 2006 -  September 30, 2007",The Molecular Profile of Prostate Tumors in Smokers,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Tiffany Marie Howe



Robert Scott Hudson","William  Isaacs; PhD
(Department of Urology, Johns Hopkins School of Medicine)




Chris  Loffredo
(Cancer Genetics and Epidemiology Program, Georgetown University)




Jun  Luo
(Urology, Johns Hopkins University)","Neil Edward Caporaso; MS, MD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45507
331,BC010661-03,"October 01, 2006 -  September 30, 2007",The Use of Cancer Vaccines and Combination Therapies,James W Hodge; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Marion G Taylor



Elizabeth K Wansley



Michael B Bernstein



Amanda L Boehm; PhD



Anais  Kasten-sportes","Jorge A Carrasquillo; MD
(CC)




Alex  Franzusoff
(Research and Development, GlobeImmune)




Chandan  Guha
(Radiation Oncology, Montefiore Medical Center)




Howard  Kaufman
(Surgical Oncology, Columbia University College of Physicians and Surgeons)




Jacques  Neefjes
(Division of Tumor Biology, The Netherlands Cancer Institute)",Kevin A Camphausen; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Chakraborty M, Schlom J, Hodge JW (2007). The combined activation of positive costimulatory signals with modulation of a negative costimulatory signal for the enhancement of vaccine-mediated T-cell responses. Cancer Immunol Immunother  56, 1471-84.   https://doi.org/10.1007/s00262-007-0291-6




PubMed


 


PubMed ID 17318654
    
     


 



2.
Kudo-Saito C, Garnett CT, Wansley EK, Schlom J, Hodge JW (2007). Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T cell avidity and anti-tumor activity. Cancer Immunol Immunother  56, 1897-910.   https://doi.org/10.1007/s00262-007-0332-1




PubMed


 


PubMed ID 17503041
    
     


 



3.
Kudo-Saito C, Wansley EK, Gruys ME, Wiltrout R, Schlom J, Hodge JW (2007). Combination therapy of an orthotopic renal cell carcinoma model using intratumoral vector-mediated costimulation and systemic interleukin-2. Clin Cancer Res  13, 1936-46.   https://doi.org/10.1158/1078-0432.CCR-06-2398




PubMed


 


PubMed ID 17363550
    
     


 



4.
Sharp HJ, Wansley EK, Garnett CT, Chakraborty M, Camphausen K, Schlom J, Hodge JW (2007). Synergistic antitumor activity of immune strategies combined with radiation. Front Biosci  12, 4900-10.   https://doi.org/10.2741/2436




PubMed


 


PubMed ID 17569618",https://intramural.nih.gov/search/searchview.taf?ipid=45548
332,BC010662-03,"October 01, 2006 -  September 30, 2007",Vaccine Clinical Trials,Philip M Arlen; MD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Sandra  Doren



James L Gulley; MD, PhD



Mary P Pazdur



Theresa A Ferrara



Myrna B Rauckhorst



Jacquin L Jones



Show all 8","Robert  DiPaola
(Medicine, Cancer Institute of New Jersey)




Guido  Francini
(Human pathology and oncology, Siena University School of Medicine)




Alex  Franzusoff
(Research and Development, GlobeImmune)




Edmund  Lattime
(Surgery, molecular genetics, microbiology & immunology, Cancer Institute of New Jersey)




John  Marshall





Anthony T Walker","William Marston Linehan; MD (National Cancer Institute)



William Laurence Dahut; MD (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Howard Z Streicher (National Cancer Institute)



Peter A Pinto; MD (National Cancer Institute)



Jonathan A Coleman (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Arlen P, Gulley J   (2007) The role of vaccine therapy in cancer: biology and practice.  Curr Oncol, in press.




 



2.
Arlen P, Hodge J, Schlom J, Gulley J (2007) Combining vaccines with conventional therapies for cancer. Update on Cancer Therapeutics 33-9.




 



3.
Arlen P, Madan R, Hodge J, Schlom J   (2007) Preclinical and clinical studies of recombinant poxvirus vaccines for carcinoma  therapy.  Crit Rev Immunol (Supp), in press.




 



4.
Arlen P, Pazdur M, Seetharam M, Tsang K, Grosenbach D, Feldman J, Poole D, Litzinger M, Steinberg S, Jones E, Chen C, Marte J, Parnes H, Wright J, Dahut W, Schlom J, Gulley J   (2007) Clinical safety of a viral vector-based prostate cancer vaccine strategy.  J Urol, in press.




 



5.
Figg WD, Li H, Sissung T, Retter A, Wu S, Gulley JL, Arlen P, Wright JJ, Parnes H, Fedenko K, Latham L, Steinberg SM, Jones E, Chen C, Dahut W (2007). Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer. BJU Int  99, 1047-55.   https://doi.org/10.1111/j.1464-410X.2007.06763.x




PubMed


 


PubMed ID 17437439
    
     


 



6.
Gulley JL, Madan RA, Arlen PM (2007). Enhancing efficacy of therapeutic vaccinations by combination with other modalities. Vaccine  25 Suppl 2, B89-96.   https://doi.org/10.1016/j.vaccine.2007.04.091




PubMed



        
     
Free Article


 


PubMed ID 17573164
         Pubmed Central ID 2062504 


 



7.
Madan RA, Arlen PM, Gulley JL (2007). PANVAC-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma. Expert Opin Biol Ther  7, 543-54.   https://doi.org/10.1517/14712598.7.4.543




PubMed


 


PubMed ID 17373905
    
     


 



8.
Madan RA, Lieberman R, Gulley JL, Dahut W, Arlen PM (2007). Significant prostate-specific antigen (PSA) response to low-dose ketoconazole in a patient with non-metastatic androgen-independent prostate cancer (AIPC) and a review of the literature. Am J Ther  14, 310-3.   https://doi.org/10.1097/01.pap.0000249955.77460.f4




PubMed


 


PubMed ID 17515709
    
     


 



9.
Schlom J, Arlen PM, Gulley JL (2007). Cancer vaccines: moving beyond current paradigms. Clin Cancer Res  13, 3776-82.   https://doi.org/10.1158/1078-0432.CCR-07-0588




PubMed



        
     
Free Article


 


PubMed ID 17606707
         Pubmed Central ID 2536755 


 



10.
Theoret MR, Arlen PM, Pazdur M, Dahut WL, Schlom J, Gulley JL (2007). Phase I trial of an enhanced prostate-specific antigen-based vaccine and anti-CTLA-4 antibody in patients with metastatic androgen-independent prostate cancer. Clin Genitourin Cancer  5, 347-50.   https://doi.org/10.3816/CGC.2007.n.017




PubMed


 


PubMed ID 17645835
    
     


 



11.
Wu SL, Jones E, Gulley JL, Arlen PM, Chen CC, Figg WD, Dahut WL (2007). Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone. BJU Int  99, 525-8.   https://doi.org/10.1111/j.1464-410X.2006.06654.x




PubMed


 


PubMed ID 17155971
    
     


 



12.
Yokokawa J, Bera TK, Palena C, Cereda V, Remondo C, Gulley JL, Arlen PM, Pastan I, Schlom J, Tsang KY (2007). Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4). Int J Cancer  121, 595-605.   https://doi.org/10.1002/ijc.22698




PubMed


 


PubMed ID 17397028",https://intramural.nih.gov/search/searchview.taf?ipid=45501
333,BC010663-03,"October 01, 2006 -  September 30, 2007",The Role of JAM-C in Adhesive Interactions of Immune Cells,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI","Valeria  Orlova



Eun-Young  Choi



Sunil  Kaul","Sentot  Santoso
(Clinical Immunology, University Giessen)




Dietmar  Vestweber
(Clinical Immunology, MPI)",NULL,NULL,"Ordered by publication type and then author name.



1.
Langer HF, Orlova VV, Xie C, Kaul S, Schneider D, Lonsdorf AS, Fahrleitner M, Choi EY, Dutoit V, Pellegrini M, Grossklaus S, Nawroth PP, Baretton G, Santoso S, Hwang ST, Arnold B, Chavakis T (2011). A novel function of junctional adhesion molecule-C in mediating melanoma cell metastasis. Cancer Res  71, 4096-105.   https://doi.org/10.1158/0008-5472.CAN-10-2794




PubMed



        
     
Free Article


 


PubMed ID 21593193
         Pubmed Central ID 3117056",https://intramural.nih.gov/search/searchview.taf?ipid=45521
334,BC010664-03,"October 01, 2006 -  September 30, 2007",Crosstalk between inflammation and angiogenesis,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI",Valeria  Orlova,"Douglas  Cines
(Dept. Pathology and Laboratory medicine, University of Pennsylvania)




Carl  Gahmberg
(Biochemistry, University of Helsinki)




John  Lambris
(University of Pennsylvania)",Andre A Nussenzweig; PhD (National Cancer Institute),Manfred  Boehm; MD (NHLBI),"Ordered by publication type and then author name.



1.
Athanasopoulos AN, Schneider D, Keiper T, Alt V, Pendurthi UR, Liegibel UM, Sommer U, Nawroth PP, Kasperk C, Chavakis T   (2007) Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing.  J Biol Chem 282:26746-53.




PubMed



        
     
Free Article


 


PubMed ID 17626014
         Pubmed Central ID 2831223",https://intramural.nih.gov/search/searchview.taf?ipid=45522
335,BC010666-03,"October 01, 2006 -  September 30, 2007",Vaccine Clinical Trials,"James L Gulley; MD, PhD",Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Sandra  Doren



Philip M Arlen; MD



Mary P Pazdur



Theresa A Ferrara



Myrna B Rauckhorst



Jacquin L Jones



Show all 8","Robert  DiPaola
(Medicine, Cancer Institute of New Jersey)




Guido  Francini
(Human pathology and oncology, Siena University School of Medicine)




Alex  Franzusoff
(Research and Development, GlobeImmune)




Edmund  Lattime
(Surgery, molecular genetics, microbiology & immunology, Cancer Institute of New Jersey)




John  Marshall





Anthony T Walker","William Laurence Dahut; MD (National Cancer Institute)



Howard Z Streicher (National Cancer Institute)



Claude  Sportes (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Peter A Pinto; MD (National Cancer Institute)",Clara Chi Chen; MD (CC),"Ordered by publication type and then author name.



1.
Gulley J, Sharifi N (2007) Androgens, androgen suppression, and prostate cancer: recent preclinical and clinical findings and implications, in Testosterone Research. Nova Science Publishers, in press.




 



2.
Aragon-Ching JB, Williams KM, Gulley JL (2007). Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer. Front Biosci  12, 4957-71.   https://doi.org/10.2741/2441




PubMed


 


PubMed ID 17569623
    
     


 



3.
Figg WD, Li H, Sissung T, Retter A, Wu S, Gulley JL, Arlen P, Wright JJ, Parnes H, Fedenko K, Latham L, Steinberg SM, Jones E, Chen C, Dahut W (2007). Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer. BJU Int  99, 1047-55.   https://doi.org/10.1111/j.1464-410X.2007.06763.x




PubMed


 


PubMed ID 17437439
    
     


 



4.
Gulley J, Arlen P   (2007) The role of vaccine therapy in cancer: biology and practice.  Curr Oncol, in press.




 



5.
Gulley J, Madan R, Hodge J, Schlom J   (2007) Combining vaccines with conventional therapies for cancer.  Update on Cancer Therapeutics, in press.




 



6.
Gulley J, Madan R, Hodge J, Schlom J   (2007) Preclinical and clinical studies of recombinant poxvirus vaccines for carcinoma  therapy.  Crit Rev Immunol (Supp), in press.




 



7.
Gulley J, Skarupa L, Pazdur M, Seetharam M, Tsang K, Grosenbach D, Feldman J, Poole D, Litzinger M, Steinberg S, Jones E, Chen C, Marte J, Parnes H, Wright J, Dahut W, Schlom J   (2007) Clinical safety of a viral vector-based prostate cancer vaccine strategy.  J Urol, in press.




 



8.
Gulley JL, Dahut WL (2007). Future directions in tumor immunotherapy: CTLA4 blockade. Nat Clin Pract Oncol  4, 136-7.   https://doi.org/10.1038/ncponc0749




PubMed


 


PubMed ID 17327854
    
     


 



9.
Gulley JL, Madan RA, Arlen PM (2007). Enhancing efficacy of therapeutic vaccinations by combination with other modalities. Vaccine  25 Suppl 2, B89-96.   https://doi.org/10.1016/j.vaccine.2007.04.091




PubMed



        
     
Free Article


 


PubMed ID 17573164
         Pubmed Central ID 2062504 


 



10.
Madan RA, Arlen PM, Gulley JL (2007). PANVAC-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma. Expert Opin Biol Ther  7, 543-54.   https://doi.org/10.1517/14712598.7.4.543




PubMed


 


PubMed ID 17373905
    
     


 



11.
Madan RA, Lieberman R, Gulley JL, Dahut W, Arlen PM (2007). Significant prostate-specific antigen (PSA) response to low-dose ketoconazole in a patient with non-metastatic androgen-independent prostate cancer (AIPC) and a review of the literature. Am J Ther  14, 310-3.   https://doi.org/10.1097/01.pap.0000249955.77460.f4




PubMed


 


PubMed ID 17515709
    
     


 



12.
O'Mahony D, Morris JC, Quinn C, Gao W, Wilson WH, Gause B, Pittaluga S, Neelapu S, Brown M, Fleisher TA, Gulley JL, Schlom J, Nussenblatt R, Albert P, Davis TA, Lowy I, Petrus M, Waldmann TA, Janik JE (2007). A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy. Clin Cancer Res  13, 958-64.   https://doi.org/10.1158/1078-0432.CCR-06-1974




PubMed


 


PubMed ID 17289891
    
     


 



13.
Schlom J, Arlen PM, Gulley JL (2007). Cancer vaccines: moving beyond current paradigms. Clin Cancer Res  13, 3776-82.   https://doi.org/10.1158/1078-0432.CCR-07-0588




PubMed



        
     
Free Article


 


PubMed ID 17606707
         Pubmed Central ID 2536755 


 



14.
Theoret MR, Arlen PM, Pazdur M, Dahut WL, Schlom J, Gulley JL (2007). Phase I trial of an enhanced prostate-specific antigen-based vaccine and anti-CTLA-4 antibody in patients with metastatic androgen-independent prostate cancer. Clin Genitourin Cancer  5, 347-50.   https://doi.org/10.3816/CGC.2007.n.017




PubMed


 


PubMed ID 17645835
    
     


 



15.
Wu S, Dahut WL, Gulley JL (2007). The use of bisphosphonates in cancer patients. Acta Oncol  46, 581-91.   https://doi.org/10.1080/02841860701233435




PubMed


 


PubMed ID 17562434
    
     


 



16.
Wu SL, Jones E, Gulley JL, Arlen PM, Chen CC, Figg WD, Dahut WL (2007). Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone. BJU Int  99, 525-8.   https://doi.org/10.1111/j.1464-410X.2006.06654.x




PubMed


 


PubMed ID 17155971
    
     


 



17.
Yokokawa J, Bera TK, Palena C, Cereda V, Remondo C, Gulley JL, Arlen PM, Pastan I, Schlom J, Tsang KY (2007). Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4). Int J Cancer  121, 595-605.   https://doi.org/10.1002/ijc.22698




PubMed


 


PubMed ID 17397028",https://intramural.nih.gov/search/searchview.taf?ipid=45547
336,BC010668-03,"October 01, 2006 -  September 30, 2007",Instrumentation for microSPECT and microPET imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI",Jurgen  Seidel; PhD,NULL,Martin W Brechbiel; PhD (Radiation Oncology Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45523
337,BC010669-03,"October 01, 2006 -  September 30, 2007",Role of Gene Methylation in Tumor Microenvironment,Karen  Woodson,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,"Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)



John W Gillespie (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Perry AS, Loftus B, Moroose R, Lynch TH, Hollywood D, Watson RW, Woodson K, Lawler M (2007). In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer. Br J Cancer  96, 1587-94.   https://doi.org/10.1038/sj.bjc.6603767




PubMed



        
     
Free Article


 


PubMed ID 17453001
         Pubmed Central ID 2359953 


 



2.
Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, Richardson AM, Pinto PA, Linehan WM, Gillespie JW, Merino MJ, Libutti SK, Woodson KG, Emmert-Buck MR, Chuaqui RF (2007). Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol  211, 410-9.   https://doi.org/10.1002/path.2133




PubMed


 


PubMed ID 17278115
    
     


 



3.
Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN, Chanock SJ, National Osteosarcoma Etiology Study Group (2007). Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev  16, 1667-74.   https://doi.org/10.1158/1055-9965.EPI-07-0214




PubMed


 


PubMed ID 17684144",https://intramural.nih.gov/search/searchview.taf?ipid=45546
338,BC010670-03,"October 01, 2006 -  September 30, 2007",Molecular-targeted Radiation Therapy,"Norman Norman Coleman; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Sanjeewani T Palayoor



David  Cerna",NULL,"James B Mitchell; PhD (National Cancer Institute)



Stephen  Yoo (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Palayoor ST, Mitchell JB, Cerna D, Degraff W, John-Aryankalayil M, Coleman CN (2008). PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells. Int J Cancer  123, 2430-7.   https://doi.org/10.1002/ijc.23807




PubMed



        
     
Free Article


 


PubMed ID 18729192
         Pubmed Central ID 4277812",https://intramural.nih.gov/search/searchview.taf?ipid=45505
339,BC010671-03,"October 01, 2006 -  September 30, 2007",Genetic analysis of T-cell differentiation,"Remy J Bosselut; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI","Kathryn F Wildt



Lie  Wang



Monica B Zamisch



Yumei  Xiong; PhD","Marc  Ehlers
(Tolerance & auto-immunity, DRFZ)




I-Cheng  Ho
(Rheumatology, Immunology and Allergy, Harvard (Brigham and Women's))




Steven  Reiner
(Abramson, U Penn)",Lionel  Feigenbaum (Office Of The Director),"Paul P. Liu; MD, PhD (NHGRI) 



William E Paul; MD (NIAID)","Ordered by publication type and then author name.



1.
Berthet C, Rodriguez-Galan MC, Hodge DL, Gooya J, Pascal V, Young HA, Keller J, Bosselut R, Kaldis P (2007). Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2. Mol Cell Biol  27, 5079-89.   https://doi.org/10.1128/MCB.00029-07




PubMed



        
     
Free Article


 


PubMed ID 17485443
         Pubmed Central ID 1951952 


 



2.
Jenkinson SR, Intlekofer AM, Sun G, Feigenbaum L, Reiner SL, Bosselut R (2007). Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4-CD8 lineage differentiation. J Exp Med  204, 267-72.   https://doi.org/10.1084/jem.20061982




PubMed



        
     
Free Article


 


PubMed ID 17296789
         Pubmed Central ID 2118724 


 



3.
Zhao L, Cannons JL, Anderson S, Kirby M, Xu L, Castilla LH, Schwartzberg PL, Bosselut R, Liu PP (2007). CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus. Blood  109, 3432-40.   https://doi.org/10.1182/blood-2006-10-051508




PubMed



        
     
Free Article


 


PubMed ID 17185462
         Pubmed Central ID 1852246",https://intramural.nih.gov/search/searchview.taf?ipid=45503
340,BC010673-03,"October 01, 2006 -  September 30, 2007",Regulation of Metastasis and Angiogenesis by Autotaxin,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Malgorzata  Ptaszynska



Elliott  Schiffman",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Koh E, Bandle R, Clair T, Roberts DD, Stracke ML (2007). Trichostatin A and 5-aza-2'-deoxycytidine switch S1P from an inhibitor to a stimulator of motility through epigenetic regulation of S1P receptors. Cancer Lett  250, 53-62.   https://doi.org/10.1016/j.canlet.2006.09.017




PubMed


 


PubMed ID 17189669
    
     


 



2.
Koh E, Clair T, Hermansen R, Bandle RW, Schiffmann E, Roberts DD, Stracke ML (2007). Sphingosine-1-phosphate initiates rapid retraction of pseudopodia by localized RhoA activation. Cell Signal  19, 1328-38.   https://doi.org/10.1016/j.cellsig.2007.01.005




PubMed


 


PubMed ID 17307336
    
     


 



3.
Ptaszynska MM, Pendrak ML, Bandle RW, Stracke ML, Roberts DD (2008). Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells. Mol Cancer Res  6, 352-63.   https://doi.org/10.1158/1541-7786.MCR-07-0143




PubMed



        
     
Free Article


 


PubMed ID 18337445
         Pubmed Central ID 2442564",https://intramural.nih.gov/search/searchview.taf?ipid=45545
341,BC010675-03,"October 01, 2006 -  September 30, 2007",Development of a Carbohydrate Microarray,"Jeffrey  Gildersleeve



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Anthony S Stapon



Oyindasola O Oyelaran",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Gildersleeve J (2007) An armed-disarmed approach for blocking aglycon transfer of thioglycosides. Tetrahedron Lett 559-562.




 



2.
Li Z, Gildersleeve JC (2007). An armed-disarmed approach for blocking aglycon transfer of thioglycosides. Tetrahedron Lett  48, 559-562.   https://doi.org/10.1016/j.tetlet.2006.11.126




PubMed



        
     
Free Article


 


PubMed ID 19043616
         Pubmed Central ID 2587334",https://intramural.nih.gov/search/searchview.taf?ipid=45529
342,BC010676-03,"October 01, 2006 -  September 30, 2007",Clinical Proteomics and Laser Capture Microdissection,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Michael R Emmert-Buck; MD, PhD



Katherine Rainsford Calvo",NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)



Wyndham H Wilson; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45531
343,BC010677-03,"October 01, 2006 -  September 30, 2007",NADPH Oxidase 1: A Novel Target for Colon Cancer Therapy,"James Halpern Doroshow



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Smitha  Antony



Yun  Ge",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Doroshow J   (2007) Preclinical Development of Molecularly Targeted Agents in Oncology., in Cancer Drug Discovery and Development: Molecular Targeting in Oncology. Humana Press (Totowa, NJ), pp. 703-718.",https://intramural.nih.gov/search/searchview.taf?ipid=45528
344,BC010678-03,"October 01, 2006 -  September 30, 2007",Keratinocyte Growth Factor: Epithelial Homeostatic Factor with Clinical Applicat,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45550
345,BC010679-03,"October 01, 2006 -  September 30, 2007",Characterization of novel substrates of budding yeast polo kinase Cdc5,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",Jung Eun  Park,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45537
346,BC010680-03,"October 01, 2006 -  September 30, 2007",Characterization of the hCenexin-Plk1 interaction at the centrosomes of cultured,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45538
347,BC010681-03,"October 01, 2006 -  September 30, 2007",Development of anti-polo-box therapeutic agents,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",Jung Eun  Park,NULL,"Marc C Nicklaus (National Cancer Institute)



James  McMahon; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45539
348,BC010683-03,"October 01, 2006 -  September 30, 2007",Role of FH loss in development of HLRCC heriditary kidney cancer,"Leonard  Neckers; PhD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI",Hye-Sik  Kong,NULL,William Marston Linehan; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45541
349,BC010684-03,"October 01, 2006 -  September 30, 2007",Anatomic Pathology Residency Program,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Andrea  Abati; BS, MD



Diane Carol Arthur; MD



David Erwin Kleiner; MD, PhD



Maria  Merino; PhD



Mark  Raffeld; MD



Martha Maria Nicacio Quezado; MD



Show all 14",NULL,"Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



Paul S Meltzer; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Geho DH, Killian JK, Nandi A, Pastor J, Gurnani P, Rosenblatt KP   (2007) Fluorescence-based analysis of cellular protein lysate arrays using quantum dots.  Methods Mol Biol 374:229-38.




PubMed


 


PubMed ID 17237542",https://intramural.nih.gov/search/searchview.taf?ipid=45532
350,BC010685-03,"October 01, 2006 -  September 30, 2007",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","David  Levens; PhD



Susan  Mackem; MD



Martha Maria Nicacio Quezado; MD



Stephen M Hewitt; MD, PhD



Willie J Young",NULL,NULL,"Theo  Heller; MD (NIDDK) 



Steven M Holland; MD (NIAID) 



Raphael  Schiffmann; MD (NINDS)","Ordered by publication type and then author name.



1.
Askari H, Kaneski CR, Semino-Mora C, Desai P, Ang A, Kleiner DE, Perlee LT, Quezado M, Spollen LE, Wustman BA, Schiffmann R (2007). Cellular and tissue localization of globotriaosylceramide in Fabry disease. Virchows Arch  451, 823-34.   https://doi.org/10.1007/s00428-007-0468-6




PubMed


 


PubMed ID 17674039
    
     


 



2.
Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, Puck JM, Holland SM (2007). Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol  119, 1234-40.   https://doi.org/10.1016/j.jaci.2006.12.666




PubMed


 


PubMed ID 17335882
    
     


 



3.
Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, Koziel DE, Anderson V, Hilligoss D, Choyke P, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T (2007). Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology  45, 675-83.   https://doi.org/10.1002/hep.21524




PubMed


 


PubMed ID 17326162
    
     


 



4.
Rapkiewicz AV, Patel SY, Holland SM, Kleiner DE (2007). Hepatoportal venopathy due to disseminated Mycobacterium avium complex infection in a child with IFN-gamma receptor 2 deficiency. Virchows Arch  451, 95-100.   https://doi.org/10.1007/s00428-007-0427-2




PubMed


 


PubMed ID 17554558",https://intramural.nih.gov/search/searchview.taf?ipid=45534
351,BC010686-03,"October 01, 2006 -  September 30, 2007",Clinical Operations for Laboratory of Pathology,"David Erwin Kleiner; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Earle J Barnes



Fidelia  Acevedo



Joseph  Chinquee",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45535
352,BC010687-03,"October 01, 2006 -  September 30, 2007",Histology Core Laboratory,"David Erwin Kleiner; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Helen G Lynch



Martha A Pruden



Kathy A Kalinyak



John A Polite","Elizabeth  Brunt
(Pathology, St. Louis University)




Hari  Conjeevaram
(Gastroenterology, The University of Michigan)




Robert  Fontana
(Gastroenterology, The University of Michigan)




Allan  Kirk
(Surgery, Emory University)




Joel  Lavine
(Pediatrics, University of California San Diego Medical Center)




Arthur  Mccullough
(Gastroenterology/Hepatology, Cleveland Clinic Foundation)


Show all 9","Steven  Pavletic; MD, MS (National Cancer Institute)



Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)","Jay  Hoofnagle; MD (NIDDK) 



Theo  Heller; MD (NIDDK) 



Gabor  Illei; MD, PhD (NIDCR) 



Roslyn B Mannon; MD (NIDDK) 



Marc Gregory Ghany; MD (NIDDK) 



Steven M Holland; MD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45536
353,BC010688-03,"October 01, 2006 -  September 30, 2007",Dermatology Consultation Clinic and Clinical Research,Maria L Turner; MD,Mark  Udey; MD,"Dermatology Branch, NCI",Jonathan  Vogel; MD,NULL,Susan  Bates; MD (Cancer Therapeutics Branch),"Raphaela  Goldbach-Mansky; MD, MHS (NIAMS)","Ordered by publication type and then author name.



1.
Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Schäffer AA, Puck JM, Grimbacher B (2007). STAT3 mutations in the hyper-IgE syndrome. N Engl J Med  357, 1608-19.   https://doi.org/10.1056/NEJMoa073687




PubMed


 


PubMed ID 17881745
    
     


 



2.
Kong HH, Cowen EW, Azad NS, Dahut W, Gutierrez M, Turner ML (2007). Keratoacanthomas associated with sorafenib therapy. J Am Acad Dermatol  56, 171-2.   https://doi.org/10.1016/j.jaad.2006.10.032




PubMed



        
     
Free Article


 


PubMed ID 17190642
         Pubmed Central ID 1781060",https://intramural.nih.gov/search/searchview.taf?ipid=45504
354,BC010692-03,"October 01, 2006 -  September 30, 2007",Significance of Bone Marrow Karyotypes in Patients with Inherited Bone Marrow Fa,Diane Carol Arthur; MD,NULL,"Laboratory of Pathology, NCI",Shannon I Skarshaug,NULL,Blanche P Alter (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45508
355,BC010693-03,"October 01, 2006 -  September 30, 2007",Legume Inflammation Study,Elaine L Lanza,NULL,"Laboratory of Cancer Prevention, NCI","Gerd  Bobe



Roycelynn  Mentor-Marcel","Maurice  Bennink
(Michigan State University)




Terryl  Hartman
(Nutrition, Pennsylvannia State University)",Paul Stuart Albert (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Flood A, Mai V, Pfeiffer R, Kahle L, Remaley AT, Rosen CJ, Lanza E, Schatzkin A (2008). The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3. Eur J Clin Nutr  62, 186-96.   https://doi.org/10.1038/sj.ejcn.1602726




PubMed


 


PubMed ID 17487212",https://intramural.nih.gov/search/searchview.taf?ipid=45549
356,BC010694-03,"October 01, 2006 -  September 30, 2007",Clinical Cancer Cytogenetics,Diane Carol Arthur; MD,NULL,"Laboratory of Pathology, NCI","Shannon I Skarshaug



Valerie M Zgonc



Alexander Cm Smith",NULL,"Wyndham H Wilson; MD, PhD (National Cancer Institute)



Blanche P Alter (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Daniel H Fowler (National Cancer Institute)



Elaine S Jaffe; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Arthur D, Akin C, Cools J, Wilson T, Mentens N, Maric I, Noel P, Kocabas C, Marynen P, Lessin H, Wlodarska I, Robyn J, Metcalfe D   (2007) Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia  and a PRKG2-PDGFRB fusion.  Haematologica, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45509
357,BC010695-03,"October 01, 2006 -  September 30, 2007",Prostate stem cells and cancer stem cells,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI",NULL,"Fernando  Bianco
(Urology, George Washington Univ. Medical Center)




Jason  Engel
(Transgenic Core, George Washington Univ)




Johng  Rhim
(Center for Prostate Disease Research, Uniformed Service University of Health sciences)




Arnold  Schwartz
(Pathology, George Washington Univ. Medical Center)","Lionel  Feigenbaum (Office Of The Director)



William G Telford (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



Peter A Pinto; MD (Urologic Oncology Branch)",Rocky S Tuan; PhD (NIAMS),"Ordered by publication type and then author name.



1.
Vogel J, Zhou J, Miki J, Furusato B, Gu Y, Srivastava S, Mcleod D, Rhim J   (2007) Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.  Experimenatal Cell Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=45551
358,BC010696-03,"October 01, 2006 -  September 30, 2007",Study of Hereditary Renal Syndromes,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Vladmir Alexander Valera Romero; MD, PhD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Grubb RL, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM (2007). Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol  177, 2074-9; discussion 2079-80.   https://doi.org/10.1016/j.juro.2007.01.155




PubMed


 


PubMed ID 17509289
    
     


 



2.
Linehan WM, Pinto PA, Srinivasan R, Merino M, Choyke P, Choyke L, Coleman J, Toro J, Glenn G, Vocke C, Zbar B, Schmidt LS, Bottaro D, Neckers L (2007). Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics. Clin Cancer Res  13, 671s-679s.   https://doi.org/10.1158/1078-0432.CCR-06-1870




PubMed


 


PubMed ID 17255292
    
     


 



3.
Zbar B, Glenn G, Merino M, Middelton L, Peterson J, Toro J, Coleman J, Pinto P, Schmidt LS, Choyke P, Linehan WM (2007). Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development. J Urol  177, 461-5; discussion 465.   https://doi.org/10.1016/j.juro.2006.09.037




PubMed


 


PubMed ID 17222609",https://intramural.nih.gov/search/searchview.taf?ipid=45540
359,BC010698-03,"October 01, 2006 -  September 30, 2007",Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Nancy M Hardy



Jennifer Sproul Wilder",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Hardy NM, Hakim F, Steinberg SM, Krumlauf M, Cvitkovic R, Babb R, Odom J, Fowler DH, Gress RE, Bishop MR (2007). Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation. Biol Blood Marrow Transplant  13, 1022-30.   https://doi.org/10.1016/j.bbmt.2007.05.008




PubMed



        
     
Free Article


 


PubMed ID 17697964
         Pubmed Central ID 2699412",https://intramural.nih.gov/search/searchview.taf?ipid=45510
360,BC010701-02,"October 01, 2006 -  September 30, 2007",Human Monoclonal Antibodies and Antibody-Guided Nanoparticles,Dimiter Stanchev Dimitrov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Yang  Feng



Xiaodong  Xiao



Mei-Yun  Zhang



Prabakaran  Ponraj



Zhongyu  Zhu



Samitabh  Chakraborti



Show all 9","Christopher  Broder
(Immunology and Microbiology, USUHS)




Barton  Haynes
(Preventive Medicine, Duke University)




Barton  Haynes
(Preventive Medicine, Duke University)




Shibo  Jiang
(Virology, New York Blood Center)




Gerald  Quinnan
(Uniformed Services University of the Health Sciences)




Gerald  Quinnan
(Uniformed Services University of the Health Sciences)


Show all 9","Xinhua  Ji; PhD (National Cancer Institute)



Robert  Blumenthal; PhD (National Cancer Institute)



Ira H Pastan; MD (National Cancer Institute)",Peter D Kwong; PhD (NIAID),"Ordered by publication type and then author name.



1.
Blumenthal R, Dimitrov DS (2007). Targeting the sticky fingers of HIV-1. Cell  129, 243-5.   https://doi.org/10.1016/j.cell.2007.04.005




PubMed


 


PubMed ID 17448985
    
     


 



2.
Bossart KN, McEachern JA, Hickey AC, Choudhry V, Dimitrov DS, Eaton BT, Wang LF (2007). Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems. J Virol Methods  142, 29-40.   https://doi.org/10.1016/j.jviromet.2007.01.003




PubMed


 


PubMed ID 17292974
    
     


 



3.
Choudhry V, Zhang MY, Sidorov IA, Louis JM, Harris I, Dimitrov AS, Bouma P, Cham F, Choudhary A, Rybak SM, Fouts T, Montefiori DC, Broder CC, Quinnan GV, Dimitrov DS (2007). Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies. Virology  363, 79-90.   https://doi.org/10.1016/j.virol.2007.01.015




PubMed



        
     
Free Article


 


PubMed ID 17306322
         Pubmed Central ID 2696119 


 



4.
Dimitrov DS, Wang LF (2007). In utero transmission of Nipah virus: role played by pregnancy and vertical transmission in Henipavirus epidemiology. J Infect Dis  196, 807-9.   https://doi.org/10.1086/520822




PubMed


 


PubMed ID 17703408
    
     


 



5.
Jiménez-Baranda S, Gómez-Moutón C, Rojas A, Martínez-Prats L, Mira E, Ana Lacalle R, Valencia A, Dimitrov DS, Viola A, Delgado R, Martínez-A C, Mañes S (2007). Filamin-A regulates actin-dependent clustering of HIV receptors. Nat Cell Biol  9, 838-46.   https://doi.org/10.1038/ncb1610




PubMed


 


PubMed ID 17572668
    
     


 



6.
Prabakaran P, Dimitrov AS, Fouts TR, Dimitrov DS (2007). Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors. Adv Pharmacol  55, 33-97.   https://doi.org/10.1016/S1054-3589(07)55002-7




PubMed


 


PubMed ID 17586312
    
     


 



7.
Zhang MY, Dimitrov DS (2007). Novel approaches for identification of broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies and improvement of their potency. Curr Pharm Des  13, 203-12.   https://doi.org/10.2174/138161207779313669




PubMed


 


PubMed ID 17269928
    
     


 



8.
Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH, Yang X, Zhang MY, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, Nabel GJ, Kwong PD (2007). Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature  445, 732-7.   https://doi.org/10.1038/nature05580




PubMed



        
     
Free Article


 


PubMed ID 17301785
         Pubmed Central ID 2584968 


 



9.
Zhu Z, Chakraborti S, He Y, Roberts A, Sheahan T, Xiao X, Hensley LE, Prabakaran P, Rockx B, Sidorov IA, Corti D, Vogel L, Feng Y, Kim JO, Wang LF, Baric R, Lanzavecchia A, Curtis KM, Nabel GJ, Subbarao K, Jiang S, Dimitrov DS (2007). Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc Natl Acad Sci U S A  104, 12123-8.   https://doi.org/10.1073/pnas.0701000104




PubMed



        
     
Free Article


 


PubMed ID 17620608
         Pubmed Central ID 1924550 


 



10.
Dimitrov DS (submitted in 2007) Engineered Antibody Constant Domain Molecules. Patents issued: 2250196 (CH in 2013); 602009012223 (DE in 2013); 2250196 (EP in 2013); 2250196 (FR in 2013); 2250196 (GB in 2013); 2009212747 (AU in 2014); 101977932 (CN in 2014); 8,580,927 (US in 2014); 2594584 (CH in 2015); 2594584 (DE in 2015); 2594584 (EP in 2015); 2594584 (FR in 2015); 2594584 (GB in 2015); 5889533 (JP in 2016); 2014200215 (AU in 2017); 9,527,903 (US in 2017). Patents pending: 2,713,281 (CA application); 201410422052.8 (CN application); 2818/KOLNP/2010 (IN application); 2014-112059 (JP application); PCT/US2009/032692 (PC application); 15/367,488 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=45559
361,BC010702-02,"October 01, 2006 -  September 30, 2007",HIV-1 Integrase Inhibitors,Peter P Roller; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",NULL,NULL,Yves  Pommier; PhD (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45602
362,BC010703-02,"October 01, 2006 -  September 30, 2007",Matriptase Inhibitory Agents as Anti-metastatics,Peter P Roller; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",NULL,"Robert  Dickson
(Lombardi Cancer Center, Georgetown University Medical Center)




Michael Anthony Johnson
(Information Technology Branch)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45603
363,BC010704-02,"October 01, 2006 -  September 30, 2007",Inhibition of Grb2 mediated cellular signaling,Peter P Roller; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",NULL,"Robert  Fisher
(Protein Chemistry, Saic-Frederick)




Dajun  Yang
(School of Medicine, Univ. of Michigan)",Marc C Nicklaus (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Jiang S, Li P, Lee SL, Lin CY, Long YQ, Johnson MD, Dickson RB, Roller PP (2007). Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptase. Org Lett  9, 9-12.   https://doi.org/10.1021/ol0621497




PubMed


 


PubMed ID 17192072
    
     


 



2.
Li P, Jiang S, Pero SC, Oligino L, Krag DN, Michejda CJ, Roller PP (2007). Design and synthesis of paclitaxel conjugated with an ErbB2-recognizing peptide, EC-1. Biopolymers  87, 225-30.   https://doi.org/10.1002/bip.20828




PubMed


 


PubMed ID 17879382
    
     


 



3.
Tang G, Ding K, Nikolovska-Coleska Z, Yang CY, Qiu S, Shangary S, Wang R, Guo J, Gao W, Meagher J, Stuckey J, Krajewski K, Jiang S, Roller PP, Wang S (2007). Structure-based design of flavonoid compounds as a new class of small-molecule inhibitors of the anti-apoptotic Bcl-2 proteins. J Med Chem  50, 3163-6.   https://doi.org/10.1021/jm070383c




PubMed



        
     
Free Article


 


PubMed ID 17552510
         Pubmed Central ID 2527594 


 



4.
Tang G, Yang CY, Nikolovska-Coleska Z, Guo J, Qiu S, Wang R, Gao W, Wang G, Stuckey J, Krajewski K, Jiang S, Roller PP, Wang S (2007). Pyrogallol-based molecules as potent inhibitors of the antiapoptotic Bcl-2 proteins. J Med Chem  50, 1723-6.   https://doi.org/10.1021/jm061400l




PubMed



        
     
Free Article


 


PubMed ID 17378545
         Pubmed Central ID 2536619",https://intramural.nih.gov/search/searchview.taf?ipid=45604
364,BC010706-02,"October 01, 2006 -  September 30, 2007",The immunomodulatory role of bacterial proteins,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI",Valeria  Orlova,"Brian  Geisbrecht
(Biology, University of Kansas)




Matthias  Herrmann
(Microbiology, University of Saarland)




Francis  Luscinskas
(Pathology, Harvard Medical School)




Klaus  Preissner
(Biochemistry, University Giessen)",NULL,NULL,"Ordered by publication type and then author name.



1.
Chavakis T, Preissner KT, Herrmann M (2007). The anti-inflammatory activities of Staphylococcus aureus. Trends Immunol  28, 408-18.   https://doi.org/10.1016/j.it.2007.07.002




PubMed


 


PubMed ID 17681885
    
     


 



2.
Schneider D, Liaw L, Daniel C, Athanasopoulos AN, Herrmann M, Preissner KT, Nawroth PP, Chavakis T (2007). Inhibition of breast cancer cell adhesion and bone metastasis by the extracellular adherence protein of Staphylococcus aureus. Biochem Biophys Res Commun  357, 282-8.   https://doi.org/10.1016/j.bbrc.2007.03.143




PubMed



        
     
Free Article


 


PubMed ID 17418809
         Pubmed Central ID 1913187",https://intramural.nih.gov/search/searchview.taf?ipid=45581
365,BC010707-02,"October 01, 2006 -  September 30, 2007",Role of T regulatory suppression in autoimmunity and cancer,"Joost J Oppenheim; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Christina  Burks




Tiziana  Cavinato




Xin  Chen




Ola Mae Zack Howard




Jie  Li




Poonam  Tewary



Show all 7","Robert  Goldman
(Peptides, Peprotech)




Michael  Kron
(Michigan State University, East Lansing, MI)




Daniela  Maennel
(Immunology, University of Regensburg)




Kouji  Matsushima
(Molecular Preventive Medicine, University of Toyko)




Tom  Wakatsuki
(Biotechnology Core, University of Wisconsin)",Howard A Young; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45565
366,BC010708-02,"October 01, 2006 -  September 30, 2007",Consequences of receptor cross talk on inflammation and algesia,"Joost J Oppenheim; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Christina  Burks




Ola Mae Zack Howard




Krisztina  Kormondine Buzas




Thomas J Rogers","Robert  Goldman
(Peptides, Peprotech)




Michael  Kron
(Michigan State University, East Lansing, MI)




Kouji  Matsushima
(Molecular Preventive Medicine, University of Toyko)




Thomas  Rogers
(Center for Drug Abuse, Temple University)",Howard A Young; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45566
367,BC010709-02,"October 01, 2006 -  September 30, 2007",An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Laurie  Steffen



Robyn S Bent","Gerard  Gioia
(Neuropschology, CNMC)




Roger  Packer
(Neurology, CNMC)","Paul Stuart Albert (National Cancer Institute)



Pamela  Wolters (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



Stephen J Chanock; MD, PhD (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)



Deborah E Citrin (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45606
368,BC010712-02,"October 01, 2006 -  September 30, 2007",Breast Cancer Prevention,Sandra M Swain; MD,NULL,"Medical Oncology Branch, NCI",NULL,"Robert  Chatterton
(Robert H. Lurie Comprehensive Cancer Center, Northwestern University)




Stephen D Hursting; PhD, MPH
(Epidemiology and Carcinogenesis, NCI)




V.  Jordan
(Medical Oncology, Fox Chase Cancer Center)","Barbara V Vonderhaar; PhD (National Cancer Institute)



Katherine Rainsford Calvo (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)



Ashley W Smith (National Cancer Institute)



Jo Anne N Zujewski (National Cancer Institute)



Jessica M Faupel-Badger (National Cancer Institute)","Ahalya  Premkumar (CC) 



Pamela  Stratton; MD (NICHD) 



Catherine K Chow; MD (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45572
369,BC010714-02,"October 01, 2006 -  September 30, 2007",Angiogenesis imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Hisataka  Kobayashi



Marcelino  Bernardo



Tristan  Barrett



Gregory C Ravizzini",NULL,"William Marston Linehan; MD (National Cancer Institute)



William Laurence Dahut; MD (National Cancer Institute)",David M Thomasson; PhD (CC),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45582
370,BC010715-02,"October 01, 2006 -  September 30, 2007",Phase II study of flavopiridol in mantle cell lymphoma and DLBCL,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,"Elaine S Jaffe; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Miljkovic MD, Roschewski M, Dunleavy K, Wilson WH (2019) Hybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphoma. Leuk Lymphoma, in press (e-pub ahead of print)  https://doi.org/10.1080/10428194.2019.1627540




PubMed



               Available in future as a Free Article 


 


PubMed ID 31204529
         Pubmed Central ID 6917991",https://intramural.nih.gov/search/searchview.taf?ipid=45607
371,BC010716-02,"October 01, 2006 -  September 30, 2007",Phase III study of BCL-family inhibitors in lymphoma,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)



Elaine S Jaffe; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45608
372,BC010717-02,"October 01, 2006 -  September 30, 2007",Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)



Elaine S Jaffe; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45609
373,BC010719-02,"October 01, 2006 -  September 30, 2007",Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,"Elaine S Jaffe; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45610
374,BC010720-02,"October 01, 2006 -  September 30, 2007","Isolation, Characterization, and Behavior of Melanocyte and Melanoma Stem Cells",Thomas J Hornyak,NULL,"Dermatology Branch, NCI","Shunlin  Jiang



Ha-Young  Hwang",NULL,Glenn  Merlino; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45588
375,BC010721-02,"October 01, 2006 -  September 30, 2007",Modeling of the structure and functional mechanisms of voltage-gated channels,Homer Robert Guy; PhD,NULL,"Laboratory of Cell Biology, NCI",Adina L Milac,"Angie  Gelli
(Dept of Pharmacology, School of Medicine, Univ Calif, Davis)




Steffen  Hering
(Institut für Pharmakologie und Toxikologie, Universität Wien)




Gea-Ny  Tseng
(Physiology, Virginia Commonwealth Univ)",NULL,NULL,"Ordered by publication type and then author name.



1.
Beyl S, Timin EN, Hohaus A, Stary A, Kudrnac M, Guy RH, Hering S   (2007) Probing the architecture of an L-type calcium channel with a charged phenylalkylamine: evidence for a widely open pore and drug trapping.  J Biol Chem 282:3864-70.




PubMed



        
     
Free Article


 


PubMed ID 17138559
         Pubmed Central ID 3189693 


 



2.
Tseng GN, Sonawane KD, Korolkova YV, Zhang M, Liu J, Grishin EV, Guy HR (2007). Probing the outer mouth structure of the HERG channel with peptide toxin footprinting and molecular modeling. Biophys J  92, 3524-40.   https://doi.org/10.1529/biophysj.106.097360




PubMed



        
     
Free Article


 


PubMed ID 17293393
         Pubmed Central ID 1853143",https://intramural.nih.gov/search/searchview.taf?ipid=45586
376,BC010722-02,"October 01, 2006 -  September 30, 2007",Modeling of amyloid peptides and proteins,Homer Robert Guy; PhD,NULL,"Laboratory of Cell Biology, NCI",Sijung  Yun,"Andriy  Anishkin
(Biology, Univ Maryland, College Park)




Nelson  Arispe
(Anat/Physiol/Genet, Uniformed Serv Univ Hlth Sci)




Harvey  Pollard
(Anat/Physiol/Genet, Uniformed Serv Univ Hlth Sci)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45587
377,BC010723-02,"October 01, 2006 -  September 30, 2007",Role chemoattractant receptors in inflammatory aspects of neurodegenerative Dise,"Ji Ming  Wang; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Wang-Hua  Gong



Keqiang  Chen",NULL,NULL,Philip M Murphy; MD (NIAID),"Ordered by publication type and then author name.



1.
Chen K, Huang J, Liu Y, Gong W, Cui Y, Wang JM (2009). Synergy of TRIF-dependent TLR3 and MyD88-dependent TLR7 in up-regulating expression of mouse FPR2, a promiscuous G-protein-coupled receptor, in microglial cells. J Neuroimmunol  213, 69-77.   https://doi.org/10.1016/j.jneuroim.2009.05.018




PubMed



        
     
Free Article


 


PubMed ID 19559490
         Pubmed Central ID 2761824 


 



2.
Iribarren P, Chen K, Gong W, Cho EH, Lockett S, Uranchimeg B, Wang JM (2007). Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia. Neurobiol Dis  27, 90-8.   https://doi.org/10.1016/j.nbd.2007.04.010




PubMed



        
     
Free Article


 


PubMed ID 17544285
         Pubmed Central ID 1989777",https://intramural.nih.gov/search/searchview.taf?ipid=45573
378,BC010724-02,"October 01, 2006 -  September 30, 2007",Chemotactic Formylpeptide Receptor DevelopmentProgression Malignant Human Gliom,"Ji Ming  Wang; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Wang-Hua  Gong



Keqiang  Chen","Xiuwu  Bian
(Southwest Hospital, Institute of Pathology)




Chunfu  Wu
(Medicinal Chemistry, Shenyang Pharmaceutical University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Huang J, Hu J, Bian X, Chen K, Gong W, Dunlop NM, Howard OM, Wang JM (2007). Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells. Cancer Res  67, 5906-13.   https://doi.org/10.1158/0008-5472.CAN-07-0691




PubMed


 


PubMed ID 17575160",https://intramural.nih.gov/search/searchview.taf?ipid=45574
379,BC010725-02,"October 01, 2006 -  September 30, 2007",Role of Formylpeptide Receptors in Host Defense,"Ji Ming  Wang; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Nancy M Dunlop



Wang-Hua  Gong



Keqiang  Chen","Yingying  Le
(Immunology, Institute for Nutritional Sciences)




Gert  Schmid-Schonbein
(Whitaker Institute, UC San Diego)




Chunfu  Wu
(Medicinal Chemistry, Shenyang Pharmaceutical University)",NULL,Philip M Murphy; MD (NIAID),"Ordered by publication type and then author name.



1.
Iribarren P, Chen K, Gong W, Cho EH, Lockett S, Uranchimeg B, Wang JM (2007). Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia. Neurobiol Dis  27, 90-8.   https://doi.org/10.1016/j.nbd.2007.04.010




PubMed



        
     
Free Article


 


PubMed ID 17544285
         Pubmed Central ID 1989777",https://intramural.nih.gov/search/searchview.taf?ipid=45575
380,BC010727-02,"October 01, 2006 -  September 30, 2007",Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI","Alesia J Holly



Sang Bong  Lee



Gabriela  Kramer-Marek","Wei  Chen
(Department of Physics, The University of Texas at Arlington)




Wei  Chen
(Department of Physics, The University of Texas at Arlington)




Fredrik  Nilsson
(Affibody AB)




Alok  Singh
(Center for Bio/Molecular Science & Engineering, Naval Research Laboratory)",Robert  Blumenthal; PhD (National Cancer Institute),"Peter  Herscovitch; MD (CC) 



Moinuddin  Hassan; PhD (NICHD) 



Dale Oscar Kiesewetter; BS, PhD (NIBIB)","Ordered by publication type and then author name.



1.
Capala J, Kiesewetter D, Kramer-Marek G, Lee S (submitted in 2007) Radiolabeling Affibody Molecules. Patent issued: 8,303,960 (US in 2013). Patents pending: 13/608,054 (US application); PCT/US2008/055144 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45580
381,BC010728-02,"October 01, 2006 -  September 30, 2007",Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,"Bruce Allan Chabner





Bruce  Cheson
(NCI)




Myron  Czuczman
(Oncology, Roswell Park Cancer Institute)




Andrew  Zelenetz
(Medicine, MSKCC)","Louis  Staudt; MD (Lymphoid Malignancies Branch)



Elaine S Jaffe; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45611
382,BC010729-02,"October 01, 2006 -  September 30, 2007",Technology Development,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",NULL,"Jon  Cohen
(Diagnostics, 2020 GeneSystems, Inc)




Benjamin  Shapiro
(Engineering, University of Maryland)




Elisabeth  Smela
(Engineering, University of Maryland)",NULL,Robert F Bonner; PhD (NICHD),"Ordered by publication type and then author name.



1.
Gannot G, Tangrea MA, Erickson HS, Pinto PA, Hewitt SM, Chuaqui RF, Gillespie JW, Emmert-Buck MR (2007). Layered peptide array for multiplex immunohistochemistry. J Mol Diagn  9, 297-304.   https://doi.org/10.2353/jmoldx.2007.060143




PubMed



        
     
Free Article


 


PubMed ID 17591928
         Pubmed Central ID 1899424",https://intramural.nih.gov/search/searchview.taf?ipid=45560
383,BC010731-02,"October 01, 2006 -  September 30, 2007",In Vivo MRI imaging of single metastatic cells,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Ivy (Juan Juan)  Yin



Kirsten  Tracy",NULL,NULL,Alan Paul Koretsky; PhD (NINDS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45562
384,BC010732-02,"October 01, 2006 -  September 30, 2007",The Drosophilia Lgl tumor model as a functional screen for metastasis genes,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Elizabeth  Woodhouse; PhD,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45563
385,BC010733-02,"October 01, 2006 -  September 30, 2007",Dermatoscopy in the Management of Xeroderma Pigmentosum,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",NULL,NULL,"Kenneth H Kraemer; MD (National Cancer Institute)



John  Digiovanna (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45589
386,BC010734-02,"October 01, 2006 -  September 30, 2007",Growth of Dermal Neurofibromas in Neurofibromatosis Type I,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,"Douglas Russell Stewart; BA, MD (NHGRI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45590
387,BC010735-02,"October 01, 2006 -  September 30, 2007",Structural studies of fimbriae of enterotoxigenic E. coli (ETEC),"Di S Xia; PhD, MS, BS



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Lothar  Esser



Kazuya  Nishio",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Li Y   (2007) Receptor-Binding Site as Revealed by the Crystal Structure of CfaE, the CFA/I Fimbrial Adhesin of Enterotoxigenic Escherichia coli.  Journal of Biological Chemistry  23970-23980 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=45577
388,BC010736-02,"October 01, 2006 -  September 30, 2007",Using mouse knockouts to unravel endothelial gene function,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45605
389,BC010737-02,"October 01, 2006 -  September 30, 2007",IFN-lambda signal transduction,Ana M Gamero,Howard A Young; PhD,"Laboratory of Experimental Immunology, NCI",Anthony J Scarzello,NULL,Paul  Goldsmith; PhD (National Cancer Institute),Raymond  Donnelly (OD),"Ordered by publication type and then author name.



1.
Maher SG, Romero-Weaver AL, Scarzello AJ, Gamero AM (2007). Interferon: cellular executioner or white knight? Curr Med Chem  14, 1279-89.   https://doi.org/10.2174/092986707780597907




PubMed


 


PubMed ID 17504213",https://intramural.nih.gov/search/searchview.taf?ipid=45584
390,BC010738-02,"October 01, 2006 -  September 30, 2007","Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging","Steven X Hou



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI",NULL,"Neal  Copeland
(Institute of Molecular and Cell Biology)




Nancy  Jenkins
(Institute of Molecular and Cell Biology)",Lino  Tessarollo (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Hou X, Liu W   (2007) The Adult Drosophila Malpighian Tubules Are Maintained by Multipotent Stem Cells.  Cell Stem Cell  191-203 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=45591
391,BC010739-02,"October 01, 2006 -  September 30, 2007",Structural Studies of Drug Agents by Nuclear Magnetic Resonance Spectroscopy,Joseph John Barchi,Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI",NULL,NULL,"Sandra  Smith-Gill; MS, PhD, BS (National Cancer Institute)",Adriaan  Bax; PhD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45579
392,BC010740-02,"October 01, 2006 -  September 30, 2007",Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,"Jeffrey  Gildersleeve



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Oyindasola O Oyelaran



Qian  Li","Daniel  Devine
(Company, Acceptys)




Lara  Mahal
(Chemistry, University of Texas at Austin)",Christoph  Rader; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Manimala JC, Roach TA, Li Z, Gildersleeve JC (2007). High-throughput carbohydrate microarray profiling of 27 antibodies demonstrates widespread specificity problems. Glycobiology  17, 17C-23C.   https://doi.org/10.1093/glycob/cwm047




PubMed


 


PubMed ID 17483136",https://intramural.nih.gov/search/searchview.taf?ipid=45585
393,BC010742-02,"October 01, 2006 -  September 30, 2007",Utilizing Glycosyltransferases for Bioconjugation,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Elizabeth  Boeggeman



Boopathy  Ramakrishna



Maria Rita Manzoni",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45600
394,BC010743-02,"October 01, 2006 -  September 30, 2007",Metabolic Mechanisms for Programmed Cell Death,"James Ming Phang; MD



IRP Faculty Profile",NULL,"Laboratory of Comparative Carcinogenesis, NCI","Steven  Donald



Gregory L Borchert



Yongmin  Liu



Jui  Pandhare



Olga  Zabirnyk



Anit  Sharma","Chien-An  Hu
(Biochemistry & Molecular Biology, U. New Mexico School of Medicine)




David  Valle
(Human Genetics, Johns Hopkins University School of Medicine)",NULL,NULL,"Ordered by publication type and then author name.



1.
Phang JM (2008). Introduction to second proline symposium. Amino Acids  35, 653-4.   https://doi.org/10.1007/s00726-008-0103-0




PubMed



        
     
Free Article


 


PubMed ID 18491029
         Pubmed Central ID 2692295",https://intramural.nih.gov/search/searchview.taf?ipid=45569
395,BC010744-02,"October 01, 2006 -  September 30, 2007",Regulation of Proline Oxidase for Bioenergetics during Nutrient Stress,"James Ming Phang; MD



IRP Faculty Profile",NULL,"Laboratory of Comparative Carcinogenesis, NCI","Steven  Donald



Jui  Pandhare



Olga  Zabirnyk",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45570
396,BC010746-02,"October 01, 2006 -  September 30, 2007",Extracellular Matrix and Stress Substrates: the Role of Prolidase,"James Ming Phang; MD



IRP Faculty Profile",NULL,"Laboratory of Comparative Carcinogenesis, NCI","Steven  Donald



Gregory L Borchert



Yongmin  Liu



Olga  Zabirnyk



Patrick P Mccue",NULL,Konstantin V Salnikow (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45571
397,BC010747-02,"October 01, 2006 -  September 30, 2007",Charaterization of the Expression and Ligands of KIR3DS1,"Daniel  McVicar; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Laura Ann R Quigley




Eriko  Yamada","Marcus  Altfeld
(Infectious Disease Unit, Partners AIDS Research Center)




Sarah  Rowland-Jones
(Weatherall Institute of Molecular Medicine, John Radcliffe Hospital)","Stephen K Anderson; PhD (National Cancer Institute)












Mary  Carrington; MS, PhD  (Laboratory of Genomic Diversity)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45564
398,BC010748-02,"October 01, 2006 -  September 30, 2007",Clinical investigation of signal transduction inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI","Gideon Michael Blumenthal



Wendy B Bernstein",NULL,"Ilona  Linnoila; MD (National Cancer Institute)



Stephen M Hewitt; MD, PhD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)



Joanna H Shih (National Cancer Institute)



Frederic  Kaye; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Gills JJ, Lopiccolo J, Tsurutani J, Shoemaker RH, Best CJ, Abu-Asab MS, Borojerdi J, Warfel NA, Gardner ER, Danish M, Hollander MC, Kawabata S, Tsokos M, Figg WD, Steeg PS, Dennis PA (2007). Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin Cancer Res  13, 5183-94.   https://doi.org/10.1158/1078-0432.CCR-07-0161




PubMed


 


PubMed ID 17785575
    
     


 



2.
Lopiccolo J, Ballas MS, Dennis PA (2007). PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug development. Crit Rev Oncol Hematol  63, 203-14.   https://doi.org/10.1016/j.critrevonc.2007.06.002




PubMed


 


PubMed ID 17643312
    
     


 



3.
LoPiccolo J, Granville CA, Gills JJ, Dennis PA (2007). Targeting Akt in cancer therapy. Anticancer Drugs  18, 861-74.   https://doi.org/10.1097/CAD.0b013e3280cc2c6f




PubMed


 


PubMed ID 17667591",https://intramural.nih.gov/search/searchview.taf?ipid=45558
399,BC010749-02,"October 01, 2006 -  September 30, 2007",DNA Vaccines,"George N Pavlakis; MD, PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Agneta S Von Gegerfelt



Margherita  Rosati



Antonio L Valentin



Cristina  Bergamaschi



Gen-Mu  Zhang



Jeffery Sandor Smith","J. Thomas  August
(Molecular Biology and Genetics Department, Johns Hopkins University School of Medicine)




Ronald  Desrosiers
(New England Primate Research Center)




Michael  Egan
(Wyeth Lederle Vaccines)




John  Eldridge
(Wyeth Lederle Vaccines)




R. Paul  Johnson
(New England Primate Research Center)




Amitinder  Kaur
(New England Primate Research Center)


Show all 13","Barbara K Felber (National Cancer Institute)



Genoveffa  Franchini; MD (National Cancer Institute)



Marjorie  Robert-Guroff; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chong SY, Egan MA, Kutzler MA, Megati S, Masood A, Roopchard V, Garcia-Hand D, Montefiori DC, Quiroz J, Rosati M, Schadeck EB, Boyer JD, Pavlakis GN, Weiner DB, Sidhu M, Eldridge JH, Israel ZR (2007). Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. Vaccine  25, 4967-82.   https://doi.org/10.1016/j.vaccine.2006.11.070




PubMed


 


PubMed ID 17335943
    
     


 



2.
Luckay A, Sidhu MK, Kjeken R, Megati S, Chong SY, Roopchand V, Garcia-Hand D, Abdullah R, Braun R, Montefiori DC, Rosati M, Felber BK, Pavlakis GN, Mathiesen I, Israel ZR, Eldridge JH, Egan MA (2007). Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol  81, 5257-69.   https://doi.org/10.1128/JVI.00055-07




PubMed



        
     
Free Article


 


PubMed ID 17329330
         Pubmed Central ID 1900241 


 



3.
Pavlakis G, Rosati M, Kulkarni V, Patel V, Bergamaschi C, Valentin A, Zhang G, Sidhu M, Eldridge J, Weiner D, Felber B   (2007) Efficient systemic expression of bioactive IL-15 in mice upon delivery of optimized DNA expression plasmids.  DNA Cell Biol, in press.




 



4.
Robinson TM, Sidhu MK, Pavlakis GN, Felber BK, Silvera P, Lewis MG, Eldridge J, Weiner DB, Boyer JD (2007). Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses. J Med Primatol  36, 276-84.   https://doi.org/10.1111/j.1600-0684.2007.00245.x




PubMed


 


PubMed ID 17669216
    
     


 



5.
von Gegerfelt AS, Rosati M, Alicea C, Valentin A, Roth P, Bear J, Franchini G, Albert PS, Bischofberger N, Boyer JD, Weiner DB, Markham P, Israel ZR, Eldridge JH, Pavlakis GN, Felber BK (2007). Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization. J Virol  81, 1972-9.   https://doi.org/10.1128/JVI.01990-06




PubMed



        
     
Free Article


 


PubMed ID 17135321
         Pubmed Central ID 1797580 


 



6.
Pavlakis GN, Felber BN (submitted in 2007) Improved Dna Vaccination Protocol. Patent issued: 8,586,055 (US in 2014). Patent pending: 60/934,366 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45567
400,BC010750-02,"October 01, 2006 -  September 30, 2007",HIV Molecular Biology and Pathogenic Mechanisms of AIDS,"George N Pavlakis; MD, PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Antonio L Valentin



Vainav Vikram Patel



Hiroaki  Uranishi



Jeffery Sandor Smith","Angelos  Hatzakis
(University of Athens Medical School)




George  Panayotou
(Molecular Oncology, Alexander Fleming Biomedicine Sciences Research Center)




Ralf  Schneider
(GSF-National Research Center for Environment and Health)","Barbara K Felber (National Cancer Institute)



Robert  Yarchoan; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Felber BK, Zolotukhin AS, Pavlakis GN (2007). Posttranscriptional control of HIV-1 and other retroviruses and its practical applications. Adv Pharmacol  55, 161-97.   https://doi.org/10.1016/S1054-3589(07)55005-2




PubMed


 


PubMed ID 17586315
    
     


 



2.
Gragerov A, Horie K, Pavlova M, Madisen L, Zeng H, Gragerova G, Rhode A, Dolka I, Roth P, Ebbert A, Moe S, Navas C, Finn E, Bergmann J, Vassilatis DK, Pavlakis GN, Gaitanaris GA (2007). Large-scale, saturating insertional mutagenesis of the mouse genome. Proc Natl Acad Sci U S A  104, 14406-11.   https://doi.org/10.1073/pnas.0700608104




PubMed



        
     
Free Article


 


PubMed ID 17720809
         Pubmed Central ID 1964832",https://intramural.nih.gov/search/searchview.taf?ipid=45568
401,BC010752-02,"October 01, 2006 -  September 30, 2007",Anti-angiogenesis targeted vaccine therapy,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI","Jiahua  Qian



Yufei  Jiang",NULL,Michael  Birrer (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45592
402,BC010755-02,"October 01, 2006 -  September 30, 2007",Enhancing immune response strategies:,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",Raed Nabil Samara,NULL,"Yuk Ying S Pang (National Cancer Institute)



Franklin R Grollman (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)



John  Schiller; PhD (National Cancer Institute)



Masaki  Terabe (National Cancer Institute)",Francesco M. Marincola; MD (CC),"Ordered by publication type and then author name.



1.
Toubaji A, Hill S, Terabe M, Qian J, Floyd T, Simpson RM, Berzofsky JA, Khleif SN (2007). The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection. Vaccine  25, 5882-91.   https://doi.org/10.1016/j.vaccine.2007.05.040




PubMed


 


PubMed ID 17602804
    
     


 



2.
Zdanov S, Mandapathil M, Abu Eid R, Adamson-Fadeyi S, Wilson W, Qian J, Carnie A, Tarasova N, Mkrtichyan M, Berzofsky JA, Whiteside TL, Khleif SN (2016). Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells. Cancer Immunol Res  4, 354-65.   https://doi.org/10.1158/2326-6066.CIR-15-0241




PubMed



        
     
Free Article


 


PubMed ID 26880715
         Pubmed Central ID 4884020",https://intramural.nih.gov/search/searchview.taf?ipid=45593
403,BC010756-02,"October 01, 2006 -  September 30, 2007",Development a combined prophylactic and therapeutic cervical cancer vaccine u,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",Jiahua  Qian,NULL,"Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



John  Schiller; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45594
404,BC010757-02,"October 01, 2006 -  September 30, 2007",Clinical trial development in cancer vaccines,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",NULL,"Vincent  Herrin; MD





Charles  Levenbach
(Gynecologic Oncology, MD Anderson)




Joe  Lucci
(Gynecologic Oncology, University of Florida)




Therresa  Whiteside
(Immuunoligy, University of Pittsburg)","Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Franklin R Grollman (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45595
405,BC010758-02,"October 01, 2006 -  September 30, 2007",Monitoring of Basic Biochemical Processes at Single Molecule Level Using Light-e,"Mikhail V Kashlev



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Celine Marguerite Paulette Walmacq,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45561
406,BC010759-02,"October 01, 2006 -  September 30, 2007",Functional genomics of cancer,"Paul S Meltzer; MD, PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sarah L Anzick; PhD



John E Lueders



Yidong  Chen; PhD



Yuan  Jiang; MD



John R Cornelison



Robert L Walker; BS



Show all 11","Rosemary  Balleine
(Translational Oncology, Westmead Hospital)




Laurakay  Bruhn
(Genomics Institute, Agilent Technologies)




Michael  Choti
(Surgery, Johns Hopkins University)




Greg  Crawford; PhD
(Duke)




Ed  DeFabo
(Environmental and Occupational Health, George Washington University)




Jian-Bing  Fang
(Medicine, Illumina)


Show all 7","Gordon Lee Hager; PhD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)



Sheueyann  Cheng; PhD (National Cancer Institute)



Sharon Ann Savage (National Cancer Institute)



Michael Marc Gottesman; MD (Laboratory of Cell Biology)



Elaine S Jaffe; MD (National Cancer Institute)","Jeffery L Miller; MD (NIDDK) 



Judith L Rapoport; MD (NIMH)","Ordered by publication type and then author name.



1.
Bruce B, Khanna G, Ren L, Landberg G, Jirström K, Powell C, Borczuk A, Keller ET, Wojno KJ, Meltzer P, Baird K, McClatchey A, Bretscher A, Hewitt SM, Khanna C (2007). Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis  24, 69-78.   https://doi.org/10.1007/s10585-006-9050-x




PubMed


 


PubMed ID 17370041
    
     


 



2.
Davis S, Meltzer PS (2007). GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics  23, 1846-7.   https://doi.org/10.1093/bioinformatics/btm254




PubMed


 


PubMed ID 17496320
    
     


 



3.
Davis SR, Meltzer PS (2007). Modeling synovial sarcoma: timing is everything. Cancer Cell  11, 305-7.   https://doi.org/10.1016/j.ccr.2007.03.016




PubMed


 


PubMed ID 17418406
    
     


 



4.
Horak CE, Lee JH, Elkahloun AG, Boissan M, Dumont S, Maga TK, Arnaud-Dabernat S, Palmieri D, Stetler-Stevenson WG, Lacombe ML, Meltzer PS, Steeg PS (2007). Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. Cancer Res  67, 7238-46.   https://doi.org/10.1158/0008-5472.CAN-07-0962




PubMed


 


PubMed ID 17671192
    
     


 



5.
Johnston JJ, Walker RL, Davis S, Facio F, Turner JT, Bick DP, Daentl DL, Ellison JW, Meltzer PS, Biesecker LG (2007). Zoom-in comparative genomic hybridisation arrays for the characterisation of variable breakpoint contiguous gene syndromes. J Med Genet  44, e59.   https://doi.org/10.1136/jmg.2006.042473




PubMed



        
     
Free Article


 


PubMed ID 17098889
         Pubmed Central ID 2597909 


 



6.
Kamradt J, Jung V, Wahrheit K, Tolosi L, Rahnenfuehrer J, Schilling M, Walker R, Davis S, Stoeckle M, Meltzer P, Wullich B (2007). Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH. PLoS One  2, e769.   https://doi.org/10.1371/journal.pone.0000769




PubMed



        
     
Free Article


 


PubMed ID 17712417
         Pubmed Central ID 1940319 


 



7.
Kim KT, Baird K, Davis S, Piloto O, Levis M, Li L, Chen P, Meltzer P, Small D (2007). Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells. Br J Haematol  138, 603-15.   https://doi.org/10.1111/j.1365-2141.2007.06696.x




PubMed


 


PubMed ID 17686054
    
     


 



8.
Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, Rosenthal DT, Dissanayake SK, Earley R, Indig FE, Nickoloff BJ, Taub DD, Kallioniemi OP, Meltzer P, Morin PJ, Weeraratna AT (2007). Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene  26, 3846-56.   https://doi.org/10.1038/sj.onc.1210155




PubMed


 


PubMed ID 17160014
    
     


 



9.
Meltzer P   (2007) Is Ewing's Sarcoma a Stem Cell Tumor?  Cell Stem Cell  13-15 pp.




 



10.
Quignodon L, Grijota-Martinez C, Compe E, Guyot R, Allioli N, Laperrière D, Walker R, Meltzer P, Mader S, Samarut J, Flamant F (2007). A combined approach identifies a limited number of new thyroid hormone target genes in post-natal mouse cerebellum. J Mol Endocrinol  39, 17-28.   https://doi.org/10.1677/JME-06-0054




PubMed


 


PubMed ID 17601882",https://intramural.nih.gov/search/searchview.taf?ipid=45598
407,BC010761-02,"October 01, 2006 -  September 30, 2007",Studies of Proteins with Important Roles in Immunology andor Cancer Biology,Jacek Tadeusz Lubkowski,NULL,"Macromolecular Crystallography Laboratory, NCI","Marzena E Pazgier



James L Gattis



Cyril  Barinka",NULL,"Daniel  McVicar; PhD (National Cancer Institute)



Paul A Randazzo; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Barinka C, Parry G, Callahan J, Shaw DE, Kuo A, Bdeir K, Cines DB, Mazar A, Lubkowski J (2006). Structural basis of interaction between urokinase-type plasminogen activator and its receptor. J Mol Biol  363, 482-95.   https://doi.org/10.1016/j.jmb.2006.08.063




PubMed



        
     
Free Article


 


PubMed ID 16979660
         Pubmed Central ID 3443620 


 



2.
Barinka C, Rovenská M, Mlcochová P, Hlouchová K, Plechanovová A, Majer P, Tsukamoto T, Slusher BS, Konvalinka J, Lubkowski J (2007). Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II. J Med Chem  50, 3267-73.   https://doi.org/10.1021/jm070133w




PubMed


 


PubMed ID 17567119
    
     


 



3.
Barinka C, Starkova J, Konvalinka J, Lubkowski J (2007). A high-resolution structure of ligand-free human glutamate carboxypeptidase II. Acta Crystallogr Sect F Struct Biol Cryst Commun  63, 150-3.   https://doi.org/10.1107/S174430910700379X




PubMed



        
     
Free Article


 


PubMed ID 17329803
         Pubmed Central ID 2330195 


 



4.
Lubkowski J, Durbin SV, Silva MC, Farnsworth D, Gildersleeve JC, Oliva ML, Wlodawer A (2017). Structural analysis and unique molecular recognition properties of a Bauhinia forficata lectin that inhibits cancer cell growth. FEBS J  284, 429-450.   https://doi.org/10.1111/febs.13989




PubMed



        
     
Free Article


 


PubMed ID 27973758
         Pubmed Central ID 6257985",https://intramural.nih.gov/search/searchview.taf?ipid=45597
408,BC010762-02,"October 01, 2006 -  September 30, 2007",Molecular Alterations of Primary Breast Cancer and Metastasis,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",Linda S Wrathall,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45599
409,BC010763-02,"October 01, 2006 -  September 30, 2007",Building on the success of the adoptive immunotherapy of cancer,"Nicholas Phillip Restifo; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Zhiya  Yu



Nadrian F Teclar



Douglas  Palmer



Luca  Gattinoni



Claudia  Wrzesinski



Chrystal  Paulos



Show all 8",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Restifo NP, Cassard LP, Rosenberg SP, Yu ZP (submitted in 2007) Gp100-specific T Cell Receptors And Related Materials And Methods Of Use. Patents issued: 8,216,565 (US in 2012); 8,613,932 (US in 2014); 2,674,445 (CA in 2016); 9,522,948 (US in 2017). Patent pending: PCT/US2008/050841 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=45601
410,BC010764-02,"October 01, 2006 -  September 30, 2007",Pediatric Oncology Branch Clinical Care and Education,Alan S Wayne; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Joanne A Derdak



Barbara V Wise



Kristin  Baird","James F Casella; MD
(The Johns Hopkins University School of Medicine)




Kenneth  Cohen
(Pediatric Oncology, Johns Hopkins University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Fadeyi EA, De Los Angeles Muniz M, Wayne AS, Klein HG, Leitman SF, Stroncek DF (2007). The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion  47, 545-50.   https://doi.org/10.1111/j.1537-2995.2006.01148.x




PubMed


 


PubMed ID 17319838
    
     


 



2.
Ise T, Nagata S, Kreitman RJ, Wilson WH, Wayne AS, Stetler-Stevenson M, Bishop MR, Scheinberg DA, Rassenti L, Kipps TJ, Kyle RA, Jelinek DF, Pastan I (2007). Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma. Leukemia  21, 169-74.   https://doi.org/10.1038/sj.leu.2404445




PubMed


 


PubMed ID 17051241
    
     


 



3.
Paz-Priel I, Long L, Helman LJ, Mackall CL, Wayne AS (2007). Thromboembolic events in children and young adults with pediatric sarcoma. J Clin Oncol  25, 1519-24.   https://doi.org/10.1200/JCO.2006.06.9930




PubMed


 


PubMed ID 17442994
    
     


 



4.
Wiener LS, Steffen-Smith E, Fry T, Wayne AS (2007). Hematopoietic stem cell donation in children: a review of the sibling donor experience. J Psychosoc Oncol  25, 45-66.   https://doi.org/10.1300/J077v25n01_03




PubMed



        
     
Free Article


 


PubMed ID 17360315
         Pubmed Central ID 2367259",https://intramural.nih.gov/search/searchview.taf?ipid=45576
411,BC010766-01,"October 01, 2006 -  September 30, 2007",High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy,Udai S Kammula,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Danielle  Hari



Simon  Choi",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50313
412,BC010767-01,"October 01, 2006 -  September 30, 2007",Biosynthesis of Selenocysteine and Its Incorporation into Protein,"Dolph Lee Hatfield; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Bradley A Carlson



Xueming  Xu","Marla  Berry
(Molecular Biology, U of Hawaii)




Vadim  Gladyshev
(Department of Biochemistry, University of Nebraska)




Ulrich  Schweizer
(Neuroscience Research Center and, Charit-Universittsmedizin Berlin)",NULL,NULL,"Ordered by publication type and then author name.



1.
Carlson BA, Lee BJ, Hatfield DL (2008). Ribosomal frameshifting in response to hypomodified tRNAs in Xenopus oocytes. Biochem Biophys Res Commun  375, 86-90.   https://doi.org/10.1016/j.bbrc.2008.07.118




PubMed



        
     
Free Article


 


PubMed ID 18675785
         Pubmed Central ID 2674873 


 



2.
Hatfield D, Berry M, Block E, Boayke H, Carlson B, Gailer J, George G, Gladyshev V, Jacobsen N, Johnson S, Kahakachchi C, Kaminski R, Manley S, Mix H, Pickering I, Prenner E, Saira K, Skowronska A, Tyson J, Uden P, Wu O, Xu X, Yamdagni R, Zhang Y   (2007) Insights into the chemical biology of selenium.  Phosphorous Sulfur Silicon Relat Elem, in press.




 



3.
Hatfield D, Carlson B, Zhang Y, Mix H, Kryukov G, Glass R, Berry M, Gladyshev V   (2007) New developments in selenium biochemistry: Selenocysteine biosynthesis in  eukaryotes and archaea.  Biol Trace Elem Res, in press.




 



4.
Le DT, Liang X, Fomenko DE, Raza AS, Chong CK, Carlson BA, Hatfield DL, Gladyshev VN (2008). Analysis of methionine/selenomethionine oxidation and methionine sulfoxide reductase function using methionine-rich proteins and antibodies against their oxidized forms. Biochemistry  47, 6685-94.   https://doi.org/10.1021/bi800422s




PubMed



        
     
Free Article


 


PubMed ID 18505275
         Pubmed Central ID 2844923 


 



5.
Xu XM, Carlson BA, Irons R, Mix H, Zhong N, Gladyshev VN, Hatfield DL (2007). Selenophosphate synthetase 2 is essential for selenoprotein biosynthesis. Biochem J  404, 115-20.   https://doi.org/10.1042/BJ20070165




PubMed



        
     
Free Article


 


PubMed ID 17346238
         Pubmed Central ID 1868833 


 



6.
Xu XM, Carlson BA, Mix H, Zhang Y, Saira K, Glass RS, Berry MJ, Gladyshev VN, Hatfield DL (2007). Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol  5, e4.   https://doi.org/10.1371/journal.pbio.0050004




PubMed



        
     
Free Article


 


PubMed ID 17194211
         Pubmed Central ID 1717018",https://intramural.nih.gov/search/searchview.taf?ipid=50315
413,BC010768-01,"October 01, 2006 -  September 30, 2007","Isolation, Propagation and Characterization of Breast Stem Cells",Barbara V Vonderhaar; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Erika P Ginsburg



Matthew J Meyer



Jodie  Fleming



Tyler C Miller","Jennifer  Eng-Wong; MD





Valerie  Weaver
(Center for Bioengineering and Tissue Regeneration, UC-San Francisco)","Michael  Dean; PhD (National Cancer Institute)



Suparna B Wedam (National Cancer Institute)



David  Danforth (National Cancer Institute)



Gilbert  Smith; PhD (National Cancer Institute)



David  Salomon; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50316
414,BC010769-01,"October 01, 2006 -  September 30, 2007",Protein Evolution by in Vitro Compartmentalization,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Noel  Baichoo



Jason William Rausch



Christopher S Badorrek",NULL,Vineet Narain KewalRamani; PhD (National Cancer Institute),Robert Joseph Crouch; PhD (NICHD),There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50314
415,BC010770-01,"October 01, 2006 -  September 30, 2007",Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Ofelia  Olivero; PhD



Marie E Shockley



Rao L Divi



Jennifer P Borojerdi","Stephane  Blanche
(Hôpital Necker Enfants Malade)




Steve  Lipshultz
(University of Miami Medical School)




Kris  Oursler
(Veterans Administration Hospital)




Vernon  Walker
(Pathophysiology, Lovelace Respiratory Research Institute)",Gene  Shearer; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Divi RL, Leonard SL, Walker BL, Kuo MM, Shockley ME, St Claire MC, Nagashima K, Harbaugh SW, Harbaugh JW, Poirier MC (2007). Erythrocebus patas monkey offspring exposed perinatally to NRTIs sustain skeletal muscle mitochondrial compromise at birth and at 1 year of age. Toxicol Sci  99, 203-13.   https://doi.org/10.1093/toxsci/kfm143




PubMed


 


PubMed ID 17545213
    
     


 



2.
Gunter MJ, Divi RL, Kulldorff M, Vermeulen R, Haverkos KJ, Kuo MM, Strickland P, Poirier MC, Rothman N, Sinha R (2007). Leukocyte polycyclic aromatic hydrocarbon-DNA adduct formation and colorectal adenoma. Carcinogenesis  28, 1426-9.   https://doi.org/10.1093/carcin/bgm022




PubMed


 


PubMed ID 17277232
    
     


 



3.
Pratt MM, Sirajuddin P, Poirier MC, Schiffman M, Glass AG, Scott DR, Rush BB, Olivero OA, Castle PE (2007). Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study. Mutat Res  624, 114-23.   https://doi.org/10.1016/j.mrfmmm.2007.04.008




PubMed



        
     
Free Article


 


PubMed ID 17583755
         Pubmed Central ID 4383290 


 



4.
van Gijssel HE, Leil TA, Weinberg WC, Divi RL, Olivero OA, Poirier MC (2007). Cisplatin-DNA damage in p21WAF1/Cip1 deficient mouse keratinocytes exposed to cisplatin. Mutagenesis  22, 49-54.   https://doi.org/10.1093/mutage/gel050




PubMed


 


PubMed ID 17158520",https://intramural.nih.gov/search/searchview.taf?ipid=50320
416,BC010771-01,"October 01, 2006 -  September 30, 2007",Medusa(TM) Sequencer,Thomas Dana Schneider; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Ilya  Lyakhov



Danielle  Needle



Adam C Diehl","James  Adair
(www.keystonenano.com, Keystone Nano)




Raul Eduardo Cachau





Joseph  Lakowicz
(Department of Biochemistry, Center for Fluorescence Spectroscopy, University of Maryland School of Medicine)




Stephen  Lockett
(Image Analysis Laboratory, SAIC Frederick, Inc.)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50317
417,BC010772-01,"October 01, 2006 -  September 30, 2007",Rod-Tether Nanoprobe,Thomas Dana Schneider; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Ilya  Lyakhov



Danielle  Needle



Peyman  Khalichi; PhD","James  Adair
(www.keystonenano.com, Keystone Nano)




Raul Eduardo Cachau





Neil  Zimmerman
(College of Medicine, NIST)","Jacek  Capala; PhD (National Cancer Institute)



Robert J Fisher (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50318
418,BC010773-01,"October 01, 2006 -  September 30, 2007",Interactions of APOBEC3 Proteins with Murine Leukemia Virus,"Alan  Rein; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Demetria P Harvin



Jane  Mirro",NULL,David  Derse; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50319
419,BC010774-01,"October 01, 2006 -  September 30, 2007",T cell alternative p38 activation pathway,"Jonathan D Ashwell; MD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI","Paul  Mittelstadt; PhD



Bei  Dong



Ludmila  Jirmanova



Atef  Allam; PhD",NULL,Ettore  Appella; MD (National Cancer Institute),"Dragana  Jankovic; PhD (NIAID) 



David Harvey Margulies; MD, PhD (NIAID)","Ordered by publication type and then author name.



1.
Jirmanova L, Jankovic D, Fornace AJ, Ashwell JD (2007). Gadd45alpha regulates p38-dependent dendritic cell cytokine production and Th1 differentiation. J Immunol  178, 4153-8.   https://doi.org/10.4049/jimmunol.178.7.4153




PubMed


 


PubMed ID 17371971",https://intramural.nih.gov/search/searchview.taf?ipid=49993
420,BC010775-01,"October 01, 2006 -  September 30, 2007","Retroviral Gag Trafficking, Env Incorporation, and Virus Assembly","Eric O Freed; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Abdul Latheef Abdul Waheed



Benjamin G Luttge



Anjali  Joshi



Ken  Fujii



Kayoko  Waki","Beatrice H Hahn





Akira  Ono
(University of Michigan)




Akira  Ono
(University of Michigan)




Michael  Summers; PhD
(Dept. of Chemistry and Biochemistry, University of MD Baltimore County)",NULL,Juan S Bonifacino; PhD (NICHD),"Ordered by publication type and then author name.



1.
Freed E (2007) HIVs and their replication, in Fields Virology, 5th Edition (DM Knipe and PM Howley, eds). Lippincott, Williams, and Wilkins (Philadelphia), pp. 2107-2186.




 



2.
Freed E, Ono A   (2007) Methods for the study of HIV-1 assembly., in HIV Protocols, 2nd Edition (V Prasad and G Kalpana, eds).  Humana Press, Inc., in press.




 



3.
Adamson CS, Freed EO (2007). Human immunodeficiency virus type 1 assembly, release, and maturation. Adv Pharmacol  55, 347-87.   https://doi.org/10.1016/S1054-3589(07)55010-6




PubMed


 


PubMed ID 17586320
    
     


 



4.
Freed E   (2007) HIV-1 Gag trafficking.  Future HIV Therapy, in press.




 



5.
Garg H, Joshi A, Freed EO, Blumenthal R (2007). Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion. J Biol Chem  282, 16899-906.   https://doi.org/10.1074/jbc.M701701200




PubMed


 


PubMed ID 17416587
    
     


 



6.
Ono A, Waheed AA, Freed EO (2007). Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag. Virology  360, 27-35.   https://doi.org/10.1016/j.virol.2006.10.011




PubMed



        
     
Free Article


 


PubMed ID 17095032
         Pubmed Central ID 1945131 


 



7.
Saad JS, Ablan SD, Ghanam RH, Kim A, Andrews K, Nagashima K, Soheilian F, Freed EO, Summers MF (2008). Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting. J Mol Biol  382, 434-47.   https://doi.org/10.1016/j.jmb.2008.07.027




PubMed



        
     
Free Article


 


PubMed ID 18657545
         Pubmed Central ID 2581411 


 



8.
Saad JS, Loeliger E, Luncsford P, Liriano M, Tai J, Kim A, Miller J, Joshi A, Freed EO, Summers MF (2007). Point mutations in the HIV-1 matrix protein turn off the myristyl switch. J Mol Biol  366, 574-85.   https://doi.org/10.1016/j.jmb.2006.11.068




PubMed



        
     
Free Article


 


PubMed ID 17188710
         Pubmed Central ID 1853300 


 



9.
Tang S, Ablan S, Dueck M, Ayala-López W, Soto B, Caplan M, Nagashima K, Hewlett IK, Freed EO, Levin JG (2007). A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein. Virology  359, 105-15.   https://doi.org/10.1016/j.virol.2006.09.027




PubMed



        
     
Free Article


 


PubMed ID 17055023
         Pubmed Central ID 1851891 


 



10.
Viard M, Ablan SD, Zhou M, Veenstra TD, Freed EO, Raviv Y, Blumenthal R (2008). Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane. Biochemistry  47, 1977-83.   https://doi.org/10.1021/bi701920f




PubMed



        
     
Free Article


 


PubMed ID 18198900
         Pubmed Central ID 2583176",https://intramural.nih.gov/search/searchview.taf?ipid=50009
421,BC010776-01,"October 01, 2006 -  September 30, 2007",Retrovirus Budding and Endosomal Sorting,"Eric O Freed; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Catherine  Adamson



Abdul Latheef Abdul Waheed



Benjamin G Luttge



Ken  Fujii



Anjali  Joshi



Kayoko  Waki","Tim  Veenstra
(Laboratory of Systems Biology, SAIC Frederick)
















Anjon  Audhya
(Ludwig Institute for Cancer Research)




Miranda  Shehu-Xhilaga; PhD","Terrence R Burke; PhD (National Cancer Institute)



Sarah E Palmer (National Cancer Institute)",James H Hurley; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Freed E (2007) HIVs and their replication, in Fields Virology, 5th Edition (DM Knipe and PM Howley, eds). Lippincott, Williams, and Wilkins (Philadelphia), pp. 2107-2186.




 



2.
Freed E, Ono A   (2007) Methods for the study of HIV-1 assembly., in HIV Protocols, 2nd Edition (V Prasad and G Kalpana, eds).  Humana Press, Inc., in press.




 



3.
Adamson CS, Freed EO (2007). Human immunodeficiency virus type 1 assembly, release, and maturation. Adv Pharmacol  55, 347-87.   https://doi.org/10.1016/S1054-3589(07)55010-6




PubMed


 


PubMed ID 17586320
    
     


 



4.
Freed E, Hurley J   (2007) Beyond Tsg101: Alix's role in ESCRTing HIV-1.  Nature Rev Microbiol, in press.




 



5.
Garg H, Joshi A, Freed EO, Blumenthal R (2007). Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion. J Biol Chem  282, 16899-906.   https://doi.org/10.1074/jbc.M701701200




PubMed


 


PubMed ID 17416587
    
     


 



6.
Lee S, Joshi A, Nagashima K, Freed EO, Hurley JH (2007). Structural basis for viral late-domain binding to Alix. Nat Struct Mol Biol  14, 194-9.   https://doi.org/10.1038/nsmb1203




PubMed



        
     
Free Article


 


PubMed ID 17277784
         Pubmed Central ID 2377018 


 



7.
Munshi UM, Kim J, Nagashima K, Hurley JH, Freed EO (2007). An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains. J Biol Chem  282, 3847-55.   https://doi.org/10.1074/jbc.M607489200




PubMed


 


PubMed ID 17158451
    
     


 



8.
Ono A, Waheed AA, Freed EO (2007). Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag. Virology  360, 27-35.   https://doi.org/10.1016/j.virol.2006.10.011




PubMed



        
     
Free Article


 


PubMed ID 17095032
         Pubmed Central ID 1945131 


 



9.
Saad JS, Ablan SD, Ghanam RH, Kim A, Andrews K, Nagashima K, Soheilian F, Freed EO, Summers MF (2008). Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting. J Mol Biol  382, 434-47.   https://doi.org/10.1016/j.jmb.2008.07.027




PubMed



        
     
Free Article


 


PubMed ID 18657545
         Pubmed Central ID 2581411 


 



10.
Tang S, Ablan S, Dueck M, Ayala-López W, Soto B, Caplan M, Nagashima K, Hewlett IK, Freed EO, Levin JG (2007). A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein. Virology  359, 105-15.   https://doi.org/10.1016/j.virol.2006.09.027




PubMed



        
     
Free Article


 


PubMed ID 17055023
         Pubmed Central ID 1851891 


 



11.
Viard M, Ablan SD, Zhou M, Veenstra TD, Freed EO, Raviv Y, Blumenthal R (2008). Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane. Biochemistry  47, 1977-83.   https://doi.org/10.1021/bi701920f




PubMed



        
     
Free Article


 


PubMed ID 18198900
         Pubmed Central ID 2583176",https://intramural.nih.gov/search/searchview.taf?ipid=50010
422,BC010777-01,"October 01, 2006 -  September 30, 2007",Lipid Microdomains and HIV-1 Replication,"Eric O Freed; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Abdul Latheef Abdul Waheed



Kayoko  Waki",NULL,Elena  Chertova (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Freed E (2007) HIVs and their replication, in Fields Virology, 5th Edition (DM Knipe and PM Howley, eds). Lippincott, Williams, and Wilkins (Philadelphia), pp. 2107-2186.




 



2.
Freed E, Ono A (2007) Methods for the study of HIV-1 assembly, in HIV Protocols, 2nd Edition (V Prasad and G Kalpana, eds). Humana Press, Inc, in press.




 



3.
Adamson CS, Freed EO (2007). Human immunodeficiency virus type 1 assembly, release, and maturation. Adv Pharmacol  55, 347-87.   https://doi.org/10.1016/S1054-3589(07)55010-6




PubMed


 


PubMed ID 17586320
    
     


 



4.
Freed E   (2007) Influenza virus not cRAFTy enough to dodge viperin ( ).  Cell Host Microbe  71-72 pp.




 



5.
Garg H, Joshi A, Freed EO, Blumenthal R (2007). Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion. J Biol Chem  282, 16899-906.   https://doi.org/10.1074/jbc.M701701200




PubMed


 


PubMed ID 17416587
    
     


 



6.
Ono A, Waheed AA, Freed EO (2007). Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag. Virology  360, 27-35.   https://doi.org/10.1016/j.virol.2006.10.011




PubMed



        
     
Free Article


 


PubMed ID 17095032
         Pubmed Central ID 1945131 


 



7.
Tang S, Ablan S, Dueck M, Ayala-López W, Soto B, Caplan M, Nagashima K, Hewlett IK, Freed EO, Levin JG (2007). A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein. Virology  359, 105-15.   https://doi.org/10.1016/j.virol.2006.09.027




PubMed



        
     
Free Article


 


PubMed ID 17055023
         Pubmed Central ID 1851891 


 



8.
Waheed AA, Ablan SD, Roser JD, Sowder RC, Schaffner CP, Chertova E, Freed EO (2007). HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease. Proc Natl Acad Sci U S A  104, 8467-71.   https://doi.org/10.1073/pnas.0701443104




PubMed



        
     
Free Article


 


PubMed ID 17483482
         Pubmed Central ID 1895973",https://intramural.nih.gov/search/searchview.taf?ipid=50007
423,BC010778-01,"October 01, 2006 -  September 30, 2007",Inhibition of HIV-1 Maturation,"Eric O Freed; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Catherine  Adamson



Kayoko  Waki","Michael  Sakalian
(University of Oklahoma)




Karl  Salzwedel; PhD",NULL,NULL,"Ordered by publication type and then author name.



1.
Freed E (2007) HIVs and their replication, in Fields Virology, 5th Edition (DM Knipe and PM Howley, eds). Lippincott, Williams, and Wilkins (Philadelphia), pp. 2107-2186.




 



2.
Adamson CS, Freed EO (2007). Human immunodeficiency virus type 1 assembly, release, and maturation. Adv Pharmacol  55, 347-87.   https://doi.org/10.1016/S1054-3589(07)55010-6




PubMed


 


PubMed ID 17586320
    
     


 



3.
Zhang H, Zhao Q, Bhattacharya S, Waheed AA, Tong X, Hong A, Heck S, Curreli F, Goger M, Cowburn D, Freed EO, Debnath AK (2008). A cell-penetrating helical peptide as a potential HIV-1 inhibitor. J Mol Biol  378, 565-80.   https://doi.org/10.1016/j.jmb.2008.02.066




PubMed



        
     
Free Article


 


PubMed ID 18374356
         Pubmed Central ID 2695608",https://intramural.nih.gov/search/searchview.taf?ipid=50008
424,BC010779-01,"October 01, 2006 -  September 30, 2007",Regulation and consequences of ubiquitination,"Jonathan D Ashwell; MD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI","Chuanjin  Wu



Dietrich B Conze



Bei  Dong



Guozhi  Zhu



Atef  Allam; PhD",NULL,NULL,John Allan Hanover; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Zhao Y, Conze DB, Hanover JA, Ashwell JD (2007). Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling. J Biol Chem  282, 7777-82.   https://doi.org/10.1074/jbc.M609146200




PubMed


 


PubMed ID 17220297
    
     


 



2.
Zhu G, Wu CJ, Zhao Y, Ashwell JD (2007). Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr Biol  17, 1438-43.   https://doi.org/10.1016/j.cub.2007.07.041




PubMed


 


PubMed ID 17702576",https://intramural.nih.gov/search/searchview.taf?ipid=49994
425,BC010780-01,"October 01, 2006 -  September 30, 2007",Structural studies of molecular cancer targets and drug development,"David S Waugh; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Brian P Austin



George T Lountos



Di  Zhang",NULL,"Robert  Shoemaker (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50194
426,BC010782-01,"October 01, 2006 -  September 30, 2007",Study of the Roles of SDF1 and CXCR4 in Hematopoiesis,"Giovanna  Tosato; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Takayuki  Nakayama



Taeko  Ishii",NULL,Stefania  Pittaluga (National Cancer Institute),"Dragan  Maric; PhD (NINDS) 



William E Paul; MD (NIAID) 



Jinfang  Zhu; PhD (NIAID)","Ordered by publication type and then author name.



1.
De La Luz Sierra M, Gasperini P, McCormick PJ, Zhu J, Tosato G (2007). Transcription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells. Blood  110, 2276-85.   https://doi.org/10.1182/blood-2007-03-081448




PubMed



        
     
Free Article


 


PubMed ID 17596540
         Pubmed Central ID 1988943 


 



2.
Nakayama T, Mutsuga N, Tosato G (2007). Effect of fibroblast growth factor 2 on stromal cell-derived factor 1 production by bone marrow stromal cells and hematopoiesis. J Natl Cancer Inst  99, 223-35.   https://doi.org/10.1093/jnci/djk031




PubMed


 


PubMed ID 17284717
    
     


 



3.
Nakayama T, Mutsuga N, Tosato G (2007). FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc. Blood  109, 1363-72.   https://doi.org/10.1182/blood-2006-06-028217




PubMed



        
     
Free Article


 


PubMed ID 17077327
         Pubmed Central ID 1794071",https://intramural.nih.gov/search/searchview.taf?ipid=50195
427,BC010783-01,"October 01, 2006 -  September 30, 2007",The molecular mechanism of TNF-induced necrotic cell death,"Zhenggang  Liu; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Swati Suresh Choksi



You Sun  Kim



Michael J Morgan",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50196
428,BC010784-01,"October 01, 2006 -  September 30, 2007",Biochemistry of Melanins and Photoprotection of the Skin,Vincent J. Hearing; PhD,NULL,"Laboratory of Cell Biology, NCI","Yoshinori  Miyamura



Sergio  Coelho","Janusz  Beer
(Center for Devices & Radiological Health, Food & Drug Administration)




Shosuke  Ito
(Department of Chemistry, Fujita Health University)




Rainer  Wolber
(Dept Skin Research, Beiersdorf AG)",NULL,NULL,"Ordered by publication type and then author name.



1.
Brenner M, Hearing VJ (2008). Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents. Drug Discov Today Dis Mech  5, e189-e199.   https://doi.org/10.1016/j.ddmec.2008.02.001




PubMed



        
     
Free Article


 


PubMed ID 19578486
         Pubmed Central ID 2678743 


 



2.
Costin GE, Hearing VJ (2007). Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J  21, 976-94.   https://doi.org/10.1096/fj.06-6649rev




PubMed


 


PubMed ID 17242160
    
     


 



3.
Hearing V   (2007) The protective role of melanin against UV damage in human skin.  Photochem. Photobiol, in press.




 



4.
Hearing V, Beer J   (2007) Melanin mediated apoptosis of epidermal cells damaged by ultraviolet radiation:      factors influencing the incidence of skin cancer.  Arch. Dermatol. Res, in press.




 



5.
Le Pape E, Wakamatsu K, Ito S, Wolber R, Hearing VJ (2008). Regulation of eumelanin/pheomelanin synthesis and visible pigmentation in melanocytes by ligands of the melanocortin 1 receptor. Pigment Cell Melanoma Res  21, 477-86.   https://doi.org/10.1111/j.1755-148X.2008.00479.x




PubMed



        
     
Free Article


 


PubMed ID 18627531
         Pubmed Central ID 2562678 


 



6.
Miyamura Y, Coelho SG, Wolber R, Miller SA, Wakamatsu K, Zmudzka BZ, Ito S, Smuda C, Passeron T, Choi W, Batzer J, Yamaguchi Y, Beer JZ, Hearing VJ (2007). Regulation of human skin pigmentation and responses to ultraviolet radiation. Pigment Cell Res  20, 2-13.   https://doi.org/10.1111/j.1600-0749.2006.00358.x




PubMed


 


PubMed ID 17250543",https://intramural.nih.gov/search/searchview.taf?ipid=50197
429,BC010785-01,"October 01, 2006 -  September 30, 2007",Characterization of Pigmentary Disorders and Melanoma Targeting,Vincent J. Hearing; PhD,NULL,"Laboratory of Cell Biology, NCI","Julio C Valencia; MD



Michaela  Brenner



Takeshi  Namiki","Donald  Hunt
(Department of Chemistry, University of Minnesota)




Cathy  Wu
(Protein Information Resource, Georgetown University)","Michael Marc Gottesman; MD (National Cancer Institute)



Ettore  Appella; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hu ZZ, Valencia JC, Huang H, Chi A, Shabanowitz J, Hearing VJ, Appella E, Wu C (2007). Comparative Bioinformatics Analyses and Profiling of Lysosome-Related Organelle Proteomes. Int J Mass Spectrom  259, 147-160.   https://doi.org/10.1016/j.ijms.2006.09.024




PubMed



        
     
Free Article


 


PubMed ID 17375895
         Pubmed Central ID 1828028 


 



2.
Namiki T, Valencia JC, Hall MD, Hearing VJ (2008). A novel approach to enhance antibody sensitivity and specificity by peptide cross-linking. Anal Biochem  383, 265-9.   https://doi.org/10.1016/j.ab.2008.08.024




PubMed



        
     
Free Article


 


PubMed ID 18801330
         Pubmed Central ID 2596928",https://intramural.nih.gov/search/searchview.taf?ipid=50198
430,BC010786-01,"October 01, 2006 -  September 30, 2007",The Regulation of Mammalian Pigmentation,Vincent J. Hearing; PhD,NULL,"Laboratory of Cell Biology, NCI","Julio C Valencia; MD



Elodie  Le Pape



Thierry  Passeron



Takeshi  Namiki



Manpreet K Randhawa","Zalfa  Abdel-Malek





Robert  Ballotti
(Faculte de Medecine, Inserm U597)




Gregory  Barsh
(Department of Pediatrics, Stanford University)




Dorothy  Bennett
(Centre for Molecular Signaling, St. George's University of London)




Shosuke  Ito
(Department of Chemistry, Fujita Health University)




Jean-Marie  Naeyaert
(Department of Dermatology, University of Ghent)


Show all 8",NULL,NULL,"Ordered by publication type and then author name.



1.
Ando H, Kondoh H, Ichihashi M, Hearing VJ (2007). Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase. J Invest Dermatol  127, 751-61.   https://doi.org/10.1038/sj.jid.5700683




PubMed


 


PubMed ID 17218941
    
     


 



2.
Brenner M, Hearing VJ (2008). Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents. Drug Discov Today Dis Mech  5, e189-e199.   https://doi.org/10.1016/j.ddmec.2008.02.001




PubMed



        
     
Free Article


 


PubMed ID 19578486
         Pubmed Central ID 2678743 


 



3.
Costin GE, Hearing VJ (2007). Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J  21, 976-94.   https://doi.org/10.1096/fj.06-6649rev




PubMed


 


PubMed ID 17242160
    
     


 



4.
Hearing VJ (2007). Regulating melanosome transfer: who's driving the bus? Pigment Cell Res  20, 334-5.   https://doi.org/10.1111/j.1600-0749.2007.00402.x




PubMed


 


PubMed ID 17850503
    
     


 



5.
Miyamura Y, Coelho SG, Wolber R, Miller SA, Wakamatsu K, Zmudzka BZ, Ito S, Smuda C, Passeron T, Choi W, Batzer J, Yamaguchi Y, Beer JZ, Hearing VJ (2007). Regulation of human skin pigmentation and responses to ultraviolet radiation. Pigment Cell Res  20, 2-13.   https://doi.org/10.1111/j.1600-0749.2006.00358.x




PubMed


 


PubMed ID 17250543
    
     


 



6.
Passeron T, Coelho SG, Miyamura Y, Takahashi K, Hearing VJ (2007). Immunohistochemistry and in situ hybridization in the study of human skin melanocytes. Exp Dermatol  16, 162-70.   https://doi.org/10.1111/j.1600-0625.2006.00538.x




PubMed


 


PubMed ID 17286807
    
     


 



7.
Passeron T, Valencia JC, Bertolotto C, Hoashi T, Le Pape E, Takahashi K, Ballotti R, Hearing VJ (2007). SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation. Proc Natl Acad Sci U S A  104, 13984-9.   https://doi.org/10.1073/pnas.0705117104




PubMed



        
     
Free Article


 


PubMed ID 17702866
         Pubmed Central ID 1955778 


 



8.
Valencia JC, Rouzaud F, Julien S, Chen KG, Passeron T, Yamaguchi Y, Abu-Asab M, Tsokos M, Costin GE, Yamaguchi H, Jenkins LM, Nagashima K, Appella E, Hearing VJ (2007). Sialylated core 1 O-glycans influence the sorting of Pmel17/gp100 and determine its capacity to form fibrils. J Biol Chem  282, 11266-80.   https://doi.org/10.1074/jbc.M608449200




PubMed


 


PubMed ID 17303571
    
     


 



9.
Watabe H, Valencia JC, Le Pape E, Yamaguchi Y, Nakamura M, Rouzaud F, Hoashi T, Kawa Y, Mizoguchi M, Hearing VJ (2008). Involvement of dynein and spectrin with early melanosome transport and melanosomal protein trafficking. J Invest Dermatol  128, 162-74.   https://doi.org/10.1038/sj.jid.5701019




PubMed



        
     
Free Article


 


PubMed ID 17687388
         Pubmed Central ID 2167631 


 



10.
Yamaguchi Y, Brenner M, Hearing VJ (2007). The regulation of skin pigmentation. J Biol Chem  282, 27557-61.   https://doi.org/10.1074/jbc.R700026200




PubMed


 


PubMed ID 17635904
    
     


 



11.
Yamaguchi Y, Passeron T, Watabe H, Yasumoto K, Rouzaud F, Hoashi T, Hearing VJ (2007). The effects of dickkopf 1 on gene expression and Wnt signaling by melanocytes: mechanisms underlying its suppression of melanocyte function and proliferation. J Invest Dermatol  127, 1217-25.   https://doi.org/10.1038/sj.jid.5700629




PubMed


 


PubMed ID 17159916
    
     


 



12.
Hearing VJ, Passeron TJ (submitted in 2007) Compositions And Methods For Treating Pigmentary Conditions And Melanoma. Patent issued: 2008360658 (AU in 2015). Patents pending: 60/963,280 (US application); PCT/US2008/009762 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=50199
431,BC010787-01,"October 01, 2006 -  September 30, 2007",Redox Imaging using Nitroxides and MRI,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","John Andrew Cook; PhD



Anastasia L Sowers","Eli  Gladstein
(Univ. of Pennsylvania)




Dr. Kameron  Maxwell
(Research, Mitos)",Murali  Krishna; PhD (National Cancer Institute),"Bruce J Baum; DMD, PhD (NIDCR)","Ordered by publication type and then author name.



1.
Cotrim AP, Hyodo F, Matsumoto K, Sowers AL, Cook JA, Baum BJ, Krishna MC, Mitchell JB (2007). Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging. Clin Cancer Res  13, 4928-33.   https://doi.org/10.1158/1078-0432.CCR-07-0662




PubMed


 


PubMed ID 17699873
    
     


 



2.
Matsumoto K, Subramanian S, Murugesan R, Mitchell JB, Krishna MC (2007). Spatially resolved biologic information from in vivo EPRI, OMRI, and MRI. Antioxid Redox Signal  9, 1125-41.   https://doi.org/10.1089/ars.2007.1638




PubMed


 


PubMed ID 17571957
    
     


 



3.
Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB (2007). The chemistry and biology of nitroxide compounds. Free Radic Biol Med  42, 1632-50.   https://doi.org/10.1016/j.freeradbiomed.2007.02.030




PubMed



        
     
Free Article


 


PubMed ID 17462532
         Pubmed Central ID 1991293 


 



4.
Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB (2007). Therapeutic and clinical applications of nitroxide compounds. Antioxid Redox Signal  9, 1731-43.   https://doi.org/10.1089/ars.2007.1722




PubMed


 


PubMed ID 17665971",https://intramural.nih.gov/search/searchview.taf?ipid=50200
432,BC010788-01,"October 01, 2006 -  September 30, 2007",Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,"Carol J Thiele



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Amy E Mckee



Fei  Tan



Hideya  Onishi



Lauren  Marks","David  Kaplan
(Pediatric Oncology, Hospital for Sick Kids)




Jinhua  Zhang
(Hematology, 2nd China Medical School)","Javed  Khan; MD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Woo CW, Tan F, Cassano H, Lee J, Lee KC, Thiele CJ (2008). Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma. Pediatr Blood Cancer  50, 208-12.   https://doi.org/10.1002/pbc.21195




PubMed


 


PubMed ID 17420990",https://intramural.nih.gov/search/searchview.taf?ipid=50201
433,BC010789-01,"October 01, 2006 -  September 30, 2007",Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,"Carol J Thiele



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Zhi-Jie  Li



Amy E Mckee



Hideya  Onishi



Lauren  Marks",NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)



Stephen M Hewitt; MD, PhD (National Cancer Institute)



Javed  Khan; MD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)



Giovanni  Melillo (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Li Z, Zhang J, Liu Z, Woo CW, Thiele CJ (2007). Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death. Cell Death Differ  14, 318-26.   https://doi.org/10.1038/sj.cdd.4401983




PubMed


 


PubMed ID 16778834",https://intramural.nih.gov/search/searchview.taf?ipid=50202
434,BC010790-01,"October 01, 2006 -  September 30, 2007",Regulation of leukocyte integrins in inflammatory cell recruitment,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI","Valeria  Orlova



Eun-Young  Choi



Sunil  Kaul","Carl  Gahmberg
(Biochemistry, University of Helsinki)




Tom  Quertermous
(Cardiovascular Medicine, Stanford University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P, Zeiher AM, Chavakis T, Dimmeler S (2007). High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res  100, 204-12.   https://doi.org/10.1161/01.RES.0000257774.55970.f4




PubMed


 


PubMed ID 17218606
    
     


 



2.
Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, Ihanus E, Ballantyne CM, Gahmberg CG, Bianchi ME, Nawroth PP, Chavakis T (2007). A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J  26, 1129-39.   https://doi.org/10.1038/sj.emboj.7601552




PubMed



        
     
Free Article


 


PubMed ID 17268551
         Pubmed Central ID 1852832",https://intramural.nih.gov/search/searchview.taf?ipid=50001
435,BC010791-01,"October 01, 2006 -  September 30, 2007","Effects of genetic polymorphism in the MHC, KIR, and related loci on human disea","Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI","Maureen P Martin



Darlene M Marti



Xiaojiang  Gao



Minzhong  Tang



Rasmi  Thomas; PhD



Amr Mohamed Kheir Hussein



Show all 7","Marcus  Altfeld
(Infectious Disease Unit, Partners AIDS Research Center)




Steven  Deeks
(San Francisco General Hospital, University of California, San Francisco)




James  Elder
(University of Michigan)




Michael  Knowles
(Cystic Fibrosis Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill)




Rajan  Nair
(University of Michigan)




John  Rioux; PhD
(Department of Medicine, University of Montreal)


Show all 17","Allan  Hildesheim; PhD (National Cancer Institute)



Maria Teresa Pia Landi; MD, PhD (National Cancer Institute)



Ramaprasad  Srinivasan; MD, PhD (National Cancer Institute)



Sophia S Wang; PhD (National Cancer Institute)



Daniel  McVicar; PhD (National Cancer Institute)","Terrance P O'Hanlon; PhD (NIEHS) 



Frederick W Miller; MD, PhD (NIEHS) 



Richard  Childs; MD (NHLBI) 



Barbara  Rehermann; MD (NIDDK)","Ordered by publication type and then author name.



1.
Bozzacco L, Trumpfheller C, Siegal FP, Mehandru S, Markowitz M, Carrington M, Nussenzweig MC, Piperno AG, Steinman RM (2007). DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci U S A  104, 1289-94.   https://doi.org/10.1073/pnas.0610383104




PubMed



        
     
Free Article


 


PubMed ID 17229838
         Pubmed Central ID 1783096 


 



2.
Gillespie GM, Bashirova A, Dong T, McVicar DW, Rowland-Jones SL, Carrington M (2007). Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. AIDS Res Hum Retroviruses  23, 451-5.   https://doi.org/10.1089/aid.2006.0165




PubMed


 


PubMed ID 17411378
    
     


 



3.
Goedert JJ, Li HC, Gao XJ, Chatterjee N, Sonoda S, Biggar RJ, Cranston B, Kim N, Carrington M, Morgan O, Hanchard B, Hisada M (2007). Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types. Int J Cancer  121, 1092-7.   https://doi.org/10.1002/ijc.22767




PubMed


 


PubMed ID 17437273
    
     


 



4.
Loffredo JT, Maxwell J, Qi Y, Glidden CE, Borchardt GJ, Soma T, Bean AT, Beal DR, Wilson NA, Rehrauer WM, Lifson JD, Carrington M, Watkins DI (2007). Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J Virol  81, 8827-32.   https://doi.org/10.1128/JVI.00895-07




PubMed



        
     
Free Article


 


PubMed ID 17537848
         Pubmed Central ID 1951344 


 



5.
Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, Goedert JJ, Buchbinder S, Kirk GD, Telenti A, Connors M, O'Brien SJ, Walker BD, Parham P, Deeks SG, McVicar DW, Carrington M (2007). Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet  39, 733-40.   https://doi.org/10.1038/ng2035




PubMed



        
     
Free Article


 


PubMed ID 17496894
         Pubmed Central ID 4135476 


 



6.
Martin MP, Single RM, Wilson MJ, Trowsdale J, Carrington M (2008). KIR haplotypes defined by segregation analysis in 59 Centre d'Etude Polymorphisme Humain (CEPH) families. Immunogenetics  60, 767-74.   https://doi.org/10.1007/s00251-008-0334-y




PubMed



        
     
Free Article


 


PubMed ID 18972110
         Pubmed Central ID 3501931 


 



7.
Mehandru S, Vcelar B, Wrin T, Stiegler G, Joos B, Mohri H, Boden D, Galovich J, Tenner-Racz K, Racz P, Carrington M, Petropoulos C, Katinger H, Markowitz M (2007). Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection. J Virol  81, 11016-31.   https://doi.org/10.1128/JVI.01340-07




PubMed



        
     
Free Article


 


PubMed ID 17686878
         Pubmed Central ID 2045579 


 



8.
Pascal V, Yamada E, Martin MP, Alter G, Altfeld M, Metcalf JA, Baseler MW, Adelsberger JW, Carrington M, Anderson SK, McVicar DW (2007). Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection. J Immunol  179, 1625-33.   https://doi.org/10.4049/jimmunol.179.3.1625




PubMed


 


PubMed ID 17641029
    
     


 



9.
Rivera EJ, Tran LA, Hernández-Rivera M, Yoon D, Mikos AG, Rusakova IA, Cheong BY, Cabreira-Hansen MD, Willerson JT, Perin EC, Wilson LJ (2013). BismuthUS-tubes as a Potential Contrast Agent for X-ray Imaging Applications. J Mater Chem B Mater Biol Med  1.




PubMed



        
     
Free Article


 


PubMed ID 24288589
         Pubmed Central ID 3840030 


 



10.
Thananchai H, Gillespie G, Martin MP, Bashirova A, Yawata N, Yawata M, Easterbrook P, McVicar DW, Maenaka K, Parham P, Carrington M, Dong T, Rowland-Jones S (2007). Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol  178, 33-7.   https://doi.org/10.4049/jimmunol.178.1.33




PubMed


 


PubMed ID 17182537
    
     


 



11.
Thio CL, Astemborski J, Bashirova A, Mosbruger T, Greer S, Witt MD, Goedert JJ, Hilgartner M, Majeske A, O'Brien SJ, Thomas DL, Carrington M (2007). Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence. J Virol  81, 441-5.   https://doi.org/10.1128/JVI.01897-06




PubMed



        
     
Free Article


 


PubMed ID 17079285
         Pubmed Central ID 1797425 


 



12.
Torimiro JN, Wolfe ND, Thomas A, Martin MP, Mpoudi-Ngole E, Tamoufe U, Birx DL, Carrington M, Burke DS, Carr JK (2007). Frequency of CCR5 variants among rural populations with low HIV-1 prevalence in Cameroon. AIDS  21, 527-8.   https://doi.org/10.1097/QAD.0b013e328045c4bd




PubMed


 


PubMed ID 17301575
    
     


 



13.
Welzel TM, Gao X, Pfeiffer RM, Martin MP, O'Brien SJ, Goedert JJ, Carrington M, O'Brien TR (2007). HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples. AIDS  21, 225-9.   https://doi.org/10.1097/QAD.0b013e3280123840




PubMed


 


PubMed ID 17197814",https://intramural.nih.gov/search/searchview.taf?ipid=50000
436,BC010792-01,"October 01, 2006 -  September 30, 2007",Molecular genetics and population studies of the KIR and HLA gene complexes,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI","Maureen P Martin



Darlene M Marti



Xiaojiang  Gao



Minzhong  Tang



Rasmi  Thomas; PhD



Amr Mohamed Kheir Hussein



Show all 7","Marcus  Altfeld
(Infectious Disease Unit, Partners AIDS Research Center)




Stephan  Beck
(Sanger Centre)




Kidd  Judith
(Department of Genetics, Yale University)




Kenneth  Kidd
(Yale University)




John  Rioux
(Department of Medicine, Université de Montréal)




John  Rioux
(Department of Medicine, Université de Montréal)


Show all 13","Daniel  McVicar; PhD (National Cancer Institute)



Stephen K Anderson; PhD (National Cancer Institute)",Barbara  Rehermann; MD (NIDDK),"Ordered by publication type and then author name.



1.
Martin MP, Pascal V, Yeager M, Phair J, Kirk GD, Hoots K, O'Brien SJ, Anderson SK, Carrington M (2007). A mutation in KIR3DS1 that results in truncation and lack of cell surface expression. Immunogenetics  59, 823-9.   https://doi.org/10.1007/s00251-007-0240-8




PubMed


 


PubMed ID 17687550
    
     


 



2.
Single RM, Martin MP, Gao X, Meyer D, Yeager M, Kidd JR, Kidd KK, Carrington M (2007). Global diversity and evidence for coevolution of KIR and HLA. Nat Genet  39, 1114-9.   https://doi.org/10.1038/ng2077




PubMed


 


PubMed ID 17694058
    
     


 



3.
Spierings E, Hendriks M, Absi L, Canossi A, Chhaya S, Crowley J, Dolstra H, Eliaou JF, Ellis T, Enczmann J, Fasano ME, Gervais T, Gorodezky C, Kircher B, Laurin D, Leffell MS, Loiseau P, Malkki M, Markiewicz M, Martinetti M, Maruya E, Mehra N, Oguz F, Oudshoorn M, Pereira N, et al. [10 more authors] (2007). Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations. PLoS Genet  3, e103.   https://doi.org/10.1371/journal.pgen.0030103




PubMed



        
     
Free Article


 


PubMed ID 17604453
         Pubmed Central ID 1904367 


 



4.
Torimiro JN, Wolfe ND, Thomas A, Martin MP, Mpoudi-Ngole E, Tamoufe U, Birx DL, Carrington M, Burke DS, Carr JK (2007). Frequency of CCR5 variants among rural populations with low HIV-1 prevalence in Cameroon. AIDS  21, 527-8.   https://doi.org/10.1097/QAD.0b013e328045c4bd




PubMed


 


PubMed ID 17301575",https://intramural.nih.gov/search/searchview.taf?ipid=49999
437,BC010793-01,"October 01, 2006 -  September 30, 2007","Role of inflammation, innate resistance, and immunity in carcinogenesis.","Giorgio  Trinchieri



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","John W Wine



Anna T Mason



Robin T Winkler Pickett



Zsofia  Gyulai



Elena  Riboldi



Loretta R Smith","Mario  Colombo
(Experimental Oncology, National Institute of Surgery and Cure of Tumors)




Franca  Gerosa
(Pathology/Immunology, University of Verona)




Uzma  Hasan
(Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))




Dominique  Kaiserlian
(U404, INSERM)




Xiaojing  Ma
(Microbiology and Immunology, Weill Medical College)




Sergei A. Nedospasov; PhD, DSc",Nancy H Colburn; PhD (National Cancer Institute),"Alan  Sher; PhD (NIAID) 



Francesco M. Marincola; MD (CC)","Ordered by publication type and then author name.



1.
Hasan UA, Caux C, Perrot I, Doffin AC, Menetrier-Caux C, Trinchieri G, Tommasino M, Vlach J (2007). Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs. Proc Natl Acad Sci U S A  104, 8047-52.   https://doi.org/10.1073/pnas.0700664104




PubMed



        
     
Free Article


 


PubMed ID 17463087
         Pubmed Central ID 1876569 


 



2.
Lyakh L, Trinchieri G, Provezza L, Carra G, Gerosa F (2008). Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol Rev  226, 112-31.   https://doi.org/10.1111/j.1600-065X.2008.00700.x




PubMed



        
     
Free Article


 


PubMed ID 19161420
         Pubmed Central ID 2766610 


 



3.
Trinchieri G (2007). Interleukin-10 production by effector T cells: Th1 cells show self control. J Exp Med  204, 239-43.   https://doi.org/10.1084/jem.20070104




PubMed



        
     
Free Article


 


PubMed ID 17296790
         Pubmed Central ID 2118719 


 



4.
Trinchieri G (2007). Pillars of immunology: The birth of a cell type. J Immunol  178, 3-4.   https://doi.org/10.4049/jimmunol.178.1.3




PubMed


 


PubMed ID 17182534
    
     


 



5.
Trinchieri G, Sher A (2007). Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol  7, 179-90.   https://doi.org/10.1038/nri2038




PubMed


 


PubMed ID 17318230",https://intramural.nih.gov/search/searchview.taf?ipid=50203
438,BC010794-01,"October 01, 2006 -  September 30, 2007",Characterization of Cancer Stem Cells,William  Farrar,NULL,"Laboratory of Cancer Prevention, NCI","Xiaohu  Zhang



Suneethe  Thomas



George J Klarmann



Elaine M Hurt



Brian  Kawasaki



Tashan K Mistree",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Sharifi N, Hurt EM, Thomas SB, Farrar WL (2008). Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer. Clin Cancer Res  14, 6073-80.   https://doi.org/10.1158/1078-0432.CCR-08-0591




PubMed



        
     
Free Article


 


PubMed ID 18829485
         Pubmed Central ID 2670581 


 



2.
Sun L, Mathews LA, Cabarcas SM, Zhang X, Yang A, Zhang Y, Young MR, Klarmann KD, Keller JR, Farrar WL (2013). Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells. Stem Cells  31, 1454-66.   https://doi.org/10.1002/stem.1394




PubMed



        
     
Free Article


 


PubMed ID 23592398
         Pubmed Central ID 3775871",https://intramural.nih.gov/search/searchview.taf?ipid=50003
439,BC010795-01,"October 01, 2006 -  September 30, 2007",Mechanisms of transcription fidelity in prokaryotes and eukaryotes,"Mikhail V Kashlev



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Maria L Kireeva



Lucyna E Lubkowska



Yuri  Purtov",NULL,"Jeffrey N Strathern (National Cancer Institute)



Donald L Court; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lewis DE, Komissarova N, Le P, Kashlev M, Adhya S (2008). DNA sequences in gal operon override transcription elongation blocks. J Mol Biol  382, 843-58.   https://doi.org/10.1016/j.jmb.2008.07.060




PubMed



        
     
Free Article


 


PubMed ID 18691599
         Pubmed Central ID 2632883",https://intramural.nih.gov/search/searchview.taf?ipid=50204
440,BC010796-01,"October 01, 2006 -  September 30, 2007",Differentiation of tissue- and devlopment of tumor stem cells,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Christina  Stuelten



Johanna I Busch



Emily  Sutton","Zalfa  Abdel-Malek





Alan  Arslan
(NYU)




Robert  Ballotti
(Faculte de Medecine, Inserm U597)




Gregory  Barsh
(Department of Pediatrics, Stanford University)




Janusz  Beer
(Center for Devices & Radiological Health, Food & Drug Administration)




Dorothy  Bennett
(Centre for Molecular Signaling, St. George's University of London)


Show all 34","Brian P Austin (Macromolecular Crystallography Laboratory)



Swati Suresh Choksi (Laboratory Of Genitourinary Cancer Pathogenesis)



John Andrew Cook; PhD (Radiation Biology Branch)



Maria L Kireeva (Gene Regulation and Chromosome Biology Laboratory)



Zhi-Jie  Li (Pediatric Oncology Branch)



Amy E Mckee (Pediatric Oncology Branch)","Bruce J Baum; DMD, PhD (NIDCR) 



Dragan  Maric; PhD (NINDS) 



Ronald  McKay; PhD (NINDS) 



William E Paul; MD (NIAID) 



Catherine K Kuo; PhD (NIAMS) 



Jinfang  Zhu; PhD (NIAID)","Ordered by publication type and then author name.



1.
Hearing V   (2007) The protective role of melanin against UV damage in human skin.  Photochem. Photobiol, in press.




 



2.
Hearing V, Beer J   (2007) Melanin mediated apoptosis of epidermal cells damaged by ultraviolet radiation:      factors influencing the incidence of skin cancer.  Arch. Dermatol. Res, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50073
441,BC010797-01,"October 01, 2006 -  September 30, 2007",Mechanisms of Stromal Cell Activation by the Developing Tumor,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Olga  Aprelikova; PhD



Christina  Stuelten



Johanna I Busch



Emily  Sutton","Adrian  Barbul
(Sinai Hospital, Dept of Surgery, Johns Hopkins Medical Institutions)




Amir  Jazaeri
(Obstetrics & Gynecology, University of Virginia)




Irena  Pastar
(Tissue Repair Laboratory, Hospital for Special Surgery)","Kent W Hunter; PhD (National Cancer Institute)



Lalage  Wakefield; PhD (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)



Timothy D Veenstra (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)



David J Liewehr (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50205
442,BC010798-01,"October 01, 2006 -  September 30, 2007",GENETIC INVESTIGATION OF NPC AND HCC IN A CHINESE POPULATION,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI","Ping  An; PhD



Elizabeth  Binns-Roemer



Yu-Chun  Zhou



Jamba  Maidar



Tao  Peng



Philip E Coyne



Show all 7",NULL,Stephen J O'Brien; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
An P, Johnson R, Phair J, Kirk GD, Yu XF, Donfield S, Buchbinder S, Goedert JJ, Winkler CA (2009). APOBEC3B deletion and risk of HIV-1 acquisition. J Infect Dis  200, 1054-8.   https://doi.org/10.1086/605644




PubMed



        
     
Free Article


 


PubMed ID 19698078
         Pubmed Central ID 3690486 


 



2.
Guo X, Johnson RC, Deng H, Liao J, Guan L, Nelson GW, Tang M, Zheng Y, de The G, O'Brien SJ, Winkler CA, Zeng Y (2009). Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int J Cancer  124, 2942-7.   https://doi.org/10.1002/ijc.24293




PubMed



        
     
Free Article


 


PubMed ID 19296536
         Pubmed Central ID 4406046",https://intramural.nih.gov/search/searchview.taf?ipid=50206
443,BC010800-01,"October 01, 2006 -  September 30, 2007",Convection enhanced delivery of agents into the brainstem of patients with diff,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,NULL,Russell R Lonser; MD (NINDS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50207
444,BC010801-01,"October 01, 2006 -  September 30, 2007",Clinical Development of Therapies for Neurofibromatosis Type 1-Related Tumors,"Brigitte  Widemann; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Aerang  Kim



Eva  Dombi","Dusica  Babovic-Vuksanovich
(Genetics, Mayo-Clinic)




Larry  Baker
(Oncology, SARC)




Jean  Belasco
(Neurooncology, Children's Hospital of Philadelphia)




Susan  Blaney
(Pediatric Oncology, Texas Children's Cancer Center)




Jan  Friedman
(University of British Columbia)




Stewart  Goldman
(Pediatric Oncology, Children's Memorial Hospital)


Show all 17","Katherine Elizabeth Warren; MD (National Cancer Institute)



Pamela  Wolters (National Cancer Institute)



Thomas J Hornyak (National Cancer Institute)



Karlyne M Reilly; BS, PhD (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)","Douglas Russell Stewart; BA, MD (NHGRI) 



Constantine Argyrios Stratakis; MD, DSc (NICHD) 



Jeffrey M Solomon; BS, MS, PhD (CC) 



Ann M Cohen-Berger; MD (CC) 



Nicholas  Patronas; MD (CC) 



Scott Mitchell Paul; MD (CC)","Ordered by publication type and then author name.



1.
Babovic-Vuksanovic D, Widemann BC, Dombi E, Gillespie A, Wolters PL, Toledo-Tamula MA, O'Neill BP, Fox E, MacDonald T, Beck H, Packer RJ (2007). Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas. Pediatr Neurol  36, 293-300.   https://doi.org/10.1016/j.pediatrneurol.2007.01.009




PubMed


 


PubMed ID 17509460
    
     


 



2.
Dombi E, Solomon J, Gillespie AJ, Fox E, Balis FM, Patronas N, Korf BR, Babovic-Vuksanovic D, Packer RJ, Belasco J, Goldman S, Jakacki R, Kieran M, Steinberg SM, Widemann BC (2007). NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology  68, 643-7.   https://doi.org/10.1212/01.wnl.0000250332.89420.e6




PubMed


 


PubMed ID 17215493",https://intramural.nih.gov/search/searchview.taf?ipid=50208
445,BC010802-01,"October 01, 2006 -  September 30, 2007",Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Philip L Martin



Orla Majella Casey



Daniel  Camacho",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50209
446,BC010803-01,"October 01, 2006 -  September 30, 2007",Characterizing a novel tumor recognition mechanism,"James Chung-Yin Yang; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI",Qiong J Wang,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Fischkoff S, Lowy I, Rosenberg S, Yang J, Yellin M (submitted in 2007) Tnf-alpha Blocker Treatment For Enterocolitis Associated With Immunostimulatory Therapeutic Antibody Therapy. Patent issued: 7,611,702 (US in 2010). Patents pending: 200680040513.9 (CN application); 06827682.3 (EP application); 190183 (IL application); 2008-540197 (JP application); 2006311475 (AU application); 2626859 (CA application); MX/A/2008/005674 (MX application); 566758 (NZ application); PCT/US2006/043691 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=50210
447,BC010804-01,"October 01, 2006 -  September 30, 2007",Using Glycosyltransferases for the Development of Targeted Drug Delivery System,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Elizabeth  Boeggeman



Boopathy  Ramakrishna",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50211
448,BC010805-01,"October 01, 2006 -  September 30, 2007",Using Glycosyltransferases for Conjugation of Single-Chain Antibodies and Lipids,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Boopathy  Ramakrishna



Maria Rita Manzoni",NULL,"Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)



Robert  Blumenthal; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50212
449,BC010806-01,"October 01, 2006 -  September 30, 2007",Targeting High-risk Neuroblastoma using high through put siRNA screening,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Jun S Wei



Patricia S Tsang; PhD",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50213
450,BC010807-01,"October 01, 2006 -  September 30, 2007",Mechanisms of Cell-to-Cell Infection with HTLV-1 and HIV-1,David  Derse; PhD,NULL,"Retroviral Replication Laboratory, NCI","Gisela H Fanning-Heidecker



Patricia  Lloyd",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50002
451,BC010808-01,"October 01, 2006 -  September 30, 2007",Nucleosome Dynamics,"Yawen  Bai; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Hanqiao  Feng



Zheng  Zhou



Hidenori  Kato",NULL,Carl  Wu; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=49995
452,BC010809-01,"October 01, 2006 -  September 30, 2007",NCI-Frederick Support and Technical Services,Craig W Reynolds,NULL,"Office Of The Director, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50322
453,BC010810-01,"October 01, 2006 -  September 30, 2007",Modeling Structural and Functional Mechanisms of TRP Channels,Homer Robert Guy; PhD,NULL,"Laboratory of Cell Biology, NCI",NULL,"Andriy  Anishkin
(Biology, Univ Maryland, College Park)




Ching  Kung
(Genetics Molecular Biology, College of Agricultural & Life Sciences, Univ Wisdonsin-Madison)




Sergei  Sukharev
(Biology, Univ Maryland, College Park)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50214
454,BC010811-01,"October 01, 2006 -  September 30, 2007",Combination of TNF-Gold Nanoparticles with Radiation,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI",Alesia J Holly,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=49998
455,BC010812-01,"October 01, 2006 -  September 30, 2007",Time-dependent receptor-target interactions in molecular interaction networks,"Sandra  Smith-Gill; MS, PhD, BS",NULL,"Structural Biophysics Laboratory, NCI",Claudia A Lipschultz,NULL,"Yun  Wang (Nucleic Acid NMR Section)



Nadya I Tarasova; PhD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50215
456,BC010813-01,"October 01, 2006 -  September 30, 2007",Modeling the structure and functional mechanisms of P-glycoprotein,Homer Robert Guy; PhD,NULL,"Laboratory of Cell Biology, NCI",Michael Marc Gottesman; MD,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50216
457,BC010814-01,"October 01, 2006 -  September 30, 2007",Understanding the Pseudodiploidy of the Retroviral Genome,"Wei-Shau  Hu; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Islam T Mohammad Hussein



Olga A Nikolaitchik



Vitaly P Boyko",NULL,"Vinay K Pathak; PhD (National Cancer Institute)



Alan  Rein; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chin MP, Lee SK, Chen J, Nikolaitchik OA, Powell DA, Fivash MJ, Hu WS (2008). Long-range recombination gradient between HIV-1 subtypes B and C variants caused by sequence differences in the dimerization initiation signal region. J Mol Biol  377, 1324-33.   https://doi.org/10.1016/j.jmb.2008.02.003




PubMed



        
     
Free Article


 


PubMed ID 18314135
         Pubmed Central ID 2706499 


 



2.
Fu W, Prasad VV, Chen J, Nikolaitchik O, Hu WS (2007). Molecular mechanisms of simian immunodeficiency virus SIV(agm) RNA encapsidation. Virology  363, 210-9.   https://doi.org/10.1016/j.virol.2007.01.030




PubMed



        
     
Free Article


 


PubMed ID 17321560
         Pubmed Central ID 2920611 


 



3.
Moore MD, Fu W, Nikolaitchik O, Chen J, Ptak RG, Hu WS (2007). Dimer initiation signal of human immunodeficiency virus type 1: its role in partner selection during RNA copackaging and its effects on recombination. J Virol  81, 4002-11.   https://doi.org/10.1128/JVI.02589-06




PubMed



        
     
Free Article


 


PubMed ID 17267488
         Pubmed Central ID 1866129 


 



4.
Nikolaitchik OA, Gorelick RJ, Leavitt MG, Pathak VK, Hu WS (2008). Functional complementation of nucleocapsid and late domain PTAP mutants of human immunodeficiency virus type 1 during replication. Virology  375, 539-49.   https://doi.org/10.1016/j.virol.2008.02.026




PubMed



        
     
Free Article


 


PubMed ID 18353416
         Pubmed Central ID 2459335",https://intramural.nih.gov/search/searchview.taf?ipid=50217
458,BC010815-01,"October 01, 2006 -  September 30, 2007",Regulation of Hypoxia-Inducible Factors in Pluripotent Cancer Cells.,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Olga  Aprelikova; PhD,NULL,"Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50219
459,BC010816-01,"October 01, 2006 -  September 30, 2007",Immunotherapy for Malignant Mesothelioma,"Raffit  Hassan



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Jingli  Zhang



Barbara S Schuler",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Hassan R   (2007) Mesothelin targeted cancer immunotherapy.  European J of Cancer, in press.




 



2.
Hassan R, Bullock S, Premkumar A, Kreitman RJ, Kindler H, Willingham MC, Pastan I (2007). Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers. Clin Cancer Res  13, 5144-9.   https://doi.org/10.1158/1078-0432.CCR-07-0869




PubMed


 


PubMed ID 17785569
    
     


 



3.
Hassan R, Gal A, Murray D, Premkumar A, Berman D   (2007) Malignant mesothelioma of the inguinal canal with an unusually long survival.  Am. J. Clin. Oncol, in press.




 



4.
Ho M, Bera TK, Willingham MC, Onda M, Hassan R, FitzGerald D, Pastan I (2007). Mesothelin expression in human lung cancer. Clin Cancer Res  13, 1571-5.   https://doi.org/10.1158/1078-0432.CCR-06-2161




PubMed


 


PubMed ID 17332303
    
     


 



5.
Pastan I, Hassan R, FitzGerald DJ, Kreitman RJ (2007). Immunotoxin treatment of cancer. Annu Rev Med  58, 221-37.   https://doi.org/10.1146/annurev.med.58.070605.115320




PubMed


 


PubMed ID 17059365",https://intramural.nih.gov/search/searchview.taf?ipid=50220
460,BC010817-01,"October 01, 2006 -  September 30, 2007",Role of normal cervical stem cells in the HPV induced initiation of cervical can,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Xiang  Yu,NULL,John  Schiller; PhD (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50221
461,BC010818-01,"October 01, 2006 -  September 30, 2007",Replication Dynamics in Patients on Suppressive Antiretroviral Therapy,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",NULL,"Scott  Brun
(-, Abbott Laboratories)




George  Hanna
(-, Abbott Laboratories)




Dale  Kempf





David M Margolis





John  McKinnon
(University of Pittsburgh)




Deborah  McMahon
(University of Pittsburgh)


Show all 10",NULL,"Michael  Polis; MD (NIAID) 



Henry  Masur; MD (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50222
462,BC010819-01,"October 01, 2006 -  September 30, 2007",HIV-1 Genetic Variation in Infected Individuals,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",NULL,"Eric  Daar
(Infectious Diseases, Harbor-UCL Medical Center)




Anuradha  Ganesan
(Henry M. Jackson Foundation)




Joseph  Margolick
(School of Public Health, Johns Hopkins University)




John W Mellors","Eric O Freed; PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)","Michael  Polis; MD (NIAID) 



Henry  Masur; MD (CC)","Ordered by publication type and then author name.



1.
Nikolenko GN, Delviks-Frankenberry KA, Palmer S, Maldarelli F, Fivash MJ, Coffin JM, Pathak VK (2007). Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistance. Proc Natl Acad Sci U S A  104, 317-22.   https://doi.org/10.1073/pnas.0609642104




PubMed



        
     
Free Article


 


PubMed ID 17179211
         Pubmed Central ID 1765458",https://intramural.nih.gov/search/searchview.taf?ipid=50223
463,BC010820-01,"October 01, 2006 -  September 30, 2007",Appearance and Disappearance of Drug Resistance Mutations,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",NULL,"Zandrea  Ambrose
(University of Pittsburgh)




John W Mellors





Lynn  Morris
(National Institute for Communicable Diseases)




Pat  Robertson
(-, Boehringer Ingelheim)","Eric O Freed; PhD (National Cancer Institute)



Vineet Narain KewalRamani; PhD (National Cancer Institute)",Henry  Masur; MD (CC),"Ordered by publication type and then author name.



1.
Kearney M, Palmer S, Maldarelli F, Shao W, Polis MA, Mican J, Rock-Kress D, Margolick JB, Coffin JM, Mellors JW (2008). Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase. AIDS  22, 497-501.   https://doi.org/10.1097/QAD.0b013e3282f29478




PubMed



        
     
Free Article


 


PubMed ID 18301062
         Pubmed Central ID 2921824",https://intramural.nih.gov/search/searchview.taf?ipid=50224
464,BC010821-01,"October 01, 2006 -  September 30, 2007",Role of Specific Drugs and Mutations in Partial Suppression of Viremia,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",NULL,NULL,NULL,"Richard T Davey; MD (NIAID) 



Henry  Masur; MD (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50225
465,BC010822-01,"October 01, 2006 -  September 30, 2007",Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation,"Munira A Basrai; PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","John S Choy



Wei-Chun  Au



Suveena  Sharma; PhD



Matthew  Crisp","Kenneth  Belanger
(Biology, Colgate University)




Grant  Hartzog
(MCD Biology, Univ. of California, Santa Cruz)




Forrest  Spencer
(Mol Biol and Genetics, The Johns Hopkins School of Medicine)




Forrest  Spencer
(Mol Biol and Genetics, The Johns Hopkins School of Medicine)




Mark  Winey
(Mol. Cell and Dev. Biology, Univ. of Colorado)",Natasha  Caplen (Cancer Genetics Branch),Alexander V Strunnikov; PhD (NICHD),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=49996
466,BC010823-01,"October 01, 2006 -  September 30, 2007",Asparagine Synthetase as a Biomarker for L-asparaginase Rx of Ovarian Cancer,"John N Weinstein; MD, PhD",NULL,"Developmental Therapeutics Branch, NCI","William Curtis Reinhold



David  Kane



Philip L Lorenzi","Geoffrey  Cossman
(GeneLogic, Inc., .)




Felice  de Jong
(Metabolon)




Douglas  Dolginow
(., GeneLogic, Inc.)




Ivan  Horak
(., ENZON, Inc.)




Eric  Kaldjian
(., GeneLogic, Inc.)




Emanuel  Petricoin
(Proteomics Program, FDA)


Show all 8","Natasha  Caplen (National Cancer Institute)



Paul  Goldsmith; PhD (National Cancer Institute)



Frank Jess Gonzalez; PhD (National Cancer Institute)



Satoshi  Nishizuka (National Cancer Institute)



Stephen M Hewitt; MD, PhD (National Cancer Institute)","Peter Jonathan Munson; BA, MA, PhD (CIT)","Ordered by publication type and then author name.



1.
Claerhout S, Lorenzi PL, Weinstein JN, Mills GB (2011) MODULATION OF AUTOPHAGY AND ITS POTENTIAL FOR CANCER THERAPY. Drugs Future 36:




PubMed



        
     
Free Article


 


PubMed ID 25419038
         Pubmed Central ID 4239665 


 



2.
Lorenzi PL, Llamas J, Gunsior M, Ozbun L, Reinhold WC, Varma S, Ji H, Kim H, Hutchinson AA, Kohn EC, Goldsmith PK, Birrer MJ, Weinstein JN (2008). Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines. Mol Cancer Ther  7, 3123-8.   https://doi.org/10.1158/1535-7163.MCT-08-0589




PubMed



        
     
Free Article


 


PubMed ID 18852115
         Pubmed Central ID 4123961 


 



3.
Lorenzi PL, Weinstein JN (2009). Asparagine synthetase: a new potential biomarker in ovarian cancer. Drug News Perspect  22, 61-4.   https://doi.org/10.1358/dnp.2009.22.1.1303820




PubMed



        
     
Free Article


 


PubMed ID 19209300
         Pubmed Central ID 4096155 


 



4.
Martin SE, Jones TL, Thomas CL, Lorenzi PL, Nguyen DA, Runfola T, Gunsior M, Weinstein JN, Goldsmith PK, Lader E, Huppi K, Caplen NJ (2007). Multiplexing siRNAs to compress RNAi-based screen size in human cells. Nucleic Acids Res  35, e57.   https://doi.org/10.1093/nar/gkm141




PubMed



        
     
Free Article


 


PubMed ID 17392344
         Pubmed Central ID 1885663",https://intramural.nih.gov/search/searchview.taf?ipid=50226
467,BC010824-01,"October 01, 2006 -  September 30, 2007",Molecular structure of the bacterial chemotaxis apparatus,"Sriram  Subramaniam; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Cezar  Khursigara



Jun  Liu



Martin  Kessel; BSc, PhD



Lisa M. Hartnell","Jerry  Hazelbauer
(Biochemistry, University of Missouri)




Terry P Lybrand





Mark  McBride
(Microbiology, University of Wisconsin)




Sandy  Parkinson
(Biochemistry, University of Utah)",NULL,NULL,"Ordered by publication type and then author name.



1.
Liu J, McBride MJ, Subramaniam S (2007). Cell surface filaments of the gliding bacterium Flavobacterium johnsoniae revealed by cryo-electron tomography. J Bacteriol  189, 7503-6.   https://doi.org/10.1128/JB.00957-07




PubMed



        
     
Free Article


 


PubMed ID 17693495
         Pubmed Central ID 2168446 


 



2.
Zhang P, Khursigara CM, Hartnell LM, Subramaniam S (2007). Direct visualization of Escherichia coli chemotaxis receptor arrays using cryo-electron microscopy. Proc Natl Acad Sci U S A  104, 3777-81.   https://doi.org/10.1073/pnas.0610106104




PubMed



        
     
Free Article


 


PubMed ID 17360429
         Pubmed Central ID 1820660 


 



3.
Zhang P, Weis RM, Peters PJ, Subramaniam S (2007). Electron tomography of bacterial chemotaxis receptor assemblies. Methods Cell Biol  79, 373-84.   https://doi.org/10.1016/S0091-679X(06)79014-8




PubMed


 


PubMed ID 17327165",https://intramural.nih.gov/search/searchview.taf?ipid=50227
468,BC010825-01,"October 01, 2006 -  September 30, 2007",HIV neutralization and mechanisms of cellular entry,"Sriram  Subramaniam; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Jun  Liu



Jason H Leung



Kamal N Menghrajani



Adam  Bennett



Lisa M. Hartnell",NULL,"Jeffrey D Lifson; MD (National Cancer Institute)



Robert  Blumenthal; PhD (National Cancer Institute)



Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)



Eric O Freed; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bennett A, Liu J, Van Ryk D, Bliss D, Arthos J, Henderson RM, Subramaniam S (2007). Cryoelectron tomographic analysis of an HIV-neutralizing protein and its complex with native viral gp120. J Biol Chem  282, 27754-9.   https://doi.org/10.1074/jbc.M702025200




PubMed


 


PubMed ID 17599917
    
     


 



2.
Sougrat R, Bartesaghi A, Lifson JD, Bennett AE, Bess JW, Zabransky DJ, Subramaniam S (2007). Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry. PLoS Pathog  3, e63.   https://doi.org/10.1371/journal.ppat.0030063




PubMed



        
     
Free Article


 


PubMed ID 17480119
         Pubmed Central ID 1864992 


 



3.
Subramaniam S, Liu J, Bennett A, Sougrat R   (2007) Electron Tomography of Viruses.  Current Opinion in Structural Biology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50228
469,BC010826-01,"October 01, 2006 -  September 30, 2007",Technology Development for 3D Electron Microscopy,"Sriram  Subramaniam; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Rajesh  Narasimha



Jeffrey S Lengyel



Alberto  Bartesaghi","Robert  Morrison
(GATAN Inc.)




Guillermo  Sapiro
(Electrical Engineering, Uinversity of Minnesota)




John Henry  Scott
(NIST)",NULL,NULL,"Ordered by publication type and then author name.



1.
Lefman J, Morrison R, Subramaniam S (2007). Automated 100-position specimen loader and image acquisition system for transmission electron microscopy. J Struct Biol  158, 318-26.   https://doi.org/10.1016/j.jsb.2006.11.007




PubMed



        
     
Free Article


 


PubMed ID 17240161
         Pubmed Central ID 1952209 


 



2.
Lengyel JS, Milne JL, Subramaniam S (2008). Electron tomography in nanoparticle imaging and analysis. Nanomedicine (Lond)  3, 125-31.   https://doi.org/10.2217/17435889.3.1.125




PubMed



        
     
Free Article


 


PubMed ID 18393671
         Pubmed Central ID 2712644",https://intramural.nih.gov/search/searchview.taf?ipid=50229
470,BC010827-01,"October 01, 2006 -  September 30, 2007",Structural Studies of bacterial architecture using electron tomography,Jacqueline L Milne,NULL,"Laboratory of Cell Biology, NCI",Mario J Borgnia; PhD,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50230
471,BC010828-01,"October 01, 2006 -  September 30, 2007",STAT2 role in inflammation and cancer,Ana M Gamero,Howard A Young; PhD,"Laboratory of Experimental Immunology, NCI",Anthony J Scarzello,NULL,Nancy H Colburn; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50011
472,BC010829-01,"October 01, 2006 -  September 30, 2007",TIMP-2-mediated Tumor Cell Differentiation and Chemo-sensitization Therapy,"William G Stetler-Stevenson; MD, PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Lana  Kandalaft



Hongmei  Li



Beiyang  Wei",NULL,"David  Salomon; PhD (National Cancer Institute)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Stetler-Stevenson WG (2008). Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal  1, re6.   https://doi.org/10.1126/scisignal.127re6




PubMed



        
     
Free Article


 


PubMed ID 18612141
         Pubmed Central ID 2493614",https://intramural.nih.gov/search/searchview.taf?ipid=50231
473,BC010830-01,"October 01, 2006 -  September 30, 2007",Mechanisms of non-classical multidrug resistance in cancer,"Michael Marc Gottesman; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Kimberly L Jackson



Matthew David Hall



Jean-Pierre  Gillet



Carol O Cardarelli



Ding wu  Shen; PhD



Rajalakshm L Padmanabhan","Ram  Ganapathy
(Cleveland Clinic)




Gary  Kruh; MD, PhD
(Medical Science Division, Fox Chase Cancer Center)




Michael  Seiden
(Hematology Oncology, Dana-Farber/Partners Cancer Care Program)




Brian P. Sorrentino; MD
(Div of Experimental Hematology, St Jude Children's Research Hosp)","Vincent J. Hearing; PhD (National Cancer Institute)



Paul S Meltzer; MD, PhD (National Cancer Institute)



Anna Maria Calcagno (Transport Biochemistry Section)",Kevin G Chen; MD (NINDS),"Ordered by publication type and then author name.



1.
Paterson JK, Shukla S, Black CM, Tachiwada T, Garfield S, Wincovitch S, Ernst DN, Agadir A, Li X, Ambudkar SV, Szakacs G, Akiyama S, Gottesman MM (2007). Human ABCB6 localizes to both the outer mitochondrial membrane and the plasma membrane. Biochemistry  46, 9443-52.   https://doi.org/10.1021/bi700015m




PubMed


 


PubMed ID 17661442
    
     


 



2.
Rahamimoff H, Elbaz B, Alperovich A, Kimchi-Sarfaty C, Gottesman MM, Lichtenstein Y, Eskin-Shwartz M, Kasir J (2007). Cyclosporin A-dependent downregulation of the Na+/Ca2+ exchanger expression. Ann N Y Acad Sci  1099, 204-14.   https://doi.org/10.1196/annals.1387.046




PubMed


 


PubMed ID 17446460",https://intramural.nih.gov/search/searchview.taf?ipid=50232
474,BC010831-01,"October 01, 2006 -  September 30, 2007",Characterization of small open reading frames (sORFs) that encode for proteins 2,"Munira A Basrai; PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Wei-Chun  Au,"Jef  Boeke
(Molecular Biology and Genetics, The Johns Hopkins School of Medicine)




Jef  Boeke
(Molecular Biology and Genetics, The Johns Hopkins School of Medicine)




Ron  Davis
(Biochemistry and Genome Technology Center, Stanford University)




Michael  Snyder
(Molecular, Cellular and Developmental Biology, Yale University)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=49997
475,BC010832-01,"October 01, 2006 -  September 30, 2007",Fundamentals of Ligand-Protein Interactions,Marc C Nicklaus,Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI","Igor V Filippov



Iwona Elzbieta Weidlich",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50233
476,BC010833-01,"October 01, 2006 -  September 30, 2007",Identification and functional characterization of colorectal cancer genes,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Georg  Emons



Tom  Ellerman



Marian  Grade



Amanda  Hummon



Hesed M Padilla Nash



Linda I Stapleton



Show all 10","Gert  Auer





Michael  Ghadimi
(Surgery, U. of Goettingen)",NULL,NULL,"Ordered by publication type and then author name.



1.
Grade M, Hörmann P, Becker S, Hummon AB, Wangsa D, Varma S, Simon R, Liersch T, Becker H, Difilippantonio MJ, Ghadimi BM, Ried T (2007). Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. Cancer Res  67, 41-56.   https://doi.org/10.1158/0008-5472.CAN-06-1514




PubMed



        
     
Free Article


 


PubMed ID 17210682
         Pubmed Central ID 4721580 


 



2.
Habermann JK, Paulsen U, Roblick UJ, Upender MB, McShane LM, Korn EL, Wangsa D, Krüger S, Duchrow M, Bruch HP, Auer G, Ried T (2007). Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer  46, 10-26.   https://doi.org/10.1002/gcc.20382




PubMed


 


PubMed ID 17044061",https://intramural.nih.gov/search/searchview.taf?ipid=50234
477,BC010834-01,"October 01, 2006 -  September 30, 2007","Identification of genomic markers for disease progression in cervical, breast an","Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Kerstin  Heselmeyer



Tom  Ellerman



Buddy  Chen



Linda I Stapleton



Damrong M Wangsa",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50236
478,BC010835-01,"October 01, 2006 -  September 30, 2007",Consequences of chromosomal aberrations on the cancer transcriptome,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Amanda  Hummon



Tom  Ellerman



Marian  Grade



Kundan  Sengupta; MS, PhD



Hesed M Padilla Nash



Linda I Stapleton



Show all 10",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Duelli DM, Padilla-Nash HM, Berman D, Murphy KM, Ried T, Lazebnik Y (2007). A virus causes cancer by inducing massive chromosomal instability through cell fusion. Curr Biol  17, 431-7.   https://doi.org/10.1016/j.cub.2007.01.049




PubMed


 


PubMed ID 17320392
    
     


 



2.
Grade M, Hörmann P, Becker S, Hummon AB, Wangsa D, Varma S, Simon R, Liersch T, Becker H, Difilippantonio MJ, Ghadimi BM, Ried T (2007). Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. Cancer Res  67, 41-56.   https://doi.org/10.1158/0008-5472.CAN-06-1514




PubMed



        
     
Free Article


 


PubMed ID 17210682
         Pubmed Central ID 4721580 


 



3.
Habermann JK, Paulsen U, Roblick UJ, Upender MB, McShane LM, Korn EL, Wangsa D, Krüger S, Duchrow M, Bruch HP, Auer G, Ried T (2007). Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer  46, 10-26.   https://doi.org/10.1002/gcc.20382




PubMed


 


PubMed ID 17044061
    
     


 



4.
Sengupta K, Upender MB, Barenboim-Stapleton L, Nguyen QT, Wincovitch SM, Garfield SH, Difilippantonio MJ, Ried T (2007). Artificially introduced aneuploid chromosomes assume a conserved position in colon cancer cells. PLoS One  2, e199.   https://doi.org/10.1371/journal.pone.0000199




PubMed



        
     
Free Article


 


PubMed ID 17332847
         Pubmed Central ID 1805818",https://intramural.nih.gov/search/searchview.taf?ipid=50238
479,BC010836-01,"October 01, 2006 -  September 30, 2007",Cancer proteomics,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Damrong M Wangsa



Tom  Ellerman



Amanda  Hummon



Buddy  Chen



Nicole E Mcneil



Linda I Stapleton","Gert  Auer





Michael  Ghadimi
(Surgery, U. of Goettingen)",NULL,NULL,"Ordered by publication type and then author name.



1.
Habermann JK, Roblick UJ, Luke BT, Prieto DA, Finlay WJ, Podust VN, Roman JM, Oevermann E, Schiedeck T, Homann N, Duchrow M, Conrads TP, Veenstra TD, Burt SK, Bruch HP, Auer G, Ried T (2006). Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors. Gastroenterology  131, 1020-9; quiz 1284.   https://doi.org/10.1053/j.gastro.2006.07.011




PubMed



        
     
Free Article


 


PubMed ID 17030172
         Pubmed Central ID 2532535 


 



2.
Hummon AB, Lim SR, Difilippantonio MJ, Ried T (2007). Isolation and solubilization of proteins after TRIzol extraction of RNA and DNA from patient material following prolonged storage. Biotechniques  42, 467-70, 472.   https://doi.org/10.2144/000112401




PubMed



        
     
Free Article


 


PubMed ID 17489233
         Pubmed Central ID 4721573",https://intramural.nih.gov/search/searchview.taf?ipid=50240
480,BC010837-01,"October 01, 2006 -  September 30, 2007",Understanding the mechanisms of chromosomal aberrations in cancer,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Tom  Ellerman



Hesed M Padilla Nash



Linda I Stapleton



Damrong M Wangsa



Michael John Difilippantonio; PhD



Buddy  Chen



Show all 7","Katrin  Chua
(Stanford University)




Siegfried  Janz
(University of Iowa Carver College of Medicine)




Yuri  Lazebnik
(Cold Spring Harbor Laboratories)",Andre A Nussenzweig; PhD (National Cancer Institute),"Chuxia  Deng; PhD (NIDDK) 



Robert Simon Adelstein; MD (NHLBI)","Ordered by publication type and then author name.



1.
Callén E, Jankovic M, Difilippantonio S, Daniel JA, Chen HT, Celeste A, Pellegrini M, McBride K, Wangsa D, Bredemeyer AL, Sleckman BP, Ried T, Nussenzweig M, Nussenzweig A (2007). ATM prevents the persistence and propagation of chromosome breaks in lymphocytes. Cell  130, 63-75.   https://doi.org/10.1016/j.cell.2007.06.016




PubMed


 


PubMed ID 17599403
    
     


 



2.
Duelli DM, Padilla-Nash HM, Berman D, Murphy KM, Ried T, Lazebnik Y (2007). A virus causes cancer by inducing massive chromosomal instability through cell fusion. Curr Biol  17, 431-7.   https://doi.org/10.1016/j.cub.2007.01.049




PubMed


 


PubMed ID 17320392
    
     


 



3.
Hsu C, Jones SA, Cohen CJ, Zheng Z, Kerstann K, Zhou J, Robbins PF, Peng PD, Shen X, Gomes TJ, Dunbar CE, Munroe DJ, Stewart C, Cornetta K, Wangsa D, Ried T, Rosenberg SA, Morgan RA (2007). Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene. Blood  109, 5168-77.   https://doi.org/10.1182/blood-2006-06-029173




PubMed



        
     
Free Article


 


PubMed ID 17353346
         Pubmed Central ID 1890824 


 



4.
Padilla-Nash HM, Wu K, Just H, Ried T, Thestrup-Pedersen K (2007). Spectral karyotyping demonstrates genetically unstable skin-homing T lymphocytes in cutaneous T-cell lymphoma. Exp Dermatol  16, 98-103.   https://doi.org/10.1111/j.1600-0625.2006.00507.x




PubMed


 


PubMed ID 17222222
    
     


 



5.
Soutoglou E, Dorn JF, Sengupta K, Jasin M, Nussenzweig A, Ried T, Danuser G, Misteli T (2007). Positional stability of single double-strand breaks in mammalian cells. Nat Cell Biol  9, 675-82.   https://doi.org/10.1038/ncb1591




PubMed



        
     
Free Article


 


PubMed ID 17486118
         Pubmed Central ID 2442898 


 



6.
Wang X, Liu L, Montagna C, Ried T, Deng CX (2007). Haploinsufficiency of Parp1 accelerates Brca1-associated centrosome amplification, telomere shortening, genetic instability, apoptosis, and embryonic lethality. Cell Death Differ  14, 924-31.   https://doi.org/10.1038/sj.cdd.4402105




PubMed


 


PubMed ID 17318223
    
     


 



7.
Xiao C, Sharp JA, Kawahara M, Davalos AR, Difilippantonio MJ, Hu Y, Li W, Cao L, Buetow K, Ried T, Chadwick BP, Deng CX, Panning B (2007). The XIST noncoding RNA functions independently of BRCA1 in X inactivation. Cell  128, 977-89.   https://doi.org/10.1016/j.cell.2007.01.034




PubMed


 


PubMed ID 17350580",https://intramural.nih.gov/search/searchview.taf?ipid=50242
481,BC010838-01,"October 01, 2006 -  September 30, 2007",NCI Enterprise caCORE,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50275
482,BC010839-01,"October 01, 2006 -  September 30, 2007",Exploration of the TranslationalTherapeutic Potential of Stem Cell B,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50004
483,BC010840-01,"October 01, 2006 -  September 30, 2007",The Pre-clinical and Clinical Development of Novel Molecularly Target,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50005
484,BC010841-01,"October 01, 2006 -  September 30, 2007",ROLE OF NONCANONICAL WNT PATHWAYS IN TISSUE MORPHOGENESIS.,"Terence P Yamaguchi; PhD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Kristin K Biris



William C Dunty



Rieko  Ajima","Ernest  Arenas
(CEDB, Karolinska Institute)




Hans  Clevers
(Hubrecht Laboratory and Centre for Biomedical Genetics, Netherlands Institute for Developmental Biology)




Raymond  Habas





Xi  He
(NCI)




Sarah  Millar
(Dermatology, U. Pennsylvania)




Edward  Morrisey
(Cell and Developmental Biology, University of Pennsylvania)


Show all 7",NULL,NULL,"Ordered by publication type and then author name.



1.
Tsukiyama T, Yamaguchi TP (2012). Mice lacking Wnt2b are viable and display a postnatal olfactory bulb phenotype. Neurosci Lett  512, 48-52.   https://doi.org/10.1016/j.neulet.2012.01.062




PubMed



        
     
Free Article


 


PubMed ID 22326927
         Pubmed Central ID 3298629",https://intramural.nih.gov/search/searchview.taf?ipid=50244
485,BC010842-01,"October 01, 2006 -  September 30, 2007",The Miner Suite: State of the Art Bioinformatic Tools and Data Resources,"John N Weinstein; MD, PhD",NULL,"Developmental Therapeutics Branch, NCI","Barry R Zeeberg; PhD



Gabriel  Eichler



Margot  Sunshine



Hong  Cao



David  Kane","Ari  Kahn
(SRA Intl)




Hongfang  Liu





Michael  Ryan
(Tigerteam Associates, Inc.)",NULL,NULL,"Ordered by publication type and then author name.



1.
Eichler GS, Reimers M, Kane D, Weinstein JN (2007). The LeFE algorithm: embracing the complexity of gene expression in the interpretation of microarray data. Genome Biol  8, R187.   https://doi.org/10.1186/gb-2007-8-9-r187




PubMed



        
     
Free Article


 


PubMed ID 17845722
         Pubmed Central ID 2375025 


 



2.
Kahn AB, Ryan MC, Liu H, Zeeberg BR, Jamison DC, Weinstein JN (2007). SpliceMiner: a high-throughput database implementation of the NCBI Evidence Viewer for microarray splice variant analysis. BMC Bioinformatics  8, 75.   https://doi.org/10.1186/1471-2105-8-75




PubMed



        
     
Free Article


 


PubMed ID 17338820
         Pubmed Central ID 1839109 


 



3.
Lee JK, Havaleshko DM, Cho H, Weinstein JN, Kaldjian EP, Karpovich J, Grimshaw A, Theodorescu D (2007). A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proc Natl Acad Sci U S A  104, 13086-91.   https://doi.org/10.1073/pnas.0610292104




PubMed



        
     
Free Article


 


PubMed ID 17666531
         Pubmed Central ID 1941805 


 



4.
Liu H, Zeeberg BR, Qu G, Koru AG, Ferrucci A, Kahn A, Ryan MC, Nuhanovic A, Munson PJ, Reinhold WC, Kane DW, Weinstein JN (2007). AffyProbeMiner: a web resource for computing or retrieving accurately redefined Affymetrix probe sets. Bioinformatics  23, 2385-90.   https://doi.org/10.1093/bioinformatics/btm360




PubMed


 


PubMed ID 17660211
    
     


 



5.
Martin SE, Jones TL, Thomas CL, Lorenzi PL, Nguyen DA, Runfola T, Gunsior M, Weinstein JN, Goldsmith PK, Lader E, Huppi K, Caplen NJ (2007). Multiplexing siRNAs to compress RNAi-based screen size in human cells. Nucleic Acids Res  35, e57.   https://doi.org/10.1093/nar/gkm141




PubMed



        
     
Free Article


 


PubMed ID 17392344
         Pubmed Central ID 1885663 


 



6.
Okabe M, Szakács G, Reimers MA, Suzuki T, Hall MD, Abe T, Weinstein JN, Gottesman MM (2008). Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters. Mol Cancer Ther  7, 3081-91.   https://doi.org/10.1158/1535-7163.MCT-08-0539




PubMed



        
     
Free Article


 


PubMed ID 18790787
         Pubmed Central ID 2597359 


 



7.
Shankavaram UT, Reinhold WC, Nishizuka S, Major S, Morita D, Chary KK, Reimers MA, Scherf U, Kahn A, Dolginow D, Cossman J, Kaldjian EP, Scudiero DA, Petricoin E, Liotta L, Lee JK, Weinstein JN (2007). Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther  6, 820-32.   https://doi.org/10.1158/1535-7163.MCT-06-0650




PubMed


 


PubMed ID 17339364",https://intramural.nih.gov/search/searchview.taf?ipid=50245
486,BC010843-01,"October 01, 2006 -  September 30, 2007",Medical Oncology Fellowship Program,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Janet A Edds,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50006
487,BC010844-01,"October 01, 2006 -  September 30, 2007",DNA Folding in Chromatin and Interaction with Transcription Factors,"Victor  Zhurkin; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Feng  Cui



Difei  Wang","Tom  Jovin
(Dept Mol Biol, Max Planck Inst. Biophys. Chem)




Wilma  Olson
(Wright-Rieman Laboratories, Rutgers University)",Sankar  Adhya; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Tolstorukov MY, Colasanti AV, McCandlish DM, Olson WK, Zhurkin VB (2007). A novel roll-and-slide mechanism of DNA folding in chromatin: implications for nucleosome positioning. J Mol Biol  371, 725-38.   https://doi.org/10.1016/j.jmb.2007.05.048




PubMed



        
     
Free Article


 


PubMed ID 17585938
         Pubmed Central ID 2000845",https://intramural.nih.gov/search/searchview.taf?ipid=50246
488,BC010845-01,"October 01, 2006 -  September 30, 2007",p53-induced Regulation of Transcription in the Chromatin Context,"Victor  Zhurkin; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Feng  Cui



Difei  Wang",NULL,"Curtis  Harris; MD (National Cancer Institute)



Ettore  Appella; MD (National Cancer Institute)",Ronald D Neumann; MD (CC),"Ordered by publication type and then author name.



1.
Shen WH, Wang J, Wu J, Zhurkin VB, Yin Y (2006). Mitogen-activated protein kinase phosphatase 2: a novel transcription target of p53 in apoptosis. Cancer Res  66, 6033-9.   https://doi.org/10.1158/0008-5472.CAN-05-3878




PubMed


 


PubMed ID 16778175
    
     


 



2.
Cui F, Sirotin M, Zhurkin V   (2006) Comparative Sequence Analysis of the p53 Response Elements Associated with Apoptosis and Cell Cycle Arrest.  BIOCOMP '06  48-55 pp.




 



3.
Cui F, Sirotin M, Zhurkin V   (2007) The p53-DNA Binding in the Chromatin Context: p53-induced Activation of the Apoptotic and Cell Cycle Arrest Genes.  JBSD 24:644-645.",https://intramural.nih.gov/search/searchview.taf?ipid=50033
489,BC010846-01,"October 01, 2006 -  September 30, 2007",Mechanisms of Transcriptional Control by p300,"Kevin  Gardner; MD, PhD",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Jung Shin  Byun



Gila  Idelman



Jesse F Quintero",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Cui W, Taub DD, Gardner K (2007). qPrimerDepot: a primer database for quantitative real time PCR. Nucleic Acids Res  35, D805-9.   https://doi.org/10.1093/nar/gkl767




PubMed



        
     
Free Article


 


PubMed ID 17068075
         Pubmed Central ID 1635330 


 



2.
Idelman G, Taylor JG, Tongbai R, Chen RA, Haggerty CM, Bilke S, Chanock SJ, Gardner K (2007). Functional profiling of uncommon VCAM1 promoter polymorphisms prevalent in African American populations. Hum Mutat  28, 824-9.   https://doi.org/10.1002/humu.20523




PubMed


 


PubMed ID 17431880",https://intramural.nih.gov/search/searchview.taf?ipid=50012
490,BC010847-01,"October 01, 2006 -  September 30, 2007",Gene-specific Mechanisms of BRCA1 transcriptional Control,"Kevin  Gardner; MD, PhD",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Cynthia  Haggerty



Jesse F Quintero



Jonathan  Jacobs",NULL,"Kent W Hunter; PhD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



Charles  Vinson; PhD (National Cancer Institute)",Dan L Longo; MD (NIA),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50013
491,BC010848-01,"October 01, 2006 -  September 30, 2007",Regulation of Expression and Mechanism of Action of Granulysin and RANTES,Alan M Krensky,NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Krensky AM, Clayberger C (2009). Biology and clinical relevance of granulysin. Tissue Antigens  73, 193-8.   https://doi.org/10.1111/j.1399-0039.2008.01218.x




PubMed



        
     
Free Article


 


PubMed ID 19254247
         Pubmed Central ID 2679253 


 



2.
Li Q, Morimoto K, Kobayashi M, Inagaki H, Katsumata M, Hirata Y, Hirata K, Suzuki H, Li YJ, Wakayama Y, Kawada T, Park BJ, Ohira T, Matsui N, Kagawa T, Miyazaki Y, Krensky AM (2008). Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol  21, 117-27.   https://doi.org/10.1177/039463200802100113




PubMed


 


PubMed ID 18336737
    
     


 



3.
Nguyen KD, Fohner A, Booker JD, Dong C, Krensky AM, Nadeau KC (2008). XCL1 enhances regulatory activities of CD4+ CD25(high) CD127(low/-) T cells in human allergic asthma. J Immunol  181, 5386-95.   https://doi.org/10.4049/jimmunol.181.8.5386




PubMed



        
     
Free Article


 


PubMed ID 18832695
         Pubmed Central ID 2674584 


 



4.
Zheng CF, Jones GJ, Shi M, Wiseman JC, Marr KJ, Berenger BM, Huston SM, Gill MJ, Krensky AM, Kubes P, Mody CH (2008). Late expression of granulysin by microbicidal CD4+ T cells requires PI3K- and STAT5-dependent expression of IL-2Rbeta that is defective in HIV-infected patients. J Immunol  180, 7221-9.   https://doi.org/10.4049/jimmunol.180.11.7221




PubMed



        
     
Free Article


 


PubMed ID 18490721
         Pubmed Central ID 2661617",https://intramural.nih.gov/search/searchview.taf?ipid=50302
492,BC010849-01,"October 01, 2006 -  September 30, 2007",Evaluation of Novel Radiation Modifiers,"Deborah E Citrin



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Citrin DE (2016). Short-Term Screening Assays for the Identification of Therapeutics for Cancer. Cancer Res  76, 3443-5.   https://doi.org/10.1158/0008-5472.CAN-16-1299




PubMed



        
     
Free Article


 


PubMed ID 27306870
         Pubmed Central ID 6349361 


 



2.
Citrin DE, Mitchell JB (2014) Altering the response to radiation: sensitizers and protectors. Semin Oncol 41:848-59




PubMed



        
     
Free Article


 


PubMed ID 25499642
         Pubmed Central ID 4270009 


 



3.
Premo C, Apolo AB, Agarwal PK, Citrin DE (2015). Trimodality therapy in bladder cancer: who, what, and when? Urol Clin North Am  42, 169-80, vii.   https://doi.org/10.1016/j.ucl.2015.02.002




PubMed



        
     
Free Article


 


PubMed ID 25882559
         Pubmed Central ID 4465095 


 



4.
Reed A, Valle LF, Shankavaram U, Krauze A, Kaushal A, Schott E, Cooley-Zgela T, Wood B, Pinto P, Choyke P, Turkbey B, Citrin DE (2017). Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations. Int J Radiat Oncol Biol Phys  97, 947-951.   https://doi.org/10.1016/j.ijrobp.2016.12.016




PubMed



        
     
Free Article


 


PubMed ID 28333017
         Pubmed Central ID 5364814 


 



5.
Scroggins BT, Burkeen J, White AO, Chung EJ, Wei D, Chung SI, Valle LF, Patil SS, McKay-Corkum G, Hudak KE, Linehan WM, Citrin DE (2018). Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA Damage. Int J Radiat Oncol Biol Phys  100, 344-352.   https://doi.org/10.1016/j.ijrobp.2017.09.049




PubMed



        
     
Free Article


 


PubMed ID 29157749
         Pubmed Central ID 5777897",https://intramural.nih.gov/search/searchview.taf?ipid=50293
493,BC010850-01,"October 01, 2006 -  September 30, 2007",Mechanisms of Normal Tissue Toxicity,"Deborah E Citrin



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50294
494,BC010851-01,"October 01, 2006 -  September 30, 2007",caBIG pilot,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50273
495,BC010852-01,"October 01, 2006 -  September 30, 2007",Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo,"Dennis M Klinman; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50300
496,BC010853-01,"October 01, 2006 -  September 30, 2007",Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"Dennis M Klinman; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Tross D, Klinman DM (2008). Effect of CpG oligonucleotides on vaccine-induced B cell memory. J Immunol  181, 5785-90.   https://doi.org/10.4049/jimmunol.181.8.5785




PubMed



        
     
Free Article


 


PubMed ID 18832738
         Pubmed Central ID 2562272",https://intramural.nih.gov/search/searchview.taf?ipid=50301
497,BC010854-01,"October 01, 2006 -  September 30, 2007",Lung Cancer Program,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Gadalla SM, Rajan A, Pfeiffer R, Kristinsson SY, Björkholm M, Landgren O, Giaccone G (2011). A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer  128, 2688-94.   https://doi.org/10.1002/ijc.25583




PubMed



        
     
Free Article


 


PubMed ID 20669226
         Pubmed Central ID 2992797 


 



2.
Giaccone G, Wang Y (2011). Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors. Cancer Treat Rev  37, 456-64.   https://doi.org/10.1016/j.ctrv.2011.01.003




PubMed



        
     
Free Article


 


PubMed ID 21367530
         Pubmed Central ID 3139833 


 



3.
Harada T, Yatabe Y, Takeshita M, Koga T, Yano T, Wang Y, Giaccone G (2011). Role and relevance of TrkB mutations and expression in non-small cell lung cancer. Clin Cancer Res  17, 2638-45.   https://doi.org/10.1158/1078-0432.CCR-10-3034




PubMed



        
     
Free Article


 


PubMed ID 21242122
         Pubmed Central ID 3086954 


 



4.
Kelly RJ, Rajan A, Force J, Lopez-Chavez A, Keen C, Cao L, Yu Y, Choyke P, Turkbey B, Raffeld M, Xi L, Steinberg SM, Wright JJ, Kummar S, Gutierrez M, Giaccone G (2011). Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib. Clin Cancer Res  17, 1190-9.   https://doi.org/10.1158/1078-0432.CCR-10-2331




PubMed



        
     
Free Article


 


PubMed ID 21224376
         Pubmed Central ID 3048919 


 



5.
Lai CH, Park KS, Lee DH, Alberobello AT, Raffeld M, Pierobon M, Pin E, Petricoin Iii EF, Wang Y, Giaccone G (2014). HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer. Oncogene  33, 4867-76.   https://doi.org/10.1038/onc.2013.439




PubMed



        
     
Free Article


 


PubMed ID 24166505
         Pubmed Central ID 4002667 


 



6.
Lee JH, Park KS, Alberobello AT, Kallakury B, Weng MT, Wang Y, Giaccone G (2013). The Janus kinases inhibitor AZD1480 attenuates growth of small cell lung cancers in vitro and in vivo. Clin Cancer Res  19, 6777-86.   https://doi.org/10.1158/1078-0432.CCR-13-1110




PubMed



        
     
Free Article


 


PubMed ID 24158701
         Pubmed Central ID 3872034 


 



7.
Moon YW, Rao G, Kim JJ, Shim HS, Park KS, An SS, Kim B, Steeg PS, Sarfaraz S, Changwoo Lee L, Voeller D, Choi EY, Luo J, Palmieri D, Chung HC, Kim JH, Wang Y, Giaccone G (2015). LAMC2 enhances the metastatic potential of lung adenocarcinoma. Cell Death Differ  22, 1341-52.   https://doi.org/10.1038/cdd.2014.228




PubMed



        
     
Free Article


 


PubMed ID 25591736
         Pubmed Central ID 4495359 


 



8.
Rajan A, Carter CA, Berman A, Cao L, Kelly RJ, Thomas A, Khozin S, Chavez AL, Bergagnini I, Scepura B, Szabo E, Lee MJ, Trepel JB, Browne SK, Rosen LB, Yu Y, Steinberg SM, Chen HX, Riely GJ, Giaccone G (2014). Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial. Lancet Oncol  15, 191-200.   https://doi.org/10.1016/S1470-2045(13)70596-5




PubMed



        
     
Free Article


 


PubMed ID 24439931
         Pubmed Central ID 3954701 


 



9.
Thomas A, Rajan A, Berman A, Giaccone G (2015) Multiorgan autoimmune manifestations associated with thymoma. J Thorac Oncol 10:e5-7




PubMed



        
     
Free Article


 


PubMed ID 25611232
         Pubmed Central ID 4306236 


 



10.
Thomas A, Rajan A, Szabo E, Tomita Y, Carter CA, Scepura B, Lopez-Chavez A, Lee MJ, Redon CE, Frosch A, Peer CJ, Chen Y, Piekarz RL, Steinberg SM, Trepel JB, Figg W, Schrump DS, Giaccone G (2014) A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study. Clin Cancer Res 20:5392-402




PubMed



        
     
Free Article


 


PubMed ID 25189481
         Pubmed Central ID 4216756 


 



11.
Zucali PA, Petrini I, Lorenzi E, Merino M, Cao L, Di Tommaso L, Lee HS, Incarbone M, Walter BA, Simonelli M, Roncalli M, Santoro A, Giaccone G (2010). Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas. Cancer  116, 4686-95.   https://doi.org/10.1002/cncr.25367




PubMed



        
     
Free Article


 


PubMed ID 20597130
         Pubmed Central ID 3057766",https://intramural.nih.gov/search/searchview.taf?ipid=50297
498,BC010855-01,"October 01, 2006 -  September 30, 2007",caBIG Enterprise,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50274
499,BC010856-01,"October 01, 2006 -  September 30, 2007",Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,Mary C Custer,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50295
500,BC010857-01,"October 01, 2006 -  September 30, 2007",Science and Technology Partnerships,David Jay Goldstein,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50298
501,BC010858-01,"October 01, 2006 -  September 30, 2007",CCR Confocal Microscopy Core,Susan H Garfield,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=50296
502,BC010859-01,"October 01, 2006 -  September 30, 2007",DNA Sequencing MiniCore,Kathleen D Hartman,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=50299
503,CP000101-03,"October 01, 2006 -  September 30, 2007",Human Studies of Diet and Nutrition,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,"David  Baer
(BHNRC, USDA)




Beverly  Clevidence
(BHNRC, USDA)




Jerry  Combs
(USDA)




Joanne  Dorgan; PhD
(NCI)




Terryl  Hartman
(DCEG, NCI, NIH)




Joseph  Judd
(BHNRC, USDA)


Show all 7",Blossom  Patterson (Biometry Research Group),NULL,"Ordered by publication type and then author name.



1.
Mahabir S, Ettinger S, Johnson L, Baer DJ, Clevidence BA, Hartman TJ, Taylor PR (2008). Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study. Eur J Clin Nutr  62, 644-50.   https://doi.org/10.1038/sj.ejcn.1602771




PubMed



        
     
Free Article


 


PubMed ID 17457338
         Pubmed Central ID 3236439",https://intramural.nih.gov/search/searchview.taf?ipid=45812
504,CP000112-03,"October 01, 2006 -  September 30, 2007",Nutrition Intervention Trials in Linxian China,"Christian Cormac Abnet; PhD, MPH



IRP Faculty Profile
 


 

Sanford Martin Dawsey; MD



IRP Faculty Profile
 




Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",Nan  Hu,"Zhi-Wei  Dong
(CICAMS)




You-Lin  Qiao
(Cancer Institute of the Chinese Academy of Science)




Guo-Qing  Wang
(CICAMS)




Wen-Qiang  Wei
(Cancer Institute, Chinese Academy of Medical Sciences)","Farin  Kamangar (Nutritional Epidemiology Branch)



Mark J Roth (Nutritional Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Chen W, Dawsey SM, Qiao YL, Mark SD, Dong ZW, Taylor PR, Zhao P, Abnet CC (2007). Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer  97, 123-8.   https://doi.org/10.1038/sj.bjc.6603834




PubMed



        
     
Free Article


 


PubMed ID 17551495
         Pubmed Central ID 2359654 


 



2.
Kamangar F, Qiao YL, Blaser MJ, Sun XD, Katki H, Fan JH, Perez-Perez GI, Abnet CC, Zhao P, Mark SD, Taylor PR, Dawsey SM (2007). Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer  96, 172-6.   https://doi.org/10.1038/sj.bjc.6603517




PubMed



        
     
Free Article


 


PubMed ID 17179990
         Pubmed Central ID 2360212 


 



3.
Qu CX, Kamangar F, Fan JH, Yu B, Sun XD, Taylor PR, Chen BE, Abnet CC, Qiao YL, Mark SD, Dawsey SM (2007). Chemoprevention of primary liver cancer: a randomized, double-blind trial in Linxian, China. J Natl Cancer Inst  99, 1240-7.   https://doi.org/10.1093/jnci/djm084




PubMed


 


PubMed ID 17686823",https://intramural.nih.gov/search/searchview.taf?ipid=45810
505,CP000150-03,"October 01, 2006 -  September 30, 2007",UGI Cancer Genetic Studies,"Sanford Martin Dawsey; MD



IRP Faculty Profile
 


 

Alisa  Goldstein; PhD



IRP Faculty Profile
 




Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI","Chaoyu C Wang



David  Ng; AB, MD



Nan  Hu",NULL,"Christian Cormac Abnet; PhD, MPH (Nutritional Epidemiology Branch)



Mark J Roth (Nutritional Epidemiology Branch)



Maxwell P Lee; PhD (Laboratory of Population Genetics)



Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)



Ruth  Pfeiffer; PhD (Biostatistics Branch)



Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"Ordered by publication type and then author name.



1.
Golozar A, Beaty TH, Gravitt PE, Ruczinski I, Qiao YL, Fan JH, Ding T, Tang ZZ, Etemadi A, Hu N, Hyland PL, Wang L, Wang C, Dawsey SM, Freedman ND, Abnet CC, Goldstein AM, Taylor PR (2014) Oesophageal squamous cell carcinoma in high-risk Chinese populations: Possible role for vascular epithelial growth factor A. Eur J Cancer 50:2855-65




PubMed



        
     
Free Article


 


PubMed ID 25172294
         Pubmed Central ID 4363989 


 



2.
Kadota M, Yang HH, Hu N, Wang C, Hu Y, Taylor PR, Buetow KH, Lee MP (2007). Allele-specific chromatin immunoprecipitation studies show genetic influence on chromatin state in human genome. PLoS Genet  3, e81.   https://doi.org/10.1371/journal.pgen.0030081




PubMed



        
     
Free Article


 


PubMed ID 17511522
         Pubmed Central ID 1868950 


 



3.
Li WQ, Hu N, Hyland PL, Gao Y, Wang ZM, Yu K, Su H, Wang CY, Wang LM, Chanock SJ, Burdett L, Ding T, Qiao YL, Fan JH, Wang Y, Xu Y, Shi JX, Gu F, Wheeler W, Xiong XQ, Giffen C, Tucker MA, Dawsey SM, Freedman ND, Abnet CC, et al. [2 more authors] (2013). Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population. Carcinogenesis  34, 1536-42.   https://doi.org/10.1093/carcin/bgt094




PubMed



        
     
Free Article


 


PubMed ID 23504502
         Pubmed Central ID 3697889 


 



4.
Shou JZ, Hu N, Takikita M, Roth MJ, Johnson LL, Giffen C, Wang QH, Wang C, Wang Y, Su H, Kong LH, Emmert-Buck MR, Goldstein AM, Hewitt SM, Taylor PR (2008). Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China. Cancer Epidemiol Biomarkers Prev  17, 1424-35.   https://doi.org/10.1158/1055-9965.EPI-06-0666




PubMed



        
     
Free Article


 


PubMed ID 18559558
         Pubmed Central ID 2729558 


 



5.
Yang XR, Rotunno M, Xiao Y, Ingvar C, Helgadottir H, Pastorino L, van Doorn R, Bennett H, Graham C, Sampson JN, Malasky M, Vogt A, Zhu B, Bianchi-Scarra G, Bruno W, Queirolo P, Fornarini G, Hansson J, Tuominen R, Burdett L, Hicks B, Hutchinson A, Jones K, Yeager M, Chanock SJ, et al. [7 more authors] (2016). Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations. Hum Genet  135, 1241-1249.   https://doi.org/10.1007/s00439-016-1715-1




PubMed



        
     
Free Article


 


PubMed ID 27449771
         Pubmed Central ID 5152573",https://intramural.nih.gov/search/searchview.taf?ipid=45811
506,CP000176-03,"October 01, 2006 -  September 30, 2007",Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,"You-Lin  Qiao
(Cancer Institute of the Chinese Academy of Science)




Wendy  Wang
(NCI/DCP)",Ping  Hu; MS (Biometry Research Group),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45813
507,CP000185-03,"October 01, 2006 -  September 30, 2007",Upper Gastrointestinal Cancer Studies,"Christian Cormac Abnet; PhD, MPH



IRP Faculty Profile
 




Philip  Taylor; MD, ScD

 


 

Sanford Martin Dawsey; MD



IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI","Farin  Kamangar



Mark J Roth","Paolo  Boffetta
(International Agency for Research on Cancer)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




Zhi-Wei  Dong
(CICAMS)




Renato  Fagundes





David  Fleischer
(Mayo Clinic (Scottsdale))




Paul J Limburg



Show all 13","Edward L Korn (Clinical Trials Section)



Nan  Hu (Genetic Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Abnet CC, Chen W, Dawsey SM, Wei WQ, Roth MJ, Liu B, Lu N, Taylor PR, Qiao YL (2007). Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev  16, 1889-93.   https://doi.org/10.1158/1055-9965.EPI-07-0461




PubMed



        
     
Free Article


 


PubMed ID 17855710
         Pubmed Central ID 2812415 


 



2.
Abnet CC, Fagundes RB, Strickland PT, Kamangar F, Roth MJ, Taylor PR, Dawsey SM (2007). The influence of genetic polymorphisms in Ahr, CYP1A1, CYP1A2, CYP1B1, GST M1, GST T1 and UGT1A1 on urine 1-hydroxypyrene glucuronide concentrations in healthy subjects from Rio Grande do Sul, Brazil. Carcinogenesis  28, 112-7.   https://doi.org/10.1093/carcin/bgl131




PubMed


 


PubMed ID 16864595
    
     


 



3.
Kamangar F, Gao YT, Shu XO, Kahkeshani K, Ji BT, Yang G, Li HL, Rothman N, Chow WH, Zheng W (2007). Ginseng intake and gastric cancer risk in the Shanghai Women's Health Study cohort. Cancer Epidemiol Biomarkers Prev  16, 629-30.   https://doi.org/10.1158/1055-9965.EPI-06-1009




PubMed


 


PubMed ID 17372265",https://intramural.nih.gov/search/searchview.taf?ipid=45815
508,CP004410-31,"October 01, 2006 -  September 30, 2007",Family Studies,"Neil Edward Caporaso; MS, MD



IRP Faculty Profile
 




Lynn Rachel Goldin; PhD

 


 

Alisa  Goldstein; PhD



IRP Faculty Profile
 


 

Maria Teresa Pia Landi; MD, PhD



IRP Faculty Profile
 




Jorge R Toro

 


 

Margaret Anne Tucker



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI","David  Ng; AB, MD



Dilys  Parry; PhD



Gladys M. Glenn; MD, PhD



Mary Louise McMaster; MD



Mary C Fraser



Ola Anders Landgren



Show all 8","Janis  Beach
(Information Management Systems)




Giovanna  Bianchi-Scarra
(University of Genova)




Tim  Bishop
(Institute for Cancer Research)




Donato  Calista
(Bufalini Hospital)




Florence  Demenais
(Institut National de la Sante et de la Recherche Medicale)




David  Elder
(University of Pennsylvania School of Medicine, Philadelphia, PA)


Show all 12","June  Peters (Clinical Genetics Branch)



Kenneth H Kraemer; MD (DNA Repair Section)",NULL,"Ordered by publication type and then author name.



1.
Brau-Javier CN, Gonzales-Chavez J, Toro JR (2012). Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2q13: excellent response to anakinra. Arch Dermatol  148, 301-4.   https://doi.org/10.1001/archdermatol.2011.2857




PubMed



        
     
Free Article


 


PubMed ID 22431772
         Pubmed Central ID 3313085 


 



2.
Fraser MC (2008). dna and DNA: linked for life. Dermatol Nurs  20, 102.




PubMed


 


PubMed ID 18549124
    
     


 



3.
Gao Y, Linet MS, Gridley G, Mellemkjaer L, Hemminki K, Goldin LR, Landgren O (2008). Shared susceptibility for celiac disease and inflammatory bowel disease? Scand J Gastroenterol  43, 1279-80.   https://doi.org/10.1080/00365520802158630




PubMed



        
     
Free Article


 


PubMed ID 18609125
         Pubmed Central ID 3240943 


 



4.
Gerstenblith MR, Goldstein AM, Fargnoli MC, Peris K, Landi MT (2007). Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat  28, 495-505.   https://doi.org/10.1002/humu.20476




PubMed


 


PubMed ID 17279550
    
     


 



5.
Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon Albright LA, Demenais F, Elder DE, Ghiorzo P, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, Melanoma Genetics Consortium (GenoMEL), et al. [14 more authors] (2006). High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res  66, 9818-28.   https://doi.org/10.1158/0008-5472.CAN-06-0494




PubMed


 


PubMed ID 17047042
    
     


 



6.
Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W, Calista D, Albright LA, Chaudru V, Chompret A, Cuellar F, Elder DE, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lund Melanoma Study Group, Melanoma Genetics Consortium (GenoMEL), et al. [14 more authors] (2007). Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet  44, 99-106.   https://doi.org/10.1136/jmg.2006.043802




PubMed



        
     
Free Article


 


PubMed ID 16905682
         Pubmed Central ID 2598064 


 



7.
Goldstein AM, Stacey SN, Olafsson JH, Jonsson GF, Helgason A, Sulem P, Sigurgeirsson B, Benediktsdottir KR, Thorisdottir K, Ragnarsson R, Kjartansson J, Kostic J, Masson G, Kristjansson K, Gulcher JR, Kong A, Thorsteinsdottir U, Rafnar T, Tucker MA, Stefansson K (2008). CDKN2A mutations and melanoma risk in the Icelandic population. J Med Genet  45, 284-9.   https://doi.org/10.1136/jmg.2007.055376




PubMed



        
     
Free Article


 


PubMed ID 18178632
         Pubmed Central ID 3236640 


 



8.
McHale CM, Zhang L, Hubbard AE, Zhao X, Baccarelli A, Pesatori AC, Smith MT, Landi MT (2007). Microarray analysis of gene expression in peripheral blood mononuclear cells from dioxin-exposed human subjects. Toxicology  229, 101-13.   https://doi.org/10.1016/j.tox.2006.10.004




PubMed


 


PubMed ID 17101203
    
     


 



9.
McMaster ML, Csako G, Giambarresi TR, Vasquez L, Berg M, Saddlemire S, Hulley B, Tucker MA (2007). Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families. Clin Cancer Res  13, 5063-9.   https://doi.org/10.1158/1078-0432.CCR-07-0299




PubMed


 


PubMed ID 17785558
    
     


 



10.
McMaster ML, Goldin LR, Bai Y, Ter-Minassian M, Boehringer S, Giambarresi TR, Vasquez LG, Tucker MA (2006). Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families. Am J Hum Genet  79, 695-701.   https://doi.org/10.1086/507687




PubMed



        
     
Free Article


 


PubMed ID 16960805
         Pubmed Central ID 1592553 


 



11.
Sellick GS, Goldin LR, Wild RW, Slager SL, Ressenti L, Strom SS, Dyer MJ, Mauro FR, Marti GE, Fuller S, Lyttelton M, Kipps TJ, Keating MJ, Call TG, Catovsky D, Caporaso N, Houlston RS (2007). A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia. Blood  110, 3326-33.   https://doi.org/10.1182/blood-2007-05-091561




PubMed



        
     
Free Article


 


PubMed ID 17687107
         Pubmed Central ID 2200912 


 



12.
Toro JR, Pautler SE, Stewart L, Glenn GM, Weinreich M, Toure O, Wei MH, Schmidt LS, Davis L, Zbar B, Choyke P, Steinberg SM, Nguyen DM, Linehan WM (2007). Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome. Am J Respir Crit Care Med  175, 1044-53.   https://doi.org/10.1164/rccm.200610-1483OC




PubMed



        
     
Free Article


 


PubMed ID 17322109
         Pubmed Central ID 1899269",https://intramural.nih.gov/search/searchview.taf?ipid=45770
509,CP005782-13,"October 01, 2006 -  September 30, 2007",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,NULL,"Charles  Rabkin (Infection & Immunoepidemiology Branch)



Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
An P, Goedert J   (2007) Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals.  PLoS Genet  123-132 pp.




 



2.
O'Brien TR, Kachapati K, Zhang M, Bergeron J, Edlin BR, Dean M (2007). HCV infection clearance with functional or non-functional caspase-12. Scand J Gastroenterol  42, 416-7.   https://doi.org/10.1080/00365520601076074




PubMed


 


PubMed ID 17354126
    
     


 



3.
Tseng FC, O'Brien TR, Zhang M, Kral AH, Ortiz-Conde BA, Lorvick J, Busch MP, Edlin BR (2007). Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. Hepatology  46, 666-71.   https://doi.org/10.1002/hep.21765




PubMed



        
     
Free Article


 


PubMed ID 17657818
         Pubmed Central ID 4751875",https://intramural.nih.gov/search/searchview.taf?ipid=45769
510,CP005803-13,"October 01, 2006 -  September 30, 2007",Genetic Epidemiology,"Alisa  Goldstein; PhD



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI","David  Ng; AB, MD



Dilys  Parry; PhD



Gladys M. Glenn; MD, PhD



Jorge R Toro



Lynn Rachel Goldin; PhD



Margaret Anne Tucker



Show all 13","Timothy  Bishop
(Institute for Cancer Research)




Julianne  Byrne
(Washington Children's hospital)




Donato  Calista
(Bufalini Hospital)




Florence  Demenais
(Institut National de la Sante et de la Recherche Medicale)




Kari  Hemminki; PhD
(Department of Biosciences, Karolinska Institute)




David  Hogg
(University of Toronto)


Show all 9","Gloria L Gridley (Biostatistics Branch)



Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Martha S Linet; PhD (Radiation Epidemiology Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,"Ordered by publication type and then author name.



1.
Landgren O, Pfeiffer RM, Stewart L, Gridley G, Mellemkjaer L, Hemminki K, Goldin LR, Travis LB (2007). Risk of second malignant neoplasms among lymphoma patients with a family history of cancer. Int J Cancer  120, 1099-102.   https://doi.org/10.1002/ijc.22414




PubMed


 


PubMed ID 17131330
    
     


 



2.
Landgren O, Rapkin JS, Mellemkjaer L, Gridley G, Goldin LR, Engels EA (2006). Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia. Haematologica  91, 1697-700.




PubMed


 


PubMed ID 17145609
    
     


 



3.
Lea CS, Holly EA, Hartge P, Lee JS, Guerry D, Elder DE, Halpern A, Sagebiel RW, Tucker MA (2007). Reproductive risk factors for cutaneous melanoma in women: a case-control study. Am J Epidemiol  165, 505-13.   https://doi.org/10.1093/aje/kwk040




PubMed


 


PubMed ID 17158470
    
     


 



4.
Wong WT, Agrón E, Coleman HR, Reed GF, Csaky K, Peterson J, Glenn G, Linehan WM, Albert P, Chew EY (2007). Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis. Arch Ophthalmol  125, 239-45.   https://doi.org/10.1001/archopht.125.2.239




PubMed



        
     
Free Article


 


PubMed ID 17296901
         Pubmed Central ID 3019103 


 



5.
Yang X, Sherman M, Rimm D, Lissowska J, Brinton L, Peplonska B, Hewitt S, Anderson W, SzeszeniaDabrowska N, BardinMikolajczak A, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, Garcia-Closas M (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiology Biomarkers Prevention 16:439-443




 



6.
Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, García-Closas M (2007). Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev  16, 439-43.   https://doi.org/10.1158/1055-9965.EPI-06-0806




PubMed


 


PubMed ID 17372238",https://intramural.nih.gov/search/searchview.taf?ipid=45768
511,CP005804-13,"October 01, 2006 -  September 30, 2007",Pharmacogenetic Studies,"Neil Edward Caporaso; MS, MD



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI","Alisa  Goldstein; PhD



Lynn Rachel Goldin; PhD



Margaret Anne Tucker



Maria Teresa Pia Landi; MD, PhD



Naoko  Ishibe; ScD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Baccarelli A, Hirt C, Pesatori AC, Consonni D, Patterson DG, Bertazzi PA, Dölken G, Landi MT (2006). t(14;18) translocations in lymphocytes of healthy dioxin-exposed individuals from Seveso, Italy. Carcinogenesis  27, 2001-7.   https://doi.org/10.1093/carcin/bgl011




PubMed


 


PubMed ID 16543249
    
     


 



2.
Morton LM, Wang SS, Bergen AW, Chatterjee N, Kvale P, Welch R, Yeager M, Hayes RB, Chanock SJ, Caporaso NE (2006). DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Pharmacogenet Genomics  16, 901-10.   https://doi.org/10.1097/01.fpc.0000230417.20468.d0




PubMed


 


PubMed ID 17108814
    
     


 



3.
Wang SS, Morton LM, Bergen AW, Lan EZ, Chatterjee N, Kvale P, Hayes RB, Chanock SJ, Caporaso NE (2007). Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Hum Genet  122, 41-9.   https://doi.org/10.1007/s00439-007-0374-7




PubMed


 


PubMed ID 17497175",https://intramural.nih.gov/search/searchview.taf?ipid=45767
512,CP010119-12,"October 01, 2006 -  September 30, 2007",Studies of Occupational Cancer (Pesticides),"Aaron E Blair; PhD, MPH

 




Michael  Alavanja; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Debra  Silverman; ScD, ScM



Gabriella  Andreotti



Joanne S Colt



Kenneth  Cantor; PhD



Mary Helen Ward; MS, PhD



Show all 9","Lisbeth  Lopez-Carrillo
(Mexican National Institute of Public Health)




Andrew  Olshan
(University of North Carolina)




Sandra  Petralia
(Roche Laboratories)




Dennis  Weisenburger
(University of Nebraska Medical Center)","Jay  Lubin; PhD (Biostatistics Branch)



Ola Anders Landgren (Genetic Epidemiology Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Shelia K Zahm; ScM, ScD (Office of the Director)",NULL,"Ordered by publication type and then author name.



1.
Beseler C, Stallones L, Hoppin JA, Alavanja MC, Blair A, Keefe T, Kamel F (2006). Depression and pesticide exposures in female spouses of licensed pesticide applicators in the agricultural health study cohort. J Occup Environ Med  48, 1005-13.   https://doi.org/10.1097/01.jom.0000235938.70212.dd




PubMed



        
     
Free Article


 


PubMed ID 17033500
         Pubmed Central ID 1626656 


 



2.
Blair A, Alavanja M, Sandler D, Hoppin J   (2007) Pesticide Exposure and Gestational Diabetes in the Agricultural Health Study.  Diabetes Care  529-534 pp.




 



3.
Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, Hoppin JA, Sandler DP, Langston JW, Tanner CM (2012). Head injury, α-synuclein Rep1, and Parkinson's disease. Ann Neurol  71, 40-8.   https://doi.org/10.1002/ana.22499




PubMed



        
     
Free Article


 


PubMed ID 22275250
         Pubmed Central ID 3270814 


 



4.
Hines CJ, Deddens JA, Coble J, Alavanja MC (2007). Fungicide application practices and personal protective equipment use among orchard farmers in the agricultural health study. J Agric Saf Health  13, 205-23.   https://doi.org/10.13031/2013.22620




PubMed


 


PubMed ID 17555208
    
     


 



5.
Hoppin JA, Umbach DM, Kullman GJ, Henneberger PK, London SJ, Alavanja MC, Sandler DP (2007). Pesticides and other agricultural factors associated with self-reported farmer's lung among farm residents in the Agricultural Health Study. Occup Environ Med  64, 334-41.   https://doi.org/10.1136/oem.2006.028480




PubMed



        
     
Free Article


 


PubMed ID 17182642
         Pubmed Central ID 1945110 


 



6.
Kamel F, Tanner C, Umbach D, Hoppin J, Alavanja M, Blair A, Comyns K, Goldman S, Korell M, Langston J, Ross G, Sandler D (2007). Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am J Epidemiol  165, 364-74.   https://doi.org/10.1093/aje/kwk024




PubMed


 


PubMed ID 17116648
    
     


 



7.
Koutros S, Cross AJ, Sandler DP, Hoppin JA, Ma X, Zheng T, Alavanja MC, Sinha R (2008). Meat and meat mutagens and risk of prostate cancer in the Agricultural Health Study. Cancer Epidemiol Biomarkers Prev  17, 80-7.   https://doi.org/10.1158/1055-9965.EPI-07-0392




PubMed



        
     
Free Article


 


PubMed ID 18199713
         Pubmed Central ID 2935655 


 



8.
Lee WJ, Sandler DP, Blair A, Samanic C, Cross AJ, Alavanja MC (2007). Pesticide use and colorectal cancer risk in the Agricultural Health Study. Int J Cancer  121, 339-46.   https://doi.org/10.1002/ijc.22635




PubMed



        
     
Free Article


 


PubMed ID 17390374
         Pubmed Central ID 2928992 


 



9.
Mahajan R, Blair A, Coble J, Lynch CF, Hoppin JA, Sandler DP, Alavanja MC (2007). Carbaryl exposure and incident cancer in the Agricultural Health Study. Int J Cancer  121, 1799-805.   https://doi.org/10.1002/ijc.22836




PubMed


 


PubMed ID 17534892
    
     


 



10.
Purdue MP, Hoppin JA, Blair A, Dosemeci M, Alavanja MC (2007). Occupational exposure to organochlorine insecticides and cancer incidence in the Agricultural Health Study. Int J Cancer  120, 642-9.   https://doi.org/10.1002/ijc.22258




PubMed



        
     
Free Article


 


PubMed ID 17096337
         Pubmed Central ID 1971137 


 



11.
Saldana TM, Basso O, Hoppin JA, Baird DD, Knott C, Blair A, Alavanja MC, Sandler DP (2007). Pesticide exposure and self-reported gestational diabetes mellitus in the Agricultural Health Study. Diabetes Care  30, 529-34.   https://doi.org/10.2337/dc06-1832




PubMed



        
     
Free Article


 


PubMed ID 17327316
         Pubmed Central ID 3902103 


 



12.
Samanic C, Rusiecki J, Dosemeci M, Hou L, Hoppin JA, Sandler DP, Lubin J, Blair A, Alavanja MC (2006). Cancer incidence among pesticide applicators exposed to dicamba in the agricultural health study. Environ Health Perspect  114, 1521-6.   https://doi.org/10.1289/ehp.9204




PubMed



        
     
Free Article


 


PubMed ID 17035136
         Pubmed Central ID 1626435",https://intramural.nih.gov/search/searchview.taf?ipid=45762
513,CP010120-12,"October 01, 2006 -  September 30, 2007",Studies of Occupational Cancer,"Michael  Alavanja; PhD

 




Kenneth  Cantor; PhD

 




Wong H Chow

 




Mustafa  Dosemeci; PhD

 


 

Nathaniel C Rothman; MD



IRP Faculty Profile
 


 

Debra  Silverman; ScD, ScM



IRP Faculty Profile
 




Richard  Hayes; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji



Claudine M Samanic



Dalsu  Baris



Jennifer A Rusiecki



Joanne S Colt



Joseph B Coble



Show all 14","Paolo  Boffetta
(International Agency for Research on Cancer)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




Leon  Burmeister
(University of Iowa)




Brian  Chiu
(Northwestern University)




Pierluigi  Cocco
(University of Cagliari)




Larwence  Figgs
(St. Louis University)


Show all 21","Jay  Lubin; PhD (Biostatistics Branch)



Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Blair A, Lubin J   (2007) Issues regarding confounding and exposure misclassification in epidemiologic studies of occupational exposures.  Am J Ind Med  199-207 pp.




 



2.
Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Chow WH, Rothman N, Chabrier A, Gaborieau V, Odefrey F, Southey M, Hashibe M, Hall J, Boffetta P, Peto J, Peto R, Hung RJ (2007). Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. Hum Mol Genet  16, 1794-801.   https://doi.org/10.1093/hmg/ddm127




PubMed


 


PubMed ID 17517688
    
     


 



3.
Cocco P, Dosemeci M, Rice C (2007). Lung cancer among silica-exposed workers: the quest for truth between chance and necessity. Med Lav  98, 3-17.




PubMed


 


PubMed ID 17240640
    
     


 



4.
García-Closas M, Malats N, Real FX, Yeager M, Welch R, Silverman D, Kogevinas M, Dosemeci M, Figueroa J, Chatterjee N, Tardón A, Serra C, Carrato A, García-Closas R, Murta-Nascimento C, Rothman N, Chanock SJ (2007). Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet  3, e29.   https://doi.org/10.1371/journal.pgen.0030029




PubMed



        
     
Free Article


 


PubMed ID 17319747
         Pubmed Central ID 1802828 


 



5.
Hsu CC, Chow WH, Boffetta P, Moore L, Zaridze D, Moukeria A, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Brennan P (2007). Dietary risk factors for kidney cancer in Eastern and Central Europe. Am J Epidemiol  166, 62-70.   https://doi.org/10.1093/aje/kwm043




PubMed


 


PubMed ID 17456477
    
     


 



6.
Hung RJ, Moore L, Boffetta P, Feng BJ, Toro JR, Rothman N, Zaridze D, Navratilova M, Bencko V, Janout V, Kollarova H, Szeszenia-Dabrowska N, Mates D, Chow WH, Brennan P (2007). Family history and the risk of kidney cancer: a multicenter case-control study in Central Europe. Cancer Epidemiol Biomarkers Prev  16, 1287-90.   https://doi.org/10.1158/1055-9965.EPI-06-0963




PubMed


 


PubMed ID 17548699
    
     


 



7.
Karami S, Boffetta P, Rothman N, Hung RJ, Stewart T, Zaridze D, Navritalova M, Mates D, Janout V, Kollarova H, Bencko V, Szeszenia-Dabrowska N, Holcatova I, Mukeria A, Gromiec J, Chanock SJ, Brennan P, Chow WH, Moore LE (2008). Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms. Carcinogenesis  29, 1567-71.   https://doi.org/10.1093/carcin/bgn153




PubMed



        
     
Free Article


 


PubMed ID 18566013
         Pubmed Central ID 2733189 


 



8.
Moore LE, Brennan P, Karami S, Hung RJ, Hsu C, Boffetta P, Toro J, Zaridze D, Janout V, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Welch R, Chanock S, Rothman N, Chow WH (2007). Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis  28, 1960-4.   https://doi.org/10.1093/carcin/bgm151




PubMed


 


PubMed ID 17617661
    
     


 



9.
Moore LE, Malats N, Rothman N, Real FX, Kogevinas M, Karami S, García-Closas R, Silverman D, Chanock S, Welch R, Tardón A, Serra C, Carrato A, Dosemeci M, García-Closas M (2007). Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer  120, 2452-8.   https://doi.org/10.1002/ijc.22565




PubMed


 


PubMed ID 17311259
    
     


 



10.
Purdue MP, Gold L, Järvholm B, Alavanja MC, Ward MH, Vermeulen R (2007). Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax  62, 51-6.   https://doi.org/10.1136/thx.2006.064196




PubMed



        
     
Free Article


 


PubMed ID 16928722
         Pubmed Central ID 2111275 


 



11.
Villanueva CM, Cantor KP, Grimalt JO, Malats N, Silverman D, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castaño-Vinyals G, Marcos R, Rothman N, Real FX, Dosemeci M, Kogevinas M (2007). Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools. Am J Epidemiol  165, 148-56.   https://doi.org/10.1093/aje/kwj364




PubMed


 


PubMed ID 17079692
    
     


 



12.
Zhang L, Rothman N, Li G, Guo W, Yang W, Hubbard AE, Hayes RB, Yin S, Lu W, Smith MT (2007). Aberrations in chromosomes associated with lymphoma and therapy-related leukemia in benzene-exposed workers. Environ Mol Mutagen  48, 467-74.   https://doi.org/10.1002/em.20306




PubMed


 


PubMed ID 17584886",https://intramural.nih.gov/search/searchview.taf?ipid=45764
514,CP010121-12,"October 01, 2006 -  September 30, 2007",Molecular Epidemiology Studies of Occupational and Environmental Exposures,"Nathaniel C Rothman; MD



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Kenneth  Cantor; PhD



Laura Elizabeth Beane Freeman



Mark  Purdue



Mary Helen Ward; MS, PhD



Michael  Alavanja; PhD



Show all 11","Robert  Branch
(University of Pittsburgh)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




David  DeMarini
(United States Environmental Protection Agency)




Manolis  Kogevinas





NÃºria  Malats
(Institut Municipal dÂInvestigaciÃ³ MÃ¨dica)




Stephen  Rappaport
(University of North Carolina)


Show all 12","Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Shelia K Zahm; ScM, ScD (Office of the Director)",NULL,"Ordered by publication type and then author name.



1.
Alguacil J, Pfeiffer RM, Moore LE, Del Fresno MR, Medina-Lopez R, Kogevinas M, Vermeulen R, Dosemeci M, Silverman DT, Rothman N, García-Closas M (2007). Measurement of urine pH for epidemiological studies on bladder cancer. Eur J Epidemiol  22, 91-8.   https://doi.org/10.1007/s10654-006-9101-2




PubMed


 


PubMed ID 17334820
    
     


 



2.
Carreón T, Kadlubar FF, Ruder AM, Schulte PA, Hayes RB, Waters M, Grant DJ, Boissy R, Bell DA, Hemstreet GP, Yin S, Lemasters GK, Rothman N (2007). Reply to the letter to the Editor: ""N-Acetyltransferases and the susceptibility to benzidine-induced bladder carcinogenesis"". Int J Cancer  121, 1637-9; author reply 1640-1.   https://doi.org/10.1002/ijc.22906




PubMed


 


PubMed ID 17583575
    
     


 



3.
Figueroa JD, Malats N, Real FX, Silverman D, Kogevinas M, Chanock S, Welch R, Dosemeci M, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, Rothman N, García-Closas M (2007). Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet  121, 233-42.   https://doi.org/10.1007/s00439-006-0294-y




PubMed


 


PubMed ID 17203305
    
     


 



4.
Figueroa JD, Malats N, Rothman N, Real FX, Silverman D, Kogevinas M, Chanock S, Yeager M, Welch R, Dosemeci M, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, García-Closas M (2007). Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis  28, 1788-93.   https://doi.org/10.1093/carcin/bgm132




PubMed


 


PubMed ID 17557904
    
     


 



5.
Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wünsch-Filho V, Franceschi S, Hayes RB, Herrero R, Koifman S, La Vecchia C, Lazarus P, Levi F, Mates D, Matos E, Menezes A, Muscat J, Eluf-Neto J, Olshan AF, Rudnai P, et al. [12 more authors] (2007). Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst  99, 777-89.   https://doi.org/10.1093/jnci/djk179




PubMed


 


PubMed ID 17505073
    
     


 



6.
Hosgood HD, Berndt SI, Lan Q (2007). GST genotypes and lung cancer susceptibility in Asian populations with indoor air pollution exposures: a meta-analysis. Mutat Res  636, 134-43.   https://doi.org/10.1016/j.mrrev.2007.02.002




PubMed



        
     
Free Article


 


PubMed ID 17428724
         Pubmed Central ID 2170530 


 



7.
Lan Q, Shen M, Berndt S, Bonner M, He X, Yeager M, Welch R, Chanock S (2007) Genetic Polymorphism in NBS1 Gene, p53 Gene Expression, Smoky Coal Exposure, and Lung Cancer Risk in Xuan Wei, China. International Journal of Cancer 28:1437-41




 



8.
Lan Q, Zheng T, Chanock S, Zhang Y, Shen M, Wang SS, Berndt SI, Zahm SH, Holford TR, Leaderer B, Yeager M, Welch R, Hosgood D, Boyle P, Rothman N (2007). Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis  28, 823-7.   https://doi.org/10.1093/carcin/bgl196




PubMed


 


PubMed ID 17071630
    
     


 



9.
Lee KM, Shen M, Chapman RS, Yeager M, Welch R, He X, Zheng T, Hosgood HD, Yang D, Berndt SI, Chanock S, Lan Q (2007). Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis  28, 1437-41.   https://doi.org/10.1093/carcin/bgm030




PubMed


 


PubMed ID 17361014
    
     


 



10.
Lin YS, Vermeulen R, Tsai CH, Waidyanatha S, Lan Q, Rothman N, Smith MT, Zhang L, Shen M, Li G, Yin S, Kim S, Rappaport SM (2007). Albumin adducts of electrophilic benzene metabolites in benzene-exposed and control workers. Environ Health Perspect  115, 28-34.   https://doi.org/10.1289/ehp.8948




PubMed



        
     
Free Article


 


PubMed ID 17366815
         Pubmed Central ID 1797829 


 



11.
Moore LE, Malats N, Rothman N, Real FX, Kogevinas M, Karami S, García-Closas R, Silverman D, Chanock S, Welch R, Tardón A, Serra C, Carrato A, Dosemeci M, García-Closas M (2007). Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer  120, 2452-8.   https://doi.org/10.1002/ijc.22565




PubMed


 


PubMed ID 17311259
    
     


 



12.
Murta-Nascimento C, Silverman DT, Kogevinas M, García-Closas M, Rothman N, Tardón A, García-Closas R, Serra C, Carrato A, Villanueva C, Dosemeci M, Real FX, Malats N (2007). Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev  16, 1595-600.   https://doi.org/10.1158/1055-9965.EPI-06-0743




PubMed


 


PubMed ID 17684133
    
     


 



13.
Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, Turner J, Whitby D, Chanock S, Rothman N, Armstrong BK (2007). Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis  28, 704-12.   https://doi.org/10.1093/carcin/bgl200




PubMed


 


PubMed ID 17056605
    
     


 



14.
Purdue MP, Lan Q, Kricker A, Vajdic CM, Rothman N, Armstrong BK (2007). Vitamin D receptor gene polymorphisms and risk of non-Hodgkin's lymphoma. Haematologica  92, 1145-6.   https://doi.org/10.3324/haematol.11053




PubMed


 


PubMed ID 17650449
    
     


 



15.
Serra C, Kogevinas M, Silverman DT, Turuguet D, Tardon A, Garcia-Closas R, Carrato A, Castaño-Vinyals G, Fernandez F, Stewart P, Benavides FG, Gonzalez S, Serra A, Rothman N, Malats N, Dosemeci M (2008). Work in the textile industry in Spain and bladder cancer. Occup Environ Med  65, 552-9.   https://doi.org/10.1136/oem.2007.035667




PubMed


 


PubMed ID 18045847
    
     


 



16.
Shen M, Lan Q, Zhang L, Chanock S, Li G, Vermeulen R, Rappaport SM, Guo W, Hayes RB, Linet M, Yin S, Yeager M, Welch R, Forrest MS, Rothman N, Smith MT (2006). Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity. Carcinogenesis  27, 2083-9.   https://doi.org/10.1093/carcin/bgl061




PubMed


 


PubMed ID 16728435
    
     


 



17.
Shen M, Vermeulen R, Chapman RS, Berndt SI, He X, Chanock S, Caporaso N, Lan Q (2008). A report of cytokine polymorphisms and COPD risk in Xuan Wei, China. Int J Hyg Environ Health  211, 352-6.   https://doi.org/10.1016/j.ijheh.2007.05.002




PubMed



        
     
Free Article


 


PubMed ID 17681858
         Pubmed Central ID 2639784 


 



18.
Vermeulen R, Lan Q, Li G, Rappaport SM, Kim S, van Wendel de Joode B, Shen M, Bohong X, Smith MT, Zhang L, Yin S, Rothman N (2006). Assessment of dermal exposure to benzene and toluene in shoe manufacturing by activated carbon cloth patches. J Environ Monit  8, 1143-8.   https://doi.org/10.1039/b608076f




PubMed


 


PubMed ID 17075621
    
     


 



19.
Villanueva CM, Cantor KP, Grimalt JO, Malats N, Silverman D, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castaño-Vinyals G, Marcos R, Rothman N, Real FX, Dosemeci M, Kogevinas M (2007). Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools. Am J Epidemiol  165, 148-56.   https://doi.org/10.1093/aje/kwj364




PubMed


 


PubMed ID 17079692",https://intramural.nih.gov/search/searchview.taf?ipid=45765
515,CP010122-12,"October 01, 2006 -  September 30, 2007",Occupational Exposure Assessment,Mustafa  Dosemeci; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji



Claudine M Samanic



Dalsu  Baris



Debra  Silverman; ScD, ScM



John R Nuckols



Joanne S Colt



Show all 16","Olufemi  Adegoke
(Meharry Medical College, Nashville, TN)




Wolfgang  Ahrens
(University of Bremen)




Ruth  Allen
(Environmental Protection Agency, Washington, DC)




Tye  Arbuckle
(Health Canada)




Michael  Attfield
(National Institute for Occupational Safety and Health, Morgantown, WV)




Berit  Bakke
(National Institute of Occupational Health)


Show all 52","Allan  Hildesheim; PhD (Hormonal and Reproductive Epidemiology Branch)



Gloria L Gridley (Biostatistics Branch)



Jay  Lubin; PhD (Biostatistics Branch)



Linda M Brown; MPH, DPhil (Biostatistics Branch)



Martha S Linet; PhD (Radiation Epidemiology Branch)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45763
516,CP010123-12,"October 01, 2006 -  September 30, 2007",Occupational and Environmental Determinants of Cancer among Women and Minorities,"Michael  Alavanja; PhD

 




Aaron E Blair; PhD, MPH

 




Kenneth  Cantor; PhD

 




Mustafa  Dosemeci; PhD

 




Richard  Hayes; PhD

 


 

Qing  Lan



IRP Faculty Profile
 




Jay  Lubin; PhD

 




Lee Elizabeth Moore; PhD, MD

 


 

Nathaniel C Rothman; MD



IRP Faculty Profile
 


 

Debra  Silverman; ScD, ScM



IRP Faculty Profile
 


 

Mary Helen Ward; MS, PhD



IRP Faculty Profile
 




Wong H Chow",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji



Dalsu  Baris



Joanne S Colt","Hans-Olov  Adami
(Karolinska Institute)




Eleuterio  Bravo-Otero
(University of Puerto Rico)




S  Cooper
(The University of Texas)




Yu-Tang  Gao
(Shanghai Cancer Institute)




N  Heyer
(University of Washington)




L  Hoffman-Goetz
(University of Waterloo)


Show all 19","Gloria L Gridley (Biostatistics Branch)



Linda M Brown; MPH, DPhil (Biostatistics Branch)



Martha S Linet; PhD (Radiation Epidemiology Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)



Shelia K Zahm; ScM, ScD (Office of the Director)",NULL,"Ordered by publication type and then author name.



1.
Brown EE, Lan Q, Zheng T, Zhang Y, Wang SS, Hoar-Zahm S, Chanock SJ, Rothman N, Baris D (2007). Common variants in genes that mediate immunity and risk of multiple myeloma. Int J Cancer  120, 2715-22.   https://doi.org/10.1002/ijc.22618




PubMed


 


PubMed ID 17315188
    
     


 



2.
Cai Q, Gao YT, Chow WH, Shu XO, Yang G, Ji BT, Wen W, Rothman N, Li HL, Morrow JD, Zheng W (2006). Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk. J Clin Oncol  24, 5010-6.   https://doi.org/10.1200/JCO.2006.06.4931




PubMed


 


PubMed ID 17075120
    
     


 



3.
Chiu BC, Lan Q, Dave BJ, Blair A, Zahm SH, Weisenburger DD (2008). The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma. J Natl Cancer Inst Monogr   69-73  https://doi.org/10.1093/jncimonographs/lgn018




PubMed



        
     
Free Article


 


PubMed ID 18648007
         Pubmed Central ID 2972188 


 



4.
Hosgood HD, Baris D, Zahm SH, Zheng T, Cross AJ (2007). Diet and risk of multiple myeloma in Connecticut women. Cancer Causes Control  18, 1065-76.   https://doi.org/10.1007/s10552-007-9047-z




PubMed


 


PubMed ID 17694422
    
     


 



5.
Krstev S, Ji BT, Shu XO, Blair A, Zheng W, Lubin J, Vermeulen R, Hauptmann M, Rothman N, Gao YT, Mustafa D, Chow WH (2007). Occupation and adult-onset asthma among Chinese women in a population-based cohort. Am J Ind Med  50, 265-73.   https://doi.org/10.1002/ajim.20439




PubMed


 


PubMed ID 17311256
    
     


 



6.
Krstev S, Ji BT, Shu XO, Gao YT, Blair A, Lubin J, Vermeulen R, Dosemeci M, Zheng W, Rothman N, Chow WH (2008). Occupation and chronic bronchitis among Chinese women. J Occup Environ Med  50, 64-71.   https://doi.org/10.1097/JOM.0b013e31815c6cdf




PubMed



        
     
Free Article


 


PubMed ID 18188083
         Pubmed Central ID 3073998 


 



7.
Landgren O, Zhang Y, Zahm SH, Inskip P, Zheng T, Baris D (2006). Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women. Cancer Epidemiol Biomarkers Prev  15, 2342-7.   https://doi.org/10.1158/1055-9965.EPI-06-0097




PubMed


 


PubMed ID 17132770
    
     


 



8.
Radican L, Blair A, Stewart P, Wartenberg D (2008). Mortality of aircraft maintenance workers exposed to trichloroethylene and other hydrocarbons and chemicals: extended follow-up. J Occup Environ Med  50, 1306-19.   https://doi.org/10.1097/JOM.0b013e3181845f7f




PubMed



        
     
Free Article


 


PubMed ID 19001957
         Pubmed Central ID 2763375 


 



9.
Yang G, Shu XO, Li H, Chow WH, Ji BT, Zhang X, Gao YT, Zheng W (2007). Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev  16, 1219-23.   https://doi.org/10.1158/1055-9965.EPI-07-0097




PubMed


 


PubMed ID 17548688",https://intramural.nih.gov/search/searchview.taf?ipid=45766
517,CP010124-12,"October 01, 2006 -  September 30, 2007",Cervical cancer and human papillomavirus (HPV) infection,"Philip E Castle; PhD, MPH

 


 

Allan  Hildesheim; PhD



IRP Faculty Profile
 




Sophia S Wang; PhD

 


 

Mark  Schiffman; MD



IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","James V Lacey; MPH, PhD



Jose A Jeronimo



Joseph  Carreon



Mahboobeh  Safaeian



Mark E Sherman; MD","Concepcion  Bratti
(Costa Rican Social Security)




Robert  Burk
(Albert Einstein College of Medicine)




Michael  Gold
(University of Oklahoma Health Sciences Center)




Patti  Gravitt
(Johns Hopkins University)




Sharon  Hillier
(University of Pittsburgh)




Martha  Hutchinson
(Brown University)


Show all 13","Aimee Rebecca Kreimer (Early Detection Research Group)



Diane  Solomon; PhD (Breast and Gynecologic Cancer Research Group)



Douglas  Lowy; MD (Laboratory of Cellular Oncology)



John  Schiller; PhD (Laboratory of Cellular Oncology)



Kenneth  Chu (Integrated Networks Branch)



Mary  Carrington; MS, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Castle PE, Dockter J, Giachetti C, Garcia FA, McCormick MK, Mitchell AL, Holladay EB, Kolk DP (2007). A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer. Clin Cancer Res  13, 2599-605.   https://doi.org/10.1158/1078-0432.CCR-06-2881




PubMed


 


PubMed ID 17473189
    
     


 



2.
Castle PE, Rausa A, Walls T, Gravitt PE, Partridge EE, Olivo V, Niwa S, Morrissey KG, Tucker L, Katki H, Scarinci I (2011). Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med  52, 452-5.   https://doi.org/10.1016/j.ypmed.2011.03.018




PubMed



        
     
Free Article


 


PubMed ID 21497619
         Pubmed Central ID 3114876 


 



3.
Castle PE, Shaber R, LaMere BJ, Kinney W, Fetterma B, Poitras N, Lorey T, Schiffman M, Dunne A, Ostolaza JM, McKinney S, Burk RD (2011). Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California. Cancer Epidemiol Biomarkers Prev  20, 946-53.   https://doi.org/10.1158/1055-9965.EPI-10-1267




PubMed



        
     
Free Article


 


PubMed ID 21415357
         Pubmed Central ID 3117227 


 



4.
Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M (2007). Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol  197, 356.e1-6.   https://doi.org/10.1016/j.ajog.2007.07.049




PubMed



        
     
Free Article


 


PubMed ID 17904958
         Pubmed Central ID 2128712 


 



5.
Chaux A, Netto GJ, Rodríguez IM, Barreto JE, Oertell J, Ocampos S, Boggino H, Codas R, Xavier Bosch F, de Sanjose S, Muñoz N, Hildesheim A, Cubilla AL (2013). Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol  31, 861-7.   https://doi.org/10.1007/s00345-011-0802-0




PubMed



        
     
Free Article


 


PubMed ID 22116602
         Pubmed Central ID 3292668 


 



6.
Kinney W, Fetterman B, Cox JT, Lorey T, Flanagan T, Castle PE (2011). Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice. Gynecol Oncol  121, 309-13.   https://doi.org/10.1016/j.ygyno.2010.12.361




PubMed



        
     
Free Article


 


PubMed ID 21276605
         Pubmed Central ID 3081890 


 



7.
LaMere BJ, Howell R, Fetterman B, Shieh J, Castle PE, Pap Cohort Study Group (2008). Impact of 6-month frozen storage of cervical specimens in alkaline buffer conditions on human papillomavirus genotyping. J Virol Methods  151, 298-300.   https://doi.org/10.1016/j.jviromet.2008.05.017




PubMed



        
     
Free Article


 


PubMed ID 18571737
         Pubmed Central ID 2577906 


 



8.
LaMere BJ, Kornegay J, Fetterman B, Sadorra M, Shieh J, Castle PE, PaP Cohort Study Group (2007). Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort. J Virol Methods  146, 80-5.   https://doi.org/10.1016/j.jviromet.2007.06.001




PubMed



        
     
Free Article


 


PubMed ID 17673302
         Pubmed Central ID 2683347 


 



9.
Meijer CJ, Snijders PJ, Castle PE (2006). Clinical utility of HPV genotyping. Gynecol Oncol  103, 12-7.   https://doi.org/10.1016/j.ygyno.2006.07.031




PubMed


 


PubMed ID 16934860
    
     


 



10.
Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM, ALTS  Group (2007). A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis  195, 1582-9.   https://doi.org/10.1086/516784




PubMed


 


PubMed ID 17471427
    
     


 



11.
Rodriguez AC, Burk R, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillen D, Alfaro M, Viscidi R, Morales J, Hutchinson M, Wacholder S, Schiffman M (2007). The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life. Sex Transm Dis  34, 494-502.   https://doi.org/10.1097/01.olq.0000251241.03088.a0




PubMed


 


PubMed ID 17237737
    
     


 



12.
Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, Goldie SJ, Harper DM, Kinney W, Moscicki AB, Noller KL, Wheeler CM, Ades T, Andrews KS, Doroshenk MK, Kahn KG, Schmidt C, Shafey O, Smith RA, Partridge EE, Gynecologic Cancer Advisory Group, Garcia F (2007). American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin  57, 7-28.   https://doi.org/10.3322/canjclin.57.1.7




PubMed


 


PubMed ID 17237032
    
     


 



13.
Sherman ME, Kahler J, Gustafson KS, Wang SS (2006). ""Sip volume"" as a quality indicator in liquid-based cervical cytology. Cancer  108, 462-7.   https://doi.org/10.1002/cncr.22283




PubMed


 


PubMed ID 17096435
    
     


 



14.
Shivapurkar N, Sherman ME, Stastny V, Echebiri C, Rader JS, Nayar R, Bonfiglio TA, Gazdar AF, Wang SS (2007). Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol Oncol  107, 549-53.   https://doi.org/10.1016/j.ygyno.2007.08.057




PubMed



        
     
Free Article


 


PubMed ID 17894941
         Pubmed Central ID 2718832 


 



15.
Wheeler CM, Hunt WC, Schiffman M, Castle PE, Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group (2006). Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis  194, 1291-9.   https://doi.org/10.1086/507909




PubMed


 


PubMed ID 17041856
    
     


 



16.
Zuna RE, Wang SS, Schiffman M, Solomon D (2006). Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion. Cancer  108, 288-97.   https://doi.org/10.1002/cncr.22168




PubMed


 


PubMed ID 16952155",https://intramural.nih.gov/search/searchview.taf?ipid=45755
518,CP010125-12,"October 01, 2006 -  September 30, 2007",Cancer Risk and Environmental Exposures,"Mary Helen Ward; MS, PhD



IRP Faculty Profile
 




Kenneth  Cantor; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI","An-Tsun  Huang



Bu Tian  Ji



Claudine M Samanic



Dalsu  Baris



Debra  Silverman; ScD, ScM



John R Nuckols



Show all 14","Lorraine  Backer
(Centers for Disease Control)




Benjamin  Blount
(CDC)




Robert  Branch
(University of Pittsburgh)




John W Brock
(CDC)




James  Cerhan
(Mayo Clinic)




R.  Field
(University of Iowa)


Show all 18","Jay  Lubin; PhD (Biostatistics Branch)



Peter D Inskip; ScD (Radiation Epidemiology Branch)



Shelia K Zahm; ScM, ScD (Office of the Director)



Allan  Hildesheim; PhD (Hormonal and Reproductive Epidemiology Branch)



Daryl  Freedman (Radiation Epidemiology Branch)



Rashmi P Sinha; PhD (Nutritional Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Brock KE, Gridley G, Lynch CF, Ershow AG, Cantor KP (2007). Obesity and hypertension interact to increase risk of renal cell carcinoma in Iowa, USA. Obes Res Clin Pract  1, I-II.   https://doi.org/10.1016/j.orcp.2007.02.004




PubMed


 


PubMed ID 24351456
    
     


 



2.
Cantor KP, Lubin JH (2007). Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations. Toxicol Appl Pharmacol  222, 252-7.   https://doi.org/10.1016/j.taap.2007.01.026




PubMed



        
     
Free Article


 


PubMed ID 17382983
         Pubmed Central ID 2692340 


 



3.
Colt JS, Cyr MJ, Zahm SH, Tobias GS, Hartge P (2007). Inferring past pesticide exposures: a matrix of individual active ingredients in home and garden pesticides used in past decades. Environ Health Perspect  115, 248-54.   https://doi.org/10.1289/ehp.9538




PubMed



        
     
Free Article


 


PubMed ID 17384773
         Pubmed Central ID 1817710 


 



4.
Ward MH, Heineman EF, Markin RS, Weisenburger DD (2008). Adenocarcinoma of the stomach and esophagus and drinking water and dietary sources of nitrate and nitrite. Int J Occup Environ Health  14, 193-7.   https://doi.org/10.1179/oeh.2008.14.3.193




PubMed



        
     
Free Article


 


PubMed ID 18686719
         Pubmed Central ID 2797489",https://intramural.nih.gov/search/searchview.taf?ipid=45771
519,CP010126-12,"October 01, 2006 -  September 30, 2007",Hormone-Related Cancers,"Montserrat  Garcia-Closas; MD, PhD



IRP Faculty Profile
 




James V Lacey; MPH, PhD

 


 

Katherine Ann McGlynn; PhD



IRP Faculty Profile
 




Louise  Brinton; PhD",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Allan  Hildesheim; PhD



Gretchen L Gierach



Kim N Danforth



Mark E Sherman; MD



Mia  Gaudet



Michael Blaise Cook



Show all 8","David  Alberts
(University of Arizona Cancer Center)




Douglas  Bauer
(University of California at San Francisco)




Ralph  Coates
(Centers for Disease Control and Prevention)




Joanne  Dorgan; PhD
(NCI)




R  Erickson
(Department of Defense)




Jolanta  Lissowsaka
(Maria Sklodowsak-Curie Memorial Cancer Center)


Show all 10","Barry Ira Graubard; PhD (Biostatistics Branch)



Nilanjan  Chatterjee (Biostatistics Branch)



Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)



Stephen J Chanock; MD, PhD (National Cancer Institute)



William Frederick Anderson (Biostatistics Branch)",Katharine D Egan (NIMH),"Ordered by publication type and then author name.



1.
Abrahamson PE, Gammon MD, Lund MJ, Britton JA, Marshall SW, Flagg EW, Porter PL, Brinton LA, Eley JW, Coates RJ (2006). Recreational physical activity and survival among young women with breast cancer. Cancer  107, 1777-85.   https://doi.org/10.1002/cncr.22201




PubMed


 


PubMed ID 16967443
    
     


 



2.
Abrahamson PE, Gammon MD, Lund MJ, Flagg EW, Porter PL, Stevens J, Swanson CA, Brinton LA, Eley JW, Coates RJ (2006). General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomarkers Prev  15, 1871-7.   https://doi.org/10.1158/1055-9965.EPI-06-0356




PubMed


 


PubMed ID 17035393
    
     


 



3.
Anderson WF, Matsuno RK, Sherman ME, Lissowska J, Gail MH, Brinton LA, Yang XR, Peplonska B, Chen BE, Rosenberg PS, Chatterjee N, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Devesa SS, García-Closas M (2007). Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control  18, 439-47.   https://doi.org/10.1007/s10552-006-0092-9




PubMed


 


PubMed ID 17216325
    
     


 



4.
Bertelsen L, Mellemkjaer L, Frederiksen K, Kjaer SK, Brinton LA, Sakoda LC, van Valkengoed I, Olsen JH (2007). Risk for breast cancer among women with endometriosis. Int J Cancer  120, 1372-5.   https://doi.org/10.1002/ijc.22490




PubMed


 


PubMed ID 17187365
    
     


 



5.
Bray F, Ferlay J, Devesa SS, McGlynn KA, Møller H (2006). Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol  3, 532-43.   https://doi.org/10.1038/ncpuro0606




PubMed


 


PubMed ID 17031378
    
     


 



6.
Brinton LA, Richesson D, Leitzmann MF, Gierach GL, Schatzkin A, Mouw T, Hollenbeck AR, Lacey JV (2008). Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev  17, 3150-60.   https://doi.org/10.1158/1055-9965.EPI-08-0435




PubMed



        
     
Free Article


 


PubMed ID 18990757
         Pubmed Central ID 2755180 


 



7.
Cook MB, Sigurdson AJ, Jones IM, Thomas CB, Graubard BI, Korde L, Greene MH, McGlynn KA (2009). Endogenous DNA damage and testicular germ cell tumors. Int J Androl  32, 599-606.   https://doi.org/10.1111/j.1365-2605.2008.00905.x




PubMed



        
     
Free Article


 


PubMed ID 18657195
         Pubmed Central ID 2874631 


 



8.
Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, McCredie MR, Giles GG, Fletcher O, Johnson N, dos Santos Silva I, Gibson L, Bojesen SE, Nordestgaard BG, Axelsson CK, Torres D, Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, Breast Cancer Association Consortium, et al. [54 more authors] (2007). A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet  39, 352-8.   https://doi.org/10.1038/ng1981




PubMed


 


PubMed ID 17293864
    
     


 



9.
Garcia-Closas M, Brinton LA, Lissowska J, Richesson D, Sherman ME, Szeszenia-Dabrowska N, Peplonska B, Welch R, Yeager M, Zatonski W, Chanock SJ (2007). Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study. BMC Cancer  7, 60.   https://doi.org/10.1186/1471-2407-7-60




PubMed



        
     
Free Article


 


PubMed ID 17411440
         Pubmed Central ID 1855931 


 



10.
Garcia-Closas M, Chanock S (2008). Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res  14, 8000-9.   https://doi.org/10.1158/1078-0432.CCR-08-0975




PubMed



        
     
Free Article


 


PubMed ID 19088016
         Pubmed Central ID 2668137 


 



11.
Garcia-Closas M, Kristensen V, Langerød A, Qi Y, Yeager M, Burdett L, Welch R, Lissowska J, Peplonska B, Brinton L, Gerhard DS, Gram IT, Perou CM, Børresen-Dale AL, Chanock S (2007). Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer. Int J Cancer  121, 2532-8.   https://doi.org/10.1002/ijc.22985




PubMed


 


PubMed ID 17683073
    
     


 



12.
Garcia-Closas M, Troester MA, Qi Y, Langerød A, Yeager M, Lissowska J, Brinton L, Welch R, Peplonska B, Gerhard DS, Gram IT, Kristensen V, Børresen-Dale AL, Chanock S, Perou CM (2007). Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status. Cancer Epidemiol Biomarkers Prev  16, 2269-75.   https://doi.org/10.1158/1055-9965.EPI-07-0449




PubMed


 


PubMed ID 18006915
    
     


 



13.
Gaudet MM, Chanock S, Lissowska J, Berndt SI, Peplonska B, Brinton LA, Welch R, Yeager M, Bardin-Mikolajczak A, Garcia-Closas M (2006). Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk. Cancer Res  66, 9781-5.   https://doi.org/10.1158/0008-5472.CAN-06-1294




PubMed


 


PubMed ID 17018638
    
     


 



14.
Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-Ernstoff L, Yeager M, Chanock S, Welch R, Peplonska B, Trentham-Dietz A, Garcia-Closas M (2007). Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet  121, 483-90.   https://doi.org/10.1007/s00439-006-0315-x




PubMed


 


PubMed ID 17216494
    
     


 



15.
Lacey JV, Mutter GL, Nucci MR, Ronnett BM, Ioffe OB, Rush BB, Glass AG, Richesson DA, Chatterjee N, Langholz B, Sherman ME (2008). Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer  113, 2073-81.   https://doi.org/10.1002/cncr.23808




PubMed



        
     
Free Article


 


PubMed ID 18720479
         Pubmed Central ID 2587088 


 



16.
Lacey JV, Mutter GL, Ronnett BM, Ioffe OB, Duggan MA, Rush BB, Glass AG, Richesson DA, Chatterjee N, Langholz B, Sherman ME (2008). PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma. Cancer Res  68, 6014-20.   https://doi.org/10.1158/0008-5472.CAN-08-1154




PubMed



        
     
Free Article


 


PubMed ID 18632658
         Pubmed Central ID 2493615 


 



17.
Landgren O, Turesson I, Gridley G, Caporaso N (2007) Risk of hematopoietic and solid malignancies among 1,525 adult male United States veterans with Gaucher disease. Arch Int Med 167:1189-94




 



18.
Lissowska J, Gaudet MM, Brinton LA, Chanock SJ, Peplonska B, Welch R, Zatonski W, Szeszenia-Dabrowska N, Park S, Sherman M, Garcia-Closas M (2007). Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer  120, 2696-703.   https://doi.org/10.1002/ijc.22604




PubMed


 


PubMed ID 17311260
    
     


 



19.
MA M, Alberg A, Allen N, Brinton L, Dorgan J, Key T, Pollak M, Tao Y, Helzlsouer K (2007) C-reactive protein concentreations and subsequenst ovarian cancer risk. Obstet Gynecol 109:933-941




 



20.
McGlynn KA, Sakoda LC, Rubertone MV, Sesterhenn IA, Lyu C, Graubard BI, Erickson RL (2007). Body size, dairy consumption, puberty, and risk of testicular germ cell tumors. Am J Epidemiol  165, 355-63.   https://doi.org/10.1093/aje/kwk019




PubMed


 


PubMed ID 17110638
    
     


 



21.
McGlynn KA, Zhang Y, Sakoda LC, Rubertone MV, Erickson RL, Graubard BI (2006). Maternal smoking and testicular germ cell tumors. Cancer Epidemiol Biomarkers Prev  15, 1820-4.   https://doi.org/10.1158/1055-9965.EPI-06-0389




PubMed


 


PubMed ID 17035387
    
     


 



22.
Moore LE, Bergen AW, Haque KA, Qi Y, Castle P, Chanock SJ, Egan K, Newcomb P, Titus-Ernstoff L, Alguacil J, Rothman N, Garcia-Closas M (2007). Whole genome amplification of buccal cytobrush DNA collected for molecular epidemiology studies. Biomarkers  12, 303-12.   https://doi.org/10.1080/13547500601162011




PubMed


 


PubMed ID 17453743
    
     


 



23.
Park SK, Garcia-Closas M, Lissowska J, Sherman ME, McGlynn KA, Peplonska B, Pepońska B, Bardin-Mikolajczak A, Bardin-Mikoajczak A, Zatoński W, Szeszenia-Dabrowska N, Brinton LA (2006). Intrauterine environment and breast cancer risk in a population-based case-control study in Poland. Int J Cancer  119, 2136-41.   https://doi.org/10.1002/ijc.21974




PubMed


 


PubMed ID 16804898
    
     


 



24.
Peplonska B, Stewart P, Szeszenia-Dabrowska N, Rusiecki J, Garcia-Closas M, Lissowska J, Bardin-Mikolajczak A, Zatonski W, Gromiec J, Brzeznicki S, Brinton LA, Blair A (2007). Occupation and breast cancer risk in Polish women: a population-based case-control study. Am J Ind Med  50, 97-111.   https://doi.org/10.1002/ajim.20420




PubMed


 


PubMed ID 17238140
    
     


 



25.
Purdue MP, Sakoda LC, Graubard BI, Welch R, Chanock SJ, Sesterhenn IA, Rubertone MV, Erickson RL, McGlynn KA (2007). A case-control investigation of immune function gene polymorphisms and risk of testicular germ cell tumors. Cancer Epidemiol Biomarkers Prev  16, 77-83.   https://doi.org/10.1158/1055-9965.EPI-06-0573




PubMed


 


PubMed ID 17220333
    
     


 



26.
Savage SA, Chanock SJ, Lissowska J, Brinton LA, Richesson D, Peplonska B, Bardin-Mikolajczak A, Zatonski W, Szeszenia-Dabrowska N, Garcia-Closas M (2007). Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer  97, 832-6.   https://doi.org/10.1038/sj.bjc.6603934




PubMed



        
     
Free Article


 


PubMed ID 17848914
         Pubmed Central ID 2360388 


 



27.
Shah MN, Devesa SS, Zhu K, McGlynn KA (2007). Trends in testicular germ cell tumours by ethnic group in the United States. Int J Androl  30, 206-13; discussion 213-4.   https://doi.org/10.1111/j.1365-2605.2007.00795.x




PubMed


 


PubMed ID 17708751
    
     


 



28.
Sherman ME, Rimm DL, Yang XR, Chatterjee N, Brinton LA, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, Kalaylioglu Z, Harigopal M, Charrette L, Falk RT, Richesson D, Anderson WF, Hewitt SM, García-Closas M (2007). Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis. Int J Cancer  121, 1079-85.   https://doi.org/10.1002/ijc.22812




PubMed


 


PubMed ID 17487843
    
     


 



29.
Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM (2007). Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Carcinogenesis  28, 1680-6.   https://doi.org/10.1093/carcin/bgm097




PubMed


 


PubMed ID 17449902
    
     


 



30.
Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Kaufman JS, Moorman PG, Cai J, Olshan AF, Porter PL, Brinton LA, Eley JW, Coates RJ (2007). Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat  103, 93-102.   https://doi.org/10.1007/s10549-006-9346-1




PubMed


 


PubMed ID 17004111
    
     


 



31.
Zhang Y, Graubard BI, Longnecker MP, Stanczyk FZ, Klebanoff MA, McGlynn KA (2007). Maternal hormone levels and perinatal characteristics: implications for testicular cancer. Ann Epidemiol  17, 85-92.   https://doi.org/10.1016/j.annepidem.2006.03.006




PubMed



        
     
Free Article


 


PubMed ID 16882463
         Pubmed Central ID 3659778",https://intramural.nih.gov/search/searchview.taf?ipid=45772
520,CP010127-12,"October 01, 2006 -  September 30, 2007",Etiologic Studies of Diet and Cancer,"Rashmi P Sinha; PhD



IRP Faculty Profile
 




Arthur  Schatzkin; PhD",NULL,"Nutritional Epidemiology Branch, NCI","Amanda  Cross



Christian Cormac Abnet; PhD, MPH



Farin  Kamangar



Jiyoung  Ahn



Kenneth Frederick Adams



Mark J Roth



Show all 13","Henry  Appelman
(University of Michigan)




Colin  Begg
(Memorial Sloan-Kettering Cancer Center)




Sheila  Bingham
(University of Cambridge)




M  Cooper
(Wake Forest University School of Medicine)




Stanley  Hamilton
(M.D. Anderson Cancer Center)




Frank  Iber
(Edward Hines Jr. Veterans Administration Hospital)


Show all 15","Amy F Subar (Risk Factor Monitoring and Methods Branch)



Demetrius  Albanes; MD (Office of the Director)



Douglas N Midthune (Biometry Research Group)



Frances E Thompson (Risk Factor Monitoring and Methods Branch)



Richard P Troiano (Risk Factor Monitoring and Methods Branch)



Victor  Kipnis (Biometry Research Group)",NULL,"Ordered by publication type and then author name.



1.
Freedman LS, Schatzkin A, Thiebaut AC, Potischman N, Subar AF, Thompson FE, Kipnis V (2007). Abandon neither the food frequency questionnaire nor the dietary fat-breast cancer hypothesis. Cancer Epidemiol Biomarkers Prev  16, 1321-2.   https://doi.org/10.1158/1055-9965.EPI-07-0179




PubMed


 


PubMed ID 17548709
    
     


 



2.
Freedman ND, Schatzkin A, Leitzmann MF, Hollenbeck AR, Abnet CC (2007). Alcohol and head and neck cancer risk in a prospective study. Br J Cancer  96, 1469-74.   https://doi.org/10.1038/sj.bjc.6603713




PubMed



        
     
Free Article


 


PubMed ID 17387340
         Pubmed Central ID 2360181 


 



3.
Gunter MJ, Divi RL, Kulldorff M, Vermeulen R, Haverkos KJ, Kuo MM, Strickland P, Poirier MC, Rothman N, Sinha R (2007). Leukocyte polycyclic aromatic hydrocarbon-DNA adduct formation and colorectal adenoma. Carcinogenesis  28, 1426-9.   https://doi.org/10.1093/carcin/bgm022




PubMed


 


PubMed ID 17277232
    
     


 



4.
Gunter MJ, Hayes RB, Chatterjee N, Yeager M, Welch R, Schoen RE, Yakochi L, Schatzkin A, Peters U (2007). Insulin resistance-related genes and advanced left-sided colorectal adenoma. Cancer Epidemiol Biomarkers Prev  16, 703-8.   https://doi.org/10.1158/1055-9965.EPI-06-0849




PubMed


 


PubMed ID 17416760
    
     


 



5.
Schatzkin A (2007). Can biomarkers help us understand the nutritional and lifestyle factors important in cancer prognosis? J Nutr  137, 249S-252S.   https://doi.org/10.1093/jn/137.1.249S




PubMed


 


PubMed ID 17182835",https://intramural.nih.gov/search/searchview.taf?ipid=45804
521,CP010128-12,"October 01, 2006 -  September 30, 2007",Therapeutic and Diagnostic Factors as Related to Cancer Risk,"James V Lacey; MPH, PhD

 




Louise  Brinton; PhD",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Allan  Hildesheim; PhD



Mark E Sherman; MD","Douglas  Bauer
(University of California at San Francisco)




Lenore  Buckley
(Virginia Commonwealth University)




Theodore  Colton
(Boston University School of Public Health)




Olga  Dvorkina
(SUNY Health Sciences Center)




Susanne  Kruger-Kjaer
(Danish Cancer Registry)




Emmet  Lamb
(Stanford University)


Show all 8","Arthur  Schatzkin; PhD (Nutritional Epidemiology Branch)



Catherine G Schairer (Biostatistics Branch)



Jay  Lubin; PhD (Biostatistics Branch)



Michael Fred Leitzmann (Nutritional Epidemiology Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,"Ordered by publication type and then author name.



1.
Brinton L (2007). Long-term effects of ovulation-stimulating drugs on cancer risk. Reprod Biomed Online  15, 38-44.   https://doi.org/10.1016/s1472-6483(10)60689-x




PubMed


 


PubMed ID 17623533",https://intramural.nih.gov/search/searchview.taf?ipid=45773
522,CP010131-12,"October 01, 2006 -  September 30, 2007",Studies of Medical Radiation and Other Therapeutic Agents,"Peter D Inskip; ScD

 




Elaine  Ron; PhD",NULL,"Radiation Epidemiology Branch, NCI","Alice  Sigurdson; PhD



Alina V Brenner



Andre  Bouville



Charles E. Land; PhD



Kiyohiko  Mabuchi; MD, DPhil



Martha S Linet; PhD



Show all 11","David  Abramson
(New York Presbyterian Hospital)




Michael  Andersson
(Danish Cancer Society)




Anneliese  Borresen
(The Norwegian Radium Hospital, Oslo, Norway)




Sophie  Fossa





Mary  Gospodarowicz
(Princess Margaret Hospital)




Per  Hall
(Karolinska Instituet)


Show all 24",Margaret Anne Tucker (Genetic Epidemiology Branch),NULL,"Ordered by publication type and then author name.



1.
Baade PD, Fritschi L, Freedman DM (2007). Mortality due to amyotrophic lateral sclerosis and Parkinson's disease among melanoma patients. Neuroepidemiology  28, 16-20.   https://doi.org/10.1159/000097851




PubMed


 


PubMed ID 17164565
    
     


 



2.
Berrington de González A, Kim KP, Berg CD (2008). Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J Med Screen  15, 153-8.   https://doi.org/10.1258/jms.2008.008052




PubMed



        
     
Free Article


 


PubMed ID 18927099
         Pubmed Central ID 2782431 


 



3.
Bolch W, Lee C, Wayson M, Johnson P (2010). Hybrid computational phantoms for medical dose reconstruction. Radiat Environ Biophys  49, 155-68.   https://doi.org/10.1007/s00411-009-0260-x




PubMed



        
     
Free Article


 


PubMed ID 20039051
         Pubmed Central ID 2855752 


 



4.
Boukheris H, Ron E, Dores GM, Stovall M, Smith SA, Curtis RE (2008). Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis. Cancer  113, 3153-9.   https://doi.org/10.1002/cncr.23918




PubMed



        
     
Free Article


 


PubMed ID 18823043
         Pubmed Central ID 2868333 


 



5.
Chodick G, Ronckers CM, Shalev V, Ron E (2007). Excess lifetime cancer mortality risk attributable to radiation exposure from computed tomography examinations in children. Isr Med Assoc J  9, 584-7.




PubMed


 


PubMed ID 17877063
    
     


 



6.
Kleinerman RA, Tucker MA, Abramson DH, Seddon JM, Tarone RE, Fraumeni JF (2007). Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst  99, 24-31.   https://doi.org/10.1093/jnci/djk002




PubMed


 


PubMed ID 17202110
    
     


 



7.
Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, Yasui Y, Kasper CE, Mertens AC, Donaldson SS, Meadows AT, Inskip PD (2006). New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst  98, 1528-37.   https://doi.org/10.1093/jnci/djj411




PubMed


 


PubMed ID 17077355",https://intramural.nih.gov/search/searchview.taf?ipid=45774
523,CP010132-12,"October 01, 2006 -  September 30, 2007",Studies of Populations Exposed to Environmental Sources of Radiation,"Charles E. Land; PhD

 




Elaine  Ron; PhD

 


 

Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Alina V Brenner



Andre  Bouville



Ihor  Masnyk



Kiyohiko  Mabuchi; MD, DPhil



Maureen Cusack Hatch; MD



Daryl  Freedman



Show all 10","Bruce  Alexander
(University of Minnesota)




Aaron  Brill
(Vanderbilt University)




Boris  Gusev
(Kazakh Institute for Radiation Medicine and Ecology)




M  Hartshorne
(Pennsylvania State University)




Geoffrey  Howe
(Columbia University)




Margaret  Karagas
(Dartmouth University, Lebanon, NH)


Show all 13",Jay  Lubin; PhD (Biostatistics Branch),NULL,"Ordered by publication type and then author name.



1.
Bogdanova TI, Zurnadzhy LY, Greenebaum E, McConnell RJ, Robbins J, Epstein OV, Olijnyk VA, Hatch M, Zablotska LB, Tronko MD (2006). A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: pathology analysis of thyroid cancer cases in Ukraine detected during the first screening (1998-2000). Cancer  107, 2559-66.   https://doi.org/10.1002/cncr.22321




PubMed



        
     
Free Article


 


PubMed ID 17083123
         Pubmed Central ID 2983485 


 



2.
Karagas MR, Zens MS, Nelson HH, Mabuchi K, Perry AE, Stukel TA, Mott LA, Andrew AS, Applebaum KM, Linet M (2007). Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage. Am J Epidemiol  165, 719-26.   https://doi.org/10.1093/aje/kwk055




PubMed


 


PubMed ID 17204514
    
     


 



3.
O'Kane P, Shelkovoy E, McConnell RJ, Shpak V, Parker L, Bogdanova TI, Brenner A, Naida Y, Frangos A, Zablotska L, Robbins J, Greenebaum E, Zurnadzhy LY, Tronko M, Hatch M (2008). Differences in sonographic conspicuity according to papillary thyroid cancer subtype: results of the Ukrainian-American cohort study after the Chornobyl accident. AJR Am J Roentgenol  191, W293-8.   https://doi.org/10.2214/AJR.07.3812




PubMed



        
     
Free Article


 


PubMed ID 19020218
         Pubmed Central ID 2841356 


 



4.
Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, Yeager M, Ahlbom A, Albanes D, Andersson U, Freeman LE, Buring JE, Butler MA, Braganza M, Carreon T, Feychting M, Fleming SJ, Gapstur SM, Gaziano JM, Giles GG, Hallmans G, et al. [45 more authors] (2012). Genome-wide association study of glioma and meta-analysis. Hum Genet  131, 1877-88.   https://doi.org/10.1007/s00439-012-1212-0




PubMed



        
     
Free Article


 


PubMed ID 22886559
         Pubmed Central ID 3761216 


 



5.
Schonfeld SJ, Krestinina LY, Epifanova S, Degteva MO, Akleyev AV, Preston DL (2013) Solid cancer mortality in the techa river cohort (1950-2007). Radiat Res 179:183-9.




PubMed



        
     
Free Article


 


PubMed ID 23289384
         Pubmed Central ID 3613701 


 



6.
Sholom S, Desrosiers M, Bouville A, Luckyanov N, Chumak V, Simon SL (2007). EPR TOOTH DOSIMETRY OF SNTS AREA INHABITANTS. Radiat Meas  42, 1037-1040.   https://doi.org/10.1016/j.radmeas.2007.05.007




PubMed



        
     
Free Article


 


PubMed ID 19590746
         Pubmed Central ID 2707028 


 



7.
Tronko MD, Brenner AV, Olijnyk VA, Robbins J, Epstein OV, McConnell RJ, Bogdanova TI, Fink DJ, Likhtarev IA, Lubin JH, Markov VV, Bouville AC, Terekhova GM, Zablotska LB, Shpak VM, Brill AB, Tereshchenko VP, Masnyk IJ, Ron E, Hatch M, Howe GR (2006). Autoimmune thyroiditis and exposure to iodine 131 in the Ukrainian cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: results from the first screening cycle (1998-2000). J Clin Endocrinol Metab  91, 4344-51.   https://doi.org/10.1210/jc.2006-0498




PubMed


 


PubMed ID 16912122",https://intramural.nih.gov/search/searchview.taf?ipid=45756
524,CP010133-12,"October 01, 2006 -  September 30, 2007",Studies of Populations Exposed to Occupational Sources of Radiation,"Elaine  Ron; PhD

 


 

Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Alice  Sigurdson; PhD



Alina V Brenner



Andre  Bouville



Ethel S Gilbert



Maureen Cusack Hatch; MD



Daryl  Freedman



Show all 9","Bruce  Alexander
(University of Minnesota)




Anssi P Auvinen





Timo  Hakulinen
(Finnish Cancer Registry)




M  Hartshorne
(Pennsylvania State University)




Elenora  Kapitonova
(TUT)




Juozas  Kurtinaitis
(Lithuanian Cancer Registry)


Show all 18",NULL,NULL,"Ordered by publication type and then author name.



1.
Bhatti P, Church DM, Rutter JL, Struewing JP, Sigurdson AJ (2006). Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologists. Am J Epidemiol  164, 794-804.   https://doi.org/10.1093/aje/kwj269




PubMed


 


PubMed ID 16923772
    
     


 



2.
Chumak VV, Romanenko AY, Voillequé PG, Bakhanova EV, Gudzenko N, Hatch M, Zablotska LB, Golovanov IA, Luckyanov NK, Sholom SV, Kryuchkov VP, Bouville A (2008). The Ukrainian-American study of leukemia and related disorders among Chornobyl cleanup workers from Ukraine: II. Estimation of bone marrow doses. Radiat Res  170, 698-710.   https://doi.org/10.1667/RR1403.1




PubMed



        
     
Free Article


 


PubMed ID 19138037
         Pubmed Central ID 3033011 


 



3.
Freedman DM, Tarone RE (2007). Re: ""From menarche to menopause: trends among US women born from 1912 to 1969"". Am J Epidemiol  166, 860-1.   https://doi.org/10.1093/aje/kwm228




PubMed


 


PubMed ID 17698972
    
     


 



4.
Ha M, Mabuchi K, Sigurdson AJ, Freedman DM, Linet MS, Doody MM, Hauptmann M (2007). Smoking cigarettes before first childbirth and risk of breast cancer. Am J Epidemiol  166, 55-61.   https://doi.org/10.1093/aje/kwm045




PubMed


 


PubMed ID 17426039
    
     


 



5.
Lönn S, Bhatti P, Alexander BH, Pineda MA, Doody MM, Struewing JP, Sigurdson AJ (2007). Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev  16, 174-7.   https://doi.org/10.1158/1055-9965.EPI-06-0665




PubMed


 


PubMed ID 17220349
    
     


 



6.
Rajaraman P, Sigurdson AJ, Doody MM, Freedman DM, Hauptmann M, Ron E, Alexander BH, Linet MS (2006). Lung cancer risk among US radiologic technologists, 1983-1998. Int J Cancer  119, 2481-6.   https://doi.org/10.1002/ijc.22148




PubMed


 


PubMed ID 16858679",https://intramural.nih.gov/search/searchview.taf?ipid=45775
525,CP010134-12,"October 01, 2006 -  September 30, 2007",Studies of Atomic Bomb Survivors,Charles E. Land; PhD,NULL,"Radiation Epidemiology Branch, NCI","Alina V Brenner



Elaine  Ron; PhD



Kiyohiko  Mabuchi; MD, DPhil



Martha S Linet; PhD","Suminori  Akiba
(Kagoshima University)




Michinori  Kabuto
(National Institute for Environmental Studies)




Tim  Key
(Oxford University)




Kazunori  Kodama
(Radiation Effects Research Foundation, Japan)




Jun  Nagano
(Radiation Effects Research Foundation)




Dale  Preston
(Radiation Effects Research Foundation)


Show all 8",NULL,NULL,"Ordered by publication type and then author name.



1.
Hirai Y, Kodama Y, Moriwaki S, Noda A, Cullings HM, Macphee DG, Kodama K, Mabuchi K, Kraemer KH, Land CE, Nakamura N (2006). Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population. Mutat Res  601, 171-8.   https://doi.org/10.1016/j.mrfmmm.2006.06.010




PubMed


 


PubMed ID 16905156
    
     


 



2.
Mizuno T, Tokuoka S, Kishikawa M, Nakashima E, Mabuchi K, Iwamoto KS (2006). Molecular basis of basal cell carcinogenesis in the atomic-bomb survivor population: p53 and PTCH gene alterations. Carcinogenesis  27, 2286-94.   https://doi.org/10.1093/carcin/bgl107




PubMed


 


PubMed ID 16777989
    
     


 



3.
Nagano J, Mabuchi K, Yoshimoto Y, Hayashi Y, Tsuda N, Land C, Kodama K (2007). A case-control study in Hiroshima and Nagasaki examining non-radiation risk factors for thyroid cancer. J Epidemiol  17, 76-85.   https://doi.org/10.2188/jea.17.76




PubMed


 


PubMed ID 17545694",https://intramural.nih.gov/search/searchview.taf?ipid=45817
526,CP010135-12,"October 01, 2006 -  September 30, 2007",Studies of Non-Ionizing Radiation-Related Cancer,"Martha S Linet; PhD



IRP Faculty Profile
 




Peter D Inskip; ScD",NULL,"Radiation Epidemiology Branch, NCI","Alina V Brenner



Elizabeth Carhart Bluhm



Daryl  Freedman



Preetha  Rajaraman



Ruth Anne Kleinerman; MPH



Steven L Simon","Bruce  Alexander
(University of Minnesota)




Peter  Black
(Brigham and Women's Hospital & Dana Farber Cancer Center)




WA  Bleyer
(Children's Cancer Group)




Anneclaire  De Roos
(University of Washington, Seattle, WA)




H  Fine
(Neuro-Oncology Branch, National Cancer Institute)




Elizabeth  Hatch
(Boston University)


Show all 9","Joseph B Coble (Occupational and Environmental Epidemiology Branch)



Mustafa  Dosemeci; PhD (Occupational and Environmental Epidemiology Branch)



Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)



Sholom  Wacholder; PhD (Biostatistics Branch)



Gloria L Gridley (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Rajaraman P, Stewart PA, Samet JM, Schwartz BS, Linet MS, Zahm SH, Rothman N, Yeager M, Fine HA, Black PM, Loeffler J, Shapiro WR, Selker RG, Inskip PD (2006). Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev  15, 2514-20.   https://doi.org/10.1158/1055-9965.EPI-06-0482




PubMed


 


PubMed ID 17164378
    
     


 



2.
Rajaraman P, Wang SS, Rothman N, Brown MM, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Chanock SJ, Inskip PD (2007). Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev  16, 1655-61.   https://doi.org/10.1158/1055-9965.EPI-07-0314




PubMed


 


PubMed ID 17684142",https://intramural.nih.gov/search/searchview.taf?ipid=45776
527,CP010136-12,"October 01, 2006 -  September 30, 2007",Cancer Risk in Human Populations,"Debra  Silverman; ScD, ScM



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji



Claudine M Samanic



Dalsu  Baris



Joanne S Colt



Joseph B Coble



Kenneth  Cantor; PhD



Show all 11",NULL,"Linda M Brown; MPH, DPhil (Biostatistics Branch)



Mark  Schiffman; MD (Hormonal and Reproductive Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Brown LM, Devesa SS, Chow WH (2008). Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst  100, 1184-7.   https://doi.org/10.1093/jnci/djn211




PubMed



        
     
Free Article


 


PubMed ID 18695138
         Pubmed Central ID 2518165 


 



2.
Chow WH, Devesa SS (2008). Contemporary epidemiology of renal cell cancer. Cancer J  14, 288-301.   https://doi.org/10.1097/PPO.0b013e3181867628




PubMed



        
     
Free Article


 


PubMed ID 18836333
         Pubmed Central ID 3077538 


 



3.
Chow WH, Linehan WM, Devesa SS (2007). Re: Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst  99, 569-70; author reply 570-1.   https://doi.org/10.1093/jnci/djk114




PubMed


 


PubMed ID 17406001
    
     


 



4.
Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, Yeager M, Chanock SJ, Zatonski W, Sobin LH, Lissowska J, Fraumeni JF, Chow WH (2007). Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis  28, 118-23.   https://doi.org/10.1093/carcin/bgl130




PubMed


 


PubMed ID 16885196
    
     


 



5.
Kelemen LE, Wang SS, Lim U, Cozen W, Schenk M, Hartge P, Li Y, Rothman N, Davis S, Chanock SJ, Ward MH, Cerhan JR (2008). Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk. Cancer Causes Control  19, 491-503.   https://doi.org/10.1007/s10552-008-9111-3




PubMed



        
     
Free Article


 


PubMed ID 18204928
         Pubmed Central ID 2804920 


 



6.
Lee SA, Dai Q, Zheng W, Gao YT, Blair A, Tessari JD, Tian Ji B, Shu XO (2007). Association of serum concentration of organochlorine pesticides with dietary intake and other lifestyle factors among urban Chinese women. Environ Int  33, 157-63.   https://doi.org/10.1016/j.envint.2006.08.010




PubMed


 


PubMed ID 17055057
    
     


 



7.
Navarro Silvera SA, Mayne ST, Risch H, Gammon MD, Vaughan TL, Chow WH, Dubrow R, Schoenberg JB, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni JF (2008). Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer  123, 852-60.   https://doi.org/10.1002/ijc.23544




PubMed



        
     
Free Article


 


PubMed ID 18537156
         Pubmed Central ID 3008621 


 



8.
Terry MB, Gammon MD, Zhang FF, Vaughan TL, Chow WH, Risch HA, Schoenberg JB, Mayne ST, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni JF, Santella RM (2007). Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas. Cancer Causes Control  18, 1039-46.   https://doi.org/10.1007/s10552-007-9046-0




PubMed


 


PubMed ID 17665311
    
     


 



9.
Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, Stanford JL, Chow WH (2007). GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev  31, 233-6.   https://doi.org/10.1016/j.cdp.2007.03.004




PubMed



        
     
Free Article


 


PubMed ID 17646057
         Pubmed Central ID 2268246 


 



10.
Zhang FF, Terry MB, Hou L, Chen J, Lissowska J, Yeager M, Zatonski W, Chanock S, Morabia A, Chow WH (2007). Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev  16, 115-21.   https://doi.org/10.1158/1055-9965.EPI-06-0513




PubMed


 


PubMed ID 17220339",https://intramural.nih.gov/search/searchview.taf?ipid=45777
528,CP010138-10,"October 01, 2006 -  September 30, 2007",Genetic Epidemiology of BRCA12,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI",NULL,"Georgia  Chenevix-Trench





Andrew  Collins
(Genetics, University of Southampton)




Douglas  Easton; PhD
(Oncology, Cambridge University)




Kenneth  Offit





Paul  Pharoah
(Oncology, Cambridge University)","Mark H Greene; MD (National Cancer Institute)



Albert M Gold (National Cancer Institute)



Alice  Sigurdson; PhD (National Cancer Institute)



Margaret Anne Tucker (National Cancer Institute)","Barbara B Biesecker; PhD, MS, CGC (NHGRI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45778
529,CP010139-10,"October 01, 2006 -  September 30, 2007",Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Myung Soo  Lyu



Daoud M Meerzaman



Constance M Cultraro",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=45779
530,CP010140-10,"October 01, 2006 -  September 30, 2007",Molecular Genetic Epidemiology of leading U.S. Cancers,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Ying  Hu; PhD



Daoud M Meerzaman



Jenny M Kelley",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45780
531,CP010141-10,"October 01, 2006 -  September 30, 2007",The Cancer Genome Anatomy Projects Genetic Annotation Initiative,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Robert  Clifford



Hongen  Zhang



Cu  Nguyen



Jenny M Kelley",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45803
532,CP010142-09,"October 01, 2006 -  September 30, 2007",Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,"Charles  Rabkin



IRP Faculty Profile
 


 

Sharon Ann Savage



IRP Faculty Profile
 


 

Regina Gale Ziegler; PhD, MPH



IRP Faculty Profile
 


 

Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI",NULL,"John  Bryant
(National Surgical Adjuvant Breast and Bowel Project)




Joseph  Constantino
(National Surgical Adjuvant Breast & Bowel Project Statistical Center)




Chester  Douglass
(Harvard School of Dentistry)




Howard  McLeod
(Washington University)




Gareth  Morgan
(University of Leeds)




Michael  Pollak
(McGill University)


Show all 8","Barry Ira Graubard; PhD (Biostatistics Branch)



Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)



Kenneth  Buetow; PhD (Laboratory of Population Genetics)



Meredith  Yeager (National Cancer Institute)



Philip Samuel Rosenberg; PhD (Biostatistics Branch)



Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Rabkin CS, Janz S (2008). Mechanisms and consequences of chromosomal translocation. Cancer Epidemiol Biomarkers Prev  17, 1849-51.   https://doi.org/10.1158/1055-9965.EPI-07-2902




PubMed



        
     
Free Article


 


PubMed ID 18708370
         Pubmed Central ID 2562255 


 



2.
Savage S, Burdett L, Troisi R, Douglass C, Hoover R, Chanock S (2007) Germ-line genetic variation of TP53 in osteosarcoma. Ped Blood Cancer 49:28-33




 



3.
Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN, Chanock SJ, National Osteosarcoma Etiology Study Gro (2007) Analysis of Genes Critical for Growth Regulation Identifies IGF2R Variations with Possible Functional Significance as Risk Factors for Osteosarcoma. Cancer Epidemiol Biomarkers Prev 16:1667-1674",https://intramural.nih.gov/search/searchview.taf?ipid=45781
533,CP010144-09,"October 01, 2006 -  September 30, 2007",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Sharon Ann Savage



IRP Faculty Profile
 


 

Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI","Blanche P Alter



Jennifer T Loud



June  Peters



Neelam K Giri; MD



Sadie  Hutson","David  Alberts
(University of Arizona Cancer Center)




Timothy  Bishop
(Institute for Cancer Research)




Robert  Brodsky
(Johns Hopkins University School of Medicine)




Joseph  Califano
(Johns Hopkins University School of Medicine)




George  Dover
(Johns Hopkins University School of Medicine)




Peter  Durie
(Toronto Hospital for Sick Children)


Show all 58","David  Danforth (Surgery Branch)



Diane Carol Arthur; MD (Laboratory of Pathology)



Gordon B Willis (Healthcare Delivery Research Program)



Izumi  Horikawa (Molecular Genetics and Carcinogenesis Section)



Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)



Margaret Anne Tucker (Genetic Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Alter BP, Baerlocher GM, Savage SA, Chanock SJ, Weksler BB, Willner JP, Peters JA, Giri N, Lansdorp PM (2007). Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood  110, 1439-47.   https://doi.org/10.1182/blood-2007-02-075598




PubMed



        
     
Free Article


 


PubMed ID 17468339
         Pubmed Central ID 1975834 


 



2.
Alter BP, Rosenberg PS (2007). Granulocyte colony-stimulating factor and severe aplastic anemia. Blood  109, 4589; author reply 4589-90.   https://doi.org/10.1182/blood-2007-01-068866




PubMed


 


PubMed ID 17483301
    
     


 



3.
Alter BP, Rosenberg PS, Brody LC (2007). Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J Med Genet  44, 1-9.   https://doi.org/10.1136/jmg.2006.043257




PubMed



        
     
Free Article


 


PubMed ID 16825431
         Pubmed Central ID 2597904 


 



4.
Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE, CIMBA (2007) An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 9:104




PubMed



        
     
Free Article


 


PubMed ID 17466083
         Pubmed Central ID 1868919 


 



5.
Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, Porteous ME, Jakubowska A, Lubinski J, Gronwald J, Spurdle AB, kConFab, Schmutzler R, Versmold B, Engel C, Meindl A, Sutter C, Consortium of Investigators of Modifiers of BRCA1/2, et al. [46 more authors] (2007). AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev  16, 1416-21.   https://doi.org/10.1158/1055-9965.EPI-07-0129




PubMed



        
     
Free Article


 


PubMed ID 17627006
         Pubmed Central ID 2775799 


 



6.
Giri N, Batista DL, Alter BP, Stratakis CA (2007). Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab  92, 2624-31.   https://doi.org/10.1210/jc.2007-0135




PubMed


 


PubMed ID 17426088
    
     


 



7.
Giri N, Pitel PA, Green D, Alter BP (2007). Splenic peliosis and rupture in patients with dyskeratosis congenita on androgens and granulocyte colony-stimulating factor. Br J Haematol  138, 815-7.   https://doi.org/10.1111/j.1365-2141.2007.06718.x




PubMed


 


PubMed ID 17760812
    
     


 



8.
Hutson SP, Alter BP (2007). Experiences of siblings of patients with Fanconi anemia. Pediatr Blood Cancer  48, 72-9.   https://doi.org/10.1002/pbc.20913




PubMed


 


PubMed ID 16779804
    
     


 



9.
Katki H, Gail M, Greene M (2007) Keynote Comment: Breast Cancer Risk in BRCA-Mutation-Negative Women from BRCA-Mutation-Positive Families. Lancet Oncology 8:1042-1043




 



10.
Korde LA, Premkumar A, Mueller C, Rosenberg P, Soho C, Bratslavsky G, Greene MH (2008). Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives. Br J Cancer  99, 1748-53.   https://doi.org/10.1038/sj.bjc.6604704




PubMed



        
     
Free Article


 


PubMed ID 18841155
         Pubmed Central ID 2584936 


 



11.
Mai PL, Korde L, Kramer J, Peters J, Mueller CM, Pfeiffer S, Stratakis CA, Pinto PA, Bratslavsky G, Merino M, Choyke P, Linehan WM, Greene MH (2007). A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report. J Med Case Rep  1, 9.   https://doi.org/10.1186/1752-1947-1-9




PubMed



        
     
Free Article


 


PubMed ID 17411461
         Pubmed Central ID 1847830 


 



12.
Mueller CM, Caporaso N, Greene MH (2008). Familial and genetic risk of transitional cell carcinoma of the urinary tract. Urol Oncol  26, 451-64.   https://doi.org/10.1016/j.urolonc.2008.02.016




PubMed



        
     
Free Article


 


PubMed ID 18562223
         Pubmed Central ID 2574230 


 



13.
Rosenberg PS, Alter BP, Link DC, Stein S, Rodger E, Bolyard AA, Aprikyan AA, Bonilla MA, Dror Y, Kannourakis G, Newburger PE, Boxer LA, Dale DC (2008). Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. Br J Haematol  140, 210-3.   https://doi.org/10.1111/j.1365-2141.2007.06897.x




PubMed



        
     
Free Article


 


PubMed ID 18028488
         Pubmed Central ID 3143022 


 



14.
Tamary H, Alter BP (2007). Current diagnosis of inherited bone marrow failure syndromes. Pediatr Hematol Oncol  24, 87-99.   https://doi.org/10.1080/08880010601123240




PubMed


 


PubMed ID 17454774",https://intramural.nih.gov/search/searchview.taf?ipid=45782
534,CP010145-08,"October 01, 2006 -  September 30, 2007",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI","Blanche P Alter



Christine M Mueller



Jennifer T Loud



Neelam K Giri; MD","David  Alberts
(University of Arizona Cancer Center)




Deborah A. Bell; MD
(Department of Laboratory Medicine and Pathology, Mayo Clinic)




Molly  Brewer
(Arizona Cancer Center)




Robert  Brodsky
(Johns Hopkins University School of Medicine)




Joseph  Califano
(Johns Hopkins University School of Medicine)




M  Constenino
(BioTech Laboratories)


Show all 17","Alisa  Goldstein; PhD (Genetic Epidemiology Branch)



Allan  Hildesheim; PhD (Hormonal and Reproductive Epidemiology Branch)



Margaret Anne Tucker (Genetic Epidemiology Branch)



Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Paul Kj Han (Outcomes Research Branch)",NULL,"Ordered by publication type and then author name.



1.
Mueller CM, Mai PL, Bucher J, Peters JA, Loud JT, Greene MH (2008). Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer. BMC Complement Altern Med  8, 17.   https://doi.org/10.1186/1472-6882-8-17




PubMed



        
     
Free Article


 


PubMed ID 18447953
         Pubmed Central ID 2391138",https://intramural.nih.gov/search/searchview.taf?ipid=45783
535,CP010146-08,"October 01, 2006 -  September 30, 2007",Genetic Modifiers of Intitiation and Progression of Mammary Cancer,"Kent W Hunter; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Luanne M Lukes



Nigel P Crawford; MB ChB, PhD



Nicholas  Lintell



Szu-Min  Hsieh



Jude  Alsarraj","Tim  Veenstra
(Laboratory of Systems Biology, SAIC Frederick)
















Hoda  Anton-Culver
(Department of Epidemiology, UCI)




John  Foekens
(Erasmus University)




Per  Lenner
(Umeå University)




Daniel  Pomp
(UNC)




Tom  Sellers
(Moffitt Cancer Center)


Show all 8","Douglas  Lowy; MD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)



Stefan  Ambs (National Cancer Institute)



Lalage  Wakefield; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Alsarraj J, Walker RC, Webster JD, Geiger TR, Crawford NP, Simpson RM, Ozato K, Hunter KW (2011). Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion. Cancer Res  71, 3121-31.   https://doi.org/10.1158/0008-5472.CAN-10-4417




PubMed



        
     
Free Article


 


PubMed ID 21389092
         Pubmed Central ID 3078189 


 



2.
Hunter KW (2012). Mouse models of cancer: does the strain matter? Nat Rev Cancer  12, 144-9.   https://doi.org/10.1038/nrc3206




PubMed



        
     
Free Article


 


PubMed ID 22257951
         Pubmed Central ID 6309955 


 



3.
Hunter KW, Amin R, Deasy S, Ha NH, Wakefield L (2018). Genetic insights into the morass of metastatic heterogeneity. Nat Rev Cancer  18, 211-223.   https://doi.org/10.1038/nrc.2017.126




PubMed



        
     
Free Article


 


PubMed ID 29422598
         Pubmed Central ID 6290469 


 



4.
Simmons JK, Amlin-Van Schaick JC, Geiger TR, Reilly K, Hunter K, Mock BA (2012). Mouse genetics 2011: meeting report. Mamm Genome  23, 225-31.   https://doi.org/10.1007/s00335-012-9390-6




PubMed



        
     
Free Article


 


PubMed ID 22358507
         Pubmed Central ID 6342188 


 



5.
Varticovski L, Hollingshead MG, Robles AI, Wu X, Cherry J, Munroe DJ, Lukes L, Anver MR, Carter JP, Borgel SD, Stotler H, Bonomi CA, Nunez NP, Hursting SD, Qiao W, Deng CX, Green JE, Hunter KW, Merlino G, Steeg PS, Wakefield LM, Barrett JC (2007). Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models. Clin Cancer Res  13, 2168-77.   https://doi.org/10.1158/1078-0432.CCR-06-0918




PubMed


 


PubMed ID 17404101",https://intramural.nih.gov/search/searchview.taf?ipid=45760
536,CP010150-08,"October 01, 2006 -  September 30, 2007","Infections, immunity, and inflammation in cancer","James Jerome Goedert; MD

 


 

Sam  Mbulaiteye



IRP Faculty Profile
 


 

Charles  Rabkin



IRP Faculty Profile
 


 

Eric Andrew Engels; PhD



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",Anil Kumar Chaturvedi,"Malcolm  Brock; MD
(Surgery, Johns Hopkins Medical Institutions)




Stephen J Chanock; MD, PhD
(NCI)




Gregory  Fant





Charlotte  Gaydos; DPhil
(Department of Medicine, Johns Hopkins School of Medicine)




Thomas  Giordano
(Baylor College of Medicine)




Gregory D Kirk



Show all 7","Demetrius  Albanes; MD (Office of the Director)



Farin  Kamangar (Nutritional Epidemiology Branch)



Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)



Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)



Nilanjan  Chatterjee (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Anderson LA, Lauria C, Romano N, Brown EE, Whitby D, Graubard BI, Li Y, Messina A, Gafà L, Vitale F, Goedert JJ (2008). Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily. Cancer Epidemiol Biomarkers Prev  17, 3435-43.   https://doi.org/10.1158/1055-9965.EPI-08-0671




PubMed



               Available in future as a Free Article 


 


PubMed ID 19064559
         Pubmed Central ID 2701388 


 



2.
Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, Berndt SI, Ricker W, Parsons R, Wheeler W, Engels EA (2008). Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev  17, 3069-75.   https://doi.org/10.1158/1055-9965.EPI-08-0408




PubMed



        
     
Free Article


 


PubMed ID 18957521
         Pubmed Central ID 2597453 


 



3.
Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW (2010). Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer  126, 2240-6.   https://doi.org/10.1002/ijc.24676




PubMed



        
     
Free Article


 


PubMed ID 19551862
         Pubmed Central ID 2908249 


 



4.
Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA, HIV/AIDS Cancer Match Study (2007). AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst  99, 962-72.   https://doi.org/10.1093/jnci/djm010




PubMed


 


PubMed ID 17565153
    
     


 



5.
Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA (2006). Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood  108, 3786-91.   https://doi.org/10.1182/blood-2006-05-024109




PubMed



        
     
Free Article


 


PubMed ID 16917006
         Pubmed Central ID 1895473 


 



6.
Chaturvedi AK, Pfeiffer RM, Chang L, Goedert JJ, Biggar RJ, Engels EA (2007). Elevated risk of lung cancer among people with AIDS. AIDS  21, 207-13.   https://doi.org/10.1097/QAD.0b013e3280118fca




PubMed


 


PubMed ID 17197812
    
     


 



7.
Engels EA (2007). Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev  16, 401-4.   https://doi.org/10.1158/1055-9965.EPI-06-1056




PubMed


 


PubMed ID 17337646
    
     


 



8.
Engels EA, Mbulaiteye SM, Othieno E, Gomez M, Mathew S, Cesarman E, Knowles DM, Chadburn A (2007). Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda. Hum Pathol  38, 308-14.   https://doi.org/10.1016/j.humpath.2006.08.009




PubMed


 


PubMed ID 17097130
    
     


 



9.
Engels EA, Wu X, Gu J, Dong Q, Liu J, Spitz MR (2007). Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res  67, 6520-7.   https://doi.org/10.1158/0008-5472.CAN-07-0370




PubMed


 


PubMed ID 17596594
    
     


 



10.
Gadalla SM, Preiss LR, Eyster ME, Goedert JJ (2011). Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia. J Viral Hepat  18, 161-9.   https://doi.org/10.1111/j.1365-2893.2010.01289.x




PubMed



        
     
Free Article


 


PubMed ID 20337924
         Pubmed Central ID 2929328 


 



11.
Goedert JJ, Purdue MP, McNeel TS, McGlynn KA, Engels EA (2007). Risk of germ cell tumors among men with HIV/acquired immunodeficiency syndrome. Cancer Epidemiol Biomarkers Prev  16, 1266-9.   https://doi.org/10.1158/1055-9965.EPI-07-0042




PubMed


 


PubMed ID 17548695
    
     


 



12.
Hoffmann CJ, Subramanian AK, Cameron AM, Engels EA (2008). Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation. Transplantation  86, 784-90.   https://doi.org/10.1097/TP.0b013e3181837761




PubMed



        
     
Free Article


 


PubMed ID 18813102
         Pubmed Central ID 2714173 


 



13.
Kirk GD, Merlo C, O' Driscoll P, Mehta SH, Galai N, Vlahov D, Samet J, Engels EA (2007). HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis  45, 103-10.   https://doi.org/10.1086/518606




PubMed



        
     
Free Article


 


PubMed ID 17554710
         Pubmed Central ID 4078722 


 



14.
Landgren O, Rapkin JS, Caporaso NE, Mellemkjaer L, Gridley G, Goldin LR, Engels EA (2007). Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood  109, 2198-201.   https://doi.org/10.1182/blood-2006-08-044008




PubMed



        
     
Free Article


 


PubMed ID 17082317
         Pubmed Central ID 1801057 


 



15.
Nsubuga MM, Biggar RJ, Combs S, Marshall V, Mbisa G, Kambugu F, Mehta M, Biryahwaho B, Rabkin CS, Whitby D, Mbulaiteye SM (2008). Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions. Cancer Lett  263, 182-8.   https://doi.org/10.1016/j.canlet.2007.12.025




PubMed



        
     
Free Article


 


PubMed ID 18234418
         Pubmed Central ID 2440724 


 



16.
Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM (2008). Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer  123, 2658-63.   https://doi.org/10.1002/ijc.23800




PubMed



        
     
Free Article


 


PubMed ID 18767045
         Pubmed Central ID 2574984",https://intramural.nih.gov/search/searchview.taf?ipid=45784
537,CP010152-08,"October 01, 2006 -  September 30, 2007",PLCO Trial Etiologic and Early Marker Study,"Neil Edward Caporaso; MS, MD



IRP Faculty Profile
 


 

Robert  Hoover; MD, ScD



IRP Faculty Profile
 


 

Nathaniel C Rothman; MD



IRP Faculty Profile
 




Arthur  Schatzkin; PhD

 


 

Regina Gale Ziegler; PhD, MPH



IRP Faculty Profile
 




Richard  Hayes; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji



Wen-Yi  Huang","Gerry  Andriole
(Washington University)




Thomas  Beck
(NCI)




Saundra  Buys
(Hunstman Cancer Institute, University of Utah)




Timothy R. Church; PhD
(Environ & Occup Health, University of Minnesota School of Public Health)




David T Crawford





Mona  Fouad
(University of Alabama, Birmingham)


Show all 11","Christine Dorothy Berg (Early Detection Research Group)



Jimmie B Vaught (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Berndt S, Welch R, Chanock S, Hayes R, Chatterjee N   (2007) Variant in the Sex-Hormone Binding Globulin (SHBG) Gene and the Risk of Prostate Cancer.  Cancer Epidemiol Biomarkers Prev  165-168 pp.




 



2.
Berndt SI, Chatterjee N, Huang WY, Chanock SJ, Welch R, Crawford ED, Hayes RB (2007). Variant in sex hormone-binding globulin gene and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev  16, 165-8.   https://doi.org/10.1158/1055-9965.EPI-06-0689




PubMed


 


PubMed ID 17220347
    
     


 



3.
Berndt SI, Huang WY, Chatterjee N, Yeager M, Welch R, Chanock SJ, Weissfeld JL, Schoen RE, Hayes RB (2007). Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis  28, 1965-70.   https://doi.org/10.1093/carcin/bgm155




PubMed


 


PubMed ID 17615257
    
     


 



4.
Berndt SI, Huang WY, Fallin MD, Helzlsouer KJ, Platz EA, Weissfeld JL, Church TR, Welch R, Chanock SJ, Hayes RB (2007). Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma. Cancer Res  67, 1395-404.   https://doi.org/10.1158/0008-5472.CAN-06-1390




PubMed


 


PubMed ID 17283177
    
     


 



5.
Berndt SI, Potter JD, Hazra A, Yeager M, Thomas G, Makar KW, Welch R, Cross AJ, Huang WY, Schoen RE, Giovannucci E, Chan AT, Chanock SJ, Peters U, Hunter DJ, Hayes RB (2008). Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum Mol Genet  17, 2665-72.   https://doi.org/10.1093/hmg/ddn166




PubMed



        
     
Free Article


 


PubMed ID 18535017
         Pubmed Central ID 2561994 


 



6.
Daugherty SE, Hayes RB, Yeager M, Andriole GL, Chatterjee N, Huang WY, Isaacs WB, Platz EA (2007). RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. Prostate  67, 849-54.   https://doi.org/10.1002/pros.20537




PubMed


 


PubMed ID 17407163
    
     


 



7.
Daugherty SE, Platz EA, Shugart YY, Fallin MD, Isaacs WB, Chatterjee N, Welch R, Huang WY, Hayes RB (2007). Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev  16, 1536-42.   https://doi.org/10.1158/1055-9965.EPI-07-0117




PubMed


 


PubMed ID 17684125
    
     


 



8.
Kang D, Lee KM, Park SK, Berndt SI, Peters U, Reding D, Chatterjee N, Welch R, Chanock S, Huang WY, Hayes RB (2007). Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev  16, 1581-6.   https://doi.org/10.1158/1055-9965.EPI-07-0160




PubMed


 


PubMed ID 17646272
    
     


 



9.
Kang D, Lee KM, Park SK, Berndt SI, Reding D, Chatterjee N, Welch R, Chanock S, Huang WY, Hayes RB (2007). Lack of association of transforming growth factor-beta1 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial. Cancer Epidemiol Biomarkers Prev  16, 1303-5.   https://doi.org/10.1158/1055-9965.EPI-06-0895




PubMed


 


PubMed ID 17548703
    
     


 



10.
Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, Hayes RB, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (2007). Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst  99, 1200-9.   https://doi.org/10.1093/jnci/djm065




PubMed


 


PubMed ID 17652276
    
     


 



11.
Männistö S, Yaun SS, Hunter DJ, Spiegelman D, Adami HO, Albanes D, van den Brandt PA, Buring JE, Cerhan JR, Colditz GA, Freudenheim JL, Fuchs CS, Giovannucci E, Goldbohm RA, Harnack L, Leitzmann M, McCullough ML, Miller AB, Rohan TE, Schatzkin A, Virtamo J, Willett WC, Wolk A, Zhang SM, Smith-Warner SA (2007). Dietary carotenoids and risk of colorectal cancer in a pooled analysis of 11 cohort studies. Am J Epidemiol  165, 246-55.   https://doi.org/10.1093/aje/kwk009




PubMed


 


PubMed ID 17158857
    
     


 



12.
Peters U, Foster CB, Chatterjee N, Schatzkin A, Reding D, Andriole GL, Crawford ED, Sturup S, Chanock SJ, Hayes RB (2007). Serum selenium and risk of prostate cancer-a nested case-control study. Am J Clin Nutr  85, 209-17.   https://doi.org/10.1093/ajcn/85.1.209




PubMed



        
     
Free Article


 


PubMed ID 17209198
         Pubmed Central ID 1839923 


 



13.
Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, Gelmann EP, Friesen MD, Riboli E, Hayes RB (2007). Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev  16, 962-8.   https://doi.org/10.1158/1055-9965.EPI-06-0861




PubMed


 


PubMed ID 17507623
    
     


 



14.
Tsai HT, Cross AJ, Graubard BI, Oken M, Schatzkin A, Caporaso NE (2010). Dietary factors and risk of chronic lymphocytic leukemia and small lymphocytic lymphoma: a pooled analysis of two prospective studies. Cancer Epidemiol Biomarkers Prev  19, 2680-4.   https://doi.org/10.1158/1055-9965.EPI-10-0585




PubMed



        
     
Free Article


 


PubMed ID 20929883
         Pubmed Central ID 3501724",https://intramural.nih.gov/search/searchview.taf?ipid=45786
538,CP010153-08,"October 01, 2006 -  September 30, 2007","Cancer Risk and Environmental Exposures to Nitrate, Pesticides, and Industrial C","Kenneth  Cantor; PhD

 


 

Mary Helen Ward; MS, PhD



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Debra  Silverman; ScD, ScM



Joanne S Colt","P  Buffler
(Univerity of California at Berkeley)




David  Camann
(Southwest Research Institute)




James  Cerhan
(Mayo Clinic)




Anneclair  DeRoos
(University of Washington)




James  Giglierano
(Iowa Department of Natural Resources)




Martin  Kulldorf
(University of Connecticut)


Show all 13","Jay  Lubin; PhD (Biostatistics Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Shelia K Zahm; ScM, ScD (Office of the Director)



Barry Ira Graubard; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Colt JS, Cyr MJ, Zahm SH, Tobias GS, Hartge P (2007). Inferring past pesticide exposures: a matrix of individual active ingredients in home and garden pesticides used in past decades. Environ Health Perspect  115, 248-54.   https://doi.org/10.1289/ehp.9538




PubMed



        
     
Free Article


 


PubMed ID 17384773
         Pubmed Central ID 1817710 


 



2.
Dellavalle CT, Xiao Q, Yang G, Shu XO, Aschebrook-Kilfoy B, Zheng W, Lan Li H, Ji BT, Rothman N, Chow WH, Gao YT, Ward MH (2014). Dietary nitrate and nitrite intake and risk of colorectal cancer in the Shanghai Women's Health Study. Int J Cancer  134, 2917-26.   https://doi.org/10.1002/ijc.28612




PubMed



        
     
Free Article


 


PubMed ID 24242755
         Pubmed Central ID 3980001 


 



3.
Inoue-Choi M, Sinha R, Gierach GL, Ward MH (2016). Red and processed meat, nitrite, and heme iron intakes and postmenopausal breast cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer  138, 1609-18.   https://doi.org/10.1002/ijc.29901




PubMed



        
     
Free Article


 


PubMed ID 26505173
         Pubmed Central ID 4724256",https://intramural.nih.gov/search/searchview.taf?ipid=45808
539,CP010154-08,"October 01, 2006 -  September 30, 2007",Genetics and Epigenetics of Cancer,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI","Sheryl A Gere



Mitsutaka  Kadota



Howard H Yang



Natacha  Diaz-Meyer",NULL,"Jeffery P Struewing; MS, MD (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hu N, Kadota M, Liu H, Abnet CC, Su H, Wu H, Freedman ND, Yang HH, Wang C, Yan C, Wang L, Gere S, Hutchinson A, Song G, Wang Y, Ding T, Qiao YL, Koshiol J, Dawsey SM, Giffen C, Goldstein AM, Taylor PR, Lee MP (2016). Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer. Cancer Res  76, 1714-23.   https://doi.org/10.1158/0008-5472.CAN-15-0338




PubMed



        
     
Free Article


 


PubMed ID 26857264
         Pubmed Central ID 4873357",https://intramural.nih.gov/search/searchview.taf?ipid=45787
540,CP010155-08,"October 01, 2006 -  September 30, 2007",Informatics Solutions to Biomedical Research,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",Howard H Yang,NULL,"Philip  Taylor; MD, ScD (National Cancer Institute)



Alisa  Goldstein; PhD (National Cancer Institute)



Dinah  Singer; PhD (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45788
541,CP010156-07,"October 01, 2006 -  September 30, 2007",Genetic Studies in Melanoma,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,"Alisa  Goldstein; PhD (National Cancer Institute)



Margaret Anne Tucker (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45761
542,CP010157-07,"October 01, 2006 -  September 30, 2007","Genetic, Epidemiologic, and Biochemical Studies of DNA Damage Repair","Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,Alice  Sigurdson; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45759
543,CP010158-07,"October 01, 2006 -  September 30, 2007",Studies of Rare Cancers,"Allan  Hildesheim; PhD



IRP Faculty Profile
 




Ann  Hsing; PhD

 


 

Katherine Ann McGlynn; PhD



IRP Faculty Profile
 




Sophia S Wang; PhD

 




Louise  Brinton; PhD",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Kelly Jen-Yi Yu



Michael Blaise Cook","Streamson  Chua
(Columbia University)




Scott  Davis
(Fred Hutchinson Cancer Research Center)




James  Dick
(Johns Hopkins Univeristy)




James  Fox
(MIT)




Yu-Tang  Gao
(Shanghai Cancer Institute)




Evelyene  Lennette
(Virolab, Inc.)


Show all 12","Gabriella  Andreotti (Occupational and Environmental Epidemiology Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Gathany AH, Hartge P, Davis S, Cerhan JR, Severson RK, Cozen W, Rothman N, Chanock SJ, Wang SS (2009). Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma. Cancer Causes Control  20, 1291-302.   https://doi.org/10.1007/s10552-009-9348-5




PubMed



        
     
Free Article


 


PubMed ID 19396635
         Pubmed Central ID 2746901 


 



2.
Hsing A   (2007) A partially linear tree-based regression model for assessing complex joint gene-gene and gene-environment effects.  Genet Epidemiol  238-251 pp.




 



3.
Murphy G, Thornton J, McManus R, Swan N, Ryan B, Hughes DJ, O'Morain CA, O'Sullivan M (2009). Association of gastric disease with polymorphisms in the inflammatory-related genes IL-1B, IL-1RN, IL-10, TNF and TLR4. Eur J Gastroenterol Hepatol  21, 630-5.   https://doi.org/10.1097/MEG.0b013e3283140eea




PubMed



        
     
Free Article


 


PubMed ID 19295440
         Pubmed Central ID 2802816 


 



4.
Purdue MP, Graubard BI, Chanock SJ, Rubertone MV, Erickson RL, McGlynn KA (2008). Genetic variation in the inhibin pathway and risk of testicular germ cell tumors. Cancer Res  68, 3043-8.   https://doi.org/10.1158/0008-5472.CAN-07-5852




PubMed



        
     
Free Article


 


PubMed ID 18413775
         Pubmed Central ID 2997349",https://intramural.nih.gov/search/searchview.taf?ipid=45789
544,CP010162-07,"October 01, 2006 -  September 30, 2007",Gene expression profiles in lung cancer using cDNA arrays,Jin  Jen,NULL,"Laboratory of Human Carcinogenesis, NCI","Tatiana V Dracheva



Rajbir K Gill



Hyo-Sung  Jeon



Abbas  Shakoori",NULL,"Curtis  Harris; MD (National Cancer Institute)



Neil Edward Caporaso; MS, MD (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dracheva T, Philip R, Xiao W, Gee AG, McCarthy J, Yang P, Wang Y, Dong G, Yang H, Jen J (2007). Distinguishing lung tumours from normal lung based on a small set of genes. Lung Cancer  55, 157-64.   https://doi.org/10.1016/j.lungcan.2006.10.025




PubMed



        
     
Free Article


 


PubMed ID 17161497
         Pubmed Central ID 1859858 


 



2.
Hong KM, Yang SH, Chowdhuri SR, Player A, Hames M, Fukuoka J, Meerzaman D, Dracheva T, Sun Z, Yang P, Jen J (2007). Inactivation of LLC1 gene in nonsmall cell lung cancer. Int J Cancer  120, 2353-8.   https://doi.org/10.1002/ijc.22577




PubMed



        
     
Free Article


 


PubMed ID 17304513
         Pubmed Central ID 1907378 


 



3.
Zhang J, Finney RP, Rowe W, Edmonson M, Yang SH, Dracheva T, Jen J, Struewing JP, Buetow KH (2007). Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB). Genome Res  17, 1111-7.   https://doi.org/10.1101/gr.5963407




PubMed



        
     
Free Article


 


PubMed ID 17525135
         Pubmed Central ID 1899122",https://intramural.nih.gov/search/searchview.taf?ipid=45790
545,CP010163-07,"October 01, 2006 -  September 30, 2007",Genetic analysis in early age of onset lung cancer patients,Jin  Jen,NULL,"Laboratory of Human Carcinogenesis, NCI","Tatiana V Dracheva



Rajbir K Gill



Hyo-Sung  Jeon



Abbas  Shakoori","Teri  Franks
(pathology, Armed Forces Institute of Pathology)




William  Travis
(Pathology, Memorial Sloan Kettering Cancer Cancer)




Ping  Yang; MD, PhD
(Mayo Clinic)","Curtis  Harris; MD (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dracheva T, Philip R, Xiao W, Gee AG, McCarthy J, Yang P, Wang Y, Dong G, Yang H, Jen J (2007). Distinguishing lung tumours from normal lung based on a small set of genes. Lung Cancer  55, 157-64.   https://doi.org/10.1016/j.lungcan.2006.10.025




PubMed



        
     
Free Article


 


PubMed ID 17161497
         Pubmed Central ID 1859858 


 



2.
Gill RK, Vazquez MF, Kramer A, Hames M, Zhang L, Heselmeyer-Haddad K, Ried T, Shilo K, Henschke C, Yankelevitz D, Jen J (2008). The use of genetic markers to identify lung cancer in fine needle aspiration samples. Clin Cancer Res  14, 7481-7.   https://doi.org/10.1158/1078-0432.CCR-07-5242




PubMed



               Available in future as a Free Article 


 


PubMed ID 19010865
         Pubmed Central ID 2586966 


 



3.
Hong KM, Yang SH, Chowdhuri SR, Player A, Hames M, Fukuoka J, Meerzaman D, Dracheva T, Sun Z, Yang P, Jen J (2007). Inactivation of LLC1 gene in nonsmall cell lung cancer. Int J Cancer  120, 2353-8.   https://doi.org/10.1002/ijc.22577




PubMed



        
     
Free Article


 


PubMed ID 17304513
         Pubmed Central ID 1907378 


 



4.
Jin X, Zhang J, Gao Y, Ding K, Wang N, Zhou D, Jen J, Cheng S (2007). Relationship between mitochondrial DNA mutations and clinical characteristics in human lung cancer. Mitochondrion  7, 347-53.   https://doi.org/10.1016/j.mito.2007.06.003




PubMed


 


PubMed ID 17707697
    
     


 



5.
Zhang J, Finney RP, Rowe W, Edmonson M, Yang SH, Dracheva T, Jen J, Struewing JP, Buetow KH (2007). Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB). Genome Res  17, 1111-7.   https://doi.org/10.1101/gr.5963407




PubMed



        
     
Free Article


 


PubMed ID 17525135
         Pubmed Central ID 1899122",https://intramural.nih.gov/search/searchview.taf?ipid=45791
546,CP010164-07,"October 01, 2006 -  September 30, 2007",Development of non-small cell lung cancer tissue microarray for systematic analy,Jin  Jen,NULL,"Laboratory of Human Carcinogenesis, NCI","Tatiana V Dracheva



Rajbir K Gill



Hyo-Sung  Jeon



Abbas  Shakoori","Teri  Franks
(pathology, Armed Forces Institute of Pathology)




James  Herman
(Oncology, Johns Hopkins Medical School)




William  Travis
(Pathology, Memorial Sloan Kettering Cancer Cancer)




David  Yankelevitz
(Cornell Medical Center, Cornell University)","Curtis  Harris; MD (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)



Karl Thomas Ried; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dracheva T, Philip R, Xiao W, Gee AG, McCarthy J, Yang P, Wang Y, Dong G, Yang H, Jen J (2007). Distinguishing lung tumours from normal lung based on a small set of genes. Lung Cancer  55, 157-64.   https://doi.org/10.1016/j.lungcan.2006.10.025




PubMed



        
     
Free Article


 


PubMed ID 17161497
         Pubmed Central ID 1859858 


 



2.
Fukuoka J, Dracheva T, Shih JH, Hewitt SM, Fujii T, Kishor A, Mann F, Shilo K, Franks TJ, Travis WD, Jen J (2007). Desmoglein 3 as a prognostic factor in lung cancer. Hum Pathol  38, 276-83.   https://doi.org/10.1016/j.humpath.2006.08.006




PubMed


 


PubMed ID 17084439
    
     


 



3.
Hong KM, Yang SH, Chowdhuri SR, Player A, Hames M, Fukuoka J, Meerzaman D, Dracheva T, Sun Z, Yang P, Jen J (2007). Inactivation of LLC1 gene in nonsmall cell lung cancer. Int J Cancer  120, 2353-8.   https://doi.org/10.1002/ijc.22577




PubMed



        
     
Free Article


 


PubMed ID 17304513
         Pubmed Central ID 1907378 


 



4.
Ozbudak IH, Shilo K, Tavora F, Rassaei N, Chu WS, Fukuoka J, Jen J, Travis WD, Franks TJ (2009). Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis. Mod Pathol  22, 633-8.   https://doi.org/10.1038/modpathol.2009.6




PubMed



        
     
Free Article


 


PubMed ID 19234439
         Pubmed Central ID 3616507",https://intramural.nih.gov/search/searchview.taf?ipid=45792
547,CP010165-07,"October 01, 2006 -  September 30, 2007",Mechanisms of gene expression changes in lung cancer,Jin  Jen,NULL,"Laboratory of Human Carcinogenesis, NCI","Tatiana V Dracheva



Rajbir K Gill



Hyo-Sung  Jeon



Abbas  Shakoori",NULL,"Ilona  Linnoila; MD (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hong KM, Yang SH, Chowdhuri SR, Player A, Hames M, Fukuoka J, Meerzaman D, Dracheva T, Sun Z, Yang P, Jen J (2007). Inactivation of LLC1 gene in nonsmall cell lung cancer. Int J Cancer  120, 2353-8.   https://doi.org/10.1002/ijc.22577




PubMed



        
     
Free Article


 


PubMed ID 17304513
         Pubmed Central ID 1907378 


 



2.
Jeon HS, Dracheva T, Yang SH, Meerzaman D, Fukuoka J, Shakoori A, Shilo K, Travis WD, Jen J (2008). SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells. Cancer Res  68, 9686-92.   https://doi.org/10.1158/0008-5472.CAN-08-1083




PubMed



        
     
Free Article


 


PubMed ID 19047146
         Pubmed Central ID 3617041",https://intramural.nih.gov/search/searchview.taf?ipid=45793
548,CP010167-07,"October 01, 2006 -  September 30, 2007",General Studies of Epidemiology,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI","Patricia  Hartge; ScD



Rebecca  Troisi","Clark  Anderson
(University of Kansas School of Medicine)




Chester  Douglass
(Harvard School of Dentistry)




Sheila  McGuire
(Harvard School of Dentistry)",NULL,NULL,"Ordered by publication type and then author name.



1.
Albanes D, Hoover R, Chanock S, Hayes R   (2007) A Common 8q24 Variant and Prostate Cancer in a Large Nested Case-Control Study.  Cancer Res  2951-2956 pp.




 



2.
Hoover RN (2007). The evolution of epidemiologic research: from cottage industry to ""big"" science. Epidemiology  18, 13-7.   https://doi.org/10.1097/01.ede.0000249532.81073.b2




PubMed


 


PubMed ID 17179754
    
     


 



3.
Savage SA, Burdett L, Troisi R, Douglass C, Hoover RN, Chanock SJ, National Osteosarcoma Etiology study group (2007). Germ-line genetic variation of TP53 in osteosarcoma. Pediatr Blood Cancer  49, 28-33.   https://doi.org/10.1002/pbc.21077




PubMed


 


PubMed ID 17096406
    
     


 



4.
Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN, Chanock SJ, National Osteosarcoma Etiology Study Gro (2007) Analysis of Genes Critical for Growth Regulation Identifies IGF2R Variations with Possible Functional Significance as Risk Factors for Osteosarcoma. Cancer Epidemiol Biomarkers Prev 18:1667-1674




 



5.
Schumacher FR, Feigelson HS, Cox DG, Haiman CA, Albanes D, Buring J, Calle EE, Chanock SJ, Colditz GA, Diver WR, Dunning AM, Freedman ML, Gaziano JM, Giovannucci E, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Kaaks R, Key T, Kolonel LN, Kraft P, Le Marchand L, Ma J, Pike MC, et al. [11 more authors] (2007). A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res  67, 2951-6.   https://doi.org/10.1158/0008-5472.CAN-06-3591




PubMed


 


PubMed ID 17409400
    
     


 



6.
Troisi R, Masters MN, Joshipura K, Douglass C, Cole BF, Hoover RN (2006). Perinatal factors, growth and development, and osteosarcoma risk. Br J Cancer  95, 1603-7.   https://doi.org/10.1038/sj.bjc.6603474




PubMed



        
     
Free Article


 


PubMed ID 17106438
         Pubmed Central ID 2360735",https://intramural.nih.gov/search/searchview.taf?ipid=45794
549,CP010168-07,"October 01, 2006 -  September 30, 2007",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI","Nancy K Carter



Rebecca  Troisi","Ervin  Adam
(Baylor College of Medicine)




Elizabeth  Hatch
(Boston University)




Arthur  Herbst
(University of Chicago)




Chung  Hsieh
(University of Massachuetts)




Michele  Lauria
(Dartmouth Hitchcock Medical Center)




Kenneth  Noller
(New England Medical Center)


Show all 15",NULL,NULL,"Ordered by publication type and then author name.



1.
Faupel-Badger JM, Hsieh CC, Troisi R, Lagiou P, Potischman N (2007). Plasma volume expansion in pregnancy: implications for biomarkers in population studies. Cancer Epidemiol Biomarkers Prev  16, 1720-3.   https://doi.org/10.1158/1055-9965.EPI-07-0311




PubMed


 


PubMed ID 17855687
    
     


 



2.
Hatch EE, Troisi R, Wise LA, Hyer M, Palmer JR, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Adam E, Noller KL, Herbst AL, Robboy S, Hartge P, Hoover RN (2006). Age at natural menopause in women exposed to diethylstilbestrol in utero. Am J Epidemiol  164, 682-8.   https://doi.org/10.1093/aje/kwj257




PubMed


 


PubMed ID 16887893
    
     


 



3.
Hoover R, Troisi R   (2007) Secondary sex ratio among women exposed to diethylstilbestrol in utero.  Environ Health Perspectives  1314-1319 pp.




 



4.
Hoover RN (2007). The evolution of epidemiologic research: from cottage industry to ""big"" science. Epidemiology  18, 13-7.   https://doi.org/10.1097/01.ede.0000249532.81073.b2




PubMed


 


PubMed ID 17179754
    
     


 



5.
Lauren W, Palmer J, Hatch E, Troisi R, TitusErnstoff L, Herbst A, Kaufman R, Noller K, Hoover R (2007) Secondary sex ratio among women exposed to diethylstilbestrol in utero. Environ Health Perspectives 115:1314-1319




 



6.
Troisi R   (2007) Preeclampsia and maternal breast cancer risk by offspring gender: do elevated androgen concentrations play a role?  Br J Cancer  688-690 pp.




 



7.
Troisi R, Hatch EE, Titus-Ernstoff L, Hyer M, Palmer JR, Robboy SJ, Strohsnitter WC, Kaufman R, Herbst AL, Hoover RN (2007). Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer  121, 356-60.   https://doi.org/10.1002/ijc.22631




PubMed


 


PubMed ID 17390375
    
     


 



8.
Troisi R, Hoover R   (2007) Prenatal Risk Factors for Breast Cancer: Exploring the underlying mechanisms.  Cancer Epidemiology, Biomarkers and Prevention  1700-12 pp.




 



9.
Troisi R, Innes KE, Roberts JM, Hoover RN (2007). Preeclampsia and maternal breast cancer risk by offspring gender: do elevated androgen concentrations play a role? Br J Cancer  97, 688-90.   https://doi.org/10.1038/sj.bjc.6603921




PubMed



        
     
Free Article


 


PubMed ID 17687337
         Pubmed Central ID 2360362 


 



10.
Troisi R, Potischman N, Hoover R (2007) Prenatal Risk Factors for Breast Cancer: Exploring the underlying mechanisms. Cancer Epidemiology, Biomarkers and Prevention 16:1700-12




 



11.
Troisi R, Titus-Ernstoff L, Hyer M, Hatch EE, Robboy SJ, Strohsnitter W, Palmer JR, Øglaend B, Adam E, Kaufman R, Herbst AL, Hoover RN (2007). Preeclampsia risk in women exposed in utero to diethylstilbestrol. Obstet Gynecol  110, 113-20.   https://doi.org/10.1097/01.AOG.0000268796.75591.02




PubMed


 


PubMed ID 17601905
    
     


 



12.
Wise LA, Titus-Ernstoff L, Palmer JR, Hoover RN, Hatch EE, Perez KM, Strohsnitter WC, Kaufman R, Anderson D, Troisi R (2007). Time to pregnancy and secondary sex ratio in men exposed prenatally to diethylstilbestrol. Am J Epidemiol  166, 765-74.   https://doi.org/10.1093/aje/kwm136




PubMed


 


PubMed ID 17596265",https://intramural.nih.gov/search/searchview.taf?ipid=45795
550,CP010169-06,"October 01, 2006 -  September 30, 2007","Nutrition, Metabolism, and Cancer","Stephen J Chanock; MD, PhD



IRP Faculty Profile
 




Thomas  Fears; PhD

 


 

Barry Ira Graubard; PhD



IRP Faculty Profile
 


 

Robert  Hoover; MD, ScD



IRP Faculty Profile
 


 

Regina Gale Ziegler; PhD, MPH



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Patricia  Hartge; ScD,"Ray  Greenberg
(University of South Carolina)




Rudolf  Kaaks
(International Agency for Research on Cancer)




Lawrence  Kolonel
(University of Hawaii)




Abraham  Nomura
(School of Public Health, University of Hawaii)




Emmanuel  Petricoin





Malcolm  Pike
(University of Southern California)


Show all 11","Blossom  Patterson (Biometry Research Group)



Catherine G Schairer (Biostatistics Branch)



Demetrius  Albanes; MD (Office of the Director)



Gloria L Gridley (Biostatistics Branch)



Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)



Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Xu X, Keefer LK, Ziegler RG, Veenstra TD (2007). A liquid chromatography-mass spectrometry method for the quantitative analysis of urinary endogenous estrogen metabolites. Nat Protoc  2, 1350-5.   https://doi.org/10.1038/nprot.2007.176




PubMed


 


PubMed ID 17545972
    
     


 



2.
Ziegler RG, Lim U (2007). One-carbon metabolism, colorectal carcinogenesis, chemoprevention--with caution. J Natl Cancer Inst  99, 1214-5.   https://doi.org/10.1093/jnci/djm105




PubMed


 


PubMed ID 17686821",https://intramural.nih.gov/search/searchview.taf?ipid=45801
551,CP010170-07,"October 01, 2006 -  September 30, 2007",Multidisciplinary Studies of Lymphoma,Patricia  Hartge; ScD,NULL,"Epidemiology and Biostatistics Program, NCI",NULL,NULL,"Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)



Gloria L Gridley (Biostatistics Branch)



Joanne S Colt (Occupational and Environmental Epidemiology Branch)



Lindsay Mcomber Morton (Hormonal and Reproductive Epidemiology Branch)



Martha S Linet; PhD (Radiation Epidemiology Branch)



Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Boffetta P, Armstrong B, Linet M, Kasten C, Cozen W, Hartge P (2007). Consortia in cancer epidemiology: lessons from InterLymph. Cancer Epidemiol Biomarkers Prev  16, 197-9.   https://doi.org/10.1158/1055-9965.EPI-06-0786




PubMed


 


PubMed ID 17301250
    
     


 



2.
Cerhan JR, Wang S, Maurer MJ, Ansell SM, Geyer SM, Cozen W, Morton LM, Davis S, Severson RK, Rothman N, Lynch CF, Wacholder S, Chanock SJ, Habermann TM, Hartge P (2007). Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood  109, 5439-46.   https://doi.org/10.1182/blood-2006-11-058040




PubMed



        
     
Free Article


 


PubMed ID 17327408
         Pubmed Central ID 1890834 


 



3.
Colt JS, Hartge P, Davis S, Cerhan JR, Cozen W, Severson RK (2007). Hobbies with solvent exposure and risk of non-Hodgkin lymphoma. Cancer Causes Control  18, 385-90.   https://doi.org/10.1007/s10552-006-0108-5




PubMed


 


PubMed ID 17262168
    
     


 



4.
Hartge P, Lim U, Freedman DM, Colt JS, Cerhan JR, Cozen W, Severson RK, Davis S (2006). Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control  17, 1045-52.   https://doi.org/10.1007/s10552-006-0040-8




PubMed


 


PubMed ID 16933055
    
     


 



5.
Hartge P, Smith MT (2007). Environmental and behavioral factors and the risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev  16, 367-8.   https://doi.org/10.1158/1055-9965.EPI-07-0031




PubMed


 


PubMed ID 17344463
    
     


 



6.
Hill DA, Wang SS, Cerhan JR, Davis S, Cozen W, Severson RK, Hartge P, Wacholder S, Yeager M, Chanock SJ, Rothman N (2006). Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood  108, 3161-7.   https://doi.org/10.1182/blood-2005-01-026690




PubMed



        
     
Free Article


 


PubMed ID 16857995
         Pubmed Central ID 1895525 


 



7.
Kelemen LE, Cerhan JR, Lim U, Davis S, Cozen W, Schenk M, Colt J, Hartge P, Ward MH (2006). Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study. Am J Clin Nutr  83, 1401-10.   https://doi.org/10.1093/ajcn/83.6.1401




PubMed


 


PubMed ID 16762953
    
     


 



8.
Morton LM, Bernstein L, Wang SS, Hein DW, Rothman N, Colt JS, Davis S, Cerhan JR, Severson RK, Welch R, Hartge P, Zahm SH (2007). Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis  28, 1759-64.   https://doi.org/10.1093/carcin/bgm121




PubMed



        
     
Free Article


 


PubMed ID 17522066
         Pubmed Central ID 2085367 


 



9.
Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, Severson RK, Chatterjee N, Yeager M, Chanock SJ, Rothman N (2006). Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res  66, 9771-80.   https://doi.org/10.1158/0008-5472.CAN-06-0324




PubMed


 


PubMed ID 17018637
    
     


 



10.
Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, Engels EA, Davis S, Severson RK, Rothman N, Chanock SJ, Hartge P (2007). Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res  67, 5042-54.   https://doi.org/10.1158/0008-5472.CAN-06-4752




PubMed


 


PubMed ID 17510437
    
     


 



11.
Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L, Boffetta P, Cerhan JR, Maynadie M, Spinelli JJ, Chiu BC, Cocco PL, Mensah F, Zhang Y, Nieters A, Dal Maso L, Bracci PM, Costantini AS, Vineis P, Severson RK, Roman E, Cozen W, Weisenburger D, Davis S, Franceschi S, et al. [7 more authors] (2007). Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood  109, 3479-88.   https://doi.org/10.1182/blood-2006-06-031948




PubMed



        
     
Free Article


 


PubMed ID 17185468
         Pubmed Central ID 1852242 


 



12.
Zahm SH, Morton LM, Bernstein L, Wang SS, Colt JS, Severson RK, Welch R, Hartge P (2008). Re: Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma, author response. Carcinogenesis  29, 1084-5.   https://doi.org/10.1093/carcin/bgn023




PubMed



        
     
Free Article


 


PubMed ID 18212328
         Pubmed Central ID 2741144",https://intramural.nih.gov/search/searchview.taf?ipid=45796
552,CP010175-07,"October 01, 2006 -  September 30, 2007",Molecular Targets - Colon Cancer,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Robert  Clifford



Daoud M Meerzaman",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45798
553,CP010176-07,"October 01, 2006 -  September 30, 2007",Epidemiology and Natural History of Cancer-Associated Viruses,"Robert  Biggar; MD

 


 

Eric Andrew Engels; PhD



IRP Faculty Profile
 




James Jerome Goedert; MD

 


 

Barry Ira Graubard; PhD



IRP Faculty Profile
 


 

Thomas R O'Brien; BA, MPH, MD



IRP Faculty Profile
 


 

Ruth  Pfeiffer; PhD



IRP Faculty Profile
 


 

Philip Samuel Rosenberg; PhD



IRP Faculty Profile
 


 

Sam  Mbulaiteye



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",Charles  Rabkin,"M  Eyster
(Pennsylvania State University)




Angelos  Hatzakis
(University of Athens Medical School)




Michael  Lederman; MD
(Case Western Reserve University)




Nino  Romano
(University of Palermo)




Cloe  Thio
(Dept of Medicine, Johns Hopkins University School of Medicine)




David  Thomas
(Johns Hopkins University)


Show all 7","Mary  Carrington; MS, PhD (National Cancer Institute)



Stephen J Chanock; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Camargo MC, Mera R, Correa P, Peek RM, Piazuelo MB, Sicinschi L, Schneider BG, Zabaleta J, Fontham ET, Goodman KJ, Ryckman KK   (2007) IL1B polymorphisms and gastric cancer risk.  Cancer Epidemiol Biomarkers Prev 16:635; author reply 635-6.




PubMed


 


PubMed ID 17372270
    
     


 



2.
Engels EA (2007). Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev  16, 401-4.   https://doi.org/10.1158/1055-9965.EPI-06-1056




PubMed


 


PubMed ID 17337646
    
     


 



3.
Engels EA, Mbulaiteye SM, Othieno E, Gomez M, Mathew S, Cesarman E, Knowles DM, Chadburn A (2007). Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda. Hum Pathol  38, 308-14.   https://doi.org/10.1016/j.humpath.2006.08.009




PubMed


 


PubMed ID 17097130
    
     


 



4.
Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA (2007). Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA  297, 2010-7.   https://doi.org/10.1001/jama.297.18.2010




PubMed


 


PubMed ID 17488966
    
     


 



5.
Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA, Vaughan TL, McColl KE, Lissowska J, Zatonski W, Schoenberg JB, Blot WJ, Mowat NA, Fraumeni JF, El-Omar EM (2007). A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology  132, 905-12.   https://doi.org/10.1053/j.gastro.2006.12.026




PubMed


 


PubMed ID 17324405
    
     


 



6.
Mbulaiteye SM, Engels EA (2006). Kaposi's sarcoma risk among transplant recipients in the United States (1993-2003). Int J Cancer  119, 2685-91.   https://doi.org/10.1002/ijc.22233




PubMed


 


PubMed ID 16929513
    
     


 



7.
Mbulaiteye SM, Sternberg LR, Nsubuga MM, Anver MR, Mehta M, Biryahwaho B, Kambugu F, Rabkin CS, Biggar RJ (2007). Absence of Y-chromosome sequences in tumors from African women with AIDS-related Kaposi sarcoma. Cancer Lett  248, 229-33.   https://doi.org/10.1016/j.canlet.2006.07.008




PubMed


 


PubMed ID 16934394
    
     


 



8.
Newton R, Ziegler JL, Casabonne D, Carpenter L, Gold BD, Owens M, Beral V, Mbidde E, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Uganda Kaposi''s Sarcoma Study Group (2006). Helicobacter pylori and cancer among adults in Uganda. Infect Agent Cancer  1, 5.   https://doi.org/10.1186/1750-9378-1-5




PubMed



        
     
Free Article


 


PubMed ID 17150134
         Pubmed Central ID 1660530 


 



9.
Nsubuga MM, Biggar RJ, Combs S, Marshall V, Mbisa G, Kambugu F, Mehta M, Biryahwaho B, Rabkin CS, Whitby D, Mbulaiteye SM (2008). Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions. Cancer Lett  263, 182-8.   https://doi.org/10.1016/j.canlet.2007.12.025




PubMed



        
     
Free Article


 


PubMed ID 18234418
         Pubmed Central ID 2440724",https://intramural.nih.gov/search/searchview.taf?ipid=45799
554,CP010177-07,"October 01, 2006 -  September 30, 2007",HPV Vaccine Trials,"Mark  Schiffman; MD



IRP Faculty Profile
 


 

Sholom  Wacholder; PhD



IRP Faculty Profile
 


 

Allan  Hildesheim; PhD



IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Ana Cecilia  Rodriguez



Mahboobeh  Safaeian



Mark E Sherman; MD



Philip E Castle; PhD, MPH



Roni T Falk



Sophia S Wang; PhD","Concepcion  Bratti
(Costa Rican Social Security)




Clayton  Harro
(Johns Hopkins School of Medicine)




Rolando  Herrero
(Instituto de InvestigaciÃ³n EpidemiolÃ³gica)




Ana  Rodriguez","Diane  Solomon; PhD (Breast and Gynecologic Cancer Research Group)



Douglas  Lowy; MD (Laboratory of Cellular Oncology)



Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)



John  Schiller; PhD (Laboratory of Cellular Oncology)",NULL,"Ordered by publication type and then author name.



1.
Herrero R, Hildesheim A, Rodríguez AC, Wacholder S, Bratti C, Solomon D, González P, Porras C, Jiménez S, Guillen D, Morales J, Alfaro M, Cyr J, Morrisey K, Estrada Y, Cortés B, Morera LA, Freer E, Schussler J, Schiller J, Lowy D, Schiffman M, Costa Rica Vaccine Trial (CVT) Group (2008). Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine  26, 4795-808.   https://doi.org/10.1016/j.vaccine.2008.07.002




PubMed



        
     
Free Article


 


PubMed ID 18640170
         Pubmed Central ID 2652516 


 



2.
Herrero R, Wacholder S, Rodríguez AC, Solomon D, González P, Kreimer AR, Porras C, Schussler J, Jiménez S, Sherman ME, Quint W, Schiller JT, Lowy DR, Schiffman M, Hildesheim A, Costa Rica Vaccine Trial Group (2011). Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. Cancer Discov  1, 408-19.   https://doi.org/10.1158/2159-8290.CD-11-0131




PubMed



        
     
Free Article


 


PubMed ID 22586631
         Pubmed Central ID 3354733 


 



3.
Hildesheim A, Wacholder S, Catteau G, Struyf F, Dubin G, Herrero R, CVT Group (2014). Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial. Vaccine  32, 5087-97.   https://doi.org/10.1016/j.vaccine.2014.06.038




PubMed



        
     
Free Article


 


PubMed ID 25018097
         Pubmed Central ID 4166498",https://intramural.nih.gov/search/searchview.taf?ipid=45800
555,CP010178-06,"October 01, 2006 -  September 30, 2007",Core Genotyping Facility,"Stephen J Chanock; MD, PhD



IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,NULL,"Amy  Hutchinson (National Cancer Institute)



Andrew  Crenshaw (National Cancer Institute)



Ashley E Jones (National Cancer Institute)



Belynda D Hicks (National Cancer Institute)



Brian  Staats (National Cancer Institute)



Calvin  Ott (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bergen AW, Baccarelli A, McDaniel TK, Kuhn K, Pfeiffer R, Kakol J, Bender P, Jacobs K, Packer B, Chanock SJ, Yeager M (2007). Cis sequence effects on gene expression. BMC Genomics  8, 296.   https://doi.org/10.1186/1471-2164-8-296




PubMed



        
     
Free Article


 


PubMed ID 17727713
         Pubmed Central ID 2077339",https://intramural.nih.gov/search/searchview.taf?ipid=45802
556,CP010180-06,"October 01, 2006 -  September 30, 2007",Prostate Cancer Studies,Ann  Hsing; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Sabah  Quraishi,"Richard  Biritwum
(Univ of Ghana Medical School)




Peter  Carroll
(UCSF)




Chawnshang  Chang
(University of Rochester)




Chu  Chen
(University of Washington)




Streamson  Chua
(Columbia University)




Angelo  DeMarzo
(Johns Hopkins U)


Show all 15","Lisa Wey-Lan Chu (Office of Preventive Oncology)



Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)



Gabriella  Andreotti (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, Lippman SM, Platz EA, Pollak MN, Thompson IM, Kristal AR (2006). Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev  15, 1977-83.   https://doi.org/10.1158/1055-9965.EPI-06-0477




PubMed


 


PubMed ID 17035408",https://intramural.nih.gov/search/searchview.taf?ipid=45818
557,CP010181-05,"October 01, 2006 -  September 30, 2007",Methods for Epidemiology Studies,"Thomas  Fears; PhD

 


 

Mitchell Henry Gail; PhD, MD



IRP Faculty Profile
 


 

Barry Ira Graubard; PhD



IRP Faculty Profile
 




Jay  Lubin; PhD

 


 

Ruth  Pfeiffer; PhD



IRP Faculty Profile
 


 

Philip Samuel Rosenberg; PhD



IRP Faculty Profile
 


 

Sholom  Wacholder; PhD



IRP Faculty Profile
 




Nilanjan  Chatterjee",NULL,"Biostatistics Branch, NCI","Hormuzdiar Aspandiar Katki; MS



Junmo  Nam



Gloria L Gridley","Jacques  Benichou
(University of Rouen Medical School)




Efstathia  Bura
(The George Washington University, Washington, DC)




Celia  Byrne
(George Washington University)




Raymond  Carroll
(Texas A&M University)




Sarah  Daugherty
(Occupational and Environmental Epidemiology Branch, DCEG, NCI)




Laure  El Ghormli
(GW Biostat)


Show all 15","Edward L Korn (Clinical Trials Section)



Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)



Mark H Greene; MD (Clinical Genetics Branch)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Alguacil J, Pfeiffer RM, Moore LE, Del Fresno MR, Medina-Lopez R, Kogevinas M, Vermeulen R, Dosemeci M, Silverman DT, Rothman N, García-Closas M (2007). Measurement of urine pH for epidemiological studies on bladder cancer. Eur J Epidemiol  22, 91-8.   https://doi.org/10.1007/s10654-006-9101-2




PubMed


 


PubMed ID 17334820
    
     


 



2.
Chatterjee N, Kalaylioglu Z, Moslehi R, Peters U, Wacholder S (2006). Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions. Am J Hum Genet  79, 1002-16.   https://doi.org/10.1086/509704




PubMed



        
     
Free Article


 


PubMed ID 17186459
         Pubmed Central ID 1698705 


 



3.
Chen J, Chatterjee N (2007). Exploiting Hardy-Weinberg equilibrium for efficient screening of single SNP associations from case-control studies. Hum Hered  63, 196-204.   https://doi.org/10.1159/000099996




PubMed


 


PubMed ID 17317968
    
     


 



4.
Graubard BI, Flegal KM, Williamson DF, Gail MH (2007). Estimation of attributable number of deaths and standard errors from simple and complex sampled cohorts. Stat Med  26, 2639-49.   https://doi.org/10.1002/sim.2734




PubMed


 


PubMed ID 17117403
    
     


 



5.
Katki HA (2007). Incorporating medical interventions into carrier probability estimation for genetic counseling. BMC Med Genet  8, 13.   https://doi.org/10.1186/1471-2350-8-13




PubMed



        
     
Free Article


 


PubMed ID 17378937
         Pubmed Central ID 1847675 


 



6.
Lubin JH, Alavanja MC, Caporaso N, Brown LM, Brownson RC, Field RW, Garcia-Closas M, Hartge P, Hauptmann M, Hayes RB, Kleinerman R, Kogevinas M, Krewski D, Langholz B, Létourneau EG, Lynch CF, Malats N, Sandler DP, Schaffrath-Rosario A, Schoenberg JB, Silverman DT, Wang Z, Wichmann HE, Wilcox HB, Zielinski JM (2007). Cigarette smoking and cancer risk: modeling total exposure and intensity. Am J Epidemiol  166, 479-89.   https://doi.org/10.1093/aje/kwm089




PubMed


 


PubMed ID 17548786
    
     


 



7.
Lubin JH, Caporaso N, Hatsukami DK, Joseph AM, Hecht SS (2007). The association of a tobacco-specific biomarker and cigarette consumption and its dependence on host characteristics. Cancer Epidemiol Biomarkers Prev  16, 1852-7.   https://doi.org/10.1158/1055-9965.EPI-07-0018




PubMed


 


PubMed ID 17855705
    
     


 



8.
Lubin JH, Caporaso N, Wichmann HE, Schaffrath-Rosario A, Alavanja MC (2007). Cigarette smoking and lung cancer: modeling effect modification of total exposure and intensity. Epidemiology  18, 639-48.   https://doi.org/10.1097/EDE.0b013e31812717fe




PubMed


 


PubMed ID 17700253
    
     


 



9.
Lubin JH, Kogevinas M, Silverman D, Malats N, Garcia-Closas M, Tardón A, Hein DW, Garcia-Closas R, Serra C, Dosemeci M, Carrato A, Rothman N (2007). Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study. Int J Epidemiol  36, 236-41.   https://doi.org/10.1093/ije/dym043




PubMed


 


PubMed ID 17510079
    
     


 



10.
Wacholder S (2007). Untangling differences in cancer mortality rates: a closer look at race and education. J Natl Cancer Inst  99, 1356-7.   https://doi.org/10.1093/jnci/djm154




PubMed


 


PubMed ID 17848665
    
     


 



11.
Wacholder S, Loukissas JK, Hartge P (2007). Studies of genes and cancer survival: pieces of the puzzle. J Natl Cancer Inst  99, 908-9.   https://doi.org/10.1093/jnci/djm013




PubMed


 


PubMed ID 17565150",https://intramural.nih.gov/search/searchview.taf?ipid=45758
558,CP010182-05,"October 01, 2006 -  September 30, 2007",Epidemiologic Field Studies,"Nilanjan  Chatterjee

 


 

Barry Ira Graubard; PhD



IRP Faculty Profile
 




Jay  Lubin; PhD

 


 

Ruth  Pfeiffer; PhD



IRP Faculty Profile
 


 

Sholom  Wacholder; PhD



IRP Faculty Profile
 


 

Mitchell Henry Gail; PhD, MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI","Catherine G Schairer



Linda M Brown; MPH, DPhil



Philip Samuel Rosenberg; PhD



Hormuzdiar Aspandiar Katki; MS



Gloria L Gridley","Farhat  Ayed
(Institute Salah Azaiz, Tunis)




Joe  Ayotte
(US Geological Survey)




Tetyana  Bogdanova
(Institute of Endocrinology & Metabolism)




John  Boice
(International Epidemiology Institute)




Raymond  Carroll
(Texas A&M University)




Richard  Cartun
(Department of Pathology, hartford Hospital)


Show all 65","Alina V Brenner (Radiation Epidemiology Branch)



Andre  Bouville (Radiation Epidemiology Branch)



Arthur  Schatzkin; PhD (Nutritional Epidemiology Branch)



Claudine M Samanic (Occupational and Environmental Epidemiology Branch)



Dalsu  Baris (Occupational and Environmental Epidemiology Branch)



Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Lubin JH, Beane Freeman LE, Cantor KP (2007). Inorganic arsenic in drinking water: an evolving public health concern. J Natl Cancer Inst  99, 906-7.   https://doi.org/10.1093/jnci/djm012




PubMed


 


PubMed ID 17565151
    
     


 



2.
Zhang L, Gail MH, Wang YQ, Brown LM, Pan KF, Ma JL, Amagase H, You WC, Moslehi R (2006). A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins. Am J Clin Nutr  84, 912-9.   https://doi.org/10.1093/ajcn/84.4.912




PubMed


 


PubMed ID 17023720",https://intramural.nih.gov/search/searchview.taf?ipid=45805
559,CP010183-05,"October 01, 2006 -  September 30, 2007",Descriptive Studies and Record Linkage,William Frederick Anderson,NULL,"Biostatistics Branch, NCI","Catherine G Schairer



Gloria L Gridley



Jay  Lubin; PhD



Linda M Brown; MPH, DPhil



Mitchell Henry Gail; PhD, MD



Nilanjan  Chatterjee



Show all 9","Hans-Olov  Adami
(Karolinska Institute)




Johanna  Adami
(Karolinska Institute)




Johan  Askling
(Karolinska Institute)




Alicja  Bardin-Mikolajczak
(Dept. of Cancer Epi & Preven. Warsaw)




Paolo  Boffetta
(International Agency for Research on Cancer)




Paige  Bracci
(UCSF)


Show all 74","Allan  Hildesheim; PhD (Hormonal and Reproductive Epidemiology Branch)



Ann  Hsing; PhD (Hormonal and Reproductive Epidemiology Branch)



Asad  Umar (Gastrointestinal and Other Cancer Research Group)



Charles  Rabkin (Infection & Immunoepidemiology Branch)



Claudine M Samanic (Occupational and Environmental Epidemiology Branch)



Dalsu  Baris (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Anderson WF, Jatoi I, Devesa SS (2006). Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002). Breast Cancer Res Treat  99, 333-40.   https://doi.org/10.1007/s10549-006-9214-z




PubMed


 


PubMed ID 16703451
    
     


 



2.
Boukheris H, Curtis RE, Land CE, Dores GM (2009). Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev  18, 2899-906.   https://doi.org/10.1158/1055-9965.EPI-09-0638




PubMed



        
     
Free Article


 


PubMed ID 19861510
         Pubmed Central ID 2779732 


 



3.
Dores GM, Curtis RE, Toro JR, Devesa SS, Fraumeni JF (2008). Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome. Cancer  113, 3372-81.   https://doi.org/10.1002/cncr.23963




PubMed



        
     
Free Article


 


PubMed ID 18932259
         Pubmed Central ID 2613970 


 



4.
Dores GM, Huycke MM, Devesa SS, Garcia CA (2010). Primary cutaneous adenoid cystic carcinoma in the United States: incidence, survival, and associated cancers, 1976 to 2005. J Am Acad Dermatol  63, 71-8.   https://doi.org/10.1016/j.jaad.2009.07.027




PubMed



        
     
Free Article


 


PubMed ID 20447723
         Pubmed Central ID 2885489 


 



5.
Dores GM, Landgren O, McGlynn KA, Curtis RE, Linet MS, Devesa SS (2009). Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol  144, 86-94.   https://doi.org/10.1111/j.1365-2141.2008.07421.x




PubMed



        
     
Free Article


 


PubMed ID 19016727
         Pubmed Central ID 2610331 


 



6.
Edgren G, Hjalgrim H, Reilly M, Tran TN, Rostgaard K, Shanwell A, Titlestad K, Adami J, Wikman A, Jersild C, Gridley G, Wideroff L, NyrÃ©n O, Melbye M (2007) Risk of cancer after blood transfusion from donors with subclinical cancer. Lancet 369:1724-30




 



7.
Malope BI, Pfeiffer RM, Mbisa G, Stein L, Ratshikhopha EM, O'Connell DL, Sitas F, MacPhail P, Whitby D (2007). Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population. J Acquir Immune Defic Syndr  44, 351-5.   https://doi.org/10.1097/QAI.0b013e31802f12ea




PubMed


 


PubMed ID 17195763
    
     


 



8.
Matsuno RK, Anderson WF, Yamamoto S, Tsukuma H, Pfeiffer RM, Kobayashi K, Devesa SS, Levine PH (2007). Early- and late-onset breast cancer types among women in the United States and Japan. Cancer Epidemiol Biomarkers Prev  16, 1437-42.   https://doi.org/10.1158/1055-9965.EPI-07-0108




PubMed


 


PubMed ID 17627009
    
     


 



9.
Purdue MP, Freeman LE, Anderson WF, Tucker MA (2008). Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol  128, 2905-8.   https://doi.org/10.1038/jid.2008.159




PubMed



        
     
Free Article


 


PubMed ID 18615112
         Pubmed Central ID 2741632 


 



10.
Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA (2007). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol  5, 1221-8.   https://doi.org/10.1016/j.cgh.2007.05.020




PubMed



        
     
Free Article


 


PubMed ID 17689296
         Pubmed Central ID 2083573 


 



11.
Yu K, Martin R, Rothman N, Zheng T, Lan Q (2007). Two-sample comparison based on prediction error, with applications to candidate gene association studies. Ann Hum Genet  71, 107-18.   https://doi.org/10.1111/j.1469-1809.2006.00306.x




PubMed


 


PubMed ID 17227481",https://intramural.nih.gov/search/searchview.taf?ipid=45757
560,CP010184-05,"October 01, 2006 -  September 30, 2007",Consultation and Collaboration,"Barry Ira Graubard; PhD



IRP Faculty Profile
 


 

Sholom  Wacholder; PhD



IRP Faculty Profile
 




Jay  Lubin; PhD",NULL,"Biostatistics Branch, NCI","Gloria L Gridley



Junmo  Nam



Linda M Brown; MPH, DPhil



Mitchell Henry Gail; PhD, MD



Nilanjan  Chatterjee



Ruth  Pfeiffer; PhD","Paul  Bakaki
(Makerere University Medical School and Mulago Hospital, Kampala, Uganda)




A.  Barrett
(National Heart, Lung, and Blood Institute)




Eleuterio  Bravo-Otero
(University of Puerto Rico)




David  Brenner
(Columbia University)




Robert  Burk
(Albert Einstein College of Medicine)




Julianne  Byrne
(Washington Children's hospital)


Show all 82","Alice  Sigurdson; PhD (Radiation Epidemiology Branch)



Allan  Hildesheim; PhD (Hormonal and Reproductive Epidemiology Branch)



Ann  Hsing; PhD (Hormonal and Reproductive Epidemiology Branch)



Bu Tian  Ji (Occupational and Environmental Epidemiology Branch)



Charles E. Land; PhD (Radiation Epidemiology Branch)



Claudine M Samanic (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Colbert LH, Graubard BI, Michels KB, Willett WC, Forman MR (2008). Physical activity during pregnancy and age at menarche of the daughter. Cancer Epidemiol Biomarkers Prev  17, 2656-62.   https://doi.org/10.1158/1055-9965.EPI-08-0194




PubMed



        
     
Free Article


 


PubMed ID 18843007
         Pubmed Central ID 2752965 


 



2.
Kwon D, Vannucci M, Song JJ, Jeong J, Pfeiffer RM (2008). A novel wavelet-based thresholding method for the pre-processing of mass spectrometry data that accounts for heterogeneous noise. Proteomics  8, 3019-29.   https://doi.org/10.1002/pmic.200701010




PubMed



        
     
Free Article


 


PubMed ID 18615428
         Pubmed Central ID 2855839 


 



3.
Lubin JH, Cook MB, Pandeya N, Vaughan TL, Abnet CC, Giffen C, Webb PM, Murray LJ, Casson AG, Risch HA, Ye W, Kamangar F, Bernstein L, Sharp L, Nyrén O, Gammon MD, Corley DA, Wu AH, Brown LM, Chow WH, Ward MH, Freedman ND, Whiteman DC (2012). The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol  36, 306-16.   https://doi.org/10.1016/j.canep.2012.03.001




PubMed



        
     
Free Article


 


PubMed ID 22504051
         Pubmed Central ID 3489030",https://intramural.nih.gov/search/searchview.taf?ipid=45807
561,CP010185-05,"October 01, 2006 -  September 30, 2007",Bioterrorism Studies,"Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Alice  Sigurdson; PhD



Andre  Bouville



Charles E. Land; PhD



Elaine  Ron; PhD



Maureen Cusack Hatch; MD



Nickolas  Luckyanov



Show all 11","Harold  Beck
(DOE Environmental Measurements Laboratory (retired))




Victor  Kryuchkov
(Institute of Biophysics)




Dunstana Rabelo Melo





Brian  Moroz





Sergey  Shinkarev
(Moscow Institute of Biophysics)




Sergey  Sholom
(URPI)


Show all 8",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=45806
562,CP010187-03,"October 01, 2006 -  September 30, 2007",CGEMS,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Hunter DJ, Thomas G, Hoover RN, Chanock SJ (2007). Scanning the horizon: what is the future of genome-wide association studies in accelerating discoveries in cancer etiology and prevention? Cancer Causes Control  18, 479-84.   https://doi.org/10.1007/s10552-007-0118-y




PubMed


 


PubMed ID 17440825",https://intramural.nih.gov/search/searchview.taf?ipid=45816
563,CP010188-03,"October 01, 2006 -  September 30, 2007",Risk prediction methods,"Thomas  Fears; PhD

 




Patricia  Hartge; ScD

 




James V Lacey; MPH, PhD

 


 

Ruth  Pfeiffer; PhD



IRP Faculty Profile
 


 

Mitchell Henry Gail; PhD, MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Catherine G Schairer,NULL,"Andrew  Freedman (Risk Factor Monitoring and Methods Branch)



Demetrius  Albanes; MD (Office of the Director)



Kathleen A Cronin (Statistical Research and Applications Branch)",NULL,"Ordered by publication type and then author name.



1.
Gail MH (2008). Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst  100, 1037-41.   https://doi.org/10.1093/jnci/djn180




PubMed



        
     
Free Article


 


PubMed ID 18612136
         Pubmed Central ID 2528005",https://intramural.nih.gov/search/searchview.taf?ipid=45809
564,CP010190-02,"October 01, 2006 -  September 30, 2007",Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,"Mark H Greene; MD



IRP Faculty Profile
 




Richard  Hayes; PhD

 


 

Sharon Ann Savage



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI",NULL,"Richard  Cawthon
(University of Utah)




Immaculata  DeVivo
(Harvard Medical School)




David  Hunter
(Harvard School of Public Health)",NULL,NULL,"Ordered by publication type and then author name.



1.
Alter BP, Baerlocher GM, Savage SA, Chanock SJ, Weksler BB, Willner JP, Peters JA, Giri N, Lansdorp PM (2007) Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 110:1439-1447",https://intramural.nih.gov/search/searchview.taf?ipid=45819
565,CP010193-01,"October 01, 2006 -  September 30, 2007",Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer Cohort Con,"Stephen J Chanock; MD, PhD



IRP Faculty Profile
 




Patricia  Hartge; ScD

 


 

Robert  Hoover; MD, ScD



IRP Faculty Profile
 


 

Rachael Zoe Solomon



IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI",NULL,"Alan  Arslan
(NYU)




H  Bueno-de-Mesquita
(Dept of Chronic Dis Epidemiology, Natl Inst for Pub Health and the Environ)




Charles  Fuchs
(Harvard)




Myron  Gross
(University of Minnesota)




Kathy  Helzlsouer; MD
(Epidemiology, Johns Hopkins University)




Eric  Jacobs
(American Cancer Society)


Show all 8","Geoffrey Scott Tobias (Human Genetics Program)



Kai  Yu (Biostatistics Branch)



Robert  Welch (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Canzian F, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman PJ, Jacobs EJ, Kamineni A, Klein AP, Kolonel LN, Kulke MH, Li D, Malats N, Olson SH, Risch HA, et al. [92 more authors] (2014). Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet  46, 994-1000.   https://doi.org/10.1038/ng.3052




PubMed



        
     
Free Article


 


PubMed ID 25086665
         Pubmed Central ID 4191666",https://intramural.nih.gov/search/searchview.taf?ipid=50333
566,CP010194-01,"October 01, 2006 -  September 30, 2007",Diet and Cancer in India,"Rashmi P Sinha; PhD



IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Rastogi T   (2007) Gene polymorphisms in the 1-carbon metabolic pathway in Asian Indians.  International Journal of Epidemiology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50334
567,CP010195-01,"October 01, 2006 -  September 30, 2007",Studies of Alpha-tocopherol and Beta-Carotene in Finland,"Demetrius  Albanes; MD



IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,NULL,"Amanda  Cross (Nutritional Epidemiology Branch)



Ann  Hsing; PhD (Hormonal and Reproductive Epidemiology Branch)



Jennifer A Rusiecki (Occupational and Environmental Epidemiology Branch)



Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)



Michael Fred Leitzmann (Nutritional Epidemiology Branch)



Rachael Zoe Solomon (Nutritional Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Ahn J, Weinstein SJ, Snyder K, Pollak MN, Virtamo J, Albanes D (2006). No association between serum insulin-like growth factor (IGF)-I, IGF-binding protein-3, and lung cancer risk. Cancer Epidemiol Biomarkers Prev  15, 2010-2.   https://doi.org/10.1158/1055-9965.EPI-06-0580




PubMed


 


PubMed ID 17035415
    
     


 



2.
Bobe G, Taylor P, Solomon R, Weinstein S   (2007) Flavonoid Intake and the Risk of Pancreatic Cancer in Male Smokers (Finland).  American Journal of Epidemiology, in press.




 



3.
Bowers K, Albanes D, Limburg P, Pietinen P, Taylor PR, Virtamo J, Stolzenberg-Solomon R (2006). A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol  164, 652-64.   https://doi.org/10.1093/aje/kwj253




PubMed


 


PubMed ID 16877536
    
     


 



4.
Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, Abnet CC, Albanes D, Virtamo J, Taylor PR (2006). Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst  98, 1445-52.   https://doi.org/10.1093/jnci/djj393




PubMed


 


PubMed ID 17047193
    
     


 



5.
Lönn S, Inskip PD, Pollak MN, Weinstein SJ, Virtamo J, Albanes D (2007). Glioma risk in relation to serum levels of insulin-like growth factors. Cancer Epidemiol Biomarkers Prev  16, 844-6.   https://doi.org/10.1158/1055-9965.EPI-06-1010




PubMed


 


PubMed ID 17416782
    
     


 



6.
Mitrou PN, Albanes D, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, Leitzmann MF (2007). A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland). Int J Cancer  120, 2466-73.   https://doi.org/10.1002/ijc.22553




PubMed


 


PubMed ID 17278090
    
     


 



7.
Moore SC, Leitzmann MF, Weinstein SJ, Snyder K, Albanes D, Virtamo J, Graubard BI, Mayne ST, Yu H, Peters U, Gunter MJ (2007). Insulin resistance-related gene polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev  16, 1315-7.   https://doi.org/10.1158/1055-9965.EPI-07-0191




PubMed


 


PubMed ID 17548707
    
     


 



8.
Sequoia JS, Wright ME, McCarron P, Pietinen P, Taylor PR, Virtamo J, Albanes D (2006). A prospective investigation of height and prostate cancer risk. Cancer Epidemiol Biomarkers Prev  15, 2174-8.   https://doi.org/10.1158/1055-9965.EPI-06-0467




PubMed


 


PubMed ID 17119043
    
     


 



9.
Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J, Albanes D (2006). A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res  66, 10213-9.   https://doi.org/10.1158/0008-5472.CAN-06-1876




PubMed


 


PubMed ID 17047087
    
     


 



10.
Weinstein SJ, Stolzenberg-Solomon R, Pietinen P, Taylor PR, Virtamo J, Albanes D (2006). Dietary factors of one-carbon metabolism and prostate cancer risk. Am J Clin Nutr  84, 929-35.   https://doi.org/10.1093/ajcn/84.4.929




PubMed


 


PubMed ID 17023722
    
     


 



11.
Weinstein SJ, Wright ME, Lawson KA, Snyder K, Männistö S, Taylor PR, Virtamo J, Albanes D (2007). Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev  16, 1253-9.   https://doi.org/10.1158/1055-9965.EPI-06-1084




PubMed


 


PubMed ID 17548693
    
     


 



12.
Wright ME, Lawson KA, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, Albanes D (2006). Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr  84, 1200-7.   https://doi.org/10.1093/ajcn/84.5.1200




PubMed


 


PubMed ID 17093175
    
     


 



13.
Wright ME, Virtamo J, Hartman AM, Pietinen P, Edwards BK, Taylor PR, Huttunen JK, Albanes D (2007). Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial. Cancer  109, 891-8.   https://doi.org/10.1002/cncr.22482




PubMed


 


PubMed ID 17265529",https://intramural.nih.gov/search/searchview.taf?ipid=50335
568,CP010196-01,"October 01, 2006 -  September 30, 2007",Prospective Studies of Diet and Cancer in the AARP Cohort,Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI","Michael Fred Leitzmann



Yikyung  Park",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Adams KF, Leitzmann MF, Albanes D, Kipnis V, Mouw T, Hollenbeck A, Schatzkin A (2007). Body mass and colorectal cancer risk in the NIH-AARP cohort. Am J Epidemiol  166, 36-45.   https://doi.org/10.1093/aje/kwm049




PubMed


 


PubMed ID 17449892
    
     


 



2.
Calton BA, Chang SC, Wright ME, Kipnis V, Lawson K, Thompson FE, Subar AF, Mouw T, Campbell DS, Hurwitz P, Hollenbeck A, Schatzkin A, Leitzmann MF (2007). History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control  18, 493-503.   https://doi.org/10.1007/s10552-007-0126-y




PubMed


 


PubMed ID 17450441
    
     


 



3.
Chang SC, Lacey JV, Brinton LA, Hartge P, Adams K, Mouw T, Carroll L, Hollenbeck A, Schatzkin A, Leitzmann MF (2007). Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev  16, 723-30.   https://doi.org/10.1158/1055-9965.EPI-06-0675




PubMed


 


PubMed ID 17416763
    
     


 



4.
Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, Schatzkin A (2007). A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol  165, 1424-33.   https://doi.org/10.1093/aje/kwm051




PubMed


 


PubMed ID 17420181
    
     


 



5.
Howard RA, Freedman DM, Park Y, Hollenbeck A, Schatzkin A, Leitzmann MF (2008). Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH-AARP Diet and Health Study. Cancer Causes Control  19, 939-53.   https://doi.org/10.1007/s10552-008-9159-0




PubMed



        
     
Free Article


 


PubMed ID 18437512
         Pubmed Central ID 2574900 


 



6.
Lawson KA, Wright ME, Subar A, Mouw T, Hollenbeck A, Schatzkin A, Leitzmann MF (2007). Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst  99, 754-64.   https://doi.org/10.1093/jnci/djk177




PubMed


 


PubMed ID 17505071
    
     


 



7.
Park Y, Subar AF, Kipnis V, Thompson FE, Mouw T, Hollenbeck A, Leitzmann MF, Schatzkin A (2007). Fruit and vegetable intakes and risk of colorectal cancer in the NIH-AARP diet and health study. Am J Epidemiol  166, 170-80.   https://doi.org/10.1093/aje/kwm067




PubMed


 


PubMed ID 17485731
    
     


 



8.
Schatzkin A, Mouw T, Park Y, Subar AF, Kipnis V, Hollenbeck A, Leitzmann MF, Thompson FE (2007). Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr  85, 1353-60.   https://doi.org/10.1093/ajcn/85.5.1353




PubMed


 


PubMed ID 17490973
    
     


 



9.
Thiébaut AC, Schatzkin A, Ballard-Barbash R, Kipnis V (2006). Dietary fat and breast cancer: contributions from a survival trial. J Natl Cancer Inst  98, 1753-5.   https://doi.org/10.1093/jnci/djj504




PubMed


 


PubMed ID 17179470
    
     


 



10.
Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T, Hurwitz P, Hollenbeck A, Leitzmann MF (2007). Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer  109, 675-84.   https://doi.org/10.1002/cncr.22443




PubMed


 


PubMed ID 17211863
    
     


 



11.
Wright ME, Weinstein SJ, Lawson KA, Albanes D, Subar AF, Dixon LB, Mouw T, Schatzkin A, Leitzmann MF (2007). Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev  16, 1128-35.   https://doi.org/10.1158/1055-9965.EPI-06-1071




PubMed


 


PubMed ID 17548674",https://intramural.nih.gov/search/searchview.taf?ipid=53674
569,CP010197-01,"October 01, 2006 -  September 30, 2007","Physical Activity, Energy Balance, and Cancer","Demetrius  Albanes; MD



IRP Faculty Profile
 




Wong H Chow

 




Arthur  Schatzkin; PhD

 


 

Sholom  Wacholder; PhD



IRP Faculty Profile
 




Michael Fred Leitzmann",NULL,"Nutritional Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Leitzmann MF, Flood A, Ferrucci LM, Schoenfeld P, Cash B, Schatzkin A, Cross AJ (2009). Adiposity in relation to colorectal adenomas and hyperplastic polyps in women. Cancer Causes Control  20, 1497-507.   https://doi.org/10.1007/s10552-009-9346-7




PubMed



        
     
Free Article


 


PubMed ID 19387851
         Pubmed Central ID 3170996",https://intramural.nih.gov/search/searchview.taf?ipid=50353
570,CP010198-01,"October 01, 2006 -  September 30, 2007",Lower Gastrointestinal Cancer Studies,Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI","Amanda  Cross



Unhee  Lim","Andrew P Flood





Philip  Schoenfeld
(University of Michigan School of Medicine)",Elaine L Lanza (Laboratory of Cancer Prevention),NULL,"Ordered by publication type and then author name.



1.
Stolzenberg-Solomon R, Sinha R   (2007) Evaluation of integrative biochemical and molecular biomarkers of one-carbon nutrients in healthy subjects.  Cancer Epidemiology Biomarkers and Prevention, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50354
571,CP010199-01,"October 01, 2006 -  September 30, 2007",Methods for Etiologic Studies of Diet and Cancer,Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI","Amanda  Cross



Michael Fred Leitzmann



Rashmi P Sinha; PhD",NULL,"Amy F Subar (Risk Factor Monitoring and Methods Branch)



Douglas N Midthune (Biometry Research Group)



Frances E Thompson (Risk Factor Monitoring and Methods Branch)



Richard P Troiano (Risk Factor Monitoring and Methods Branch)



Victor  Kipnis (Biometry Research Group)",NULL,"Ordered by publication type and then author name.



1.
Cross A   (2007) Impact of food preservation, processing and cooking on cancer risk?  CRC Press, in press.




 



2.
Schatzkin A   (2007) Alcohol and bladder cancer.  JNCI, in press.




 



3.
Schatzkin A   (2007) Can Nutritional Change Prevent Cancer?  Cancer Prevention Newsletter, in press.




 



4.
Schatzkin A   (2007) When Mendelian randomization isn't.  LANCET, in press.




 



5.
Schatzkin A (2007). Can biomarkers help us understand the nutritional and lifestyle factors important in cancer prognosis? J Nutr  137, 249S-252S.   https://doi.org/10.1093/jn/137.1.249S




PubMed


 


PubMed ID 17182835",https://intramural.nih.gov/search/searchview.taf?ipid=50355
572,SC000165-16,"October 01, 2006 -  September 30, 2007",The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis,Michael  Birrer,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Laurent L Ozbun



Stephen  Yang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47018
573,SC000167-16,"October 01, 2006 -  September 30, 2007",Molecular Pathology of Pulmonary Carcinogenesis,Ilona  Linnoila; MD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Xiaoyang  Wang



Sandra  Jensen-Taubman



Heungnam  Kim



Shobana  Gopalswamy","Francesco  DeMayo
(Baylor College of Medicine)




Leighton  Grimes
(Cincinnati Children's Hospital Medical Center)




Enid  Neptune
(Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine)","Neil Edward Caporaso; MS, MD (National Cancer Institute)



Jin  Jen (National Cancer Institute)



Jeffrey E Green; MD (National Cancer Institute)



Phillip A Dennis; MD, PhD (National Cancer Institute)



Maria Teresa Pia Landi; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff MJ, Kavanaugh C, Li MC, Demayo FJ, Linnoila I, Deng CX, Lee EY, Medina D, Shih JH, Green JE (2007). Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. Cancer Res  67, 8065-80.   https://doi.org/10.1158/0008-5472.CAN-07-1515




PubMed


 


PubMed ID 17804718
    
     


 



2.
Granville CA, Warfel N, Tsurutani J, Hollander MC, Robertson M, Fox SD, Veenstra TD, Issaq HJ, Linnoila RI, Dennis PA (2007). Identification of a highly effective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumors. Clin Cancer Res  13, 2281-9.   https://doi.org/10.1158/1078-0432.CCR-06-2570




PubMed


 


PubMed ID 17404113
    
     


 



3.
Linnoila RI, Jensen-Taubman S, Kazanjian A, Grimes HL (2007). Loss of GFI1 impairs pulmonary neuroendorine cell proliferation, but the neuroendocrine phenotype has limited impact on post-naphthalene airway repair. Lab Invest  87, 336-44.   https://doi.org/10.1038/labinvest.3700527




PubMed



        
     
Free Article


 


PubMed ID 17377622
         Pubmed Central ID 2839158 


 



4.
Wang XY, Dakir el H, Naizhen X, Jensen-Taubman SM, DeMayo FJ, Linnoila RI (2007). Achaete-scute homolog-1 linked to remodeling and preneoplasia of pulmonary epithelium. Lab Invest  87, 527-39.   https://doi.org/10.1038/labinvest.3700552




PubMed


 


PubMed ID 17507989",https://intramural.nih.gov/search/searchview.taf?ipid=47019
574,SC000181-15,"October 01, 2006 -  September 30, 2007",The Molecular Genetics of Gynecologic Cancers,Michael  Birrer,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Laurent L Ozbun



Tomas A Bonome



Stephen  Yang","Denise  Connelly
(Ovarian SPORE, FOX Chase Cancer Center)




Samuel  Mok
(Gynecologic Oncology, Harvard University)




Anil  Sood
(Gynecologic Oncology, MDACC)",NULL,NULL,"Ordered by publication type and then author name.



1.
Birrer M, Bonome T, Lu C, Sood A (submitted in 2007) Pro-angiogenic Genes In Ovarian Tumor Endothelial Cell Isolates. Patent issued: 8,440,393 (US in 2013). Patent pending: 13/863,219 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=47020
575,SC000550-27,"October 01, 2006 -  September 30, 2007",Lymphoma Disease Discovery and Defintion,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Mark  Raffeld; MD



Stefania  Pittaluga","Elias  Campo
(University of Barcelona)




Wing  Chan
(Pathology, University of Nebraska)




Andreas  Chott
(Pathology, University of Vienna)




Falko  Fend





Leticia  Quintanilla-Martinez
(Pathology, Technical University of Munich)




Berthold  Streubel
(Pathology, University of Vienna)","Louis  Staudt; MD (Lymphoid Malignancies Branch)



Wyndham H Wilson; MD, PhD (National Cancer Institute)



Jonathan Keith Killian (National Cancer Institute)



Paul S Meltzer; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cuadros M, Dave SS, Jaffe ES, Honrado E, Milne R, Alves J, Rodríguez J, Zajac M, Benitez J, Staudt LM, Martinez-Delgado B (2007). Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol  25, 3321-9.   https://doi.org/10.1200/JCO.2006.09.4474




PubMed


 


PubMed ID 17577022
    
     


 



2.
Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD, Chan WC, Delabie J, Braziel RM, Campo E, Gascoyne RD, Jaffe ES, Muller-Hermelink K, Ott G, Calaminici M, Norton AJ, Goff LK, Fitzgibbon J, Staudt LM, Andrew Lister T (2007). Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol  136, 286-93.   https://doi.org/10.1111/j.1365-2141.2006.06439.x




PubMed



        
     
Free Article


 


PubMed ID 17278262
         Pubmed Central ID 2532951 


 



3.
Dunleavy K, Wilson WH, Jaffe ES (2007). Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications. Curr Opin Hematol  14, 348-53.   https://doi.org/10.1097/MOH.0b013e328186ffbf




PubMed


 


PubMed ID 17534160
    
     


 



4.
Hisada M, Chen BE, Jaffe ES, Travis LB (2007). Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. J Natl Cancer Inst  99, 215-22.   https://doi.org/10.1093/jnci/djk030




PubMed


 


PubMed ID 17284716
    
     


 



5.
Iqbal J, Greiner TC, Patel K, Dave BJ, Smith L, Ji J, Wright G, Sanger WG, Pickering DL, Jain S, Horsman DE, Shen Y, Fu K, Weisenburger DD, Hans CP, Campo E, Gascoyne RD, Rosenwald A, Jaffe ES, Delabie J, Rimsza L, Ott G, Müller-Hermelink HK, Connors JM, Vose JM, Leukemia/Lymphoma Molecular Profiling Project, et al. [3 more authors] (2007). Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia  21, 2332-43.   https://doi.org/10.1038/sj.leu.2404856




PubMed



        
     
Free Article


 


PubMed ID 17625604
         Pubmed Central ID 2366166 


 



6.
Kimm LR, deLeeuw RJ, Savage KJ, Rosenwald A, Campo E, Delabie J, Ott G, Muller-Hermelink HK, Jaffe ES, Rimsza LM, Weisenburger DD, Chan WC, Staudt LM, Connors JM, Gascoyne RD, Lam WL (2007). Frequent occurrence of deletions in primary mediastinal B-cell lymphoma. Genes Chromosomes Cancer  46, 1090-7.   https://doi.org/10.1002/gcc.20495




PubMed


 


PubMed ID 17823928
    
     


 



7.
Kurup SK, Levy-Clarke G, Calvo KR, Jaffe ES, Nussenblatt RB, Chan CC (2007). Primary diffuse large B-cell lymphoma of the spleen with coincident serous retinal detachments responsive to corticosteroids. Clin Exp Ophthalmol  35, 468-72.   https://doi.org/10.1111/j.1442-9071.2007.01517.x




PubMed



        
     
Free Article


 


PubMed ID 17651253
         Pubmed Central ID 1950580 


 



8.
Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Muller-Hermelink HK, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, Fisher RI, Kuehl WM, Chan WC, Staudt LM (2007). Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med  204, 633-43.   https://doi.org/10.1084/jem.20062041




PubMed



        
     
Free Article


 


PubMed ID 17353367
         Pubmed Central ID 2137913 


 



9.
Nava VE, Cohen P, Bishop M, Fowler D, Jaffe ES, Ozdemirli M (2007). Enteropathy-type T-cell lymphoma after intestinal diffuse large B-cell lymphoma. Am J Surg Pathol  31, 476-80.   https://doi.org/10.1097/01.pas.0000213391.49698.57




PubMed


 


PubMed ID 17325491
    
     


 



10.
Salaverria I, Zettl A, Beà S, Moreno V, Valls J, Hartmann E, Ott G, Wright G, Lopez-Guillermo A, Chan WC, Weisenburger DD, Gascoyne RD, Grogan TM, Delabie J, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Rosenwald A, Campo E (2007). Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol  25, 1216-22.   https://doi.org/10.1200/JCO.2006.08.4251




PubMed



        
     
Free Article


 


PubMed ID 17296973
         Pubmed Central ID 2366164 


 



11.
Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI, et al. [5 more authors] (2007). Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood  109, 4599-606.   https://doi.org/10.1182/blood-2006-08-039859




PubMed



        
     
Free Article


 


PubMed ID 17299095
         Pubmed Central ID 1885523",https://intramural.nih.gov/search/searchview.taf?ipid=47021
576,SC000853-54,"October 01, 2006 -  September 30, 2007",Surgical Pathology,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Begnami MD, Quezado M, Pinto P, Linehan WM, Merino M   (2007) Adenoid cystic/basal cell carcinoma of the prostate: review and update.  Arch Pathol Lab Med 131:637-40.




PubMed


 


PubMed ID 17425398
    
     


 



2.
Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, Richardson AM, Pinto PA, Linehan WM, Gillespie JW, Merino MJ, Libutti SK, Woodson KG, Emmert-Buck MR, Chuaqui RF (2007). Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol  211, 410-9.   https://doi.org/10.1002/path.2133




PubMed


 


PubMed ID 17278115",https://intramural.nih.gov/search/searchview.taf?ipid=47022
577,SC000892-24,"October 01, 2006 -  September 30, 2007",Molecular Biology of the Metastatic Phenotype,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Christine E Horak



Diane  Palmieri



Jong Heun Lee



Brunilde M Gril



Daniel  Fitzgerald



Emily  Hua



Show all 7","Jean-Yves  Daniel
(Biologie de Differentiation et Development, Universite Victor Segalen)




Marie-Lise  Lacombe
(Faculte de Medicine Saint Antoine, Iniversite Pierre et Marie Curie)




Kathy  Miller
(Oncology, Indiana University)","William G Stetler-Stevenson; MD, PhD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)



Nealapheur L Khan (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Horak CE, Lee JH, Elkahloun AG, Boissan M, Dumont S, Maga TK, Arnaud-Dabernat S, Palmieri D, Stetler-Stevenson WG, Lacombe ML, Meltzer PS, Steeg PS (2007). Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. Cancer Res  67, 7238-46.   https://doi.org/10.1158/0008-5472.CAN-07-0962




PubMed


 


PubMed ID 17671192",https://intramural.nih.gov/search/searchview.taf?ipid=47023
578,SC003657-33,"October 01, 2006 -  September 30, 2007",Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases,"Stephen I Katz; PhD, MD",NULL,"Dermatology Branch, NCI","Jay T Linton



Fumi  Miyagawa



Young-Hun  Cho



Emily Anne Nelson



Jan  Gutermuth",NULL,"Yutaka  Tagaya; MD, PhD (Lymphoid Malignancies Branch)",NULL,"Ordered by publication type and then author name.



1.
Miyagawa F, Tagaya Y, Kim BS, Patel HJ, Ishida K, Ohteki T, Waldmann TA, Katz SI (2008). IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease. J Immunol  181, 1109-19.   https://doi.org/10.4049/jimmunol.181.2.1109




PubMed



        
     
Free Article


 


PubMed ID 18606663
         Pubmed Central ID 2435206",https://intramural.nih.gov/search/searchview.taf?ipid=47024
579,SC003669-18,"October 01, 2006 -  September 30, 2007",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Dermatology Branch, NCI","Xu  Feng; PhD



Melanie  Neutzner



Wolfgang W Leitner; MS, PhD



Keisuke  Nagao



Michael C Lu



Christine A Dewitt; MD","Bjorn  Clausen
(University of Amsterdam)




Erika  Crouch
(Pathology, Washington University School of Medicine)




Esther  von Stebut
(Dermatology, University of Mainz)","Sam  Hwang; MD, PhD (National Cancer Institute)



Jonathan  Vogel; MD (National Cancer Institute)



Stephen I Katz; PhD, MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Neutzner M, Lopez T, Feng X, Bergmann-Leitner ES, Leitner WW, Udey MC (2007). MFG-E8/lactadherin promotes tumor growth in an angiogenesis-dependent transgenic mouse model of multistage carcinogenesis. Cancer Res  67, 6777-85.   https://doi.org/10.1158/0008-5472.CAN-07-0165




PubMed


 


PubMed ID 17638889
    
     


 



2.
Nigg AP, Zahn S, Rückerl D, Hölscher C, Yoshimoto T, Ehrchen JM, Wölbing F, Udey MC, von Stebut E (2007). Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice. J Immunol  178, 7251-8.   https://doi.org/10.4049/jimmunol.178.11.7251




PubMed


 


PubMed ID 17513774
    
     


 



3.
Terunuma A, Kapoor V, Yee C, Telford WG, Udey MC, Vogel JC (2007). Stem cell activity of human side population and alpha6 integrin-bright keratinocytes defined by a quantitative in vivo assay. Stem Cells  25, 664-9.   https://doi.org/10.1634/stemcells.2006-0434




PubMed


 


PubMed ID 17332515",https://intramural.nih.gov/search/searchview.taf?ipid=47025
580,SC003670-15,"October 01, 2006 -  September 30, 2007",Keratinocyte Gene Therapy,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,Jurgen B Schnermann; MD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47026
581,SC003800-37,"October 01, 2006 -  September 30, 2007",Surgical Consultants & Collaborative Research Involving Surgical Services at NIH,"Steven Aaron Rosenberg; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Steven  Libutti; MD



David  Danforth



David  Schrump; MD



James Chung-Yin Yang; MD, PhD



Mary Elizabeth Hughes; PhD



Richard  Sherry; MD



Show all 10",NULL,"Marybeth S Hughes (National Cancer Institute)



Nicholas Phillip Restifo; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ahmadzadeh M, Antony PA, Rosenberg SA (2007). IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells. J Immunother  30, 294-302.   https://doi.org/10.1097/CJI.0b013e3180336787




PubMed



        
     
Free Article


 


PubMed ID 17414320
         Pubmed Central ID 2174606 


 



2.
Cohen CJ, Li YF, El-Gamil M, Robbins PF, Rosenberg SA, Morgan RA (2007). Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. Cancer Res  67, 3898-903.   https://doi.org/10.1158/0008-5472.CAN-06-3986




PubMed



        
     
Free Article


 


PubMed ID 17440104
         Pubmed Central ID 2147081 


 



3.
Hsu C, Jones SA, Cohen CJ, Zheng Z, Kerstann K, Zhou J, Robbins PF, Peng PD, Shen X, Gomes TJ, Dunbar CE, Munroe DJ, Stewart C, Cornetta K, Wangsa D, Ried T, Rosenberg SA, Morgan RA (2007). Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene. Blood  109, 5168-77.   https://doi.org/10.1182/blood-2006-06-029173




PubMed



        
     
Free Article


 


PubMed ID 17353346
         Pubmed Central ID 1890824 


 



4.
Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, Palmer DC, Boni A, Muranski P, Yu Z, Gattinoni L, Antony PA, Rosenberg SA, Restifo NP (2007). Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest  117, 2197-204.   https://doi.org/10.1172/JCI32205




PubMed



        
     
Free Article


 


PubMed ID 17657310
         Pubmed Central ID 1924500 


 



5.
Shen X, Zhou J, Hathcock KS, Robbins P, Powell DJ, Rosenberg SA, Hodes RJ (2007). Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length. J Immunother  30, 123-9.   https://doi.org/10.1097/01.cji.0000211321.07654.b8




PubMed



        
     
Free Article


 


PubMed ID 17198091
         Pubmed Central ID 2151201 


 



6.
Smith FO, Goff SL, Klapper JA, Levy C, Allen T, Mavroukakis SA, Rosenberg SA (2007). Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibody. J Immunother  30, 130.   https://doi.org/10.1097/01.cji.0000211334.06762.89




PubMed



        
     
Free Article


 


PubMed ID 17198092
         Pubmed Central ID 2151199 


 



7.
Wrzesinski C, Paulos CM, Gattinoni L, Palmer DC, Kaiser A, Yu Z, Rosenberg SA, Restifo NP (2007). Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells. J Clin Invest  117, 492-501.   https://doi.org/10.1172/JCI30414




PubMed



        
     
Free Article


 


PubMed ID 17273561
         Pubmed Central ID 1783812 


 



8.
Zhao Y, Parkhurst MR, Zheng Z, Cohen CJ, Riley JP, Gattinoni L, Restifo NP, Rosenberg SA, Morgan RA (2007). Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling. Cancer Res  67, 2425-9.   https://doi.org/10.1158/0008-5472.CAN-06-3977




PubMed



        
     
Free Article


 


PubMed ID 17363559
         Pubmed Central ID 2100408",https://intramural.nih.gov/search/searchview.taf?ipid=47027
582,SC003811-33,"October 01, 2006 -  September 30, 2007",The Immunotherapy of Animal and Human Cancer,"Steven Aaron Rosenberg; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Maria  Parkhurst



Daniel J Powell



Mojgan  Ahmadzadeh



Paul  Robbins



Richard A Morgan; PhD



Bianca  Heemskerk



Show all 7",NULL,"Marybeth S Hughes (National Cancer Institute)



Udai S Kammula (National Cancer Institute)



James Chung-Yin Yang; MD, PhD (National Cancer Institute)



Nicholas Phillip Restifo; MD (National Cancer Institute)



Richard Eldon Royal (National Cancer Institute)



Richard  Sherry; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ahmadzadeh M, Antony PA, Rosenberg SA (2007). IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells. J Immunother  30, 294-302.   https://doi.org/10.1097/CJI.0b013e3180336787




PubMed



        
     
Free Article


 


PubMed ID 17414320
         Pubmed Central ID 2174606 


 



2.
Cohen CJ, Li YF, El-Gamil M, Robbins PF, Rosenberg SA, Morgan RA (2007). Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. Cancer Res  67, 3898-903.   https://doi.org/10.1158/0008-5472.CAN-06-3986




PubMed



        
     
Free Article


 


PubMed ID 17440104
         Pubmed Central ID 2147081 


 



3.
Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U, Robbins PF, Huang J, Citrin DE, Leitman SF, Wunderlich J, Restifo NP, Thomasian A, Downey SG, Smith FO, Klapper J, Morton K, Laurencot C, White DE, Rosenberg SA (2008). Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol  26, 5233-9.   https://doi.org/10.1200/JCO.2008.16.5449




PubMed



        
     
Free Article


 


PubMed ID 18809613
         Pubmed Central ID 2652090 


 



4.
Heemskerk B, Liu K, Dudley ME, Johnson LA, Kaiser A, Downey S, Zheng Z, Shelton TE, Matsuda K, Robbins PF, Morgan RA, Rosenberg SA (2008). Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2. Hum Gene Ther  19, 496-510.   https://doi.org/10.1089/hum.2007.0171




PubMed



        
     
Free Article


 


PubMed ID 18444786
         Pubmed Central ID 2656366 


 



5.
Hsu C, Jones SA, Cohen CJ, Zheng Z, Kerstann K, Zhou J, Robbins PF, Peng PD, Shen X, Gomes TJ, Dunbar CE, Munroe DJ, Stewart C, Cornetta K, Wangsa D, Ried T, Rosenberg SA, Morgan RA (2007). Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene. Blood  109, 5168-77.   https://doi.org/10.1182/blood-2006-06-029173




PubMed



        
     
Free Article


 


PubMed ID 17353346
         Pubmed Central ID 1890824 


 



6.
Klapper JA, Downey SG, Smith FO, Yang JC, Hughes MS, Kammula US, Sherry RM, Royal RE, Steinberg SM, Rosenberg S (2008). High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006. Cancer  113, 293-301.   https://doi.org/10.1002/cncr.23552




PubMed



        
     
Free Article


 


PubMed ID 18457330
         Pubmed Central ID 3486432 


 



7.
Klapper JA, Thomasian AA, Smith DM, Gorgas GC, Wunderlich JR, Smith FO, Hampson BS, Rosenberg SA, Dudley ME (2009). Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy. J Immunol Methods  345, 90-9.   https://doi.org/10.1016/j.jim.2009.04.009




PubMed



        
     
Free Article


 


PubMed ID 19389403
         Pubmed Central ID 2700005 


 



8.
Parkhurst MR, Joo J, Riley JP, Yu Z, Li Y, Robbins PF, Rosenberg SA (2009). Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells. Clin Cancer Res  15, 169-80.   https://doi.org/10.1158/1078-0432.CCR-08-1638




PubMed



        
     
Free Article


 


PubMed ID 19118044
         Pubmed Central ID 3474199 


 



9.
Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, Palmer DC, Boni A, Muranski P, Yu Z, Gattinoni L, Antony PA, Rosenberg SA, Restifo NP (2007). Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest  117, 2197-204.   https://doi.org/10.1172/JCI32205




PubMed



        
     
Free Article


 


PubMed ID 17657310
         Pubmed Central ID 1924500 


 



10.
Peng PD, Cohen CJ, Yang S, Hsu C, Jones S, Zhao Y, Zheng Z, Rosenberg SA, Morgan RA (2009). Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity. Gene Ther  16, 1042-9.   https://doi.org/10.1038/gt.2009.54




PubMed



        
     
Free Article


 


PubMed ID 19494842
         Pubmed Central ID 3469249 


 



11.
Powell DJ, Attia P, Ghetie V, Schindler J, Vitetta ES, Rosenberg SA (2008). Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration. J Immunother  31, 189-98.   https://doi.org/10.1097/CJI.0b013e31815dc0e8




PubMed



        
     
Free Article


 


PubMed ID 18481388
         Pubmed Central ID 3480218 


 



12.
Robbins PF, Li YF, El-Gamil M, Zhao Y, Wargo JA, Zheng Z, Xu H, Morgan RA, Feldman SA, Johnson LA, Bennett AD, Dunn SM, Mahon TM, Jakobsen BK, Rosenberg SA (2008). Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions. J Immunol  180, 6116-31.   https://doi.org/10.4049/jimmunol.180.9.6116




PubMed



        
     
Free Article


 


PubMed ID 18424733
         Pubmed Central ID 2424230 


 



13.
Rosenberg SA (2008). Why perform sentinel-lymph-node biopsy in patients with melanoma? Nat Clin Pract Oncol  5, 1.   https://doi.org/10.1038/ncponc1022




PubMed


 


PubMed ID 18097452
    
     


 



14.
Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME (2008). Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer  8, 299-308.   https://doi.org/10.1038/nrc2355




PubMed



        
     
Free Article


 


PubMed ID 18354418
         Pubmed Central ID 2553205 


 



15.
Shen X, Zhou J, Hathcock KS, Robbins P, Powell DJ, Rosenberg SA, Hodes RJ (2007). Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length. J Immunother  30, 123-9.   https://doi.org/10.1097/01.cji.0000211321.07654.b8




PubMed



        
     
Free Article


 


PubMed ID 17198091
         Pubmed Central ID 2151201 


 



16.
Smith FO, Downey SG, Klapper JA, Yang JC, Sherry RM, Royal RE, Kammula US, Hughes MS, Restifo NP, Levy CL, White DE, Steinberg SM, Rosenberg SA (2008). Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines. Clin Cancer Res  14, 5610-8.   https://doi.org/10.1158/1078-0432.CCR-08-0116




PubMed



        
     
Free Article


 


PubMed ID 18765555
         Pubmed Central ID 2656367 


 



17.
Smith FO, Goff SL, Klapper JA, Levy C, Allen T, Mavroukakis SA, Rosenberg SA (2007). Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibody. J Immunother  30, 130.   https://doi.org/10.1097/01.cji.0000211334.06762.89




PubMed



        
     
Free Article


 


PubMed ID 17198092
         Pubmed Central ID 2151199 


 



18.
Theoret MR, Cohen CJ, Nahvi AV, Ngo LT, Suri KB, Powell DJ, Dudley ME, Morgan RA, Rosenberg SA (2008) Relationship of p53 Overexpression on Cancers and Recognition by anti-p53 TCR Transduced T cells. Hum Gene Ther, in press (e-pub ahead of print)




PubMed



        
     
Free Article


 


PubMed ID 18707199
         Pubmed Central ID 2889139 


 



19.
Turcotte S, Gros A, Tran E, Lee CC, Wunderlich JR, Robbins PF, Rosenberg SA (2014). Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy. Clin Cancer Res  20, 331-43.   https://doi.org/10.1158/1078-0432.CCR-13-1736




PubMed



        
     
Free Article


 


PubMed ID 24218514
         Pubmed Central ID 3927404 


 



20.
Wang J, Lozier J, Johnson G, Kirshner S, Verthelyi D, Pariser A, Shores E, Rosenberg A (2008). Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment. Nat Biotechnol  26, 901-8.   https://doi.org/10.1038/nbt.1484




PubMed



        
     
Free Article


 


PubMed ID 18688246
         Pubmed Central ID 3478093 


 



21.
Wargo JA, Robbins PF, Li Y, Zhao Y, El-Gamil M, Caragacianu D, Zheng Z, Hong JA, Downey S, Schrump DS, Rosenberg SA, Morgan RA (2009). Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression. Cancer Immunol Immunother  58, 383-94.   https://doi.org/10.1007/s00262-008-0562-x




PubMed



        
     
Free Article


 


PubMed ID 18677478
         Pubmed Central ID 2684457 


 



22.
Wrzesinski C, Paulos CM, Gattinoni L, Palmer DC, Kaiser A, Yu Z, Rosenberg SA, Restifo NP (2007). Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells. J Clin Invest  117, 492-501.   https://doi.org/10.1172/JCI30414




PubMed



        
     
Free Article


 


PubMed ID 17273561
         Pubmed Central ID 1783812 


 



23.
Yang S, Cohen CJ, Peng PD, Zhao Y, Cassard L, Yu Z, Zheng Z, Jones S, Restifo NP, Rosenberg SA, Morgan RA (2008). Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition. Gene Ther  15, 1411-23.   https://doi.org/10.1038/gt.2008.90




PubMed



        
     
Free Article


 


PubMed ID 18496571
         Pubmed Central ID 2684456 


 



24.
Yang S, Rosenberg SA, Morgan RA (2008). Clinical-scale lentiviral vector transduction of PBL for TCR gene therapy and potential for expression in less-differentiated cells. J Immunother  31, 830-9.   https://doi.org/10.1097/CJI.0b013e31818817c5




PubMed



        
     
Free Article


 


PubMed ID 18833004
         Pubmed Central ID 3399689 


 



25.
Zhao Y, Parkhurst MR, Zheng Z, Cohen CJ, Riley JP, Gattinoni L, Restifo NP, Rosenberg SA, Morgan RA (2007). Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling. Cancer Res  67, 2425-9.   https://doi.org/10.1158/0008-5472.CAN-06-3977




PubMed



        
     
Free Article


 


PubMed ID 17363559
         Pubmed Central ID 2100408 


 



26.
Fischkoff S, Lowy I, Rosenberg S, Yang J, Yellin M (submitted in 2007) Tnf-alpha Blocker Treatment For Enterocolitis Associated With Immunostimulatory Therapeutic Antibody Therapy. Patent issued: 7,611,702 (US in 2010). Patents pending: 200680040513.9 (CN application); 06827682.3 (EP application); 190183 (IL application); 2008-540197 (JP application); 2006311475 (AU application); 2626859 (CA application); MX/A/2008/005674 (MX application); 566758 (NZ application); PCT/US2006/043691 (PC application).




 



27.
Restifo NP, Cassard LP, Rosenberg SP, Yu ZP (submitted in 2007) Gp100-specific T Cell Receptors And Related Materials And Methods Of Use. Patents issued: 8,216,565 (US in 2012); 8,613,932 (US in 2014); 2,674,445 (CA in 2016); 9,522,948 (US in 2017). Patent pending: PCT/US2008/050841 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=47028
583,SC004002-38,"October 01, 2006 -  September 30, 2007",Defects in Immunoregulatory Cell Receptors in Patients with LeukemiaLymphoma,"Thomas Alexander Waldmann; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Liyanage P Perera; PhD



Yutaka  Tagaya; MD, PhD



Jean  Decker



Sigrid Priscilla Dubois



Carolyn  Goldman



Michael N Petrus



Show all 10","Sandor  Damjanovich, M.D.
(Dept of Biophysics and Cell Biology, University of Debrecen)




Nicole  Urquhart
(Dept of, University of the West Indies)




David  Weiner, Ph.D.
(Dept of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine)","Martin W Brechbiel; PhD (Radiation Oncology Branch)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)","Jorge A Carrasquillo; MD (CC) 



Steven J Jacobson; PhD (NINDS) 



Henry F McFarland; MD (NINDS) 



Robert B. Nussenblatt; MD (NEI)","Ordered by publication type and then author name.



1.
Bene L, Kanyári Z, Bodnár A, Kappelmayer J, Waldmann TA, Vámosi G, Damjanovich L (2007). Colorectal carcinoma rearranges cell surface protein topology and density in CD4+ T cells. Biochem Biophys Res Commun  361, 202-7.   https://doi.org/10.1016/j.bbrc.2007.07.013




PubMed


 


PubMed ID 17658476
    
     


 



2.
O'Mahony D, Morris JC, Quinn C, Gao W, Wilson WH, Gause B, Pittaluga S, Neelapu S, Brown M, Fleisher TA, Gulley JL, Schlom J, Nussenblatt R, Albert P, Davis TA, Lowy I, Petrus M, Waldmann TA, Janik JE (2007). A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy. Clin Cancer Res  13, 958-64.   https://doi.org/10.1158/1078-0432.CCR-06-1974




PubMed


 


PubMed ID 17289891
    
     


 



3.
Perera LP, Waldmann TA, Mosca JD, Baldwin N, Berzofsky JA, Oh S (2007). Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice. J Virol  81, 8774-83.   https://doi.org/10.1128/JVI.00538-07




PubMed



        
     
Free Article


 


PubMed ID 17553867
         Pubmed Central ID 1951366 


 



4.
Sato N, Patel HJ, Waldmann TA, Tagaya Y (2007). The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells. Proc Natl Acad Sci U S A  104, 588-93.   https://doi.org/10.1073/pnas.0610115104




PubMed



        
     
Free Article


 


PubMed ID 17202253
         Pubmed Central ID 1766429 


 



5.
Waldmann TA (2007). Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey. J Clin Immunol  27, 1-18.   https://doi.org/10.1007/s10875-006-9060-0




PubMed


 


PubMed ID 17216565
    
     


 



6.
Waldmann TA (2007). Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma. Oncogene  26, 3699-703.   https://doi.org/10.1038/sj.onc.1210368




PubMed


 


PubMed ID 17530023
    
     


 



7.
Zhang M, Yao Z, Patel H, Garmestani K, Zhang Z, Talanov VS, Plascjak PS, Goldman CK, Janik JE, Brechbiel MW, Waldmann TA (2007). Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1. Proc Natl Acad Sci U S A  104, 8444-8.   https://doi.org/10.1073/pnas.0702496104




PubMed



        
     
Free Article


 


PubMed ID 17488826
         Pubmed Central ID 1895969",https://intramural.nih.gov/search/searchview.taf?ipid=47029
584,SC004017-29,"October 01, 2006 -  September 30, 2007",Biology of the Immune Response,"David  Nelson; MD, PhD",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Elaine S Jaffe; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47030
585,SC004020-30,"October 01, 2006 -  September 30, 2007","Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Charles D Pendleton



Amiran  Dzutsev; PhD



Masaki  Terabe



Qing  Zhu



Elena  Ambrosino



Deborah Marie Stewart



Show all 8","Vincenzo  Bronte





Donald  Burke
(Ctr Immunization Research, Johns Hopkins Sch Publ Health)




David  Carbone
(Medicine, Vanderbilt University)




David  Carbone
(Medicine, Vanderbilt University)




Charles  Delisi





Debra  Donaldson; PhD
(Immunology, Wyeth-Genetics Institute)


Show all 22","Allan  Hildesheim; PhD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)



Ligia  Pinto (Infection & Immunoepidemiology Branch)



Ira H Pastan; MD (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)



Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)","Warren  Strober; MD (NIAID) 



Patricia  Earl; PhD (NIAID) 



Brian R. Murphy; MD (NIAID) 



Peter Leon Collins; PhD (NIAID) 



Brian  Kelsall; MD (NIAID) 



Gary J Nabel; MD, PhD (NIAID)","Ordered by publication type and then author name.



1.
Belyakov IM, Isakov D, Zhu Q, Dzutsev A, Berzofsky JA (2007). A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells. J Immunol  178, 7211-21.   https://doi.org/10.4049/jimmunol.178.11.7211




PubMed


 


PubMed ID 17513770
    
     


 



2.
Dzutsev AH, Belyakov IM, Isakov DV, Margulies DH, Berzofsky JA (2007). Avidity of CD8 T cells sharpens immunodominance. Int Immunol  19, 497-507.   https://doi.org/10.1093/intimm/dxm016




PubMed


 


PubMed ID 17376783
    
     


 



3.
Ota MO, Ndhlovu Z, Oh S, Piyasirisilp S, Berzofsky JA, Moss WJ, Griffin DE (2007). Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination. J Infect Dis  195, 1799-807.   https://doi.org/10.1086/518006




PubMed


 


PubMed ID 17492596
    
     


 



4.
Perera LP, Waldmann TA, Mosca JD, Baldwin N, Berzofsky JA, Oh S (2007). Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice. J Virol  81, 8774-83.   https://doi.org/10.1128/JVI.00538-07




PubMed



        
     
Free Article


 


PubMed ID 17553867
         Pubmed Central ID 1951366 


 



5.
Toubaji A, Hill S, Terabe M, Qian J, Floyd T, Simpson RM, Berzofsky JA, Khleif SN (2007). The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection. Vaccine  25, 5882-91.   https://doi.org/10.1016/j.vaccine.2007.05.040




PubMed


 


PubMed ID 17602804
    
     


 



6.
Berzofsky JA, Belyakov IA, Zhu QA (submitted in 2007) Immunostimulatory Combinations Of Tlr Ligands And Methods Of Use. Patents issued: 2200639 (FR in 2016); 2200639 (GB in 2016); 9,421,254 (US in 2016); 2200639 (DE in 2016); 2200639 (EP in 2016). Patent pending: 15/244,882 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=47031
586,SC004024-20,"October 01, 2006 -  September 30, 2007",Molecular Biology of Human Lymphoid Malignancies,"Louis  Staudt; MD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Arthur L Shaffer



Richard E Davis



Hong  Zhao



Lam  Lloyd



Vu  Ngo



Laurence  Lamy



Show all 7","Elias  Campo
(Pathology, University of Barcelona)




John  Chan
(Univ. of Nebraska Medical Center)




Richard  Fisher
(Medicine, University of Rochester School of Medicine)




Randy  Gascoyne
(British Columbia Cancer Center)




Konrad  Muller-Hermelink
(Univ. of Wuerzburg)




Harinder  Singh



Show all 7","Wyndham H Wilson; MD, PhD (National Cancer Institute)



Elaine S Jaffe; MD (National Cancer Institute)



Walter M Kuehl; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, Lenz G, Hanamura I, Wright G, Xiao W, Dave S, Hurt EM, Tan B, Zhao H, Stephens O, Santra M, Williams DR, Dang L, Barlogie B, Shaughnessy JD, Kuehl WM, Staudt LM (2007). Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell  12, 115-30.   https://doi.org/10.1016/j.ccr.2007.07.004




PubMed



        
     
Free Article


 


PubMed ID 17692804
         Pubmed Central ID 2730509 


 



2.
Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD, Chan WC, Delabie J, Braziel RM, Campo E, Gascoyne RD, Jaffe ES, Muller-Hermelink K, Ott G, Calaminici M, Norton AJ, Goff LK, Fitzgibbon J, Staudt LM, Andrew Lister T (2007). Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol  136, 286-93.   https://doi.org/10.1111/j.1365-2141.2006.06439.x




PubMed



        
     
Free Article


 


PubMed ID 17278262
         Pubmed Central ID 2532951 


 



3.
Davis RE, Zhang YQ, Southall N, Staudt LM, Austin CP, Inglese J, Auld DS (2007). A cell-based assay for IkappaBalpha stabilization using a two-color dual luciferase-based sensor. Assay Drug Dev Technol  5, 85-103.   https://doi.org/10.1089/adt.2006.048




PubMed


 


PubMed ID 17355202
    
     


 



4.
Iqbal J, Greiner TC, Patel K, Dave BJ, Smith L, Ji J, Wright G, Sanger WG, Pickering DL, Jain S, Horsman DE, Shen Y, Fu K, Weisenburger DD, Hans CP, Campo E, Gascoyne RD, Rosenwald A, Jaffe ES, Delabie J, Rimsza L, Ott G, Müller-Hermelink HK, Connors JM, Vose JM, Leukemia/Lymphoma Molecular Profiling Project, et al. [3 more authors] (2007). Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia  21, 2332-43.   https://doi.org/10.1038/sj.leu.2404856




PubMed



        
     
Free Article


 


PubMed ID 17625604
         Pubmed Central ID 2366166 


 



5.
Kuo TC, Shaffer AL, Haddad J, Choi YS, Staudt LM, Calame K (2007). Repression of BCL-6 is required for the formation of human memory B cells in vitro. J Exp Med  204, 819-30.   https://doi.org/10.1084/jem.20062104




PubMed



        
     
Free Article


 


PubMed ID 17403935
         Pubmed Central ID 2118536 


 



6.
Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Muller-Hermelink HK, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, Fisher RI, Kuehl WM, Chan WC, Staudt LM (2007). Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med  204, 633-43.   https://doi.org/10.1084/jem.20062041




PubMed



        
     
Free Article


 


PubMed ID 17353367
         Pubmed Central ID 2137913 


 



7.
Salaverria I, Zettl A, Beà S, Moreno V, Valls J, Hartmann E, Ott G, Wright G, Lopez-Guillermo A, Chan WC, Weisenburger DD, Gascoyne RD, Grogan TM, Delabie J, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Rosenwald A, Campo E (2007). Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol  25, 1216-22.   https://doi.org/10.1200/JCO.2006.08.4251




PubMed



        
     
Free Article


 


PubMed ID 17296973
         Pubmed Central ID 2366164 


 



8.
Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI, et al. [5 more authors] (2007). Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood  109, 4599-606.   https://doi.org/10.1182/blood-2006-08-039859




PubMed



        
     
Free Article


 


PubMed ID 17299095
         Pubmed Central ID 1885523",https://intramural.nih.gov/search/searchview.taf?ipid=47032
587,SC006321-28,"October 01, 2006 -  September 30, 2007",Modulation of Therapeutic Response,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","John Andrew Cook; PhD



William  Degraff



Anastasia L Sowers



Janet W Gamson



Rajani  Choudhuri



Benjamin  Soule



Show all 8","Eli  Gladstein
(Univ. of Pennsylvania)




Dr. Kameron  Maxwell
(Research, Mitos)




Jim  Metz
(Univ. of Pennsylvania)




Sonya  Zabludoff
(Research, AstraZenca)","Murali  Krishna; PhD (National Cancer Institute)



Deborah E Citrin (National Cancer Institute)","Carter  Van Waes; MD, PhD (NIDCD) 



Bruce J Baum; DMD, PhD (NIDCR)","Ordered by publication type and then author name.



1.
Arany PR, Flanders KC, DeGraff W, Cook J, Mitchell JB, Roberts AB (2007). Absence of Smad3 confers radioprotection through modulation of ERK-MAPK in primary dermal fibroblasts. J Dermatol Sci  48, 35-42.   https://doi.org/10.1016/j.jdermsci.2007.05.012




PubMed



        
     
Free Article


 


PubMed ID 17624738
         Pubmed Central ID 2016790 


 



2.
Cotrim AP, Hyodo F, Matsumoto K, Sowers AL, Cook JA, Baum BJ, Krishna MC, Mitchell JB (2007). Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging. Clin Cancer Res  13, 4928-33.   https://doi.org/10.1158/1078-0432.CCR-07-0662




PubMed


 


PubMed ID 17699873
    
     


 



3.
Matsumoto K, Szajek L, Krishna MC, Cook JA, Seidel J, Grimes K, Carson J, Sowers AL, English S, Green MV, Bacharach SL, Eckelman WC, Mitchell JB (2007). The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography. Int J Oncol  30, 873-81.




PubMed


 


PubMed ID 17332926
    
     


 



4.
Simone NL, Soule BP, Gerber L, Augustine E, Smith S, Altemus RM, Mitchell JB, Camphausen KA (2007). Oral pirfenidone in patients with chronic fibrosis resulting from radiotherapy: a pilot study. Radiat Oncol  2, 19.   https://doi.org/10.1186/1748-717X-2-19




PubMed



        
     
Free Article


 


PubMed ID 17540023
         Pubmed Central ID 1891306 


 



5.
Soule BP, Brown JM, Kushnir-Sukhov NM, Simone NL, Mitchell JB, Metcalfe DD (2007). Effects of gamma radiation on FcepsilonRI and TLR-mediated mast cell activation. J Immunol  179, 3276-86.   https://doi.org/10.4049/jimmunol.179.5.3276




PubMed


 


PubMed ID 17709544
    
     


 



6.
Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB (2007). The chemistry and biology of nitroxide compounds. Free Radic Biol Med  42, 1632-50.   https://doi.org/10.1016/j.freeradbiomed.2007.02.030




PubMed



        
     
Free Article


 


PubMed ID 17462532
         Pubmed Central ID 1991293 


 



7.
Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB (2007). Therapeutic and clinical applications of nitroxide compounds. Antioxid Redox Signal  9, 1731-43.   https://doi.org/10.1089/ars.2007.1722




PubMed


 


PubMed ID 17665971
    
     


 



8.
Tsai MH, Cook JA, Chandramouli GV, DeGraff W, Yan H, Zhao S, Coleman CN, Mitchell JB, Chuang EY (2007). Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res  67, 3845-52.   https://doi.org/10.1158/0008-5472.CAN-06-4250




PubMed


 


PubMed ID 17440099",https://intramural.nih.gov/search/searchview.taf?ipid=47033
588,SC006329-26,"October 01, 2006 -  September 30, 2007",Clinical Radiation Physics Service,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","George  Li; PhD



Hu-Chen  Xie



Holly  Ning



Frank S Harrington



Barbara Chin Arora



Jason Yulin Cheng; PhD



Show all 7",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47008
589,SC006330-26,"October 01, 2006 -  September 30, 2007",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","George  Li; PhD



Hu-Chen  Xie



Holly  Ning



Frank S Harrington



Barbara Chin Arora



Jason Yulin Cheng; PhD



Show all 7","Thomas  Fearon
(Radiology, Children's National Medical Center)




Chang-Ming  Ma
(Radiation Oncology Department, Fox Chase Cancer Center)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47009
590,SC006353-25,"October 01, 2006 -  September 30, 2007",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"Martin W Brechbiel; PhD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Diane E Milenic



Charles A Boswell



Heng  Xu



Kwamena  Baidoo



Celeste A Regino","Greg  Adams
(Fox Chase Cancer Center)




Barry  Allen
(Experiemental Radiation Oncology, St. George Cancer Care Center)




Andrew  Scott
(Tumour Targeting Program, Ludwig Institute for Cancer Research)




Andrew  Scott
(Tumour Targeting Program, Ludwig Institute for Cancer Research)




Scott  Wilbur
(Radiation Oncology, U. of Washington)","Peter L Choyke; MD (National Cancer Institute)



Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Brechbiel M, Boswell C, Milenic D, Brady D (2007) Monoclonal Antibody Targeted Radiation Cancer Therapy, in Biologics in General Medicine, eds. Radeke, H. H, Boehncke, W.-H. Springer N/A.




 



2.
Brechbiel M, Garmestani K, Brady E, Albert P, Abdulla A, Flynn J   (2007) Potentiation of High LET Radiation by Gemcitabine: Targeting of HER2 with  Trastuzumab for the Treatment of Disseminated Peritoneal Disease.  Clin. Cancer Res.  1926-1935 pp.




 



3.
Brechbiel M, Yao Z, Patel H, Garmestani K, Zhang Z, Talanov V, Plascjak P, Goldman C, Janik J, Waldmann T   (2007) Effective therapy of murine models of human leukemia and lymphoma with  radiolabeled anti-CD30 antibody, HeFi-1.  PNAS  8444-8448 pp.




 



4.
Bumb A, Brechbiel MW, Choyke PL, Fugger L, Eggeman A, Prabhakaran D, Hutchinson J, Dobson PJ (2008). Synthesis and characterization of ultra-small superparamagnetic iron oxide nanoparticles thinly coated with silica. Nanotechnology  19, 335601.   https://doi.org/10.1088/0957-4484/19/33/335601




PubMed



        
     
Free Article


 


PubMed ID 19701448
         Pubmed Central ID 2600798 


 



5.
Scott AM, Tebbutt N, Lee FT, Cavicchiolo T, Liu Z, Gill S, Poon AM, Hopkins W, Smyth FE, Murone C, MacGregor D, Papenfuss AT, Chappell B, Saunder TH, Brechbiel MW, Davis ID, Murphy R, Chong G, Hoffman EW, Old LJ (2007). A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen. Clin Cancer Res  13, 3286-92.   https://doi.org/10.1158/1078-0432.CCR-07-0284




PubMed


 


PubMed ID 17545534
    
     


 



6.
Brechbiel MW, Baidoo KW, Xu HW (submitted in 2007) Trifunctional Imaging Agent  For Monoclonal Antibody Tumor-targeted Imaging. Patent issued: 8,535,639 (US in 2013). Patent pending: PCT/US08/00070133 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=47034
591,SC006358-24,"October 01, 2006 -  September 30, 2007","Radiolysis, Photolysis, Sonolysis and Sonoprotection of Cells and their Constitu",Peter  Riesz; PhD,NULL,"Radiation Biology Branch, NCI",Shinji  Ito,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Riesz P, Kondo T, Ogawa R, Zhao Q, Hassan M, Watanabe A, Takasaki I, Tabuchi Y, Shoji M, Kudo N, Feril Jr. L, Tachibana K, Buldakov M, Honda T, Tsukada K   (2007) Molecular Therapy by Ultrasound: The Mechanism of Drug Activation, Apoptosis Induction, Gene Transfer, and Change of Gene Expression.  Thermal Medicine, in press.




 



2.
Sostaric JZ (2008) A chemical sensor that can detect the frequency of ultrasound. J Am Chem Soc 130:3248-9




PubMed


 


PubMed ID 18302375
    
     


 



3.
Sostaric JZ (2008) A comparative sonochemical reaction that is independent of the intensity of ultrasound and the geometry of the exposure apparatus. Ultrason Sonochem 15:1043-8.




PubMed



        
     
Free Article


 


PubMed ID 18472292
         Pubmed Central ID 2706206",https://intramural.nih.gov/search/searchview.taf?ipid=47035
592,SC006387-20,"October 01, 2006 -  September 30, 2007",Nitroxides as Protectors Against Oxidative Stress,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","John Andrew Cook; PhD



William  Degraff



Anastasia L Sowers



Janet W Gamson



Rajani  Choudhuri



Benjamin  Soule



Show all 8",NULL,"Murali  Krishna; PhD (National Cancer Institute)



Michael  Potter; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB (2007). The chemistry and biology of nitroxide compounds. Free Radic Biol Med  42, 1632-50.   https://doi.org/10.1016/j.freeradbiomed.2007.02.030




PubMed



        
     
Free Article


 


PubMed ID 17462532
         Pubmed Central ID 1991293 


 



2.
Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB (2007). Therapeutic and clinical applications of nitroxide compounds. Antioxid Redox Signal  9, 1731-43.   https://doi.org/10.1089/ars.2007.1722




PubMed


 


PubMed ID 17665971
    
     


 



3.
Tsai MH, Cook JA, Chandramouli GV, DeGraff W, Yan H, Zhao S, Coleman CN, Mitchell JB, Chuang EY (2007). Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res  67, 3845-52.   https://doi.org/10.1158/0008-5472.CAN-06-4250




PubMed


 


PubMed ID 17440099",https://intramural.nih.gov/search/searchview.taf?ipid=47036
593,SC006536-11,"October 01, 2006 -  September 30, 2007",Sample Processing and Analytical Methods Development for New Anticancer Agents,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Kathryn  Compton



Gareth  Peters



Jeanny B Aragon-Ching



Matthew  Danish



Xiaohong  Chen



Diana  Roame",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Chen X, Gardner ER, Gutierrez M, Kummar S, Figg WD (2007). Determination of 17-dimethylaminoethylamino-17-demethoxygeldanamycin in human plasma by liquid chromatography with mass-spectrometric detection. J Chromatogr B Analyt Technol Biomed Life Sci  858, 302-6.   https://doi.org/10.1016/j.jchromb.2007.08.022




PubMed



        
     
Free Article


 


PubMed ID 17851142
         Pubmed Central ID 2118051 


 



2.
Figg W, Gardner E   (2007) Determination of 17-dimethylaminoethylamino-17-demethoxygeldanamycin in human      plasma by liquid chromatography with mass-spectrometric detection.  J Chromatogr B, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=50235
594,SC006537-14,"October 01, 2006 -  September 30, 2007",Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Tristan  Sissung



Kathryn  Compton



Jeanny B Aragon-Ching



Matthew  Danish



Xiaohong  Chen","Michael J Hawkins





Robert  Kerbel
(Department of Medical Biophysics, University of Toronto)




Sylvia  Ng
(Advanced Therapeutics, BC Cancer Research Centre)




William  Petros
(School of Pharmacy, West Virginia Unversity)




Edward  Sausville
(Greenebaum Cancer Center, University of Maryland)","Giovanni  Melillo (National Cancer Institute)



James A Zwiebel (National Cancer Institute)



James F Pingpank (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)



Patricia  Steeg; PhD (National Cancer Institute)



Anthony  Murgo (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Figg W, Gutierrez M, Gardner E, Hwang K, Chung E, Lee M, Maynard K, Kalniskiy M, Donovan E, Chen A, Melillo G, Ryan Q, Conley B, Sausville E, Sparreboom A, Trepel J, Zwiebel J, Doroshow J, Murgo A   (2007) Phase I Trial of MS-275, a Histone Deacetylase Inhibitor, in Refractory Solid  Tumors and Lymphoid Malignancies: A Comparison Between Fasting and Fed Cohorts.  Clin Cancer Res, in press.




 



2.
Figg W, Gutierrez M, Gardner E, Hwang K, Chung E, Lee M, Maynard K, Kalnitzkiy M, Donovan E, Chen A, Melillo G, Ryan Q, Conley B, Sausville E, Sparreboom A, Trepel J, Zwiebel J, Doroshow J, Murgo A   (2007) Phase I Trial of MS-275, a Histone Deacetylase Inhibitor, in Refractory Solid  Tumors and Lymphoid Malignancies: A Comparison Between Fasing and Fed Cohorts.  Clin Cancer Res, in press.




 



3.
Figg W, LoPiccolo J, Tsurutani J, Shoemaker R, Best C, Abu-Asab M, Borojerdi J, Warfel N, Gardner E, Danish M, Holland M, Tsoko M, Steeg P, Dennis P   (2007) Nelfinavir, a lead HIV protease inhibitor, is a broad spectrum, anticancer agent  that induces ER stress, autophagy and apoptosis in vitro and in vivo.  Clinical Cancer Res, in press.




 



4.
Gardner ER, Dahut WL, Scripture CD, Jones J, Aragon-Ching JB, Desai N, Hawkins MJ, Sparreboom A, Figg WD (2008). Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel. Clin Cancer Res  14, 4200-5.   https://doi.org/10.1158/1078-0432.CCR-07-4592




PubMed



        
     
Free Article


 


PubMed ID 18594000
         Pubmed Central ID 2661025 


 



5.
Gojo I, Jiemjit A, Trepel JB, Sparreboom A, Figg WD, Rollins S, Tidwell ML, Greer J, Chung EJ, Lee MJ, Gore SD, Sausville EA, Zwiebel J, Karp JE (2007). Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias. Blood  109, 2781-90.   https://doi.org/10.1182/blood-2006-05-021873




PubMed



        
     
Free Article


 


PubMed ID 17179232
         Pubmed Central ID 1852211 


 



6.
Lakhani NJ, Sparreboom A, Xu X, Veenstra TD, Venitz J, Dahut WL, Figg WD (2007). Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol. J Pharm Sci  96, 1821-31.   https://doi.org/10.1002/jps.20837




PubMed


 


PubMed ID 17252610",https://intramural.nih.gov/search/searchview.taf?ipid=50237
595,SC006538-14,"October 01, 2006 -  September 30, 2007",Development of Angiogenesis Inhibitors,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Cindy Huong-Bich Chau



Kristina  Cook



Douglas K Price



Caitlin  Baum



Haihao  Sun","Ken  Anderson
(Medical Oncology/Hematologic Neoplasia, Dana-Farber Cancer Institute)




Shaji  Kumar
(Hematology, Mayo Clinic)","Kevin  Gardner; MD, PhD (National Cancer Institute)



Phillip A Dennis; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Figg W   (2007) Angiogenesis Therapy., in Cancer: Principles and Practice of Oncology. DeVita V, Rosenberg S, eds., Lippincott Williams and Wilkins (Philadelphia), in press.




 



2.
Figg W   (2007) Investigational Agents., in Angiogenesis: An Integrative Approach from Science to Medicine. Springer (Boston), in press.




 



3.
Figg W, Dahut W   (2007) Thalidomide as an Anti-Angiogenic Agent., in Angiogenesis: An Integrative Approach from Science to Medicine. Springer (Boston), in press.




 



4.
Figg W, Gutierrez M, Gardner E, Hwang K, Chung E, Lee M, Maynard K, Kalnitzkiy M, Donovan E, Chen A, Melillo G, Ryan Q, Conley B, Sausville E, Sparreboom A, Trepel J, Zwiebel J, Doroshow J, Murgo A   (2007) Phase I Trial of MS-275, a Histone Deacetylase Inhibitor, in Refractory Solid  Tumors and Lymphoid Malignancies: A Comparison Between Fasing and Fed Cohorts.  Clin Cancer Res, in press.




 



5.
Figg W, Li H, Gardner E   (2007) Thalidomide Analogues as Anticancer Drugs.  Recent Patents on Anti-Cancer Drug Discovery, in press.




 



6.
Gojo I, Jiemjit A, Trepel JB, Sparreboom A, Figg WD, Rollins S, Tidwell ML, Greer J, Chung EJ, Lee MJ, Gore SD, Sausville EA, Zwiebel J, Karp JE (2007). Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias. Blood  109, 2781-90.   https://doi.org/10.1182/blood-2006-05-021873




PubMed



        
     
Free Article


 


PubMed ID 17179232
         Pubmed Central ID 1852211 


 



7.
Lakhani NJ, Sparreboom A, Xu X, Veenstra TD, Venitz J, Dahut WL, Figg WD (2007). Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol. J Pharm Sci  96, 1821-31.   https://doi.org/10.1002/jps.20837




PubMed


 


PubMed ID 17252610
    
     


 



8.
Li H, Price DK, Figg WD (2007). ADH1, an N-cadherin inhibitor, evaluated in preclinical models of angiogenesis and androgen-independent prostate cancer. Anticancer Drugs  18, 563-8.   https://doi.org/10.1097/CAD.0b013e328020043e




PubMed


 


PubMed ID 17414625",https://intramural.nih.gov/search/searchview.taf?ipid=47037
596,SC006581-24,"October 01, 2006 -  September 30, 2007",Molecular Pathogenesis of Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Ken  Nakahara



Anna V Roschke



Oleg K Glebov



Leslie Ann Brents



Sheila  Teves



Yulia  Demchenko



Show all 7","P.  Bergsagel
(Divison of Hematology, Mayo Clinic)




Rafael  Fonseca
(Division of Hematology, Mayo Clinic)




Thomas  Rasmussen
(Department of Hematology, University of Copenhagen)




John  Shaughnessy
(Lambert Laboratory of Myeloma Genetics, Universiy of Arkansas for Medical Sciences)",Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,"Ordered by publication type and then author name.



1.
Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, Lenz G, Hanamura I, Wright G, Xiao W, Dave S, Hurt EM, Tan B, Zhao H, Stephens O, Santra M, Williams DR, Dang L, Barlogie B, Shaughnessy JD, Kuehl WM, Staudt LM (2007). Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell  12, 115-30.   https://doi.org/10.1016/j.ccr.2007.07.004




PubMed



        
     
Free Article


 


PubMed ID 17692804
         Pubmed Central ID 2730509 


 



2.
Chng WJ, Kuehl WM, Bergsagel PL, Fonseca R (2008). Translocation t(4;14) retains prognostic significance even in the setting of high-risk molecular signature. Leukemia  22, 459-61.   https://doi.org/10.1038/sj.leu.2404934




PubMed


 


PubMed ID 17805328
    
     


 



3.
Dib A, Barlogie B, Shaughnessy JD, Kuehl WM (2007). Methylation and expression of the p16INK4A tumor suppressor gene in multiple myeloma. Blood  109, 1337-8.   https://doi.org/10.1182/blood-2006-09-049510




PubMed


 


PubMed ID 17244692
    
     


 



4.
Dib A, Gabrea A, Glebov OK, Bergsagel PL, Kuehl WM (2008). Characterization of MYC translocations in multiple myeloma cell lines. J Natl Cancer Inst Monogr   25-31  https://doi.org/10.1093/jncimonographs/lgn011




PubMed



        
     
Free Article


 


PubMed ID 18647998
         Pubmed Central ID 2737184 


 



5.
Gabrea A, Martelli ML, Qi Y, Roschke A, Barlogie B, Shaughnessy JD, Sawyer JR, Kuehl WM (2008). Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors. Genes Chromosomes Cancer  47, 573-90.   https://doi.org/10.1002/gcc.20563




PubMed



        
     
Free Article


 


PubMed ID 18381641
         Pubmed Central ID 3678755 


 



6.
Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ, Van Wier S, Tiedemann R, Shi CX, Sebag M, Braggio E, Henry T, Zhu YX, Fogle H, Price-Troska T, Ahmann G, Mancini C, Brents LA, Kumar S, Greipp P, Dispenzieri A, Bryant B, Mulligan G, Bruhn L, Barrett M, et al. [5 more authors] (2007). Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell  12, 131-44.   https://doi.org/10.1016/j.ccr.2007.07.003




PubMed



        
     
Free Article


 


PubMed ID 17692805
         Pubmed Central ID 2083698 


 



7.
Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Muller-Hermelink HK, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, Fisher RI, Kuehl WM, Chan WC, Staudt LM (2007). Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med  204, 633-43.   https://doi.org/10.1084/jem.20062041




PubMed



        
     
Free Article


 


PubMed ID 17353367
         Pubmed Central ID 2137913 


 



8.
Zhan F, Colla S, Wu X, Chen B, Stewart JP, Kuehl WM, Barlogie B, Shaughnessy JD (2007). CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms. Blood  109, 4995-5001.   https://doi.org/10.1182/blood-2006-07-038703




PubMed



        
     
Free Article


 


PubMed ID 17303695
         Pubmed Central ID 1885527",https://intramural.nih.gov/search/searchview.taf?ipid=47038
597,SC006659-25,"October 01, 2006 -  September 30, 2007",Molecular Genetics of Kidney Cancer,"William Marston Linehan; MD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI",NULL,"William  Kaelin, M.D.
(HHMI, Dana Farber Cancer Institute)




Alfred  Knudson, M.D.
(Genetics, Fox Chase Cancer Center)




Masahiro  Yao, M.D.
(Urologic Surgery, Yokohama City University Medical School)","Steven  Libutti; MD (National Cancer Institute)



Gladys M. Glenn; MD, PhD (National Cancer Institute)



Jorge R Toro (National Cancer Institute)



Wong H Chow (National Cancer Institute)



Leonard  Neckers; PhD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)","Edward H. Oldfield; MD (NINDS) 



Karel  Pacak; MD, PhD (NICHD) 



Richard  Childs; MD (NHLBI) 



Emily Y Chew; MD (NEI) 



Pamela  Stratton; MD (NICHD) 



Bradford J Wood; MD (CC)","Ordered by publication type and then author name.



1.
Atkins MB, Bukowski RM, Escudier BJ, Figlin RA, Hudes GH, Kaelin WG, Linehan WM, McDermott DF, Mier JW, Pedrosa I, Rini BI, Signoretti S, Sosman JA, Teh BT, Wood CG, Zurita AJ, King L (2009). Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference. Cancer  115, 2247-51.   https://doi.org/10.1002/cncr.24229




PubMed



        
     
Free Article


 


PubMed ID 19402064
         Pubmed Central ID 2892290 


 



2.
Atkins MB, Ernstoff MS, Figlin RA, Flaherty KT, George DJ, Kaelin WG, Kwon ED, Libermann TA, Linehan WM, McDermott DF, Ochoa AC, Pantuck AJ, Rini BI, Rosen MA, Sosman JA, Sukhatme VP, Vieweg JW, Wood CG, King L (2007). Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference. Clin Cancer Res  13, 667s-670s.   https://doi.org/10.1158/1078-0432.CCR-06-2231




PubMed


 


PubMed ID 17255291
    
     


 



3.
Baba M, Furihata M, Hong SB, Tessarollo L, Haines DC, Southon E, Patel V, Igarashi P, Alvord WG, Leighty R, Yao M, Bernardo M, Ileva L, Choyke P, Warren MB, Zbar B, Linehan WM, Schmidt LS (2008). Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst  100, 140-54.   https://doi.org/10.1093/jnci/djm288




PubMed



        
     
Free Article


 


PubMed ID 18182616
         Pubmed Central ID 2704336 


 



4.
Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA, Sellers WR, Meyerson M, Linehan WM, Kaelin WG, Signoretti S (2009). Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res  69, 4674-81.   https://doi.org/10.1158/0008-5472.CAN-09-0146




PubMed



        
     
Free Article


 


PubMed ID 19470766
         Pubmed Central ID 2745239 


 



5.
Boris R, Proano M, Linehan WM, Pinto PA, Bratslavsky G (2009). Initial experience with robot assisted partial nephrectomy for multiple renal masses. J Urol  182, 1280-6.   https://doi.org/10.1016/j.juro.2009.06.036




PubMed



        
     
Free Article


 


PubMed ID 19683275
         Pubmed Central ID 2746326 


 



6.
Bratslavsky G, Sudarshan S, Neckers L, Linehan WM (2007). Pseudohypoxic pathways in renal cell carcinoma. Clin Cancer Res  13, 4667-71.   https://doi.org/10.1158/1078-0432.CCR-06-2510




PubMed


 


PubMed ID 17699843
    
     


 



7.
Brouwers FM, Gläsker S, Nave AF, Vortmeyer AO, Lubensky I, Huang S, Abu-Asab MS, Eisenhofer G, Weil RJ, Park DM, Linehan WM, Pacak K, Zhuang Z (2007). Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B. Endocr Relat Cancer  14, 463-71.   https://doi.org/10.1677/ERC-06-0038




PubMed


 


PubMed ID 17639059
    
     


 



8.
Catherino WH, Mayers CM, Mantzouris T, Armstrong AY, Linehan WM, Segars JH (2007). Compensatory alterations in energy homeostasis characterized in uterine tumors from hereditary leiomyomatosis and renal cell cancer. Fertil Steril  88, 1039-48.   https://doi.org/10.1016/j.fertnstert.2006.11.198




PubMed


 


PubMed ID 17383644
    
     


 



9.
Chow WH, Linehan WM, Devesa SS (2007). Re: Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst  99, 569-70; author reply 570-1.   https://doi.org/10.1093/jnci/djk114




PubMed


 


PubMed ID 17406001
    
     


 



10.
Crane NJ, McHone B, Hawksworth J, Pearl JP, Denobile J, Tadaki D, Pinto PA, Levin IW, Elster EA (2008). Enhanced surgical imaging: laparoscopic vessel identification and assessment of tissue oxygenation. J Am Coll Surg  206, 1159-66.   https://doi.org/10.1016/j.jamcollsurg.2008.01.013




PubMed



        
     
Free Article


 


PubMed ID 18501814
         Pubmed Central ID 2749562 


 



11.
Dahr SS, Cusick M, Rodriguez-Coleman H, Srivastava SK, Thompson DJ, Linehan WM, Ferris FL, Chew EY (2007). Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina. Retina  27, 150-8.   https://doi.org/10.1097/IAE.0b013e318030a290




PubMed


 


PubMed ID 17290195
    
     


 



12.
Giubellino A, Burke TR, Bottaro DP (2008). Grb2 signaling in cell motility and cancer. Expert Opin Ther Targets  12, 1021-33.   https://doi.org/10.1517/14728222.12.8.1021




PubMed



        
     
Free Article


 


PubMed ID 18620523
         Pubmed Central ID 2764957 


 



13.
Giubellino A, Linehan WM, Bottaro DP (2009). Targeting the Met signaling pathway in renal cancer. Expert Rev Anticancer Ther  9, 785-93.   https://doi.org/10.1586/era.09.43




PubMed



        
     
Free Article


 


PubMed ID 19496715
         Pubmed Central ID 2737331 


 



14.
Grubb RL, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM (2007). Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol  177, 2074-9; discussion 2079-80.   https://doi.org/10.1016/j.juro.2007.01.155




PubMed


 


PubMed ID 17509289
    
     


 



15.
Hasumi H, Baba M, Hong SB, Hasumi Y, Huang Y, Yao M, Valera VA, Linehan WM, Schmidt LS (2008). Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene  415, 60-7.   https://doi.org/10.1016/j.gene.2008.02.022




PubMed



        
     
Free Article


 


PubMed ID 18403135
         Pubmed Central ID 2727720 


 



16.
Iguchi M, Kakinuma Y, Kurabayashi A, Sato T, Shuin T, Hong SB, Schmidt LS, Furihata M (2008) Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidney. Nephron Exp Nephrol 110:e82-90.




PubMed



        
     
Free Article


 


PubMed ID 18957870
         Pubmed Central ID 2657226 


 



17.
Johnson A, Sudarshan S, Liu J, Linehan WM, Pinto PA, Bratslavsky G (2008). Feasibility and outcomes of repeat partial nephrectomy. J Urol  180, 89-93; discussion 93.   https://doi.org/10.1016/j.juro.2008.03.030




PubMed



        
     
Free Article


 


PubMed ID 18485404
         Pubmed Central ID 2748387 


 



18.
Kaji P, Carrasquillo JA, Linehan WM, Chen CC, Eisenhofer G, Pinto PA, Lai EW, Pacak K (2007). The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome. Eur J Endocrinol  156, 483-7.   https://doi.org/10.1530/EJE-06-0712




PubMed


 


PubMed ID 17389464
    
     


 



19.
Korde LA, Premkumar A, Mueller C, Rosenberg P, Soho C, Bratslavsky G, Greene MH (2008). Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives. Br J Cancer  99, 1748-53.   https://doi.org/10.1038/sj.bjc.6604704




PubMed



        
     
Free Article


 


PubMed ID 18841155
         Pubmed Central ID 2584936 


 



20.
Lee SJ, Lattouf JB, Xanthopoulos J, Linehan WM, Bottaro DP, Vasselli JR (2008). Von Hippel-Lindau tumor suppressor gene loss in renal cell carcinoma promotes oncogenic epidermal growth factor receptor signaling via Akt-1 and MEK-1. Eur Urol  54, 845-53.   https://doi.org/10.1016/j.eururo.2008.01.010




PubMed



        
     
Free Article


 


PubMed ID 18243508
         Pubmed Central ID 2596938 


 



21.
Linehan WM (2008). Kidney cancer: opportunity for disease specific targeted therapy. Urol Oncol  26, 542.   https://doi.org/10.1016/j.urolonc.2008.03.014




PubMed



        
     
Free Article


 


PubMed ID 18774470
         Pubmed Central ID 2593635 


 



22.
Linehan WM (2009). Genetic basis of bilateral renal cancer: implications for evaluation and management. J Clin Oncol  27, 3731-3.   https://doi.org/10.1200/JCO.2009.23.0045




PubMed



        
     
Free Article


 


PubMed ID 19597019
         Pubmed Central ID 5036849 


 



23.
Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R (2009). Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer  115, 2252-61.   https://doi.org/10.1002/cncr.24230




PubMed



        
     
Free Article


 


PubMed ID 19402075
         Pubmed Central ID 2720093 


 



24.
Linehan WM, Pinto PA, Srinivasan R, Merino M, Choyke P, Choyke L, Coleman J, Toro J, Glenn G, Vocke C, Zbar B, Schmidt LS, Bottaro D, Neckers L (2007). Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics. Clin Cancer Res  13, 671s-679s.   https://doi.org/10.1158/1078-0432.CCR-06-1870




PubMed


 


PubMed ID 17255292
    
     


 



25.
Linehan WM, Rubin JS, Bottaro DP (2009). VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma. Int J Biochem Cell Biol  41, 753-6.   https://doi.org/10.1016/j.biocel.2008.09.024




PubMed



        
     
Free Article


 


PubMed ID 18950731
         Pubmed Central ID 2684867 


 



26.
Linguraru MG, Gautam R, Peterson J, Yao J, Linehan WM, Summers RM (2009). RENAL TUMOR QUANTIFICATION AND CLASSIFICATION IN TRIPLE-PHASE CONTRAST-ENHANCED ABDOMINAL CT. Proc IEEE Int Symp Biomed Imaging  2009, 1310-1313.   https://doi.org/10.1109/ISBI.2009.5193305




PubMed



        
     
Free Article


 


PubMed ID 20383290
         Pubmed Central ID 2851160 


 



27.
Linguraru MG, Wang S, Shah F, Gautam R, Peterson J, Linehan W, Summers RM (2009). Computer-aided renal cancer quantification and classification from contrast-enhanced CT via histograms of curvature-related features. Conf Proc IEEE Eng Med Biol Soc  2009, 6679-82.   https://doi.org/10.1109/IEMBS.2009.5334012




PubMed



        
     
Free Article


 


PubMed ID 19964705
         Pubmed Central ID 2790723 


 



28.
Linguraru MG, Yao J, Gautam R, Peterson J, Li Z, Linehan WM, Summers RM (2009). Renal Tumor Quantification and Classification in Contrast-Enhanced Abdominal CT. Pattern Recognit  42, 1149-1161.   https://doi.org/10.1016/j.patcog.2008.09.018




PubMed



        
     
Free Article


 


PubMed ID 19492069
         Pubmed Central ID 2658597 


 



29.
Liu JJ, Alemozaffar M, McHone B, Dhanani N, Gage F, Pinto PA, Gorbach AM, Elster E (2008). Evaluation of real-time infrared intraoperative cholangiography in a porcine model. Surg Endosc  22, 2659-64.   https://doi.org/10.1007/s00464-008-9792-4




PubMed



        
     
Free Article


 


PubMed ID 18347867
         Pubmed Central ID 2737323 


 



30.
Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkar S, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Schmidt LS, Toro JR, Karami S, Hung R, Gerard GF, Linehan WM, Merino M, Zbar B, Boffetta P, Brennan P, et al. [4 more authors] (2008). Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res  14, 4726-34.   https://doi.org/10.1158/1078-0432.CCR-07-4921




PubMed



        
     
Free Article


 


PubMed ID 18676741
         Pubmed Central ID 2629664 


 



31.
Pfaffenroth EC, Linehan WM (2008). Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy. Expert Opin Biol Ther  8, 779-90.   https://doi.org/10.1517/14712598.8.6.779




PubMed



        
     
Free Article


 


PubMed ID 18476789
         Pubmed Central ID 2768039 


 



32.
Rogers CG, Blatt AM, Miles GE, Linehan WM, Pinto PA (2008). Concurrent robotic partial adrenalectomy and extra-adrenal pheochromocytoma resection in a pediatric patient with von Hippel-Lindau disease. J Endourol  22, 1501-3.   https://doi.org/10.1089/end.2007.0314




PubMed



        
     
Free Article


 


PubMed ID 18690816
         Pubmed Central ID 2648969 


 



33.
Rogers CG, Linehan WM, Pinto PA (2008). Robotic nephrectomy for kidney cancer in a horseshoe kidney with renal vein tumor thrombus: novel technique for thrombectomy. J Endourol  22, 1561-3; discussion 1563.   https://doi.org/10.1089/end.2008.0043




PubMed



        
     
Free Article


 


PubMed ID 18721039
         Pubmed Central ID 2637611 


 



34.
Rogers CG, Metwalli A, Blatt AM, Bratslavsky G, Menon M, Linehan WM, Pinto PA (2008). Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis. J Urol  180, 2353-6; discussion 2356.   https://doi.org/10.1016/j.juro.2008.08.022




PubMed



        
     
Free Article


 


PubMed ID 18930263
         Pubmed Central ID 2648867 


 



35.
Rogers CG, Singh A, Blatt AM, Linehan WM, Pinto PA (2008). Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol  53, 514-21.   https://doi.org/10.1016/j.eururo.2007.09.047




PubMed



        
     
Free Article


 


PubMed ID 17961910
         Pubmed Central ID 2644902 


 



36.
Rosner I, Bratslavsky G, Pinto PA, Linehan WM (2009). The clinical implications of the genetics of renal cell carcinoma. Urol Oncol  27, 131-6.   https://doi.org/10.1016/j.urolonc.2008.11.001




PubMed



        
     
Free Article


 


PubMed ID 19285230
         Pubmed Central ID 2686112 


 



37.
Signoretti S, Bratslavsky G, Waldman FM, Reuter VE, Haaga J, Merino M, Thomas GV, Pins MR, Libermann T, Gillespie J, Tomaszewski JE, Compton CC, Hruszkewycz A, Linehan WM, Atkins MB (2008). Tissue-based research in kidney cancer: current challenges and future directions. Clin Cancer Res  14, 3699-705.   https://doi.org/10.1158/1078-0432.CCR-07-4733




PubMed



        
     
Free Article


 


PubMed ID 18559586
         Pubmed Central ID 2586673 


 



38.
Sourbier C, Ricketts CJ, Matsumoto S, Crooks DR, Liao PJ, Mannes PZ, Yang Y, Wei MH, Srivastava G, Ghosh S, Chen V, Vocke CD, Merino M, Srinivasan R, Krishna MC, Mitchell JB, Pendergast AM, Rouault TA, Neckers L, Linehan WM (2014). Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer. Cancer Cell  26, 840-850.   https://doi.org/10.1016/j.ccell.2014.10.005




PubMed



        
     
Free Article


 


PubMed ID 25490448
         Pubmed Central ID 4386283 


 



39.
Sudarshan S, Linehan WM, Neckers L (2007). HIF and fumarate hydratase in renal cancer. Br J Cancer  96, 403-7.   https://doi.org/10.1038/sj.bjc.6603547




PubMed



        
     
Free Article


 


PubMed ID 17211469
         Pubmed Central ID 2360036 


 



40.
Sudarshan S, Pinto PA, Neckers L, Linehan WM (2007). Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer. Nat Clin Pract Urol  4, 104-10.   https://doi.org/10.1038/ncpuro0711




PubMed


 


PubMed ID 17287871
    
     


 



41.
Sudarshan S, Sourbier C, Kong HS, Block K, Valera Romero VA, Yang Y, Galindo C, Mollapour M, Scroggins B, Goode N, Lee MJ, Gourlay CW, Trepel J, Linehan WM, Neckers L (2009). Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol  29, 4080-90.   https://doi.org/10.1128/MCB.00483-09




PubMed



               Available in future as a Free Article 


 


PubMed ID 19470762
         Pubmed Central ID 2715796 


 



42.
Toro JR, Pautler SE, Stewart L, Glenn GM, Weinreich M, Toure O, Wei MH, Schmidt LS, Davis L, Zbar B, Choyke P, Steinberg SM, Nguyen DM, Linehan WM (2007). Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome. Am J Respir Crit Care Med  175, 1044-53.   https://doi.org/10.1164/rccm.200610-1483OC




PubMed



        
     
Free Article


 


PubMed ID 17322109
         Pubmed Central ID 1899269 


 



43.
Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM (2008). BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet  45, 321-31.   https://doi.org/10.1136/jmg.2007.054304




PubMed



        
     
Free Article


 


PubMed ID 18234728
         Pubmed Central ID 2564862 


 



44.
Tsutsumi S, Scroggins B, Koga F, Lee MJ, Trepel J, Felts S, Carreras C, Neckers L (2008). A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene  27, 2478-87.   https://doi.org/10.1038/sj.onc.1210897




PubMed



        
     
Free Article


 


PubMed ID 17968312
         Pubmed Central ID 2754825 


 



45.
Vira M, Linehan WM (2007). Expanding the morphological and molecular genetic phenotype of kidney cancer. J Urol  177, 10-1.   https://doi.org/10.1016/j.juro.2006.10.011




PubMed


 


PubMed ID 17161990
    
     


 



46.
Vira MA, Novakovic KR, Pinto PA, Linehan WM (2007). Genetic basis of kidney cancer: a model for developing molecular-targeted therapies. BJU Int  99, 1223-9.   https://doi.org/10.1111/j.1464-410X.2007.06814.x




PubMed


 


PubMed ID 17441915
    
     


 



47.
Wong WT, Agrón E, Coleman HR, Reed GF, Csaky K, Peterson J, Glenn G, Linehan WM, Albert P, Chew EY (2007). Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis. Arch Ophthalmol  125, 239-45.   https://doi.org/10.1001/archopht.125.2.239




PubMed



        
     
Free Article


 


PubMed ID 17296901
         Pubmed Central ID 3019103 


 



48.
Xie H, Valera VA, Merino MJ, Amato AM, Signoretti S, Linehan WM, Sukhatme VP, Seth P (2009). LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer. Mol Cancer Ther  8, 626-35.   https://doi.org/10.1158/1535-7163.MCT-08-1049




PubMed



        
     
Free Article


 


PubMed ID 19276158
         Pubmed Central ID 2671637 


 



49.
Yang Y, Padilla-Nash HM, Vira MA, Abu-Asab MS, Val D, Worrell R, Tsokos M, Merino MJ, Pavlovich CP, Ried T, Linehan WM, Vocke CD (2008). The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dubé gene pathway. Cancer Genet Cytogenet  180, 100-9.   https://doi.org/10.1016/j.cancergencyto.2007.10.010




PubMed



        
     
Free Article


 


PubMed ID 18206534
         Pubmed Central ID 2440670 


 



50.
Zbar B, Glenn G, Merino M, Middelton L, Peterson J, Toro J, Coleman J, Pinto P, Schmidt LS, Choyke P, Linehan WM (2007). Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development. J Urol  177, 461-5; discussion 465.   https://doi.org/10.1016/j.juro.2006.09.037




PubMed


 


PubMed ID 17222609",https://intramural.nih.gov/search/searchview.taf?ipid=47039
598,SC006660-23,"October 01, 2006 -  September 30, 2007",Defining the T-cell Response to Human Renal Cancer,"James Chung-Yin Yang; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Qiong J Wang



Takashi  Inozume",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ilyas S, Yang JC (2015). Landscape of Tumor Antigens in T Cell Immunotherapy. J Immunol  195, 5117-22.   https://doi.org/10.4049/jimmunol.1501657




PubMed



        
     
Free Article


 


PubMed ID 26589749
         Pubmed Central ID 4656134 


 



2.
Wang QJ, Hanada K, Yang JC (2008). Characterization of a novel nonclassical T cell clone with broad reactivity against human renal cell carcinomas. J Immunol  181, 3769-76.   https://doi.org/10.4049/jimmunol.181.6.3769




PubMed



        
     
Free Article


 


PubMed ID 18768829
         Pubmed Central ID 2587430 


 



3.
Wang QJ, Yu Z, Hanada KI, Patel K, Kleiner D, Restifo NP, Yang JC (2017). Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers. Clin Cancer Res  23, 2267-2276.   https://doi.org/10.1158/1078-0432.CCR-16-1421




PubMed



        
     
Free Article


 


PubMed ID 27803044
         Pubmed Central ID 5411349",https://intramural.nih.gov/search/searchview.taf?ipid=47010
599,SC006663-18,"October 01, 2006 -  September 30, 2007",Characterization and Regulation of High Risk and Malignant Breast Epithelium,David  Danforth,NULL,"Surgery Branch, NCI",Joan E Harris,NULL,"Armando  Filie (National Cancer Institute)



Andrea  Abati; BS, MD (National Cancer Institute)



Karl Thomas Ried; MD (National Cancer Institute)



Patricia  Steeg; PhD (National Cancer Institute)



Barbara V Vonderhaar; PhD (National Cancer Institute)



Mark H Greene; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47040
600,SC006732-19,"October 01, 2006 -  September 30, 2007",Multidrug resistance Mediated by P-glycoprotein,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI","Lyn  Mickley Huff



Hui  Huang



Edina M Komlodi-pasztor","Branimir  Sikic
(Division of Oncology, Stanford University)




Wilfred  Stein
(Biological Chemistry, Silberman Institute of Life Sciences, Hebrew University of Jerusalem)","Susan  Bates; MD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Stein WD, Litman T, Fojo T, Bates SE (2007). A database study that identifies genes whose expression correlates, negatively or positively, with 5-year survival of cancer patients. Biochim Biophys Acta  1770, 857-71.   https://doi.org/10.1016/j.bbagen.2006.12.013




PubMed


 


PubMed ID 17398010",https://intramural.nih.gov/search/searchview.taf?ipid=47041
601,SC006737-16,"October 01, 2006 -  September 30, 2007",Development of Novel Therapies for HIV Infection and AIDS-Related Malignancies,"Robert  Yarchoan; MD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI","Richard  Little; MD, PhD



Muzammel  Haque



David A Davis; MD



Victoria Y Wang



Kathleen M Wyvill



Karen O Aleman



Show all 10","Jean  Chmielewski
(Purdue University)




Shinji  Harada
(Department of Medical Virology, Kumomoto University)




Indira  Hewlett; PhD





Takahiro  Okazaki
(Internal Medicine, St. Marianna School of Medicine)




Rolf  Renne
(Case Western Reserave University, Cleveland, OH)","Deirdre  O'Mahony (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)



Giovanna  Tosato; PhD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)



Hiroaki  Mitsuya (National Cancer Institute)","Moinuddin  Hassan; PhD (NICHD) 



Henry M. Fales; PhD (NHLBI) 



Paul T Wingfield; PhD (NIAMS) 



Joseph A Kovacs; MD (NIAID) 



Amir Hossein Gandjbakhche; PhD (NICHD) 



Jeffrey  Cohen; MD (NIAID)","Ordered by publication type and then author name.



1.
Yarchoan R   (2007) AIDS-Related Malignancies., in Cancer: Principles and Practice of Oncology, 8th Edition. DeVita, Jr. V, Lawrence T, Rosenberg S, eds., Lippincott, Williams, and WIlkins (Baltimore), in press.




 



2.
Yarchoan R, Pittaluga S   (2007) Non-Hodgkin lymphoma., in AIDS Therapy, 3rd Edition. Dolin R, Masur H, Saag M, eds., Chrchill Livingstone/Elsevier (Philadelphia), in press.




 



3.
Davis DA, Singer KE, Reynolds IP, Haque M, Yarchoan R (2007). Hypoxia enhances the phosphorylation and cytotoxicity of ganciclovir and zidovudine in Kaposi's sarcoma-associated herpesvirus infected cells. Cancer Res  67, 7003-10.   https://doi.org/10.1158/0008-5472.CAN-07-0939




PubMed


 


PubMed ID 17638913
    
     


 



4.
Marshall V, Parks T, Bagni R, Wang CD, Samols MA, Hu J, Wyvil KM, Aleman K, Little RF, Yarchoan R, Renne R, Whitby D (2007). Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J Infect Dis  195, 645-59.   https://doi.org/10.1086/511434




PubMed


 


PubMed ID 17262705
    
     


 



5.
O'Mahony D, Gandjbakche A, Hassan M, Vogel A, Yarchoan R (2008). Imaging techniques for Kaposi's sarcoma. J HIV Ther  13, 65-71.




PubMed



        
     
Free Article


 


PubMed ID 19039297
         Pubmed Central ID 2600536 


 



6.
Yarchoan R, Wyvill K, Aleman K, Rodriguez-Chavez I, Tosato G, Catanzaro A, Steinberg S, Little R   (2007) Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: Rationale and preliminary evidence of clinical activity.  Critical Reviews in Immunology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=47042
602,SC006738-15,"October 01, 2006 -  September 30, 2007",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI","Shigeyoshi  Harada



Kenji  Maeda



Kiyoto  Tsuchiya



Debananda  Das; PhD



Hirotomo  Nakata","Eddy  Arnold; PhD
(Chemistry and Chemical Biology, CABM and Rutgers University)




Nobutaka  Fujii
(Department of Pharmacy, Kyoto University)




Arun  Ghosh





Yoshio  Koyanagi





Masao  Matsuoka





Shinichi  Oka



Show all 9","Seth M Steinberg; PhD (National Cancer Institute)



Victor  Marquez; PhD (National Cancer Institute)



Robert  Yarchoan; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Amano M, Koh Y, Das D, Li J, Leschenko S, Wang YF, Boross PI, Weber IT, Ghosh AK, Mitsuya H (2007). A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitro. Antimicrob Agents Chemother  51, 2143-55.   https://doi.org/10.1128/AAC.01413-06




PubMed



        
     
Free Article


 


PubMed ID 17371811
         Pubmed Central ID 1891396 


 



2.
Ghosh AK, Chapsal BD, Weber IT, Mitsuya H (2008). Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance. Acc Chem Res  41, 78-86.   https://doi.org/10.1021/ar7001232




PubMed


 


PubMed ID 17722874
    
     


 



3.
Harada S, Hazra R, Tamiya S, Zeichner SL, Mitsuya H (2007). Emergence of human immunodeficiency virus type 1 variants containing the Q151M complex in children receiving long-term antiretroviral chemotherapy. Antiviral Res  75, 159-66.   https://doi.org/10.1016/j.antiviral.2007.02.004




PubMed


 


PubMed ID 17418430
    
     


 



4.
Koh Y, Matsumi S, Das D, Amano M, Davis DA, Li J, Leschenko S, Baldridge A, Shioda T, Yarchoan R, Ghosh AK, Mitsuya H (2007). Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization. J Biol Chem  282, 28709-20.   https://doi.org/10.1074/jbc.M703938200




PubMed


 


PubMed ID 17635930
    
     


 



5.
Nakata H, Amano M, Koh Y, Kodama E, Yang G, Bailey CM, Kohgo S, Hayakawa H, Matsuoka M, Anderson KS, Cheng YC, Mitsuya H (2007). Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4'-ethynyl-2-fluoro-2'-deoxyadenosine. Antimicrob Agents Chemother  51, 2701-8.   https://doi.org/10.1128/AAC.00277-07




PubMed



        
     
Free Article


 


PubMed ID 17548498
         Pubmed Central ID 1932487",https://intramural.nih.gov/search/searchview.taf?ipid=47011
603,SC006741-14,"October 01, 2006 -  September 30, 2007",Lymphoma Studies,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)



Elaine S Jaffe; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)



Andrea  Abati; BS, MD (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Dunleavy K, Davis RE, Landgren O, Staudt LM, Wilson WH (2007). BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we? Blood  109, 843-4; discussion 844-5.   https://doi.org/10.1182/blood-2006-07-038000




PubMed


 


PubMed ID 17210865
    
     


 



2.
Dunleavy K, Staudt LM, Wilson WH (2007). The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma. Leuk Lymphoma  48, 1061-3.   https://doi.org/10.1080/10428190701420467




PubMed


 


PubMed ID 17577765
    
     


 



3.
Dunleavy K, Wilson WH (2007). Angioimmunoblastic T-cell lymphoma: immune modulation as a therapeutic strategy. Leuk Lymphoma  48, 449-51.   https://doi.org/10.1080/10428190701245138




PubMed


 


PubMed ID 17454581
    
     


 



4.
Dunleavy K, Wilson WH, Jaffe ES (2007). Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications. Curr Opin Hematol  14, 348-53.   https://doi.org/10.1097/MOH.0b013e328186ffbf




PubMed


 


PubMed ID 17534160
    
     


 



5.
Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI, et al. [5 more authors] (2007). Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood  109, 4599-606.   https://doi.org/10.1182/blood-2006-08-039859




PubMed



        
     
Free Article


 


PubMed ID 17299095
         Pubmed Central ID 1885523",https://intramural.nih.gov/search/searchview.taf?ipid=47012
604,SC006743-14,"October 01, 2006 -  September 30, 2007",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Sunmin T Lee



Yeong Sang  Kim","Jay  Bradner
(Chemical Biology Program, Broad Institute)




Judith  Karp
(Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)","Daniel H Fowler (National Cancer Institute)



John Charles Morris; MD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)



J. Frederic Mushinski; MD (National Cancer Institute)



Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)



Leonard  Neckers; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Giubellino A, Gao Y, Lee S, Lee MJ, Vasselli JR, Medepalli S, Trepel JB, Burke TR, Bottaro DP (2007). Inhibition of tumor metastasis by a growth factor receptor bound protein 2 Src homology 2 domain-binding antagonist. Cancer Res  67, 6012-6.   https://doi.org/10.1158/0008-5472.CAN-07-0022




PubMed


 


PubMed ID 17616655
    
     


 



2.
Gojo I, Jiemjit A, Trepel JB, Sparreboom A, Figg WD, Rollins S, Tidwell ML, Greer J, Chung EJ, Lee MJ, Gore SD, Sausville EA, Zwiebel J, Karp JE (2007). Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias. Blood  109, 2781-90.   https://doi.org/10.1182/blood-2006-05-021873




PubMed



        
     
Free Article


 


PubMed ID 17179232
         Pubmed Central ID 1852211 


 



3.
Kajiguchi T, Chung EJ, Lee S, Stine A, Kiyoi H, Naoe T, Levis MJ, Neckers L, Trepel JB (2007). FLT3 regulates beta-catenin tyrosine phosphorylation, nuclear localization, and transcriptional activity in acute myeloid leukemia cells. Leukemia  21, 2476-84.   https://doi.org/10.1038/sj.leu.2404923




PubMed


 


PubMed ID 17851558
    
     


 



4.
Trepel J, Chung E, Lee S, Chung J, Telford W, Sausville E, Gojo I, Karp J, Gore S, Kapoor V, Kim Y, Kummar S, Gutierrez M, Hewitt S   (2007) A cell microarray patform for anticancer drug development.  Drug Dev. Res, in press.




 



5.
Trepel J, Gutierrez M, Gardner E, Donovan E, Hwang K, Chung E, Lee M, Maynard K, Kalnitskiy M, Chen A, Melillo G, Ryan Q, Conley B, Figg W, Zwiebel J, Doroshow J, Murgo A   (2007) Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies.  Clin. Cancer Res, in press.




 



6.
Trepel J, Lee S, Lee M, Neckers L   (2007) c-kit upregulates Wnt signaling in human mast cell leukemia.  Leukemia Res, in press.




 



7.
Xu W, Soga S, Beebe K, Lee MJ, Kim YS, Trepel J, Neckers L (2007). Sensitivity of epidermal growth factor receptor and ErbB2 exon 20 insertion mutants to Hsp90 inhibition. Br J Cancer  97, 741-4.   https://doi.org/10.1038/sj.bjc.6603950




PubMed



        
     
Free Article


 


PubMed ID 17712310
         Pubmed Central ID 2360392",https://intramural.nih.gov/search/searchview.taf?ipid=47102
605,SC006830-37,"October 01, 2006 -  September 30, 2007","Treatment of Infections in Immunocompromised Children with Cancer, Hematopoietic",Thomas J. Walsh; MD,NULL,"Pediatric Oncology Branch, NCI","Karoll  Cortez



Miki B Kasai



Jennifer D Rabb



Robert L Schaufele



Theodouli  Stergiopoulou



Tena A Knudsen



Show all 15","Antonio  Arrieta
(Infectious Diseases, Children's Hospital)




Donald  Buell
(Biomedical Research, Astellas)




Anthony  DeLucca
(Southern Regional Research Laboratory, USDA)




David  Denning; MD
(Department pf Medicine, Manchester University)




William  Dismukes
(Medicine, University of Alabama at Birmingham)




Gerald  Donowitz
(Medicine, Univ Virginia)


Show all 27","Terry J Fry (National Cancer Institute)



Javed  Khan; MD (National Cancer Institute)



Stephen J Chanock; MD, PhD (National Cancer Institute)



John U Dennis (National Cancer Institute)



Elizabeth  Fox; MD (National Cancer Institute)



Alan S Wayne; MD (National Cancer Institute)","Patrick R. Murray; PhD (CC) 



Anthony F Suffredini; MD (CC) 



Steven M Holland; MD (NIAID) 



Yvonne D Shea (CC) 



Richard  Childs; MD (NHLBI) 



Nilo Alonso Avila; MD (CC)","Ordered by publication type and then author name.



1.
Antachopoulos C, Meletiadis J, Sein T, Roilides E, Walsh TJ (2007). Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species. Antimicrob Agents Chemother  51, 881-7.   https://doi.org/10.1128/AAC.01160-06




PubMed



        
     
Free Article


 


PubMed ID 17145783
         Pubmed Central ID 1803126 


 



2.
Antachopoulos C, Meletiadis J, Sein T, Roilides E, Walsh TJ (2007). Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species. J Antimicrob Chemother  59, 230-7.   https://doi.org/10.1093/jac/dkl488




PubMed


 


PubMed ID 17185296
    
     


 



3.
Antachopoulos C, Walsh TJ, Roilides E (2007). Fungal infections in primary immunodeficiencies. Eur J Pediatr  166, 1099-117.   https://doi.org/10.1007/s00431-007-0527-7




PubMed


 


PubMed ID 17551753
    
     


 



4.
Cohen-Wolkowiez M, Smith PB, Mangum B, Steinbach WJ, Alexander BD, Cotten CM, Clark RH, Walsh TJ, Benjamin DK (2007). Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures. J Perinatol  27, 97-100.   https://doi.org/10.1038/sj.jp.7211628




PubMed


 


PubMed ID 17080094
    
     


 



5.
Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D (2007). Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med  356, 348-59.   https://doi.org/10.1056/NEJMoa061094




PubMed


 


PubMed ID 17251531
    
     


 



6.
Cummings JR, Jamison GR, Boudreaux JW, Howles MJ, Walsh TJ, Hayden RT (2007). Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn Microbiol Infect Dis  59, 113-5.   https://doi.org/10.1016/j.diagmicrobio.2007.04.022




PubMed


 


PubMed ID 17662550
    
     


 



7.
De Jesus M, Hackett E, Durkin M, Connolly P, Casadevall A, Petraitiene R, Walsh TJ, Wheat LJ (2007). Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol  14, 624-7.   https://doi.org/10.1128/CVI.00368-06




PubMed



        
     
Free Article


 


PubMed ID 17360857
         Pubmed Central ID 1865626 


 



8.
Espinel-Ingroff A, Fothergill A, Ghannoum M, Manavathu E, Ostrosky-Zeichner L, Pfaller MA, Rinaldi MG, Schell W, Walsh TJ (2007). Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds. J Clin Microbiol  45, 2180-2.   https://doi.org/10.1128/JCM.00399-07




PubMed



        
     
Free Article


 


PubMed ID 17475760
         Pubmed Central ID 1932988 


 



9.
Hope WW, Drusano GL, Moore CB, Sharp A, Louie A, Walsh TJ, Denning DW, Warn PA (2007). Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis. Antimicrob Agents Chemother  51, 285-95.   https://doi.org/10.1128/AAC.00601-06




PubMed



        
     
Free Article


 


PubMed ID 17088486
         Pubmed Central ID 1797682 


 



10.
Hope WW, Kruhlak MJ, Lyman CA, Petraitiene R, Petraitis V, Francesconi A, Kasai M, Mickiene D, Sein T, Peter J, Kelaher AM, Hughes JE, Cotton MP, Cotten CJ, Bacher J, Tripathi S, Bermudez L, Maugel TK, Zerfas PM, Wingard JR, Drusano GL, Walsh TJ (2007). Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis  195, 455-66.   https://doi.org/10.1086/510535




PubMed


 


PubMed ID 17205486
    
     


 



11.
Hope WW, Seibel NL, Schwartz CL, Arrieta A, Flynn P, Shad A, Albano E, Keirns JJ, Buell DN, Gumbo T, Drusano GL, Walsh TJ (2007). Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing. Antimicrob Agents Chemother  51, 3714-9.   https://doi.org/10.1128/AAC.00398-07




PubMed



        
     
Free Article


 


PubMed ID 17638696
         Pubmed Central ID 2043253 


 



12.
Hope WW, Shoham S, Walsh TJ (2007). The pharmacology and clinical use of caspofungin. Expert Opin Drug Metab Toxicol  3, 263-74.   https://doi.org/10.1517/17425255.3.2.263




PubMed


 


PubMed ID 17428155
    
     


 



13.
Hope WW, Warn PA, Sharp A, Reed P, Keevil B, Louie A, Walsh TJ, Denning DW, Drusano GL (2007). Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing. Antimicrob Agents Chemother  51, 3760-2.   https://doi.org/10.1128/AAC.00488-07




PubMed



        
     
Free Article


 


PubMed ID 17682101
         Pubmed Central ID 2043255 


 



14.
Meletiadis J, Antachopoulos C, Stergiopoulou T, Pournaras S, Roilides E, Walsh TJ (2007). Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology. Antimicrob Agents Chemother  51, 3329-37.   https://doi.org/10.1128/AAC.00345-07




PubMed



        
     
Free Article


 


PubMed ID 17576838
         Pubmed Central ID 2043246 


 



15.
Meletiadis J, Stergiopoulou T, O'Shaughnessy EM, Peter J, Walsh TJ (2007). Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model. Antimicrob Agents Chemother  51, 2053-64.   https://doi.org/10.1128/AAC.00873-06




PubMed



        
     
Free Article


 


PubMed ID 17387150
         Pubmed Central ID 1891373 


 



16.
Meletiadis J, Walsh TJ, Choi EH, Pappas PG, Ennis D, Douglas J, Pankey GA, Larsen RA, Hamill RJ, Chanock S (2007). Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients. Med Mycol  45, 513-8.   https://doi.org/10.1080/13693780701390140




PubMed


 


PubMed ID 17710620
    
     


 



17.
Reboli AC, Rotstein C, Pappas PG, Chapman SW, Kett DH, Kumar D, Betts R, Wible M, Goldstein BP, Schranz J, Krause DS, Walsh TJ, Anidulafungin Study Group (2007). Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med  356, 2472-82.   https://doi.org/10.1056/NEJMoa066906




PubMed


 


PubMed ID 17568028
    
     


 



18.
Santos RP, Sánchez PJ, Mejias A, Benjamin DK, Walsh TJ, Patel S, Jafri HS (2007). Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin. Pediatr Infect Dis J  26, 364-6.   https://doi.org/10.1097/01.inf.0000258698.98370.89




PubMed


 


PubMed ID 17414408
    
     


 



19.
Segal BH, Almyroudis NG, Battiwalla M, Herbrecht R, Perfect JR, Walsh TJ, Wingard JR (2007). Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clin Infect Dis  44, 402-9.   https://doi.org/10.1086/510677




PubMed


 


PubMed ID 17205448
    
     


 



20.
Simitsopoulou M, Roilides E, Likartsis C, Ioannidis J, Orfanou A, Paliogianni F, Walsh TJ (2007). Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus. Antimicrob Agents Chemother  51, 1048-54.   https://doi.org/10.1128/AAC.01095-06




PubMed



        
     
Free Article


 


PubMed ID 17178797
         Pubmed Central ID 1803127 


 



21.
Smith PB, Steinbach WJ, Cotten CM, Schell WA, Perfect JR, Walsh TJ, Benjamin DK (2007). Caspofungin for the treatment of azole resistant candidemia in a premature infant. J Perinatol  27, 127-9.   https://doi.org/10.1038/sj.jp.7211637




PubMed


 


PubMed ID 17262048
    
     


 



22.
Stergiopoulou T, Meletiadis J, Roilides E, Kleiner DE, Schaufele R, Roden M, Harrington S, Dad L, Segal B, Walsh TJ (2007). Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Pathol  127, 349-55.   https://doi.org/10.1309/UJRV9DLC11RM3G8R




PubMed


 


PubMed ID 17276936
    
     


 



23.
Verdaguer V, Walsh TJ, Hope W, Cortez KJ (2007). Galactomannan antigen detection in the diagnosis of invasive aspergillosis. Expert Rev Mol Diagn  7, 21-32.   https://doi.org/10.1586/14737159.7.1.21




PubMed


 


PubMed ID 17187481
    
     


 



24.
Walsh TJ, Raad I, Patterson TF, Chandrasekar P, Donowitz GR, Graybill R, Greene RE, Hachem R, Hadley S, Herbrecht R, Langston A, Louie A, Ribaud P, Segal BH, Stevens DA, van Burik JA, White CS, Corcoran G, Gogate J, Krishna G, Pedicone L, Hardalo C, Perfect JR (2007). Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis  44, 2-12.   https://doi.org/10.1086/508774




PubMed


 


PubMed ID 17143808
    
     


 



25.
Wheat LJ, Hackett E, Durkin M, Connolly P, Petraitiene R, Walsh TJ, Knox K, Hage C (2007). Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol  14, 638-40.   https://doi.org/10.1128/CVI.00479-06




PubMed



        
     
Free Article


 


PubMed ID 17344352
         Pubmed Central ID 1865624 


 



26.
Zaoutis TE, Heydon K, Localio R, Walsh TJ, Feudtner C (2007). Outcomes attributable to neonatal candidiasis. Clin Infect Dis  44, 1187-93.   https://doi.org/10.1086/513196




PubMed


 


PubMed ID 17407037",https://intramural.nih.gov/search/searchview.taf?ipid=47044
606,SC006880-30,"October 01, 2006 -  September 30, 2007",Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Can,"Frank M Balis; MD, PhD",NULL,"Pediatric Oncology Branch, NCI","Patricia O Whitcomb



Elizabeth  Fox; MD



Diane  Cole



Mary  Hawkins



Nalini M Jayaprakash



Robert F Murphy



Show all 9","Peter Charles Adamson; MD





Adekunle  Adesina





Rochelle  Bagatell
(Pediatric Oncology, University of Arizona)




Eliel  Bayever
(Oncology, Johnson & Johnson)




Stacey  Berg
(Pediatric Oncology, Baylor Univ.)




Susan  Blaney
(Pediatric Oncology, Baylor)


Show all 28","Kenneth H Kraemer; MD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)



Katherine Elizabeth Warren; MD (National Cancer Institute)","Clara Chi Chen; MD (CC) 



Danny L Sackett; PhD (NICHD) 



Stephen John Marx; MD (NIDDK) 



Constantine Argyrios Stratakis; MD, DSc (NICHD) 



Maya Beth Lodish (NICHD)","Ordered by publication type and then author name.



1.
Fox E, Widemann BC, Chuk MK, Marcus L, Aikin A, Whitcomb PO, Merino MJ, Lodish M, Dombi E, Steinberg SM, Wells SA, Balis FM (2013). Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma. Clin Cancer Res  19, 4239-48.   https://doi.org/10.1158/1078-0432.CCR-13-0071




PubMed



        
     
Free Article


 


PubMed ID 23766359
         Pubmed Central ID 4274128",https://intramural.nih.gov/search/searchview.taf?ipid=47045
607,SC006891-19,"October 01, 2006 -  September 30, 2007",Solid Tumors,"Lee Jay Helman; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Lauren M Long,NULL,"Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kummar S, Kinders R, Rubinstein L, Parchment RE, Murgo AJ, Collins J, Pickeral O, Low J, Steinberg SM, Gutierrez M, Yang S, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH (2007). Compressing drug development timelines in oncology using phase '0' trials. Nat Rev Cancer  7, 131-9.   https://doi.org/10.1038/nrc2066




PubMed


 


PubMed ID 17251919
    
     


 



2.
Paz-Priel I, Long L, Helman LJ, Mackall CL, Wayne AS (2007). Thromboembolic events in children and young adults with pediatric sarcoma. J Clin Oncol  25, 1519-24.   https://doi.org/10.1200/JCO.2006.06.9930




PubMed


 


PubMed ID 17442994",https://intramural.nih.gov/search/searchview.taf?ipid=47046
608,SC006892-19,"October 01, 2006 -  September 30, 2007",Molecular Biology of Pediatric Tumors,"Lee Jay Helman; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Xiaolin  Wan



Choh L Yeung



Patrick  Grohar



Duane  Currier",NULL,"Nealapheur L Khan (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Merchant MS, Melchionda F, Sinha M, Khanna C, Helman L, Mackall CL (2007). Immune reconstitution prevents metastatic recurrence of murine osteosarcoma. Cancer Immunol Immunother  56, 1037-46.   https://doi.org/10.1007/s00262-006-0257-0




PubMed


 


PubMed ID 17149595
    
     


 



2.
Petricoin EF, Espina V, Araujo RP, Midura B, Yeung C, Wan X, Eichler GS, Johann DJ, Qualman S, Tsokos M, Krishnan K, Helman LJ, Liotta LA (2007). Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res  67, 3431-40.   https://doi.org/10.1158/0008-5472.CAN-06-1344




PubMed


 


PubMed ID 17409454
    
     


 



3.
Wan X, Harkavy B, Shen N, Grohar P, Helman LJ (2007). Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene  26, 1932-40.   https://doi.org/10.1038/sj.onc.1209990




PubMed


 


PubMed ID 17001314",https://intramural.nih.gov/search/searchview.taf?ipid=47047
609,SC007202-23,"October 01, 2006 -  September 30, 2007",Biostatistics and Data Management Section,Seth M Steinberg; PhD,"Frank M Balis; MD, PhD","Office of the Director, NCI","David J Venzon; PhD



David J Liewehr",NULL,"Daniel H Fowler (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)



Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)



Scott  Abrams; PhD (National Cancer Institute)



Richard Lawrence Piekarz (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Demberg T, Florese RH, Heath MJ, Larsen K, Kalisz I, Kalyanaraman VS, Lee EM, Pal R, Venzon D, Grant R, Patterson LJ, Korioth-Schmitz B, Buzby A, Dombagoda D, Montefiori DC, Letvin NL, Cafaro A, Ensoli B, Robert-Guroff M (2007). A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J Virol  81, 3414-27.   https://doi.org/10.1128/JVI.02453-06




PubMed



        
     
Free Article


 


PubMed ID 17229693
         Pubmed Central ID 1866031 


 



2.
Denduluri N, Lee JJ, Walshe J, Berman AW, Vatas U, Chow CK, Steinberg SM, Cox MC, Low JA, Swain SM (2007). Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer. Invest New Drugs  25, 63-7.   https://doi.org/10.1007/s10637-006-9006-7




PubMed


 


PubMed ID 16933153
    
     


 



3.
Denduluri N, Low JA, Lee JJ, Berman AW, Walshe JM, Vatas U, Chow CK, Steinberg SM, Yang SX, Swain SM (2007). Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanes. J Clin Oncol  25, 3421-7.   https://doi.org/10.1200/JCO.2006.10.0784




PubMed


 


PubMed ID 17606971
    
     


 



4.
Dombi E, Solomon J, Gillespie AJ, Fox E, Balis FM, Patronas N, Korf BR, Babovic-Vuksanovic D, Packer RJ, Belasco J, Goldman S, Jakacki R, Kieran M, Steinberg SM, Widemann BC (2007). NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology  68, 643-7.   https://doi.org/10.1212/01.wnl.0000250332.89420.e6




PubMed


 


PubMed ID 17215493
    
     


 



5.
Figg WD, Li H, Sissung T, Retter A, Wu S, Gulley JL, Arlen P, Wright JJ, Parnes H, Fedenko K, Latham L, Steinberg SM, Jones E, Chen C, Dahut W (2007). Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer. BJU Int  99, 1047-55.   https://doi.org/10.1111/j.1464-410X.2007.06763.x




PubMed


 


PubMed ID 17437439
    
     


 



6.
Goldsmith ME, Aguila A, Steadman K, Martinez A, Steinberg SM, Alley MC, Waud WR, Bates SE, Fojo T (2007). The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems. Mol Cancer Ther  6, 496-505.   https://doi.org/10.1158/1535-7163.MCT-06-0431




PubMed


 


PubMed ID 17308048
    
     


 



7.
Hazra R, Jankelevich S, Mackall CL, Avila NA, Wolters P, Civitello L, Christensen B, Jacobsen F, Steinberg SM, Yarchoan R (2007). Immunologic, virologic, and neuropsychologic responses in human immunodeficiency virus-infected children receiving their first highly active antiretroviral therapy regimen. Viral Immunol  20, 131-41.   https://doi.org/10.1089/vim.2006.0079




PubMed


 


PubMed ID 17425427
    
     


 



8.
Hryniewicz A, Price DA, Moniuszko M, Boasso A, Edghill-Spano Y, West SM, Venzon D, Vaccari M, Tsai WP, Tryniszewska E, Nacsa J, Villinger F, Ansari AA, Trindade CJ, Morre M, Brooks D, Arlen P, Brown HJ, Kitchen CM, Zack JA, Douek DC, Shearer GM, Lewis MG, Koup RA, Franchini G (2007). Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques. J Immunol  178, 3492-504.   https://doi.org/10.4049/jimmunol.178.6.3492




PubMed


 


PubMed ID 17339444
    
     


 



9.
Kummar S, Kinders R, Rubinstein L, Parchment RE, Murgo AJ, Collins J, Pickeral O, Low J, Steinberg SM, Gutierrez M, Yang S, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH (2007). Compressing drug development timelines in oncology using phase '0' trials. Nat Rev Cancer  7, 131-9.   https://doi.org/10.1038/nrc2066




PubMed


 


PubMed ID 17251919
    
     


 



10.
Mansky P, Arai A, Stratton P, Bernstein D, Long L, Reynolds J, Chen D, Steinberg SM, Lavende N, Hoffman K, Nathan PC, Parks R, Augustine E, Chaudhry U, Derdak J, Wiener L, Gerber L, Mackall C (2007). Treatment late effects in long-term survivors of pediatric sarcoma. Pediatr Blood Cancer  48, 192-9.   https://doi.org/10.1002/pbc.20871




PubMed


 


PubMed ID 16642490
    
     


 



11.
Palmieri D, Bronder JL, Herring JM, Yoneda T, Weil RJ, Stark AM, Kurek R, Vega-Valle E, Feigenbaum L, Halverson D, Vortmeyer AO, Steinberg SM, Aldape K, Steeg PS (2007). Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res  67, 4190-8.   https://doi.org/10.1158/0008-5472.CAN-06-3316




PubMed


 


PubMed ID 17483330
    
     


 



12.
Posadas EM, Kwitkowski V, Kotz HL, Espina V, Minasian L, Tchabo N, Premkumar A, Hussain MM, Chang R, Steinberg SM, Kohn EC (2007). A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling. Cancer  110, 309-17.   https://doi.org/10.1002/cncr.22757




PubMed


 


PubMed ID 17559139
    
     


 



13.
Posadas EM, Liel MS, Kwitkowski V, Minasian L, Godwin AK, Hussain MM, Espina V, Wood BJ, Steinberg SM, Kohn EC (2007). A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer. Cancer  109, 1323-30.   https://doi.org/10.1002/cncr.22545




PubMed



        
     
Free Article


 


PubMed ID 17330838
         Pubmed Central ID 2778218 


 



14.
Toro JR, Pautler SE, Stewart L, Glenn GM, Weinreich M, Toure O, Wei MH, Schmidt LS, Davis L, Zbar B, Choyke P, Steinberg SM, Nguyen DM, Linehan WM (2007). Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome. Am J Respir Crit Care Med  175, 1044-53.   https://doi.org/10.1164/rccm.200610-1483OC




PubMed



        
     
Free Article


 


PubMed ID 17322109
         Pubmed Central ID 1899269 


 



15.
Tsurutani J, Steinberg SM, Ballas M, Robertson M, LoPiccolo J, Soda H, Kohno S, Egilsson V, Dennis PA (2007). Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma. Lung Cancer  55, 115-21.   https://doi.org/10.1016/j.lungcan.2006.09.026




PubMed



        
     
Free Article


 


PubMed ID 17097759
         Pubmed Central ID 1847612 


 



16.
Walshe JM, Berman AW, Vatas U, Steinberg SM, Anderson WF, Lippman ME, Swain SM (2007). A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up. Breast Cancer Res Treat  103, 177-83.   https://doi.org/10.1007/s10549-006-9363-0




PubMed


 


PubMed ID 17039267
    
     


 



17.
Yang SX, Hewitt SM, Steinberg SM, Liewehr DJ, Swain SM (2007). Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray. Oncol Rep  17, 281-7.




PubMed


 


PubMed ID 17203162",https://intramural.nih.gov/search/searchview.taf?ipid=47004
610,SC007256-19,"October 01, 2006 -  September 30, 2007",Mechanisms of Oncogene Action in Tumorigenesis,Frederic  Kaye; MD,NULL,"Cancer Genetics Branch, NCI","Amy B Coxon



Yoon Soo  Park



Takefumi  Komiya","Yuh Min  Chook
(Pharmacology, University of Texas Southwestern)




Adel  El-Naggar
(MD Anderson Cancer Center)




Isabel  Fonseca
(Pathology, Portugal Cancer Institute)




Pasi  Janne
(Oncology, Dana-Farber Cancer Center)




Tina  Jaskoll
(Laboratory for Developmental Genetics, University of Southern California)




Roman  Thomas
(Oncology, Broad Institute)


Show all 7",Maria  Zajac-Kaye; PhD (National Cancer Institute),Aravind L Iyer; PhD (NLM),"Ordered by publication type and then author name.



1.
Kaye F   (2007) Mucoepidermoid Cancer., in Encyclopedia of Cancer 2nd Ed. Springer –Verlag (Heidelberg), in press.




 



2.
Chen M, Rahman L, Voeller D, Kastanos E, Yang SX, Feigenbaum L, Allegra C, Kaye FJ, Steeg P, Zajac-Kaye M (2007). Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas. Oncogene  26, 4817-24.   https://doi.org/10.1038/sj.onc.1210273




PubMed


 


PubMed ID 17297449
    
     


 



3.
Kaye F, Luna M, Weber R, El-Naggar A   (2007) Crtc11/MAML2 fusion transcript detection in multiple concurrent Warthin’s tumor and mucoepidermoid carcinoma.  Genes Chrom Cancer, in press.




 



4.
Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, Macconnaill LE, Lee JC, Nicoletti R, Hatton C, Goyette M, Girard L, Majmudar K, Ziaugra L, Wong KK, Gabriel S, Beroukhim R, Peyton M, Barretina J, Dutt A, Emery C, et al. [29 more authors] (2007). High-throughput oncogene mutation profiling in human cancer. Nat Genet  39, 347-51.   https://doi.org/10.1038/ng1975




PubMed


 


PubMed ID 17293865
    
     


 



5.
Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK (2007). CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Genes Chromosomes Cancer  46, 708-15.   https://doi.org/10.1002/gcc.20458




PubMed


 


PubMed ID 17437281",https://intramural.nih.gov/search/searchview.taf?ipid=47048
611,SC007263-15,"October 01, 2006 -  September 30, 2007",Signal Transduction in Epithelial Cancer Cells,"Stanley  Lipkowitz; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Janet  Pumphrey



Marion M Nau



Monzur  Rahman



Philip  Ryan



Lyndsay M Murrow



Stephen Charles Kales","Morag  Park
(Dept. Biochemistry and Oncology, McGill University)




Yosef  Yarden
(Biological Regulation, Weizmann Institute of Science)","Dao M Nguyen; MD, MS (National Cancer Institute)



Allan M Weissman; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lipkowitz S, Dennis PA (2007). PPARgamma agonists follow an unknown TRAIL in lung cancer. Cancer Biol Ther  6, 107-9.   https://doi.org/10.4161/cbt.6.1.3751




PubMed


 


PubMed ID 17224637
    
     


 



2.
Peschard P, Kozlov G, Lin T, Mirza IA, Berghuis AM, Lipkowitz S, Park M, Gehring K (2007). Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b. Mol Cell  27, 474-85.   https://doi.org/10.1016/j.molcel.2007.06.023




PubMed


 


PubMed ID 17679095
    
     


 



3.
Sadarangani A, Kato S, Espinoza N, Lange S, Llados C, Espinosa M, Villalón M, Lipkowitz S, Cuello M, Owen GI (2007). TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract. Apoptosis  12, 73-85.   https://doi.org/10.1007/s10495-006-0492-z




PubMed


 


PubMed ID 17136491",https://intramural.nih.gov/search/searchview.taf?ipid=47049
612,SC007281-14,"October 01, 2006 -  September 30, 2007",Nitric Oxide as a Modifier of Oxidative Stress,"David Anderson Wink



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Michael G Espey; MT, PhD



Douglas D Thomas



Lisa Ann Ridnour



Christopher H Switzer



Yolanda Renee Dale



Wilmarie  Flores-santana","Piero  del Soldato
(Pharma, CTG Pharma)




Jon  Fukuto
(UCLA)




Bruce  King
(Department of Chemistry, Wake Forest University)




Nazerano  Paolocci
(Department of Cardiology, Johns Hopkins University Medical School)




Micheal  Vitek
(Neurology, Duke Uniuversity Medical School)","Terry  Moody; PhD (Experimental Biochemistry Sect)



James B Mitchell; PhD (National Cancer Institute)



Murali  Krishna; PhD (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)



Larry K Keefer; PhD (National Cancer Institute)



Grace  Yeh; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Donzelli S, Espey MG, Flores-Santana W, Switzer CH, Yeh GC, Huang J, Stuehr DJ, King SB, Miranda KM, Wink DA (2008). Generation of nitroxyl by heme protein-mediated peroxidation of hydroxylamine but not N-hydroxy-L-arginine. Free Radic Biol Med  45, 578-84.   https://doi.org/10.1016/j.freeradbiomed.2008.04.036




PubMed



        
     
Free Article


 


PubMed ID 18503778
         Pubmed Central ID 2562766 


 



2.
Isenberg JS, Hyodo F, Matsumoto K, Romeo MJ, Abu-Asab M, Tsokos M, Kuppusamy P, Wink DA, Krishna MC, Roberts DD (2007). Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation. Blood  109, 1945-52.   https://doi.org/10.1182/blood-2006-08-041368




PubMed



        
     
Free Article


 


PubMed ID 17082319
         Pubmed Central ID 1801044 


 



3.
Isenberg JS, Jia Y, Field L, Ridnour LA, Sparatore A, Del Soldato P, Sowers AL, Yeh GC, Moody TW, Wink DA, Ramchandran R, Roberts DD (2007). Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid. Br J Pharmacol  151, 63-72.   https://doi.org/10.1038/sj.bjp.0707198




PubMed



        
     
Free Article


 


PubMed ID 17351657
         Pubmed Central ID 2012973 


 



4.
Isenberg JS, Jia Y, Fukuyama J, Switzer CH, Wink DA, Roberts DD (2007). Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake. J Biol Chem  282, 15404-15.   https://doi.org/10.1074/jbc.M701638200




PubMed



        
     
Free Article


 


PubMed ID 17416590
         Pubmed Central ID 2430148 


 



5.
Isenberg JS, Romeo MJ, Abu-Asab M, Tsokos M, Oldenborg A, Pappan L, Wink DA, Frazier WA, Roberts DD (2007). Increasing survival of ischemic tissue by targeting CD47. Circ Res  100, 712-20.   https://doi.org/10.1161/01.RES.0000259579.35787.4e




PubMed


 


PubMed ID 17293482
    
     


 



6.
Lopez BE, Wink DA, Fukuto JM (2007). The inhibition of glyceraldehyde-3-phosphate dehydrogenase by nitroxyl (HNO). Arch Biochem Biophys  465, 430-6.   https://doi.org/10.1016/j.abb.2007.06.017




PubMed


 


PubMed ID 17678614
    
     


 



7.
Paolocci N, Jackson MI, Lopez BE, Miranda K, Tocchetti CG, Wink DA, Hobbs AJ, Fukuto JM (2007). The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO. Pharmacol Ther  113, 442-58.   https://doi.org/10.1016/j.pharmthera.2006.11.002




PubMed



        
     
Free Article


 


PubMed ID 17222913
         Pubmed Central ID 3501193 


 



8.
Prueitt RL, Boersma BJ, Howe TM, Goodman JE, Thomas DD, Ying L, Pfiester CM, Yfantis HG, Cottrell JR, Lee DH, Remaley AT, Hofseth LJ, Wink DA, Ambs S (2007). Inflammation and IGF-I activate the Akt pathway in breast cancer. Int J Cancer  120, 796-805.   https://doi.org/10.1002/ijc.22336




PubMed


 


PubMed ID 17096325
    
     


 



9.
Roberts DD, Isenberg JS, Ridnour LA, Wink DA (2007). Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis. Clin Cancer Res  13, 795-8.   https://doi.org/10.1158/1078-0432.CCR-06-1758




PubMed


 


PubMed ID 17289869
    
     


 



10.
Tocchetti CG, Wang W, Froehlich JP, Huke S, Aon MA, Wilson GM, Di Benedetto G, O'Rourke B, Gao WD, Wink DA, Toscano JP, Zaccolo M, Bers DM, Valdivia HH, Cheng H, Kass DA, Paolocci N   (2007) Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling.  Circ Res 100:96-104.




PubMed



        
     
Free Article


 


PubMed ID 17138943
         Pubmed Central ID 2769513",https://intramural.nih.gov/search/searchview.taf?ipid=47050
613,SC009144-23,"October 01, 2006 -  September 30, 2007",Mechanisms of transcription factor integration at the c-myc promoter,"David  Levens; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Larry  Benjamin



Hye-Jung  Chung



Juhong  Liu



Suzanne Laurie Sanford



Matthew  Vogt



Na  Salony



Show all 7",NULL,Gordon Lee Hager; PhD (National Cancer Institute),Keji  Zhao; PhD (NHLBI),"Ordered by publication type and then author name.



1.
Kouzine F, Levens D (2007). Supercoil-driven DNA structures regulate genetic transactions. Front Biosci  12, 4409-23.   https://doi.org/10.2741/2398




PubMed


 


PubMed ID 17485385",https://intramural.nih.gov/search/searchview.taf?ipid=47051
614,SC009163-20,"October 01, 2006 -  September 30, 2007",Signal Transduction Therapy--Basic Science,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI","Jareer Nabeel Kassis



Victoria M Virador



Nabila  Rasool



Shu-Fen  Mai



Ebony R Hoskins","Riccardo  Alessandro
(Molecular Pathology, U-Palermo)




Ben  Davidson
(Pathology, Norwegian Radium Hospital)","David Jay Goldstein (National Cancer Institute)



Florence M Davidson; MS, PhD, BA (National Cancer Institute)



Michael  Birrer (National Cancer Institute)



David R Gius; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Gunn AJ, Hama Y, Koyama Y, Kohn EC, Choyke PL, Kobayashi H (2007). Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore. Cancer Sci  98, 1727-33.   https://doi.org/10.1111/j.1349-7006.2007.00602.x




PubMed



        
     
Free Article


 


PubMed ID 17784874
         Pubmed Central ID 2585545",https://intramural.nih.gov/search/searchview.taf?ipid=47052
615,SC009170-20,"October 01, 2006 -  September 30, 2007",Genes regulating pattern formation during embryonic development,"Susan  Mackem; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Hai  Huang



Jianjian  Zhu



Aki  Furusawa



Junming  Yang","Denis  Duboule
(Zoology and Animal Biology, Univ. of Geneva)




Gerard  Evan
(UCSF)




Beate  Lanske
(Department of Oral & Developmental Biology, Harvard Univ.)




Lance  Liotta
(Center for Applied Proteomics and Molecular Medicine, George Mason Univ.)




John  Rasweiler
(SUNY Downstate)




Makoto  Taketo
(Orthopedics, Kyoto University)",Michael  Bustin; PhD (National Cancer Institute),"Yingzi  Yang; PhD (NHGRI) 












Alexandra L Joyner (NHGRI)","Ordered by publication type and then author name.



1.
Maeda Y, Nakamura E, Nguyen MT, Suva LJ, Swain FL, Razzaque MS, Mackem S, Lanske B (2007). Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc Natl Acad Sci U S A  104, 6382-7.   https://doi.org/10.1073/pnas.0608449104




PubMed



        
     
Free Article


 


PubMed ID 17409191
         Pubmed Central ID 1851055 


 



2.
Ohtola J, Myers J, Akhtar-Zaidi B, Zuzindlak D, Sandesara P, Yeh K, Mackem S, Atit R (2008). beta-Catenin has sequential roles in the survival and specification of ventral dermis. Development  135, 2321-9.   https://doi.org/10.1242/dev.021170




PubMed



        
     
Free Article


 


PubMed ID 18539925
         Pubmed Central ID 2732188",https://intramural.nih.gov/search/searchview.taf?ipid=47053
616,SC009172-19,"October 01, 2006 -  September 30, 2007",Cellular Interactions with Thrombospondin,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Jeffrey S Isenberg



John M Sipes



Malgorzata  Ptaszynska



Elizabeth M Perruccio



Gema  Martin-Manso



Justin Brian Maxhimer; MD","Willaim  Frazier
(Biochemistry and Molecular Biophysics, Washington University)




Julien  Furrer
(Institute for Organic Chemistry and Biochemistry, Technische Universitat Muenchen)




Cezary  Marcinkiewicz
(Temple University)




Deane  Mosher
(Medicine, University of Wisconsin)","Venkatesha  Basrur; PhD (National Cancer Institute)



David Anderson Wink (National Cancer Institute)



Joseph John Barchi (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Isenberg JS, Hyodo F, Matsumoto K, Romeo MJ, Abu-Asab M, Tsokos M, Kuppusamy P, Wink DA, Krishna MC, Roberts DD (2007). Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation. Blood  109, 1945-52.   https://doi.org/10.1182/blood-2006-08-041368




PubMed



        
     
Free Article


 


PubMed ID 17082319
         Pubmed Central ID 1801044 


 



2.
Isenberg JS, Jia Y, Fukuyama J, Switzer CH, Wink DA, Roberts DD (2007). Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake. J Biol Chem  282, 15404-15.   https://doi.org/10.1074/jbc.M701638200




PubMed



        
     
Free Article


 


PubMed ID 17416590
         Pubmed Central ID 2430148 


 



3.
Isenberg JS, Romeo MJ, Abu-Asab M, Tsokos M, Oldenborg A, Pappan L, Wink DA, Frazier WA, Roberts DD (2007). Increasing survival of ischemic tissue by targeting CD47. Circ Res  100, 712-20.   https://doi.org/10.1161/01.RES.0000259579.35787.4e




PubMed


 


PubMed ID 17293482
    
     


 



4.
Roberts D, Pappan L, Romeo M, Abu-Asab M, Tsokos M, Wink D, Frazier W   (2007) Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.  Ann Surg, in press.




 



5.
Roberts DD, Isenberg JS, Ridnour LA, Wink DA (2007). Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis. Clin Cancer Res  13, 795-8.   https://doi.org/10.1158/1078-0432.CCR-06-1758




PubMed


 


PubMed ID 17289869
    
     


 



6.
Staniszewska I, Zaveri S, Del Valle L, Oliva I, Rothman VL, Croul SE, Roberts DD, Mosher DF, Tuszynski GP, Marcinkiewicz C (2007). Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis. Circ Res  100, 1308-16.   https://doi.org/10.1161/01.RES.0000266662.98355.66




PubMed


 


PubMed ID 17413041",https://intramural.nih.gov/search/searchview.taf?ipid=47006
617,SC009173-19,"October 01, 2006 -  September 30, 2007",Host Colonization and Vascular Dissemination of ICandida albicansI,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Mike  Pendrak



John M Sipes



Dhammika  Navarathna; PhD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Pendrak ML, Roberts DD (2007). Hemoglobin is an effective inducer of hyphal differentiation in Candida albicans. Med Mycol  45, 61-71.   https://doi.org/10.1080/13693780601028691




PubMed


 


PubMed ID 17325946
    
     


 



2.
Pendrak ML, Rodrigues RG, Roberts DD (2007). Induction of a high affinity fibronectin receptor in Candida albicans by caspofungin: requirements for beta (1,6) glucans and the developmental regulator Hbr1p. Med Mycol  45, 157-68.   https://doi.org/10.1080/13693780601164314




PubMed


 


PubMed ID 17365652",https://intramural.nih.gov/search/searchview.taf?ipid=47007
618,SC009174-19,"October 01, 2006 -  September 30, 2007",Roles of Glycoconjugates and Redox Signaling in Tumor Biology,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Jeffrey S Isenberg



John M Sipes



Elizabeth M Perruccio","Anthony  Day
(Biochemistry, University of Oxford)




Thomas  Wight
(The Hope Heart Program, University of Washington)",NULL,NULL,"Ordered by publication type and then author name.



1.
Isenberg JS, Frazier WA, Krishna MC, Wink DA, Roberts DD (2008). Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling. Curr Drug Targets  9, 833-41.   https://doi.org/10.2174/138945008785909338




PubMed



        
     
Free Article


 


PubMed ID 18855617
         Pubmed Central ID 2575641 


 



2.
Isenberg JS, Frazier WA, Roberts DD (2008). Thrombospondin-1: a physiological regulator of nitric oxide signaling. Cell Mol Life Sci  65, 728-42.   https://doi.org/10.1007/s00018-007-7488-x




PubMed



        
     
Free Article


 


PubMed ID 18193160
         Pubmed Central ID 2562780 


 



3.
Isenberg JS, Jia Y, Field L, Ridnour LA, Sparatore A, Del Soldato P, Sowers AL, Yeh GC, Moody TW, Wink DA, Ramchandran R, Roberts DD (2007). Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid. Br J Pharmacol  151, 63-72.   https://doi.org/10.1038/sj.bjp.0707198




PubMed



        
     
Free Article


 


PubMed ID 17351657
         Pubmed Central ID 2012973 


 



4.
Isenberg JS, Jia Y, Fukuyama J, Switzer CH, Wink DA, Roberts DD (2007). Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake. J Biol Chem  282, 15404-15.   https://doi.org/10.1074/jbc.M701638200




PubMed



        
     
Free Article


 


PubMed ID 17416590
         Pubmed Central ID 2430148 


 



5.
Isenberg JS, Maxhimer JB, Powers P, Tsokos M, Frazier WA, Roberts DD (2008). Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling. Surgery  144, 752-61.   https://doi.org/10.1016/j.surg.2008.07.009




PubMed



        
     
Free Article


 


PubMed ID 19081017
         Pubmed Central ID 2635486 


 



6.
Isenberg JS, Romeo MJ, Maxhimer JB, Smedley J, Frazier WA, Roberts DD (2008). Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease. Ann Surg  247, 860-8.   https://doi.org/10.1097/SLA.0b013e31816c4006




PubMed



        
     
Free Article


 


PubMed ID 18438125
         Pubmed Central ID 2430143 


 



7.
Roberts D, Windhausen A, Isenberg J, Yeung N, Thomas D, Vitek M, Wink D   (2007) Nitric oxide regulates matrix metalloproteinase-9 activity by guanylate cyclase-dependent and -independent pathways.  Proc Natl Acad Sci USA, in press.




 



8.
Roberts DD (2008). Thrombospondins: from structure to therapeutics. Cell Mol Life Sci  65, 669-71.   https://doi.org/10.1007/s00018-007-7483-2




PubMed



        
     
Free Article


 


PubMed ID 18193165
         Pubmed Central ID 2430146 


 



9.
Roberts DD, Isenberg JS, Ridnour LA, Wink DA (2007). Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis. Clin Cancer Res  13, 795-8.   https://doi.org/10.1158/1078-0432.CCR-06-1758




PubMed


 


PubMed ID 17289869",https://intramural.nih.gov/search/searchview.taf?ipid=47005
619,SC009179-19,"October 01, 2006 -  September 30, 2007",The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis,"William G Stetler-Stevenson; MD, PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Beiyang  Wei



Seo-Jin  Lee



Renuka  Sivendran



Liliana  Guedez; PhD","Junseo  Oh
(Laboratory of Cellular Oncology, Korea University Graduate School Of Medicine)




Dong-Wan  Seo
(Laboratory of Molecular Biochemistry, Kangwon National University)","Frank  Cuttitta; PhD (National Cancer Institute)



Kathleen  Kelly; PhD (National Cancer Institute)



David  Salomon; PhD (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47054
620,SC009372-15,"October 01, 2006 -  September 30, 2007",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI",NULL,NULL,"Robert J Kreitman; MD, PhD (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Ira H Pastan; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



John Charles Morris; MD (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47013
621,SC009374-16,"October 01, 2006 -  September 30, 2007",Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI","Jareer Nabeel Kassis



Victoria M Virador



Amit  Dhamoon



Ebony R Hoskins","Riccardo  Alessandro
(Molecular Pathology, U-Palermo)




Ben  Davidson
(Pathology, Norwegian Radium Hospital)




Gordon  Mills
(Molecular Therapeutics, MD Anderson Cancer Center)




Nicole  Urban
(SPORE, Fred Hutchinson Cancer Center)","Seth M Steinberg; PhD (Biostatistics and Data Management Section)



David Jay Goldstein (National Cancer Institute)



Gordon  Whiteley (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Barbara V Vonderhaar; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47055
622,SC009375-15,"October 01, 2006 -  September 30, 2007",Signal Transduction Therapy--Clinical,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI","Victoria M Virador



Nabila  Rasool



Amit  Dhamoon



Nilofer S Azad","Riccardo  Alessandro
(Molecular Pathology, U-Palermo)




Mac  Barnes
(Gynecologic Oncology, U-AB)




Robert  Bast
(Medicine, MD Anderson Cancer Center)




Andrew  Berchuck
(Gyn Oncology, Duke Univ)




Mary B Daly





Ben  Davidson
(Pathology, Norwegian Radium Hospital)


Show all 11","Yves  Pommier; PhD (National Cancer Institute)



Peter L Choyke; MD (National Cancer Institute)



Seth M Steinberg; PhD (Biostatistics and Data Management Section)



David Jay Goldstein (National Cancer Institute)



Gordon  Whiteley (National Cancer Institute)



William Laurence Dahut; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Posadas EM, Kwitkowski V, Kotz HL, Espina V, Minasian L, Tchabo N, Premkumar A, Hussain MM, Chang R, Steinberg SM, Kohn EC (2007). A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling. Cancer  110, 309-17.   https://doi.org/10.1002/cncr.22757




PubMed


 


PubMed ID 17559139
    
     


 



2.
Posadas EM, Liel MS, Kwitkowski V, Minasian L, Godwin AK, Hussain MM, Espina V, Wood BJ, Steinberg SM, Kohn EC (2007). A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer. Cancer  109, 1323-30.   https://doi.org/10.1002/cncr.22545




PubMed



        
     
Free Article


 


PubMed ID 17330838
         Pubmed Central ID 2778218",https://intramural.nih.gov/search/searchview.taf?ipid=47056
623,SC009389-14,"October 01, 2006 -  September 30, 2007",A Mitogen-induced G Protein-coupled Receptor,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Yvona  Ward; PhD



Ross G Lake",NULL,Sheueyann  Cheng; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47057
624,SC009392-14,"October 01, 2006 -  September 30, 2007",Proteomic Analysis of Renal Tumors,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Vladmir Alexander Valera Romero; MD, PhD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Linehan WM, Pinto PA, Srinivasan R, Merino M, Choyke P, Choyke L, Coleman J, Toro J, Glenn G, Vocke C, Zbar B, Schmidt LS, Bottaro D, Neckers L (2007). Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics. Clin Cancer Res  13, 671s-679s.   https://doi.org/10.1158/1078-0432.CCR-06-1870




PubMed


 


PubMed ID 17255292
    
     


 



2.
Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, Richardson AM, Pinto PA, Linehan WM, Gillespie JW, Merino MJ, Libutti SK, Woodson KG, Emmert-Buck MR, Chuaqui RF (2007). Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol  211, 410-9.   https://doi.org/10.1002/path.2133




PubMed


 


PubMed ID 17278115
    
     


 



3.
Zbar B, Glenn G, Merino M, Middelton L, Peterson J, Toro J, Coleman J, Pinto P, Schmidt LS, Choyke P, Linehan WM (2007). Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development. J Urol  177, 461-5; discussion 465.   https://doi.org/10.1016/j.juro.2006.09.037




PubMed


 


PubMed ID 17222609",https://intramural.nih.gov/search/searchview.taf?ipid=47058
625,SC009394-14,"October 01, 2006 -  September 30, 2007",Diagnostic Electron Microscopy (EM),Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI",Mones  Abu-Asab,NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)","Edward H. Oldfield; MD (NINDS) 



Alexander Oliver Vortmeyer; MD (NINDS) 



James H. Shelhamer; MD (CC)","Ordered by publication type and then author name.



1.
Alesci S, Perera SM, Lai EW, Kukura C, Abu-Asab M, Tsokos M, Morris JC, Pacak K (2007). Adenoviral gene transfer in bovine adrenomedullary and murine pheochromocytoma cells: potential clinical and therapeutic relevance. Endocrinology  148, 3900-7.   https://doi.org/10.1210/en.2007-0521




PubMed



        
     
Free Article


 


PubMed ID 17525127
         Pubmed Central ID 2527237 


 



2.
Gills JJ, Lopiccolo J, Tsurutani J, Shoemaker RH, Best CJ, Abu-Asab MS, Borojerdi J, Warfel NA, Gardner ER, Danish M, Hollander MC, Kawabata S, Tsokos M, Figg WD, Steeg PS, Dennis PA (2007). Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin Cancer Res  13, 5183-94.   https://doi.org/10.1158/1078-0432.CCR-07-0161




PubMed


 


PubMed ID 17785575
    
     


 



3.
Isenberg JS, Hyodo F, Matsumoto K, Romeo MJ, Abu-Asab M, Tsokos M, Kuppusamy P, Wink DA, Krishna MC, Roberts DD (2007). Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation. Blood  109, 1945-52.   https://doi.org/10.1182/blood-2006-08-041368




PubMed



        
     
Free Article


 


PubMed ID 17082319
         Pubmed Central ID 1801044 


 



4.
Isenberg JS, Romeo MJ, Abu-Asab M, Tsokos M, Oldenborg A, Pappan L, Wink DA, Frazier WA, Roberts DD (2007). Increasing survival of ischemic tissue by targeting CD47. Circ Res  100, 712-20.   https://doi.org/10.1161/01.RES.0000259579.35787.4e




PubMed


 


PubMed ID 17293482
    
     


 



5.
Steel JC, Cavanagh HM, Burton MA, Abu-Asab MS, Tsokos M, Morris JC, Kalle WH (2007). Increased tumor localization and reduced immune response to adenoviral vector formulated with the liposome DDAB/DOPE. Eur J Pharm Sci  30, 398-405.   https://doi.org/10.1016/j.ejps.2006.12.004




PubMed


 


PubMed ID 17275269
    
     


 



6.
Valencia JC, Rouzaud F, Julien S, Chen KG, Passeron T, Yamaguchi Y, Abu-Asab M, Tsokos M, Costin GE, Yamaguchi H, Jenkins LM, Nagashima K, Appella E, Hearing VJ (2007). Sialylated core 1 O-glycans influence the sorting of Pmel17/gp100 and determine its capacity to form fibrils. J Biol Chem  282, 11266-80.   https://doi.org/10.1074/jbc.M608449200




PubMed


 


PubMed ID 17303571",https://intramural.nih.gov/search/searchview.taf?ipid=47059
626,SC009431-13,"October 01, 2006 -  September 30, 2007",Histologic and Molecular Characterization of Solid Pediatric Tumors,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI",NULL,NULL,"Lee Jay Helman; MD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)



Elizabeth  Fox; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ahmed AA, Tsokos M (2007). Sinonasal rhabdomyosarcoma in children and young adults. Int J Surg Pathol  15, 160-5.   https://doi.org/10.1177/1066896906299122




PubMed


 


PubMed ID 17478770
    
     


 



2.
Petricoin EF, Espina V, Araujo RP, Midura B, Yeung C, Wan X, Eichler GS, Johann DJ, Qualman S, Tsokos M, Krishnan K, Helman LJ, Liotta LA (2007). Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res  67, 3431-40.   https://doi.org/10.1158/0008-5472.CAN-06-1344




PubMed


 


PubMed ID 17409454",https://intramural.nih.gov/search/searchview.taf?ipid=47060
627,SC010051-12,"October 01, 2006 -  September 30, 2007",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,"Martin W Brechbiel; PhD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Diane E Milenic



Charles A Boswell



Heng  Xu



Kwamena  Baidoo



Celeste A Regino",NULL,Peter L Choyke; MD (National Cancer Institute),Robert  Star; MD (NIDDK),"Ordered by publication type and then author name.



1.
Boswell CA, Regino CA, Baidoo KE, Wong KJ, Bumb A, Xu H, Milenic DE, Kelley JA, Lai CC, Brechbiel MW (2008). Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling. Bioconjug Chem  19, 1476-84.   https://doi.org/10.1021/bc800039e




PubMed



        
     
Free Article


 


PubMed ID 18597510
         Pubmed Central ID 2505184 


 



2.
Brechbiel M, Bernardo M, Regino C, Koyama Y, Krishna M, Choyke P, Kobayashi H   (2007) MR Lymphangiography Using Dendrimer-Based Contrast Agents: A Comparison at 1.5T  and 3.0T.  J. Mag. Res. Med.  431-436 pp.




 



3.
Brechbiel M, Talanov V, Bernado M, Hama Y, Regino C, Choyke P, Kobayashi H   (2007) Choyke, P. L., Kobayashi, H: A Dendrimer-Based Nano-sized Contrast Agent  Dual-Labeled for Magnetic Resonance and Optical Fluorescence Imaging to Localize the  Sentinel Lymph Node in Mice.  J. Mag. Res. Imag. 2007, 25, 866-871.  866-871 pp.




 



4.
Bumb A, Brechbiel MW, Choyke PL, Fugger L, Eggeman A, Prabhakaran D, Hutchinson J, Dobson PJ (2008). Synthesis and characterization of ultra-small superparamagnetic iron oxide nanoparticles thinly coated with silica. Nanotechnology  19, 335601.   https://doi.org/10.1088/0957-4484/19/33/335601




PubMed



        
     
Free Article


 


PubMed ID 19701448
         Pubmed Central ID 2600798 


 



5.
Chong HS, Lim S, Baidoo KE, Milenic DE, Ma X, Jia F, Song HA, Brechbiel MW, Lewis MR (2008). Synthesis and biological evaluation of a novel decadentate ligand DEPA. Bioorg Med Chem Lett  18, 5792-5.   https://doi.org/10.1016/j.bmcl.2008.09.063




PubMed



        
     
Free Article


 


PubMed ID 18845437
         Pubmed Central ID 2784163 


 



6.
Tolmachev V, Xu H, Wållberg H, Ahlgren S, Hjertman M, Sjöberg A, Sandström M, Abrahmsén L, Brechbiel MW, Orlova A (2008). Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules. Bioconjug Chem  19, 1579-87.   https://doi.org/10.1021/bc800110y




PubMed



        
     
Free Article


 


PubMed ID 18620447
         Pubmed Central ID 2561312",https://intramural.nih.gov/search/searchview.taf?ipid=47061
628,SC010058-12,"October 01, 2006 -  September 30, 2007",Regulation of apoptosis in Ewings sarcoma and neuroblastoma,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI","Susana Beatriz Galli



Yan  Ren",NULL,"Lee Jay Helman; MD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lee B, Galli S, Tsokos M (2007). Sensitive Ewing sarcoma and neuroblastoma cell lines have increased levels of BAD expression and decreased levels of BAR expression compared to resistant cell lines. Cancer Lett  247, 110-4.   https://doi.org/10.1016/j.canlet.2006.03.033




PubMed


 


PubMed ID 16690206
    
     


 



2.
Lissat A, Vraetz T, Tsokos M, Klein R, Braun M, Koutelia N, Fisch P, Romero ME, Long L, Noellke P, Mackall CL, Niemeyer CM, Kontny U (2007). Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity. Am J Pathol  170, 1917-30.   https://doi.org/10.2353/ajpath.2007.060993




PubMed



        
     
Free Article


 


PubMed ID 17525260
         Pubmed Central ID 1899433",https://intramural.nih.gov/search/searchview.taf?ipid=47063
629,SC010074-12,"October 01, 2006 -  September 30, 2007",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,"Leonard  Neckers; PhD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Wanping  Xu



Hye-Sik  Kong



Shinji  Tsutsumi



Akihiro  Yano","Brian  Blagg
(Chemistry, University of Kansas)




Robert  Cotter
(Johns Hopkins University)




YunJin  Jung
(Pusan National University)




Larry  Karnitz
(Mayo Clinic)




Neal  Rosen
(Medicine, Memorial Sloan Kettering Cancer Center)




David  Toft
(Cell Biology, Mayo Clinic)


Show all 7","James G McNally; PhD (National Cancer Institute)



Zhenggang  Liu; PhD (National Cancer Institute)



Jane Beth Trepel (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ansar S, Burlison JA, Hadden MK, Yu XM, Desino KE, Bean J, Neckers L, Audus KL, Michaelis ML, Blagg BS (2007). A non-toxic Hsp90 inhibitor protects neurons from Abeta-induced toxicity. Bioorg Med Chem Lett  17, 1984-90.   https://doi.org/10.1016/j.bmcl.2007.01.017




PubMed


 


PubMed ID 17276679
    
     


 



2.
Jung Y, Xu W, Kim H, Ha N, Neckers L (2007). Curcumin-induced degradation of ErbB2: A role for the E3 ubiquitin ligase CHIP and the Michael reaction acceptor activity of curcumin. Biochim Biophys Acta  1773, 383-90.   https://doi.org/10.1016/j.bbamcr.2006.11.004




PubMed


 


PubMed ID 17239458
    
     


 



3.
Kajiguchi T, Chung EJ, Lee S, Stine A, Kiyoi H, Naoe T, Levis MJ, Neckers L, Trepel JB (2007). FLT3 regulates beta-catenin tyrosine phosphorylation, nuclear localization, and transcriptional activity in acute myeloid leukemia cells. Leukemia  21, 2476-84.   https://doi.org/10.1038/sj.leu.2404923




PubMed


 


PubMed ID 17851558
    
     


 



4.
Koga F, Tsutsumi S, Neckers LM (2007). Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells. Cell Cycle  6, 1393-402.   https://doi.org/10.4161/cc.6.11.4296




PubMed


 


PubMed ID 17525527
    
     


 



5.
Neckers L (2007). Heat shock protein 90: the cancer chaperone. J Biosci  32, 517-30.   https://doi.org/10.1007/s12038-007-0051-y




PubMed


 


PubMed ID 17536171
    
     


 



6.
Scroggins BT, Robzyk K, Wang D, Marcu MG, Tsutsumi S, Beebe K, Cotter RJ, Felts S, Toft D, Karnitz L, Rosen N, Neckers L (2007). An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol Cell  25, 151-9.   https://doi.org/10.1016/j.molcel.2006.12.008




PubMed



        
     
Free Article


 


PubMed ID 17218278
         Pubmed Central ID 1839984 


 



7.
Tsutsumi S, Neckers L (2007). Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis. Cancer Sci  98, 1536-9.   https://doi.org/10.1111/j.1349-7006.2007.00561.x




PubMed


 


PubMed ID 17645779
    
     


 



8.
Williams CR, Tabios R, Linehan WM, Neckers L (2007). Intratumor injection of the Hsp90 inhibitor 17AAG decreases tumor growth and induces apoptosis in a prostate cancer xenograft model. J Urol  178, 1528-32.   https://doi.org/10.1016/j.juro.2007.05.120




PubMed


 


PubMed ID 17707057
    
     


 



9.
Workman P, Burrows F, Neckers L, Rosen N (2007). Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann N Y Acad Sci  1113, 202-16.   https://doi.org/10.1196/annals.1391.012




PubMed


 


PubMed ID 17513464
    
     


 



10.
Xu W, Neckers L (2007). Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells. Clin Cancer Res  13, 1625-9.   https://doi.org/10.1158/1078-0432.CCR-06-2966




PubMed


 


PubMed ID 17363512
    
     


 



11.
Xu W, Soga S, Beebe K, Lee MJ, Kim YS, Trepel J, Neckers L (2007). Sensitivity of epidermal growth factor receptor and ErbB2 exon 20 insertion mutants to Hsp90 inhibition. Br J Cancer  97, 741-4.   https://doi.org/10.1038/sj.bjc.6603950




PubMed



        
     
Free Article


 


PubMed ID 17712310
         Pubmed Central ID 2360392 


 



12.
Xu W, Yuan X, Beebe K, Xiang Z, Neckers L (2007). Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity. Mol Cell Biol  27, 220-8.   https://doi.org/10.1128/MCB.00899-06




PubMed



        
     
Free Article


 


PubMed ID 17030621
         Pubmed Central ID 1800645",https://intramural.nih.gov/search/searchview.taf?ipid=47064
630,SC010083-11,"October 01, 2006 -  September 30, 2007",Investigation of Germ-line Genetic Variation and Susceptibility to Cancer and it,"Stephen J Chanock; MD, PhD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Renee A Chen



Vincent  Bekker



Nicholas Jon Orr","Anne-Lise  Borresen-Dale
(Radium Hospital, Oslo)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




Howard  Cann
(Centre d'Etudes du Polymorphisme Humain)




Brian  Henderson
(University of Southern California)




Brian  Henderson
(University of Southern California)




Austin L. Hughes; PhD
(University of South Carolina)


Show all 20","Shelia K Zahm; ScM, ScD (National Cancer Institute)



Thomas R O'Brien; BA, MPH, MD (National Cancer Institute)



Nathaniel C Rothman; MD (National Cancer Institute)



Charles  Rabkin (National Cancer Institute)



Thomas J. Walsh; MD (National Cancer Institute)



Javed  Khan; MD (National Cancer Institute)","James G Taylor; MD (NHLBI) 



Neal S Young; MD (NHLBI) 



Mark T Gladwin; MD (CC) 



Harry Lewis Malech; MD (NIAID) 



Steven M Holland; MD (NIAID)","Ordered by publication type and then author name.



1.
Abecasis G, Tam PK, Bustamante CD, Ostrander EA, Scherer SW, Chanock SJ, Kwok PY, Brookes AJ (2007). Human Genome Variation 2006: emerging views on structural variation and large-scale SNP analysis. Nat Genet  39, 153-5.   https://doi.org/10.1038/ng0207-153




PubMed


 


PubMed ID 17262030
    
     


 



2.
Alter BP, Baerlocher GM, Savage SA, Chanock SJ, Weksler BB, Willner JP, Peters JA, Giri N, Lansdorp PM (2007). Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood  110, 1439-47.   https://doi.org/10.1182/blood-2007-02-075598




PubMed



        
     
Free Article


 


PubMed ID 17468339
         Pubmed Central ID 1975834 


 



3.
Bergen AW, Baccarelli A, McDaniel TK, Kuhn K, Pfeiffer R, Kakol J, Bender P, Jacobs K, Packer B, Chanock SJ, Yeager M (2007). Cis sequence effects on gene expression. BMC Genomics  8, 296.   https://doi.org/10.1186/1471-2164-8-296




PubMed



        
     
Free Article


 


PubMed ID 17727713
         Pubmed Central ID 2077339 


 



4.
Berndt SI, Chatterjee N, Huang WY, Chanock SJ, Welch R, Crawford ED, Hayes RB (2007). Variant in sex hormone-binding globulin gene and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev  16, 165-8.   https://doi.org/10.1158/1055-9965.EPI-06-0689




PubMed


 


PubMed ID 17220347
    
     


 



5.
Berndt SI, Huang WY, Chatterjee N, Yeager M, Welch R, Chanock SJ, Weissfeld JL, Schoen RE, Hayes RB (2007). Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis  28, 1965-70.   https://doi.org/10.1093/carcin/bgm155




PubMed


 


PubMed ID 17615257
    
     


 



6.
Berndt SI, Huang WY, Fallin MD, Helzlsouer KJ, Platz EA, Weissfeld JL, Church TR, Welch R, Chanock SJ, Hayes RB (2007). Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma. Cancer Res  67, 1395-404.   https://doi.org/10.1158/0008-5472.CAN-06-1390




PubMed


 


PubMed ID 17283177
    
     


 



7.
Bernig T, Boersma BJ, Howe TM, Welch R, Yadavalli S, Staats B, Mechanic LE, Chanock SJ, Ambs S (2007). The mannose-binding lectin (MBL2) haplotype and breast cancer: an association study in African-American and Caucasian women. Carcinogenesis  28, 828-36.   https://doi.org/10.1093/carcin/bgl198




PubMed


 


PubMed ID 17071626
    
     


 



8.
Breunis WB, Biezeveld MH, Geissler J, Kuipers IM, Lam J, Ottenkamp J, Hutchinson A, Welch R, Chanock SJ, Kuijpers TW (2007). Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease. Clin Exp Immunol  150, 83-90.   https://doi.org/10.1111/j.1365-2249.2007.03457.x




PubMed



        
     
Free Article


 


PubMed ID 17672867
         Pubmed Central ID 2219275 


 



9.
Brown EE, Lan Q, Zheng T, Zhang Y, Wang SS, Hoar-Zahm S, Chanock SJ, Rothman N, Baris D (2007). Common variants in genes that mediate immunity and risk of multiple myeloma. Int J Cancer  120, 2715-22.   https://doi.org/10.1002/ijc.22618




PubMed


 


PubMed ID 17315188
    
     


 



10.
Calado RT, Graf SA, Wilkerson KL, Kajigaya S, Ancliff PJ, Dror Y, Chanock SJ, Lansdorp PM, Young NS (2007). Mutations in the SBDS gene in acquired aplastic anemia. Blood  110, 1141-6.   https://doi.org/10.1182/blood-2007-03-080044




PubMed



        
     
Free Article


 


PubMed ID 17478638
         Pubmed Central ID 1939897 


 



11.
Cerhan JR, Wang S, Maurer MJ, Ansell SM, Geyer SM, Cozen W, Morton LM, Davis S, Severson RK, Rothman N, Lynch CF, Wacholder S, Chanock SJ, Habermann TM, Hartge P (2007). Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood  109, 5439-46.   https://doi.org/10.1182/blood-2006-11-058040




PubMed



        
     
Free Article


 


PubMed ID 17327408
         Pubmed Central ID 1890834 


 



12.
Chanock S, Yeager M (2007). The future of pediatric cancer and complex diseases: aren't they all? Pediatr Blood Cancer  48, 719-22.   https://doi.org/10.1002/pbc.21115




PubMed


 


PubMed ID 17226845
    
     


 



13.
Chanock SJ, Burdett L, Yeager M, Llaca V, Langerød A, Presswalla S, Kaaresen R, Strausberg RL, Gerhard DS, Kristensen V, Perou CM, Børresen-Dale AL (2007). Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas. Breast Cancer Res  9, R5.   https://doi.org/10.1186/bcr1637




PubMed



        
     
Free Article


 


PubMed ID 17224074
         Pubmed Central ID 1851401 


 



14.
Chanock SJ, Thomas G (2007). The devil is in the DNA. Nat Genet  39, 283-4.   https://doi.org/10.1038/ng0307-283




PubMed


 


PubMed ID 17325673
    
     


 



15.
Collard CD, Shernan SK, Fox AA, Bernig T, Chanock SJ, Vaughn WK, Takahashi K, Ezekowitz AB, Jarolim P, Body SC (2007). The MBL2 'LYQA secretor' haplotype is an independent predictor of postoperative myocardial infarction in whites undergoing coronary artery bypass graft surgery. Circulation  116, I106-12.   https://doi.org/10.1161/CIRCULATIONAHA.106.679530




PubMed



        
     
Free Article


 


PubMed ID 17846289
         Pubmed Central ID 3000829 


 



16.
Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, McCredie MR, Giles GG, Fletcher O, Johnson N, dos Santos Silva I, Gibson L, Bojesen SE, Nordestgaard BG, Axelsson CK, Torres D, Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, Breast Cancer Association Consortium, et al. [54 more authors] (2007). A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet  39, 352-8.   https://doi.org/10.1038/ng1981




PubMed


 


PubMed ID 17293864
    
     


 



17.
Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, SEARCH collaborators, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, kConFab, AOCS Management Group, et al. [77 more authors] (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature  447, 1087-93.   https://doi.org/10.1038/nature05887




PubMed



        
     
Free Article


 


PubMed ID 17529967
         Pubmed Central ID 2714974 


 



18.
Feigelson HS, Rodriguez C, Welch R, Hutchinson A, Shao W, Jacobs K, Diver WR, Calle EE, Thun MJ, Hunter DJ, Thomas G, Chanock SJ (2007). Successful genome-wide scan in paired blood and buccal samples. Cancer Epidemiol Biomarkers Prev  16, 1023-5.   https://doi.org/10.1158/1055-9965.EPI-06-0859




PubMed


 


PubMed ID 17507632
    
     


 



19.
Figueroa JD, Malats N, Real FX, Silverman D, Kogevinas M, Chanock S, Welch R, Dosemeci M, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, Rothman N, García-Closas M (2007). Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet  121, 233-42.   https://doi.org/10.1007/s00439-006-0294-y




PubMed


 


PubMed ID 17203305
    
     


 



20.
Figueroa JD, Malats N, Rothman N, Real FX, Silverman D, Kogevinas M, Chanock S, Yeager M, Welch R, Dosemeci M, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, García-Closas M (2007). Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis  28, 1788-93.   https://doi.org/10.1093/carcin/bgm132




PubMed


 


PubMed ID 17557904
    
     


 



21.
Fuselli S, Gilman RH, Chanock SJ, Bonatto SL, De Stefano G, Evans CA, Labuda D, Luiselli D, Salzano FM, Soto G, Vallejo G, Sajantila A, Pettener D, Tarazona-Santos E (2007). Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity. Pharmacogenomics J  7, 144-52.   https://doi.org/10.1038/sj.tpj.6500407




PubMed



        
     
Free Article


 


PubMed ID 16847467
         Pubmed Central ID 3099416 


 



22.
García-Closas M, Malats N, Real FX, Yeager M, Welch R, Silverman D, Kogevinas M, Dosemeci M, Figueroa J, Chatterjee N, Tardón A, Serra C, Carrato A, García-Closas R, Murta-Nascimento C, Rothman N, Chanock SJ (2007). Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet  3, e29.   https://doi.org/10.1371/journal.pgen.0030029




PubMed



        
     
Free Article


 


PubMed ID 17319747
         Pubmed Central ID 1802828 


 



23.
Garcia-Closas M, Brinton LA, Lissowska J, Richesson D, Sherman ME, Szeszenia-Dabrowska N, Peplonska B, Welch R, Yeager M, Zatonski W, Chanock SJ (2007). Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study. BMC Cancer  7, 60.   https://doi.org/10.1186/1471-2407-7-60




PubMed



        
     
Free Article


 


PubMed ID 17411440
         Pubmed Central ID 1855931 


 



24.
Garcia-Closas M, Kristensen V, Langerød A, Qi Y, Yeager M, Burdett L, Welch R, Lissowska J, Peplonska B, Brinton L, Gerhard DS, Gram IT, Perou CM, Børresen-Dale AL, Chanock S (2007). Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer. Int J Cancer  121, 2532-8.   https://doi.org/10.1002/ijc.22985




PubMed


 


PubMed ID 17683073
    
     


 



25.
Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-Ernstoff L, Yeager M, Chanock S, Welch R, Peplonska B, Trentham-Dietz A, Garcia-Closas M (2007). Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet  121, 483-90.   https://doi.org/10.1007/s00439-006-0315-x




PubMed


 


PubMed ID 17216494
    
     


 



26.
Haiman CA, Dossus L, Setiawan VW, Stram DO, Dunning AM, Thomas G, Thun MJ, Albanes D, Altshuler D, Ardanaz E, Boeing H, Buring J, Burtt N, Calle EE, Chanock S, Clavel-Chapelon F, Colditz GA, Cox DG, Feigelson HS, Hankinson SE, Hayes RB, Henderson BE, Hirschhorn JN, Hoover R, Hunter DJ, et al. [14 more authors] (2007). Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res  67, 1893-7.   https://doi.org/10.1158/0008-5472.CAN-06-4123




PubMed


 


PubMed ID 17325027
    
     


 



27.
Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, Yeager M, Chanock SJ, Zatonski W, Sobin LH, Lissowska J, Fraumeni JF, Chow WH (2007). Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis  28, 118-23.   https://doi.org/10.1093/carcin/bgl130




PubMed


 


PubMed ID 16885196
    
     


 



28.
Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J, Yu K, Chatterjee N, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Hayes RB, Tucker M, et al. [5 more authors] (2007). A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet  39, 870-4.   https://doi.org/10.1038/ng2075




PubMed



        
     
Free Article


 


PubMed ID 17529973
         Pubmed Central ID 3493132 


 



29.
Hunter DJ, Thomas G, Hoover RN, Chanock SJ (2007). Scanning the horizon: what is the future of genome-wide association studies in accelerating discoveries in cancer etiology and prevention? Cancer Causes Control  18, 479-84.   https://doi.org/10.1007/s10552-007-0118-y




PubMed


 


PubMed ID 17440825
    
     


 



30.
Idelman G, Taylor JG, Tongbai R, Chen RA, Haggerty CM, Bilke S, Chanock SJ, Gardner K (2007). Functional profiling of uncommon VCAM1 promoter polymorphisms prevalent in African American populations. Hum Mutat  28, 824-9.   https://doi.org/10.1002/humu.20523




PubMed


 


PubMed ID 17431880
    
     


 



31.
Kang D, Lee KM, Park SK, Berndt SI, Peters U, Reding D, Chatterjee N, Welch R, Chanock S, Huang WY, Hayes RB (2007). Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev  16, 1581-6.   https://doi.org/10.1158/1055-9965.EPI-07-0160




PubMed


 


PubMed ID 17646272
    
     


 



32.
Kang D, Lee KM, Park SK, Berndt SI, Reding D, Chatterjee N, Welch R, Chanock S, Huang WY, Hayes RB (2007). Lack of association of transforming growth factor-beta1 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial. Cancer Epidemiol Biomarkers Prev  16, 1303-5.   https://doi.org/10.1158/1055-9965.EPI-06-0895




PubMed


 


PubMed ID 17548703
    
     


 



33.
Lan Q, Zheng T, Chanock S, Zhang Y, Shen M, Wang SS, Berndt SI, Zahm SH, Holford TR, Leaderer B, Yeager M, Welch R, Hosgood D, Boyle P, Rothman N (2007). Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis  28, 823-7.   https://doi.org/10.1093/carcin/bgl196




PubMed


 


PubMed ID 17071630
    
     


 



34.
Lan Q, Zheng T, Shen M, Zhang Y, Wang SS, Zahm SH, Holford TR, Leaderer B, Boyle P, Chanock S (2007). Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma. Hum Genet  121, 161-8.   https://doi.org/10.1007/s00439-006-0288-9




PubMed


 


PubMed ID 17149600
    
     


 



35.
Lee KM, Shen M, Chapman RS, Yeager M, Welch R, He X, Zheng T, Hosgood HD, Yang D, Berndt SI, Chanock S, Lan Q (2007). Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis  28, 1437-41.   https://doi.org/10.1093/carcin/bgm030




PubMed


 


PubMed ID 17361014
    
     


 



36.
Lim U, Wang SS, Hartge P, Cozen W, Kelemen LE, Chanock S, Davis S, Blair A, Schenk M, Rothman N, Lan Q (2007). Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood  109, 3050-9.   https://doi.org/10.1182/blood-2006-07-034330




PubMed



        
     
Free Article


 


PubMed ID 17119116
         Pubmed Central ID 1852210 


 



37.
Lissowska J, Gaudet MM, Brinton LA, Chanock SJ, Peplonska B, Welch R, Zatonski W, Szeszenia-Dabrowska N, Park S, Sherman M, Garcia-Closas M (2007). Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer  120, 2696-703.   https://doi.org/10.1002/ijc.22604




PubMed


 


PubMed ID 17311260
    
     


 



38.
Mechanic LE, Bowman ED, Welsh JA, Khan MA, Hagiwara N, Enewold L, Shields PG, Burdette L, Chanock S, Harris CC (2007). Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors. Cancer Epidemiol Biomarkers Prev  16, 214-22.   https://doi.org/10.1158/1055-9965.EPI-06-0790




PubMed


 


PubMed ID 17301252
    
     


 



39.
Meletiadis J, Walsh TJ, Choi EH, Pappas PG, Ennis D, Douglas J, Pankey GA, Larsen RA, Hamill RJ, Chanock S (2007). Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients. Med Mycol  45, 513-8.   https://doi.org/10.1080/13693780701390140




PubMed


 


PubMed ID 17710620
    
     


 



40.
Moore LE, Brennan P, Karami S, Hung RJ, Hsu C, Boffetta P, Toro J, Zaridze D, Janout V, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Welch R, Chanock S, Rothman N, Chow WH (2007). Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis  28, 1960-4.   https://doi.org/10.1093/carcin/bgm151




PubMed


 


PubMed ID 17617661
    
     


 



41.
Moore LE, Malats N, Rothman N, Real FX, Kogevinas M, Karami S, García-Closas R, Silverman D, Chanock S, Welch R, Tardón A, Serra C, Carrato A, Dosemeci M, García-Closas M (2007). Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer  120, 2452-8.   https://doi.org/10.1002/ijc.22565




PubMed


 


PubMed ID 17311259
    
     


 



42.
NCI-NHGRI Working Group on Replication in Association Studies, Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-Wilson JE, Brooks LD, Cardon LR, Daly M, Donnelly P, Fraumeni JF, Freimer NB, Gerhard DS, Gunter C, Guttmacher AE, Guyer MS, Harris EL, Hoh J, Hoover R, Kong CA, Merikangas KR, et al. [12 more authors] (2007). Replicating genotype-phenotype associations. Nature  447, 655-60.   https://doi.org/10.1038/447655a




PubMed


 


PubMed ID 17554299
    
     


 



43.
Peters U, Foster CB, Chatterjee N, Schatzkin A, Reding D, Andriole GL, Crawford ED, Sturup S, Chanock SJ, Hayes RB (2007). Serum selenium and risk of prostate cancer-a nested case-control study. Am J Clin Nutr  85, 209-17.   https://doi.org/10.1093/ajcn/85.1.209




PubMed



        
     
Free Article


 


PubMed ID 17209198
         Pubmed Central ID 1839923 


 



44.
Pine SR, Mechanic LE, Ambs S, Bowman ED, Chanock SJ, Loffredo C, Shields PG, Harris CC (2007). Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J Natl Cancer Inst  99, 1401-9.   https://doi.org/10.1093/jnci/djm128




PubMed



        
     
Free Article


 


PubMed ID 17848669
         Pubmed Central ID 6278934 


 



45.
Purdue MP, Hartge P, Davis S, Cerhan JR, Colt JS, Cozen W, Severson RK, Li Y, Chanock SJ, Rothman N, Wang SS (2007). Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control  18, 989-99.   https://doi.org/10.1007/s10552-007-9039-z




PubMed


 


PubMed ID 17653830
    
     


 



46.
Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, Turner J, Whitby D, Chanock S, Rothman N, Armstrong BK (2007). Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis  28, 704-12.   https://doi.org/10.1093/carcin/bgl200




PubMed


 


PubMed ID 17056605
    
     


 



47.
Purdue MP, Sakoda LC, Graubard BI, Welch R, Chanock SJ, Sesterhenn IA, Rubertone MV, Erickson RL, McGlynn KA (2007). A case-control investigation of immune function gene polymorphisms and risk of testicular germ cell tumors. Cancer Epidemiol Biomarkers Prev  16, 77-83.   https://doi.org/10.1158/1055-9965.EPI-06-0573




PubMed


 


PubMed ID 17220333
    
     


 



48.
Rajaraman P, Wang SS, Rothman N, Brown MM, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Chanock SJ, Inskip PD (2007). Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev  16, 1655-61.   https://doi.org/10.1158/1055-9965.EPI-07-0314




PubMed


 


PubMed ID 17684142
    
     


 



49.
Savage SA, Burdett L, Troisi R, Douglass C, Hoover RN, Chanock SJ, National Osteosarcoma Etiology study group (2007). Germ-line genetic variation of TP53 in osteosarcoma. Pediatr Blood Cancer  49, 28-33.   https://doi.org/10.1002/pbc.21077




PubMed


 


PubMed ID 17096406
    
     


 



50.
Savage SA, Chanock SJ, Lissowska J, Brinton LA, Richesson D, Peplonska B, Bardin-Mikolajczak A, Zatonski W, Szeszenia-Dabrowska N, Garcia-Closas M (2007). Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer  97, 832-6.   https://doi.org/10.1038/sj.bjc.6603934




PubMed



        
     
Free Article


 


PubMed ID 17848914
         Pubmed Central ID 2360388 


 



51.
Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN, Chanock SJ, National Osteosarcoma Etiology Study Group (2007). Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev  16, 1667-74.   https://doi.org/10.1158/1055-9965.EPI-07-0214




PubMed


 


PubMed ID 17684144
    
     


 



52.
Schumacher FR, Feigelson HS, Cox DG, Haiman CA, Albanes D, Buring J, Calle EE, Chanock SJ, Colditz GA, Diver WR, Dunning AM, Freedman ML, Gaziano JM, Giovannucci E, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Kaaks R, Key T, Kolonel LN, Kraft P, Le Marchand L, Ma J, Pike MC, et al. [11 more authors] (2007). A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res  67, 2951-6.   https://doi.org/10.1158/0008-5472.CAN-06-3591




PubMed


 


PubMed ID 17409400
    
     


 



53.
Shen M, Purdue MP, Kricker A, Lan Q, Grulich AE, Vajdic CM, Turner J, Whitby D, Chanock S, Rothman N, Armstrong BK (2007). Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica  92, 1180-5.   https://doi.org/10.3324/haematol.11324




PubMed


 


PubMed ID 17666372
    
     


 



54.
Shen M, Vermeulen R, Chapman RS, Berndt SI, He X, Chanock S, Caporaso N, Lan Q (2008). A report of cytokine polymorphisms and COPD risk in Xuan Wei, China. Int J Hyg Environ Health  211, 352-6.   https://doi.org/10.1016/j.ijheh.2007.05.002




PubMed



        
     
Free Article


 


PubMed ID 17681858
         Pubmed Central ID 2639784 


 



55.
Solomou EE, Gibellini F, Stewart B, Malide D, Berg M, Visconte V, Green S, Childs R, Chanock SJ, Young NS (2007). Perforin gene mutations in patients with acquired aplastic anemia. Blood  109, 5234-7.   https://doi.org/10.1182/blood-2006-12-063495




PubMed



        
     
Free Article


 


PubMed ID 17311987
         Pubmed Central ID 1890825 


 



56.
Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM (2007). Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Carcinogenesis  28, 1680-6.   https://doi.org/10.1093/carcin/bgm097




PubMed


 


PubMed ID 17449902
    
     


 



57.
Subbiah V, Chanock SJ (2007). Modifiers of risk for infectious complications of cancer therapy in children: the long road ahead. Pediatr Blood Cancer  49, 3-5.   https://doi.org/10.1002/pbc.21164




PubMed


 


PubMed ID 17330833
    
     


 



58.
Taylor JG, Ackah D, Cobb C, Orr N, Percy MJ, Sachdev V, Machado R, Castro O, Kato GJ, Chanock SJ, Gladwin MT (2008). Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease. Am J Hematol  83, 6-14.   https://doi.org/10.1002/ajh.21035




PubMed



        
     
Free Article


 


PubMed ID 17724704
         Pubmed Central ID 3509176 


 



59.
Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, Engels EA, Davis S, Severson RK, Rothman N, Chanock SJ, Hartge P (2007). Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res  67, 5042-54.   https://doi.org/10.1158/0008-5472.CAN-06-4752




PubMed


 


PubMed ID 17510437
    
     


 



60.
Wang SS, Morton LM, Bergen AW, Lan EZ, Chatterjee N, Kvale P, Hayes RB, Chanock SJ, Caporaso NE (2007). Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Hum Genet  122, 41-9.   https://doi.org/10.1007/s00439-007-0374-7




PubMed


 


PubMed ID 17497175
    
     


 



61.
Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, et al. [10 more authors] (2007). Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet  39, 645-9.   https://doi.org/10.1038/ng2022




PubMed


 


PubMed ID 17401363
    
     


 



62.
Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, Farrington SM, Prendergast J, Olschwang S, Chiang T, Crowdy E, Ferretti V, Laflamme P, Sundararajan S, Roumy S, Olivier JF, Robidoux F, Sladek R, Montpetit A, Campbell P, Bezieau S, O'Shea AM, Zogopoulos G, Cotterchio M, Newcomb P, McLaughlin J, et al. [18 more authors] (2007). Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet  39, 989-94.   https://doi.org/10.1038/ng2089




PubMed


 


PubMed ID 17618283
    
     


 



63.
Zhang FF, Hou L, Terry MB, Lissowska J, Morabia A, Chen J, Yeager M, Zatonski W, Chanock S, Chow WH (2007). Genetic polymorphisms in alcohol metabolism, alcohol intake and the risk of stomach cancer in Warsaw, Poland. Int J Cancer  121, 2060-4.   https://doi.org/10.1002/ijc.22973




PubMed


 


PubMed ID 17631643
    
     


 



64.
Zhang FF, Terry MB, Hou L, Chen J, Lissowska J, Yeager M, Zatonski W, Chanock S, Morabia A, Chow WH (2007). Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev  16, 115-21.   https://doi.org/10.1158/1055-9965.EPI-06-0513




PubMed


 


PubMed ID 17220339",https://intramural.nih.gov/search/searchview.taf?ipid=47065
631,SC010084-36,"October 01, 2006 -  September 30, 2007",Pediatric HIVAIDS Clinical Research,"Robert  Yarchoan; MD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI",NULL,NULL,"Pamela  Wolters (National Cancer Institute)



Rohan  Hazra (National Cancer Institute)","H. Clifford  Lane; MD (NIAID) 



Eugene O Major; PhD (NINDS)","Ordered by publication type and then author name.



1.
Harada S, Hazra R, Tamiya S, Zeichner SL, Mitsuya H (2007). Emergence of human immunodeficiency virus type 1 variants containing the Q151M complex in children receiving long-term antiretroviral chemotherapy. Antiviral Res  75, 159-66.   https://doi.org/10.1016/j.antiviral.2007.02.004




PubMed


 


PubMed ID 17418430
    
     


 



2.
Hazra R, Jankelevich S, Mackall CL, Avila NA, Wolters P, Civitello L, Christensen B, Jacobsen F, Steinberg SM, Yarchoan R (2007). Immunologic, virologic, and neuropsychologic responses in human immunodeficiency virus-infected children receiving their first highly active antiretroviral therapy regimen. Viral Immunol  20, 131-41.   https://doi.org/10.1089/vim.2006.0079




PubMed


 


PubMed ID 17425427
    
     


 



3.
Schwartz L, Civitello L, Dunn-Pirio A, Ryschkewitsch S, Berry E, Cavert W, Kinzel N, Lawrence DM, Hazra R, Major EO (2007). Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue. J Neurovirol  13, 274-83.   https://doi.org/10.1080/13550280701344975




PubMed


 


PubMed ID 17613718",https://intramural.nih.gov/search/searchview.taf?ipid=47066
632,SC010090-11,"October 01, 2006 -  September 30, 2007",Fluorescent Pteridine Nucleoside Analogs,"Frank M Balis; MD, PhD",NULL,"Pediatric Oncology Branch, NCI",Mary  Hawkins,"Jean  Brochon
(Biology, Centre National de la Recherche Scientifique)




Lesley  Davenport
(Biochemistry, Brooklyn College)




Lesley  Davenport
(Biochemistry, Brooklyn College)




Basil  Hanss
(Biochemistry, Mt. Sinai Univer)




Basil  Hanss
(Biochemistry, Mt. Sinai Univer)




Craig  Martin
(University of Massachusetts)


Show all 13",Victor  Zhurkin; PhD (National Cancer Institute),Jay Robert Knutson; PhD (NHLBI),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47067
633,SC010093-10,"October 01, 2006 -  September 30, 2007",Targeting the Epigenome for Lung Cancer Therapy,"David  Schrump; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Ana R Hancox



Julie A Hong



Tricia  Kunst



Evgeny  Kruchinin



Mahadev  Rao



Yuwei  Zhang



Show all 8","Nasser  Altorki
(Thoracic Surgery, Cornell University Medical Center)




Xinmin  Li
(Functional Genomics, University of Chicago)




Lloyd  Old
(Cancer Immunology, Ludwig Cancer Institute)




Xiaodan  Yu
(Cell Biology, Institute of Basic Medical Sciences)","Dao M Nguyen; MD, MS (National Cancer Institute)



Jane Beth Trepel (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)",Richard  Childs; MD (NHLBI),"Ordered by publication type and then author name.



1.
Kang Y, Hong JA, Chen GA, Nguyen DM, Schrump DS (2007). Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells. Oncogene  26, 4394-403.   https://doi.org/10.1038/sj.onc.1210218




PubMed


 


PubMed ID 17260018
    
     


 



2.
Risinger JI, Chandramouli GV, Maxwell GL, Custer M, Pack S, Loukinov D, Aprelikova O, Litzi T, Schrump DS, Murphy SK, Berchuck A, Lobanenkov V, Barrett JC (2007). Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression. Clin Cancer Res  13, 1713-9.   https://doi.org/10.1158/1078-0432.CCR-05-2569




PubMed


 


PubMed ID 17363524
    
     


 



3.
Schrump D, Loprieato J, Hong J, Kang Y, Zhao M, Chen G, Humphries A, Chen G, Nguyen D, Thomas C, Trepel J, Rao M, Yu X   (2007) Aurora A and the chromosome passenger complex are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung carcinoma.  Mol Cancer Therapeutics, in press.




 



4.
Schrump D, Nguyen D, Zhao M, Li X, Kunst T, Hancox A, Hong J, Chen G, Pischtak V, Kruchin E, Sparreboon A, Figg W, Rosing D, Wright J, Steinberg S   (2007) Clinical and molecular responses in lung cancer patients receiving Depsipeptide FK228 infusions.  Clin Cancer Res, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=47015
634,SC010097-08,"October 01, 2006 -  September 30, 2007",Inflammatory Breast Cancer,Sandra M Swain; MD,NULL,"Medical Oncology Branch, NCI",NULL,NULL,"Stephen M Hewitt; MD, PhD (National Cancer Institute)



Seth M Steinberg; PhD (Biostatistics and Data Management Section)



Kevin A Camphausen; MD (National Cancer Institute)



Peter L Choyke; MD (National Cancer Institute)","Catherine K Chow; MD (CC) 



David M Thomasson; PhD (CC)","Ordered by publication type and then author name.



1.
Thukral A, Thomasson DM, Chow CK, Eulate R, Wedam SB, Gupta SN, Wise BJ, Steinberg SM, Liewehr DJ, Choyke PL, Swain SM (2007). Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab--initial experience. Radiology  244, 727-35.   https://doi.org/10.1148/radiol.2443060926




PubMed


 


PubMed ID 17709827",https://intramural.nih.gov/search/searchview.taf?ipid=47068
635,SC010098-05,"October 01, 2006 -  September 30, 2007",The Evaluation of Novel Therapeutics for Genitourinary Malignancies,"William Laurence Dahut; MD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Lea  Latham



Marcia L Mulquin



Anna C Couvillon; NP



David D Draper",NULL,"Philip M Arlen; MD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



James L Gulley; MD, PhD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Aragon-Ching JB, Dahut WL (2007). Chemotherapy in Androgen-Independent Prostate Cancer (AIPC): What's next after taxane progression? Cancer Ther  5A, 151-160.




PubMed



        
     
Free Article


 


PubMed ID 17712400
         Pubmed Central ID 1950481 


 



2.
Arlen PM, Skarupa L, Pazdur M, Seetharam M, Tsang KY, Grosenbach DW, Feldman J, Poole DJ, Litzinger M, Steinberg SM, Jones E, Chen C, Marte J, Parnes H, Wright J, Dahut W, Schlom J, Gulley JL (2007). Clinical safety of a viral vector based prostate cancer vaccine strategy. J Urol  178, 1515-20.   https://doi.org/10.1016/j.juro.2007.05.117




PubMed


 


PubMed ID 17707059
    
     


 



3.
Figg WD, Li H, Sissung T, Retter A, Wu S, Gulley JL, Arlen P, Wright JJ, Parnes H, Fedenko K, Latham L, Steinberg SM, Jones E, Chen C, Dahut W (2007). Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer. BJU Int  99, 1047-55.   https://doi.org/10.1111/j.1464-410X.2007.06763.x




PubMed


 


PubMed ID 17437439
    
     


 



4.
Gulley JL, Dahut WL (2007). Future directions in tumor immunotherapy: CTLA4 blockade. Nat Clin Pract Oncol  4, 136-7.   https://doi.org/10.1038/ncponc0749




PubMed


 


PubMed ID 17327854
    
     


 



5.
Hamada A, Danesi R, Price DK, Sissung T, Chau C, Venzon D, Sparreboom A, Dahut WL, Figg WD (2007). Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent prostate cancer. Urology  70, 217-20.   https://doi.org/10.1016/j.urology.2007.06.1097




PubMed



        
     
Free Article


 


PubMed ID 17826473
         Pubmed Central ID 1994899 


 



6.
Kong HH, Cowen EW, Azad NS, Dahut W, Gutierrez M, Turner ML (2007). Keratoacanthomas associated with sorafenib therapy. J Am Acad Dermatol  56, 171-2.   https://doi.org/10.1016/j.jaad.2006.10.032




PubMed



        
     
Free Article


 


PubMed ID 17190642
         Pubmed Central ID 1781060 


 



7.
Lakhani NJ, Sparreboom A, Xu X, Veenstra TD, Venitz J, Dahut WL, Figg WD (2007). Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol. J Pharm Sci  96, 1821-31.   https://doi.org/10.1002/jps.20837




PubMed


 


PubMed ID 17252610
    
     


 



8.
Srinivasan R, Armstrong AJ, Dahut W, George DJ (2007). Anti-angiogenic therapy in renal cell cancer. BJU Int  99, 1296-300.   https://doi.org/10.1111/j.1464-410X.2007.06834.x




PubMed


 


PubMed ID 17441927
    
     


 



9.
Theoret MR, Arlen PM, Pazdur M, Dahut WL, Schlom J, Gulley JL (2007). Phase I trial of an enhanced prostate-specific antigen-based vaccine and anti-CTLA-4 antibody in patients with metastatic androgen-independent prostate cancer. Clin Genitourin Cancer  5, 347-50.   https://doi.org/10.3816/CGC.2007.n.017




PubMed


 


PubMed ID 17645835
    
     


 



10.
Wu S, Dahut WL, Gulley JL (2007). The use of bisphosphonates in cancer patients. Acta Oncol  46, 581-91.   https://doi.org/10.1080/02841860701233435




PubMed


 


PubMed ID 17562434
    
     


 



11.
Wu SL, Jones E, Gulley JL, Arlen PM, Chen CC, Figg WD, Dahut WL (2007). Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone. BJU Int  99, 525-8.   https://doi.org/10.1111/j.1464-410X.2006.06654.x




PubMed


 


PubMed ID 17155971
    
     


 



12.
Zhu X, Wu S, Dahut WL, Parikh CR (2007). Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. Am J Kidney Dis  49, 186-93.   https://doi.org/10.1053/j.ajkd.2006.11.039




PubMed


 


PubMed ID 17261421",https://intramural.nih.gov/search/searchview.taf?ipid=50239
636,SC010100-08,"October 01, 2006 -  September 30, 2007",Molecular and Genetic Characterization of Human Gliomas to Identify New Targets,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",NULL,"Lauren  Abrey
(NABTC, NABTC)




Ken  Aldape
(NABTC, NABTC)




Gene  Barnett
(NABTT, NABTT)




Tracy  Batchelor
(NABTT, NABTT)




Mitchel  Berger
(Neurosurgery, University of California)




Darell  Bigner; NABTC
(NABTC)


Show all 49",Kevin A Camphausen; MD (Radiation Oncology Branch),"McDonald K Horne; MD (CC) 



John Anthony Butman; MD, PhD (CC) 



Joseph A Frank; MD, MS (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47069
637,SC010277-10,"October 01, 2006 -  September 30, 2007",Chemokines in Skin Immune Cell Trafficking & Cancer Progression,"Sam  Hwang; MD, PhD",NULL,"Dermatology Branch, NCI","Lei  Fang



Anke Susanne Lonsdorf



Vivian C Lee



Hiroshi  Mitsui",NULL,"Douglas  Palmer (National Cancer Institute)



Chyi-Chia Richard Lee (National Cancer Institute)



Gordon  Whiteley (National Cancer Institute)



Nicholas Phillip Restifo; MD (National Cancer Institute)



Mark  Udey; MD (National Cancer Institute)



Wolfgang W Leitner; MS, PhD (National Cancer Institute)",Joshua  Farber; MD (NIAID),"Ordered by publication type and then author name.



1.
Kakinuma T, Nadiminti H, Lonsdorf AS, Murakami T, Perez BA, Kobayashi H, Finkelstein SE, Pothiawala G, Belkaid Y, Hwang ST (2007). Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary location. Cancer Immunol Immunother  56, 1119-31.   https://doi.org/10.1007/s00262-006-0253-4




PubMed


 


PubMed ID 17139493",https://intramural.nih.gov/search/searchview.taf?ipid=47070
638,SC010281-10,"October 01, 2006 -  September 30, 2007",Biology and Therapy of T Cell Depletion,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI","Hua  Zhang



Martin  Guimond



Aviva  Krauss



Christian  Capitini



Yongzhi  Cui; MD



Meghaan  Walsh



Show all 7","Bruce  Blazar
(Department of Pediatrics, University of Minnesota)




Francesca  Chiodi; PhD
(Microbiology-Tumor Biology, Karolinska)","Terry J Fry (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Claude  Sportes (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)



Alan S Wayne; MD (National Cancer Institute)","Daniel C Douek; MD (NIAID) 



Elizabeth J Read; MD (CC)","Ordered by publication type and then author name.



1.
Capitini CM, Cooper LJ, Egeler RM, Handgretinger R, Locatelli F, Sondel PM, Mackall CL (2009). Highlights of the First International ""Immunotherapy in Pediatric Oncology: Progress and Challenges"" Meeting. J Pediatr Hematol Oncol  31, 227-44.   https://doi.org/10.1097/MPH.0b013e31819a5d8d




PubMed



        
     
Free Article


 


PubMed ID 19346873
         Pubmed Central ID 2714285 


 



2.
Fluur C, De Milito A, Fry TJ, Vivar N, Eidsmo L, Atlas A, Federici C, Matarrese P, Logozzi M, Rajnavölgyi E, Mackall CL, Fais S, Chiodi F, Rethi B (2007). Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection. J Immunol  178, 5340-50.   https://doi.org/10.4049/jimmunol.178.8.5340




PubMed


 


PubMed ID 17404319
    
     


 



3.
Guimond M, Veenstra RG, Grindler DJ, Zhang H, Cui Y, Murphy RD, Kim SY, Na R, Hennighausen L, Kurtulus S, Erman B, Matzinger P, Merchant MS, Mackall CL (2009). Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Nat Immunol  10, 149-57.   https://doi.org/10.1038/ni.1695




PubMed



        
     
Free Article


 


PubMed ID 19136960
         Pubmed Central ID 2713006 


 



4.
Hazra R, Jankelevich S, Mackall CL, Avila NA, Wolters P, Civitello L, Christensen B, Jacobsen F, Steinberg SM, Yarchoan R (2007). Immunologic, virologic, and neuropsychologic responses in human immunodeficiency virus-infected children receiving their first highly active antiretroviral therapy regimen. Viral Immunol  20, 131-41.   https://doi.org/10.1089/vim.2006.0079




PubMed


 


PubMed ID 17425427
    
     


 



5.
Merchant MS, Melchionda F, Sinha M, Khanna C, Helman L, Mackall CL (2007). Immune reconstitution prevents metastatic recurrence of murine osteosarcoma. Cancer Immunol Immunother  56, 1037-46.   https://doi.org/10.1007/s00262-006-0257-0




PubMed


 


PubMed ID 17149595",https://intramural.nih.gov/search/searchview.taf?ipid=47072
639,SC010282-10,"October 01, 2006 -  September 30, 2007",Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),Diane Carol Arthur; MD,NULL,"Laboratory of Pathology, NCI",Alexander Cm Smith,NULL,"Wyndham H Wilson; MD, PhD (National Cancer Institute)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Michael R Bishop; MD (National Cancer Institute)



Daniel H Fowler (National Cancer Institute)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)



Neil Edward Caporaso; MS, MD (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47073
640,SC010288-10,"October 01, 2006 -  September 30, 2007",Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI","J  Foley



Jacopo  Mariotti



Shoba M Amarnath","Carl  June
(Abramson Family Cancer Research Institute, University of Penn)




Carl  June
(Abramson Family Cancer Research Institute, University of Penn)




Bruce  Levine
(Abramson Family Cancer Research Center, University of Pennsylvania)","Ronald E Gress; MD (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Steven  Pavletic; MD, MS (National Cancer Institute)



Frances  Hakim; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hardy NM, Hakim F, Steinberg SM, Krumlauf M, Cvitkovic R, Babb R, Odom J, Fowler DH, Gress RE, Bishop MR (2007). Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation. Biol Blood Marrow Transplant  13, 1022-30.   https://doi.org/10.1016/j.bbmt.2007.05.008




PubMed



        
     
Free Article


 


PubMed ID 17697964
         Pubmed Central ID 2699412 


 



2.
Imanguli MM, Atkinson JC, Harvey KE, Hoehn GT, Ryu OH, Wu T, Kingman A, Barrett AJ, Bishop MR, Childs RW, Fowler DH, Pavletic SZ, Hart TC (2007). Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation. Exp Hematol  35, 184-92.   https://doi.org/10.1016/j.exphem.2006.10.009




PubMed



        
     
Free Article


 


PubMed ID 17258067
         Pubmed Central ID 1832107 


 



3.
Liang SB, Yoshimitsu M, Poeppl A, Rasaiah VI, Cai J, Fowler DH, Medin JA (2007). Multiple reduced-intensity conditioning regimens facilitate correction of Fabry mice after transplantation of transduced cells. Mol Ther  15, 618-27.   https://doi.org/10.1038/sj.mt.6300075




PubMed


 


PubMed ID 17228315
    
     


 



4.
Sato T, Neschadim A, Konrad M, Fowler DH, Lavie A, Medin JA (2007). Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy. Mol Ther  15, 962-70.   https://doi.org/10.1038/mt.sj.6300122




PubMed


 


PubMed ID 17375075
    
     


 



5.
Snyder JT, Shen J, Azmi H, Hou J, Fowler DH, Ragheb JA (2007). Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1/Th2 cytokine production. Blood  109, 5399-406.   https://doi.org/10.1182/blood-2006-12-062943




PubMed



        
     
Free Article


 


PubMed ID 17344465
         Pubmed Central ID 1890831 


 



6.
Subramaniam DS, Fowler DH, Pavletic SZ (2007). Chronic graft-versus-host disease in the era of reduced-intensity conditioning. Leukemia  21, 853-9.   https://doi.org/10.1038/sj.leu.2404642




PubMed


 


PubMed ID 17377592",https://intramural.nih.gov/search/searchview.taf?ipid=47074
641,SC010289-09,"October 01, 2006 -  September 30, 2007",Immunobiology and Immunotherapy of Pediatric Tumors,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI","Hua  Zhang



Aviva  Krauss



Christian  Capitini



Meghaan  Walsh



Jessica  Davis","Nai-Kong  Cheung
(Memorial Sloan Kettering Cancer Center)




Carl  June
(Abramson Cancer Center, University of Pennsylvania)




Hans  Kontny
(NCI)




Melinda S Merchant





Robert  Vonderheide
(UNIVERSITY OF PENNSYLVANIA)","Lee Jay Helman; MD (National Cancer Institute)



Terry J Fry (National Cancer Institute)



Javed  Khan; MD (National Cancer Institute)



Carol J Thiele (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Maria  Tsokos; MD (National Cancer Institute)",Elizabeth J Read; MD (CC),"Ordered by publication type and then author name.



1.
Capitini CM, Cooper LJ, Egeler RM, Handgretinger R, Locatelli F, Sondel PM, Mackall CL (2009). Highlights of the First International ""Immunotherapy in Pediatric Oncology: Progress and Challenges"" Meeting. J Pediatr Hematol Oncol  31, 227-44.   https://doi.org/10.1097/MPH.0b013e31819a5d8d




PubMed



        
     
Free Article


 


PubMed ID 19346873
         Pubmed Central ID 2714285 


 



2.
Lissat A, Vraetz T, Tsokos M, Klein R, Braun M, Koutelia N, Fisch P, Romero ME, Long L, Noellke P, Mackall CL, Niemeyer CM, Kontny U (2007). Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity. Am J Pathol  170, 1917-30.   https://doi.org/10.2353/ajpath.2007.060993




PubMed



        
     
Free Article


 


PubMed ID 17525260
         Pubmed Central ID 1899433 


 



3.
Mackall C, Snyder K, Suhoski M, Maus M, Kapoor V, June C   (2007) 4-1BB is Superior to CD28 Costimulation for Generating CD8+ Cytotoxic Lymphocytes for Adoptive Immunotherapy.  Journal of Immunology, in press.




 



4.
Mansky P, Arai A, Stratton P, Bernstein D, Long L, Reynolds J, Chen D, Steinberg SM, Lavende N, Hoffman K, Nathan PC, Parks R, Augustine E, Chaudhry U, Derdak J, Wiener L, Gerber L, Mackall C (2007). Treatment late effects in long-term survivors of pediatric sarcoma. Pediatr Blood Cancer  48, 192-9.   https://doi.org/10.1002/pbc.20871




PubMed


 


PubMed ID 16642490
    
     


 



5.
Merchant MS, Melchionda F, Sinha M, Khanna C, Helman L, Mackall CL (2007). Immune reconstitution prevents metastatic recurrence of murine osteosarcoma. Cancer Immunol Immunother  56, 1037-46.   https://doi.org/10.1007/s00262-006-0257-0




PubMed


 


PubMed ID 17149595
    
     


 



6.
Paz-Priel I, Long L, Helman LJ, Mackall CL, Wayne AS (2007). Thromboembolic events in children and young adults with pediatric sarcoma. J Clin Oncol  25, 1519-24.   https://doi.org/10.1200/JCO.2006.06.9930




PubMed


 


PubMed ID 17442994
    
     


 



7.
Snyder KM, Mackall CL (2007). Therapy for metastatic ESFT: is it time to ask new questions? Pediatr Blood Cancer  49, 115-6.   https://doi.org/10.1002/pbc.21238




PubMed


 


PubMed ID 17474114",https://intramural.nih.gov/search/searchview.taf?ipid=47075
642,SC010292-09,"October 01, 2006 -  September 30, 2007",Identification and regulation of signal transduction pathways that promote survi,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI","Chunyu  Zhang



Joell J Gills



Courtney A Granville



Wei  Han","Vali  Egilsson
(Pathology, University of Iceland)




William  Travis
(Pathology, Memorial Sloan Kettering Cancer Center)




William  Travis
(Pathology, Memorial Sloan Kettering Cancer Center)","Ilona  Linnoila; MD (National Cancer Institute)



Stephen M Hewitt; MD, PhD (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Joanna H Shih (National Cancer Institute)



Frederic  Kaye; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Granville CA, Warfel N, Tsurutani J, Hollander MC, Robertson M, Fox SD, Veenstra TD, Issaq HJ, Linnoila RI, Dennis PA (2007). Identification of a highly effective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumors. Clin Cancer Res  13, 2281-9.   https://doi.org/10.1158/1078-0432.CCR-06-2570




PubMed


 


PubMed ID 17404113
    
     


 



2.
Lipkowitz S, Dennis PA (2007). PPARgamma agonists follow an unknown TRAIL in lung cancer. Cancer Biol Ther  6, 107-9.   https://doi.org/10.4161/cbt.6.1.3751




PubMed


 


PubMed ID 17224637
    
     


 



3.
Lopiccolo J, Ballas MS, Dennis PA (2007). PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug development. Crit Rev Oncol Hematol  63, 203-14.   https://doi.org/10.1016/j.critrevonc.2007.06.002




PubMed


 


PubMed ID 17643312
    
     


 



4.
LoPiccolo J, Granville CA, Gills JJ, Dennis PA (2007). Targeting Akt in cancer therapy. Anticancer Drugs  18, 861-74.   https://doi.org/10.1097/CAD.0b013e3280cc2c6f




PubMed


 


PubMed ID 17667591
    
     


 



5.
Tsurutani J, Steinberg SM, Ballas M, Robertson M, LoPiccolo J, Soda H, Kohno S, Egilsson V, Dennis PA (2007). Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma. Lung Cancer  55, 115-21.   https://doi.org/10.1016/j.lungcan.2006.09.026




PubMed



        
     
Free Article


 


PubMed ID 17097759
         Pubmed Central ID 1847612",https://intramural.nih.gov/search/searchview.taf?ipid=47076
643,SC010353-08,"October 01, 2006 -  September 30, 2007",Experimental Therapeutics of Pediatric Hematopoietic Malignancies,Alan S Wayne; MD,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Cynthia P Love



Kristin  Baird","Robert  Arceci
(Pediatric Hematology-Oncology, Johns Hopkins University)




Civin  Curt
(Pediatric Oncology, Johns Hopkins University)




Harry  Findley
(Pediatric Hematology-Oncology, Emory University/AFLAC Cancer Center)




Glen  Lew
(Pediatric Hematology-Oncology, Emory University/AFLAC Cancer Center)




David  Loeb
(Pediatric Hematology-Oncology, Johns Hopkins University)","Michael R Bishop; MD (National Cancer Institute)



Nealapheur L Khan (National Cancer Institute)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)



Diane Carol Arthur; MD (National Cancer Institute)



Ira H Pastan; MD (National Cancer Institute)



Robert J Kreitman; MD, PhD (National Cancer Institute)","Austin John Barrett; MD (NHLBI) 



Charles  Bolan; BS, MS, MD (CC) 



Roger  Kurlander; MD (CC) 



Susan  Leitman; MD (CC) 



Katayoun  Rezvani; MD, PhD (NHLBI) 



Hanh M Khuu; MD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47080
644,SC010354-08,"October 01, 2006 -  September 30, 2007",Clinical Development of Novel Drugs for Children with Refractory Cancers,"Brigitte  Widemann; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Aerang  Kim



Eva  Dombi","Peter Charles Adamson; MD





Robert  Arceci
(Pediatric Oncology, Johns Hopkins)




Larry  Baker
(Oncology, SARC)




Susan  Blaney
(Pediatric Oncology, Texas Children's Cancer Center)




Robert  Castleberry
(Pediatrics, University of Alabama)




Stewart  Goldman
(Pediatric Oncology, Children's Memorial Hospital)


Show all 13","Antonio  Fojo; MD, PhD (National Cancer Institute)



Katherine Elizabeth Warren; MD (National Cancer Institute)



Pamela  Wolters (National Cancer Institute)



Karlyne M Reilly; BS, PhD (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)","Jeffrey M Solomon; BS, MS, PhD (CC) 



Ann M Cohen-Berger; MD (CC) 



Nicholas  Patronas; MD (CC) 



Daniel L Handel (CC) 



Clara Chi Chen; MD (CC) 



James C Reynolds; MD (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47081
645,SC010355-08,"October 01, 2006 -  September 30, 2007",Angiogenesis and Tumor Growth,"Giovanna  Tosato; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI",NULL,NULL,"Peter L Choyke; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)



Robert  Yarchoan; MD (National Cancer Institute)



David A Davis; MD (National Cancer Institute)","Dragan  Maric; PhD (NINDS) 



Jinfang  Zhu; PhD (NIAID) 



Joshua  Farber; MD (NIAID) 



Henry M. Fales; PhD (NHLBI)","Ordered by publication type and then author name.



1.
Huegel R, Velasco P, De la Luz Sierra M, Christophers E, Schröder JM, Schwarz T, Tosato G, Lange-Asschenfeldt B (2007). Novel anti-inflammatory properties of the angiogenesis inhibitor vasostatin. J Invest Dermatol  127, 65-74.   https://doi.org/10.1038/sj.jid.5700484




PubMed


 


PubMed ID 16888632
    
     


 



2.
Nakayama T, Mutsuga N, Tosato G (2007). FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc. Blood  109, 1363-72.   https://doi.org/10.1182/blood-2006-06-028217




PubMed



        
     
Free Article


 


PubMed ID 17077327
         Pubmed Central ID 1794071 


 



3.
Narazaki M, Tosato G (submitted in 2007) Induced Internalization Of Surface Receptors. Patent issued: 8,420,620 (US in 2013). Patents pending: 13/862,929 (US application); 09704018.2 (EP application); PCT/US2009/031865 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=47082
646,SC010356-08,"October 01, 2006 -  September 30, 2007",A Role for KSHV in the Pathogenesis of Malignancies,"Giovanna  Tosato; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Maria N Labo



Paola  Gasperini



Taeko  Ishii



Peter J Mccormick",NULL,"Stefania  Pittaluga (National Cancer Institute)



Robert  Yarchoan; MD (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)



Richard  Little; MD, PhD (National Cancer Institute)



David A Davis; MD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)","Joshua  Farber; MD (NIAID) 



Henry M. Fales; PhD (NHLBI)","Ordered by publication type and then author name.



1.
Aoki Y, Tosato G (2007). Interactions between HIV-1 Tat and KSHV. Curr Top Microbiol Immunol  312, 309-26.   https://doi.org/10.1007/978-3-540-34344-8_12




PubMed


 


PubMed ID 17089803",https://intramural.nih.gov/search/searchview.taf?ipid=47083
647,SC010357-08,"October 01, 2006 -  September 30, 2007",Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"Zhi Ming  Zheng; MD, PhD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI","Vladimir  Majerciak



Rong  Jia



Xiaohong  Wang","Elliot  Androphy
(Medicine, University of Massachusetts Medical School)




Louise T Chow





David  Lukac
(UMDNJ)




Craig  Meyers
(Microbiology and Immunology, Penn State University College of Medicine)




Janet  Rader
(Gynercology, Washington University)




Rolf  Renne
(Case Western Reserave University, Cleveland, OH)","Robert  Yarchoan; MD (National Cancer Institute)



Michael John Kruhlak; PhD (National Cancer Institute)



Barbara K Felber (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)",John Philip McCoy (NHLBI),"Ordered by publication type and then author name.



1.
Majerciak V, Pripuzova N, McCoy JP, Gao SJ, Zheng ZM (2007). Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus. J Virol  81, 1062-71.   https://doi.org/10.1128/JVI.01558-06




PubMed



        
     
Free Article


 


PubMed ID 17108026
         Pubmed Central ID 1797518",https://intramural.nih.gov/search/searchview.taf?ipid=47084
648,SC010364-07,"October 01, 2006 -  September 30, 2007",Tissue Microarray Design and Development for Novel Gene and Gene Product Screeni,"David Erwin Kleiner; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Stephen M Hewitt; MD, PhD",NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)



Philip  Taylor; MD, ScD (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



Nealapheur L Khan (National Cancer Institute)



Javed  Khan; MD (National Cancer Institute)



Mark E Sherman; MD (National Cancer Institute)","Ira W Levin; PhD (NIDDK) 



Robert  Star; MD (NIDDK)","Ordered by publication type and then author name.



1.
Ashktorab H, Daremipouran M, Wilson M, Siddiqi S, Lee EL, Rakhshani N, Malekzadeh R, Johnson AC, Hewitt SM, Smoot DT (2007). Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer. Am J Gastroenterol  102, 2135-46.   https://doi.org/10.1111/j.1572-0241.2007.01400.x




PubMed


 


PubMed ID 17617207
    
     


 



2.
Bruce B, Khanna G, Ren L, Landberg G, Jirström K, Powell C, Borczuk A, Keller ET, Wojno KJ, Meltzer P, Baird K, McClatchey A, Bretscher A, Hewitt SM, Khanna C (2007). Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis  24, 69-78.   https://doi.org/10.1007/s10585-006-9050-x




PubMed


 


PubMed ID 17370041
    
     


 



3.
Chung JY, Braunschweig T, Tuttle K, Hewitt SM (2007). Tissue microarrays as a platform for proteomic investigation. J Mol Histol  38, 123-8.   https://doi.org/10.1007/s10735-006-9049-2




PubMed


 


PubMed ID 16953460
    
     


 



4.
Evans A, Bates V, Troy H, Hewitt S, Holbeck S, Chung YL, Phillips R, Stubbs M, Griffiths J, Airley R (2008). Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. Cancer Chemother Pharmacol  61, 377-93.   https://doi.org/10.1007/s00280-007-0480-1




PubMed


 


PubMed ID 17520257
    
     


 



5.
Fukuoka J, Dracheva T, Shih JH, Hewitt SM, Fujii T, Kishor A, Mann F, Shilo K, Franks TJ, Travis WD, Jen J (2007). Desmoglein 3 as a prognostic factor in lung cancer. Hum Pathol  38, 276-83.   https://doi.org/10.1016/j.humpath.2006.08.006




PubMed


 


PubMed ID 17084439
    
     


 



6.
Gannot G, Tangrea MA, Erickson HS, Pinto PA, Hewitt SM, Chuaqui RF, Gillespie JW, Emmert-Buck MR (2007). Layered peptide array for multiplex immunohistochemistry. J Mol Diagn  9, 297-304.   https://doi.org/10.2353/jmoldx.2007.060143




PubMed



        
     
Free Article


 


PubMed ID 17591928
         Pubmed Central ID 1899424 


 



7.
Goldstein NS, Hewitt SM, Taylor CR, Yaziji H, Hicks DG, Members of Ad-Hoc Committee On Immunohistochemistry Standardization (2007) Recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morphol 15:124-33.




PubMed


 


PubMed ID 17525622
    
     


 



8.
Molinolo AA, Hewitt SM, Amornphimoltham P, Keelawat S, Rangdaeng S, Meneses García A, Raimondi AR, Jufe R, Itoiz M, Gao Y, Saranath D, Kaleebi GS, Yoo GH, Leak L, Myers EM, Shintani S, Wong D, Massey HD, Yeudall WA, Lonardo F, Ensley J, Gutkind JS (2007). Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res  13, 4964-73.   https://doi.org/10.1158/1078-0432.CCR-07-1041




PubMed


 


PubMed ID 17785546
    
     


 



9.
Sherman ME, Rimm DL, Yang XR, Chatterjee N, Brinton LA, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, Kalaylioglu Z, Harigopal M, Charrette L, Falk RT, Richesson D, Anderson WF, Hewitt SM, García-Closas M (2007). Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis. Int J Cancer  121, 1079-85.   https://doi.org/10.1002/ijc.22812




PubMed


 


PubMed ID 17487843
    
     


 



10.
Takikita M, Chung JY, Hewitt SM (2007). Tissue microarrays enabling high-throughput molecular pathology. Curr Opin Biotechnol  18, 318-25.   https://doi.org/10.1016/j.copbio.2007.05.007




PubMed


 


PubMed ID 17643281
    
     


 



11.
Traicoff JL, Chung JY, Braunschweig T, Mazo I, Shu Y, Ramesh A, D'Amico MW, Galperin MM, Knezevic V, Hewitt SM   (2007) Expression of EIF3-p48/INT6, TID1 and Patched in cancer, a profiling of multiple tumor types and correlation of expression.  J Biomed Sci 14:395-405.




PubMed


 


PubMed ID 17385060
    
     


 



12.
Whiteford CC, Bilke S, Greer BT, Chen Q, Braunschweig TA, Cenacchi N, Wei JS, Smith MA, Houghton P, Morton C, Reynolds CP, Lock R, Gorlick R, Khanna C, Thiele CJ, Takikita M, Catchpoole D, Hewitt SM, Khan J (2007). Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis. Cancer Res  67, 32-40.   https://doi.org/10.1158/0008-5472.CAN-06-0610




PubMed


 


PubMed ID 17210681
    
     


 



13.
Yang SX, Hewitt SM, Steinberg SM, Liewehr DJ, Swain SM (2007). Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray. Oncol Rep  17, 281-7.




PubMed


 


PubMed ID 17203162
    
     


 



14.
Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, García-Closas M (2007). Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev  16, 439-43.   https://doi.org/10.1158/1055-9965.EPI-06-0806




PubMed


 


PubMed ID 17372238",https://intramural.nih.gov/search/searchview.taf?ipid=47016
649,SC010365-08,"October 01, 2006 -  September 30, 2007",Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Sergio  Giralt
(M.D. ANDERSON CANCER CENTER)




Carl  June
(University of Pennsylvania)




Carl  June
(University of Pennsylvania)




Larry  Kwak
(NCI)




Sattva  Neelapu
(M.D. ANDERSON CANCER CENTER)","Daniel H Fowler (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47086
650,SC010366-07,"October 01, 2006 -  September 30, 2007",Identification of Genes for Predicting Prognosis in Pediatric Cancers,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Jun S Wei



Young K Song



Patricia S Tsang; PhD","Peter  Ambros
(Children’s Cancer Research Institute)




John  Maris
(Pharmacology, Children's Hospital of Philadelphia)




Andrew  Pearson
(Paediatric Section, Institute of Cancer Research)




Manfred  Schwab
(Division Tumour Genetics, German Cancer Research Center)",Carol J Thiele (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Catchpoole D, Lail A, Guo D, Chen QR, Khan J (2007). Gene expression profiles that segregate patients with childhood acute lymphoblastic leukaemia: an independent validation study identifies that endoglin associates with patient outcome. Leuk Res  31, 1741-7.   https://doi.org/10.1016/j.leukres.2007.04.021




PubMed


 


PubMed ID 17572488
    
     


 



2.
Westermann F, Henrich KO, Wei JS, Lutz W, Fischer M, König R, Wiedemeyer R, Ehemann V, Brors B, Ernestus K, Leuschner I, Benner A, Khan J, Schwab M (2007). High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status. Clin Cancer Res  13, 4695-703.   https://doi.org/10.1158/1078-0432.CCR-06-2818




PubMed


 


PubMed ID 17652624",https://intramural.nih.gov/search/searchview.taf?ipid=47087
651,SC010367-07,"October 01, 2006 -  September 30, 2007",Regulation of the cell cycle by cyclin-dependent kinases,Philipp  Kaldis; PhD,NULL,"Mouse Cancer Genetics Program, NCI",NULL,"Hiroaki  Kiyokawa
(Molecular Pharmacology and Biological Chemistry, Northwestern University The Feinberg School of Medicine)




Keiichi  Nakayama
(Molecular and Cellular Biology, Division of Cell Biology, Kyushu University)




Neil  Segil
(Cell and Molecular Biology, House Ear Institute)",Jonathan  Keller; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Berthet C, Kaldis P (2007). Cell-specific responses to loss of cyclin-dependent kinases. Oncogene  26, 4469-77.   https://doi.org/10.1038/sj.onc.1210243




PubMed


 


PubMed ID 17297466
    
     


 



2.
Berthet C, Rodriguez-Galan MC, Hodge DL, Gooya J, Pascal V, Young HA, Keller J, Bosselut R, Kaldis P (2007). Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2. Mol Cell Biol  27, 5079-89.   https://doi.org/10.1128/MCB.00029-07




PubMed



        
     
Free Article


 


PubMed ID 17485443
         Pubmed Central ID 1951952 


 



3.
Geng Y, Lee YM, Welcker M, Swanger J, Zagozdzon A, Winer JD, Roberts JM, Kaldis P, Clurman BE, Sicinski P (2007). Kinase-independent function of cyclin E. Mol Cell  25, 127-39.   https://doi.org/10.1016/j.molcel.2006.11.029




PubMed


 


PubMed ID 17218276
    
     


 



4.
Gopinathan L, Tan SL, Padmakumar VC, Coppola V, Tessarollo L, Kaldis P (2014). Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis. Cancer Res  74, 3870-9.   https://doi.org/10.1158/0008-5472.CAN-13-3440




PubMed



        
     
Free Article


 


PubMed ID 24802190
         Pubmed Central ID 4102624 


 



5.
Kaldis P (2007). Another piece of the p27Kip1 puzzle. Cell  128, 241-4.   https://doi.org/10.1016/j.cell.2007.01.006




PubMed


 


PubMed ID 17254963
    
     


 



6.
Kotoshiba S, Gopinathan L, Pfeiffenberger E, Rahim A, Vardy LA, Nakayama K, Nakayama KI, Kaldis P (2014). p27 is regulated independently of Skp2 in the absence of Cdk2. Biochim Biophys Acta  1843, 436-45.   https://doi.org/10.1016/j.bbamcr.2013.11.005




PubMed



        
     
Free Article


 


PubMed ID 24269842
         Pubmed Central ID 3915056 


 



7.
Mikule K, Delaval B, Kaldis P, Jurcyzk A, Hergert P, Doxsey S (2007). Loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrest. Nat Cell Biol  9, 160-70.   https://doi.org/10.1038/ncb1529




PubMed


 


PubMed ID 17330329
    
     


 



8.
Rajareddy S, Reddy P, Du C, Liu L, Jagarlamudi K, Tang W, Shen Y, Berthet C, Peng SL, Kaldis P, Liu K   (2007) p27kip1 (cyclin-dependent kinase inhibitor 1B) controls ovarian development by suppressing follicle endowment and activation and promoting follicle atresia in mice.  Mol Endocrinol 21:2189-202.




PubMed


 


PubMed ID 17565040
    
     


 



9.
Satyanarayana A, Berthet C, Lopez-Molina J, Coppola V, Tessarollo L, Kaldis P (2008). Genetic substitution of Cdk1 by Cdk2 leads to embryonic lethality and loss of meiotic function of Cdk2. Development  135, 3389-400.   https://doi.org/10.1242/dev.024919




PubMed



        
     
Free Article


 


PubMed ID 18787066
         Pubmed Central ID 2668819",https://intramural.nih.gov/search/searchview.taf?ipid=47088
652,SC010368-07,"October 01, 2006 -  September 30, 2007",Targeting the Tumor Vasculature to Treat Cancer,Steven  Libutti; MD,NULL,"Surgery Branch, NCI","Dominique  Lorang; PhD



Anita T Tandle



Geoffrey D Seidel



Mei  He



Michael  Tangrea



Yvonne  Shutack



Show all 17","Wadih  Arap





Renata  Pasqualini
(Urology, MD Anderson)




David  Stirling
(R&D, Celgene Corporation)




Lawrence  Tamarkin
(President, Cytimmune Sciences)","Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)



William G Stetler-Stevenson; MD, PhD (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Blansfield JA, Choyke L, Morita SY, Choyke PL, Pingpank JF, Alexander HR, Seidel G, Shutack Y, Yuldasheva N, Eugeni M, Bartlett DL, Glenn GM, Middelton L, Linehan WM, Libutti SK (2007). Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery  142, 814-8; discussion 818.e1-2.   https://doi.org/10.1016/j.surg.2007.09.012




PubMed



        
     
Free Article


 


PubMed ID 18063061
         Pubmed Central ID 6771023 


 



2.
Dromi S, Frenkel V, Luk A, Traughber B, Angstadt M, Bur M, Poff J, Xie J, Libutti SK, Li KC, Wood BJ (2007). Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res  13, 2722-7.   https://doi.org/10.1158/1078-0432.CCR-06-2443




PubMed



        
     
Free Article


 


PubMed ID 17473205
         Pubmed Central ID 2555974 


 



3.
He M, Mangiameli DP, Kachala S, Hunter K, Gillespie J, Bian X, Shen HC, Libutti SK (2010). Expression signature developed from a complex series of mouse models accurately predicts human breast cancer survival. Clin Cancer Res  16, 249-59.   https://doi.org/10.1158/1078-0432.CCR-09-1602




PubMed



        
     
Free Article


 


PubMed ID 20028755
         Pubmed Central ID 2866744 


 



4.
He M, Rosen J, Mangiameli D, Libutti SK (2007). Cancer development and progression. Adv Exp Med Biol  593, 117-33.   https://doi.org/10.1007/978-0-387-39978-2_12




PubMed


 


PubMed ID 17265722
    
     


 



5.
Libutti SK, Paciotti GF, Byrnes AA, Alexander HR, Gannon WE, Walker M, Seidel GD, Yuldasheva N, Tamarkin L (2010). Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res  16, 6139-49.   https://doi.org/10.1158/1078-0432.CCR-10-0978




PubMed



        
     
Free Article


 


PubMed ID 20876255
         Pubmed Central ID 3004980 


 



6.
Mangiameli DP, Blansfield JA, Kachala S, Lorang D, Schafer PH, Muller GW, Stirling DI, Libutti SK (2007). Combination therapy targeting the tumor microenvironment is effective in a model of human ocular melanoma. J Transl Med  5, 38.   https://doi.org/10.1186/1479-5876-5-38




PubMed



        
     
Free Article


 


PubMed ID 17640369
         Pubmed Central ID 1941722 


 



7.
Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, Richardson AM, Pinto PA, Linehan WM, Gillespie JW, Merino MJ, Libutti SK, Woodson KG, Emmert-Buck MR, Chuaqui RF (2007). Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol  211, 410-9.   https://doi.org/10.1002/path.2133




PubMed


 


PubMed ID 17278115
    
     


 



8.
Teo BK, Seo Y, Bacharach SL, Carrasquillo JA, Libutti SK, Shukla H, Hasegawa BH, Hawkins RA, Franc BL (2007). Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med  48, 802-10.   https://doi.org/10.2967/jnumed.106.035576




PubMed


 


PubMed ID 17475970
    
     


 



9.
Wettschureck N, Lee E, Libutti SK, Offermanns S, Robey PG, Spiegel AM (2007). Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extracellular Ca2+ -sensing receptor. Mol Endocrinol  21, 274-80.   https://doi.org/10.1210/me.2006-0110




PubMed


 


PubMed ID 16988000
    
     


 



10.
Libutti S, Kwon M, Tandle A (submitted in 2007) Doc1 Compositions And Methods For Treating Cancer. Patents issued: 8,501,912 (US in 2013); 9,279,009 (US in 2016); 2268664 (EP in 2017); 2268664 (FR in 2017); 2268664 (GB in 2017); 2706317 (CA in 2017); 602008050435 (DE in 2017). Patents pending: PCT/IB2008/005015 (PC application); 15/058,116 (US application).




 



11.
Zeiger M, Libutti S, Prasad N, Umbricht C (submitted in 2007) Diagnostic Tool For Diagnosing Benign Versus Malignant Thyroid Lesions. Patent issued: 9,234,244 (US in 2016). Patent pending: PCT/US2008/010139 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=47089
653,SC010370-07,"October 01, 2006 -  September 30, 2007",Comparative Genomics of Genes Located on Chromosomes X and Y,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Shujin  Luo



Warren  Johnson



Jill  Slattery



Marilyn  Raymond; PhD



Agostinho  Antunes; PhD



Nicole J Crumpler



Show all 12","Eduardo  Eizirik
(Biosciences Department, Pontifcia Universidade Catlica do Rio Grande do Sul)




Douglas U Smith",Robert H Stephens (National Cancer Institute),James Copeland Mullikin; PhD (NHGRI),"Ordered by publication type and then author name.



1.
Luo SJ, Johnson WE, David VA, Menotti-Raymond M, Stanyon R, Cai QX, Beck T, Yuhki N, Pecon-Slattery J, Smith JL, O'Brien SJ (2007). Development of Y chromosome intraspecific polymorphic markers in the Felidae. J Hered  98, 400-13.   https://doi.org/10.1093/jhered/esm063




PubMed


 


PubMed ID 17646273
    
     


 



2.
Murphy WJ, Davis B, David VA, Agarwala R, Schäffer AA, Pearks Wilkerson AJ, Neelam B, O'Brien SJ, Menotti-Raymond M (2007). A 1.5-Mb-resolution radiation hybrid map of the cat genome and comparative analysis with the canine and human genomes. Genomics  89, 189-96.   https://doi.org/10.1016/j.ygeno.2006.08.007




PubMed



        
     
Free Article


 


PubMed ID 16997530
         Pubmed Central ID 3760348 


 



3.
O'Brien S   (2007) The Evolution of the Cats.  Scientific American  68-75 pp.




 



4.
O'Brien S, Cai Q, David V, Zang L, Martelli P, Lim N, Ferrand N, Chin S, Gaubert P, Ramos M, Antunes A, Johnson W   (2007) Isolation and characterization of microsatellite markers in pangolins (Mammalia, Pholidota, Manis spp.).  Molecular Ecology Notes  269-272 pp.




 



5.
O'Brien S, Goodfellow P, Pearks-Wilkerson A, Johnson W, Pecon-Slattery J   (2007) Evolution of the male-determining gene SRY within the cat family Felidae.  Genetics  1855-1867 pp.




 



6.
O'Brien S, Mullikin J, Smith D, Agencourt Sequencing Team, Lindblad-Toh K, Gnerre S, Clamp M, Chang J, Stephens R, Neelam B, Volfovsky N, Schaffer A, Agarwala R, Narfstrom K, Murphy W, Giger U, Roca A, Antunes A, Menotti-Raymond M, Yuhki N, Pecon-Slattery J, Johnson W, Bourque G, Tesler G   (2007) The domestic cat genome sequence: annotation and comparative inferences.  Genome Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=47090
654,SC010371-07,"October 01, 2006 -  September 30, 2007",Mechanisms of Tumor Escape and Metastatic Development in Mouse Models of Experim,Scott  Abrams; PhD,NULL,"Laboratory of Tumor Immunology and Biology, NCI",NULL,"Kebin  Liu
(Biochemistry & Molecular Biology, Medical College of Georgia)




Kebin  Liu
(Biochemistry & Molecular Biology, Medical College of Georgia)




Michail  Sitkovsky
(New England Inflammation and Tissue Protection Institute, Northeastern University)




Michail  Sitkovsky
(New England Inflammation and Tissue Protection Institute, Northeastern University)","James W Hodge; PhD (National Cancer Institute)



Philip M Arlen; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)",Richard  Childs; MD (NHLBI),"Ordered by publication type and then author name.



1.
Stewart TJ, Liewehr DJ, Steinberg SM, Greeneltch KM, Abrams SI (2009). Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells. J Immunol  183, 117-28.   https://doi.org/10.4049/jimmunol.0804132




PubMed



        
     
Free Article


 


PubMed ID 19542426
         Pubmed Central ID 2744444",https://intramural.nih.gov/search/searchview.taf?ipid=47091
655,SC010372-07,"October 01, 2006 -  September 30, 2007",Molecular profiling of patients undergoing radiotherapy,"Kevin A Camphausen; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Mary T Sproull



Merriline M Satyamitra



Melissa  Kirk; BS



Shuping  Zhao",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47092
656,SC010373-07,"October 01, 2006 -  September 30, 2007",The synergy between radiotherapy and molecularly targeted agents,"Kevin A Camphausen; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Mary T Sproull



Tamalee  Scott



Merriline M Satyamitra



Pamela  Tulleners



Hyuk-Chan  Kwon



Shuping  Zhao",NULL,"Howard A Fine; MD, PhD (National Cancer Institute)



Patricia  Steeg; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Camphausen K, Tofilon PJ (2007). Inhibition of Hsp90: a multitarget approach to radiosensitization. Clin Cancer Res  13, 4326-30.   https://doi.org/10.1158/1078-0432.CCR-07-0632




PubMed


 


PubMed ID 17671112
    
     


 



2.
Seggewiss R, Loré K, Guenaga FJ, Pittaluga S, Mattapallil J, Chow CK, Koup RA, Camphausen K, Nason MC, Meier-Schellersheim M, Donahue RE, Blazar BR, Dunbar CE, Douek DC (2007). Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood  110, 441-9.   https://doi.org/10.1182/blood-2006-12-065623




PubMed



        
     
Free Article


 


PubMed ID 17374737
         Pubmed Central ID 1975851 


 



3.
Sharp HJ, Wansley EK, Garnett CT, Chakraborty M, Camphausen K, Schlom J, Hodge JW (2007). Synergistic antitumor activity of immune strategies combined with radiation. Front Biosci  12, 4900-10.   https://doi.org/10.2741/2436




PubMed


 


PubMed ID 17569618",https://intramural.nih.gov/search/searchview.taf?ipid=47093
657,SC010375-07,"October 01, 2006 -  September 30, 2007",Regulation of TAFI Activity by TAF7,"Dinah  Singer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Anne G M Gegonne Bosselut



Jocelyn D Weissman",NULL,John N Brady; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=47094
658,SC010376-07,"October 01, 2006 -  September 30, 2007",Molecular mechanism of TNF signaling and apoptosis,"Zhenggang  Liu; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Swati Suresh Choksi



Elena  Pobezinskaya



Hong Sug Kim",NULL,NULL,Chuxia  Deng; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Kim YS, Morgan MJ, Choksi S, Liu ZG (2007). TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell  26, 675-87.   https://doi.org/10.1016/j.molcel.2007.04.021




PubMed


 


PubMed ID 17560373
    
     


 



2.
Zhang D, Li J, Wu K, Ouyang W, Ding J, Liu ZG, Costa M, Huang C (2007). JNK1, but not JNK2, is required for COX-2 induction by nickel compounds. Carcinogenesis  28, 883-91.   https://doi.org/10.1093/carcin/bgl186




PubMed


 


PubMed ID 17065197
    
     


 



3.
Zhang S, Lin Y, Kim YS, Hande MP, Liu ZG, Shen HM (2007). c-Jun N-terminal kinase mediates hydrogen peroxide-induced cell death via sustained poly(ADP-ribose) polymerase-1 activation. Cell Death Differ  14, 1001-10.   https://doi.org/10.1038/sj.cdd.4402088




PubMed


 


PubMed ID 17218956",https://intramural.nih.gov/search/searchview.taf?ipid=47095
659,SC010378-07,"October 01, 2006 -  September 30, 2007",Activation of Proto-Oncogenes by Chromosomal Translocation,"Peter D Aplan; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Christopher  Slape



David L Caudell



Yang-Jo  Chung



Chul Won  Choi","Adolfo  Ferrando
(Genetics, Columbia U.)




Theresa  Hahn
(Medicine, Roswell Park Cancer Institute)




Trang  Hoang
(Immunology, U. Montreal)




Trang  Hoang
(Immunology, U. Montreal)




Christoph  Plass
(Genetics, Ohio State Univ.)




Armelle  Regnault
(Hematology, Hopital St. Louis)


Show all 7","John J Letterio; MD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



Linda  Wolff; PhD (National Cancer Institute)","Paul P. Liu; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Aplan P, Lin Y, Hartung H, Zhang Z, Wolff L   (2007) NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men.  Journal of the National Cancer Institute, in press.




 



2.
Caudell D, Zhang Z, Chung YJ, Aplan PD (2007). Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice. Cancer Res  67, 8022-31.   https://doi.org/10.1158/0008-5472.CAN-06-3749




PubMed



        
     
Free Article


 


PubMed ID 17804713
         Pubmed Central ID 1986634 


 



3.
Fasseu M, Aplan PD, Chopin M, Boissel N, Bories JC, Soulier J, von Boehmer H, Sigaux F, Regnault A (2007). p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis. Blood  110, 2610-9.   https://doi.org/10.1182/blood-2007-01-066209




PubMed



        
     
Free Article


 


PubMed ID 17507663
         Pubmed Central ID 1988920 


 



4.
Lin YW, Aplan PD (2007). Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets. Leukemia  21, 1276-84.   https://doi.org/10.1038/sj.leu.2404685




PubMed



        
     
Free Article


 


PubMed ID 17429429
         Pubmed Central ID 2063467 


 



5.
Oliansky DM, Rizzo JD, Aplan PD, Arceci RJ, Leone L, Ravindranath Y, Sanders JE, Smith FO, Wilmot F, McCarthy PL, Hahn T (2007). The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. Biol Blood Marrow Transplant  13, 1-25.   https://doi.org/10.1016/j.bbmt.2006.10.024




PubMed


 


PubMed ID 17222748
    
     


 



6.
Slape C, Chung YJ, Soloway PD, Tessarollo L, Aplan PD (2007). Mouse embryonic stem cells that express a NUP98-HOXD13 fusion protein are impaired in their ability to differentiate and can be complemented by BCR-ABL. Leukemia  21, 1239-48.   https://doi.org/10.1038/sj.leu.2404648




PubMed



        
     
Free Article


 


PubMed ID 17377591
         Pubmed Central ID 2063470 


 



7.
Slape C, Hartung H, Lin YW, Bies J, Wolff L, Aplan PD (2007). Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation. Cancer Res  67, 5148-55.   https://doi.org/10.1158/0008-5472.CAN-07-0075




PubMed



        
     
Free Article


 


PubMed ID 17545593
         Pubmed Central ID 1950322",https://intramural.nih.gov/search/searchview.taf?ipid=47096
660,SC010379-07,"October 01, 2006 -  September 30, 2007",Mechanisms of Chromosomal Translocation,"Peter D Aplan; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Zhenhua  Zhang



Yue  Cheng



David L Caudell",NULL,Andre A Nussenzweig; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Harper DP, Aplan PD (2008). Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects. Cancer Res  68, 10024-7.   https://doi.org/10.1158/0008-5472.CAN-08-2208




PubMed



        
     
Free Article


 


PubMed ID 19074864
         Pubmed Central ID 2614694",https://intramural.nih.gov/search/searchview.taf?ipid=47097
661,SC010384-07,"October 01, 2006 -  September 30, 2007",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,"Dennis D Hickstein



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Thomas R Bauer



Laura M Tuschong



Yuchen  Gu



Mehreen  Hai","Carlos  Barbas; PhD
(DepartmentMolec Biol, Scripps Research Inst)




Alan W Flake; MD
(Department of Surgery, Children's Hospital of Philadelphia)




David  Russell
(Hematology, University of Washington)",NULL,Harry Lewis Malech; MD (NIAID),"Ordered by publication type and then author name.



1.
Malech HL, Hickstein DD (2007). Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency. Curr Opin Hematol  14, 29-36.   https://doi.org/10.1097/00062752-200701000-00007




PubMed


 


PubMed ID 17133097",https://intramural.nih.gov/search/searchview.taf?ipid=47098
662,SC010385-08,"October 01, 2006 -  September 30, 2007",Molecular Classification of Human and Mouse Hepatocellular Carcinoma by Gene Exp,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Timothy V Benjamin



Elizabeth A Conner



Anita  Ton



Tanya N Hoang



Joe W Grisham



Cedric  Coulouarn



Show all 10","Ghassan  Abou-Alfa
(Gastrointestinal Medical Oncology, Memorial Sloan-Kettering Cancer Center)




Diego F Calvisi
(NCI)




Anthony  Demetris
(Transplantation Pathology, University of Pittsburgh Medical Center)




Jean–François  Dufour
(Clinical Pharmacology, University of Bern)




Nelson  Fausto
(Pathology, University of Washington School of Medicine)




Scott  Friedman
(Division of Liver Diseases, Mount Sinai School of Medicine)


Show all 10","Valentina  Factor (Cellular and Molecular Biology Section)



Curtis  Harris; MD (National Cancer Institute)



Douglas  Lowy; MD (National Cancer Institute)



Nicolae C Popescu; PhD (National Cancer Institute)



Frank Jess Gonzalez; PhD (National Cancer Institute)



Udai S Kammula (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kremer-Tal S, Narla G, Chen Y, Hod E, DiFeo A, Yea S, Lee JS, Schwartz M, Thung SN, Fiel IM, Banck M, Zimran E, Thorgeirsson SS, Mazzaferro V, Bruix J, Martignetti JA, Llovet JM, Friedman SL (2007). Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. J Hepatol  46, 645-54.   https://doi.org/10.1016/j.jhep.2006.10.012




PubMed



        
     
Free Article


 


PubMed ID 17196295
         Pubmed Central ID 3533246 


 



2.
Thorgeirsson S, Ladu S, Gorden A, Farina M, Lee J, Conner E, Schroeder I, Factor V   (2007) Molecular Pathogenesis of Human Hepatocellular Carcinoma: Mechanistic and Prognostic Significance of Aberrant Methylation.  Journal of Clinical Investigation, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=47099
663,SC010386-06,"October 01, 2006 -  September 30, 2007","Crystallographic Studies of Chemokines, Chemokine Receptors, and Related Protein",Jacek Tadeusz Lubkowski,NULL,"Macromolecular Crystallography Laboratory, NCI","Marzena E Pazgier



James L Gattis



Cyril  Barinka","Wuyuan  Lu
(Institute of Virology, University of Maryland)




Scott  Sieg
(Department of Biological Sciences, Case Western Reserve University)




Aaron  Weinberg
(Department of Biological Sciences, Case Western Reserve University)","Joost J Oppenheim; MD (National Cancer Institute)



Douglas  Lowy; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lubkowski J, Lu X, Lu W   (2007) Human defensins-structures, chemical synthesis and recombinant production.  Curr. Pharm. Des, in press.




 



2.
Wu Z, Li X, Ericksen B, de Leeuw E, Zou G, Zeng P, Xie C, Li C, Lubkowski J, Lu WY, Lu W (2007). Impact of pro segments on the folding and function of human neutrophil alpha-defensins. J Mol Biol  368, 537-49.   https://doi.org/10.1016/j.jmb.2007.02.040




PubMed



        
     
Free Article


 


PubMed ID 17355880
         Pubmed Central ID 2754399 


 



3.
Zou G, de Leeuw E, Li C, Pazgier M, Li C, Zeng P, Lu WY, Lubkowski J, Lu W (2007). Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs. J Biol Chem  282, 19653-65.   https://doi.org/10.1074/jbc.M611003200




PubMed


 


PubMed ID 17452329",https://intramural.nih.gov/search/searchview.taf?ipid=47100
664,SC010437-07,"October 01, 2006 -  September 30, 2007",Molecular Pathology of Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",NULL,NULL,"Steven  Libutti; MD (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)



Philip  Taylor; MD, ScD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Catena R, Muniz-Medina V, Moralejo B, Javierre B, Best CJ, Emmert-Buck MR, Green JE, Baker CC, Calvo A (2007). Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis. Int J Cancer  120, 2096-109.   https://doi.org/10.1002/ijc.22461




PubMed


 


PubMed ID 17278099
    
     


 



2.
Emmert-Buck M, Woodson K, Wang Y, Rodriguez-Canales J, Erickson H, Tangrea M, Novakovic K, Gonzales S, Velasco A, Kawasaki E, Chuaqui R, Player A   (2007) A Global Expression Analysis of Prostate Cancer Associated Stroma and Epithelia.  Diagn Mol Pathol, in press.




 



3.
Erickson HS, Albert PS, Gillespie JW, Wallis BS, Rodriguez-Canales J, Linehan WM, Gonzalez S, Velasco A, Chuaqui RF, Emmert-Buck MR (2007). Assessment of normalization strategies for quantitative RT-PCR using microdissected tissue samples. Lab Invest  87, 951-62.   https://doi.org/10.1038/labinvest.3700659




PubMed


 


PubMed ID 17643124
    
     


 



4.
Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, Richardson AM, Pinto PA, Linehan WM, Gillespie JW, Merino MJ, Libutti SK, Woodson KG, Emmert-Buck MR, Chuaqui RF (2007). Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol  211, 410-9.   https://doi.org/10.1002/path.2133




PubMed


 


PubMed ID 17278115",https://intramural.nih.gov/search/searchview.taf?ipid=47101
